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A B S T R A C T
Background
Tobacco smoking remains one of the few preventable factors associated with complications in pregnancy, and has serious long-term
implications for women and babies. Smoking in pregnancy is decreasing in high-income countries, but is strongly associated with
poverty and is increasing in low- to middle-income countries.
Objectives
To assess the effects of smoking cessation interventions during pregnancy on smoking behaviour and perinatal health outcomes.
Search methods
In this sixth update, we searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (13 November 2015), checked
reference lists of retrieved studies and contacted trial authors.
Selection criteria
Randomised controlled trials, cluster-randomised trials, and quasi-randomised controlled trials of psychosocial smoking cessation
interventions during pregnancy.
Data collection and analysis
Two review authors independently assessed trials for inclusion and trial quality, and extracted data. Direct comparisons were conducted
in RevMan, with meta-regression conducted in STATA 14.
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Main results
The overall quality of evidence was moderate to high, with reductions in confidence due to imprecision and heterogeneity for some
outcomes. One hundred and two trials with 120 intervention arms (studies) were included, with 88 trials (involving over 28,000
women) providing data on smoking abstinence in late pregnancy. Interventions were categorised as counselling, health education,
feedback, incentives, social support, exercise and dissemination.
In separate comparisons, there is high-quality evidence that counselling increased smoking cessation in late pregnancy compared with
usual care (30 studies; average risk ratio (RR) 1.44, 95% confidence interval (CI) 1.19 to 1.73) and less intensive interventions (18
studies; average RR 1.25, 95% CI 1.07 to 1.47). There was uncertainty whether counselling increased the chance of smoking cessation
when provided as one component of a broader maternal health intervention or comparing one type of counselling with another. In
studies comparing counselling and usual care (largest comparison), it was unclear whether interventions prevented smoking relapse
among women who had stopped smoking spontaneously in early pregnancy. However, a clear effect was seen in smoking abstinence at
zero to five months postpartum (11 studies; average RR 1.59, 95% CI 1.26 to 2.01) and 12 to 17 months (two studies, average RR
2.20, 95% CI 1.23 to 3.96), with a borderline effect at six to 11 months (six studies; average RR 1.33, 95% CI 1.00 to 1.77). In other
comparisons, the effect was unclear for most secondary outcomes, but sample sizes were small.
Evidence suggests a borderline effect of health education compared with usual care (five studies; average RR 1.59, 95% CI 0.99 to
2.55), but the quality was downgraded to moderate as the effect was unclear when compared with less intensive interventions (four
studies; average RR 1.20, 95% CI 0.85 to 1.70), alternative interventions (one study; RR 1.88, 95% CI 0.19 to 18.60), or when
smoking cessation health education was provided as one component of a broader maternal health intervention.
There was evidence feedback increased smoking cessation when compared with usual care and provided in conjunction with other
strategies, such as counselling (average RR 4.39, 95%CI 1.89 to 10.21), but the confidence in the quality of evidence was downgraded to
moderate as this was based on only two studies and the effect was uncertain when feedback was compared to less intensive interventions
(three studies; average RR 1.29, 95% CI 0.75 to 2.20).
High-quality evidence suggests incentive-based interventions are effectivewhen comparedwith an alternative (non-contingent incentive)
intervention (four studies; RR 2.36, 95% CI 1.36 to 4.09). However pooled effects were not calculable for comparisons with usual
care or less intensive interventions (substantial heterogeneity, I2 = 93%).
High-quality evidence suggests the effect is unclear in social support interventions provided by peers (six studies; average RR 1.42, 95%
CI 0.98 to 2.07), in a single trial of support provided by partners, or when social support for smoking cessation was provided as part
of a broader intervention to improve maternal health.
The effect was unclear in single interventions of exercise compared to usual care (RR 1.20, 95% CI 0.72 to 2.01) and dissemination
of counselling (RR 1.63, 95% CI 0.62 to 4.32).
Importantly, high-quality evidence from pooled results demonstrated that women who received psychosocial interventions had a 17%
reduction in infants born with low birthweight, a significantly higher mean birthweight (mean difference (MD) 55.60 g, 95% CI 29.82
to 81.38 g higher) and a 22% reduction in neonatal intensive care admissions. However the difference in preterm births and stillbirths
was unclear. There did not appear to be adverse psychological effects from the interventions.
The intensity of support women received in both the intervention and comparison groups has increased over time, with higher-
intensity interventions more likely to have higher-intensity comparisons, potentially explaining why no clear differences were seen
with increasing intervention intensity in meta-regression analyses. Among meta-regression analyses: studies classified as having ’unclear’
implementation and unequal baseline characteristics were less effective than other studies. There was no clear difference between
trials implemented by researchers (efficacy studies), and those implemented by routine pregnancy staff (effectiveness studies), however
there was uncertainty in the effectiveness of counselling in four dissemination trials where the focus on the intervention was at an
organisational level. The pooled effects were similar in interventions provided for women classified as having predominantly low socio-
economic status, compared to other women. The effect was significant in interventions among women from ethnic minority groups;
however not among indigenous women. There were similar effect sizes in trials with biochemically validated smoking abstinence and
those with self-reported abstinence. It was unclear whether incorporating use of self-help manuals or telephone support increased the
effectiveness of interventions.
Authors’ conclusions
Psychosocial interventions to support women to stop smoking in pregnancy can increase the proportion of women who stop smoking
in late pregnancy and the proportion of infants born low birthweight. Counselling, feedback and incentives appear to be effective,
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however the characteristics and context of the interventions should be carefully considered. The effect of health education and social
support is less clear. New trials have been published during the preparation of this review and will be included in the next update.
P L A I N L A N G U A G E S U M M A R Y
Psychosocial interventions for supporting women to stop smoking in pregnancy
What is the issue?
Tobacco smoking during pregnancy increases the risk of the mother having complications during pregnancy and the baby being born
low birthweight. Nicotine and other contents of cigarettes can have harmful effects on the baby’s growth and development.
Why is this important?
The number of women smoking in pregnancy is decreasing in high-income countries, where it is associated with poverty, but is
increasing in low- to middle-income countries. Non-pharmacological interventions that address mental, emotional or social factors are
known as psychosocial interventions. We set out to identify the evidence on the effectiveness of the various psychosocial interventions
to support pregnant women to stop smoking.
What evidence did we find?
The review includes 102 randomised controlled trials with 120 intervention arms (studies) and data from 88 randomised controlled
trials (involving over 28,000 women). The main intervention strategies were categorised as counselling (n = 54), health education (n =
12), feedback (n = 6), incentives (n = 13), social support (n = 7) and exercise (n = 1).
Our review provided moderate- to-high quality evidence that psychosocial interventions increased the proportion of women who had
stopped smoking in late pregnancy (by 35%) and mean infant birthweight (by 56 g), and reduced the number of babies born with low
birthweight (by 17%) and admitted to neonatal intensive care immediately after birth (by 22%). The psychosocial interventions did
not appear to have any adverse effects. For some findings there were unexplained differences between studies and some studies were
small, reducing our confidence in their results. Nearly all studies were conducted in high-income countries.
Counselling interventions had a clear effect on stopping smoking compared with providing usual care (from 30 studies), and a smaller
effect when comparedwith less intensive interventions (18 studies). No clear effect was seenwith counselling provided as one component
of a broader intervention to improve maternal health or comparing one type of counselling with another. Interventions that provided
feedback had a clear effect when compared with usual care and when combined with other strategies such as counselling (two studies),
but not when compared with less intensive interventions (three studies). Interventions based on financial incentives had a clear effect
when compared with an alternative like a non-contingent incentive intervention (four studies).
Health education was not clearly effective when compared with usual care (five studies), or when it was one component of a broader
maternal health intervention. Social support interventions were not clearly effective when provided by peers (six studies) or in a single
trial of support provided by partners; or when social support for smoking cessation was provided as part of a broader intervention to
improve maternal health. In single studies, exercise and dissemination of counselling did not have a clear effect compared to usual care.
The pooled effects were similar for interventions provided to women who were poor. A clear effect was also seen with interventions
among women from ethnic minority groups, but not among indigenous women (four studies). Pooled results suggest that interventions
in pregnancy can also reduce smoking cessation after birth. The effects on preterm births (19 studies) and stillbirths (eight studies)
were unclear.
What does this mean?
Counselling, feedback and financial incentives appear to reduce the number of women smoking in late pregnancy, however the
interventions and the context of the interventions need to be carefully considered. The effect of health education and social support is
less clear.Most of the studies were carried out in high-income countries making it difficult to assess if the findings are applicable to other
contexts. The intensity of support women received in both the intervention and comparison groups has increased over time. Many of
the studies did not provide information on the number of individual women who were eligible for inclusion or were approached to
take part in studies, which would have provided useful information about the general acceptability of the interventions and selection
bias in the studies. The timing of the final assessment of smoking status during pregnancy also varied considerably among the studies.
New trials have been published during review preparation will be included in the next update.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Separate intervention comparisons for supporting women to stop smoking in pregnancy (comparisons 1-19)
Patient or population: Pregnant women who smoke
Setting: Any
Outcome: Smoking abst inence in late pregnancy
Comparison: Usual care unless other comparison indicated
Interventions and com-
parisons
Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
∗thesef ootnotesoutlineconsistentf indings
of participants
(studies)
Quality of the evidence
(GRADE)
Comments (details of
variations from main
results)
Risk with comparison Risk with main inter-
vention strategy
Counselling vs usual
care
Study populat ion RR 1.44
(1.19 to 1.73) 3
12,432
(30 RCTs) 2
⊕⊕⊕⊕
HIGH 1
No clear ef fect when
compared to an alter-
nat ive counselling in-
tervent ion (RR 1.15,
95% CI 0.86 to 1.
53) or if 1 component
of a broader maternal
health intervent ion (RR
0.93, 95% CI 0.69 to 1.
25)
9 per 100 2 13 per 100
(11 to 16)
Health educat ion vs
usual care
Study populat ion RR 1.59
(0.99 to 2.55) 5
629
(5 RCTs)
⊕⊕⊕©
MODERATE 4
8 per 100 12 per 100
(8 to 20)
Feedback vs usual care Study populat ion RR 4.39
(1.89 to 10.21) 6
355
(2 RCTs)
⊕⊕⊕©
MODERATE 4
No clear ef fect when
compared to a less in-
tensive (RR 1.29, 95%
CI 0.75 to 2.20) or alter-
nat ive intervent ion; or 1
component of broader
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maternal health inter-
vent ion (RR 2.11 95% CI
0.98 to 4.57)
4 per 100 17 per 100
(7 to 39)
Incent ives vs alterna-
t ive intervent ions 7
Study populat ion RR 2.36
(1.36 to 4.09) 8
212
(4 RCTs)
⊕⊕⊕⊕
HIGH
16 per 100 37 per 100
(21 to 64)
Social support vs less
intensive intervent ions
9
Study populat ion RR 1.21
(0.93 to 1.58) 10
781
(7 RCTs)
⊕⊕⊕⊕
HIGH
19 per 100 23 per 100
(18 to 31)
Exercise vs usual care Study populat ion RR 1.20
(0.72 to 2.01)
785
(1 RCT)
⊕⊕⊕©
MODERATE 4
6 per 100 8 per 100
(5 to 13)
Other (act ive dissemi-
nat ion vs passive dis-
seminat ion)
Study populat ion RR 1.63
(0.62 to 4.32)
194
(1 RCT)
⊕⊕⊕©
MODERATE 4
6 per 100 10 per 100
(4 to 27)
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
CI: Conf idence interval; RR: Risk rat io.
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
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1 Not downgraded for moderate heterogeneity (49%) as while there was some inconsistency in the magnitude, most RRs
favoured counselling.
2 All control group risks are mean values of control group among included studies.
3 While there was no clear dif f erence f rom this primary result , ef fect sizes varied if results restricted to biochemically validated
smoking cessat ion (RR 1.23, 95% CI 1.04 to 1.45) or compared to less intensive intervent ions (RR 1.25, 95% CI 1.07 to 1.47).
4 Downgraded as relat ively small numbers and wide conf idence intervals.
5 Also no clear ef fect when compared to a less intensive or alternat ive intervent ion, restricted to biochemically validated
cessat ion, single/ mult iple subgroups, provided as 1 component of a broader maternal health intervent ion, or are provided as
a technological intervent ion only.
6 Remains clear ef fect when restricted to single study with biochemically validated cessat ion
7 Ef fect not calculable in usual care comparison due to zero cell counts, and not pooled in less intensive comparison due to
substant ial heterogeneity (I2 = 84%)
8 Clear ef fect also seen in subset of 3 counselling intervent ions which included lottery t ickets (RR 1.72, 95% CI 1.04 to 2.85).
9 No usual care comparisons for this intervent ion
10 Remains unclear when restricted to biochemically validated cessat ion, all subgroups, when partner intervent ion removed
and when provided as part of a broader maternal health intervent ion.
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B A C K G R O U N D
Description of the condition
Risks associated with smoking in pregnancy
Tobacco smoking in pregnancy is associated with serious com-
plications in pregnancy (Mund 2013), such as placental abrup-
tion, miscarriage, low birthweight (Kramer 1987), preterm birth
(US DHHS 2004; Hammoud 2005; Salihu 2007; Rogers 2009;
Vardavas 2010; Baba 2012), stillbirth (Marufu 2015) and neonatal
death (Kallen 2001). Tobacco smoking also has serious long-term
health implications for women and infants; 5.4 million people per
year currently die from tobacco use, and this is expected to rise to
eight million per year in the next 30 years (WHO 2008a).
Nicotine and other harmful compounds in cigarettes are develop-
mental toxicants (Rogers 2009), which impact on the brain at crit-
ical developmental periods (Dwyer 2008), restricting the supply
of oxygen and other essential nutrients, fetal growth (Crawford
2008), development of organs (Morales-Suarez-Varela 2006), in-
cluding the lungs (Maritz 2008), and neurological development
(Herrmann 2008; Blood-Siegfried 2010). Growing evidence sug-
gests these ’developmental origins of disease’ have life-long impli-
cations (Gluckman 2008).
Youngwomen start smoking formany reasons including: belief it is
a rite of passage into adult life, a gesture against authority, trying to
appearmodern and affluent, or to fit in with social networks (Todd
2001). Tobacco addiction is then caused by nicotine in tobacco
which produces a cascade of actions, including release of “pleasure
enhancing” dopamine, which strengthens associations of positive
feelings with smoking behaviour and appears to be involved in all
addictive behaviours (Schmidt 2004). Some suggest the negative
feelings of “nicotine hunger” and unpleasant symptoms associated
with nicotine withdrawal (Balfour 2004; Hughes 2014) may be
stronger for pregnant women due to the physiological adaptations
in pregnancy which accelerate nicotine metabolism (Ebert 2009;
Ussher 2014), however a recent study reported less severe with-
drawal symptoms among pregnant women in the first 24 hours of
abstinence, compared to non-pregnant women (Ussher 2012b).
Epidemiology of smoking in pregnancy
In high-income countries, such as Australia, Canada, Denmark,
NewZealand, Sweden, the United Kingdom (UK) and theUnited
States (USA), the prevalence of smoking in pregnancy has declined
frombetween 20% to 35% in the 1980s to between 10% and 20%
in the early 2000s (Cnattingius 2004; US DHHS 2004; Giovino
2007; Dixon 2009b; Tong 2009; Al-Sahab 2010; Tappin 2010),
with significant declines in the last decade bringing the prevalence
of smoking in pregnancy well below 10% by 2010 (Lanting 2012;
Curtin 2016). However, the decline has not been consistent across
all sectors of society, with lower rates of decline among women
with lower socio-economic status (USDHHS 2004; Pickett 2009;
Graham 2010; Johnston 2011b; Lanting 2012). Tobacco smok-
ing in high-income countries is a marker of social disadvantage
and has been cited as one of the principal causes of health in-
equality between rich and poor (Wanless 2004), and understand-
ing these disparities are central to understanding the tobacco epi-
demic (Graham 2010). In Scotland, 30% of women living in
the most deprived areas continued to smoke during pregnancy in
2008, compared to 7% in the least deprived areas (Tappin 2010).
Women who continue to smoke in pregnancy are more likely to:
have a low income, higher parity, no partner, low levels of so-
cial support, limited education; access publicly funded maternity
care (Graham 1977; Frost 1994; Graham 1996; Tappin 1996;
Wakschlag 2003;USDHHS 2004; Schneider 2008; Pickett 2009;
Smedberg 2014); and feel criticised by society (Ebert 2007). The
World Health Organization (WHO) report into the Social Deter-
minants of Health recognises a paradigm whereby disadvantaged
people aremore likely to use substances in response to their circum-
stances (WHO 2008b). There is also a significantly higher preva-
lence of smoking in pregnancy in several ethnic and aboriginal
minority groups (Wiemann 1994; Kaplan 1997; Chan 2001; US
DHHS 2004; Wood 2008; Dixon 2009b; Johnston 2011b). In
Australia, smoking during pregnancy is three times more prevalent
among Aboriginal and Torres Strait Islander women (53%) than
among non-Aboriginal women (16%) (Johnston 2011b), and sim-
ilar disparities are reported betweenMaori and non-Maori women
in New Zealand (Dixon 2009b). These disparities are largely in
accord with social andmaterial deprivation. However, in somemi-
grant groups, cultural differences may cut across this social gradi-
ent (Troe 2008), which suggests that there are aspects of smoking
socialisation not entirely explained bymaterial deprivation. In the
USA, the highest rates of pre-pregnancy smoking were reported
among Alaskan Native women (6%), American Indian women
(47%), and white women (46%), with significantly lower rates
(less than 20%) reported among African American, Hispanic and
Asian-Pacific women (Tong 2011; Watt 2012). Women who are
migrants or refugees to Australia, Canada, New Zealand, North-
ern Europe, the UK, or the USA or who originate from South
East Asia also retain a lower prevalence of smoking, despite major
social disadvantage (Potter 1996; Small 2000; Bush 2003; Dixon
2009b). However, second-generation migrant women are more
likely to smoke during pregnancy than first-generation women
(Troe 2008), reflecting movement between stages of ’the tobacco
epidemic’ (Lopez 1994).
In low- and middle-income countries there is marked variation
in the prevalence of smoking in pregnancy, which reflects the dy-
namic nature of the tobacco epidemic in these regions (Richmond
2003; Polanska 2004; Bloch 2008). Smoking rates among preg-
nant women have been comparatively low (9%) compared to men
(50%), due to historical cultural constraints on women’s smoking
inmany low- tomiddle-income countries (Bloch 2008). However,
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the prevalence of tobacco smoking among women is increasing
and is expected to rise to 20% by 2025, shifting the global tobacco
smoking epidemic from high-income countries to low- and mid-
dle-income countries (Samet 2001; Richmond 2003). The highest
rates of smoking during pregnancy were reported in Latin Amer-
ica (18.3% in Uruguay 2004 to 2005) (Bloch 2008) and Eastern
Europe (15% in Romania 2005 to 2006) (Meghea 2010). Low
rates were reported in Pakistan (3%) (Bloch 2008), South East
Asia (1.3%) (Barraclough 1999; Ostrea 2008), and China (2%
in 1999), though increasing rates among female school children
are causing concern (Kong 2008). In India and Africa, rates of
cigarette smoking were low (1.7% and 6.1% pregnant women
reporting smoking cigarettes, respectively), (Steyn 2006; Bloch
2008; Palipudi 2009), while use of smokeless tobacco products
was high among Indian (4% to 5%) (Bloch 2008; Palipudi 2009)
and African women (6% to 8%) (Steyn 2006; Bloch 2008). The
WHO has identified this rise of tobacco use in young females in
low-income, high-population countries as one of the most omi-
nous developments of the tobacco epidemic (WHO 2008a), jeop-
ardising efforts to improve maternal and child health (Cnattingius
2004; Bloch 2008). This increase is beingdrivenby aggressivemar-
keting from tobacco companies, who are predicting high profits
from sales in low- and middle-income countries (Kaufman 2001),
along with increased tobacco production in these regions (FAO
2003), which further entrenches the countries’ tobacco depen-
dence. Marketing strategies are specifically targeted at women and
weak regulation of tobacco company marketing has been linked to
a rapid increase in smoking among women, particularly those who
are vulnerable (Kaufman 2001; Gilmore 2004; Graham 2009). A
survey of women’s knowledge in two African countries suggests
women’s knowledge of the risks of tobacco products was extremely
limited (Chomba 2010), making women more vulnerable to to-
bacco marketing.
Issues around smoking in pregnancy are complicated by the inter-
section of gender (Healton 2009), where awoman’s role is seen pri-
marily as a ’reproducer’, and emphasis is placed on the rights of the
unborn fetus (pxii; WHO 2001). There is a risk these arguments
may be used to impose authority over women’s behaviour, ’blam-
ing’ women for their own plight and that of their children, and
using guilt or other means to undermine self-confidence; further
reducing the control women have in their lives (Greaves 2007a).
In addition to the socio-economic factors associated with con-
tinued smoking, there are strong psychological associations, es-
pecially with depression and stress (Blalock 2005; Aveyard 2007;
Crittenden 2007; Orr 2012), including race-related stress (Heath
2006; Fernander 2010; Nguyen 2012a). Depressed women are up
to four times more likely to smoke during pregnancy than non-de-
pressed women (Blalock 2005). Furthermore, while tobacco con-
trol initiatives in high-income countries have been effective in re-
ducing smoking, the stigmatisation of smokers has been an un-
intended consequence (Burgess 2009; Wigginton 2013), which
is being increasingly recognised by the tobacco control commu-
nity (Farrimond 2006; Thompson 2007a; Burgess 2009). Anti-
smoking campaigns strive to inform, shock or shame people into
quitting smoking and rarely take into account low self-esteem,
low self-efficacy, poverty, stress and increased caring responsibil-
ities that are common among women who continue to smoke
during pregnancy (Gilbert 2005). A systematic review of qualita-
tive experiences of women describes how smoking in pregnancy
triggered “intense feelings of personal responsibility and inade-
quacy” and that women’s responses to social disapproval varied
(Flemming 2013). For some, it provided an incentive to attempt
to quit, while among others it resulted in increased smoking, ei-
ther in response to the stress of social pressure or as an act of re-
bellion against it (Flemming 2013). A recent update of this review
highlighted four main barriers and facilitators to quitting smoking
in pregnancy: psychological well-being, relationships with signifi-
cant others, changing connections with her baby through and after
pregnancy; appraisal of the risk of smoking; and concluded that
“for disadvantaged smokers, these factors are more often experi-
enced as barriers than facilitators to quitting” (Flemming 2015).
Some argue that health risk narratives and the associated social
stigma produced through anti-smoking campaigns contribute to
oppression among marginalised people, and a consequence is that
these strategies may inspire resistance and resentment rather than
compliance (Bond 2012; Flemming 2013; Wigginton 2013).
Although commercial cigarettes are the most prevalent form of
tobacco use worldwide, the use of other forms of tobacco (e.g.
e-cigarettes, smokeless tobacco, cigars and pipes, and waterpipes)
are becoming more popular in many parts of the world, especially
low- and middle-income countries (England 2010; Ratsch 2014).
Of particular concern are increasing efforts by the tobacco indus-
try to commercialise and market smokeless tobacco products to
young adults (Lambe 2007). Since the last version of this review
was published, electronic nicotine device systems (ENDS) or e-
cigarettes have been used with increasing frequency; these are de-
vices that heat a solution that contains nicotine, and the user in-
hales an aerosol that is released (Cobb 2010). While there is very
little evidence about the safety and efficacy of ENDS in pregnancy
(Coleman 2015), aWHO report states there is sufficient evidence
to caution pregnant women about the use of ENDS due to con-
cerns about the risks of exposure on fetal and child brain devel-
opment, including from flavourings, and concludes ENDS pose
potential threats to adolescents and fetuses, but this is less than
conventional cigarettes (WHO 2013). In high-income countries,
the use of smokeless tobacco appears to be highly localised among
some indigenous groups inCanada and theUS, including Lumbee
Indian, Navajo, and Alaskan Native communities (Strauss 1997;
Spangler 2001; Patten 2009; Kim 2009a; Kim 2010). In India,
one-third (4%) of all pregnant women reported using smokeless
tobacco (Bloch 2008). In the Democratic Republic of Congo,
6% to 42% of pregnant women surveyed reported using other
forms of tobacco, primarily snuff (Bloch 2008; Chomba 2010).
In South Africa, 8% of pregnant women surveyed reported using
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snuff (Steyn 2006). In Iran there has been concern over the 8%
prevalence of local waterpipe tobacco smoking among pregnant
women (Mirahmadizadeh 2008). These tobacco products may be
cheaper and viewed as less harmful than cigarettes (England 2010).
In some cases use may be a traditional cultural norm or a medici-
nal aid to reduce nausea in early pregnancy. However, these prod-
ucts can be high in nicotine content and cause nicotine addic-
tion. Use of these products has been associated with increased oral
and pancreatic cancer, and cardiovascular disease (England 2010).
There is a paucity of research into the effect of these products on
pregnancy outcomes and studies into the effects of these prod-
ucts can be challenging as the chemical content of various toxic
compounds is variable and often poorly regulated. However, lim-
ited evidence suggests smokeless tobacco use is associated with de-
creased birthweight and preterm birth (Verma 1983; Gupta 2004;
Pratinidhi 2010), stillbirth (Gupta 2006; Gupta 2012), mater-
nal anaemia (Subramoney 2008), degenerative placental changes
(Ashfaq 2008), and adverse infant neurobehavioural outcomes
(Hurt 2005). Smoking more than one waterpipe per day (Tamim
2008) or starting to smoke waterpipes during the first trimester
(Mirahmadizadeh 2008), was also associatedwith an increased risk
of having a low birthweight baby.
Exposure to environmental tobacco smoke (ETS) also poses risks
to pregnant women and their infants (Yang 2010). Studies sug-
gest the risk may be exacerbated in low-income countries where
exposure to indoor cooking smoke is also common (Kadir 2010).
In China, 75% of pregnant non-smoking women were regularly
exposed to environmental tobacco smoke from their husbands’
smoking (Yang 2010). Studies in high-income countries demon-
strate that eliminating smoking in the workplace and other pub-
lic spaces significantly reduces environmental tobacco smoke ex-
posure and improves health outcomes, including preterm births
(Cox 2013). One study in Indonesia reported increased collec-
tive efficacy when environmental tobacco smoke exposure was ad-
dressed through a well-publicised community household smoking
ban (Nichter 2010). However, as these measures do not extend
to homes (Oncken 2009), some argue domestic environmental
tobacco smoke exposure may be increasing as public health poli-
cies restrict smoking of partners in public places, and the social
position of women may limit their ability to enforce smoke-free
policies within their homes (Tong 2009).
A positive theme emerging from this literature is that a higher
proportion of women stop smoking during pregnancy than at
other times in their lives. Up to 49% of women who smoked
before pregnancy ‘spontaneously quit’ before their first antenatal
visit (Quinn 1991;Woodby 1999;Hotham 2008), a quit rate sub-
stantially higher than reported in the general population (Ershoff
1999 (AvC); McBride 2003; Tong 2008). However, these spon-
taneous quitting rates may be lower among women with lower
socio-economic status (Mullen 1999). There are significant psy-
chosocial differences between women who ’spontaneously quit’
and women who continue to smoke in late pregnancy. Women
who spontaneously quit usually smoke less, are more likely to have
stopped smoking before, have a non-smoking partner, have more
support and encouragement at home for quitting, are less seriously
addicted, and have stronger beliefs about the dangers of smoking
(Baric 1976); Ryan 1980; Cinciripini 2000; Passey 2012). Preg-
nant women are also more likely to use coping strategies to avoid
relapse than non-pregnant women (Ortendahl 2007c; Ortendahl
2008a; Ortendahl 2009a), however less than a third of these
women remain abstinent after one year postpartum (CDCP 2002;
Fang 2004), supporting qualitative evidence that many women
see pregnancy as a temporary period of abstinence for the sake
of the baby (Stotts 1996; Lawrence 2005a; Flemming 2013). De-
spite high relapse rates, some studies suggest that the long-term ef-
fects of spontaneous quitting in pregnancy are significant (Rattan
2013), and others argue this success is important to recognise to
avoid ’pathologising’ smoking cessation and eroding confidence
in human agency to overcome problems (Chapman 2010).
Given the complexity of the health and social dimensions of smok-
ing in pregnancy, there are conflicting perspectives regarding the
most appropriate approaches. A dominant theme is that smoking
in pregnancy is a lifestyle choice, however, there is concern this
can lead to ’victim blaming’ (Bond 2005), that individualised, be-
haviourist approaches are unlikely to adequately address health in-
equalities alone (Baum 2009), and that drug dependence and ad-
diction is best dealt with in the domain of social policy and public
health (Ebert 2009). Nevertheless, some suggest there is a role for
individual support which is positive, not punitive (Bond 2012),
and others express a concern that framing smoking in pregnancy
solely as a social problem may make health professionals reluctant
to intervene and offer support (McLellan 2000).
Description of the intervention
This review evaluates the effectiveness of individual psychoso-
cial interventions that aim to motivate and support women to
stop smoking in pregnancy, or prevent smoking relapse among
women who have spontaneously quit. Psychosocial interventions
are defined as non-pharmacological strategies that use cognitive-
behavioural, motivational and supportive therapies to helpwomen
to quit, including counselling, health education, feedback, finan-
cial incentives, social support from peers and/or partners, and ex-
ercise (see Types of interventions), as well as dissemination trials.
Other smoking cessation intervention reviews
At the time of this update (May 2016) there were 83 other
Cochrane reviews assessing the effectiveness of tobacco smoking
cessation interventions for all populations (see Appendix 1). These
include reviews on the following.
• Population wide measures such as: legislative smoking
bans, mass media campaigns, healthcare financing systems for
increasing use of tobacco dependence treatment, advertising and
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promotion to reduce tobacco use, preventing tobacco smoking in
public places, tobacco packaging and impact of advertising on
adolescent smoking.
• Community interventions including family-based
programmes, group behaviour interventions, family and carer
interventions for reducing environmental tobacco smoke,
organisational interventions (workplace and school-based
interventions).
• Individual psychosocial interventions including aversive
smoking, acupuncture, hypnotherapy, self-help materials,
exercise, individual behavioural counselling, motivational
interviewing, stage-based interventions, incentives, telephone
counselling, mobile phone-based interventions, Internet-based
interventions, nursing and physician advice, enhancing partner
support, feedback, community pharmacy interventions, training
health professionals in smoking cessation, use of electronic
records, prevention of weight gain after smoking cessation,
improving recruitment into cessation programs, harm reduction,
reduction versus abrupt cessation, biomedical risk assessments,
relapse prevention, and interventions to reduce non-cigarette
tobacco use, including waterpipe smoking cessation.
• Individual pharmacological interventions including
antidepressants, anxiolytics, electronic cigarettes, nicotine
replacement therapy (NRT), clonidine, mecamylamine,
nicobrevin, nicotine agonists, opioid agonists, cannabinoid type
1 receptor agonists, silver acetate, lobeline, and nicotine vaccines,
increasing adherence to medications for tobacco dependence,
behavioural interventions as adjuncts to pharmacotherapies,
combined pharmacotherapy and behavioural interventions; and
an ‘overview of pharmacological reviews’.
• Interventions in specific population groups including
people with: schizophrenia and serious mental illness, depression,
substance abuse, HIV/AIDS, lung cancer, cardiovascular and
pulmonary disease; pre-operative and hospitalised patients;
Indigenous populations and Indigenous youth; and people in
primary care, psychiatric and dental settings.
• Other reviews, assessing effectiveness of interventions to
recruit patients into smoking cessation programs, and reduce
harm from continued tobacco use, and system change
interventions.
How the intervention might work
Pregnancy has been described as a ‘window of opportunity’ for
smoking cessation (McBride 2003). Pregnancy increases awoman’s
perception of risk and personal outcomes, therefore strong affec-
tive or emotional responses are more likely to be prompted (Slade
2006; Ortendahl 2008b). It also redefines a woman’s self-concept
or social role (Ortendahl 2007b), especially when failure to com-
ply with a social role results in social stigmatisation (Ortendahl
2007a; Ortendahl 2008c). Psychosocial interventions involve a
range of social and psychological components which aim to in-
crease motivation or affective or emotional responses to support
pregnant women to stop smoking and support women to develop
coping strategies to avoid relapse (Ortendahl 2007c; Pilling 2010).
For example, counselling, feedback and financial incentives are all
designed to enhance motivation to quit and move women closer
towards the ’action’ stage of change. Thirty-seven individual ’be-
haviour change techniques’ or observable components used in in-
terventions in the previous version of this review have been iden-
tified (Lorencatto 2012).
Psychosocial interventions to support women to stop smoking in
pregnancy increasingly incorporate theoretical frameworks to in-
form, develop and evaluate strategies designed to influence be-
haviour (Green 2005b; Glanz 2008; Michie 2008; Bartholomew
2011). Using behaviour change theories in the context of addic-
tion has been identified as a useful way to identify modifiable
determinants and/or behaviour change techniques (Webb 2010).
There aremany theories of behaviour, which provide a summary of
constructs, procedures and methods for understanding behaviour,
and present hypothesised relationships or causal pathways that in-
fluence behaviour (Michie 2012). While some argue there is little
apparent consensus about which theories are best to use in design-
ing interventions (Noar 2005), most theories of behaviour change
postulate a role for six broad classes of variables (Glanz 2008):
1. attitudes and beliefs about the behaviours or the outcomes
of change (used in health education and counselling strategies);
2. beliefs about self-efficacy or perceived ability to enact and/
or maintain the target behaviour change (used in counselling
strategies such as motivational interviewing or cognitive
behaviour therapy);
3. the role of contextual factors, particularly social factors,
either directly and/or mediated through people’s beliefs (used in
social support strategies);
4. previous experience with the behaviour either directly or
indirectly through the processes of modelling (modelling can be
seen as an element of social influence) (used in social support
strategies);
5. priority for action, a person can only pursue a limited
number of goals of any one time; and
6. the notion of a stage-based or systematic step-like
progression towards behaviour change, which is incorporated
into the assessment stage of many smoking cessation
interventions (Prochaska 1992).
Why it is important to do this review
There are many psychosocial interventions that have been evalu-
ated to support women to stop smoking during pregnancy, which
reflects the public health significance of the issue. This review syn-
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thesises the evidence from these trials and is of direct relevance
for practitioners, policy-makers, and researchers. Synthesis enables
comparison of whether interventions have been shown to be ef-
fective in individual studies and whether this effect has been repli-
cated in other settings. Importantly, individual studies are unlikely
to have sufficient power to evaluate the effect of interventions on
perinatal outcomes or to conduct subgroup analyses to assess if
there are differential effects among vulnerable subpopulationswith
high rates of smoking during pregnancy. Finally, collation of the
body of evidence helps to identify any gaps for future research.
This is the sixth update of this Cochrane review, previously enti-
tled ‘Interventions to promote smoking cessation during pregnancy’.
The first version was published in 1995 on CD Rom and pre-
viously updated in the Cochrane Library in 1999, 2004, 2009,
and 2013. Previous versions of this review have demonstrated the
potential for individual interventions during pregnancy to have a
modest but important effect on reducing smoking, preterm births
and infants born with low birthweight (Chamberlain 2013). This
evidence has been instrumental in individual psychosocial inter-
ventions becoming a part of guidelines and routine pregnancy care
in many countries in the past decade (Flenady 2005; Ministry
of Health 2007; Fiore 2008; NICE 2010; Wong 2011; WHO
2013b; Siu 2015).
Since 2013, we have ‘split’ the previous version into two reviews:
(1) this review focusing on psychosocial interventions to support
women to stop smoking in pregnancy; and (2) a second review
specifically focusing on pharmacological interventions to promote
smoking cessation in pregnancy (Coleman 2015). We felt this
enabled more detailed consideration of specific issues of concern
for psychosocial and pharmacological interventions. Psychosocial
interventions are now part of routine care in many high-income
countries and contemporary issues focus on strategies to increase
effectiveness, and adaptation of psychosocial interventions to dif-
ferent contexts and settings, sometimes requiring different study
designs (e.g. cluster trials of implementation). As many interven-
tions involve multiple strategies or use of components which are
tailored to individual women, it is very difficult to assess the in-
dependent effect of individual components of psychosocial inter-
ventions. As the safety of pharmacological treatments (e.g. NRT,
bupropion, electronic cigarettes) during pregnancy are a particular
concern due to the risks for the developing fetus (Slotkin 2008),
more rigid study designs (i.e. randomised placebo-controlled tri-
als, with blinding of participants, trialists, and outcome assessors,
where possible) are required to assess the risks and efficacy.
To complement what is known from research literature about
smoking in pregnancy, direct contributions to this review were
sought from women who smoked before or during pregnancy in
1999. Women were identified through community networks, and
their views emphasised the need to focus attention on potential
adverse effects of smoking cessation programmes; in particular,
the consequent guilt, anxiety and additional stress experienced by
those who continue to smoke, especially through ’high-risk’ preg-
nancies, and the detrimental effect on their relationships with their
family and maternity care providers (Oliver 2001).
In this update, we indirectly considered women’s views reported
in a systematic review of qualitative studies (Flemming 2013;
Flemming 2015), which reinforce the previous contributions.
Four main themes were identified which could present as barri-
ers or facilitators, but were more likely to be seen as barriers for
women living in disadvantaged circumstances.
1. Women see smoking in pregnancy in terms of the risks it
presents to their unborn baby, which causes an appraisal of
smoking risk but can trigger guilt.
2. Changing connections with baby through and after
pregnancy.
3. Quitting was not seen in unambiguously positive terms and
was seen to have downsides, disrupting relationships and
removing a habit perceived as helping women cope, with an
impact on psychological well-being.
4. Partners/relationships play an important role in influencing
women’s smoking behaviour in pregnancy, either as barriers or
facilitators to quitting.
We also indirectly considered the views of pregnancy care providers
reported in consultation for a Clinical Practice Guideline on
Smoking Cessation in pregnancy (Williams 2010) in the UK; and
the views of guideline developers requesting evidence for an inter-
national guideline on ’Management of Tobacco Use in Pregnancy’
(CDCP 2013; WHO 2013b). Some of the major issues and gaps
included:
• whether psychological interventions are effective;
• whether interventions are effective for pregnant teens and
other hard-to-reach and vulnerable groups, including ethnic and
minority populations;
• whether interventions are effective for women who are
mentally unwell or experiencing substance misuse;
• whether interventions are effective in low- and middle-
income countries.
We also considered thesis critiques of the previous version of
this review (Gilligan 2008; Vilches 2009 (AvD)), health pro-
gramme planning models (Green 2005b; Bartholomew 2011;
Michie 2011), various publications on factors affecting interven-
tion efficacy (Greenhalgh 2004; Hoddinott 2010), descriptions
of intervention components (Lorencatto 2012), and the ’critical
factors’ identified by authors of included studies reported in the
results or discussion. As smoking in pregnancy has important im-
pacts on health inequalities, we have introduced a focus on eq-
uity in this review, as recommended in the ’PRISM-Equity’ guide-
lines for reporting interventions with a potential impact on equity
(Welch 2012). We have synthesised this information into a logic
model to identify key variables that may impact on intervention
effectiveness (see Figure 1), to guide analysis and subgroup analy-
ses planning ’a priori’ (Petticrew 2012).
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Figure 1. Logic model for systematic review analysis of potential factors impacting on efficacy of
interventions for supporting women to stop smoking in pregnancy.
O B J E C T I V E S
This review evaluated the effect of psychosocial interventions de-
signed to support women to stop smoking in pregnancy and aimed
to address the following objectives.
Primary objectives
• To identify whether psychosocial interventions can support
women to stop smoking in pregnancy.
• To compare the effectiveness of the main psychosocial
intervention strategies in supporting women to stop smoking in
pregnancy (i.e. counselling, health education, feedback, social
support, incentives, exercise).
Secondary objectives
• To identify if the intensity of the intervention was
associated with effect size.
• To identify if specific intervention components (e.g.
telephone counselling, self-help manuals) were associated with
effect size.
• To identify if psychosocial interventions in pregnancy had
an impact on health outcomes for the mother (i.e. caesarean
section, breastfeeding) and infant (i.e. mean birthweight, low
birthweight, preterm births, very preterm births, perinatal
mortality).
• To identify if there were any positive or negative
psychological effects reported among women receiving
psychosocial interventions in pregnancy.
• To identify participants’ (women and pregnancy care
providers) views of the psychosocial interventions in this review.
• To identify if psychosocial interventions had an effect on
family functioning or other relationships for the mother,
including non-accidental injury.
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• To identify if psychosocial interventions during pregnancy
reduced the proportion of women who start smoking
postpartum.
• To identify whether any methods for training and
implementing psychosocial interventions had an effect on the
knowledge, attitudes and behaviour of pregnancy care providers.
• To identify whether psychosocial interventions provided for
women who had spontaneously quit smoking in early pregnancy,
reduced the proportion of women who started smoking by late
pregnancy (relapse).
• To identify whether psychosocial interventions were
effective for women in vulnerable subpopulation groups
(including women categorised as having low socio-economic
status, young women (less than 20 years), ethnic minority and
aboriginal women, and women in low- and middle-income
countries.
• To identify whether psychosocial interventions, which are
shown to be effective when implemented under trial conditions
by a dedicated research team (efficacy studies), were still effective
when implemented in a routine pregnancy care setting by
existing staff (effectiveness studies).
• To identify if psychosocial interventions to support women
to stop smoking in pregnancy were cost-effective.
• To identify if there were any adverse effects reported as a
result of women receiving psychosocial interventions to support
them to stop smoking in pregnancy.
• To identify whether the effect size was modified by recently
included trials compared with trials included in previous versions
of this review.
• To identify if any of the ’Risk of bias’ assessments associated
with effect size.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All individually-randomised controlled trials, cluster-randomised
controlled trials, and randomised cross-over trials of psychosocial
interventions where a primary aim of the study was smoking ces-
sation in pregnancy. Quasi-randomised studies were only consid-
ered for inclusion if there was a very low risk of interference with
the sequence generation (e.g. allocation by odd or even maternal
or infant birth date or hospital record number).
Types of participants
1. Women who are currently smoking or have recently quit
smoking and are pregnant, in any care setting.
2. Women who are currently smoking or have recently quit
smoking and are seeking a pre-pregnancy consultation.
3. Health professionals in trials of implementation strategies
of psychosocial interventions to support pregnant women to stop
smoking.
Where possible, we have separated outcomes forwomenwho spon-
taneously quit smoking when they become pregnant, and women
who continue to smoke duringpregnancy, as significant differences
have been reported previously (Baric 1976;Ryan1980;Cinciripini
2000; Passey 2012).
Types of interventions
In the first instance, we have differentiated between interventions
that:
• have a sole aim of supporting smoking cessation in
pregnancy;
• aim to improve broader maternal health outcomes, but
include a smoking cessation component or module.
This is because women enrolling in these different types of tri-
als may have different motivations for participating in interven-
tions and characteristics in relation to smoking that are difficult
to quantify. Trials that aimed to improve broader maternal health
outcomes included only smoking cessation and reduction out-
comes, but not infant outcome measures such as birthweight,
preterm birth, breastfeeding and perinatal mortality, which might
be attributable to other components of the intervention package.
Within these two categories, comparisons are based on the follow-
ing interventions.
1. Counselling interventions are those which provide
motivation to quit, support to increase problem solving and
coping skills (Ortendahl 2007c; Ortendahl 2008a; Ortendahl
2009b), and may incorporate ’transtheoretical’ models of change
(Prochaska 1992; Prochaska 2007). This includes interventions
such as motivational interviewing, cognitive behaviour therapy,
psychotherapy, relaxation, problem solving facilitation, and other
strategies. Counselling interventions may be provided face-to-
face, by telephone, via interactive computer programs, or using
audiovisual equipment. The duration of counselling may range
from brief interventions (less than five minutes) to more
intensive interventions, which can last for up to an hour and be
repeated over multiple sessions. Counselling may be provided by
a range of personnel, including pregnancy care providers, trained
counsellors, or others, on-site or by referral to specialist stop
smoking services. Interventions that involved provision of videos
with personal stories were included as counselling in this review.
2. Health education interventions are defined as those where
women are provided with information about the risks of
smoking and advice to quit, but are not given further support or
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advice about how to make this change. Interventions where the
woman was provided with automated support such as self-help
manuals or automated text messaging (e.g. Naughton 2012), but
there was no personal interaction at all, were coded as health
education in this review.
3. Feedback interventions are those where the mother is
provided with feedback with information about the fetal health
status or measurement of by-products of tobacco smoking to the
mother. This includes interventions such as ultrasound
monitoring and carbon monoxide or urine cotinine
measurements, with results fed back to the mother. We did
4. Incentive-based interventions include those interventions
where women receive a financial incentive, contingent on their
smoking cessation; these incentives may be gift vouchers.
Interventions that provided a ’chance’ of incentive (e.g. lottery
tickets) combined with counselling were coded as ’counselling’ in
this review, and subgroup analysis of trials incorporating use of
lottery tickets were reported. However one study arm where
participants were enrolled in a ’quit and win’ contest without
counselling (Parker 2007 (AvB)) was coded as an incentive
intervention, and sensitivity analysis was conducted with and
without this trial in the analysis. Gifts and other incentives to
promote participation in the study (but were not contingent on
smoking cessation), were not coded as incentive-based
interventions in this review, but are reported in the
Characteristics of included studies.
5. Social support (peer, professional and/or partner)
includes those interventions where the intervention explicitly
included provision of support from a peer (including self-
nominated peers, ’lay’ peers trained by project staff, or support
from healthcare professionals), or from partners, as a strategy to
promote smoking cessation.
6. Exercise interventions are those where structured support
for exercise is provided with the specific aim of promoting
smoking cessation in pregnancy, with the first exercise
intervention identified in 2016.
7. Other strategies, which could not be included in the
categories listed above, including dissemination interventions
(where both intervention and control group received the same
intervention, but the dissemination strategy differed) (e.g.
Campbell 2006).
In this review we have categorised interventions according to the
’main’ strategy used, however many interventions incorporate sev-
eral components. Therefore, interventions are coded according to
whether the strategy was a:
• single intervention - with only one main strategy used;
• multiple intervention - which included several strategies
being offered to all women;
• tailored intervention - where several strategies were
available, but the choice was optional for women.
We have included interventions that offered pharmacological ther-
apies as part of a tailored intervention where there were higher
levels of psychosocial support provided to participants in the inter-
vention arm, compared with the control arm. Trials were excluded
where the sole aim was to reduce: smokeless tobacco use; environ-
mental tobacco smoke exposure; where the primary population
was not pregnant women (e.g. partners, non-pregnant women);
or the intervention was not primarily aimed at cessation during
pregnancy (e.g. postpartum interventions). Studies were included
where smokeless tobacco use, environmental tobacco smoke ex-
posure or partner smoking were targeted in conjunction with in-
terventions addressing the primary aim of supporting pregnant
women to stop smoking in pregnancy. We have included dissemi-
nation studies, where the primary intervention includes strategies
to disseminate smoking cessation interventions in pregnancy care
settings (e.g. training, audit and feedback).
Types of comparisons
Any type of comparison group was included and was coded ac-
cording to the following.
1. ’Usual care’ or no additional intervention reported.
2. Less intensive interventions where the control group
received some of the intervention or an approximation of ’usual
care’ consistently provided by the research team.
3. Alternative interventions, where the control group
received different intervention components than the
intervention group, of the same intensity.
Types of settings
Any setting, including residential and community settings, family
planning clinics, pre-pregnancy planning clinics or general prac-
titioner clinics, prenatal care clinics and hospitals.
The ’PROGRESS-Plus’ criteria (Oliver 2008b; Ueffing 2009)
were used to categorise interventions which were provided for vul-
nerable populations, including: social capital; place of residence;
occupation; education; socio-economic status; ethnicity; age; or
other factors which might impact on vulnerability.
Types of outcome measures
Primary outcomes
1. Smoking abstinence in late pregnancy (point prevalence
abstinence):
i) self-reported or biochemically validated;
ii) biochemically validated only.
Secondary outcomes
1. Continued abstinence in late pregnancy after spontaneous
quitting (relapse prevention) in early pregnancy (self-reported or
biochemically validated).
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2. Smoking abstinence in the postpartum period (self-reported
or biochemically validated):
i) zero to five months;
ii) six to 11 months;
iii) 12 to 17 months;
iv) 18 months or longer.
3. Smoking reduction from the first antenatal visit to late
pregnancy:
i) reducing smoking (any definition, > 50% self-
reported, or biochemically validated);
ii) biochemical measures (cotinine and thiocyanate);
iii) cigarettes per day (self-reported).
4. Perinatal outcomes:
i) birthweight;
ii) low birthweight (less than 2500 g);
iii) very low birthweight (less than 1500 g);
iv) preterm births (less than 37 weeks);
v) stillbirths;
vi) neonatal deaths;
vii) all perinatal deaths;
viii) neonatal intensive care unit (NICU) admissions.
5. Mode of birth (caesarean section).
6. Breastfeeding initiation and breastfeeding at three and six
months after birth.
7. Psychological effects: measures of anxiety, depression and
maternal health status in late pregnancy and after birth.
8. Impact on family functioning and other relationships in
late pregnancy and postpartum.
9. Participants’ views of the interventions, both women’s and
pregnancy care providers’ views.
10. Measures of knowledge, attitudes and behaviour of health
professionals (obstetricians, midwives and family physicians)
with respect to facilitating smoking cessation in pregnancy.
11. Cost-effectiveness.
12. Adverse effects of smoking cessation programmes.
Search methods for identification of studies
This is the sixth update of this review and the details of previous
searches are described in other published versions of this review
(Lumley 1995c; Lumley 1995a; Lumley 1995b; Lumley 1995d;
Lumley 1999; Lumley 2004; Lumley 2009; Chamberlain 2013).
The followingmethods section of this review is based on a standard
template used by the Cochrane Pregnancy and Childbirth Group.
Electronic searches
We searched Cochrane Pregnancy and Childbirth’s Trials Register
by contacting their Information Specialist (13 November 2015).
The Register is a database containing over 22,000 reports of con-
trolled trials in the field of pregnancy and childbirth. For full search
methods used to populate Pregnancy andChildbirth’s Trials Regis-
ter including the detailed search strategies for CENTRAL, MED-
LINE, Embase and CINAHL; the list of handsearched journals
and conference proceedings, and the list of journals reviewed via
the current awareness service, please follow this link to the edi-
torial information about the Cochrane Pregnancy and Childbirth
in the Cochrane Library and select the ‘Specialized Register ’ sec-
tion from the options on the left side of the screen.
Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is
maintained by their Information Specialist and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE (Ovid);
3. weekly searches of Embase (Ovid);
4. monthly searches of CINAHL (EBSCO);
5. handsearches of 30 journals and the proceedings of major
conferences;
6. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Search results are screened by two people and the full text of all
relevant trial reports identified through the searching activities de-
scribed above is reviewed. Based on the intervention described,
each trial report is assigned a number that corresponds to a spe-
cific Pregnancy and Childbirth review topic (or topics), and is
then added to the Register. The Information Specialist searches
the Register for each review using this topic number rather than
keywords. This results in a more specific search set which has
been fully accounted for in the relevant review sections (Included
studies; Excluded studies; Ongoing studies).
Searching other resources
We also checked cited studies while reviewing the trial reports and
key reviews. We contacted the authors of any published protocols
or ’ongoing studies’ to ask if studies have been finalised. Where
necessary, we contacted trial authors to locate additional unpub-
lished data.
We did not apply any language or date restrictions.
[In addition, authors conducted a supplementary search for non-ran-
domised studies, for the background and discussion, in MEDLINE,
Embase, PsycLIT, and CINAHL (March 2013 to 31 May 2016)
using the search strategy detailed in Appendix 2.]
Data collection and analysis
For methods used in the previous version of this review, see
Chamberlain 2013. For this update, the following methods were
used for assessing the 16 new studies that were identified as a result
of the updated search.
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Selection of studies
Two review authors independently reviewed the full text of search
results from the Cochrane Pregnancy and Childbirth Group and
potential trials identified through other sources (CC/JP) to de-
termine if they met the inclusion criteria for this review. Where
there was disagreement, advice from co-authors was sought (AO/
JT/TC/SP) and consensus reached by discussion.
Data extraction and management
Two review authors (CC/JP) independently extracted data from
the published reports without blinding as to journal, author, or
research group. For each trial the following aspects were reported
and coded into EPPI-Reviewer 4 software (Thomas 2010). In-
dependent data extraction was checked and areas of conflicting
judgement were resolved by consensus, and where necessary dis-
cussion with co-authors. A summary of data collected is outlined
in Appendix 3 and a summary reported for individual studies in
the Characteristics of included studies table.
Assessment of risk of bias in included studies
We assessed the methodological quality of the included studies as
recommended in the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011). The ’quality assessment’ from pre-
vious reviews has been replaced with the ’Risk of bias’ assessment.
(1) Sequence generation (checking for possible selection
bias)
We have described for each included study the methods used to
generate the allocation sequence, and have assessed the methods
as:
• low risk of bias (any truly random process, e.g. random
number table; computer random number generator);
• high risk of bias (any non random process, e.g. alternate
clinic date; odd or even date of birth; hospital or clinic record
number);
• or unclear risk of bias.
Studies where sequence generation was assessed as inadequate and
there is a reasonable opportunity to interfere with random alloca-
tion (e.g. alternate clinic date) have been excluded in this update
of the review. Studies randomised by odd or even date of birth or
medical record number remain in this review, as there is limited
opportunity to manipulate the allocation.
(2) Equal baseline characteristics (checking for possible
selection bias)
To further assess the risk of selection bias, we assessed whether
the baseline characteristics were equal in each included study, and
have assessed them as:
• low risk of bias (baseline characteristics were assessed and
equal in both study arms);
• high risk of bias (where there were important differences in
baseline characteristics, suggesting possible bias in the selection
of participants);
• or unclear risk of bias.
(3) Allocation concealment (checking for possible selection
bias)
We have described for each included study the method used to
conceal the allocation sequence in sufficient detail to determine
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment. We
have assessed the methods as:
• low risk of bias (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• high risk of bias (e.g. open random allocation; unsealed or
non-opaque envelopes; medical record number; date of birth);
• or unclear risk of bias.
(4) Blinding (checking for possible performance bias) of
study participants and intervention providers
We have described for each included study the methods used, if
any, to blind study participants and intervention providers from
knowledge of which intervention a participant received. However,
it is rarely feasible in psychosocial interventions to blind women or
the intervention providers to group allocation. We have assessed
the methods as:
• low risk of bias;
• high risk of bias;
• or unclear risk of bias.
(5) Blinding (checking for possible performance bias) of
outcome assessor
We have described for each included study the methods used, if
any, to blind outcome assessors from knowledge of which inter-
vention a participant received as recommended (West 2005). We
have assessed the methods as:
• low risk of bias;
• high risk of bias;
• or unclear risk of bias.
(6) Dealing with incomplete outcome data (checking for
possible attrition bias through withdrawals, dropouts,
protocol deviations, and intention-to-treat analysis)
We have described for each included study and for each outcome
or class of outcomes the completeness of data including attrition
and exclusions from the analysis. We have noted whether attritions
and exclusions were reported, the numbers included in the analysis
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at each stage (compared with the total randomised participants),
reasons for attrition or exclusion where reported, and whether
missing data were balanced across groups. We considered it was
reasonable to exclude women from the final analysis who had
experiencedmiscarriage or fetal demise, developed serious medical
conditions, moved out of the area, or changed to another provider
of care. However, as there are also clear associations between these
outcomes and smoking, we have categorised the risk of attrition
bias as ’unclear’.Where possible, we included all other randomised
women in themeta-analysis.Where datawere not provided in such
a way to enable inclusion of all other randomised participants, we
have categorised these studies as high risk of attrition bias. We
have assessed the methods as:
• low risk of bias (outcomes for all randomised participants
included in analysis);
• high risk of bias (outcomes for all participants not reported,
particularly if unequal attrition in both study arms);
• or unclear risk of bias, which includes exclusions for
medical conditions or moving.
(7) Reporting all outcomes (checking for possible selective
reporting bias)
We have described for each included study how the possibility of
selective outcome reporting bias was examined by us and what we
found. We assessed the methods as:
• low risk of bias (where it is clear that all of the studies’ pre-
specified primary outcomes and all expected outcomes of interest
to the review have been reported);
• high risk of bias (where not all the studies’ pre-specified
outcomes have been reported); one or more reported primary
outcomes were not pre-specified; outcomes of interest are
reported incompletely and so cannot be used; study fails to
include results of a key outcome that would have been expected
to have been reported);
• or unclear risk of bias.
(8) Reliability of outcome measures used (checking for
possible detection bias)
The unreliability of self-report as a measure of smoking status in
healthcare settings, especially in maternity care (Pettiti 1981), was
noted even in the first pregnancy trial (Donovan 1977).While this
finding has not always been consistent (Windsor 1985 (AvC); Fox
1989; Pickett 2009), the majority of other trials show substantial
misclassification by self-report, with up to a quarter or a third of
women who describe themselves as non-smokers having levels of
salivary or urine cotinine (a metabolite of nicotine) incompatible
with their self-description (Mullen 1991; Peterson 1992; Kendrick
1995; Lillington 1995; Walsh 1997; Moore 2002; Tappin 2005;
Parker 2007 (AvC)). A degree of misclassification is not surprising
given the social stigma associated with smoking in pregnancy, and
there appears to be less misclassification in non-pregnant popula-
tions (Patrick 1994). Some studies suggest that measurement of
abstinence is reasonably accurate, but that there is greater inconsis-
tency with reporting the amount of cigarettes smoked (Klebanoff
1998; Venditti 2012). Given this potential for bias, biochemical
validation of smoking abstinence is now the standard for smok-
ing cessation studies (West 2005; Shipton 2009). Use of cotinine
concentration (saliva, urine or plasma) is the most sensitive and
specific (saliva less than 15 ng/mL and urine less than 50 ng/
mL). However, cotinine does not distinguish between smoking
and use of nicotine replacement products, so expired air carbon
monoxide is the preferred method for detecting recent smoking
(less than 9 ppm) in many studies. Trials measuring cotinine need
to ask participants about NRT use (available over the counter),
ignore high levels in NRT users, and verify smoking abstinence
with carbon monoxide levels (West 2005). However, studies in-
cluding use of NRT did use cotinine cut-offs to distinguish be-
tween smokers and non-smokers (Hegaard 2007; Eades 2012).
There may also be differential misclassification between interven-
tion and control groups, though no investigations have published
this effect. Where > one validation method of smoking outcomes
were reported (e.g. Ondersma 2012 (A+C v B+D)), we chose find-
ings determined by the validation methodwhich could potentially
validate the longest period of abstinence. Therefore, in this paper
where reported smoking status at the same time point was vali-
dated by two different measures (cotinine and expired air carbon
monoxide) and these were reported separately (Ondersma 2012
(A+C v B+D), we used the cotinine-validated results. We have
described for each included study whether the smoking outcome
was biochemically validated (including measures used) or assessed
by self-report only, and have included data on misclassification by
self-report where they have been reported:
• low risk of bias (biochemical validation);
• high risk of bias (no biochemical validation);
• or unclear risk of bias (including partial biochemical
validation of a sample of the study population).
(9) Risk of control group contamination
Exposure of the control group to aspects of the intervention is
a common challenge for intervention trials, particularly studies
where healthcare providers are required to offer an intervention to
some women, and not to others. Some trials use cluster-randomi-
sation in order to reduce the risk of contamination, particularly
when healthcare providers are involved in the intervention. The
most likely impact is to increase the effect in the control arm, re-
ducing the potential effect size between the intervention and con-
trol arms of the study. We have assessed the methods as:
• low risk of bias, where the intervention providers are
separate from the control group or strategies are employed to
minimise the risk (such as cluster-randomisation);
• high risk of bias, where the same provider is required to
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administer the intervention to both study arms, or there is
specific reporting of suspected contamination in the trial report;
• or unclear risk of bias.
(10) Other bias
Wehave considered any other potential sources of bias in the study,
and assessed these as:
• low risk of bias;
• high risk of bias;
• or unclear risk of bias.
Implementation of intervention (intervention fidelity)
We also assessed the impact of implementation or intervention
fidelity on the effect. There are three main types of potential im-
plementation problems trials (Walsh 2000): not all participants in
the intervention groups receiving the intervention; intervention
group participants not receiving all components of the interven-
tion; control groups receiving the intervention. Failure to imple-
ment the intervention as planned limits the exposure of women to
the intervention, and may negatively impact on the effectiveness
of the intervention. Where possible, we included a description of
any process evaluation reported. We have assessed the implemen-
tation of the intervention as:
• low risk of bias (where process evaluation suggests the
majority of participants received the intervention as planned);
• high risk of bias (where process evaluation suggests a
significant proportion (>= 50%) of women did not receive the
intervention as planned);
• or unclear risk of bias (where process evaluation is not
reported).
Assessing the quality of the evidence using GRADE
For this update the quality of the evidence was assessed using the
GRADE approach as outlined in the GRADE handbook in order
to assess the quality of the body of evidence in two ’Summary
of findings’ tables, based on information considered important to
decision-makers.
1. The first ’Summary of findings’ table summarises the
primary outcome effect (smoking abstinence in late pregnancy)
for each of the main intervention comparisons with usual care.
Any significant differences in outcomes by different comparison
group, subgroup (single, multiple or tailored), or if smoking
cessation is one component of a broader maternal health
intervention are noted under ’comments’. Similarities are noted
in footnotes.
2. The second ’Summary of findings’ table summarises the
following outcomes for ’all interventions compared to all
controls’.
• Not smoking in late pregnancy (summary of meta-
regression analyses)
• Not smoking at zero to five months postpartum
• Low birthweight
• Preterm births
• Birthweight
• Stillbirths
• Neonatal intensive care unit (NICU) admissions
• Psychological effect
We used GRADEpro Guideline Development Tool to create
’Summary of findings’ tables. A summary of the intervention effect
and an assessment of quality for each of the above main interven-
tions strategies and outcomes was produced using theGRADE ap-
proach. The GRADE approach considers five criteria (study lim-
itations, consistency of effect, imprecision, indirectness and pub-
lication bias) to assess the quality of the body of evidence for each
intervention strategy and outcome. The evidence can be down-
graded from ’high quality’ by one or two levels for serious, or very
serious, limitations, based on the assessments for each of the cri-
teria.
Measures of treatment effect
Dichotomous data
For dichotomous data, we calculated risk ratios (RR) with 95%
confidence intervals (CIs). Smoking cessation outcomes are re-
ported as an ’RR’ for quitting, in line with other Cochrane To-
bacco Group reviews. Therefore, RRs > 1 for the smoking cessa-
tion outcomes indicate benefit of the intervention. For undesirable
outcomes, such as preterm births and low birthweight infants),
RRs < 1 indicate benefit of the intervention.
Continuous data
For continuous data, we used the mean difference (MD) if out-
comes were measured on the same scale across trials (e.g. birth-
weight). We used the standardised mean difference (SMD) when
trials measured the same underlying concept (e.g. biochemically-
validated smoking reduction), but used different methods.
In one study (Donovan 1977), the SD was calculated from the
standard error (SE). Where no SDs or SEs were reported, we im-
puted the missing SDs with the mean SD from the available tri-
als, as recommended in the Cochrane Handbook Section 16.1.3.1
(Higgins 2011). The mean of the birthweight SDs was calculated
from 13 trials with available SDs in 2013 (mean SD 578), and
imputed for six trials. The mean of the cigarettes per day SDs was
calculated from 14 trials with available SDs in 2013 (mean SD
6.5), and imputed for five trials.
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Unit of analysis issues
There are good reasons for considering random allocation of mid-
wives, clinics, health educators, hospitals, general practitioners,
or antenatal classes to intervention or comparison group, rather
than random allocation of pregnant women. It may be difficult for
pregnancy care providers to treat women differently according to
the intervention or usual care protocol, and not to introduce co-
interventions in one or other groups (contamination). However,
womenwithin a cluster aremore likely to be similar to one another,
and less like the women in another cluster, resulting in correlated
outcomes. Standard statistical methods assume independence of
outcomes, and their use in these trials may result in artificially
small P values and overly narrow CIs. Therefore, in cluster trials
which had not used a statistical method that appropriately ad-
justed for the correlation (e.g. generalised estimating equations),
we adjusted for the clustering through the calculation of a design
effect, as described below.
Adjustment for cluster-randomisation was conducted using a re-
ported intra-cluster correlation (ICC) if available, and if not, a
range of ICCs (from 0.003 to 0.20) was assumed and a sensitiv-
ity analysis conducted as recommended by Merlo 2005. The re-
sults of the sensitivity analyses showed no substantial difference
between the different ICCs. As such, for studies in which an ICC
was not reported, an ICC value of 0.10 was used for the primary
analysis and the cluster trials were included by adjusting the SEs
(reported ICCs were used where available). The methods used for
individual studies are reported in the Characteristics of included
studies and are available on request from the corresponding au-
thor. The adjustment involved reducing the size of each trial to
its ‘effective sample size’ by dividing the sample size by the ’design
effect’, where the design effect is equal to 1 + (m - 1) × ICC, and
m is the average cluster size (see Section 16.3.4 of the Cochrane
Handbook, Higgins 2011).
All study arms are included in this review in accordance with the
Cochrane Handbook (Higgins 2011). The study arms are indi-
cated in the study ID label with an ’A’ for the control arm, and
subsequent arms denoted as ’B’, ’C’ and ’D’ (e.g. Albrecht 2006
(AvB); Albrecht 2006 (AvC)). To avoid ’multiply-counting’ par-
ticipants in meta-analyses that included multiple pair-wise com-
parisons with the same control group, we appropriately reduced
the control event rate and sample size so that the same partici-
pants did not contribute more than once. When the number of
participants in the control arm was odd, we randomly allocated
the additional participant with equal probability to a comparison
by ’coin toss’ (heads = largest number to first study arm). There
are several instances where the control arm did not need to be
split in the main comparison (Ershoff 1999 (AvB); Ershoff 1999
(AvC); McBride 2004 (AvB); McBride 2004 (AvC); Parker 2007
(AvB); Parker 2007 (AvC); Bullock 2009 (A+C v B+D); Bullock
2009 (AvC); Bullock 2009 (AvD); Ondersma 2012 (A+C v B+D);
Ondersma 2012 (AvC); Ondersma 2012 (AvD)), but then has
subsequently been split in the final ’all interventions versus all
controls’ comparisons, and these are noted in the Characteristics
of included studies table.
To best utilise the available results from factorial (2 x 2) design
studies, we combined arms to isolate the ’intervention effect’ of
particular strategies where possible (e.g. Bullock 2009 (A+C v
B+D); Ondersma 2012 (A+C v B+D)).
Dealing with missing data
Due to the nature of the intervention, there is a high likelihood
that women withdrawing from the study or not providing a bio-
chemical sample for analysis, without a ’plausible explanation’ (e.g.
miscarriage/fetal demise, moving out of the area or changed to an-
other provider of care) are likely to be continuing smokers. Where
sufficient information has been reported or has been supplied by
the trial authors, we have re-includedmissing data from each treat-
ment group in the analyses to comply with recommended out-
come criteria assessment for smoking cessation trials (West 2005).
That is, we have assumed that missing women have continued to
smoke. Only data which were excluded for medical reasons (e.g.
miscarriage or preterm birth) or moving from a study site were not
re-included in this review. We have indicated where an intention-
to-treat (ITT) (or available-case) analysis was carried out for the
smoking cessation outcome in the published report, or adjusted for
this review. These assessments and any adjustments are reported
in the ’Risk of bias’ tables (see incomplete outcome data). Where
data could not be re-included, these studies were categorised as
high risk of attrition bias and we conducted sensitivity analysis to
determine the effect of inclusion of these trials.
Assessment of heterogeneity
We considered both clinical and statistical heterogeneity. For the
primary outcome, we did not calculate an overall pooled effect
size for all intervention types versus all comparison types because
clinical heterogeneity makes the overall effect size difficult to in-
terpret.
We examined levels of heterogeneity in all pooled analyses
(Cochran 1954).We assessed for heterogeneity visually by inspect-
ing the overlap of CIs on the forest plots, and quantified hetero-
geneity using the I² statistic (Higgins 2011), which provides a
measure of the degree of inconsistency in the trial effects (Lipsey
2001; Higgins 2011).
We expected to find a substantial degree of heterogeneity given the
breadth of types of interventions, which are broadly categorised as
’psychosocial’ and the differences in comparisons. Therefore, we
attempted to minimise heterogeneity by reporting separate com-
parisons for each main intervention strategy (counselling, health
education, feedback, incentives, social support and exercise; and
whether the intervention was provided as a specific smoking inter-
vention or as part of a broader intervention to improve maternal
health) and comparison type (usual care, less intensive interven-
tion, or alternative intervention). Further, we subgrouped studies
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within each comparison according to whether the intervention
was provided as a single, multiple or tailored intervention for sub-
group analyses within the forest plots.
To indicate substantial statistical heterogeneity, we set a threshold
of inconsistency of I2 > 75%. Where substantial heterogeneity ex-
isted, two review authors visually inspected the data in the forest
plot (CC/JM), and we did not present a pooled effect estimate
if the constituent effect estimates sat on either side of the null
value (e.g. 1 for RRs, and 0 for SMDs/MDs) with non-overlap-
ping CIs. We further explored heterogeneity through examination
of treatment by covariate interactions. These analyses were pre-
specified and identified during development of a logic model (see
Figure 1 and section on Subgroup analysis and investigation of
heterogeneity for a description).
Assessment of reporting biases
We used a funnel plot to investigate if there was evidence of small-
study effects for the overall comparisons (Analysis 20.1, Figure 2)
(Sterne 2001; Higgins 2011). In the absence of publication bias,
we would expect a roughly symmetrical distribution of effect sizes
in the inverted funnel shape. Two review authors (CC/JM) inde-
pendently examined the plot for evidence of small-study effects.
Figure 2. Funnel plot of comparison: 20 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, outcome: 20.1 Abstinence in late pregnancy: self-reported and
biochemically validated.
Data synthesis
For the meta-analyses, we used the statistical methods as imple-
mented in RevMan 2014. We chose to use random-effects models
because of the expected diversity in the interventions. We used
the Mantel-Haenszel method to combine effects across the trials,
with the between-trial variance estimated using DerSimonian and
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Laird’s method of moments estimator (DerSimonian 2007).
For two of the binary outcomes, abstinence in late pregnancy and
perinatal deaths, zero cell counts for events in both the treatment
and control groups occurred for one trial each. The affected stud-
ies were Olds 1986; Tuten 2012 (AvB) (abstinence in late preg-
nancy) and Valbo 1996 (perinatal deaths). The affected analy-
ses are Analysis 18.1, Analysis 18.2, Analysis 20.1, and Analysis
20.2 for Olds 1986; Analysis 9.1; Analysis 9.2; Analysis 20.1;
and Analysis 20.2 for Tuten 2012 (AvB); and Analysis 1.16 and
Analysis 20.16 for Valbo 1996. While these trials are included in
the forest plot, they are implicitly deleted from the meta-analysis,
since our chosen meta-analysis method cannot use the informa-
tion from double-zero trials. While it is possible that excluding
these trials may introduce some bias (Kuss 2015), any impact is
likely to be small because these trials generally contribute only a
small amount of information to the meta-analyses.
The number needed to treat for an additional beneficial outcome
(NNTB) (Altman 1998) was calculated to give an approximation
of how many women would need to receive the intervention for
one of them to avoid an adverse outcome. We based the compu-
tation on the random-effects odds ratio, since, unlike the RR, the
odds ratio is invariant to whether the outcome is presented as a
beneficial or harmful outcome (Cates 2002).
Finally, we fitted random-effects meta-regressions to explore fac-
tors (described below) hypothesised to explain heterogeneity in
the observed RRs for the primary outcome, smoking abstinence.
We used the restricted maximum likelihood between-trial vari-
ance estimator with the Knapp and Hartung adjustment (Higgins
2004b). Factor levels (e.g. counselling as a level of main interven-
tion strategy) were only included if there were at least three tri-
als, otherwise they were excluded from the meta-regression. The
reported coefficients provide an estimate of the ratio of RRs for
each category compared to the reference category. We present ad-
justed R2, which is the percentage of between-trial variance that
is explained by the factor, and the I2res which is the percentage
of residual between-trial variation that is due to heterogeneity as
opposed to within-trial sampling variability (Harbord 2008). We
used the metareg command in Stata version 14.0 (Statacorp 2015)
to fit the meta-regressions.
Subgroup analysis and investigation of heterogeneity
Investigation of heterogeneity is critical in such a large review that
includes many different types of interventions and comparisons. It
is likely that there are significant differences between studies based
on characteristics of the interventions, participants, comparisons,
study bias etc, as outlined in Figure 1.
Subgroup analyses
Asdescribed inAssessment of heterogeneity (above), we conducted
subgroup analyses (in RevMan 2014) by whether the interven-
tions were provided as single, multiple or tailored interventions.
Since the establishment of these subgroups within separate com-
parisons (usual care, less intensive or alternative interventions) for
each main intervention strategy, the number of analyses with sub-
stantial heterogeneity (I2 > 75%) are very few (total of six), and
the majority are low (I2 < 30%); when compared to high rates
of heterogeneity within main comparisons in previous versions of
the review.
In the section on Assessment of heterogeneity above, we described
how we identified the presence or absence of heterogeneity; in the
current section,we describe howwe attempted to identify themain
sources of variability in the effect-size estimates, that is, to attempt
to explain inconsistency across studies. We therefore explored how
the observed effectiveness differs under different conditions. We
used two main methods to investigate heterogeneity.
1. Meta-regression.
2. Weighted pooled effect size estimate for subsets of studies.
Meta-regression
The following factors hypothesised to explain heterogeneity were
investigated using meta-regression analyses for the primary out-
come of smoking abstinence in late pregnancy (from Analysis
20.1). The reference categories for each analysis are reported in
Table 2.
1. Main intervention strategy (counselling, health education,
incentives, feedback, exercise, social support, or other).
2. Smoking cessation interventions versus broader maternal
health interventions with a smoking cessation component.
3. Comparison type (usual care, less intensive interventions,
or alternative interventions.
4. Intensity of the intervention (duration and frequency).
5. Efficacy (interventions administered by research staff ),
effectiveness (interventions administered by routine staff ) and
dissemination trials.
6. Features of the intervention (self-help manuals and
telephone support).
7. Socio-economic status (SES) of the participants (’low SES’
versus ’not low SES’).
8. Newly included studies in this review update.
We used meta-regression to examine whether domains of risk of
bias were associated with the magnitude of intervention effects.
We examined the following domains.
1. Random sequence generation selection bias.
2. Equal baseline characteristics in study arms.
3. Allocation concealment selection bias.
4. Incomplete outcome data attrition bias.
5. Selective reporting bias.
6. Detection bias (biochemical validation of abstinence).
7. Blinding of participants and personnel.
8. Blinding of outcome assessment.
9. Contamination of control group.
10. Other bias.
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We also assessed the effect of intervention fidelity or implementa-
tion on the primary outcome.
Heterogeneity in the secondary outcomes
Due to the small number of trials reporting results for the 16
secondary outcomes, we did not conduct analyses investigating if
the ’Risk of bias’ domains explained heterogeneity in the observed
effect estimates for these outcomes.
For secondary smoking cessation/reduction outcomes, we did not
calculate an overall pooled effect, but instead focused on compar-
isons within clinically homogeneous subsets. However, for infant
outcomes, we calculated overall pooled effect sizes for all inter-
vention types versus all comparison types, for two reasons. Firstly,
there was less extreme clinical heterogeneity in terms of interven-
tion strategy in the infant outcomes. Secondly, as a primary objec-
tive of this review is to determine whether psychosocial interven-
tions to support women to abstain from smoking in pregnancy
have an impact on infant and maternal health outcomes, and large
numbers are needed to detect relatively rare events, the pooled in-
fant outcomes are informative. The overall pooled effect size esti-
mates demonstrate the relationship between being randomised to
a smoking cessation intervention and birth outcomes only, rather
than the effectiveness of any particular intervention strategy.
Meta-analyses of subsets of studies on primary outcomes
A number of potentially significant factors were identified as out-
lined in ’why it is important to do this review’ and Figure 1 (e.g.
where ’counselling’ was provided by a video-tape, text or com-
puter rather than in person; where ’counselling’ included optional
provision of NRT or incentives such as lottery tickets; where the
counselling intervention included support from peers and/or part-
ners to quit or for partners to quit; and interventions provided for
ethnic minority or indigenous groups etc.). The studies with these
characteristics were coded and meta-analyses were calculated for
these subset of studies. Changes in effect size and heterogeneity
from removing the remaining studies in the comparison were ex-
amined.
Descriptions of trends across studies
To gain a greater understanding of key issues that we were not able
to synthesise statistically, we present narrative summaries of the
within-study reports of intervention effectiveness for dissemination
trials; intervention effectiveness by ethnicity of the participants;
and other participant characteristic analyses reported by individual
study authors.
Sensitivity analysis
As noted above, we used meta-regression rather than sensitivity
analysis to explore heterogeneity in this review. We explored a
limited range of factors as described in ’meta-analysis of subsets of
studies’, and these are reported in the results text.
R E S U L T S
Description of studies
Results of the search
The original version of this review included a total of 19 studies
identified up until 1993 included as separate reports in the Preg-
nancy and Childbirth CD Rom: Behavioural strategies for reducing
smoking (n = 9) (Lumley 1995c); Counselling for reducing smoking
in pregnancy (n = 1) (Lumley 1995a); Advice as a strategy for reduc-
ing smoking (n = 6) (Lumley 1995b); and Feedback as a strategy for
reducing smoking (n = 3) (Lumley 1995d).
Following publication of a protocol in 1998, a search was con-
ducted by the Pregnancy and Childbirth Group for the second
update of the review published in the Cochrane Library in 1999.
This update included a total of 44 trials: 37 trials including 16,916
women providing data on smoking cessation and over 800 women
in five trials of relapse prevention (Lumley 1999).
The third update in 2004 was based on a search until July 2003
conducted by the Pregnancy and Childbirth Group, the Tobacco
Addiction Group Trials Register and a search of MEDLINE, Em-
base, PsycLIT and AustHealth. A total of 65 trials were included
involving over 20,000 women: 48 trials provided data on smoking
cessation, six additional cluster trials involving over 7500 women
were not included in the meta-analysis (Lumley 2004).
In the fourth update, published in 2009; a search from January
2003 to June 2008 identified 898 reports which were screened,
the full text of 35 reports were reviewed and a total of 73 studies,
involving over 20,000 women, were included (72 provided out-
come data): 56 randomised and quasi-randomised trials and nine
cluster-randomised trials provided primary outcome data for this
update (Lumley 2009).
In the fifth update, published in 2013; we screened 2030 abstracts
(in addition to the search of the Pregnancy and ChildbirthGroup’s
Trials Register) and reviewed the full text of 64 reports. We iden-
tified 16 new studies meeting the inclusion criteria. As a result of
a change in the inclusion criteria we excluded 13 studies from the
previous version of the review, including nine quasi-randomised
trials, as well as four randomised controlled trials of pharmaco-
logical interventions, which are now included in a separate review
(Coleman 2015). We also included four studies that had been
previously excluded (three cluster trials and one abstract report of
a trial), as well as nine studies that did not report any outcomes
which could be used in meta-analyses, and which are reported in
a separate table. We combined two reports of relapse prevention
(Ershoff 1995; Secker-Walker 1995) as ‘Associated references’ to
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the primary papers reporting smoking cessation (Ershoff 1989;
Secker-Walker 1994), and another paper which did not report
any usable outcomes (Solomon 1996) as an ’Associated reference’
to the primary report (Secker-Walker 1998). A total of 77 ran-
domised controlled trials, involving over 25,000 women with rel-
evant outcome data, were included in the meta-analysis for this
report (primary outcome data for 21,948 women participating
in 70 trials and secondary outcome data only for a further 7404
women participating in seven trials). A further nine trials without
outcomes were included, making a total of 86 studies.
In this sixth update, we screened 46 reports from studies from the
Pregnancy and Childbirth Group register, 14 reports from studies
identified through additional searching and contacted the authors
for 14 (seven from previous update) ongoing studies (n = 67 re-
ports of new studies).We excluded 12 studies and reasons are listed
in Characteristics of excluded studies. We identified 25 reports
’associated with’ primary included’ or ’excluded’ studies, 13 ’on-
going studies’ and 16 new studies. We also included an additional
18 arms from multi-arm studies in this update, making a total of
102 studies with 120 ’study arms’. Included studies involved over
30,000 women with relevant outcome data, including primary
smoking cessation outcome data provided for 28,403 women par-
ticipating in 88 studies (106 study arms). Ninety-seven of these
study arms included smoking outcome data among women who
were categorised as ’smokers’ in early pregnancy and are included in
meta-regression. A further 14 studies without smoking outcomes
reported are included in the review but results are summarised in
Table 1. However, some new trials have been published during
review preparation, after the search date, and will be included in
the next update.
See Figure 3 for summary of search results.
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Figure 3. Flow chart of included studies
24Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Included studies
Participants
Over 26,000 pregnant women participating in 88 trials (106 study
arms) with outcomes included in the meta-analysis were assessed
as current or recent ‘smokers’ at recruitment. The criteria used to
assess a woman as a ‘smoker’ varied substantially between trials,
and are detailed for each study in the Characteristics of included
studies table. There were 1766 women who reported they had
’spontaneously quit’ smoking when they became pregnant, and
had outcomes reported separately from women who continued
to smoke. In one study only one third of the study population
smoked commercial cigarettes, while two thirds chewed traditional
or commercial smokeless tobacco (Patten 2009).
Participants were generally healthy pregnant adult women over
16 years of age, with 23 trials explicitly excluding women with
medical and/or psychological complications. While smoking in
pregnancy is recognised as a strong marker of low socio-economic
status, approximately half the trials (n = 52 trials, 66 study arms)
explicitly included women categorised as having low socio-eco-
nomic status; 51 of these measured the primary outcome. Most
trials included women over 16 years of age, with only two trials
explicitly targeting young women under 20 years (Albrecht 1998;
Albrecht 2006 (AvB); Albrecht 2006 (AvC)) and several broader
maternal health programs targeting ’young mothers’ as at least
one criteria (Olds 1986; Kemp 2011; Mejdoubi 2014; Robling
2016). Eight trials were specifically targeted towards women with
‘psychosocial risk factors’ (Graham 1992; Belizan 1995; Albrecht
1998; El-Mohandes 2011; Albrecht 2006 (AvB); Albrecht 2006
(AvC); Kemp 2011; Mejdoubi 2014; Olds 1986), and two tri-
als were conducted among women requiring methadone treat-
ment for opioid addiction (Haug 2004; Tuten 2012 (AvB); Tuten
2012 (AvC)). Most trials recruited women at the first antenatal
clinic visit and during the second trimester of pregnancy, excluding
women in the last trimester due to limited time remaining to re-
ceive the intervention. However, four trials were explicitly targeted
towardswomenwho continued to smoke in late pregnancy (’heavy
smokers’) (Valbo 1994; Valbo 1996; Stotts 2002; Stotts 2009
(AvC)). Ten studies included mainly (> 50%) women belonging
to an ethnicminority population (Graham 1992; Lillington 1995;
Gielen 1997; Manfredi 1999; Cinciripini 2000; Malchodi 2003;
Dornelas 2006; El-Mohandes 2011; Ondersma 2012 (A+C v
B+D); Lee 2015). Three trials were conducted in indigenous com-
munities (Oxford Dictionary 2016) among Aboriginal women in
Australia (Eades 2012), Alaskan Native women the US (Patten
2009),Maori women inNewZealand (Glover 2014 (AvB); Glover
2014 (AvC)), and one trial includedmore than40%Maori women
in New Zealand (McLeod 2004). Thirty-five studies explicitly
excluded women who were not able to speak English (n = 35),
English or Spanish (Malchodi 2003; Mauriello 2013), Greek
(Loukopoulou 2012), Danish (Hegaard 2003), Dutch (Mejdoubi
2014) or Swedish (Hjalmarson 1991). In 12 studies access to a
telephone,mobile phone, computer or video recorder was required
for participation in the study.
Interventions
Of the studies which had outcomes included in the meta-analy-
sis (n = 106/120 study arms): 94 were aimed exclusively at sup-
porting smoking cessation, and the main intervention strategies
were categorised as counselling (n = 54), health education (n =
12), feedback (n = 6), incentives (n = 13), social support (n =
7) and exercise (n = 1). In one study the intervention was clas-
sified as ’intensive dissemination’ as both arms received the same
counselling intervention, with only the dissemination differing
(Campbell 2006), and is therefore reported as a separate compar-
ison. In 12 studies, the primary aim of the study was to improve
maternal health, which included a smoking cessation component
of counselling (El-Mohandes 2011; Wilkinson 2012); health ed-
ucation (Bullock 2009 (A+C v B+D)); feedback (Reading 1982;
LeFevre 1995); social support (Olds 1986; Belizan 1995; Bullock
1995; Bullock 2009 (AvC); Bullock 2009 (AvD);Mejdoubi 2014;
Robling 2016). These studies are reported as separate comparisons
and only smoking outcomes are included, as there is potential for
other aspects of these interventions to impact on birth outcomes.
One trial was designed exclusively for women who had sponta-
neously quit smoking (Lowe 1997), and 14 trials included a relapse
prevention component for women who had spontaneously quit.
Interventions which were provided only during the postpartum
period were excluded from this review, though many interventions
during pregnancy continued support into the postpartum period
and measured postpartum outcomes.
Smoking cessation interventions implemented during pregnancy
differ substantially in their intensity, their duration, and the people
involved in their implementation. In 57/106 study arms the in-
tervention was coded as a single intervention, therefore the ’main
intervention strategy’ most accurately reflects the type of inter-
vention. However in 36 study arms the intervention was coded
as ’multiple’, where other components of the intervention were
offered to all women. In 12 studies the intervention was coded
as ’tailored’ whereby different intervention components were of-
fered and tailored to women’s needs. For example, two trials of-
fered optional nicotine replacement therapy (NRT) as part of a
counselling intervention (Hegaard 2003; Eades 2012), and one
trial offered NRT to both intervention and control participants
(Patten 2009). Of the 56 study arms coded as counselling, most
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involved face-to-face contact, using a variety of strategies either
alone or in combination (such as motivational interviewing, cog-
nitive behavioural therapy, stages of change). Four trials with the
main intervention strategy coded as counselling included a lottery
chance for womenwho reported quitting (Lillington 1995; Sexton
1984; Walsh 1997; Parker 2007 (AvC)); nine included support
from peers and/or partners with three of these including support
for partners to quit (Thornton 1997; Vilches 2009 (AvB); Vilches
2009 (AvC); Vilches 2009 (AvD); Eades 2012). The duration and
frequency of the intervention also varied considerably, and has
generally increased over time, as illustrated in Figure 4 and Figure
5
Figure 4. Intensity (duration) of interventions and controls over time
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Figure 5. Intensity (frequency) of interventions and controls over times
Twenty of the interventions involved telephone counselling and
in five of these studies all counselling was provided via telephone
(Ershoff 1989; Bullock 1995; Solomon 2000; Stotts 2002; Rigotti
2006), and one had only brief additional face-to-face contact
(Bullock 2009 (AvD)). Thirty-eight study arms included self-help
manuals as part of the intervention, and in 27 study arms there
was a brief introduction to the manuals (less than five minutes)
and the intervention was therefore coded as counselling, with sen-
sitivity analysis conducted to assess the independent effect of these
studies. In 10 study arms the intervention involved use of a video;
11 study arms included use of computers in the intervention.
Studies using tools or technology where there was no clear per-
sonal contact were coded as health education, including: self-help
manuals (Lilley 1986; Hjalmarson 1991; Bullock 2009 (A+C v
B+D)); text messaging (Naughton 2012; Pollak 2013); audiotape
(Peterson 1992); and computer (Ershoff 1999 (AvB); Ondersma
2012 (A+C v B+D); Herbec 2014). Three other studies that re-
ported the intervention consisted of advice to quit only, either in
person (Donovan 1977; Lilley 1986) or by post (Burling 1991)
were coded as health education.
Among all 120 study arms with and without outcomes: six dissem-
ination trials were identified, carried out in Australia (Lowe 2002;
Campbell 2006), the US (Manfredi 1999; Pbert 2004; Windsor
2011), and Europe (Oude Wesselink 2014). Three trials reported
only dissemination outcomes (Manfredi 1999; Lowe 2002; Oude
Wesselink 2014), and not the primary outcomes of abstinence
in late pregnancy, therefore outcomes not able to be included
in the meta-analysis are reported in Table 1. Nine studies (with
12 study arms) were cluster-randomised at service level, provid-
ing an indication of implementation under routine care condi-
tions (Messimer 1989; Kendrick 1995; Lillington 1995; Lawrence
2003 (AvB); Lawrence 2003 (AvC); Pbert 2004; Polanska 2004;
Campbell 2006; Vilches 2009 (AvB); Vilches 2009 (AvC); Vilches
2009 (AvD); OudeWesselink 2014); while four studies were clus-
ter-randomised at provider level (Haug 1994; Hajek 2001; Moore
2002; McLeod 2004). In 27 study arms the intervention was pro-
vided by staff involved in routine pregnancy care (coded as effec-
tiveness studies), and in 70 study arms the intervention was pro-
vided by dedicated research project staff (coded as efficacy stud-
ies), with 11 coded as unclear or not applicable as dissemination
trials or the intervention was automated (e.g. text messaging) or
provided by use of other materials (e.g. mail-outs).
Comparisons
Women in the control arms in 56 of 106 study arms with pri-
mary outcome data received ’usual care’ in relation to smoking
cessation, which generally included information about the risks
of smoking and advice to quit. In 44 study arms the comparison
group received some kind of ’less intensive’ intervention, which
included studies where a dedicated research team consistently pro-
vided what they considered to be ’usual care’ for women in the
comparison group. In six study arms the comparison group re-
ceived an ’alternative intervention’, which was categorised as hav-
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ing the same intensity (duration and frequency) as the intervention
group, providing a comparison as close to a ’placebo-controlled
trial as is feasible for psychosocial interventions, to assess the inde-
pendent effect of the intervention component). One was a coun-
selling intervention using cognitive behavioural therapy compared
with traditional health education (Cinciripini 2010), one com-
pared two types of text messaging strategies (Pollak 2013), and
four compared provision of incentives, contingent or not contin-
gent on smoking status (Heil 2008; Higgins 2014 (AvB); Higgins
2014 (AvC); Harris 2015). As expected, the intensity of both in-
terventions and controls has increased over time, as indicated by
the change in frequency (Figure 4) and duration of contact during
the interventions (Figure 5).
Setting
Included trials were conducted between 1976 and 2015 and al-
most all trials were conducted in high-income countries. Among
106 study arms with primary outcome data, these include: the
USA (n=68), theUK (n=18), Europe (Norway,Holland,Nether-
lands, Sweden, Spain, Poland) (n = 10), Australia/New Zealand
(n = 9) and South America (n = 1). Despite the rapid increases in
smoking in pregnancy, only two studies were conducted in low-
or middle-income countries (Belizan 1995; Polanska 2004): one
trial was conducted in four Latin American countries (Argentina,
Brazil, Cuba and Mexico) (Belizan 1995), and the other in Poland
(Polanska 2004). Neither trial had biochemically validated smok-
ing outcomes. Two studies were conducted in Canada (Hughes
2000; Prapavessis 2014), and one in Greece (Loukopoulou 2012).
Most trials of interventions to support pregnant women were con-
ducted in public hospitals or community antenatal clinics.
Outcomes reported
Primary outcomes
Among the 106 study arms with data; 86/91 individually-ran-
domised and 11/15 cluster-randomised study arms reported the
primary outcome measure of smoking abstinence in late preg-
nancy, up to and including the period of hospitalisation for birth,
and in 71 study arms, the abstinence was biochemically validated.
This includes 26,640 women classified as ’current smokers’ and
1766 women who were classified separately as having ’sponta-
neously quit’ in early pregnancy, although in many studies these
womenwere grouped together as ’current smokers’. Fourteen stud-
ies did not report any outcomes that could be included in meta-
analysis and a summary table of outcomes for these studies is re-
ported in Table 1.
Secondary outcomes included in meta-analysis
Continued abstinence in the postpartum period was categorised
as zero to five months (n = 35 study arms), six to 11 months (n
= 19), 12 to 17 months (n = 6) and 18 months and over (n =
4). Two of these trials did not have outcomes in late pregnancy
as the assessment was undertaken at home after birth (Strecher
2000; Polanska 2004). Continued abstinence for baseline smokers
and spontaneous quitters are combined in this outcome measure
for some studies, with abstinence among baseline smokers only
reported where available. The details of the outcomes for each
study are reported in the Characteristics of included studies table,
with those marked with an * included in meta-analysis.
Various measures of smoking reduction in late pregnancy were
reported, including self-reported ’any reduction’ (n = 5), self-re-
ported reduction greater than 50% (n = 4), and biochemically
validated reduction (n = 9). Three study arms recorded both self-
reported and biochemically validated reduction (Windsor 1985
(AvB);Windsor 1985 (AvC); Tappin 2005); in these cases we have
included only the validated data in the analysis. Other reduction
measures of reduced smoking included mean biochemical coti-
nine (n = 10) thiocyanate (n = 1), or mean cigarettes per day (n =
24). Three studies (five study arms) that reported smoking reduc-
tion did not include the primary outcomes of smoking abstinence
(Donovan 1977; LeFevre 1995; Vilches 2009 (AvB); Vilches 2009
(AvC); Vilches 2009 (AvD)).
Twenty-six study arms reported mean birthweight, one of which
had not reported any smoking cessation outcomes (Haddow
1991). Seventeen study arms reported rates of low birthweight ba-
bies (less than 2500 g) and three reported rates of very low birth-
weight babies (less than 1500 g). Nineteen study arms reported
rates of preterm births less than 37 weeks’ gestation. Other study
arms reporting perinatal outcomes included: perinatal deaths (n =
4), stillbirths (n = 8), neonatal deaths (n = 5), and neonatal inten-
sive care unit (NICU) admissions (n = 8).
Other perinatal outcome measures reported included fetal growth
(Cope 2003; Heil 2008; Higgins 2014 (AvB); Higgins 2014
(AvC)), mean Apgar scores (Tuten 2012 (AvC)), and head circum-
ference (Cope 2003).
Secondary outcomes included in narrative synthesis
Four trials measured mode of birth (Thornton 1997; Cope 2003;
Tappin 2005; Ussher 2015).
Four specific smoking cessation trials measured breastfeeding ini-
tiation and/or duration (Panjari 1999; McLeod 2004; Wilkinson
2010 and an associated reference to Heil 2008) (Higgins 2010a).
Several other studies which included a smoking component as part
of broader aims to improve maternal health also included breast-
feeding outcomes, but these are not reported in this review as there
are other aspects of the intervention which are likely to have in-
fluenced these outcomes.
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Numerous studies reported baseline psychological measures of in-
terventions, four studies reported associations between smoking
outcomes and psychological measures, and 13 studies reported
psychological outcomes.
No studies reported measures of family functioning. However,
three studies reported perceptions of partner (McBride 2004
(AvB); McBride 2004 (AvC)) and peer support (Bullock 2009
(AvC); Bullock 2009 (AvD);Hennrikus 2010), and one study pro-
vided analysis of social networks (Stotts 2009 (AvB); Stotts 2009
(AvC)).
Thirty-three study arms addressed issues identified as important
to women in a consultation for this review (Oliver 2001); with
two associated references (Berg 2008; Washio 2011) to included
studies (Rigotti 2006; Heil 2008), reporting effects of smoking
cessation on maternal weight gain.
Seven studies explicitly included the views of women or commu-
nity in development of the intervention; and 35 study arms re-
ported women’s views about the content or delivery of the in-
tervention. Three studies reported measures of knowledge, atti-
tudes or practice among pregnancy care providers (Haug 1994;
Secker-Walker 1994; Lawrence 2003 (AvC)).
Six studies reported cost-effectiveness measures (Windsor 1985
(AvC); Ershoff 1989; Dornelas 2006; Parker 2007 (AvC); Heil
2008; Tappin 2015).
Two studies reported rates of women who reported an increase in
smoking (adverse events) (Haug 1994; Tappin 2005).
Excluded studies
Eighty-four studies did not meet the eligibility criteria and were
excluded from the review, for the following reasons:
• design not adequately randomised (e.g. cohort studies, pre-
post design, quasi-experimental designs);
• primary population was not pregnant women or
intervention was not primarily aimed at cessation during
pregnancy (e.g. postpartum interventions, intervention for
partners, non-pregnant women);
• trial evaluated efficacy of pharmacological treatment with
equal psychosocial support in both arms;
• cluster-randomised trials with insufficient information (e.g.
number of clusters) provided to enable adjustment for clustering.
See Characteristics of excluded studies for details.
Risk of bias in included studies
Allocation
Of the 106 study arms with outcomes included; sequence gener-
ation was described and adequate in 49 study arms. In 54 study
arms the sequence generation was not described or simply de-
scribed as ‘randomised’ so it was unclear whether this was ade-
quate or not. Three trials were included which had non-random
sequence generation, such as allocation by medical record num-
bers and date of birth, as it was considered the risk of interfer-
ence with this sequence is low. There are also many studies where
the method of sequence generation was not reported. Quasi-ran-
domised trials where there was a potential for interference, such
as clinic attendance day or other quasi-randomised methods were
excluded from this update of the review and the reasons are listed
in the Characteristics of excluded studies table.
Themethodof randomisationwas not described in sufficient detail
to permit assessment of whether the allocation was concealed at
the time of trial entry in 74 study arms. In only 20 study arms was
the allocation adequately concealed and in 12 study arms there
was clearly no concealment of group allocation.
Equal baseline characteristics
As the sequence generation was not reported in the majority of
trials, we assessed whether the baseline characteristics were equal
and these were assessed as adequate in 57 study arms, unclear (mi-
nor differences or not reported) in 34 study arms, and inadequate
or significant differences in 15 study arms. Of the 54 trials with
unclear sequence generation, 21 had equal baseline characteristics,
seven had unequal baseline characteristics and in 26 there were
some minor differences or the baseline characteristics were not re-
ported.
Blinding
Very few trials had any blinding of participants or providers, as this
is not practicable in delivering most psychosocial interventions. In
73 study arms the participants and providers were clearly aware
of group allocation, it was unclear in 29 study arms, and in four
study arms they were able to blind participants and/or providers
to group allocation.
Blinding of the outcome assessment was rarely reported (unclear
in 87 study arms) and was assessed as adequate in only 19 study
arms.
Incomplete outcome data
Withdrawals from the trials were common. When women were
recruited at their first antenatal visit, some participants had a mis-
carriage or a termination of pregnancy before the timewhen smok-
ing behaviour was reassessed. These women were often excluded
from outcome measurement, which means that important out-
comes linked in observational studies to smoking exposure were
not ascertained. Assessing smoking at 20 to 28 weeks instead of
at 36 to 38 weeks would reduce the need to exclude women with
particularly adverse outcomes, since their smoking status in mid-
pregnancy would have been ascertained before preterm birth or
a perinatal death had occurred. Others moved out of the area or
changed to another provider of care. The latter was a common
cause of attrition in those trials carried out among populations
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characterised by severe poverty and the receipt of special needs
benefits such as Medicaid, or WIC (food program for women,
infants and children) clinics.
In studies where there was longer-term follow-up, attrition was
sometimes high; approximately half of the included studies had
high levels of missing data (greater than 20%) for some outcomes.
All randomised women were included in analysis for the primary
outcome (abstinence in late pregnancy) in 44 study arms trials.
In 42 study arms, some women were excluded from the analysis
due to miscarriage or pregnancy loss, or moving, and these were
assessed as unclear risk of attrition bias as there are some associa-
tions with smoking. In 20 study arms, primary outcome data were
missing and were unable to be included in this review, and they
were assessed as inadequate due to risk of attrition bias. Levels of
attrition for each study and information about any intention-to-
treat analysis have been reported in the ’Risk of bias’ tables in the
Characteristics of included studies.
Selective reporting
Among the 106 study arms with included outcome data, it was not
clear in many trials the extent of outcome data that were collected
and therefore, unclear whether the outcomes were selectively re-
ported in 41 study arms. All primary outcomes were adequately
reported in 53 study arms, and 12 study arms were assessed as
inadequately reporting primary outcomes. Additionally, eight of
the 14 studies without outcome data were assessed as ’unclear risk
of reporting bias’ (Table 1).
Other potential sources of bias
Detection bias from misclassification by self-report
Seventy-one study arms reported biochemical validation of the
primary outcome measure, smoking abstinence. In 11 study arms
there was unclear or partial validation of smoking status. Twenty-
seven study arms measured smoking status by self-report and are
included in this review as ‘high risk’ of bias. Later trials more often
relied on a definition of smoking abstinence requiring biochemical
validation.
Exposure of the control group to the intervention
Another problem with trials in this area can be ’contamination’
or exposure of the control group to intervention components,
particularly if the study is being implemented in a routine care
setting. Eighty-four study arms were implemented by dedicated
research staff or technology and were assessed as having a low risk
of exposing the control group to the intervention. In six study
arms it was unclear, and in 16 study arms the authors reported
problems with exposure of the control group, or the intervention
was provided by routine care providers and the study design was
assessed as having a ’high risk’ of control group exposure.
Other bias
Among all 120 study arms, no other risk of bias was suspected
in 80 study arms. However, in 12 study arms there were some
other risks, such as unequal recruitment to study arms in cluster-
randomised trials or financial conflicts of interest, and in 14 study
arms it was unclear if there may be other risks of bias.
Implementation of intervention
Some studies reported process evaluation demonstrating chal-
lenges implementing the intervention and delivering it to all
women (Walsh 2000). In 32 study arms, process evaluation sug-
gested that the majority of women received the intervention as
planned, however in 42 study arms, reports note thatmanywomen
had not received the intervention as planned and in 34 studies it
was unclear or not reported.
Smoking cessation interventions implemented during pregnancy
differ substantially in their intensity, their duration, and the people
involved in their implementation.The timingof the final antenatal
assessment of smoking status varied considerably between trials
between the second and third trimester. Thismay have affected the
amount of time the participants were exposed to the intervention
(if it involved ongoing support), as well as the number of those
lost to follow-up and measurement of perinatal outcomes.
Change in ’usual care’
In many cases the comparison/control group was described as re-
ceiving ’usual care’ without specifying further what constituted
usual practice (at a particular time and in a particular setting) with
respect to advice and assistance. It can be seen from Figure 4 and
Figure 5 that current ’usual care’ may be a more substantial inter-
vention than the defined intervention in some of the earliest trials
(for example, Baric 1976).
A summary of ’Risk of bias’ assessments in the included trials is
set out in Figure 6 and Figure 7.
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Figure 6. ’Risk of bias’ graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies.
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Figure 7. ’Risk of bias’ summary
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Effects of interventions
See: Summary of findings for the main comparison Separate
intervention comparisons for supporting women to stop smoking
in pregnancy (comparisons 1-19); Summary of findings 2
Outcomes for all interventions for smoking cessation in pregnancy
compared to control: subgrouped by main intervention strategy
(comparison 20)
Meta-analyses were conducted and are presented in data tables
for a total of 20 comparisons involving 127 outcomes. In addi-
tion, weighted pooled estimates of subsets of studies conducted in
RevMan 2014 were reported in text, to assess the effect of specific
factors (e.g. where ’counselling’ involved provision of a videotape
or computer program only; where lottery tickets were included as
part of a counselling intervention). The results of meta-regression
analyses conducted in STATA 14 to assess risk of bias and sensi-
tivity analyses were conducted on primary outcome data from a
comparison of all studies Analysis 20.1 and are also reported in
text and not reported in tables.
1. Primary outcome: Smoking abstinence in late
pregnancy
1.1 Comparisons: Main intervention strategy compared with
usual care, less intensive intervention, or an alternative
intervention, and subgrouped by single, multiple or tailored
components
A cross-tabulation of the main intervention strategies and com-
parison type is presented in Table 3, for studies that report the pri-
mary outcome. The large number of cells that have very few (i.e. n
≤ 2) or zero studies means that it is not appropriate to run an in-
teraction analysis with these two variables. Therefore, the synthe-
sis in this section was not achieved through meta-analytic regres-
sion analyses; rather, the synthesis is a description of trends in the
weighted pooled effect size estimate for subgroups of studies based
on the intervention strategy, the comparison type, and the number
of components in the intervention (single component, multiple
components, and tailored components). As such, we cannot draw
any conclusions about statistical differences between subgroups of
studies in this section.
1.1.1 Counselling versus usual care
There was high quality evidence that counselling was more ef-
fective than ’usual care’, with those receiving counselling being
44% more likely to abstain from smoking in late pregnancy (30
studies; average risk ratio (average RR) 1.44, 95% confidence in-
terval (CI) 1.19 to 1.73). While there was some inconsistency in
the magnitude of RRs (I2 = 49%), see Analysis 1.1, most RRs
favoured counselling. There was no evidence that counselling pro-
vided as a single, multiple or tailored intervention explained het-
erogeneity (P value from subgroup analysis =0.88) and the pooled
RRs across these subgroups were similar in magnitude (1.33, 1.42
and 1.49, respectively). There was also clear evidence of an effect
of counselling when restricted to those reporting biochemically
validated smoking abstinence (21 studies; average RR 1.23, 95%
CI 1.04 to 1.45), I2 = 22%, (Analysis 1.2). However, there was
uncertainty whether when counselling was provided as part of a
broader intervention to improve maternal health (El-Mohandes
2011;Wilkinson 2012), that this increased the chance of smoking
cessation compared to usual care (RR 0.93, 95% CI 0.69 to 1.25),
I2 = 0% (see Analysis 15.1).
1.1.2 Counselling versus less intensive interventions
There was evidence that counselling was more effective than less
intensive interventions (control) (18 studies; average RR 1.25,
95% CI 1.07 to 1.47), (I2 = 28%), see Analysis 2.1.
1.1.3 Counselling versus alternative intervention
There was uncertainty in the effectiveness in the single study
(Cinciripini 2010) that compared one counselling strategy (cog-
nitive behavioural therapy (CBT)) to an alternative counselling
intervention (traditional health education or motivational inter-
viewing) (RR 1.15, 95% CI 0.86 to 1.53), see Analysis 3.1.
Other counselling subset analyses (not displayed)
In two studies where counselling was provided as part of a tailored
intervention that included optional NRT and was compared with
usual care (Eades 2012; Hegaard 2003), one of which was pro-
vided for Aboriginal women (Eades 2012), the effect was unclear
(average RR 1.63, 95% CI 0.25 to 10.50), with a high degree of
inconsistency (I2 = 59%) and imprecisely estimated.
There was uncertainty as to whether ’counselling’ provided via a
video tape (Secker-Walker 1997; Cinciripini 2000) increased the
chance of smoking cessation compared to a less intensive inter-
vention (two studies; average RR 2.31, 95% CI 0.08 to 65.02),
with a high degree of inconsistency (I2 = 78%). The effect was
also unclear in a single study (Price 1991 (AvC)), which provided
brief advice (less than five minutes) in conjunction with provision
of a video, compared with usual care (RR 3.94, 95% CI 0.45 to
34.41).
Five studies coded as counselling provided brief advice (less than
five minutes) and a self-help manual (Ershoff 1989; Messimer
1989;Price 1991 (AvB); Kendrick 1995; Moore 2002). There was
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uncertainty in the effectiveness from four of these studies reporting
abstinence in late pregnancy (average RR 1.07, 95% CI 0.82 to
1.40), I2 = 31%.
Nine study arms coded as counselling included peer and/or part-
ner support for women as part of an intervention (Hajek 2001;
Vilches 2009 (AvB); Vilches 2009 (AvC); Vilches 2009 (AvD);
Eades 2012;Gielen1997; Lillington 1995;Hartmann 1996; Lowe
1997) compared with usual care, and the combined effect of six
studies that reported abstinence in late pregnancy was also unclear
(average RR 1.21, 95% CI 0.97 to 1.51), I2 = 0%.
There was uncertainty as to whether counselling which included
support for partners to quit smoking (Thornton 1997; Eades2012)
compared with usual care, was effective (average RR 1.23, 95%
CI 0.66 to 2.31), I2 = 0%. The confidence interval was wide
suggesting that counselling may be harmful, beneficial or have an
unimportant effect.
There was evidence that combining a lottery chance with coun-
selling (Sexton 1984; Walsh 1997; Parker 2007 (AvC)), impor-
tantly increased the rate of smoking cessation in late pregnancy
(three studies; average RR 1.72, 95% CI 1.04 to 2.85; I2 = 7%),
compared with control.
1.1.5 Health education versus usual care
For studies in which the main intervention strategy was health
education compared with usual care, those receiving counselling
were 59% more likely to abstain from smoking in late pregnancy
(five studies; average RR 1.59, 95% CI 0.99 to 2.55), I2 = 0%,
see Analysis 4.1. However, the confidence interval did not exclude
no difference or small unimportant differences, thus the evidence
was graded as moderate quality. When restricted to studies with
biochemical validation of abstinence, the average RR was similar,
but the confidence interval was wider, due to fewer studies in the
meta-analysis (three studies; average RR 1.45, 95% CI 0.82 to
2.58), see Analysis 4.2.
1.1.6 Health education versus less intensive interventions
There was uncertainty in the effectiveness of health education
compared with a less intensive intervention (four studies; average
RR 1.20, 95% CI 0.85 to 1.70), I2 = 33%, see Analysis 5.1.
The estimated RR was similar when restricting the meta-analysis
to studies with biochemically validated outcomes (three studies;
average RR 1.15, 95% CI 0.70 to 1.91), see Analysis 5.2. The
effect was also unclear in a single study where health education
was provided as part of a broader maternal health intervention
(RR 0.93, 95% CI 0.65 to 1.32), see Analysis 16.1.
1.1.7 Health education versus alternative intervention
There was uncertainty in the estimated effect in one study that
compared two different types of text messaging schedules, support
messages and support messages plus gradual scheduled reduction
(Pollak 2013) (average RR 1.88, 95% CI 0.19 to 18.60), see
Analysis 6.1.
Other health education subset analyses (not displayed)
There was uncertainty in evidence from three studies coded as
health education that involved provision of self-help manuals
with no additional personal advice (Bullock 2009 (A+C v B+D);
Hjalmarson 1991) or an audiotape (Peterson 1992) (average RR
1.09, 95% CI 0.80 to 1.50), I2 = 4%.
There was also uncertainty whether health education provided
by automated advice via text-messaging (Naughton 2012; Pollak
2013) (two studies; average RR 1.63, 95% CI 0.73 to 3.61) or a
computer (Ershoff 1999 (AvB); Ondersma 2012 (A+C v B+D);
Herbec 2014) (three studies; average RR 1.22; 95% CI 0.66 to
2.28, I2 = 58%), compared to controls, increased the chance of
smoking cessation in late pregnancy.
1.1.7 Feedback versus usual care
There was moderate quality evidence from two trials that feedback
provided by ultrasound (Valbo 1994) or carbon monoxide moni-
toring (Cope 2003), importantly increased the chance of smoking
cessation (average RR 4.39, 95% CI 1.89 to 10.21), I = 0%, see
Analysis 7.1, compared with usual care. Many studies conducted
carbon monoxide monitoring as part of validating smoking ab-
stinence, but these are not included as ’feedback’ interventions in
this review, as the effect of carbon monoxide monitoring in these
trials could not be determined because both arms received the in-
tervention.
There was uncertainty from a single study as towhether ultrasound
feedback alone (with no smoking cessation advice) as part of a
broader intervention to improve maternal health increased the
chance of smoking cessation (Reading 1982) (RR 2.11, 95% CI
0.98 to 4.57), see Analysis 17.1, compared with usual care.
1.1.8 Feedback versus less intensive interventions
There was uncertainty whether feedback increased smoking ces-
sation when provided alone (Bauman 1983) or in combination
with other strategies, for women still smoking in late pregnancy
(i.e. heavy smokers) (Stotts 2009 (AvB); Stotts 2009 (AvC)) (three
study arms; average RR 1.29, 95% CI 0.75 to 2.20), I = 0%, see
Analysis 8.1, when compared to less intensive interventions.
1.1.9 Incentives versus usual care
We were unable to calculate a pooled effect for this comparison
as one ’single intervention’ study (Tuten 2012 (AvB))) had zero
events in both study arms and the RRwas therefore ’not estimable’
in RevMan 2014. See Analysis 9.1 for separate study results.
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1.1.10 Incentives versus less intensive interventions
There was uncertainty in whether incentives provided in combi-
nation with peer support compared to a less intensive intervention
were effective. We chose not to pool the results due to substantial
inconsistency (I2 = 93%). This comparison included one study
arm which involved provision of lottery tickets (’quit and win
contest’) alone (Parker 2007 (AvB)), which is different to other
included incentive interventions that involve direct financial in-
centives, and when this study was removed, the I2 statistic reduced
to 21%. See Analysis 10.1.
1.1.11 Incentives versus alternative interventions
There was high quality evidence that incentives provided con-
tingent on non-smoking status importantly increased the rate of
smoking cessation in late pregnancy compared to an equally in-
tensive alternative intervention of incentives which were not con-
tingent on non-smoking status (four studies; RR 2.36, 95% CI
1.36 to 4.09), I2 = 0%, see Analysis 11.1.
1.1.12 Social support versus less intensive interventions
There was uncertainty whether peer or partner (social) support
increased the chance of smoking cessation in late pregnancy com-
pared to a less intensive intervention (seven studies; average RR
1.21, 95% CI 0.93 to 1.58), I = 0%, see Analysis 12.1. This ev-
idence was graded as high quality. The effect was also uncertain
in the single trial where the intervention involved partner support
(McBride 2004 (AvB); McBride 2004 (AvC)). There was also un-
certainty where peer support was provided as part of a broader
intervention to improve maternal health, and the control group
received a less intensive intervention (three studies; average RR
1.06, 95% CI 0.68 to 1.63); see Analysis 19.1 and Analysis 19.2.
We were unable to pool results of studies where social support was
provided as part of a broader maternal health program and the
control group received usual care, as one study (Olds 1986) had
zero events in both study arms and the effect size estimate was
therefore ’not estimable’ in RevMan 2014, see Analysis 18.1.
1.1.13 Exercise versus usual care
There was uncertainty whether exercise increased the chance of
smoking cessation in late pregnancy when compared to usual care
in one study (Ussher 2015) (RR 1.20, 95% CI 0.72 to 2.01), see
Analysis 13.1. The confidence interval was wide suggesting that
exercise may be harmful, beneficial or have an unimportant effect,
therefore the evidence was graded as moderate quality.
1.1.14 Other (dissemination)
There was uncertainty in moderate quality evidence from one
study (Campbell 2006) evaluating whether intensive dissemina-
tion of a smoking cessation intervention to organisations increased
the chance of smoking cessation compared to organisations re-
ceiving passive dissemination of a smoking cessation program (RR
1.63, 95% CI 0.62 to 4.32), see Analysis 14.1.
1.2 Meta-regression analyses
The following meta-regression analyses were conducted on the
whole dataset using all studies for the primary outcome (smoking
abstinence in late pregnancy) (see Analysis 20.1 for list of studies).
These analyses were conducted in STATA 14 and are summarised
in Table 2, which includes the reference categories used for each
analyses.
1.2.1a Meta-regression analysis: Main intervention strategy
The random-effects RRs ranged from 1.19 to 1.91 across the in-
tervention strategies (Table 2); however, there was no evidence that
the type of intervention explained the heterogeneity in the ob-
served RRs (P = 0.257). The type of intervention strategy only ex-
plained (adjustedR2 =) 5%of the between-trial variance, and there
still remained moderate unexplained heterogeneity (I2 = 41%).
A summary of the main intervention by comparison type is pre-
sented in Table 3.
1.2.1b Meta-regression analysis: Specific smoking cessation
versus broader maternal interventions
There was evidence that trials with a specific smoking cessation
focus (n = 84 studies) increased the rate of smoking cessation in late
pregnancy (RR 1.40, 95% CI 1.27 to 1.55), while the effect was
unclear among studies with a broader maternal health focus and a
smoking cessation component (n = 10) (RR 1.07, 95% CI 0.85 to
1.36), but there was moderate inconsistency with these results (I
2 = 40%). One dissemination study, Campbell 2006, was treated
as missing from this analysis as the intervention type category was
unclear.
1.2.2 Meta-regression analysis: Comparison type
The random-effects RR for studies with a usual care comparison (n
= 46) was 1.41 (95% CI 1.22 to 1.62), an alternative intervention
(n = 6) was 1.62 (1.06 to 2.48), and a less intensive comparison
(n = 43) was 1.27 (95% CI 1.11 to 1.46). However, there was no
evidence of a difference in these RRs (P = 0.421), and comparison
type did not explain the observed heterogeneity. It should be noted
that studies where the comparison group received only ’usual care’
were also more likely to provide a low-intensity intervention, as
shown in Figure 4 and Figure 5, and discussed below.
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1.2.3a Meta-regression analysis: Intensity (frequency) of the
intervention
The random-effects RRs ranged from 1.11 to 1.90 categorised ac-
cording to the frequency of contact in the intervention (Figure 4);
however, there was evidence that intervention frequency explained
differences in these RRs (P = 0.18), and the strong correlation be-
tween intervention and comparison intensity may be confounding
these findings. The intervention frequency explained (adjusted R
2 =) -0.79% of the between-trial variance, and there still remained
moderate unexplained heterogeneity (I2 = 42%). See Table 4 for
pooled effect sizes by frequency category.
1.2.3b Meta-regression analysis: Intensity (duration) of the
intervention
Moreover, there was no evidence that intervention duration ex-
plained differences between effect sizes estimates categorised ac-
cording to the duration of contact in the intervention (P = 0.15)
and intervention duration explained (adjusted R2 =) -2.81%of the
between-trial variance, with moderate unexplained heterogeneity
(I2 = 37%) (see Table 5 for pooled effect sizes by duration cate-
gory). However, the strong correlation between intervention and
comparison duration (Figure 5) may be confounding these find-
ings.
1.2.4a Meta-regression analysis: Features of the intervention
(self-help manuals)
A meta-regression with two dichotomous predictor variables - the
use of self-helpmanuals and the availability of telephone support -
was conducted. Of the studies that reported the primary outcome,
30 studies offered self-help materials to participants (11 coded as
unclear) and 20 provided telephone support. The analyses indi-
cated that there was no evidence self-help materials explained het-
erogeneity in RRs (P = 0.34); the pooled RR for studies without
self-help manuals was 1.33 (95% CI 1.16 to 1.52) compared to a
pooled RR of 1.48 (95% CI 1.25 to 1.74) of studies providing a
self-help manual.
1.2.4b Meta-regression analysis: Features of the intervention
(telephone support)
Moreover, there was evidence telephone support explained hetero-
geneity between RRs (P = 0.87); the pooled results for trials pro-
viding telephone support was 1.33 (95% CI 1.09 to 1.62) com-
pared to a pooled RR of 1.36 (95 % CI 1.22 to 1.51, n = 75)
among studies that didn’t provide telephone support.
1.2.5 Meta-regression analysis: Socio-economic status (SES)
of the participants
For the primary outcome of abstinence in late pregnancy, there
was no evidence that SES explained the heterogeneity in observed
risk ratios (P = 0.71) with moderate unexplained heterogeneity (I2
= 42%). Additionally, the pooled effect size estimate for interven-
tions provided for women categorised as ’low’ SES interventions
was similar (63 studies; average RR 1.34, 95% CI 1.18 to 1.52, P
= 0.00), to those provided for women categorised as ’not low’ SES
(29 studies; average RR 1.39, 95% CI 1.19 to 1.63, P = 0.00).
1.2.6 Meta-regression analysis: Newly included studies in
this review update
Of the 95 study arms reporting smoking abstinence in late preg-
nancy outcomes, 82 came from studies in the previous review
(Chamberlain 2013), while 13 were from new studies identified
in the updated search.We conducted this meta-regression analysis
to address concerns that newer trials may have a reduced effect
due to the increased information about the risks of smoking in
pregnancy in the general population. Although effect sizes from
the newly-included studies were slightly lower (13 studies; aver-
age RR 1.26, 95% CI 0.99 to 1.61, P = 0.06), than those from
the previous version of the review (82 studies; average RR 1.36,
95% CI 1.23 to 1.51, P = 0.00), there was no evidence that newer
studies explained heterogeneity (P = 0.56).
1.2.7 Meta-regression analysis: Efficacy versus effectiveness
trials
Given concerns about whether clinical trial efficacy will translate
to clinical effectiveness when implemented in healthcare practice
(Walsh 2000), we conducted a sensitivity analysis to determine
whether effectiveness studies (defined as those assessing the imple-
mentation of an intervention that uses existing service providers)
demonstrate a beneficial outcome, compared to efficacy trials pro-
vided by dedicated research staff (n = 62). There was evidence of a
difference between studies categorised as efficacy or effectiveness
(P = 0.14); for the 23 effectiveness trials with primary outcome
data, the pooled effect size estimate was 1.50 (95% CI 1.22 to
1.83), compared to RR 1.26 (95% CI 1.12 to 1.41) among 62
efficacy studies.
1.2.8a Meta-regression analysis: Dissemination trials
There was uncertainty in the evidence from ’dissemination’ trials,
where there was an explicit strategy to implement the intervention
into routine practice, whether this translated into an increase in
smoking cessation,with a pooledRRof 1.16 (four studies; 95%CI
0.78 to 1.72); while the RR of the other 91 studies was 1.36 (95%
CI 1.23 to 1.50). However, there was no significant difference
in meta-regression analysis (P = 0.43) between dissemination and
other trials.
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1.2.8b Meta-regression analysis: Cluster-randomised trials
There was no evidence that the type of randomisation (individu-
ally-randomised and cluster-randomised) explained heterogeneity
between trials (P = 0.55). There was evidence that interventions
increased the rate of smoking cessation when provided as individ-
ually-randomised trials (RR 1.35, 95% CI 1.22 to 1.50, n = 84);
quasi-randomised studies (RR 1.93, 95% CI 1.07 to 3.47, n = 2);
and cluster trials randomised at service level (RR 1.51, 95% CI
1.00 to 2.29, n = 7); however, the effect was unclear in pooled
results of cluster trials randomised at practitioner level (RR 1.23,
95% CI 0.88 to 1.73, n = 4).
1.2.9 Meta-regression analysis: Assessment of risk of bias
across studies
1.2.9a Random sequence generation selection bias
Forty-five study arms were classified as low risk of bias, three were
high risk of bias and 47 were unclear. There was no evidence
that the risk of sequence generation bias explained the difference
between the categories (P = 0.11) and there was 40% unexplained
heterogeneity; although high risk of bias studies had a larger pooled
effect size (RR 2.21, 95% CI 1.32 to 3.71) compared to low-risk
studies (average RR 1.27, 95% CI 1.10 to 1.45), or unclear-bias
studies (average RR 1.38, 95% CI 1.21 to 1.57).
1.2.9b Allocation concealment selection bias
Twenty study arms were classified as low risk of bias, 12 were high
risk of bias, and 63 were unclear. There was evidence allocation
concealment bias explained some of the difference between the
groups (P = 0.03) and 40% unexplained between-group hetero-
geneity, with high-risk studies having a larger pooled effect size es-
timate (average RR 2.01, 95% CI 1.46 to 2.75) compared to low-
risk studies (average RR 1.26, 95% CI 1.06 to 1.49), or unclear
bias studies (average RR 1.31, 95% CI 1.17 to 1.48).
1.2.9c Incomplete outcome data attrition bias
Forty-two study arms were classified as low risk of bias, seven were
high risk of bias, and 38 were unclear. There was no evidence
incomplete outcome data bias explained heterogeneity between
the groups in meta-regression analysis (P = 0.93) and there was
43% unexplained heterogeneity. The mean effect size was similar
for studies rated as high on this type of bias (average RR 1.39,
95% CI 1.09 to 1.78), unclear risk of bias (average RR 1.36, 95%
CI 1.18 to 1.57), and low risk of bias (average RR 1.32, 95% CI
1.14 to 1.54).
1.2.9d Selective reporting bias
Fifty study arms were classified as low risk of bias, seven were high
risk of bias, and 38 were unclear. There was no evidence that se-
lective reporting bias explained heterogeneity between the classifi-
cations (P = 0.37) and there was 42% unexplained heterogeneity.
The mean effect size was similar for studies rated as low on this
type of bias (average RR 1.43, 95% CI 1.24 to 1.64), high risk of
bias (average RR 1.47, 95% CI 1.09 to 1.99), and unclear risk of
bias (average RR 1.25, 95% CI 1.09 to 1.44).
1.2.9e Detection bias (biochemical validation of smoking
abstinence)
Sixty-seven studies were classified as low risk of bias (i.e. biochem-
ically-validated smoking cessation), 23 were high risk of bias (self-
report), and five were unclear. Given concerns about the poten-
tial biases (e.g. social desirability bias) of self-report measures of
smoking behaviours, we examined whether random-effects RRs
were modified by whether the outcome measure was biochemi-
cally validated, self-report, or unclear. There was no evidence that
biochemical validation on smoking cessation explained the differ-
ence in RRs (P = 0.41), and there was moderate unexplained het-
erogeneity (I2 = 40%). The random-effects RR for trials with self-
report measures of smoking abstinence (average RR 1.37, 95% CI
1.14 to 1.64) was very similar to random-effects RR for trials with
biochemically validated outcomes (average RR 1.38, 95%CI 1.23
to 1.55) (ratio of risk ratios (RoRR) = 0.99 (95% CI 0.80, 1.23))
(Table 2).
1.2.9f Blinding of participants and personnel performance
bias
Three study arms were classified as low risk of bias, 66 were high
risk of bias, and 26 were unclear. There was evidence that blinding
of participants explained the differences in RRs (P = 0.21) and
there was 43% unexplained heterogeneity. The RR for trials clas-
sified as low risk of bias was (average RR 1.94, 95% CI 0.86 to
4.39) compared to high risk of bias (average RR 1.40, 95% CI
1.25 to 1.56), and unclear risk of bias (average RR 1.18, 95% CI
0.98 to 1.43).
1.2.9g Blinding of outcome assessment detection bias
Fifteen study arms were classified as low risk of bias and 80 were
unclear. There was no evidence that blinding of outcome assess-
ment explained heterogeneity in observed RRs (P = 0.11) and
there was 41% unexplained heterogeneity (I2 = 41%). The aver-
age RR for studies classified as low risk of bias was 1.18 (95% CI
0.98 to 1.43) compared to 1.41 (95% CI 1.26 to 1.57) for studies
classified as unclear risk of bias.
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1.2.9h Equal baseline characteristics in study arms
Fifty-two studies were classified as low risk of bias, 13 were high
risk of bias (unequal baseline), and 30 were unclear. There was
evidence of a difference in RRs according to equality of baseline
characteristics (P = 0.0) and moderate unexplained heterogeneity
(I2 =40%).Themean effect sizewas largest for studieswith unclear
risk of this type of bias (average RR 1.61, 95% CI 1.32 to 1.95),
followed by low risk of bias (average RR 1.33, 95% CI 1.18 to
1.50), and high risk of bias (average RR 1.09, 95% CI 0.86 to
1.38).
1.2.9i Contamination of control group
Seventy-five studies were classified as low risk of bias, 14 were
high risk of bias, and six were unclear. There was no evidence of
a between-group difference (P = 0.72) and there was moderate
unexplained heterogeneity (I2 = 43%). The mean effect size was
largest for studies with unclear risk of this type of bias (average RR
1.46, 95% CI 0.99 to 2.14), followed by low risk of bias (average
RR 1.36, 95% CI 1.22 to 1.52), and high risk of bias (average RR
1.24, 95% CI 0.98 to 1.58), which were not significantly different
from the null effect.
1.2.10 Meta-regression analysis: Incomplete implementation
(intervention fidelity)
Twenty-seven studies were classified as low risk of bias, 37 were
high risk of bias, and 31 were unclear. There was evidence of a
difference between groups according to intervention implementa-
tion (P = 0.0001), though this is due to the difference in studies
coded as ’unclear’ (average RR 1.79, 95% CI 1.52 to 2.10). Low
risk of bias studies, assessed as having good implementation, had
a lower effect size (average RR 1.26, 95% CI 1.10 to 1.44), as did
high risk of bias studies (average RR 1.12, 95% CI 0.99 to 1.26).
1.3 Description of trends in intervention effectiveness:
minority ethnic and indigenous participants (not displayed)
The synthesis in this section was not achieved through meta-an-
alytic subgroup analyses; rather, the synthesis is a description of
trends in the weighted pooled effect size estimate for subsets of
studies based on ethnicity of the participants. As such, we cannot
draw any conclusions about statistical differences between subsets
of studies in this section.
1.3.1 Ethnic minority populations
There was evidence that interventions (six counselling study arms,
one social support study, one health education study and two in-
centives study arms) among women predominantly (> 50%) from
a minority ethnic group (African-American and/or Hispanic liv-
ing in the USA) increased the rate of smoking cessation compared
to controls (average RR 1.20, 95% CI 1.01 to 1.43), I2 = 0%.
Of those 10 study arms, six were conducted with African-Amer-
ican women (three counselling: Gielen 1997; Cinciripini 2010;
El-Mohandes 2011; one health education Ondersma 2012 (A+C
v B+D), and two incentives (Ondersma 2012 (AvC); Ondersma
2012 (AvD)) (average RR 1.11, 95% CI 0.91 to 1.36), I2 = 0%.
The effect size estimate in four studies among African-American
andHispanic women (three counsellingDornelas 2006; Lee 2015;
Lillington 1995 and one social support study (Malchodi 2003)
were borderline (RR 1.49, 95% CI 1.00 to 2.20).
1.3.2 Indigenous populations
There is uncertainty whether interventions provided for indige-
nous women in Australia (tailored counselling: Eades 2012),
Canada (tailored counselling: Patten 2009) and New Zealand (in-
centives: Glover 2014 (AvB); Glover 2014 (AvC)) increased the
chance of smoking cessation in late pregnancy (average RR 0.54,
95% CI 0.13 to 2.20), I2 = 0%. The confidence interval was
wide suggesting that these interventions may be harmful, bene-
ficial, or have an unimportant effect. Another counselling study
with 40%Maori participants reported borderline effects (McLeod
2004) (RR 1.77, 95% CI 1.00 to 3.11).
1.3.3 Low- and middle-income countries
There was evidence that interventions conducted in low- to mid-
dle-income countries increased the rate of smoking cessation in
late pregnancy (Belizan 1995; Polanska 2004). One study of so-
cial support in several South American countries (Belizan 1995)
reported an RR of 1.83 (95% CI 1.22 to 2.73) and in Poland
(Polanska 2004) reported an RR of 2.86 (95% CI 1.31 to 6.26).
1.4 Description of participant characteristic analyses
reported by study authors
The following is a narrative synthesis of the findings of subgroup
analyses within studies reported by primary study authors.
1.4.1 Low socio-economic status (SES)
Of 13 studies that reported sensitivity analysis by a measure of
SES within studies (including education levels and employment),
eight reported lower abstinence rates or a negative association with
quitting among women with lower SES (Baric 1976; Ershoff
1989; Kendrick 1995;Hajek 2001;Hegaard 2003;McLeod 2004;
Pbert 2004; Rigotti 2006), three reported no difference (Peterson
1992; Strecher 2000; Tappin 2005), and two studies reported
high/higher rates of intervention success among women with low
SES (Secker-Walker 1997; Polanska 2004).
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1.4.2 Ethnicity or race
Of 11 studies that reported outcomes or sensitivity analysis by
ethnic status, one study reported the intervention was less effective
amongHispanic andAfrican-Americanwomen (Lillington 1995),
one study reported the intervention was less effective among His-
panic compared to African American women (Kendrick 1995),
four studies reported no difference in outcomes by race or eth-
nicity (including other ethnic groups) (Burling 1991; Strecher
2000; Campbell 2006; Dornelas 2006), and five study arms re-
ported higher quit rates amongAfrican-American and/orHispanic
women compared to otherwomen (Peterson 1992;Windsor 1993;
Pbert 2004; Parker 2007 (AvB); Parker 2007 (AvC)).
1.4.3 Depression
Four studies that reported outcomes by rates of depression reported
a negative association between smoking abstinence and depression
(Cinciripini 2000; Rigotti 2006; Cinciripini 2010; El-Mohandes
2011), howeverCinciripini 2010 showed a larger effect in smoking
abstinence among women with depression receiving a depression-
focused intervention than a health education intervention.
1.4.4 Low social support
Of six studies that reported measures of social support, four re-
ported a negative association with low social support (e.g. sin-
gle mothers, ’unhelpful family’) and quitting (Loeb 1983; Gielen
1997; Thornton 1997; Rigotti 2006), and two reported no differ-
ence among women reporting low levels of social support (Pbert
2004; Tappin 2015).
1.4.5 Partner smoking
Of nine study arms reporting associations with partner smoking
and abstinence in late pregnancy, four reported no difference (
Rigotti 2006; Stotts 2009 (AvB); Stotts 2009 (AvC); Pbert 2004)
and four reported a negative association (i.e. lower rates of quitting
among women whose partners smoked) (McLeod 2004; Bullock
2009 (A+C v B+D); Bullock 2009 (AvC); Bullock 2009 (AvD))
and one study reported the intervention was more effective among
women whose partners smoked (Polanska 2004).
2. Secondary outcomes
2.1 Relapse prevention
In examining trends in separate comparisons of studies, there was
no evidence that counselling prevented smoking relapse compared
to usual care (eight studies; average RR 1.06, 95% CI 0.93 to
1.21; see Analysis 1.3) or a less intensive intervention (five studies;
average RR 1.06, 95% CI 0.99 to 1.13; see Analysis 2.3). There
was also uncertainty whether health education prevented smoking
relapse compared with usual care (Peterson 1992) and whether so-
cial support prevented relapse when compared with a less intensive
intervention (McBride 2004 (AvC)) (RR 1.02, 95% CI 0.86 to
1.23 (Analysis 4.3) and RR 1.02, 95% CI 0.89 to 1.16 (Analysis
12.3), respectively).
2.2 Continued abstinence in the postnatal period
2.2.1 Zero to five months
In examining trends in separate comparisons of studies, there was
high quality evidence that health education increased smoking
abstinence in the early postpartum period (0 to five months) (two
studies: average RR3.56, 95%CI 1.31 to 9.67, I2 = 0%) compared
with usual care see Analysis 4.4 or less intensive interventions (two
studies: average RR 1,55, 95% CI 1.01 to 2.36, I2 = 0%) Analysis
5.3. There was also evidence that counselling increased the rate
of smoking abstinence in the early postpartum period (11 studies;
average RR 1.59, 95% CI 1.26 to 2.01, see Analysis 1.4), I2 = 0%,
compared with usual care; and also that incentives increased early
postpartum smoking abstinence (Donatelle 2000) (RR 3.63, 95%
CI 1.54 to 8.58) compared with less intensive interventions.
However, there was uncertainty whether there was an increase in
early postpartum smoking abstinence where: counsellingwas com-
pared with a less intensive intervention (eight studies; average RR
1.15, 95% CI 0.93 to 1.43; I2 = 23%, see Analysis 2.4) or alter-
native intervention (Cinciripini 2010) (RR 1.05, 95% CI 0.63
to 1.76; see Analysis 3.3); where incentives were compared with
usual care (two studies; average RR 1.09, 95% CI 0.56 to 2.13, I
2 = 0%) (Analysis 9.3) or alternative interventions (three studies;
average RR 1.79, 95% CI 0.57 to 5.61) (Analysis 11.3), or where
social support was compared with usual care (two studies; average
RR 1.34, 95% CI 0.35 to 5.14; I2 = 52%, see Analysis 12.4).
There was also uncertainty in evidence from interventions pro-
vided as part of a broader maternal health program for social sup-
port compared to less intensive interventions (two studies; average
RR 0.89, 95% CI 0.51 to 1.55; seeAnalysis 19.3) or usual care
(Mejdoubi 2014) (RR 1.53, 95% CI 0.76 to 3.06); counselling
compared to usual care (El-Mohandes 2011) (RR 1.46, 95% CI
0.97 to 2.19); or where health education was compared to a less
intensive intervention (Bullock 2009 (A+C v B+D)).
2.2.2 Six to 11 months
In examining trends in medium-term postpartum abstinence in
separate comparisons of studies, there is borderline evidence of an
increase in smoking abstinence at six to 11 months postpartum
with counselling (six studies; average RR 1.33, 95% CI 1.00 to
1.77; Analysis 1.5), I2 = 0%, and strong evidence with incentives
(Tappin 2015) (RR 3.99, 95% CI 2.10 to 7.16), compared to
usual care.
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However, there was uncertainty in evidence when counselling was
compared with a less intensive intervention (four studies; average
RR 1.09, 95% CI 0.91 to 1.31, see Analysis 2.5 or alternative
intervention (Cinciripini 2010) (RR 0.76, 95% CI 0.33 to 1.73)
(Analysis 3.4); when incentives were compared to alternative in-
terventions (three studies, average RR 0.93, 95%CI 0.85 to 1.01),
I2 = 0% (Analysis 11.4); when social support was compared with
a less intensive intervention (three studies; average RR 1.08, 95%
CI 0.81 to 1.44; see Analysis 12.5); or in a single studies compar-
ing exercise to usual care (Ussher 2015) (RR 1.50, 95% CI 0.81
to 2.79) (Analysis 13.3).
2.2.3 12 to 17 months
In examining trends in the longer postpartumperiod separate com-
parisons of studies, there was evidence that counselling increased
smoking abstinence at 12 to 17 months postpartum (two studies;
average RR 2.20, 95% CI 1.23 to 3.96, see Analysis 1.6), I2 = 0%,
compared with usual care.
However there was uncertainty whether counselling increased
smoking abstinence in the longer term when compared with a less
intensive intervention (three studies; RR 1.11, 95% CI 0.87 to
1.41, see Analysis 2.6) I2 = 26%; or whether a multiple social sup-
port intervention (McBride 2004 (AvC)) increased longer-term
smoking abstinence when compared with a less intensive inter-
vention (RR 1.07, 95% CI 0.76 to 1.51, see Analysis 12.6).
2.2.4 18+ months
Three trials of counselling combined with other strategies, and
comparedwith usual care,measured self-reported continued absti-
nence beyond 17 months postpartum, but there was uncertainty
whether this increased in longer-term postpartum smoking ab-
stinence (average RR 0.98, 95% CI 0.50 to 1.92, see Analysis
20.7). There was also uncertainty whether social support within
a broader maternal heath program increased smoking abstinence
after 17 months (Kemp 2011) (RR 1.07, 95% CI 0.58 to 1.98)
compared to usual care.
2.3 Smoking reduction
There was uncertainty whether any interventions increased the
rate of validated smoking reduction in all comparisons, including:
a comparison of counselling with usual care (two studies; average
RR 0.79, 95%CI 0.49 to 1.28, see Analysis 1.8); counselling with
less intensive interventions (two studies; average RR 1.35, 95%
CI 0.98 to 1.87, see Analysis 2.7); incentives with usual care (two
studies; average RR 0.71, 95% CI 0.18 to 2.88, I2 = 79%, see
Analysis 11.5); and single studies comparing feedback to usual
care (Cope 2003) (RR 1.48, 95% CI 0.93 to 2.37), incentives and
alternative interventions (Harris 2015) (RR 0.60, 95% CI 0.08 to
4.76).
There was evidence of a small decrease in mean cotinine in six
studies comparing counselling and usual care (standardised mean
difference (SMD) -0.44, 95%CI -0.76 to -0.12, seeAnalysis 1.10),
but there is high heterogeneity (I2 =87%) so these results should be
interpreted with caution. There was also evidence that counselling
reduced mean thiocyanate in one study (Sexton 1984) (SMD -
0.29, 95% CI -0.44 to -0.15) compared to usual care. However,
there was uncertainty whether incentives reduced mean cotinine
(two studies, SMD -2.00, 95% CI -6.61 to 2.60, I2 = 85%, see
Analysis 9.6) compared to usual care; and also when counselling
was compared with usual care as part of a broader maternal health
program (El-Mohandes 2011) (SMD0.11, 95%CI -0.17 to 0.39,
see Analysis 15.4).
There was evidence of a decrease in self-reported smoking (RR)
and mean cigarettes per day (SMD) in separate comparisons of:
counselling and usual care (five studies; average RR 1.66, 95%
CI 1.27 to 2.17, Analysis 1.9) (11 studies; SMD -0.20, 95% CI
-0.41 to -0.00, Analysis 1.11 (no pooled results as I2 = 85%));
counselling and less intensive interventions (two studies; average
RR 1.35, 95% CI 1.07 to 1.71, Analysis 2.8); health education
and usual care (two studies; SMD -0.55, 95% CI -0.94 to -0.15,
see Analysis 4.5); feedback and usual care (Valbo 1994) (RR 1.88,
95% CI 1.24 to 2.84; Analysis 7.4), and (SMD -3.00, 95% CI -
4.68 to -1.32; Analysis 7.5); and social support as part of a broader
maternal health intervention with usual care inmean cigarettes per
day (two studies; SMD -0.31, 95% CI -0.55 to -0.07, see Analysis
18.5).
However, there was uncertainty whether there was a reduction in
self-reported smoking (mean cigarettes per day) in comparisons
of: counselling and less intensive interventions (two studies; SMD
-0.11, 95% CI -0.30 to 0.09, see Analysis 2.9); health education
comparedwith usual care (Ershoff 1999 (AvC)) (SMD-0.70, 95%
CI -3.37 to 1.97, seeAnalysis 5.4) feedback as part of a broaderma-
ternal health intervention with usual care (LeFevre 1995) (SMD
1.50, 95% CI 1.07 to 1.93, not adjusted for clustering) (Analysis
17.3), and (Reading 1982) (RR 0.95, 95%CI 0.42 to 2.18); or so-
cial support compared with a less intensive intervention (Solomon
2000) (RR 0.96, 95% CI 0.64 to 1.44) (Analysis 12.7), or as part
of a broader maternal health intervention with a less intensive in-
tervention (Bullock 1995) (SMD 0.15, 95% CI -0.34 to 0.64, see
Analysis 19.4).
2.4 Infant outcomes
As a primary objective of this review is to determine if psychosocial
interventions to support women to stop smoking in pregnancy
have an impact on infant and maternal health outcomes, and large
numbers are needed to detect relatively rare events, the pooled
infant outcomes are included in this section of the review (see
comparison 20). These outcomes demonstrate the relationship be-
tween being randomised to a smoking cessation intervention and
birth outcomes only, rather than the effectiveness of any partic-
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ular intervention strategy. There was evidence that ’all interven-
tions’, used in this analysis of infant outcomes, increased the rate
of smoking cessation in late pregnancy (average RR 1.35, 95%
CI 1.23 to 1.48, I2 = 44%, see Analysis 20.1) when compared
with ’all controls’; and when trials were restricted to those with
biochemically validated abstinence only (average RR 1.32, 95%
CI 1.19 to 1.46, I2 = 38%, see Analysis 20.2).
2.4.1 Low birthweight
The pooled results of 18 study arms which reported low birth-
weight (less than 2500 g) provided high quality evidence that
smoking interventions reduced the proportion of infants born low
birthweight by 17% (average RR 0.83, 95% CI 0.72 to 0.94; see
Analysis 20.11). The number needed to treat for an additional
beneficial outcome (NNTB) in terms of low birthweight is 63,
with a 95% CI of 39 to 203. Presented in a different way, 92
out of every 1000 participants in the control group experienced
low birthweight births, compared to 76 (95% CI 66 to 87) out
of 1000 for the intervention group. However, there was uncer-
tainty whether smoking cessation interventions reduced the pro-
portion of infants born very low birthweight (less than 1500 g).
While the pooled effect suggested interventions may be beneficial
(three studies; average RR 1.11, 95%CI 0.62 to 2.01, see Analysis
20.12), the confidence interval was wide and included both harm-
ful and unimportant effects.
In separate comparisons of studies, the effect was unclear in smaller
comparisons of: counselling and usual care (Analysis 1.19) or less
intensive interventions (Analysis 2.10); or incentives and usual
care (Analysis 9.8) or alternative interventions (Analysis 11.6), as
large sample sizes are required to detect a significant difference in
this outcome. There was also uncertainty whether specific inter-
ventions reduced the proportion of infants born low birthweight
in all of the single studies comparing: health education and usual
care (Donovan 1977) (RR 1.10, 95% CI 0.66 to 1.84) or a less
intensive intervention (Hjalmarson 1991) (RR 0.60, 95%CI 0.28
to 1.29); feedback and usual care (Haddow 1991) (RR 0.82, 95%
CI 0.63 to 1.06); exercise and usual care (Analysis 13.4); and so-
cial support with a less intensive intervention (Malchodi 2003)
(RR 1.00, 95% CI 0.33 to 2.99). The effect was also unclear in
the three studies reporting very low birthweight infants (less than
1500 g) when separated into comparison of counselling and usual
care (Analysis 1.13) and in a single study (Haddow 1991) com-
paring feedback and usual care (RR 0.90, 95% CI 0.35 to 2.32)
(Analysis 20.12).
2.4.2 Preterm births
There was uncertainty in high quality pooled data from 19 studies
reporting preterm births (less than 37 weeks’ gestation) whether
there were lower rates of preterm births among women receiving
psychosocial interventions (averageRR0.93, 95%CI0.77 to 1.11;
see Analysis 20.13), compared to women in the control groups.
In separate comparisons of studies, the effect was also unclear in
comparisons of counselling and usual care (five studies; average
RR 0.90, 95% CI 0.64 to 1.27, Analysis 1.14), counselling and
less intensive interventions (three studies; average RR 0.82, 95%
CI 0.47 to 1.42, Analysis 2.11), feedback and usual care (two
studies; average RR 0.60, 95% CI 0.28 to 1.29, Analysis 7.7), or
incentives and usual care (five studies; average RR 1.15, 95% CI
0.73 to 1.82, I2 = 12%) or alternative interventions (three studies;
average RR 0.43, 95% CI 0.16 to 1.15, I2 = 0%). There was
also uncertainty in single studies comparing: health education and
usual care (Donovan 1977) (RR 1.05, 95% CI 0.53 to 2.00) or a
less intensive intervention (Hjalmarson 1991) (RR 0.76, 95% CI
0.32 to 1.80); or exercise (Ussher 2015) (RR 1.32, 95% CI 0.81
to 2.14) with usual care.
2.4.3 Mean birthweight
There was high quality evidence that infants born to women re-
ceiving smoking cessation interventions had an increase in mean
birthweight of 55.60 g among women receiving the intervention
(26 studies; 95% CI 29.82 to 81.38 g, see Analysis 20.14), com-
pared to women in the control group.
In examining trends in separate comparisons of studies, there was
evidence of an increase in mean birthweight in comparisons of
counselling and usual care (11 studies; MD 40.27, 95% CI 7.87
to 72.66, see Analysis 1.15), incentives compared to usual care
(five studies; MD 109.38, 95% CI 60.51 to 158.26, see Analysis
9.10), and incentives compared to alternative interventions (three
studies; MD 134.58, 95% CI 76.32 to 192.83, see Analysis 11.8).
However, the evidence was uncertain in comparisons of coun-
selling and less intensive interventions (three studies; MD 56.02,
95% CI -31.46 to 143.50, see Analysis 2.12), or feedback and
usual care (two studies; MD 79.43, 95% CI -53.05 to 211.91,
see Analysis 7.8). There was also uncertainty in the evidence of a
difference inmean birthweight in single studies comparing: health
education and usual care (Donovan 1977) (MD -12.00, 95%
CI -102.29 to 78.29) or less intensive interventions (Hjalmarson
1991) (MD 71.00, 95% CI -26.58 to 168.58); exercise and usual
care (Ussher 2015) (MD-14.40, 95% CI -104.15 to 75.35), or
social support provided as part of a broader maternal health inter-
vention and a less intensive intervention (Malchodi 2003) (MD
28.00, 95% CI -152.48 to 208.48).
2.4.4 Other perinatal outcomes
Therewas high quality evidence that infants born towomen receiv-
ing psychosocial smoking cessation interventions were 22% less
likely to be admitted toNICU immediately after birth (eight stud-
ies; average RR 0.78, 95% CI 0.61 to 0.98, see Analysis 20.18).
However, there was uncertainty whether psychosocial smoking
cessation interventions reduced perinatal deaths (four studies; av-
erage RR 1.13, 95% CI 0.72 to 1.77, see Analysis 20.16; although
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note that Valbo 1996 had a non-estimable effect), stillbirths (eight
studies (high quality evidence); average RR 1.20, 95% CI 0.76
to 1.90, see Analysis 20.15), neonatal deaths (five studies; average
RR 1.04, 95% CI 0.41 to 2.64, see Analysis 20.17). These pooled
effect size estimates, however, were based on small numbers of
studies and had low power to detect clinically important differ-
ences. A number of trials also excluded women who had a perina-
tal death or a preterm birth from the study population, although,
where possible, we have re-included these in the denominator and
numerator.
In separate comparisons of studies, it was unclear whether any spe-
cific interventions improved perinatal outcomes. This includes:
comparisons of counselling and usual care for stillbirths (four stud-
ies; average RR 1.08, 95% CI 0.51 to 2.30, Analysis 1.17), neona-
tal deaths (three studies; average RR 2.06, 95% CI 0.61 to 6.92,
Analysis 1.18), and NICU admissions (two studies; average RR
0.82, 95% CI 0.52 to 1.29, Analysis 1.12). There was unclear evi-
dence in relation to counselling and usual care for perinatal deaths
because the effect size for one of the two studies (Valbo 1996) was
not estimable due to zero events in both groups, therefore pooled
effect size was not calculable (see Analysis 1.16). There was un-
certainty observed for: feedback and usual care in stillbirths (two
studies; average RR 1.28, 95% CI 0.69 to 2.39, Analysis 7.9); in
NICU admissions for incentives and usual care (two studies; RR
0.61, 95% CI 0.21 to 1.77); and alternative interventions (three
studies; RR 0.59, 95% CI 0.22 to 1.62). There was also unclear
evidence in single studies comparing: counselling and a less inten-
sive intervention (Ershoff 1989) in stillbirths (RR 1.84, 95% CI
0.17 to 20.04); health education and usual care (Donovan 1977)
in perinatal deaths (RR 4.40, 95% CI 0.49 to 39.08); feedback
and usual care (Haddow 1991) in perinatal deaths (RR 1.05, 95%
CI 0.59 to 1.87) and neonatal deaths (RR 0.40, 95% CI 0.08 to
2.07); and exercise and usual care (Ussher 2015) for stillbirths and
perinatal deaths.
NB. The following sections for outcomes 2.4.5 to 2.12 are nar-
rative descriptions based on the findings reported in the stud-
ies, rather than on results of statistical synthesis
2.4.5 Non pre-specified infant outcomes
There was evidence from four study arms (Cope 2003; Heil 2008;
Higgins 2014 (AvB); Higgins 2014 (AvC)) that smoking cessation
interventions increased fetal growth measures including fetal fe-
mur length and fetal abdominal circumference, and infant length,
but there was uncertainty in the evidence for a difference in head
circumference between control and intervention groups. There
was uncertainty whether interventions improved Apgar scores at
one and five minutes post-birth in four study arms (Cope 2003;
Tuten 2012 (AvB); Tuten 2012 (AvC); Ussher 2015).
2.5 Mode of birth
Three trials measuring mode of birth by intervention group
(Thornton 1997; Cope 2003; Tappin 2005) reported uncertainty
in whether interventions reduced the rate of operative births by
intervention group and one trial reported a difference (Ussher
2015).
2.6 Breastfeeding
There were mixed results for the effect of interventions on breast-
feeding from smoking cessation interventions. Two trials thatmea-
sured breastfeeding initiation (Panjari 1999; McLeod 2004) re-
ported uncertainty in whether interventions increased initiation
or duration of breastfeeding. However, one trial of incentives
reported that incentives increased breastfeeding duration (Heil
2008) at both eight weeks and 12 weeks postpartum.
2.7 Psychological effects
Many studies reported baseline psychological measures of inter-
ventions, reinforcing the findings from observational studies that
there are significant psychological symptoms among many preg-
nant women who smoke. Up to 75% of pregnant women who
smoked had current or previous psychological symptoms (Belizan
1995; Ershoff 1999 (AvC); Cinciripini 2010; Ondersma 2012
(A+C v B+D); Higgins 2014 (AvB); Higgins 2014 (AvC)) and
approximately 18% to 25% of women reported major depression
based on CES-D scale assessments (Blalock 2005; Dornelas 2006;
Bullock 2009 (A+C v B+D); Cinciripini 2010; El-Mohandes
2011; Ussher 2015). Four studies identified baseline depression
or stress as a ‘mediator’ or ‘predictor’ of continued smoking at
follow-up (Crittenden 2007; Linares 2009; Stotts 2009 (AvC);
El-Mohandes 2011), suggesting depressive symptoms may be an
‘independent contributor to the problem of continued smok-
ing during pregnancy’ (Linares 2009). Cinciripini 2010 found a
stronger smoking cessation effect from a psychological depression-
focused intervention among women with depression, compared
to women receiving an alternative health education intervention
of the same intensity.
Thirteen trials reported post-intervention psychological outcome
measures and none reported any negative psychological effects.
Eight study arms showed that smoking cessation interventions
in pregnancy do not increase stress and psychological symptoms
for women (Manfredi 1999; Panjari 1999; Aveyard 2004; Rigotti
2006; Solomon 2006; El-Mohandes 2011; Higgins 2014 (AvB);
Higgins 2014 (AvC)). Furthermore, five studies demonstrated that
smoking cessation interventions have the potential to improve
women’s psychological well-being and self-esteem (Stotts 2004;
Bullock 2009 (A+C v B+D); Cinciripini 2010) and self-efficacy
(Stotts 2004; Naughton 2012; Lee 2015). One study (Ussher
2015), found higher rates of depression at birth among women
receiving an exercise intervention, however there was no clear dif-
ference by six months postpartum.
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2.8 Impact on family functioning and other relationships
No studies reported measures of family functioning. Studies re-
porting analysis of social networks (Stotts 2009 (AvB); Stotts 2009
(AvC)), suggest an interaction between smoking networks (house-
hold and other) or partner smoking (Bullock 2009 (AvC); Bullock
2009 (AvD)) and continued smoking of participants in late preg-
nancy. Two studies reporting perceptions of partner (McBride
2004 (AvB); McBride 2004 (AvC)) and peer support (Hennrikus
2010) had mixed findings. Pregnant women reported less nega-
tive partner support through pregnancy, but this increased in the
postpartum period (McBride 2004 (AvB); McBride 2004 (AvC)).
Women in another study reported an increase in both positive
and negative support from a peer including: comments about the
woman’s lack of willpower, trying to make them feel guilty, ex-
pressing anger about smoking and trying to scare women about
smoking (Hennrikus 2010).
2.9 Participants views
Thirty-five studies included women’s views of the interventions,
13 studies reported providers’ views of the interventions and
three studies reportedmeasures of knowledge, attitudes or practice
among pregnancy care providers.
2.9.1 Women’s views
Thirty-three studies reported that they addressed in the interven-
tion issues identified as concerns by women when consulted for
this review (Oliver 2001); including ‘coping with stress and emo-
tions’, weight gain, misconceptions about smoking risks, and feel-
ings of guilt.
While not a pre-specified outcome, four studies reported out-
comes related to maternal weight gain. One study (Sexton 1984),
reported a slightly higher mean weight gain in the intervention
group (12.9 kg) compared to the control group (11.9 kg). Two
other studies did not report weight gain by intervention exposure
(Rigotti 2006;Ussher 2015), but an associated reference to Rigotti
2006 reported that women with a ‘high concern’ about weight
gain were less likely to quit smoking during pregnancy or remain
abstinent postpartum (Berg 2008), and an associated reference to
Heil 2008 reported an increased weight gain of 2.8 kg in women
who were abstinent compared to women who continued to smoke
(P = 0.04), with an estimated 0.34 kg increase in weight gain for
every 10% increase in smoking abstinence (Washio 2011).
Thirty-three studies explicitly mentioned consideration of
women’s views in developing the intervention, and 12 study arms
explicitly described the involvement of communitymembers or or-
ganisational staff in the development of the intervention (Windsor
1985 (AvB); Windsor 1985 (AvC); Belizan 1995; Kendrick 1995;
Gielen 1997; Donatelle 2000; Albrecht 2006 (AvB); Albrecht
2006 (AvC); Campbell 2006; Patten 2009; Windsor 2011; Eades
2012).
Thirty-five studies reported women’s views about the content and
delivery of the interventions. When asked, most women gave
favourable feedback on the intervention and intervention mate-
rials (Baric 1976; Belizan 1995; Bullock 1995; Lillington 1995;
Secker-Walker 1997; Walsh 1997; Cinciripini 2000; Strecher
2000; Tappin 2000; Hajek 2001; Cope 2003; Tappin 2005;
Cinciripini 2010; El-Mohandes 2011; Ondersma 2012 (AvC)),
particularly audiovisual materials (Windsor 1993; Patten 2009;
Ondersma 2012 (AvC)) and telephone support (Bullock 1995;
Solomon 2000; Rigotti 2006; Bullock 2009 (AvC); Bullock 2009
(AvD); Naughton 2012). Women offered personal contact and
a manual considered the personal contact the most important
element and women appreciated printed materials much less if
they were also offered a video, although the video combined with
printed materials was no more effective than the printed materials
alone (Secker-Walker 1997; Cinciripini 2000). Similarly, women
offeredmotivational interviewing for relapse preventionweremore
likely to be satisfied than those offered a booklet (Ershoff 1989),
although the motivational interviewing was no more effective
(Ershoff 1999 (AvC). Women participating in a study in Ireland
(Thornton 1997) reported the importance of providing the in-
tervention in privacy, and suggested that telephone follow-up be-
tween visits and a video would have been helpful components
in that intervention. Two studies reported that even if they did
not like it, women expected to be asked about smoking from
their care provider (Walsh 1997; McLeod 2004). Two trials us-
ing computer-assisted technology were rated positively (Strecher
2000; Ondersma 2012 (AvC)), but in an earlier trial women ex-
pressed concern about entering personal information into a com-
puter (Ershoff 1999 (AvC)).
Despite positive feedback about the content of the intervention,
several trials reported difficulty recruiting and retaining women’s
participation in the intervention (Loeb 1983; Secker-Walker 1994;
Cinciripini 2000; Stotts 2004; Patten 2009), andmany studies had
low participation rates. In a multimodal intervention including
counselling and NRT, only 87/327 women in the intervention
group participated in counselling and only 75 women used NRT
(Hegaard 2003).
Offering additional group sessions for smoking cessation was gen-
erally a poorly accepted intervention even in otherwise successful
trials (Loeb 1983; Windsor 1985 (AvC)), though one study re-
ported groups were well-accepted (Sexton 1984). Hypnosis was
also a poorly accepted intervention in two studies (Sexton 1984;
Valbo 1996). Five studies reported women’s negative views of in-
tervention components, including: use of carbon monoxide mon-
itoring and prompt cards (Thornton 1997); some peer support
behaviours (Hennrikus 2010), limited perceived efficacy of book-
lets (Ershoff 1989; Moore 2002), and phone messages (Ershoff
1999 (AvC)).
2.9.2 Providers’ views
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Thirteen studies reported providers’ views of the intervention.
While providers’ views about the interventions were generally pos-
itive, a recurrent theme was their concern about the time taken
by the intervention (Kendrick 1995; Hajek 2001; Moore 2002;
Campbell 2006), the ’busyness’ of the clinic (Thornton 1997),
and the impact on their relationship with women (Hajek 2001;
Eades 2012 reported in associated reference Wood 2008). Sixty-
five per cent of midwives asked to use a carbon monoxide moni-
tor and provide ’stage of change’-based advice considered that this
could not be achieved in the time available. This led to less than
full implementation and variable motivation to promote smok-
ing cessation counselling among staff in some studies (Kendrick
1995; Moore 2002), but not all (Walsh 1997; Windsor 2011).
One of the reasons given for tailoringmessages to ‘stages of change’
was to address providers’ concerns that interventions may alienate
women not ready to quit (Hajek 2001). A survey of general prac-
titioners suggested the smoking status of the provider influenced
participation in intervention delivery (Haug 1994). Despite these
challenges, engagement and involvement of providers was identi-
fied as a critical element of implementation (Lowe 1997; McLeod
2004; Campbell 2006) and providers reported that they would
like more involvement (Tappin 2000). One study (Tappin 2015)
reported public perceptions and acceptability of providing finan-
cial incentives for women who stop smoking in pregnancy.
2.10 Measures of knowledge attitudes and behaviour of
health professionals with respect to facilitating smoking
cessation in pregnancy
Three study arms reported positive effects of the interventions
on providers’ understanding, confidence in delivering the inter-
vention, optimism that the intervention may influence women’s
smoking behaviour (Lawrence 2003 (AvB); Lawrence 2003 (AvC);
Pbert 2004 (reported in associated references (Zapka 2000; Zapka
2004) and obstetric knowledge and practice (Secker-Walker 1992;
Secker-Walker 1998).
2.11 Cost-effectiveness
Four studies reported that the interventions were cost-effective
using a variety of measures. Pregnancy-specific, self-help materi-
als were more cost-effective than standard smoking cessation in-
formation or self-help materials (Windsor 1985 (AvB); Windsor
1985 (AvC)). Specific estimates include: a benefit-cost ratio of
2.8:1 (Ershoff 1990); one (non-smoker): $84 (Parker 2007 (AvB);
Parker 2007 (AvC)); and an average cost of $56 per person for
each smoking cessation intervention, and $299 to produce a non-
smoker at the end of pregnancy (Dornelas 2006). Several trials de-
scribe the relative cost-effectiveness of their interventions (Peterson
1992; Hartmann 1996), including a recent trial of financial in-
centives (Tappin 2015), which found the short-term incremen-
tal cost per quitter at 34 to 38 weeks’ gestation was £1127, and
longer-term cost per quality adjusted life year gained was £482;
well below the UK National Health Service threshold of £20,000.
2.12 Adverse effects
High quality evidence suggests that smoking cessation interven-
tions have minimal adverse effects. Four studies that measured
whether women increased their smoking following exposure to the
intervention showed mixed results. One trial reported a slightly
lower level of cotinine in the intervention group, compared to the
control group (Tappin 2005), another reported no difference in
self-reported smoking (Hjalmarson 1991), and another two tri-
als reported an increase in smoking among women who did not
quit (Haug 1994; LeFevre 1995). A trial of financial incentives
reported no increases in people taking up smoking or ’gaming’ the
system (Tappin 2015).
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
Outcomes for all interventions for smoking cessation in pregnancy compared to all controls: subgrouped by main intervention strategy (comparison 20)
Patient or population: Pregnant women who smoke
Setting: Any
Intervention: All intervent ions for smoking cessat ion in pregnancy
Comparison: Any controls
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with control Risk with Interventions
for smoking cessation
in pregnancy
Abst inence
in late pregnancy: self -
reported and biochemi-
cally validated
Study populat ion RR 1.35
(1.23 to 1.48) 3
26,637
(97 RCTs) 2
⊕⊕⊕©
MODERATE 1
12 per 100 2 16 per 100
(15 to 18)
Abst inence at 0 to 5
months postpartum
Study populat ion RR 1.32
(1.17 to 1.50)
8366
(35 RCTs)
⊕⊕⊕⊕
HIGH
131 per 1000 173 per 1000
(153 to 196)
Low birthweight (under
2500 g)
Study populat ion RR 0.83
(0.72 to 0.94)
9402
(18 RCTs)
⊕⊕⊕⊕
HIGH
92 per 1000 76 per 1000
(66 to 87)
Preterm birth (under 37
weeks)
Study populat ion RR 0.93
(0.77 to 1.11)
9222
(19 RCTs)
⊕⊕⊕⊕
HIGH
72 per 1000 67 per 1000
(55 to 80)
4
5
P
sy
c
h
o
so
c
ia
l
in
te
r
v
e
n
tio
n
s
fo
r
su
p
p
o
rtin
g
w
o
m
e
n
to
sto
p
sm
o
k
in
g
in
p
re
g
n
a
n
c
y
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
7
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
Mean birthweight (g) The mean birthweight
(g) was 0
MD 55.60 higher
(29.82 higher to 81.38
higher)
11,338
(26 RCTs)
⊕⊕⊕⊕
HIGH
Stillbirths Study populat ion RR 1.20
(0.76 to 1.90)
6170
(8 RCTs)
⊕⊕⊕⊕
HIGH
11 per 1000 13 per 1000
(8 to 20)
NICU admissions Study populat ion RR 0.78
(0.61 to 0.98)
2100
(8 RCTs)
⊕⊕⊕⊕
HIGH
118 per 1000 92 per 1000
(72 to 116)
Adverse events and
psychological impact
There did not appear to be any adverse ef fects
f rom the psychosocial intervent ions. While there
were mixed views f rom women about compo-
nents of some intervent ions, 5 of 13 trials eval-
uat ing psychological impact measured an im-
provement in women’s psychological well-being
and none reported a negat ive impact
- (13 RCTs) ⊕⊕⊕⊕
HIGH
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
CI: Conf idence interval; M D: mean dif ference; RR: Risk rat io.
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Moderate heterogeneity (44%): refer to intervent ion comparisons for more consistent ef fect est imates
2 All control group risks are mean values of control group among included studies
3 No clear dif f erence seen in meta-regression analysis among women with low socio-economic or ethnic minority status,
intervent ions provided by rout ine care staf f , comparison group, intervent ion intensity (f requency and durat ion), newly included
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studies, use of self -help manuals or telephone support , or risk of bias. Evidence of dif f erences with unclear implementat ion
and unequal baseline characterist ics.
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D I S C U S S I O N
Summary of main results
Studies in this review demonstrate that psychosocial interventions
can support women to stop smoking in pregnancy and reduce the
proportion of infants born low birthweight or admitted to neona-
tal intensive care after birth. Importantly, the interventions do not
appear to have any overall negative physical or psychological ef-
fects, are positively received bymostwomen, andmay improve psy-
chological well-being. Counselling was effective when provided in
conjunction with other strategies or tailored to individual women,
but it is unclear whether any types of counselling are more effective
than others. Incentives had a large effect size when compared with
non-contingent incentives, but variable effects when compared
with usual care or less intensive interventions. Feedback had a large
effect in two trials when combined with other strategies, such as
counselling, and compared with usual care, but not less intensive
interventions. The effect of health education, social support from
peers or partners and exercise was less clear. Among women who
received psychosocial interventions there was a significant reduc-
tion (17%) in the proportion of babies born low birthweight (less
than 2500 g), and a significant increase in mean birthweight of
56 g. Using data from this review, the number needed to treat
for an additional beneficial outcome (NNTB) to prevent one in-
fant being born low birthweight is 63 (95% confidence interval
(CI) 39 to 203). Given the benefits of stopping smoking in preg-
nancy for the woman and her infant, this would seem to be an
important intervention, particularly when applied at a population
level. However, it remains unclear from dissemination trials and
smoking cessation interventions provided as one component of a
broader maternal health intervention, whether interventions are
likely to be effective when implemented into routine pregnancy
care. This may be due to various reasons, including different mo-
tivations of women participating in smoking cessation trials and
reduced implementation.
Among the subgroups of ’main intervention strategies’ categorised
in this review, the 14 study arms that included use of incentives
had a strong effect. Non-contingent comparisons provide a ’time-
matched’ alternative comparison of similar intensity, which helps
to identify if it is the ’additional assistance’ or incentives which
are effective (Mantzari 2012). The effect was also significantly dif-
ferent from zero in the pooled results of three counselling inter-
ventions that included lottery tickets (Sexton 1984; Walsh 1997;
Parker 2007 (AvC)). These findings are consistent with other re-
views of financial incentives in pregnancy (Higgins 2012; Cahill
2015), and the mechanisms for the effectiveness of incentives
for reducing substance abuse more generally has been well-docu-
mented (Higgins 2008b). However, the results of the incentives
trials should be considered with caution as there are high levels of
inconsistency in some comparisons. In comparisons of incentives
with ’usual care’, there was no effect seen in ’low-intensity’ in-
centives (’CM Lite’) combined with an interactive computer-gen-
erated counselling program (Ondersma 2012 (AvC); Ondersma
2012 (AvD)), which relied on women initiating contact with the
research team for urine cotinine testing, and provided a maximum
of only five verification and ’incentive’ interactions, with less than
half thewomen in this arm submitting evenone urine test. Interest-
ingly, women in this four-armed trial who received the interactive
computer-generated counselling program alone were more likely
to quit than women who received the combined incentive and
computer-counselling intervention (see Ondersma 2012 (AvC)).
In comparisons of incentives versus less intensive interventions,
there was very high heterogeneity (I2 = 93%), which decreased
to 23% in sensitivity analysis when one intervention which in-
volved provision of lottery tickets was removed from the analysis.
This highlights the importance of considering the characteristics
of the intervention and the context in interpreting the results. Pro-
vision of financial incentives to support pregnant women to stop
smoking can be a contentious issue: Hoddinott 2015 explored
perspectives and found a number of themes around ’moral ten-
sions around acceptability’, ’need for incentives’, ’goals’, ’collec-
tive or divisive action’ and ’monitoring and proof ’. Concerns were
identified around additional pressure on women, burden of proof,
gaming, box-ticking bureaucracies and the impact on health in-
equalities. In an associated paper, Thomson 2014 concluded “Fi-
nancial incentives are controversial and generated emotive and op-
positional responses. The planning, design and delivery of future
incentive interventions should evaluate unexpected consequences
to inform the evidence for effectiveness, cost-effectiveness and fu-
ture implementation”.
Pooled results of interventions in which counselling was the main
intervention strategy showed a significant effect in abstinence in
late pregnancy. There was no significant difference seen when one
type of counselling (cognitive behavioural therapy (CBT)) was
compared with traditional health education (Cinciripini 2010), or
when counselling was provided as part of a broader intervention to
improve maternal health (El-Mohandes 2011). Group interven-
tions were generally not well-accepted in this population of preg-
nant women, despite being reported as a potentially well-accepted
intervention in the general population (Bauld 2010). Findings
from this review support recommendations that pregnant women
may need more support than just brief advice or health educa-
tion (Coleman 2004), as it was unclear whether health education
alone helped women to quit. Qualitative evidence suggests this
support should be positive, not punitive (Bond 2012), and is sen-
sitive to potential feelings of guilt and worry, and concerns about
the impact of quitting on women’s lives and their relationship
with significant others (Flemming 2013). A qualitative analysis of
messages to promote smoking cessation among pregnant women
(Hoek 2014), suggested cessation messages should aim to evoke
emotional responses and focus less on informational approaches.
Burgess 2009 suggests it may help for healthcare providers to be-
come aware of any of their own biases against mothers who smoke.
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Feedback was shown to have a large effect in two studies when
compared to usual care but not when compared to less intensive
interventions, highlighting the need for caution in interpreting
these results. Additionally, an implementation trial of routine bio-
chemical validation and an ’opt out’ referral pathway for smok-
ing cessation in pregnancy (Bauld 2012), found that while more
women were referred for support to quit, there were not higher
numbers of quitters. This reinforces suggestions from interven-
tions where smoking cessation is provided as one component of
a broader maternal health intervention and dissemination trials,
that the motivations of women participating in specific smoking
cessation trials may be influencing the effect seen, and that this
effect may not translate to a population level.
Social networks have been suggested as a major cause of relapse
(Nguyen 2012b), and a systematic review of qualitative studies
identified partners as one of the most important influences on
women’s smoking and relapse (Flemming 2013). In this update of
this review, social support was no longer effective when provided as
a targeted intervention. This represents a change from the previous
update and is likely to be due to the inclusion of additional study
arms (previously excluded), which tended to be the ’less intensive’
study arms, as we had previously only included the ’most inten-
sive’ arm of multi-arm studies; as well as the inclusion of two new
large social studies with non-significant results (Mejdoubi 2014;
Robling 2016). As in previous versions of this review, there was
uncertainty in the effectiveness of social support provided as part
of a broader intervention to improve maternal health; with the
exception of one large study conducted in South America (Belizan
1995). It is unclear from the single trial of partner-assisted support
(McBride 2004 (AvB);McBride 2004 (AvC)), that this strategy can
help women to stop smoking. Mixed results have similarly been
reported in a systematic review of five randomised controlled trials
(Duckworth 2012), and another review of seven studies reported a
non-significant effect (Hemsing 2012), concluding that, “Despite
the importance of partner smoking, there are very few effective
smoking cessation interventions for pregnant/postpartum women
that include or target male partners”. This raises questions about
arguments that a major reason for the modest effect of smoking
interventions is the focus on individual behavioural change rather
than acknowledging social factors and focusing on external moti-
vation (Okoli 2010). Additionally, feedback fromwomen demon-
strates the support from both partners and peers can sometimes be
negative, which raises concerns about the potential risks for vul-
nerable women in physically or emotionally violent or controlling
relationships. Evidence from this review suggests that while part-
ner and peer support may be important factors influencing smok-
ing behaviour, eliciting peer and partner support that is positive
and can actually support women to stop smoking in pregnancy
may not always be possible (Hennrikus 2010). A qualitative review
of partners smoking by Flemming 2015b found several factors
that hindered (barriers) and encouraged (facilitators) partners to
consider quitting during the woman’s pregnancy and postpartum
period. Workplaces were considered an important space for influ-
encing on partners’ smoking habits, while health and community
settings were seen to offer little support to fathers.
Despite promising evidence that exercise has an impact onnicotine
cravings (Taylor 2007), supported by one included study in this
review which did not report any smoking cessation outcomes (
Prapavessis 2014); the results were unclear in a large high-quality
trial of an exercise intervention (Ussher 2015).
Newly included studies in this review had lower effect sizes than
older studies in the previous version, despite a general trend to-
wards higher-intensity interventions in more recent trials. The
lack of a clear difference in effect seen by increasing intervention
intensity may be due to the strong correlation of higher-intensity
interventions with higher-intensity controls. However, it may also
support reports questioning the assumption that ever-increasing
the intensity of support will increase quit rates (Lando 2001), and
views that there may be an upper limit of what women accept
(Chapman 2012). It may be that women who continue to smoke
are not getting ’more hard core’ but that there are many options
already available and additional strategies may not be offering a
lot of extra benefit, as risks of smoking during pregnancy, due
to health education campaigns, are well known in high-income
countries (Campion 1994; Eriksson 1996; Eriksson 1998). One
included study found relapse within the first two weeks was pre-
dictive of continued abstinence, and suggested that it may be the
timing of intensive support during the earlier period of nicotine
withdrawal that may be an important component of interventions
(Higgins 2006b).
Studies in this review suggest the effect during pregnancy contin-
ues into the postpartumperiod, up until approximately 18months
postpartum, though the smaller effect size shows many women
who did quit during pregnancy relapse postpartum. Some suggest
that many pregnant smokers simply suspend their smoking for
the duration of pregnancy as opposed to quitting altogether or
they commit to ’temporary abstinence’ for pregnancy (Stotts 1996;
Lawrence 2005a; Flemming 2013), but these relapse rates are sim-
ilar for non-pregnant women (Bombard 2012). Rather than being
disappointed by these limited effects, some authors suggest health-
care workers should focus on the positive aspects of these findings
and reinforce the positive decisionsmanywomen aremakingwhen
pregnant (Hotham 2008). High post-pregnancy relapse rates have
led to some commentators calling for an extension of the period
of support for women to stop smoking (Coleman-Cowger 2012).
Hjalmarson 1991 reported a high proportion of women abstain-
ing from smoking during their hospital stay for the birth, and sug-
gests this may be an opportunity for intervention to reduce the
risk of postpartum relapse. These findings suggest there may be
a need for different approaches to promote continued abstinence
postpartum, including focusing on the benefits for the mother,
without excessive emphasis solely on the benefits for the baby.
Continued nicotine and cigarette exposure may have effects on
other outcomes not measured in this review. The level of re-
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duction required to improve health outcomes remains unclear
(Secker-Walker 2002a). One study analysing data from Kendrick
1995 suggested that reduction in smoking to fewer than eight
cigarettes a day is necessary to avoid a reduction in infant birth-
weight (England 2001), and estimated approximately a mean
birthweight which was 200 g higher among women who quit
smoking after enrolment, compared to women who continued to
smoke during pregnancy. Therefore, extrapolating these data to
this review, if all women in the intervention groups stopped smok-
ing and none of those in the control group did, the expected mean
birthweight difference would be about 200 g, rather than 56 g.
With an absolute difference of four in every 100 women stopping
smoking, the expected mean difference from the extent of smok-
ing cessation alone would have been about 8 g. This suggests that
smoking reduction is also happening to a greater extent in the
intervention than comparison groups, in line with self-reported
changes.
There was no evidence from studies in this review that smoking
cessation increases the rate of caesarean section (Thornton 1997;
Cope 2003; Tappin 2005), contrary to concerns raised by women
about the effects of increased fetal size (Sexton 1984). One ob-
servational study modelled increases in birthweight (from 2450 g
to 2550 g) in Guatemala which suggested theoretically there may
be an increased risk in caesarean section among women stopping
smoking due to obstruction in eight out of every 1000 cases, but
this was outweighed by a likely reduction in caesarean section due
to a reduction in fetal distress of 34 per 1000 cases (Merchant
2001).
Women who smoke are less likely to initiate breastfeeding (Amir
2001a; Amir 2002a; Donath 2004; Einarson 2009; Disantis
2010b), and breastfeed for shorter duration (Sayers 1995; Horta
1997). Therefore, supporting women to initiate and maintain
breastfeeding should be considered an important part of any in-
tervention in this population group, and reported as an outcome
in intervention studies. Studies in this review had mixed reports
of the effect of smoking cessation interventions on breastfeeding
(Panjari 1999; McLeod 2004; Higgins 2010b).
Studies in this review (Cinciripini 2000; Rigotti 2006) support
a recent qualitative study that concluded “Pregnant women with
mental disorders appearmoremotivated...yet find itmore difficult,
to stop smoking” (Howard 2013), and other studies that report
higher rates of quitting among women with higher self-esteem and
self-efficacy (Massey 2013). For these reasons, healthcare workers
have reported difficulty addressing smoking with pregnant women
(Wood 2008). Qualitative studies have identified concerns about
adverse effects of quitting, or increased guilt over continued smok-
ing, on women’s psychological well-being and capacity to cope
with adverse circumstances, with follow-on effects to the women’s
families (Oliver 2001; Wood 2008; Flemming 2013; Flemming
2015b). In earlier versions of this review, it has been difficult to as-
sess the effect of interventions on depression, as, despite the strong
associations with poor mental health and smoking in pregnancy,
women with mental illness were frequently excluded from trials.
However, mental well-being has been addressed in more recent
trials and, contrary to the above concerns, there is no evidence
from studies in this review that there are any negative psycholog-
ical consequences from delivery of individual smoking cessation
interventions in pregnancy. Rather, feedback from women from
studies in this review was positive with women feeling that “some-
body cared” (Bullock 1995). Three studies have shown that pro-
vision of psychosocial support can in fact improve women’s psy-
chological well-being, which has the potential to have enormous
benefits for the mother, the infant, and the whole family (Bullock
1995; Stotts 2004; Cinciripini 2010). In earlier versions of this
review, there appeared to be little evidence of the involvement of
pregnant women who smoked or caregivers being involved in the
design and evaluation of interventions (Oliver 2001). However,
there has been increasing discussion of women’s preferences for
cessation support in recent years (Ussher 2004). Studies included
in this review suggest women prefer individual personal contact,
particularly by telephone, though studies inclusive of telephone
support in this review did not appear to be significantly more ef-
fective. Rates of satisfaction with interventions delivered by com-
puters or mobile phones were generally positive, but again there
was no evidence in this review that the use of these technologies
increased the rate of abstinence in late pregnancy. Nevertheless,
acceptability of an intervention is an important aspect of popula-
tion-based interventions.
Some evidence suggests that women in high-income countries are
more likely to smoke to control their weight, and that female
body image is extensively targeted by tobacco marketing cam-
paigns (Pomerleau 2000; CDCP 2002; Levine 2006), although
concerns about gaining weight through stopping smoking during
pregnancy were not raised by any of the women consulted for this
review (Oliver 2001). The systematic review of qualitative studies
of women smoking in pregnancy (Flemming 2013), found two
studies mentioning weight gain as a factor in considering smok-
ing cessation. Hotham 2002 found that fear of weight gain was a
barrier to smoking cessation for some women and Lawson 1994
found some women used smoking to cope with weight gain. Four
studies in this update of the review (Sexton 1984; Berg 2008;
Washio 2011; Ussher 2015) address weight gain. Only one study
reported a small increase in weight gain among women in the in-
tervention group (Sexton 1984), and there was no significant dif-
ference reported from an exercise intervention (Ussher 2015). This
concern should be considered in interventions, with interventions
available to support women to avoid unwanted weight gain (Farley
2012). It should be noted that weight gain in pregnancy may not
necessarily be a negative outcome for many women, particularly
women in low- and middle-income countries. The association be-
tween smoking and glucose intolerance, a potential mechanism
for these effects, remains unclear (Wendland 2008). A Cochrane
systematic review of interventions for preventing weight gain after
smoking cessationmentioned neither pregnancy nor breastfeeding
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(Farley 2012), and therefore cannot be relied upon for evidence
relevant to a population where weight may fluctuate for normal
physiological reasons and where babies may be sensitive to drug
treatments in utero or when breastfeeding. Current guidelines rec-
ommend inclusion of support for breastfeeding and prevention of
weight gain are considered as part of smoking interventions for
pregnant women, as obesity has overtaken smoking as a major
cause of preterm births in high-income countries (Flenady 2011).
Public health impact of the interventions
Importantly, psychosocial interventions to support women to stop
smoking during pregnancy reduce the population-attributable risk
of neonatal intensive care unit (NICU) admissions (by 22%) and
low birthweight (by 17%), with approximately 63 interventions
to prevent one infant being born with low birthweight. As such,
smoking cessation is recommended as a key recommendation for
reducing the risk of recurrent preterm birth (Chang 2012; Cypher
2012). The number of interventions needed to treat for benefit
is extraordinarily low, given the serious clinical consequences of
these adverse outcomes. Based on the similar effectiveness pub-
lished in the 2004 version of this Cochrane review, if 75% of preg-
nant women in the USA disclosed their smoking status and all
received the intervention, then it has been estimated that 31,573
(6%) ’new quitters’ would be gained and the prevalence of smok-
ing in pregnancywould potentially decrease from16.4% to 15.6%
(Kim 2009b). While these effect size estimates may appear mod-
est, the response to interventions is similar to that of psychoso-
cial interventions to reduce Type 2 diabetes mellitus, hypertension
and asthma, all of which are conditions that involve a combina-
tion of medical illness, personal choice and environmental factors
(McLellan 2000). Importantly, the high prevalence of these con-
ditions in the community means that interventions with a modest
effect size estimate can have a substantial impact on population
health if widely implemented.
Economic costs
Studies in this review report variable cost-effectiveness measures
and costs of interventions. A systematic review of previous eco-
nomic evaluations of smoking cessation in pregnancy (Jones
2015), found that the majority of the literature suggests that in-
terventions offer good value for money; despite methodological
issues with evaluations. Based on a NNTB of one quitter for each
19 interventions, our cost estimates ($US1,064) based on $US56
per interventions is significantly higher than the $US299 reported
in Dornelas 2006. However, even with higher estimates, other
studies that evaluated the cost-effectiveness of these interventions
clearly show that there is a ‘rapid return on investment’ (Lightwood
1999). Early studies estimated the smoking-attributable mater-
nal costs during pregnancy alone ranged from $US150 million to
$US995 million in the early 1990s (Adams 1998), with 2004 es-
timates of $US122 million or $US279 per smoker (Adams 2011).
Estimated birth and first year costs for both mothers and infants
attributed to smoking were $1142 to $1358 per smoking woman
over a decade ago (Aligne 1997;Miller 2001; Adams 2002). Infant
costs are approximately 10 times maternal costs, accounting for
90% of costs in the first year. Low birthweight produces the high-
est economic burden as it is the most common adverse outcome
(Hueston 1994; Miller 2001). A 1% drop in smoking prevalence
was estimated to prevent approximately 1300 low birthweight live
births and save $US21 million in direct medical costs (Lightwood
1999). Inclusion of smoking attributable and environmental to-
bacco smoke exposure costs in birth and childhood conditions,
pushes estimates into the billions (Aligne 1997), and long-term
costs due to chronic disease up to $US57 billion in 1997, in theUS
alone (Bartlett 1994). An economic evaluation of data provided
in the 2009 version of this review estimated the societal benefits
from these interventions could be in excess of 500 million pounds
sterling per annum in the UK (Taylor 2009). In contrast with that
finding, the quality of diet in pregnancy (in high-income coun-
tries) has not been shown to affect themean birthweight of infants
over 32 weeks’ gestation (Rogers 1998). While there is variation
in reported costs dependent on conditions included and changing
healthcare costs (Ayadi 2006), it is clear that healthcare costs due
to smoking in pregnancy are substantial.
Impact on health inequalities
In high-income countries, the reduction in rates of smoking has
not been as substantial in women experiencing psychosocial dis-
advantage, as for the general population. Hence smoking has been
identified as a major preventable cause of the health inequalities
experienced by women who suffer psychosocial disadvantage, in-
cluding psychological illness, low educational attainment, young
early motherhood, lack of social support, and limited employ-
ment (Graham 2006). Some of the reasons may be that disad-
vantaged women are unable to change the environmental factors
that increase the risk of smoking; population-based interventions
may have the effect of being judgemental and alienate women;
and women are unable to change generational patterns (Graham
2009). Several authors have suggested that women who continue
to smoke in late pregnancy would be unlikely to benefit from the
usual antenatal interventions, which rely on women’s capacity for
self-initiation, self-control and social resources, which they sug-
gest helps to explain why it remains such an intractable problem
(Wakschlag 2003; Pickett 2009) and that individual interventions
alone are unlikely to impact on inequalities (Baum 2009). How-
ever, meta-regression analysis of studies included in this review
suggests that individual interventions provided during pregnancy
have similar effectiveness among women with low socio-economic
status (SES), as women who are not classified as having low SES,
despite several studies reporting a lower effect among participants
with lower SES (Baric 1976; McLeod 2004; Pbert 2004; Rigotti
2006). This non-significant effect may be confounded by the
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strong association between smoking and pregnancy and poverty
(i.e. women classified as ’not low’ SES because they belong to a
particular population group, may belong to a low SES sub-pop-
ulation which has not been identified). However, current find-
ings support qualitative studies that suggest individual support,
which is positive rather than punitive, has an important role (Bond
2012). Therefore, individual psychosocial support should form
a part of the tobacco control ‘package’ to reduce smoking dur-
ing pregnancy, in conjunction with population-based measures,
which have also been shown to have a significant impact on birth
outcomes (Adams 2012; Cox 2013) and reducing smoking in dis-
advantaged populations (Thomas 2008).
The pooled resultswere significantly different from zero in 10 stud-
ies, which were developed predominantly or specifically for ethnic
minority women (African-American women, African American
andHispanic women, andHispanic women), and primary authors
in several studies reported subgroup analysis of higher quitting
rates among African-American and Hispanic women than other
women from interventions (Peterson 1992; Windsor 1993; Pbert
2004; Parker 2007 (AvB); Parker 2007 (AvC)). However, there
was no significant effect seen in the pooled results of four studies
conducted among indigenous women. This highlights the impor-
tance of considering context, with a very high baseline prevalence
of smoking among indigenous people, which may overwhelm the
capacity of individual people to quit. Some experts in this area ar-
gue for the need to provide comprehensive approaches and syner-
gistic environmental interventions to help ’de-normalise’ smoking
in the longer term, such as supporting smoke-free homes, and cul-
turally-targeted support (Gould 2013; Gould 2013b). One small
included pilot study among predominantly New Zealand Maori
women (Glover 2014 (AvB); Glover 2014 (AvC), trialled two dif-
ferentmodes of incentives (voucher and product), and found there
was very low participation rates (24/74 women), but that there
were statistically insignificant but higher proportions of quitters
in the small pilot intervention groups. This suggests that, while
potentially effective, the acceptability of incentives among indige-
nous women needs careful consideration, as this has a major im-
pact on effectiveness of interventions at a population level. Stud-
ies involving ethnic minority and indigenous women tended to
include women more in the development of the intervention and
all used several strategies to tailor the intervention (e.g. American
Legacy Foundation 2012) for initiatives that aim to address the
disparities in tobacco use; including hiring culturally competent
staff, conducting formative research to identify community needs,
piloting and field-testing programs, ‘cultural tailoring’ of smoking
cessation resources, and collaborating with key stakeholders and
community organisations. Three studies adapted ‘SCRIPT’ mate-
rials in the US (see Windsor 2011), which include: ’asking’ about
smoking status; ’advising’ women toquit; ’assisting’ women to quit
by providing advice on skills and materials such as video’s and self-
help materials; and arranging for follow-up by referral at future
appointments. Two studies developed audiovisual resources for
African-American (Ondersma 2012 (A+C v B+D)) and Alaskan
Indian (Patten 2009) women, and these resources received posi-
tive feedback. Despite interventions being reported as feasible and
acceptable to communities, there were challenges with implemen-
tation. Further suggestions from study authors included trying to
recruit from different settings and including elders to improve re-
cruitment, and recognising the importance of broader social in-
terventions for potentially reaching a larger proportion of preg-
nant women (Patten 2009).Other reviews of interventions in non-
pregnant indigenous peoples have demonstrated interventions can
be effective (Carson 2012), and suggest mobile phone technol-
ogy may be a feasible intervention strategy (Johnston 2013). Only
one study included women using smokeless tobacco products, and
identified conflicting beliefs about the effect of these products dur-
ing pregnancy and the primary change recommended by partici-
pants in the study was to provide “more objective” information on
the risks of Iqmik (smokeless tobacco) use for the infant (Patten
2009).
Most interventions have been developed in high-income countries
and there is very limited information about the effectiveness of
psychosocial interventions for individual women in low- to mid-
dle-income countries (Murthy 2010). The restrictions on tobacco
marketing inhigh-income countriesmay result in an increase in to-
baccomarketing companies in low- andmiddle-income countries.
Smoking has the potential to undermine health improvements in
low- andmiddle-income countries and a range of interventions are
needed to manage the emerging epidemic (Lopez 1994; Abdullah
2004). However, given the modest effect size estimate of individ-
ual interventions, population-based tobacco control strategies are
an urgent priority, as there is now a brief ’window of opportunity’
to prevent the increase of smoking among women in many low-
income countries (Chomba 2010).
Translation of evidence into practice
The first trials of anti-smoking interventions during pregnancy
were published more than 30 years ago (Baric 1976; Donovan
1977). The first trial to demonstrate the reversibility of the birth-
weight reduction associated with smoking by an intensive inter-
vention during pregnancy was published in 1984 (Sexton 1984).
Since then, attempts at widespread implementation of psychoso-
cial interventions to support women to stop smoking in preg-
nancy have demonstrated many of the challenges of translat-
ing ‘evidence into practice’, particularly non-pharmacological evi-
dence (Windsor 1998;Windsor 2000b; Lowe 2002;Moore 2002;
NICS 2003; McLeod 2004; Herbert 2005; McDermott 2006;
Abatemarco 2007; Manfredi 2011).
Studies in this review can be conveniently categorised within
a framework for translation of research into practice (Nutbeam
2006), which suggests progression through several stages from;
problem definition (descriptive studies) and formative research for
intervention design; intervention efficacy research; to implemen-
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tation in routine/normal settings (effectiveness research); dissemi-
nation across several settings; and institutionalisation (as interven-
tions are provided as part of routine care). Many studies in this re-
view clearly defined the problemand conducted formative research
for intervention development (Katz 2008; Gilligan 2009), par-
ticularly interventions developed for vulnerable women, includ-
ing young women (Albrecht 1998; Albrecht 2006 (AvB); Albrecht
2006 (AvC)). The modest but significant efficacy of psychosocial
interventions provided by researchers has been well-demonstrated
by studies in this review, including counselling interventions.
The transfer of an intervention from one setting to another may
reduce its effectiveness if elements are changed or aspects of the
materials are culturally inappropriate. An example in these trials
was the performance of the Windsor self-help manual. This was
developed and shown to be effective in Birmingham, Alabama
(Windsor 1985 (AvC); Windsor 1993). However, when it was
implemented into routine care (Windsor 2011), used in Balti-
more with peer counsellors who receivedminimal training instead
of trained health educators (Gielen 1997), adapted for Alaskan
Native women (Patten 2009) and transferred to other countries
(Lowe 1998a; Lowe 1998b), the effectiveness was much lower. An
analysis of health promotion trials has concluded that where the
providers are also the researchers (more likely in single-centre stud-
ies than multicentre studies), they appear to be better providers
for influencing behavioural outcomes and about the same as other
providers for other outcome domains (Oliver 2008a). The larger,
multicentre trials may therefore be a more accurate representation
of implementing policy than smaller, single-centre trials. In this
review, interventions provided by usual care providers were as ef-
fective as interventions provided by researchers, including coun-
selling interventions. However, there was substantial heterogene-
ity in trials provided by usual care providers in this review, which
supports the views that there are many variables to consider when
implementing interventions in routine settings (Hoddinott 2010).
Despite evidence of efficacy and effectiveness, dissemination trials
of counselling interventions into pregnancy care settings suggest
challenges to translating this efficacy research into routine practice
and policy. Data from the four dissemination trials that targeted
the intervention at the organisational level, demonstrated impor-
tant effects in terms of increased implementation of interventions
in routine practice, although challenges were reported and this
did not translate into a clear reduction in rates of smoking among
women in the intervention arms of these studies. One study that
provided clinics with resources and referral options reported an
increase in women’s recall of receiving interventions (Manfredi
1999). A significantly higher program implementation rate was
reported when using an intervention based on Rogers’ ’Diffusion
of Innovation’ theory (43% compared with only 9% implemen-
tation in the control group after one year), but there were no data
on the impact on smoking outcomes (Lowe 2002). An increased
uptake of the intervention by staff was demonstrated using ‘ac-
tive’ dissemination compared to a simple mail-out of information
(Cooke 2001), but not at levels sufficient to have a clear impact on
smoking outcomes in women (Campbell 2006), which was similar
to other dissemination trials reporting smoking outcomes (Pbert
2004; Windsor 2011). Another non-randomised study compared
the use of the RE-AIM dissemination model to increase the reach,
efficacy, adoption, implementation and maintenance of interven-
tions (Lando 2001), and concluded that multi-faceted approaches
using strategies from each intervention were most likely to im-
prove implementation.
There are a number of possible explanations for the limited effect
in dissemination trials. Firstly, many of the studies that recruited
individual women did not provide information on the number of
women who were eligible for inclusion or were approached to take
part in trials. The ’participation rate’ would have provided useful
information about the general ‘acceptability’ of the intervention,
as well as the degree of ‘selection bias’ in the study population
(Sedgwick 2013). Among those studies that did report the propor-
tion approached and recruited from the total ‘eligible’ population,
low participation rates were often reported. The lack of effect seen
among women participating in broader maternal health interven-
tions with a smoking cessation component also reinforces this as
a possible explanation, as women participating in these trials are
likely to have different motivations about smoking. Much of the
evidence in this review is from selective samples of the population
of women who smoke during pregnancy. Women participating in
studies (Mullen 1997) were more likely to be in contemplative
and preparation stages of change, be ‘recent quitters’ and have a
lower gestational age, compared to women not participating in
studies (Ruggiero 2003). The majority of women categorised as
‘Black’, ‘White’ and ‘Native American’ did enrol in the study, while
women categorised as ‘Hispanic’ were less likely (51.6%) to enrol
and the majority of Asian women did not enrol (Ruggiero 2003).
Dissemination trials and ‘cluster trials’ that randomise clinics or
providers, and trials which recruit a broader population of preg-
nant women, are likely to provide a more accurate estimate of the
likely effect in a non-selective population of pregnant women.
Secondly, the implementation of interventions under conditions
less stringent than an individually-randomised controlled trialmay
be reduced (Perlen 2013), which may limit exposure of the inter-
vention group to the intervention, or components of the inter-
ventions (Walsh 2000). Several trials implemented in routine care
settings bymidwives (Moore 2002;DeVries 2006), doctors (Valbo
1994; Walsh 1997), and routine clinic staff (Kendrick 1995) re-
ported difficulties with implementation. Some of the issues in-
cluded: variable perceptions of smoking cessation as part of the
providers’ role (DeVries 2006), stating they were too busy and
did not have enough time to complete the intervention (Dunkley
1997; Haines 1998; Hajek 2001; Valanis 2001b; Leviton 2003),
difficulty recruiting providers to the study (Lawrence 2003 (AvB);
Lawrence 2003 (AvC)), providers reporting pessimism about the
efficacy of the intervention (Moore 2002), inadequate provider
knowledge and perceived low self-efficacy (Colomar 2015), and
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lack of acceptability of resources (Lowe 1998a; McBride 1999).
Several studies reported positive ’facilitators or enabling factors’
associated with implementation. Proposed criteria for interven-
tions to be implemented into routine maternity care include: hav-
ing program materials readily available (Colomar 2015); feasible
provider time commitments; clear training requirements; mini-
mal organisational and administrative barriers (Strand 2003); and
program components that are acceptable to providers and women
(Haynes 1998; Cabana 1999; Grol 1999; Walsh 2000; Cooke
2001a). Written resources, a written protocol to identify staff
responsibilities, and reimbursement have also been suggested as
other strategies to improve implementation (Hartmann 2007). A
significant increase in both intervention delivery and smoking out-
comes was seen in a cluster trial that supported staff with training
based on national guidelines, a clinic management system, and es-
tablishment of program boards (Pbert 2004). Suggestions to over-
come the barriers in a busy clinic setting included increasing the
use of referral services and technology to reduce demand on clin-
icians’ time (Moore 2002). Subsequently, use of referral services
such as ‘quitline’ (Williams 2010) and technology-driven inter-
ventions have gained popularity in the past five years (Tsoh 2010;
Naughton 2012; Ondersma 2012 (A+C v B+D)). In the UK,
most services reported use of ‘quitline’ referral services (Williams
2010). One excluded (non-randomised) study in South Australia
(Bowden 2010), describes positive experiences and perceptions of
staff in implementing a ’Smoke-free Pregnancy’ Project involving
brief ’5A’s’ intervention and referrals to ‘quitline’. While use of
materials such as self-helpmaterials and technological aids did not
appear to significantly increase rates of smoking abstinence in this
review, they may help to increase the feasibility and reduce the
costs of delivering interventions.
A third possible explanation for the limited effect seen in imple-
mentation is that trials that involve broader implementation across
the system and provision by usual care providers (effectiveness
studies), may result in greater exposure of the comparison group to
the intervention. While the difference was not significantly differ-
ent, the pooled effect size was lower among trials that were assessed
as having a high risk of contamination in this review. One study
illustrated this effect by including a ‘historical control’ group, in
which only 4% stopped smoking, compared to 10% who stopped
in the randomised ‘concurrent control’ and 12% in the interven-
tion group who stopped (Windsor 2011).
Institutionalisation, where interventions are part of routine care,
is the final stage of the evidence-practice translation process. Aus-
tralia, Canada, the UK and the United States (USA) have devel-
oped guidelines recommending all pregnant women receive in-
terventions to promote smoking cessation in pregnancy (Aveyard
2007; Fiore 2008). However, studies of clinicians’ practice in Aus-
tralia, Canada, the USA and Argentina suggest that while the ma-
jority (50% to 100%) ‘ask’ about smoking status, rates of assistance
with effective strategies to support women to stop smoking are
very low (11.5% to below 50%) (Floyd 2001; Hartmann 2007;
Tong 2008; Mejia 2010; Okoli 2010; Perlen 2013). Strategies to
address the deficiencies identified in these surveys are reported
(Chapin 2004), and several studies in this review have trialled
strategies to adapt these guidelines and improve implementation
into routine settings (Tsoh 2010; Ondersma 2012 (A+C v B+D)).
A recent survey suggests attitudes may be shifting in the UK about
the provision of advice and support, but not the efficacy of the
interventions (Beenstock 2012). A recent survey of women giving
birth in Australia suggests there has been a significant increase in
the provision of smoking advice and support in routine pregnancy
care from 2000 to 2008, though half of smokers still did not re-
ceive the full complement of advice and support according to state
guidelines, and there was marked variability according to where
and from whom women received antenatal care (Perlen 2013).
Strategies to increase disclosure of smoking status
Barriers to implementation have been identified at each step of
service provision in relation to support for smoking cessation in
pregnancy. This includes detection of women who smoke so they
can then be offered a supportive intervention (Tappin 2010). As
previously noted, self-reported disclosure of smoking status can be
variable. Disclosure is influenced by several factors, including the
stigma and guilt associated with smoking in pregnancy, the rela-
tionship between the care provider and the way the woman is asked
about smoking. In general, it appears that less direct questioning
increases disclosure, for example, changing the question format
from ‘yes’ or ‘no’ to a series of multiple choice questions and ask-
ing women to best describe their smoking status (Mullen 1991).
There is some evidence from the literature around broader sub-
stance use in pregnancy, that asking about substance use of family
members (e.g. second-hand smoke exposure) first (Chasnoff 2005;
Chasnoff 2007), and leaving sensitive probing personal questions
until later in the interview, when a rapport has been established.
The rationale is that this provides an opportunity for the woman
to gauge the response of the healthcare provider and feel more
confident disclosing her smoking status. In the UK, ‘opt out’ car-
bon monoxide screening has been proposed to increase disclosure
(Tappin 2010; Bauld 2012; Campbell 2016). Biochemical valida-
tion of smoking status is an understandable pre-requisite prior to
receipt of contingent incentives, to provide feedback on cotinine
levels as a motivational aid; or in the context of a smoking trial.
However, the benefits and rationale for not accepting women’s dis-
closure outside these contexts is unclear and was not well-received
by women in this review (Thornton 1997). Furthermore, there
are questions about the accuracy of carbon monoxide monitoring
among women with high second-hand smoke exposure (McLaren
2010), and whether there are any adverse effects from routine
screening, such as increased domestic violence or effects on mental
health.
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Adverse effects of interventions
While psychosocial interventions do not pose the same risks to
fetal health as pharmacological agents in pregnancy, there are con-
cerns about the potential unintended consequences of these inter-
ventions that aim to encourage pregnant women to stop smoking
(Burgess 2009). The potential adverse effects identified in this re-
view include: increased smoking; unhelpful peer or partner sup-
port; stigmatisation; and nicotine withdrawal.
Despite the number of studies reporting smoking reduction, only
three studies reported rates of women who increased smoking by
intervention group, and these showed mixed results (Hjalmarson
1991; Haug 1994; Tappin 2005). It would be helpful for stud-
ies to measure any increased smoking, particularly in light of re-
cent qualitative evidence that suggests anti-smoking advice may
increase resistance to smoking messages for some women (Bond
2012; Flemming 2013).
There has been an increasing focus on the partners and peers of
pregnant women, with the additional aim of facilitating cessa-
tion by the women themselves (Stanton 2004; Gage 2007). In
some cases this reflects cultural and demographic patterns of smok-
ing, where smoking rates are still highest amongst men (Loke
2005; Kazemi 2012); in others, interest in environmental barri-
ers that hinder smoking cessation has led to an understanding of
the influence of a woman’s social networks on smoking behaviour
(McBride 2004 (AvC)). Studies in this review suggest that there are
both positive and negative aspects to partner and peer assistance
with supporting women to stop smoking in pregnancy (McBride
2004 (AvC); Hennrikus 2010). This legitimises concerns about
the potential adverse effects on relationships and women’s posi-
tion (Greaves 2007a). Cheng 2015 found much higher rates of
smoking in pregnancy among women experiencing domestic vi-
olence, and these risks should be taken into consideration when
developing interventions involving partners or peers, particularly
in subpopulations or regions where protection for women’s rights
are less than optimal. Pro-active measures to identify women at
risk and ensure their safety should be implemented as part of in-
terventions involving peer or partner support (Greaves 2007b).
No studies measured the impact of interventions on stigmati-
sation of women. However, studies of psychological impact do
not suggest there are any negative effects, and individual psy-
chological support may be beneficial (Stotts 2004; Bullock 2009
(AvD); Cinciripini 2010). Nevertheless, public health profession-
als must remain vigilant when implementing population-based
measures, as policies can disrupt highly complex systems and unin-
tended consequences of tobacco policy may differentially impact
on vulnerable population groups (Healton 2009). Stigmatisation
research suggests that such policies may have unanticipated out-
comes for vulnerable mothers, including decreased mental health;
increased use of alcohol or cigarettes; avoidance or delay in seek-
ing medical care; and poorer treatment by health professionals
(Moore 2009). This stigmatisation may be compounded for some
population groups, such as racial minority groups (Bond 2012;
Flemming 2013).
Few studies reported the effect of nicotine withdrawal, which is
a gap given that these withdrawal effects may be more acute dur-
ing pregnancy (Ussher 2014; Ussher 2012b). One newly included
intervention of exercise found no significant difference in with-
drawal symptoms, despite previous studies suggesting exercisemay
have a positive impact (Ussher 2015).
Overall completeness and applicability of
evidence
Most of the included studies were carried out in high-income
countries and it is not clear whether the results are applicable in
other contexts. Given the rapidly evolving nature of the smoking
epidemic in low- to middle-income countries, this is a major gap
in the current body of evidence.
Many of the studies that recruited individual women did not pro-
vide information on the number of women who were eligible for
inclusion or were approached to take part in trials (i.e. the par-
ticipation rate), which would have provided useful information
about the general ‘acceptability’ of the intervention, as well as the
degree of ‘selection bias’ in the study population (Sedgwick 2013).
Among those studies that did report the proportion approached
and recruited from the total ‘eligible’ population, low participa-
tion rates were often reported. Therefore, some of the evidence in
this review is from selective samples of the population of women
who smoke during pregnancy and may affect the applicability of
the evidence into routine settings.
The timing of the final antenatal assessment of smoking status
varied considerably among trials between the second and third
trimester. This may affect the amount of time the participants
were exposed to the intervention (if it involved ongoing support),
as well as the number of those lost to follow-up and measurement
of perinatal outcomes.
Furthermore, there are limited data for some outcomes (e.g. some
perinatal outcomes, family functioning).
Quality of the evidence
The studies included in the review were generally relatively low
risk of bias, as discussed in Risk of bias in included studies. How-
ever the confidence in the overall pooled results, outlined in the
Summary of findings 2, was downgraded to moderate quality due
to moderate heterogeneity or inconsistency between trials. Het-
erogeneity was substantially reduced with subgrouping interven-
tions by main strategy, whether single, multiple or tailored, and
comparison type, and a selection of these results are presented
in Summary of findings for the main comparison, however the
degree of confidence was downgraded to ’moderate’ quality due
to the low numbers in some subgroups, resulting in imprecision.
This included for comparisons of health education and usual care,
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feedback and usual care, and incentives and alternative interven-
tions. Hence, we would emphasise the need to consider the Risk
of bias’ tables and the Characteristics of included studies when
interpreting the combined effect of the interventions.
Potential biases in the review process
Wehave endeavoured tominimise bias in the review process wher-
ever possible. However, we have made explicit decisions about
grouping a diverse range of interventions according to an assess-
ment of the ’main intervention strategies’ and this may pose po-
tential bias. These are subgrouped according to whether the ’main
strategy’ was single, multiple or tailored, but there is still a fair
degree of inherent variation within those groupings. Similarly, we
have grouped control groups according to ’usual care, less intensive
or alternative intervention’ comparisons, and there is considerable
variation in the interventions received by the comparison group.
However, despite the risks of potential bias, the heterogeneity has
been considerably reduced with these groupings from the overall
combined results.
Other potential bias in the review bias include exclusion of women
experiencing miscarriage, fetal demise or moving, as there are as-
sociations with these factors and smoking. There is also likely to
be a potential bias from excluding some outcomes with zero cell
counts from pooled analyses, although these effects are likely to be
small. Finally, new trial results have been published during review
preparation, after the search for this review update, and will be
included in the next update.
Agreements and disagreements with other
studies or reviews
Agreements and disagreements with the previous
review
The major findings from this review are similar to the previous re-
view, namely that psychosocial interventions which include coun-
selling, incentives and feedback support women to stop smoking
in pregnancy appear to be effective; and can reduce the proportion
of infants born low birthweight or admitted to neonatal intensive
care after birth.
However, there are a few minor disagreements with the previous
review, including:
• the effect of all interventions on preterm births is no longer
statistically significant;
• the effect of social support interventions from peers is no
longer statistically significant;
• exercise interventions were included as a separate
comparison, but there was no significant effect seen in one trial
reporting smoking cessation outcomes (Ussher 2015).
These effect changes are likely to be due to the inclusion of several
new large trials and additional arms demonstrating non-signifi-
cant but higher rates of preterm births in the intervention groups
(Tuten 2012 (AvB); Tappin 2015; Ussher 2015); and non-signifi-
cant effects of social support on smoking cessation (Albrecht 2006
(AvB); Bullock 2009 (AvC); Mejdoubi 2014; Robling 2016). The
additional study arms included are generally ’less intensive’ than
the previously included study arms, as we had previously selected
the ’most intensive’ study arm for inclusion where there had been
more than one study arm in the trial.
Agreements and disagreements with other Cochrane
reviews
See Appendix 1 for a full list of other reviews of smoking inter-
ventions.
Pharmacological interventions in pregnancy
A review of pharmacological interventions to support women to
stop smoking in pregnancy (Coleman 2015) did not report a
significant effect (risk ratio (RR) 1.33, 95% confidence interval
(CI) 0.93 to 1.91). http://onlinelibrary.wiley.com/doi/10.1002/
14651858.CD010078/abstract.
Effects of types of interventions for the general population
Relapse prevention
The findings in this review of a significant effect on re-
lapse prevention in the early postpartum period contrast to
findings in another Cochrane review of relapse prevention (
Hajek 2013). However, relapse prevention interventions for
women who had spontaneously quit in this review did not
demonstrate a significant effect, which is similar to the find-
ings of Hajek 2013. http://onlinelibrary.wiley.com/doi/10.1002/
14651858.CD003999.pub3/abstract.
Enhanced partner support
The findings in this review were similar to findings in a review of
enhanced partner support in the general population (Park 2012),
which did not demonstrate a significant effect (RR 0.99, 95%
CI0.84 to 1.15). See http://onlinelibrary.wiley.com/doi/10.1002/
14651858.CD002928.pub3/abstract.
Stages of change
A systematic review of stage-based interventions concluded they
are no more effective in general than interventions that do not
tailor the intervention according to the stage of change (Riemsma
2003). This is similar to the findings in the previous version of this
review. In contrast, Cahill 2010 showed that stage-based individual
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counselling compared to any control condition gave an RR of 1.24
(95% CI 1.08 to 1.42) in 13 trials.
Individual behavioural support
Our review findings for counselling interventions were sim-
ilar to those reported by Lancaster 2005a in a review of
individual interventions (RR 1.39, 95% CI 1.24 to 1.57),
with little difference between intensive support and brief
interventions. See http://onlinelibrary.wiley.com/doi/10.1002/
14651858.CD001292.pub2/abstract.
Self-help materials
Our review findings were different from a review of provision of
self-help materials in the general population (Lancaster 2005b)
that demonstrated a modest but significant effect (RR 1.21, 95%
CI 1.05 to 1.39), particularly when thematerials were tailored (RR
1.31, 95% CI 1.20 to 1.42). Another review by Hartmann-Boyce
2014 showed a similar finding for tailored materials.
Competitions and incentives
The findings of our review are similar to findings of a review of in-
centives among the general population (Cahill 2015) that showed
incentives seem to make a difference while they are in place. The
findings of this review are also similar to findings of a review of
incentives that showed that full financial interventions directed at
smokers had a statistically significant effect on abstinence at six
months or longer when compared to no intervention (RR 2.45,
95%CI 1.17 to 5.12, I² = 59%, four studies). There was addition-
ally a significant effect of full financial interventions when com-
pared to no interventions on the number of participants making
a quit attempt (RR 1.11, 95% CI 1.04 to 1.32, I² = 15%) (Reda
2012).
Feedback
The findings of our review were in contrast to those reported by
Bize 2012 in a review of biomedical risk assessment that showed
no evidence that carbon monoxide measurement in primary care
(RR 1.06, 95% CI 0.85 to 1.32) increased cessation rates.
Exercise
Our review findings were different from a review of exercise inter-
ventions (Ussher 2014) where two of 20 trials provided evidence
for exercise helping smoking cessation in the long term.
Effects of interventions among other population groups
Psychosocial interventions among patients with coronary
heart disease
The findings of this review are similar to findings of psychosocial
interventions among patients with coronary heart disease (Barth
2015), another population with strong motivational factors to
stop smoking (odds ratio (OR) 1.66, 95% CI 1.25 to 2.22), with
high heterogeneity, and a reduced effect among validated smoking
outcomes (OR 1.44, 95% CI 0.99 to 2.11).
Pre-operative interventions
The effect of brief smoking cessation interventions among the
patients preparing for surgery Thomsen 2014 was similar to our
review, although the effect of intensive interventions was signifi-
cantly higher than in our review.
Hospitalised patients
Our results were similar to those among hospitalised patients (RR
1.37, 95% CI 1.27 to 1.48) (Rigotti 2012).
Interventions in Indigenous populations
The findings of our review were in contrast to a review of four
studies of non-pregnant Indigenous communities (Carson 2012)
in New Zealand (2), United States (1) and Australia (1) that re-
ported a modest but significant effect using psychosocial inter-
ventions, two of which were supplemented with pharmacological
therapy.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Psychosocial interventions can support women to stop smoking in
pregnancy; there is also high-quality evidence these interventions
reduce the risks of infants being born low birthweight and being
admitted to neonatal intensive care units immediately after birth.
Therefore, psychosocial support to stop smoking should be con-
sidered for women who are pregnant, or seeking to become preg-
nant. Contrary to concerns that women may be upset by offering
support to stop smoking, studies in this review suggest women
expect and appreciate the support; and interventions are more
likely to improve women’s psychological well-being than worsen
it. However we acknowledge that new trials have been published
during review preparation which may influence results, and these
will be included in the next update.
Evidence from this review suggests provision of health education
and risk advice alone is not sufficient, and any psychosocial sup-
port should include additional intervention components to sup-
port women to quit, such as counselling, incentives or feedback.
The effect of partner support is unclear in the single study in
this review, and care is needed when including peer- or partner-
57Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
support components, as some peer- and/or partner-support be-
haviours may be unhelpful, and may potentially expose vulnera-
ble women to increased risk. Given the high co-morbidity with
psychological symptoms and the potential to improve psycholog-
ical well-being, interventions that include psychological support
for women with symptoms should be considered. Studies in this
review suggest many women resume smoking after pregnancy, so
consideration should be given to messages that reinforce the ben-
efits for the mother, rather than solely focusing on benefits for the
infant.
Consultation with women and local piloting of programs shown
elsewhere to be effective may be a good place to begin to develop
strategies suitable for each population. Additionally, consultative
processes that involve healthcare providers andorganisational lead-
ers should be another important consideration for implementa-
tion.
Given the clear difficulties which most women still smoking at
the first antenatal visit have in stopping smoking, population-wide
strategies for smoking control in the whole community are needed
to reduce the initiation of smoking by young women: action to
prevent sales of tobacco products to young people, prohibition of
smoking in all public places, increases in tobacco taxation, work-
place smoking cessation programs and bans on tobacco sponsor-
ship (WHO 2008a). However, these interventions should incor-
porate strategies to reduce risks identified in this review, including
stigmatisation, and negative effects on relationships; avoid singling
out mothers and focus more broadly on ’parents’; avoid depict-
ing mothers who smoke as ’harming’ their infants, but as women
who are important in their own right; and assisting vulnerable
women to develop alternative ’coping’ strategies to deal with living
in difficult circumstances (Burgess 2009). Given the strong asso-
ciation between social inequality and continued smoking by preg-
nant women shown in this review, there is a rationale to support
World Health Organization (WHO) recommendations to reduce
social inequalities in the wider community (WHO 2008b).
Implications for research
There is little doubt about ‘whether’ psychosocial interventions
are effective in reducing smoking during pregnancy or the pro-
portion of infants born with low birthweight. What is not clear is
‘which’ interventions are effective, ‘how’ these interventions work,
‘who for’ and ‘how’ should these interventions should be imple-
mented, disseminated and institutionalised. As smoking rates have
decreased in the general population in high-income countries, it is
becoming increasingly recognised that smoking has become more
closely correlated with entrenched social disadvantage and psy-
chological co-morbidity (Shoff 2013). Studies are needed that re-
fine interventions to address the specific needs of these subpopu-
lations, without compounding problems of social alienation and
low self-efficacy. Given the shifting demographics and burden of
diseases from tobacco smoking from high- to low- and middle-
income countries, more research is needed to develop strategies
which are appropriate for these settings. In reflecting on whether
the objectives of this review have been addressed, the authors feel
that further research is needed into:
• the feasibility and effectiveness of interventions in low- and
middle-income countries, particularly given the aggressive
tobacco marketing in these regions;
• how to implement and disseminate interventions into
routine care, and measures of whether they are effective when
implemented at a population level;
• the feasibility and effectiveness of the use of incentives to
support pregnant women to quit smoking, including evaluation
of any adverse effects or negative unforeseen circumstances for
pregnant women or the broader community;
• demonstrating effective interventions, including
descriptions of how these were developed, to support ethnic and
aboriginal women, and young women to stop smoking;
• interventions to support pregnant women with mental
illness to stop smoking, and whether interventions that improve
mental health can also help women to quit smoking;
• developing strategies to ensure that smoking interventions
do not have a negative impact on breastfeeding, which would
counteract some of the health benefits of quitting smoking for
both the mother and her infant;
• whether the timing of the psychosocial support is
important, for instance, is more frequent support required in the
early stages of quitting and less frequent support required later?
A WHO expert working group (Hunt 2012) recommended re-
search in three areas to help reduce smoking during pregnancy:
• social and cultural factors influencing pregnant women’s use
of tobacco and exposure to secondhand smoke;
• interventions to promote tobacco cessation and reduce
secondhand smoke exposure during pregnancy in high-, low-
and middle-income countries;
• describing non-cigarette tobacco use by women and
characterising the resulting risks for adverse pregnancy outcomes.
In 2009 the National Institute of Clinical Excellence (NICE) de-
veloped guidance on Quitting smoking in pregnancy and follow-
ing childbirth. Background documents for this guidance (Bauld
2010a; Williams 2010) identified a number of gaps in existing
evidence, including:
• whether the way the intervention is delivered influences the
effect;
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• whether the site or setting influence the effect;
• evidence of effective interventions for vulnerable
population groups, including teenage mothers, disabled mothers,
women with mental illness, and other women.
Future trials need to include the following elements:
• number of potentially eligible women and number agreeing
to participate, as this can help to assess the degree of selection
bias in the trial and the potential acceptability and
generalisability if implemented at a population level;
• strategies to minimise contamination, as this appears to
have an impact on the effect size;
• a description of the intervention in sufficient detail for its
replication even if the detail requires a separate paper;
• process data as evidence of implementation;
• women’s views of the intervention, particularly if partner or
peer support are incorporated;
• biochemical validation of non-smoking status;
• nicotine withdrawal and adverse effects such as increased
smoking, or disengagement with services;
• the collection of perinatal outcome data on birthweight,
preterm birth and perinatal deaths, particularly for nicotine
replacement therapy (NRT) trials;
• collection of outcome data on breastfeeding, weight gain,
operative delivery, maternal psychological well-being, and the
perceived impact of the intervention on family functioning or
other significant relationships;
• subgroup analysis by vulnerabilities (to enable an equity
analysis);
• the impact factor or intra-cluster correlation needs to be
reported, in order to assess the effect of clustering and include
cluster-randomised trials in meta-analysis;
• Implementation (fidelity) among studies in this review, as
these were often poorly described and meta-regression analyses in
this review suggests this may be an important factor, and this has
been identified by others (Bryant 2014).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Albrecht 1998
Methods 3-armed randomised-controlled trial (pilot study) evaluated 2 different interventions
provided to ’pregnant teens’ to reduce smoking in pregnancy and relapse postpartum.
The hypothesis was that an intervention including peer support would be more effective
than the intervention alone.
Study conducted in Pittsburgh, USA. Data collection dates not reported
Participants Inclusion criteria: 12 to 20 years of age; 4 to 28 weeks’ gestation; reported smoking at
least 1 cigarette a day; single marital status; no previous live birth; able to read and write
English.
Exclusion criteria: Pregnancy complications preventing attendance at group sessions or
participation in a home study program.
Recruitment: Participants were recruited through local prenatal clinics and public
schools. 84 women recruited (not known how many were eligible or approached) and
randomised (C = 29, I1 = 29, I2 = 26).
Baseline characteristics: Mean cigarettes/day at first visit: C = 6.44; I1 (TFS) = 5.87;
I2 (TFSB) = 6.81.
63% African-American heritage, 37% European-American heritage
Progress + coding: Coded as single (low social capital) and young age (less than 20)
Interventions A: Control: 30 mins individual educational session with project nurse including infor-
mation about the risks of smoking to themother and the fetus and brochures on smoking
and pregnancy.
B: Intervention 1 (TFS): Cognitive behavioural group model designed specifically for
adolescents based on problem-behaviour theory: 8 modules to heighten awareness and
attention to smoking messages; build and enhance smoking cessation skills; teach skills
for maintenance of smoking control; includes experiential learning and round robin
discussion. TFS was modified to include additional information on smoking and the
fetus, body image changes and overall health. The intervention also included social
activities, immediate rewards/incentives and adult modelling.
C: Intervention 2 - TFS plus peer support (TFSB): Utilised all the components of
TFS plus 1-to-1 support through a non-smoking peer (buddy) chosen by the young
woman. Buddies were asked to attend all 8 sessions and to be available at other times for
reinforcement of techniques learned and encouragement for continued cessation
Main intervention strategy: Social support (multiple intervention) compared to less
intensive intervention. TFSB (C) compared with TFS (B) and control (A) in this review
as outcomes for A and B only reported as combined figures
Intensity rating: Frequency (C = 2, I = 6); Duration (C = 2, I = 6).
Intervention provided by project staff:efficacy study.
Outcomes Biochemically validated point prevalence abstinence at 4-6 weeks post baseline (late
pregnancy*).Intervention arms B and C were combined so unable to report separately
in this review
Reduction in exhaled CO and self-reported mean cigarettes per day are reported as
’reduction’ but actual post-intervention measures were not reported so are not included
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Albrecht 1998 (Continued)
in this review. Baseline modified Fagerstrom Tolerance questionnaire for adolescents to
assess nicotine dependence
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as ’randomly assigned’.
Allocation concealment (selection bias) Unclear risk No information.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 46/84 had complete outcome data
(high attrition rate = 45%),UC=12 (41%)
, TFS = 13 (46%), TFSB = 13 (50%). No
explanation for attrition. ITT analysis not
mentioned. All those lost to follow-up were
included as continuing smokers in this re-
view
Selective reporting (reporting bias) High risk Only smoking outcomes reported and out-
comes not reported separately for each of
the control arms
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk CO level (>= 8 ppm) in exhaled air used to
identify smokers.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Provider and participants unable to be
blinded to educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed there was a ’sig-
nificant dropout rate’ (45%)
Equal baseline characteristics in study arms Unclear risk Baseline smoking characteristics similar,
but other baseline characteristics not re-
ported
Contamination of control group Low risk Intervention provided by research project
staff.
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Albrecht 2006 (AvB)
Methods 3-armed randomised controlled trial evaluated the short- and long-term effects of 2
smoking cessation strategies tailored to support pregnant adolescents to attain abstinence
in pregnancy and maintain abstinence postpartum
The study was conducted in 5 hospital-based and 2 community-based prenatal clinics
in Pittsburgh, Pennsylvania, USA. Years of data collection not reported
Participants Inclusion criteria: ’Pregnant teens’ aged 14 to 19 years; 12 to 28 weeks’ gestation; able to
read, write, and understand English; smoking at least 1 cigarette per day; single marital
status; having no previous live births; and capable of being reached by telephone
Exclusion criteria: pregnancy complications (i.e. bleeding or preterm labor) or required
confinement to home by their physician
Recruitment: During prenatal assessment, adolescents self-reporting smoking were in-
vited to participate in study. Those expressing interest signed a consent form to allow
the research team to contact them. Expressions of interest also advertised through flyers
and brochures
470 screened; 142/224 (63%) eligible women randomised (C = 50; I1: (TFS) = 47; I2:
(TFS + B) = 45.
Baseline characteristics: Number of cigarettes per day before pregnancy: Control 15.
75 (10.38); I1: (TFS) 14.08 (7.22); I2: (TFSB) 14.62 (9.72)
Fagerstrom dependence score: Control 3.38 (2.05); I1: (TFS) 3.44 (1.79); I2: (TFSB)
3.68 (1.89)
Progress + coding: Low SES, Low educational attainment, low social capital (single)
and young age (< 20 years)
Interventions A:Control: UC that all teens would typically receive from a healthcare provider through-
out their pregnancy. Smoking during pregnancy was addressed in the clinic by giving
the teens educational materials on this subject during the initial prenatal visit. In this
study, this material was explained and distributed to the participants by a research team
member during the initial assessment. The meetings lasted 45-60 mins and occurred at
1 of the AN clinics or centrally located community site. During the meeting, addresses
and telephone numbers of the control group participants were updated after completion
of the assessment. Prior to leaving the meeting, participants were informed of the date
and time of their next assessment. Participants also received an attendance incentive (e.
g. lipstick, nail polish). If the participant had delivered, the attendance incentive was a
baby item
B: Intervention 1 (TFS): The TFS intervention consisted of an 8-week group program
designed to promote and maintain smoking abstinence based on the Cognitive Behav-
ioral Theory, with modification that incorporated developmental components of Jessor’s
Problem Behavior Theory, including a peer buddy and a peer co-leader for peer mod-
elling and sanctioning on smoking. Information pertinent to pregnancy and smoking
was provided at the beginning of the 8-week program.
C: Intervention 2 (TFS-B): The TFS-B group received the same 8-week programming,
but participants were required to bring a non-smoking female of a similar age as their
buddy to the sessions. The role of the buddy was to reinforce smoking cessation strategies
and to provide social support to the participant throughout the study
Main intervention strategy: Social support (multiple intervention) compared to a less
intensive intervention. The control group and TFS-B are compared in Albrecht 2006
(AvC)
Intensity rating: Frequency (C = 2, I = 6); Duration (C = 3, I = 6).
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Albrecht 2006 (AvB) (Continued)
Provided by dedicated project staff: efficacy study.
Outcomes Biochemically validated point prevalence abstinence 8 weeks (late pregnancy*) and 1
year (6-11 months post partum*) after the intervention
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Consenting adolescents were assigned ran-
domly to 1 of 3 group assignments (TFS,
TFS-B, or control) by a computer algo-
rithm with a permutated block design,
stratified by entry site
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk High attrition: C = 60% (i.e. 40% did
not complete 1 yr follow-up), TFS = 55%,
TFS-B = 53%. Participants included in
primary aim analysis pertaining to ran-
domised treatment assignment, regardless
of adherence to study treatment (ITT anal-
ysis)
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of self-reported
smoking status (point prevalence absti-
nence) using salivary cotinine (> 10 ng).
Women reporting less than 1 cigarette per
day with salivary cotinine 10-15 ng had
salivary nicotine assessment to rule out en-
vironmental exposure, and were classified
as smokers if that test was > 5 ng
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and providers unlikely to be
blinded to this educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessor not reported.
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Albrecht 2006 (AvB) (Continued)
Incomplete implementation High risk Process evaluation showed poor implemen-
tation with almost 50% participants not
completing study
Equal baseline characteristics in study arms Low risk Baseline characteristics appear equal.
Contamination of control group Low risk Intervention provided by research team.
Albrecht 2006 (AvC)
Methods 3-armed randomised controlled trial evaluated the short- and long-term effects of 2
smoking cessation strategies tailored to support pregnant adolescents to attain abstinence
in pregnancy and maintain abstinence postpartum
The study was conducted in 5 hospital-based and 2 community-based prenatal clinics
in Pittsburgh, Pennsylvania, USA. Years of data collection not reported
Participants Inclusion criteria: ’Pregnant teens’ aged 14 to 19 years; 12 to 28 weeks’ gestation; able to
read, write, and understand English; smoking at least 1 cigarette per day; single marital
status; having no previous live births; and capable of being reached by telephone
Exclusion criteria: pregnancy complications (i.e. bleeding or preterm labor) or required
confinement to home by their physician
Recruitment: During prenatal assessment, adolescents self-reporting smoking were in-
vited to participate in study. Those expressing interest signed a consent form to allow
the research team to contact them. Expressions of interest also advertised through flyers
and brochures
470 screened; 142/224 (63%) eligible women randomised (C = 50; I1: (TFS) = 47; I2:
(TFS + B) = 45.
Baseline characteristics: Number of cigarettes per day before pregnancy: Control 15.
75 (10.38); I1: (TFS) 14.08 (7.22); I2: (TFSB) 14.62 (9.72)
Fagerstrom dependence score: Control 3.38 (2.05); I1: (TFS) 3.44 (1.79); I2: (TFSB)
3.68 (1.89)
Progress + coding: Low SES, Low educational attainment, low social capital (single)
and young age (< 20 years)
Interventions A:Control: UC that all teens would typically receive from a healthcare provider through-
out their pregnancy. Smoking during pregnancy was addressed in the clinic by giving
the teens educational materials on this subject during the initial prenatal visit. In this
study, this material was explained and distributed to the participants by a research team
member during the initial assessment. The meetings lasted 45-60 mins and occurred at
1 of the AN clinics or centrally located community site. During the meeting, addresses
and telephone numbers of the control group participants were updated after completion
of the assessment. Prior to leaving the meeting, participants were informed of the date
and time of their next assessment. Participants also received an attendance incentive (e.
g. lipstick, nail polish). If the participant had delivered, the attendance incentive was a
baby item
B: Intervention 1 (TFS): The TFS intervention consisted of an 8-week group program
designed to promote and maintain smoking abstinence based on the Cognitive Behav-
ioral Theory, with modification that incorporated developmental components of Jessor’s
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Albrecht 2006 (AvC) (Continued)
Problem Behavior Theory, including a peer buddy and a peer co-leader for peer mod-
elling and sanctioning on smoking. Information pertinent to pregnancy and smoking
was provided at the beginning of the 8-week program.
C: Intervention 2 (TFS-B): The TFS-B group received the same 8-week programming,
but participants were required to bring a non-smoking female of a similar age as their
buddy to the sessions. The role of the buddy was to reinforce smoking cessation strategies
and to provide social support to the participant throughout the study
Main intervention strategy: Social support (multiple intervention) compared to a less
intensive intervention. The control group and TFS are compared in Albrecht 2006
(AvB).
Intensity rating: Frequency (C = 2, I = 6); Duration (C = 3, I = 6).
Provided by dedicated project staff: efficacy study.
Outcomes Biochemically validated 24-hr point prevalence abstinence 8 weeks (late pregnancy*)
and 1 year (6-11 months post partum*) after the intervention
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Consenting adolescents were assigned ran-
domly to 1 of 3 group assignments (TFS,
TFS-B, or control) by a computer algo-
rithm with a permutated block design,
stratified by entry site
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk High attrition: C = 60% (i.e. 40% did
not complete 1 yr follow-up), TFS = 55%,
TFS-B = 53%. Participants included in
primary aim analysis pertaining to ran-
domised treatment assignment, regardless
of adherence to study treatment (ITT anal-
ysis)
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of self-reported
smoking status (point prevalence absti-
nence) using salivary cotinine (> 10 ng).
Women reporting less than 1 cigarette per
day with salivary cotinine 10-15 ng had
salivary nicotine assessment to rule out en-
vironmental exposure, and were classified
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as smokers if that test was > 5 ng
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and providers unlikely to be
blinded to this educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessor not reported.
Incomplete implementation High risk Process evaluation showed poor implemen-
tation with almost 50% participants not
completing study
Equal baseline characteristics in study arms Low risk Baseline characteristics appear equal.
Contamination of control group Low risk Intervention provided by research team.
Baric 1976
Methods A 2-arm randomised controlled pilot study to evaluate whether medical advice had a
effect on smoking cessation in pregnancy
Study conducted in Bolton, England. Years of data collection not reported
Participants Inclusion criteria: Pregnant smokers at their first AN visit, less than 20 weeks’ gestation
Exclusion criteria: Not reported.
Recruitment: Women recruited from public AN clinic at Bolton and District General
Hospital. 510 women screened, 142 eligible, 8 moved house and could not be followed
up, and 24 women had spontaneously quit. 110 women randomised: control = 47,
intervention = 63
Baseline characteristics: 89% heavy smokers and 75% had been smoking for 5 years
or more
72% ’working-class’ (majority low SES) and 75% had no educational qualifications
Progress + coding: Low SES and low educational attainment.
Interventions Control: UC, which was advice at the discretion of the doctor.
Intervention: 1 to 1 counselling (’a short interview’) from a senior medical student
which involved discussion of the disadvantages of smoking during pregnancy: risk to the
fetus; long-term risks of physical and intellectual impairment and possible reasons for
this; possible effects on the mother’s own health; costs of smoking; special dangers of
smoking in late pregnancy; various ways to help someone to stop smoking. Given strong
encouragement to quit and to make a commitment to do so. If this was not agreed then
reduction to less than 5 cigarettes a day. Half the intervention group were given a diary
to record each cigarette smoked and a gift of a free smoking diary
Main intervention strategy: Counselling (single intervention) compared with UC.
Intensity: Frequency (C = 0, I = 1); Duration: (C = 0, I = 1).
UC intensity: Frequency = 1, duration = 1.
Intervention conducted by existing staff (medical student): effectiveness study
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Outcomes Self-reported abstinence 11 weeks after baseline visit (late pregnancy*)
Smoking reduction reported for whole cohort, not by intervention group, therefore not
included in this review
Discusses participants’ views of intervention.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided. Described as
“randomly divided”.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk There are some missing data in the tables.
It is not clear if there was any overall loss
to follow-up or whether missing data relate
to specific outcomes only. All randomised
women included in this review and those
lost to follow-up were included as contin-
uing smokers in this review
Selective reporting (reporting bias) Unclear risk No other outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Smoking outcomes were self-reported by
participants during a visit at home. There
was no biochemical validation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention at first AN visit.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Not reported.
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Medical student provided intervention
(not UC provider).
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Bauman 1983
Methods Randomised controlled trial of use of exhaled CO feedback for promoting smoking
cessation in pregnancy
Study conducted in Guildford County, North Carolina, USA over 6 months in 1981
Participants Inclusion criteria: Women currently or recently smoking, attending public clinics
Exclusion criteria: Not reported.
All women attending AN care-orientation sessions were randomly allocated to experi-
mental or control groups
Recruitment: 226women entered prenatal programand170 (75%) included in analyses.
The authors compared those who did not participate and did not find any significant
differences. 47% (79/170) were current smokers (C = 43, I = 36)
Baseline characteristics: 43% had completed high school education, 56% were black,
80%classified as having no pregnancy risks other than smoking. 38% in the first trimester
and 46% in the second trimester of pregnancy
Progress + coding: Low SES as all attending public prenatal clinic.
Interventions Control:Women were read a 135 script that described the relationship among cigarette
smoking, CO, and the harmful consequences of smoking
Intervention: Experimental group received same information as control group, and they
provided breath specimen in which CO was measured, with feedback of the result
Main intervention strategy: Feedback (single intervention) compared to a less intensive
intervention
Intensity: Frequency (C = 1, I = 1); Duration (C = 1, I = 1).
Implemented by regular health educators: effectiveness study
Outcomes Biochemically validated abstinence 6 weeks after intervention (late pregnancy*)
Exhaled CO (ppm), but no SD reported; unclear if ’quantity of cigarettes’ is mean
cigarettes per day; how recent was smoking; depth of inhalation
Notes Not clear whether this was a group intervention - in which case there was no adjustment
for clustering
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number table.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear exactly how many women were
randomised to each group, however we as-
sume that those reported as ’current smok-
ers’ in table 1 are the baseline numbers,
which were all included in this review
Selective reporting (reporting bias) Unclear risk None apparent.
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Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of reported smok-
ing behaviour for those followed up (CO
>= 9 ppm in exhaled air)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Intervention was carried out by clinical
staff, no participant blinding reported
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk All women apparently received the inter-
vention.
Equal baseline characteristics in study arms Low risk No difference between experimental and
control arms on 12 variables measured
Contamination of control group Low risk Implemented by regular health educators
at the maternity clinics
Belizan 1995
Methods Randomised controlled trial of psychosocial support in pregnancy which aimed to im-
prove maternal health, including reducing smoking during pregnancy
Conducted in 4 countries in Latin America (Argentina, Brazil, Cuba, and Mexico) from
January 1989 to March 1991
Participants Inclusion criteria: High-risk women whose AN care began at 15-22 weeks’ gestation,
singleton pregnancy, 1 or more of the following: prior LBW infant; preterm birth;
perinatal/infant death; < 18 years; body weight <= 50 kg; height <= 150 cm; low family
income (local definitions applied); < 3 years school; crowded household (4 or more
persons/bedroom); smoking; not living with husband or partner.
Exclusion criteria: Heart or renal failure; diastolic BP > 100 mmHg; history of cervical
cerclage; Rh negative; mental disease or any chronic disease that might interfere with
pregnancy
Recruitment: 2235 women met eligibility criteria and gave consent (I = 1115-though
1110 in table, C = 1120)
Baseline characteristics: Smokers (I = 23.9%, C = 21.8%), with variation between
countries - Argentina (I = 21.9%, C = 20.6%), Brazil (I = 40.7%, C = 33.1%), Cuba
(I = 27.4%, C = 28.9%), Mexico (I = 9%, C = 6.8%). Mean cigarettes per day at
randomisation: C = 7.9, I = 7.5
Progress + coding: Low SES based on place of residence (low family income 20% in
Cuba, 52% in Mexico, 53% in Brazil and 100% in Argentina)
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Belizan 1995 (Continued)
Interventions Control: Routine AN care, otherwise unspecified.
Intervention: Flexible use of a standardised manual, based on site-specific ethnographic
studies of needs, fears, expectations, social support networks, including detailed descrip-
tions of situations likely to occur during home visits. 4 to 6 home visits of 1 to 2 hours
with emphasis on psychosocial support, education on health habits including better nu-
trition, reducing smoking alcohol and other drugs, reducing their physical workload,
recognition of alarm signs and symptoms, improved access to hospital facilities, rein-
forcement of health service utilisation. Additional components were a poster, a booklet,
hotline to project office, guided tour of hospital, encouragement of family support and
participation. Intervention was provided by specially trained female social workers or
obstetric nurses with previous experience of childbirth
Main intervention strategy: Maternal health intervention with smoking component:
social support (tailored) compared with UC
Intensity: Frequency (C = 0, I = 6), Duration (C = 0, I = 5).
UC frequency and duration = 0 (unclear).
Intervention provided by study team: efficacy study.
Outcomes Self-reported point prevalence abstinence at 36 weeks’ gestation (late pregnancy*); Mean
cigarettes per day.*
Multiple perinatal and maternal health outcome data were collected, but not included
in this review as other aspects of the intervention may have had an impact
Baseline state anxiety score and associations with other factors
Notes Sample size was planned for the primary trial objective.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Centrally prepared, method not stated.
Allocation concealment (selection bias) Low risk Allocation was by opening sealed, opaque
envelopes.
Incomplete outcome data (attrition bias)
All outcomes
High risk Attrition 202/2230 (9%): 101 in each arm.
Unclear what attrition among smokers and
no ITT analysis of dropouts as continuing
smokers, so not able to re-include smokers
who dropped out in this review
Selective reporting (reporting bias) Unclear risk None apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation of reported
smoking behaviour.
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Home visitors were aware of group allo-
cation. Social support intervention with
home visits
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The evaluation of the interventions was
conducted by a team of independent pro-
fessional interviewers who were not in-
formed of the characteristics of the study
Incomplete implementation Low risk Most (83%) of the women randomly as-
signed to the intervention group received
the planned number of home visits, and
90% were visited at least once
Equal baseline characteristics in study arms Low risk The distribution of risk factors was similar
in the 2 groups and the 2 groups had similar
demographic, obstetric, and psychological
characteristics at baseline
Contamination of control group Low risk The clinic personnel were unaware of the
identity of thewomen in the control group,
and no attempts were made to inform them
of which women were in the intervention
group. Health educators providing inter-
vention were separate from care providers
Bullock 1995
Methods 2-armed randomised controlled trial of telephone support for improving maternal health
outcomes, including smoking cessation during pregnancy
Study conducted in a metropolitan city in the south island of New Zealand fromMarch
to December 1993
Participants Inclusion criteria: Women with telephone access, who were either single or with an
unemployed partner, less than 20 weeks’ gestation
Exclusion criteria: None stated.
Recruitment: Recruited in the outpatient department of a large maternity hospital, or
its associated GP practices, or self-referral via an introductory letter, phone call, and full
discussion of “Healthy Mothers/Healthy Babies”
The eligible population was 221 women of whom 49 were never located, 23 were not
interested, 10 refused after explanation, and 8 moved away, did not speak English or
had a miscarriage. 131 (59%) participated (103 OPD, 22 from GPs, 6 self-referred) (C
= 66, I = 65 randomised). Just over 50% were smokers (C = 35, I = 31).
Baseline characteristics: Mean cigarettes per day at baseline = 6.
88% European, 10% Maori. 53% single.
Progress + coding: Low SES.
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Interventions Control:Package of publicly available educationalmaterial on healthy behaviours during
pregnancy.
Intervention: Package plus weekly telephone call from trained volunteer with the aim
of providing minimal support until 12 weeks after birth; aim “to be a friend and a good
listener”; to ask about symptoms; signs; alcohol; drugs; smoking and meals in every call;
to encourage attendance at AN clinic appointments and to ask about “feeling stressed”.
Intervention provided by 19 female volunteers, trained for the project with a “case load”
of 2 to 6 women each
Main intervention strategy: Maternal health intervention with smoking component:
Social support (single intervention) compared to a less intensive intervention
Intensity: Frequency (C = 2, I = 6); Duration (C = 1, I = 4).
Intervention provided by project staff: efficacy study.
Outcomes Self-reported abstinence at 34/40 (late pregnancy*).
Mean cigarettes per day*.
Anxiety (Speilbergers State anxiety score) and depression (Levine Pilowsky Depression
inventory) at baseline and 34/40; stress; social support; self-esteem. There were other
intervention components which might have influenced these outcomes
Notes No process evaluation is reported. No sample size justification
SDs for mean cigarettes per day were not reported, therefore we calculated a mean SD
from 14 studies with available mean cigarette SDs (6.5) to include in this review, as
recommended by the cochrane handbook.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random assignment
to control or intervention in balanced
blocks of 50
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
High risk Data being reported were analysed on 122/
131 of randomised women (control = 63/
66, intervention = 59/65). 1 woman re-
quested to be removed from the study, but
there were 8 women who for various rea-
sons had incomplete data. p477 4.5% con-
trol 9.2% intervention. Only a proportion
were smokers (I = 31, C = 35), and the at-
trition among these is not reported so we
were unable to re-include them in the anal-
ysis for this review
Selective reporting (reporting bias) Unclear risk None apparent.
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Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation of reported
smoking behaviour.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Caregiver blinded to allocation. Women
not blinded to intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk No process evaluation.
Equal baseline characteristics in study arms Unclear risk Baseline psychosocial variables (stress; so-
cial support; self-esteem; depression; anxi-
ety) reported inTable 2.Demographic vari-
ables not reported
Contamination of control group Unclear risk Care providers blinded to allocation and
not involved in intervention delivery
Bullock 2009 (A+C v B+D)
Methods Randomised controlled trial (2 x 2 factorial design) evaluating nurse delivered telephone
social support (“Baby BEEP”) to improve a range of maternal health outcomes, including
smoking during pregnancy.
Study conducted in 21 rural Women, Infant and Children Nutritional Supplement
(WIC) clinics in a Midwestern state, USA, from January 2002 to July 2006
Participants Inclusion criteria:Women attending rural WIC clinic who reported smoking at least 1
cigarette per day, spoke English, were 18 years or older, and less than 24 weeks’ gestation
Exclusion criteria: Not further specified.
Recruitment: When a woman attending a WIC clinic reported current smoking, staff
explained the availability of a smoking cessation study and asked permission to provide
her name and telephone number to the Baby BEEP research team. If the woman agreed,
a nurse from the research team was assigned to contact her to arrange a face-to-face visit
to explain the study and request written consent
1420 referrals from WIC clinics, 932 eligible, 695 (75%) randomised (C = 171; I1
(booklets) = 179; I2 (social support) = 175, I3 (social support + booklets) = 170.
Baseline characteristics: > 90% ’ready to quit this pregnancy’.
Fagerstrom scores: C = 4.8, I1 (Booklets) = 5.0, I2 (SS) = 4.9, I3 (SS + booklets) = 4.7
Mean age: 22 years, 95% white, 63% high school diploma, 70% in relationship
Psychosocial assessments indicated participants experienced high levels of perceived stress
and depression and low levels of support generally and from partners
Progress + coding: Low SES as women recruited from WIC clinics.
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Interventions A: Control: Quit Smoking for Good pamphlet from the American Heart Association
and instructed that a member of the research team would call each month to arrange a
saliva sample, measure exposure to tobacco smoke and ask some questions for 2 more
interviews
Intervention (3 arms):
B: I1 Serialised Pregnancy-Smoking Cessation Booklets (Booklets):Eight booklets com-
prised a programcalled “Stop Smoking!A Special Program for PregnantWomen” adapted
to a 7th grade reading level. The first booklet was given to the woman at the recruitment
visit without counselling, and the 7 remaining booklets were mailed at weekly intervals
C: I2Nurse-DeliveredGeneral Social Support (SS): scheduled weekly telephone call and
24-hour access to the nurse for any additional social support needed. The research nurse’s
role on the calls was to use empathetic listening skills and provide social, emotional and/
or informational support in response to each woman’s individual needs, such as stressors
she was facing and ways she could manage her stress responses. The nurses kept logs
of all conversations so that they would be able to follow-up on issues of importance on
subsequent calls and as a measure of treatment integrity.
All participants in these intervention study groups were encouraged to call the nurse any
time they felt stressed or the need to talk, and they were also provided with a refrigerator
magnet and a business card with their nurse’s first name and a toll-free number. The
nurses received 40 h of training for the telephone support intervention. Each research
nurse was given information about a variety of community resources available
D: I3 SS + Booklets:
This study ID included comparisons arms A + C v B + D to utilise the factorial design
to assess impact of booklets and arm B (Booklets)
Main intervention strategy: Maternal health intervention with smoking component:
Health education(single) compared to a less intensive intervention
Intensity: Frequency (C = 1, I = 2); Duration (C = 1, I = 1).
Intervention provided by project staff: Efficacy study.
Outcomes Biochemically validated point prevalence abstinence at 28-32 weeks’ gestation* (late
pregnancy) and 6 weeks post-delivery (0-5 months postpartum*)
Baseline perceived stress scale, prenatal psychosocial profile, mental health index 5; readi-
ness to stop smoking; Fagerstrom Test for Nicotine Dependence. Subgroup analysis for
patterns of quitting and associations with partner smoking
Notes Process evaluation to follow-up phone calls. Low attrition rate suggested as indicator of
acceptability. The sample size of the control group is split in comparison ’all interventions
vs all controls’ to avoid double counting of participants in analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Assignments were prepared individually for
each nurse, were computer generated using
SAS
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Allocation concealment (selection bias) Low risk Opaque, sealed envelope, prepared by the
principle investigator that contained the
study group assignment
Incomplete outcome data (attrition bias)
All outcomes
High risk Attrition: 9 had a spontaneous abortion (C
= 2, I1 = 3, I2 = 3, I3 = 1) or non-viable
infant (C = 0, I1 = 4,I2 = 1, I3 = 4) andwere
excluded from the analysis in this review.
Those who dropped out and were lost to
follow-up for other reasons were included
in the final analysis as continuing smokers
(C = 7, I1 = 11, I2 = 11, I3 = 7).
However, 165 women were lost to lab er-
ror in analysing their saliva samples and
were not included in analysis. Only 530/
695 (76%) randomised participants were
included in this analysis
C = 128, I1 = 141, I2 = 132, I3 = 129
(n = 530) included as denominators in this
review
Selective reporting (reporting bias) Low risk All primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk 165/695 sample lost. Self-reported absti-
nence in remaining women biochemically
validated using salivary cotinine (30 ng/mL
or less classified as non-smokers)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The nurses who collected samples when
they conducted the follow-up interviews
in late pregnancy and 6-weeks postdelivery
were aware of the study group assignment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The laboratory was blind to study group
assignment while running the cotinine
analyses. The assistants who collected the
monthly saliva samplemay ormay not have
been blinded to the study group but the
rule was to treat all the women the same
way
Incomplete implementation High risk Percentage of calls completed in each of
their caseloads ranged from 58% to 80%
(p400)
Equal baseline characteristics in study arms Low risk Characteristics appear equal.
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Contamination of control group Low risk Care-providers not involved in provision of
the intervention
Bullock 2009 (AvC)
Methods Randomised controlled trial (2 x 2 factorial design) evaluating nurse delivered telephone
social support (“Baby BEEP”) to improve a range of maternal health outcomes, including
smoking during pregnancy.
Study conducted in 21 rural Women, Infant and Children Nutritional Supplement
(WIC) clinics in a Midwestern state, USA, from January 2002 to July 2006
Participants Inclusion criteria:Women attending rural WIC clinic who reported smoking at least 1
cigarette per day, spoke English, were 18 years or older, and less than 24 weeks’ gestation
Exclusion criteria: Not further specified.
Recruitment: When a woman attending a WIC clinic reported current smoking, staff
explained the availability of a smoking cessation study and asked permission to provide
her name and telephone number to the Baby BEEP research team. If the woman agreed,
a nurse from the research team was assigned to contact her to arrange a face-to-face visit
to explain the study and request written consent
1420 referrals from WIC clinics, 932 eligible, 695 (75%) randomised (C = 171; I1
(booklets) = 179; I2 (social support) = 175, I3 (social support + booklets) = 170.
Baseline characteristics: > 90% ’ready to quit this pregnancy’.
Fagerstrom scores: C = 4.8, I1 (Booklets) = 5.0, I2 (SS) = 4.9, I3 (SS + booklets) = 4.7
Mean age: 22 years, 95% white, 63% high school diploma, 70% in relationship
Psychosocial assessments indicated participants experienced high levels of perceived stress
and depression and low levels of support generally and from partners
Progress + coding: Low SES as women recruited from WIC clinics.
Interventions A: Control: Quit Smoking for Good pamphlet from the American Heart Association
and instructed that a member of the research team would call each month to arrange a
saliva sample, measure exposure to tobacco smoke and ask some questions for 2 more
interviews
Intervention (3 arms):
B: I1 Serialised Pregnancy-Smoking Cessation Booklets (Booklets):Eight booklets com-
prised a programcalled “Stop Smoking!A Special Program for PregnantWomen” adapted
to a 7th grade reading level. The first booklet was given to the woman at the recruitment
visit without counselling, and the 7 remaining booklets were mailed at weekly intervals
C: I2Nurse-DeliveredGeneral Social Support (SS): scheduled weekly telephone call and
24-hour access to the nurse for any additional social support needed. The research nurse’s
role on the calls was to use empathetic listening skills and provide social, emotional and/
or informational support in response to each woman’s individual needs, such as stressors
she was facing and ways she could manage her stress responses. The nurses kept logs
of all conversations so that they would be able to follow-up on issues of importance on
subsequent calls and as a measure of treatment integrity.
All participants in these intervention study groups were encouraged to call the nurse any
time they felt stressed or the need to talk, and they were also provided with a refrigerator
magnet and a business card with their nurse’s first name and a toll-free number. The
nurses received 40 h of training for the telephone support intervention. Each research
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nurse was given information about a variety of community resources available
D: I3 SS + Booklets:
This study ID included comparisons with the control group and arm C (SS)
Main intervention strategy: Maternal health intervention with smoking component:
Social support (single) compared to a less intensive intervention
Intensity: Frequency (C = 1, I = 6); Duration (C = 1, I = 4).
Intervention provided by project staff: Efficacy study.
Outcomes Biochemically validated point prevalence abstinence at 28-32 weeks’ gestation* (late
pregnancy) and 6 weeks post-delivery (0-5 months postpartum*)
Baseline perceived stress scale, prenatal psychosocial profile, mental health index 5; readi-
ness to stop smoking; Fagerstrom Test for Nicotine Dependence. Subgroup analysis for
patterns of quitting and associations with partner smoking
Notes Process evaluation to follow-up phone calls. Low attrition rate suggested as indicator of
acceptability. The sample size of the control group is split in comparison ’all interventions
vs all controls’ to avoid double counting of participants in analysis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Assignments were prepared individually for
each nurse, were computer generated using
SAS
Allocation concealment (selection bias) Low risk Opaque, sealed envelope, prepared by the
principle investigator that contained the
study group assignment
Incomplete outcome data (attrition bias)
All outcomes
High risk Attrition: 9 had a spontaneous abortion (C
= 2, I1 = 3, I2 = 3, I3 = 1) or non-viable
infant (C = 0, I1 = 4,I2 = 1, I3 = 4) andwere
excluded from the analysis in this review.
Those who dropped out and were lost to
follow-up for other reasons were included
in the final analysis as continuing smokers
(C = 7, I1 = 11, I2 = 11, I3 = 7).
However, 165 women were lost to lab er-
ror in analysing their saliva samples and
were not included in analysis. Only 530/
695 (76%) randomised participants were
included in this analysis
C = 128, I1 = 141, I2 = 132, I3 = 129
(n = 530) included as denominators in this
review
Selective reporting (reporting bias) Low risk All primary outcomes reported.
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Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk 165/695 sample lost. Self-reported absti-
nence in remaining women biochemically
validated using salivary cotinine (30 ng/mL
or less classified as non-smokers)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The nurses who collected samples when
they conducted the follow-up interviews
in late pregnancy and 6-weeks postdelivery
were aware of the study group assignment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The laboratory was blind to study group
assignment while running the cotinine
analyses. The assistants who collected the
monthly saliva samplemay ormay not have
been blinded to the study group but the
rule was to treat all the women the same
way
Incomplete implementation High risk Percentage of calls completed in each of
their caseloads ranged from 58% to 80%
(p400)
Equal baseline characteristics in study arms Low risk Characteristics appear equal.
Contamination of control group Low risk Care-providers not involved in provision of
the intervention
Bullock 2009 (AvD)
Methods Randomised controlled trial (2 x 2 factorial design) evaluating nurse delivered telephone
social support (“Baby BEEP”) to improve a range of maternal health outcomes, including
smoking during pregnancy.
Study conducted in 21 rural Women, Infant and Children Nutritional Supplement
(WIC) clinics in a Midwestern state, USA, from January 2002 to July 2006
Participants Inclusion criteria:Women attending rural WIC clinic who reported smoking at least 1
cigarette per day, spoke English, were 18 years or older, and less than 24 weeks’ gestation
Exclusion criteria: Not further specified.
Recruitment: When a woman attending a WIC clinic reported current smoking, staff
explained the availability of a smoking cessation study and asked permission to provide
her name and telephone number to the Baby BEEP research team. If the woman agreed,
a nurse from the research team was assigned to contact her to arrange a face-to-face visit
to explain the study and request written consent
1420 referrals from WIC clinics, 932 eligible, 695 (75%) randomised (C = 171; I1
(booklets) = 179; I2 (social support) = 175, I3 (social support + booklets) = 170.
Baseline characteristics: > 90% ’ready to quit this pregnancy’.
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Fagerstrom scores: C = 4.8, I1 (Booklets) = 5.0, I2 (SS) = 4.9, I3 (SS + booklets) = 4.7
Mean age: 22 years, 95% white, 63% high school diploma, 70% in relationship
Psychosocial assessments indicated participants experienced high levels of perceived stress
and depression and low levels of support generally and from partners
Progress + coding: Low SES as women recruited from WIC clinics.
Interventions A: Control: Quit Smoking for Good pamphlet from the American Heart Association
and instructed that a member of the research team would call each month to arrange a
saliva sample, measure exposure to tobacco smoke and ask some questions for 2 more
interviews
Intervention (3 arms):
B: I1 Serialised Pregnancy-Smoking Cessation Booklets (Booklets):Eight booklets com-
prised a programcalled “Stop Smoking!A Special Program for PregnantWomen” adapted
to a 7th grade reading level. The first booklet was given to the woman at the recruitment
visit without counselling, and the 7 remaining booklets were mailed at weekly intervals
C: I2Nurse-DeliveredGeneral Social Support (SS): scheduled weekly telephone call and
24-hour access to the nurse for any additional social support needed. The research nurse’s
role on the calls was to use empathetic listening skills and provide social, emotional and/
or informational support in response to each woman’s individual needs, such as stressors
she was facing and ways she could manage her stress responses. The nurses kept logs
of all conversations so that they would be able to follow-up on issues of importance on
subsequent calls and as a measure of treatment integrity.
All participants in these intervention study groups were encouraged to call the nurse any
time they felt stressed or the need to talk, and they were also provided with a refrigerator
magnet and a business card with their nurse’s first name and a toll-free number. The
nurses received 40 h of training for the telephone support intervention. Each research
nurse was given information about a variety of community resources available
D: I3 SS + Booklets:
This study ID included comparisons with the control group and arm D(I3) (SS +
Booklets)
Main intervention strategy: Maternal health intervention with smoking component:
Social support (multiple) compared to a less intensive intervention
Intensity: Frequency (C = 1, I = 6); Duration (C = 1, I = 4).
Intervention provided by project staff: Efficacy study.
Outcomes Biochemically validated point prevalence abstinence at 28-32 weeks’ gestation* (late
pregnancy) and 6 weeks post-delivery (0-5 months postpartum*)
Baseline perceived stress scale, prenatal psychosocial profile, mental health index 5; readi-
ness to stop smoking; Fagerstrom Test for Nicotine Dependence. Subgroup analysis for
patterns of quitting and associations with partner smoking
Notes Process evaluation to follow-up phone calls. Low attrition rate suggested as indicator of
acceptability. The sample size of the control group is split in comparison ’all interventions
vs all controls’ to avoid double counting of participants in analysis
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Assignments were prepared individually for
each nurse, were computer generated using
SAS
Allocation concealment (selection bias) Low risk Opaque, sealed envelope, prepared by the
principle investigator that contained the
study group assignment
Incomplete outcome data (attrition bias)
All outcomes
High risk Attrition: 9 had a spontaneous abortion (C
= 2, I1 = 3, I2 = 3, I3 = 1) or non-viable
infant (C = 0, I1 = 4,I2 = 1, I3 = 4) andwere
excluded from the analysis in this review.
Those who dropped out and were lost to
follow-up for other reasons were included
in the final analysis as continuing smokers
(C = 7, I1 = 11, I2 = 11, I3 = 7).
However, 165 women were lost to lab er-
ror in analysing their saliva samples and
were not included in analysis. Only 530/
695 (76%) randomised participants were
included in this analysis
C = 128, I1 = 141, I2 = 132, I3 = 129
(n = 530) included as denominators in this
review
Selective reporting (reporting bias) Low risk All primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk 165/695 sample lost. Self-reported absti-
nence in remaining women biochemically
validated using salivary cotinine (30 ng/mL
or less classified as non-smokers)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk The nurses who collected samples when
they conducted the follow-up interviews
in late pregnancy and 6-weeks postdelivery
were aware of the study group assignment
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The laboratory was blind to study group
assignment while running the cotinine
analyses. The assistants who collected the
monthly saliva samplemay ormay not have
been blinded to the study group but the
rule was to treat all the women the same
way
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Incomplete implementation High risk Percentage of calls completed in each of
their caseloads ranged from 58% to 80%
(p400)
Equal baseline characteristics in study arms Low risk Characteristics appear equal.
Contamination of control group Low risk Care-providers not involved in provision of
the intervention
Burling 1991
Methods Randomised controlled trial of CO feedback and brief directive feedback to reduce
smoking in pregnancy
Study conducted in a large USA municipal hospital AN clinic, over an 18-month study
period (dates not specified)
Participants Inclusion criteria: Pregnant women, currently smoking, at any gestation, attending a
clinic for ’uncomplicated pregnancies’
Exclusion criteria: Very young age (not specified) or “complications” (not specified)
Recruitment: All attending women were screened for smoking by questionnaire + CO
breath measurement (>= 9 ppm) (over 50% were current smokers) and 139 women were
randomly assigned (C = 69, I = 70)
Baseline characteristics: An average of 12.7 cigarettes per day.
The population consisted primarily poor and stable ’working class’ Caucasian women
(52.4%), Black (44.6%) and Asian (3%)
Progress + coding: Low SES.
Interventions Control:UC,where a clinic nurse provided health education, including risks of smoking.
Intervention: A personal letter from the Chief (physician) of the prenatal clinic within
3 days of the visit, mentioning the CO test, discussing the risks of smoking to herself
and the fetus and urging her to stop plus the American Cancer Society pamphlet (“Why
start life under a cloud?”) about the negative effects of smoking and simple guidelines
for self-directed smoking cessation
Main intervention strategy: Health education (single intervention) compared to UC.
CO feedback was provided to both groups so not included as a feedback trial
Intensity: Frequency (C = 0, I = 1), Duration (C = 0, I = 1).
UC intensity: Frequency = 1, Duration = 1.
Intervention provided by routine clinic staff: Effectiveness study
Outcomes Biochemically validated point prevalence smoking cessation at 34 weeks’ gestation (late
pregnancy*). Number of cigarettes per day and CO levels collected but not reported
Notes Simple intervention so no process evaluation.
Clinic-wide implementation so no consent sought.
Risk of bias
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Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk No consent sought and no loss to follow-
up apparent.
Selective reporting (reporting bias) Unclear risk None apparent. Primary outcomes re-
ported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of reported be-
haviour by exhaled CO (>= 9 ppm counted
as smoking)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk The authors state that clinic staff were un-
aware of group allocation. Women would
not have been blind to educational inter-
vention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk All intervention participants provided with
letter. No information regarding whether
they read it or not
Equal baseline characteristics in study arms Unclear risk There were no significant baseline differ-
ences between 2 groups in terms of age,
ethnicity, term of pregnancy, number of
children, number of reported cigarettes
smoked, or CO
Contamination of control group Low risk Intervention was a letter so unlikely to be
sent to control group in error
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Methods This 2-armed randomised controlled study aimed to evaluate the effectiveness of nurse
counselling to reduce smoking in pregnancy.
The study was conducted in 2 community-based obstetric clinics in Milwaukee (USA).
Study dates unclear
Participants Inclusion criteria: Pregnant, ‘a current smoker’, English speaking, visually able to read
12 point typeset, being able to give free consent, and expecting to reside in Milwaukee
following delivery
Exclusion criteria: Not specified.
Recruitment: 50% of patients enrolled in third trimester. 57 women randomised, but
unclear how many to each group
Baseline characteristics: Cigarette consumption mean at entry = 8.6
93% participants smoked fewer than 10 cigarettes per day.
79% Black participants, 16% had partner, 70% single, 77% unemployed, 32% < grade
12 education, 61% < $10,000 per year
No coding as outcomes not able to be included in this review
Interventions Control: A smoking cessation booklet at 6th grade reading level or 11 min videotape.
Intervention: Booklet or video Nurse counselling based on 4 As recommended by
National Cancer Institute. The nurse intervention was a systematic tailored smoking
cessation approach that was based on the 4 A (Ask, Advise, Assist, Arrange) approach by
the National Cancer Institute
Main intervention strategy and intensity not coded as not included in meta-analysis
Outcomes Self-reported smoking status (20% had CO screening) 1 month after enrolment, in the
ninth month of pregnancy, and 1 month postpartum. But not reported by intervention
group so unable to include any outcomes in meta-analysis
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method of sequence generation not stated.
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Of the 57 participants enrolled in the study,
50 were available for 1- and 9-month fol-
low-up, and 48 responded to the 1-month
postpartum survey. All non-respondents
were considered to be smokers at follow-
up and considered to have made no quit
attempts in the follow-up interval
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Selective reporting (reporting bias) Unclear risk Outcomes not reported by intervention
group, but did not claim results were sig-
nificant
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking status for 80% sam-
ple.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personal unlikely to be
blinded in educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Not reported.
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Home visits.
Campbell 2006
Methods Cluster-randomised controlled trial which aimed to assess 2 methods of disseminating
smoking cessation programmes to public AN clinics
Study conducted in Newcastle, New South Wales, Australia. Data collection dates not
reported
Participants Inclusion criteria: Public AN clinics with an AN clinic and more than 500 births per
year (unit of randomisation).Womenwho attended the clinics and reported to be current
smokers were the unit of analysis
Exclusion criteria: Under 16 years of age, too sick, non-English speaking, illiterate,
attendance was first visit
Recruitment: 23/25 public hospitals agreed to participate 22 clinics randomised (C =
11, I = 11). Assume smoking prevalence identifies eligible smokers (2284 in control
clinics and 2821 in intervention clinics). Included in post-dissemination assessment: C
= 688, I = 781
Baseline characteristics: Smoking details not reported.
Proportion more than high school: 22%; Language other than English at home: C =
35%, I = 33%
Progress + coding: Low SES as all attending a public pre-natal clinic.
Interventions The cessation programme “Fresh Start for you and your baby”, developed by Windsor,
based onCBT,was used.More details are described inWalsh 1997.Coded as a counselling
(multi-modal) intervention.
Control: Simple dissemination of programme to clinics which included mail out of
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written information on programme benefit and resources
Intervention: Intensive dissemination of programme which included written informa-
tion and feedback about programme benefits to managers, provision of programme re-
sources, offers of visits to explain programme and provide training, sample smoking ces-
sation policy, regular contacts to offer support, and computerised feedback on activities
Main intervention strategy: Intensive dissemination vs less intensive dissemination.
Intensity:Not coded as same intervention for women in both arms (counselling-tailored)
. This study is not included in intensity analysis
Study provided by existing service providers: effectiveness/dissemination study
Outcomes Primary outcomes were the proportion of women whose smoking status was assessed
and were provided smoking cessation advice
Biochemically validated point prevalence smoking cessation at end of pregnancy* (The
proportion of women who had been smokers when they first visited the clinic who had
now quit, p99) was a secondary outcome for this study
Provider views of interventions discussed.
Notes No intracluster correlation or impact factor reported, so sensitivity analysis conducted
using 4 ICCs and figures adjusting using ICC of 0.1 in outcome tables
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Methodof randomallocationnot specified,
but taken within strata based on clinic size
and baseline smoking rates
Allocation concealment (selection bias) Unclear risk Not specified.
Incomplete outcome data (attrition bias)
All outcomes
High risk One clinic excluded as did not report final
data and some missing data for post-dis-
semination measures. No ITT of women
dropping out of study. Only women com-
pleting study measures included in analy-
sis. Unable to re-include in this review
Selective reporting (reporting bias) Low risk Smoking status and recall of intervention
reported.
Other bias High risk There was a shorter recruitment period (1
week instead of 2 weeks) at post-dissemina-
tion for the 11 largest clinics (out of the 22
clinics involved), so the sample sizes have
been adjusted to account for the shorter re-
cruitment period for those clinics, by in-
creasing the sample size to what they would
have expected to have recruited if the pe-
riod was over 2 weeks instead of 1. We have
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adjusted for these estimates in this review
as outlined in Table 1
Also lower recruitment in control arms
compared to intervention arms
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Exhaled CO >= 9 ppm.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention. Neither women
nor providers would have been blind to the
intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed good imple-
mentation in intervention group. However
time constraints within clinics meant that
training sessions could not be repeated.
Although training permitted information
about the programme to be provided to
clinicians and the training videotape mod-
elled smoking cessation skills, the time pe-
riod was usually inadequate to provide skill
development as originally planned. p100
Equal baseline characteristics in study arms Low risk Patient population differences on nearly all
14 characteristics were minimal (less than
5%)
Contamination of control group High risk Similar proportions of control women re-
ceived the specific risk information which
indicated that midwives had increased the
pre-study level of UC advice
Cinciripini 2000
Methods Randomised controlled trial evaluating provision of videotaped vignettes for promoting
smoking cessation and relapse prevention during pregnancy
Study conducted in a community-based university setting, Texas, USA. Data collection
dates not reported
Participants Inclusion criteria: Volunteers who were willing to quit within 2 weeks.
Exclusion criteria:Women smoking < 3 cigarettes per day; < 18 years; > 30 weeks’ preg-
nant; do not have a working video recorder (approximately 12% Americans); depressed
Recruitment: Through local media, such as newspaper, radio, subscriber letters, com-
munity business flyers, waiting room posters
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146 women screened and 82 women who met inclusion criteria were randomised (C =
40, I = 42)
Baseline characteristics: Mean cigarettes/day at first visit: C = 14.5, I = 17.3.
Progress + coding: None.
Interventions Control: Received a quit calendar and tip guide.
Intervention: As for control plus were mailed a video with 6 x 25-30 min vignettes
covering a range of topics and strategies from initial quitting to relapse prevention
Main intervention strategy: Counselling (single intervention) compared to a less in-
tensive intervention
Intensity: Frequency (C = 2, I = 2), Duration (C = 1, I = 4).
Intervention provided by study staff: efficacy study.
Outcomes Biochemically validated point prevalence abstinence obtained within 2-3 days of quit
date, 4-5 weeks after the quit date (late pregnancy)* and 1 month postpartum (0-5
months postpartum*).
Participant evaluation of intervention materials.
Associated references report association between quitting and depressive disorders, but
not by intervention exposure. CES-D scores at baseline only
Notes Authors say women in this study tend to be heavier smokers than described in previous
studies
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not stated.
Allocation concealment (selection bias) Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 61% of participants completed all as-
sessments. All those with missing data were
treated as continuing smokers in this review
Selective reporting (reporting bias) Low risk Pre-specified outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk All reports of abstinence were validated by
measurement of salivary cotinine < 30 ng/
mL
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Video mailed to participants. Not clear if
UC givers were aware of group allocation
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed only 53% of the
intervention group viewed 1-3 of the 6
videos. 47% did not view them
Equal baseline characteristics in study arms Low risk No significant difference in socioeconomic
variables between groups
Contamination of control group Low risk Video mailed out to participants only.
Cinciripini 2010
Methods 2-armed randomised controlled trial to evaluate a depression-focused intervention which
aims to promote smoking cessation during pregnancy
Study conducted in Texas (USA) between January 2005 and January 2008
Participants Inclusion criteria: >= 16 years of age, to be <= 32 weeks pregnant, to have smoked
at least a puff or more during the past 7 days, to have a telephone, and to express a
willingness to quit smoking during the study (i.e. women with a goal of only reducing
cigarette consumption were not eligible)
Exclusion criteria: Currently participating in psychotherapy or other smoking cessa-
tion treatment, had unstable medical conditions that would adversely affect attendance,
or demonstrated psychological instability during the screening (e.g. high suicide risk,
symptoms of cognitive disorder, or severe intellectual impairment)
Recruitment:Throughnewspaper and television advertisements, and physician referrals.
730 women were screened for basic eligibility by telephone. 266/294 (90%) eligible
women were randomised (C = 133, I = 133)
Baseline characteristics: Smoking rate before finding out pregnant (mean cigarettes per
day): I = 16.8 (8.7), C = 15.8 (9.1);
Current smoking rate (mean cigarettes per day): I = 9.8 (7.1), C = 9.7 (6.7)
Fagerstrom Test for Nicotine Dependence score I = 3.2 (2.1), C = 3.5 (2.0)
63% receiving medicaid or county health care, 54% African-American, 10% Hispanic,
33.5%Caucasian; 31.9% had less than high school education. 34.2% had family income
< $10,000
75.5% had lifetime major depressive disorder (23.5% current major disorder)
Progress + coding: Ethnic minority.
Interventions Ten individual counselling sessions were scheduled for 60 min. Each session consisted of
15 min of standard behavioural and motivational smoking cessation counselling (com-
mon to both groups). Counselling typically involved active efforts to prepare for quitting
and maintaining abstinence using self-monitoring of their smoking prior to the quit
date, identification of high-risk situations for smoking, and development of coping skills
and support before and after the quit date. Therapists used motivational enhancement
strategies based on techniques of MI if resistant to quitting. The core features included
exploration of participant ambivalence, use of open-ended questions, reflective listening,
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expressed empathy, rolling with resistance, and use of strategies to develop perceived
discrepancy between smoking behaviour and important personal goals and values
Control: The primary goal of the HW treatment was to educate women on ways to
decrease stress, to respond to stressful events, and to take care of themselves physically
during their pregnancies. The purpose was to provide a time- and attention-matched
control for CBASP that was pregnancy relevant but instructional in nature-typical of
health-education interventions. Participants chose from a list of discussion topics, in-
cluding stress, pregnancy symptoms, sleep, exercise, yoga, relaxation training, time man-
agement, parenting tips, dealing with anger, negative thoughts and feelings, and post-
partum depression.
Intervention: CBASP was originally developed for the treatment of chronic depression.
The primary CBASP treatment strategy is a social problem-solving exercise called Sit-
uational Analysis (SA), which is a technique used to create awareness of the contin-
gent relationship between participants’ behaviour and outcomes in stressful interpersonal
situations. Another CBASP treatment strategy involved increasing participants’ aware-
ness of the contingent relationship between their behaviour and interpersonal outcomes
within the therapeutic relationship and to apply this learning to relationships within the
participants’ daily living arenas. The CBASP model assumes that repeated practice of
SA within and outside of treatment and increased understanding of participants’ inter-
personal impact on the therapist lead to acquisition of new perceptual and behavioural
skills that improve interpersonal problem resolution. In turn, this is assumed to decrease
interpersonal stress and depressive symptoms
Main intervention strategy: Counselling (single intervention) compared to alternative
intervention
Intensity: Frequency (C = 6, I = 6); Duration (C = 6, I = 6).
Intervention provided by study staff: efficacy study.
Outcomes Biochemically validated 7-day point prevalence abstinence at end of 10 weeks treatment
(late pregnancy*), self-reported smoking cessation 3 and 6months after treatment, smok-
ing cessation 3 (0-5*) and 6 (6-11*) months postpartum. Continuous and prolonged
abstinence also reported
Depression (CES-D scores) and probability of cessation 6 months post-treatment
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Adaptive randomisationwas used to stratify
the groups on age, race, history of depres-
sion, baseline smoking rate, baseline de-
pressive symptom severity (CES-D >= 16)
, and longest duration of last depressive
episode
Allocation concealment (selection bias) Unclear risk No information provided.
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Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: 3 months: C = 9/133, I = 22/
133; 6 months C = 42/133, I = 54/133. All
analyses were carried out on the ITT sam-
ple, which included 128 participants in the
Intervention group and 129 control - ex-
cluding only those who experienced a mis-
carriage during the study (5 participants in
Intervention and 4 participants in control)
Selective reporting (reporting bias) Low risk All primary outcomes reported
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of self-reported
smoking status (7-day point prevalence
only) using expiredCO (<4ppm) through-
out treatment or salivary cotinine (< 15
ng/mL) with self-report only at 3- and 6-
month follow-up contacts
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and providers unlikely to be
blinded to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Process evaluation showed high levels of
compliance with counselling standards in
both groups. Participants attended an av-
erage of 8/10 sessions of approximately 58
mins
Equal baseline characteristics in study arms Low risk No significant differences noted.
Contamination of control group Low risk There is a potential risk with the same
counsellors providing counselling for the
intervention and control groups. However
global competence ratings forCBASP,HW,
and the smoking cessation counselling in-
terventions were measured on a scale rang-
ing from 1 (does not attempt intervention)
to 4 (good use of intervention). No differ-
ences in competence between the groups
were noted, averaging 3.8 (SD across con-
ditions. Statistical agreement of compe-
tence ratings between primary and sec-
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ondary raters was high, with a Cohen’s
kappa (Landis & Koch, 1977) of .93 (95%
CI 0.86 to 1.0)
Cook 1995
Methods Randomised controlled trial of counselling to support women to stop smoking during
pregnancy in the USA. Location and dates of data collection not reported (abstract only
available)
Participants Inclusion criteria: Self-reported smokers presenting for prenatal care before 24 weeks’
gestation
Exclusion criteria: Not specified.
150 women randomised. Data for only 43 women (C = 20, I = 23) who had delivered by
the time of report are available. 2 women in control group had baseline cotinine levels
consistent with abstinence so are not included (C = 18, I = 23)
Baseline characteristics: Not reported.
Progress + coding: None.
Interventions Control:Discussion of smoking risks by a nutritionist and again by a resident physician
at initial prenatal visit
Intervention:Control + regularmeetings with a smoking cessation counsellor and physi-
cian reinforcement at each visit. The women also received biochemical feedback from
urine cotinine
Main intervention strategy: Counselling (multiple intervention) compared to a less
intensive intervention
Intensity: Frequency (C = 1, I = 5); Duration (C = 1, I = 3). Estimates for intervention
as little detail provided
Intervention provided by routine care staff: effectiveness study
Outcomes Biochemically validated point prevalence abstinence at term or birth (late pregnancy*);
> 50% reduction in cotinine*; and mean birthweight*
Notes SDs for mean birthweight were not reported, therefore we calculated a mean SD from 13
studies with available birthweight SDs (578) to include in this review, as recommended
by the cochrane handbook.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported.
Allocation concealment (selection bias) Unclear risk Not reported.
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Incomplete outcome data (attrition bias)
All outcomes
Unclear risk One woman in the intervention group
dropped out of the study and was not in-
cluded in the original analysis but has been
re-included as a continuing smoker in this
review, but not included in the mean birth-
weight analysis
Selective reporting (reporting bias) High risk Preliminary results only available. Final re-
sults not reported and unable to be accessed
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation by urine cotinine
but cut-off levels not reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible for participants and personnel
to be blinded to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Not reported.
Equal baseline characteristics in study arms Unclear risk Baseline characteristics not reported (ab-
stract only).
Contamination of control group High risk Appears that same physician provided ad-
vice to control and intervention women,
and not clear if this was not repeated for
control group
Cope 2003
Methods 2-armed randomised controlled trial evaluating effectiveness of feedback from a point-
of-care cotinine test for supporting women to stop smoking during pregnancy
Study conducted in Birmingham, UK. Dates of data collection not reported
Participants Inclusion criteria: ’Current smokers’ (> 10 mg/L in preliminary urine cotinine result)
Exclusion criteria: Not specified.
Recruitment: Seen at initial AN visit and given brief explanation of test and aims of
research, and asked to give verbal consent to participate in study. Women then had urine
screened for cotinine and completed a questionnaire
745/856 (87%) eligible women agreed to participate and were randomised (C = 447, I =
298 in flow chart and 409 in results text). 280 women were smokers (C = 164, I = 116)
Baseline characteristics: Average consumption of 11.8 cigarettes per day. Other char-
acteristics not reported
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Progress + coding: None
Interventions Control: Routine counselling from a doctor or midwife. Urine measured at initial visit
but no feedback given to woman
Intervention: 6-min urine test completed in their presence. Results given as a number
and graphic illustration. A specific quit date within the next 14 days was mutually agreed
and the woman was given a printed leaflet containing practical advice on how to reduce
their smoking measurement at each visit. A positive friendly attitude of providers - infor-
mation, feedback, encouragement protocol was repeated whenever the patient returned
to the clinic up to and including the 36 week visit, with measurement, questioning about
changes in smoking, specific events on the quit date and reinforcement of advice
Main intervention strategy: Feedback (multiple intervention) compared to UC.
Intensity: Frequency (C = 0, I = 5); Duration (C = 0, I = 3). UC intensity: F = 1, D = 1
Intervention provided by study staff: Efficacy study.
Outcomes Biochemically validated point prevalence smoking cessation at 36 weeks’ gestation (late
pregnancy*)
Proportion with ’some reduction*’ (20% to 80% urine cotinine)
Mean birthweight* and length. Preterm births* reported in attrition and re-included in
both numerator and denominator for this outcome
Gestation, type of delivery, and Apgar scores collected but results not reported
Participants view of interventions reported.
Notes SDs for mean birthweight were not reported, therefore we calculated a mean SD from 13
studies with available birthweight SDs (578) to include in this review, as recommended
by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quasi-randomised: New referrals to 3 large
inner-city hospital AN clinics were ran-
domised on the basis of their allocated hos-
pital unit number, even numbers being
placed in the case or intervention group,
or those who were provided with feedback
from the smoking test at point of care. p675
Allocation concealment (selection bias) High risk Group allocation could be anticipated.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Only 83/116 women in the control group
and 109/164 women in the intervention
group completed the study. Those who
dropped out for medical reasons: miscar-
riage (C = 2, I = 3) or premature delivery (C
= 6, I = 13), or transferred care (C = 3, I = 5)
were excluded (C = 11, I = 21) from smok-
ing outcome analysis. Those who failed to
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attend appointments, or refused further in-
volvement were re-included as continuing
smokers in this review (C = 18, I = 34),
leaving a total sample of C = 101, I = 143
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported.
Other bias High risk Clear financial conflict of interest declared
by author (directorship of company pro-
ducing feedback tests)
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking status biochemically validated
with urine cotinine (> 10 mg/L indicates
active smoker)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Neither providers nor women were blind
to intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Not reported.
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Contamination unlikely with provision of
specific biochemical test
Donatelle 2000
Methods Randomised controlled trial of “Significant Other Supporter” (SOS) program, of social
support anddirect financial rewards to reduce smokingduringpregnancy andpostpartum
Study conducted in Oregon WIC program sites, USA, between June 1996 and June
1997
Participants Inclusion criteria: Women smoking (even a puff in the last 7 days); less than 28 weeks’
gestation; over 15 years of age; literate in English
Exclusion criteria: Not specified.
Recruitment: 220/309 (71%) eligible women were randomised (C = 108, I = 112)
Baseline characteristics: Mean salivary cotinine at baseline: I = 45.4; C = 45.7.
Caucasian (I = 90%, C = 88%), household income < $20000 (I = 87%, C = 89%), Single
(I = 47%, C = 42%), Mean age (I = 23.5, C = 24.0)
Progress + coding: Low SES.
Interventions Control: Verbal and written information on the importance of smoking cessation, a
pregnancy specific smoking cessation self-help kit, and monthly telephone calls for self-
134Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Donatelle 2000 (Continued)
reports on their smoking status.
Intervention: As for the control group plus were asked to designate a social supporter
(preferably a female non-smoker), and were advised both she and her supporter would
receive an incentive: participants were given $50 voucher for each month biochemically
confirmed as quit. Supporter received $50 voucher in first month and at 2 months
postpartum, and $25 voucher for other months
Main intervention strategy: Incentives (multiple intervention) compared with a less
intensive intervention
Intensity: Frequency (C = 2, I = 6), Duration (C = 1, I = 3)-estimated duration as limited
information available
The intervention was delivered by trained program staff or research staff: efficacy study
Outcomes Biochemically validated 7-day point prevalence smoking cessation at 34 weeks’ gestation
(late pregnancy*) and 2 (0-5*) months postpartum
Notes Data in outcome tables is inconsistent.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk High attrition rates I = 32%; C = 51.5%
(reasons not specified), but all dropouts in-
cluded as continuing smokers in this anal-
ysis
Selective reporting (reporting bias) Low risk Main outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk 7-day point prevalence validated by salivary
cotinine analysis (> 30 ng/mL considered
to be smokers). Salivary thiocyanate also
used to confirm non-smokers for immedi-
ate feedback only (> 100 ug/mL considered
to be smokers)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Neither providers nor women were blinded
for this educational intervention with in-
centives
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
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Incomplete implementation Unclear risk No process evaluation reported.
Equal baseline characteristics in study arms Low risk Preliminary analysis indicates no signifi-
cant differences exist between randomised
groups on baseline demographic character-
istics
Contamination of control group Low risk Control group not reported clearly - how-
ever intervention given by trained research
staff rather than UC providers so unlikely
that there was contamination
Donovan 1977
Methods Randomised controlled trial of medical advice to stop smoking in pregnancy
Study conducted in 3 public maternity units in the UK. Dates of data collection not
stated
Participants Inclusion criteria: Pregnant women < 35 years; currently smoking >= 5 cigarettes/day
and had been smoking >= 1/day at the onset of pregnancy; < 30 weeks’ gestation at first
visit; no prior perinatal death; not seeking termination
Exclusion criteria: Not further specified.
Recruitment: Consecutive series of patients who contacted 3 maternity units regard-
ing confinement were posted reply-paid questionnaires (including smoking questions),
which were used to select eligible participants
588 women provided consent and were randomised.
Baseline characteristics: Mean cigarettes/day at beginning of pregnancy (C = 17.6, I =
17.9); mean cigarettes/day at study entry (C = 15.2, I = 15.2),
Mean age (C = 24.2, I = 23.8). Even distribution of social class categories
Progress + coding: None.
Interventions Control: ANC usually provided by the hospital, including any anti-smoking advice
which may have been given routinely
Intervention: Individualised medical advice by clinic doctor,
(i) tell the woman the facts about smoking in pregnancy;
(ii) encourage questions about these facts;
(iii) once the woman has agreed to try, discuss how she may best give up;
(iv) follow-up the advice at all later contacts. Medical records labelled asking other staff
to reinforce advice
Details of the intervention are in Donovan 1975.
Main intervention strategy: Health education (single intervention) compared to UC.
Intensity: Frequency (C = 0, I = 5); Duration: (C = 0, I = 2)-estimate. UC intensity: F
= 1, I = 1
Intervention provided by existing service providers: effectiveness study
Outcomes Self-reportedmean cigarettes/day at 4 stages of pregnancy (late pregnancy*), mean birth-
weight*, LBW*, preterm birth* (< 36 weeks), perinatal deaths*. No data on smoking
cessation
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Notes Discussion of common problems identified when advising women to stop and on the
contextual factors which encourage the continuation of smoking.
Major inconsistency in smoking reports pre- and post-birth is a problem in this trial
Actual standard errors were able to be incorporated into software for this update (previ-
ously SD 500 used), so effect size estimates have altered slightly
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Table of random numbers.
Allocation concealment (selection bias) Unclear risk Information not provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Twins (C = 2, I = 6) and miscarriages (C
= 17, I = 11) not included in analysis. 552
women analysed (C = 289, I = 263). No
further attrition reported
Selective reporting (reporting bias) Unclear risk Smoking cessation rates not reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation of reported
smoking behaviour.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Notes labelled. Caregivers asked to rein-
force information. Educational interven-
tion
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation of the reinforcement of
advice showed little difference between the
groups in recall of advice being given
Equal baseline characteristics in study arms Unclear risk From table 2 characteristics appear to be
equal - but there is no statement or statistic
confirming this
Contamination of control group High risk Same providers offering intervention and
control advice. Process evaluation of the re-
inforcement of advice showed little differ-
ence between the groups in recall of advice
being given
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Methods Randomised controlled trial of counselling and telephone support to support women to
stop smoking during pregnancy and postpartum
Study conducted inHartford, Connecticut (USA), between January 2001 andDecember
2002
Participants Inclusion criteria: Pregnant women, over 18 years old, less than 30 weeks’ gestation,
current smokers (recent quitters included in associated relapse prevention paper (Morasco
2006).
Exclusion criteria: Recent history of abuse or dependence on alcohol or other non-
nicotine substance, major psychiatric illness, no access to a telephone
Recruitment: Study conducted in the prenatal clinic of a non-profit tertiary care com-
munity hospital. Written consent obtained. Unclear how many eligible women partici-
pated. 140 women enrolled in study. 33 spontaneously quit (C = 19, I = 14), 107 were
randomised but 2 were excluded due to missing data, leaving 105 included in analysis
(I = 53, C = 52)
Baseline characteristics: 70.5% smoked less than 10 cigarettes per day at baseline.Mean
20.8 (12.37) pre-pregnancy
66% Hispanic, 17% Caucasian, 11% African American. 61% unemployed, 54% less
than high school education, 60% single, 49% household income < $15000/yr, 52% 1
or more depression items and 19% all 4 items
Progress + coding: Low SES and minority ethnic group.
Interventions Control: UC according to standard smoking cessation guidelines, with providers offered
2 x 1-hour training sessions. Research study co-ordinator provided all participants with
a booklet, inserted a chart prompt to remind providers to provide personalised quit
messages at each visit, and audited charts to ensure the advice was documented
Intervention: 1 90-min psychotherapy session provided by masters-prepared mental
health therapist trained in smoking cessation. The main goals were to assess readiness to
quit, identify potential psychological or social problems that might pose as barriers to
quitting, and set a quit date. This was followed by bi-monthly telephone calls from the
therapist during pregnancy, and monthly calls after delivery
Main intervention strategy: Counselling (single intervention) compared to a less in-
tensive intervention
Intensity: Frequency (C = 5, I = 6), Duration (C = 2, I = 6).
Intervention provided by study staff: efficacy study.
Outcomes Biochemically validated 7-day point prevalence abstinence in late pregnancy* and 6 (6-
11) months postpartum*
Aggregated results by week of gestation to enter study. An associated study (Morasco
2006) reports abstinence rates for recent quitters (relapse prevention*)
Cost-effectiveness of ’cost per quitter’.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Unclear risk No description of methods of randomisa-
tion.
Allocation concealment (selection bias) Unclear risk No description.
Incomplete outcome data (attrition bias)
All outcomes
High risk 2/107 randomised women were excluded
from analysis due to missing data and were
unable to be re-included in this report as
the group allocation is not reported.The re-
maining dropouts (18% at 6 months post-
partum) are included as continuing smok-
ers in this analysis
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation with exhaled CO
readings (cut off < 8 ppm but all partici-
pants less than 4 ppm)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention so blinding not
feasible.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed 17/53 did not
receive the phone calls as planned
Equal baseline characteristics in study arms Unclear risk No significant differences in any of the
baseline characteristic between the 2 groups
Contamination of control group Low risk Counselling and follow-up sessions pro-
vided by psychotherapist not involved in
UC
Dunkley 1997
Methods Randomised controlled trial ofmidwifery counselling to support women to stop smoking
in pregnancy
Study conducted in a large UK maternity service. Data collection dates not specified
Participants Inclusion criteria: Pregnant and booked for maternity care; < 18 weeks’ gestation;
currently smoking 1 or more cigarettes/day
Practising midwives regularly attending AN clinic.13 midwives selected for the inter-
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vention group and 13 for the control group
Exclusion criteria: Not specified.
Recruitment: All women identified as smokers in a busy teaching hospital with 3700
deliveries a year received a letter asking if they would like to participate. 100 women
participated (described as ’all 100 women contacted’) and were randomised (C = 50, I =
50)
Baseline characteristics: ’Contemplators’ (C = 70%, I = 60%), ’pre-contemplators’ (C
= 15%, I = 22%), ’ready for action’ (C = 15%, I = 18%)
No other baseline characteristics reported.
Progress + coding: None.
Interventions Control: UC.
Intervention: Midwives were trained to assess the stages of change and provide a be-
havioural intervention, using the Health Education Authority material “Helping preg-
nant smokers quit: training for health professionals”, 1994
Main intervention strategy: Counselling (single intervention) compared to UC.
Intensity: Frequency (C = 0, I = 5), duration (C = 0, I = 2)-based on estimated brief
contact (< 5 min) at a standard number of AN visits (8), as very little information about
intervention provided. UC intensity: F = 0, I = 0
Intervention provided by existing staff: effectiveness study
Outcomes Self-reported smoking cessation at 37 weeks (late pregnancy)*; and at 4 weeks (0-5
months*) postpartum
Reduction in cigarettes/day (not reported as results unclear), “stage of change” at 11
to 18 weeks vs 37 weeks. No biochemical validation of smoking status. Care providers’
views discussed
Notes No process evaluation reported.
Abstract data used. States ’after one year’ which is assumed to be of year of the study,
at 37 weeks’ gestation, as reported in figure 1. As there were no quitters in the control
group, the relapse rates of 4% within 1 month postpartum are assumed to be from the
treatment group only
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not stated.
Allocation concealment (selection bias) Unclear risk Described as ’randomly allocated’.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 94 of 100 randomised women followed up
(reasons for attritionnot reported).No ITT
analysis reported.However, all dropouts re-
included as continuing smokers in this re-
view
Selective reporting (reporting bias) Unclear risk All outcomes reported.
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Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation of reported
smoking status.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel unlikely to be
blinded to educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Not reported.
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Midwives randomised so low risk of con-
tamination.
Eades 2012
Methods Randomised controlled trial which aims to promote smoking cessation and relapse pre-
vention during pregnancy and postpartum
The study was conducted in 3 urban community-controlled health services in far north
Queensland and Western Australia June 2005 and December 2009
Participants Inclusion criteria: Pregnant Aboriginal or Torres Strait Islander women attending their
first AN appointment at 1 of the Aboriginal community-controlled health services at
or before 20 weeks’ gestation; were aged 16 years or older, were self-reported current
smokers or recent quitters (quitting when they knew they were pregnant); and were
residents of the local area
Exclusion criteria: Women whose pregnancy was complicated by a mental illness or
they were receiving treatment for chemical dependencies other than tobacco or alcohol
use
Recruitment: 1119/1180 women attending the AN clinic were assessed for eligibility.
263/379 (69%) eligible women agreed to participate (C = 115, I = 148)
Baseline characteristics: Median cigarettes per day: C = 10 (4-15), I = 10 (5-15);
Spontaneous quitting since pregnancy: C = 8, I = 24
100% Aboriginal and Torres Strait Islander women. Partner (C = 88%, I = 92%)
Progress + coding: Low SES and minority ethnic group.
Interventions Control: UC consisting of general advice from a GP about quitting smoking, based on
existing brief intervention guidelines
Intervention: Intervention developed after review of the literature and consultation with
service providers and community members. At first AN visit women received a scripted
invitation from the doctor to quit smoking and advised to quit ’cold turkey’ and return
to the clinic in 3-5 days and at 7-10 days. The woman received an appointment reminder
141Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Eades 2012 (Continued)
card, fridge magnet, and a letter for other household members requesting their support.
Women were asked to bring a partner or support person with them on their second
visit. Women still smoking after 7-10 days were offered NRT if no contra-indications.
Follow-up visits were conducted by female Aboriginal or Torres Strait Islander health
workers and midwives who received training from a behavioural scientist and a GP, a
study manual and a 1 page guide with scripted advice
Main intervention strategy: Counselling (tailored) compared to UC.
Intensity: Frequency (C = 0, I = 4), Duration (C = 0, I = 3). UC intensity: F = 1, D = 1
Existing staff delivered intervention: effectiveness study.
Outcomes Biochemically validated point prevalence smoking abstinence* and relapse prevention*
at 36 weeks’ gestation (late pregnancy)
Postpartum cessation (6 months) not reported due to very high rates of attrition
Notes Cluster-randomisation by weeks but number of weeks not reported. No analysis for
adjustment for clustering reported. Treated as individually-randomised controlled trial
in this review
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk An Excel computer program was used to
randomly allocate weeks to intervention or
control for all clinics
Allocation concealment (selection bias) High risk Author notes lack of allocation conceal-
ment a methodological limitation of the
study, which may account for unequal al-
location in study arms
Incomplete outcome data (attrition bias)
All outcomes
Low risk High rates of attrition (C = 37/115, I =
50/148) at end of pregnancy (reasons not
reported). Very high attrition at 6 months
postpartum. ITT analysis. Women lost to
follow-up or with missing smoking status
were classified as current smokers
Selective reporting (reporting bias) Unclear risk 6 months postpartum outcomes not re-
ported due to high attrition
Other bias High risk Unequal numbers in each group with
greater allocation to intervention groups
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported smoking cessation biochem-
ically validated using urinary cotinine (<
250 ng/mL)
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Blinding of participants and personnel
(performance bias)
All outcomes
High risk Clinic staff made aware of treatment allo-
cation at beginning of each week and un-
likely participants were blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcome assessor blinding not reported.
Incomplete implementation High risk 64% doctors adhered to protocol and a
lower proportion of nurses and health
workers
Equal baseline characteristics in study arms High risk A slightly higher proportion of interven-
tion group were in clinic 1, a slightly lower
proportion had a partner, and had recently
quit
Contamination of control group High risk SameAN care providers delivered interven-
tion and control arms. High likelihood of
contamination noted in discussion
El-Mohandes 2011
Methods This randomised controlled trial examines whether an integrated behavioural interven-
tion improves pregnancy outcomes, including smoking cessation
The study was conducted in 6 community-based clinical sites serving minority women
(African-Americans and Hispanics) in Columbia, USA, from July 2001 to July 2004
Participants Inclusion criteria: Women attending prenatal care in 6 community-based sites who self-
identified as belonging to a minority group, being >= 18 years,
< 29 weeks pregnant, a DC resident and English speaking. Had to have 1 risk factor
(smoking, ETSE, depression, and IPV). Only women reporting smoking at baseline are
included in this review
Exclusion criteria: Suicidal women.
Recruitment: 2913 women approached while waiting for prenatal appointments. 1044/
1398 (75%) eligible women provided signed consent to participate in the study (C =
523, I = 521)
302 women reported smoking ’1+ puff in the preceding 6 months and 198 reported
’active’ smoking at baseline. These 198 ’active’ smokers at baseline are included in this
analysis (C = 92, I = 106)
Baseline characteristics:
100% African American, 43.7% reliant on social housing, ~80% Medicaid recipients
Progress + coding: Minority ethnic group and low SES.
Interventions Control: Not reported-UC.
Intervention: The 10-session intervention was delivered during prenatal (eight sessions)
and postpartum (2 booster sessions) care visits. 4 prenatal sessions were considered min-
imal adherence. The session duration was approximately 35 min. The smoking inter-
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vention was consistent with the Smoking Cessation or Reduction in Pregnancy Trial
(SCRIPT) and the Counseling and Behavioral Interventions Work Group of the United
States Preventive Services Task Force recommendations, a 5-step behavioral counselling
approach. The intervention was tailored to the woman’s stage of change. Women were
encouraged to avoid triggers and to use alternative coping and behavioural change strate-
gies. The intervention included content to address both active smoking and ETSE,
whether or not they met criteria for ETSE. Women with other risk factors (IPV, depres-
sion and drug or alcohol use) also received additional targeted interventions to address
those issues
Main intervention strategy: Maternal health intervention with smoking component:
Counselling (single intervention) compared to UC
Intensity: Frequency (C = 0, I = 5), Duration (C = 0, I = 5).
Intervention provided by study staff: efficacy study.
Outcomes Biochemically validated smoking cessation prior to delivery* (late pregnancy) and at 8-
10 weeks (0-5 months*) postpartum. Mean urine cotinine*
Outcomes also reported by intervention group for environmental tobacco smoke expo-
sure, depression, intimate partner violence and illicit drug use
Detailed pregnancy outcomes reported but not included in this analysis as they were not
reported by smoking status at baseline, and these outcomes may be affected by several
of the multi-modal interventions aimed at reducing risk factors other than smoking
Notes Detailed participant satisfaction and intervention acceptability was reported in an asso-
ciated reference (Katz 2008).
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Site- and risk-specific block randomisation
to IGorUCGwas conducted. A computer-
generated randomisation scheme consid-
ered all possible risk combinations within
each of the recruitment sites
Allocation concealment (selection bias) Low risk Investigators and field workers were
blinded to the block size. Recruitment staff
at each site called in the details of the risk
profile for a new recruit, and the assign-
ment was generated centrally by the data
co-ordinating centre
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition: 104/500 (21%) prior to deliv-
ery and 116/500 (23%) in the postpartum
assessment. Participant data were analysed
according to their care group assignment,
regardless of whether they received any in-
tervention sessions, using an ITT model
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Selective reporting (reporting bias) Unclear risk Data onwomen spontaneously quitting be-
fore pregnancy were not reported
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking cessation biochemically validated
using salivary cotinine (< 10 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and providers not able to
be blinded by dedicated intervention
providers minimised risk of contamination
of study arms
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk 4 research teams were allocated to ensure
blinding of outcome assessors
Incomplete implementation High risk Process evaluation showed16%womendid
not attend any sessions, 43% randomised
womendid not complete first follow-up in-
terview and 31% did not complete 2nd fol-
low-up interview
Equal baseline characteristics in study arms Low risk No significant differences noted.
Contamination of control group Low risk Persons delivering intervention were sepa-
rate from care provider team
Ershoff 1989
Methods Randomised controlled trial of self-help booklets to support women to stop smoking in
pregnancy
Study conducted in 5 health centres of the same HMO in Los Angeles (USA), from
1985 to 1987
Participants Inclusion criteria: English-speaking women attending 1 of 5 health centres for prenatal
care, < 18 weeks’ gestation; still smoking >= 7 cigarettes a week
Exclusion criteria: Not specified further.
Recruitment: 323 who self-reported still smoking >= 7 cigarettes/week were randomised
(C = 158, I = 165). 242 included in final analysis (C = 116, I = 126). 228 women who
had spontaneously quit also included (C = 108, I = 110)
Baseline characteristics (smokers): Prepregnancy smoking: 27.3% 1-10 cigarettes/day,
14% 11-19 cigarettes/day, 58.7% 20 + cigarettes/day. At intake: 71.9% 1-10 cigarettes/
day, 14.9% 11-19 cigarettes/day, 13.2% 20 + cigarettes/day. Spontaneous quitters: mean
pre-pregnancy cigarettes/day = 10.3
Smokers: 64% white, 73% had high school or some college education, 59.9% married
Progress + coding: None.
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Interventions Control: 2-page pamphlet on hazards of smoking and on the need to quit; 2 mins
discussion with a health educator (within a 45 mins individual conference); advised of
free 5 session smoking cessation program available through the HMO. Coverage in AN
classes remained unchanged.
Intervention: As for the control group + first of series of 8 self-help booklets aimed to
increase motivation for quitting; teach behavioural strategies for cessation and relapse
prevention; 3 mins introduction to these by health educator; asked to make a commit-
ment to read the first 1 and list reasons for not smoking; others mailed weekly. Booklets
were pregnancy-specific, multi-ethnic, and at a 9th Grade reading level
Main intervention strategy: Counselling (single intervention) compared to less inten-
sive intervention
Intensity: Frequency (C = 6, I = 6), Duration (C = 4, I = 4). Estimate based on uptake
of optional HMO sessions x 5 approximately 20-40 mins
Intervention provided by existing health staff: effectiveness study
Outcomes Biochemically validated abstinence at 34 weeks’ gestation (late pregnancy*)
Ershoff 1995 reports relapse prevention* among women who had spontaneously quit
Ershoff 1990 reports birth outcomes (mean birthweight*, LBW*, preterm birth* (< 37
weeks), very preterm birth (< 34 weeks), stillbirths*, ’confidence in ability to quit’ and
cost outcomes (economic evaluation)
Associated reference (Mullen 1991) describes question structure’s to improve accurate
disclosure of smoking status
Notes SDs for mean birthweight were not reported, therefore we calculated a mean SD from 13
studies with available birthweight SDs (578) to include in this review, as recommended
by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information
Allocation concealment (selection bias) High risk The authors state that women had been
randomised in advance of their visit. It was
not clear how women were recruited to the
study or gave consent for participation.The
health educator turned over a ’pre-assigned
card’ to randomise women
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Smokers: Attrition I = 39/165, C = 44/158
not included in analysis. Losses due to ter-
mination (C = 11, I = 7); miscarriage (C
= 13, I = 12); disenrolment or transfer to
another HMO (C = 18, I = 20)
Spontaneous quitters: Attrition 22% -
Abortion (n = 5), miscarriage (n = 17), dis-
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enrolment from HMO or transfer (n = 25)
Not re-included in analysis for this review
as excluded for medical reasons or moving
Selective reporting (reporting bias) Unclear risk None apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation by urinary cotinine
levels. For participants reporting no smok-
ing and low exposure to passive smoke
urine cotinine had to be less than or equal
to 10 ng/mL. For participants reporting a
relapse and high exposure to passive smoke
some values could be as high as 29 ng/mL
though at least 1 sample had to be 10 ng/
mL or less
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk The authors state that the health educator
delivering the intervention was not aware
of group allocation, but materials were pro-
vided to the experimental group at the
clinic visit. Prenatal care providers were
blinded to group assignment and no effort
was made tomodify their usual counselling
practices
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Process evaluation reports good implemen-
tation.
Equal baseline characteristics in study arms Unclear risk With the exception of partners smoking
status.
Contamination of control group Low risk Prenatal care providers not involved in in-
tervention so risk of contamination likely
to be low
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Methods 3-armed randomised controlled trial of interactive computer program and telephone
counselling to support women to stop smoking in pregnancy
Study conducted in a large group model managed care organisation in Los Angeles,
California (USA) with recruitment from November 1996 to June 1997
Participants Inclusion criteria: Smokers were identified at first visit as women who self-report “smok-
ing now”, “smoke but have cut down since pregnancy”, or “smoke from time to time”
Exclusion criteria: < 18 years of age, > 26 weeks’ gestation, do not speak English, or
smoked less than 7 cigarettes pre-pregnancy
Recruitment: Researchers attempted to phone 931 women. 150 could not be contacted,
90 refused to be interviewed, 158 were not eligible and 34 were excluded as they expe-
rienced miscarriage (n = 34). 390/458 women (82%) agreed to participate (C = 131,I1
= 133, I2 = 126).
Baseline characteristics: Pre-pregnancy mean cigarettes per day: C = 17.1 (9.7), I1 =
17.6 (9.8), I2 = 16.3 (7.6). Mean cigarettes per day at intake: C = 6.6(7.3), I1 = 6.7(6.
5), I2 = 6.3(6.5).
60% white, approximately 50% college educated, with a mean age of 29.4. Mean
cigarette/day at first visit = 6.6
Progress + coding: None.
Interventions 3 interventions, based on stages of change model.
A: Control: Received a 32-page self-help booklet “living smoke-free”.
B: Intervention 1 (interactive computer program-IVR): received the same self-help
booklet and had access to a computerised interactive telephone support system, which
provided customised messages from a voice model. Participants responded to questions
using a touch-tone keypad.
C: Intervention 2 (MI): received the same self-help booklet and 4-6 x 10-15 min
telephone counselling sessions by nurse educators trained inMI. A personalised postcard
sent to reinforce verbal communication
Main intervention strategy: Health education (tailored intervention) compared to a
less intensive intervention (self-help booklet). This study ID compares arms A and B,
see Ershoff 1999 (AvC) for A and C.
Intensity: Frequency (C = 2, I = 2), Duration (C = 1, I = 1).
Intervention provided by study staff: efficacy study.
Outcomes Biochemically validated smoking cessation at 34weeks’ gestation (late pregnancy*).Mean
cigarettes per day*
Baseline mental health index and Cohen’s perceived stress scale.
Number of quit attempts and movement in stages of change.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “random assignment”
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Allocation concealment (selection bias) Unclear risk No information.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition 58/390 (14.87) due to abortion
(n = 31), disenrolment from health plan (n
= 22) and preterm birth less than 32 weeks
(n = 5). Lost to follow-up not included as
continuing smokers in analysis as attrition
due to medical reasons and moving not re-
included in this review, and attrition from
each study group not reported separately.
332 included in analysis (C = 111, I1 = 120,
I2 = 101)
Selective reporting (reporting bias) Unclear risk Results were difficult to interpret.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation by urinary cotinine
levels (< 80 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Authors state that care providers were blind
to group allocation. Educational interven-
tion so blinding women not feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete implementation Low risk Good process evaluation of each of the
methods. 79.2% received at least 1 call.
Mean 4 calls lasting 12 mins each
Equal baseline characteristics in study arms Low risk No significant differences reported.
Contamination of control group High risk 11% control group received individual
smoking cessation counselling as they were
classified as high-risk patients
Ershoff 1999 (AvC)
Methods 3-armed randomised controlled trial of interactive computer program and telephone
counselling to support women to stop smoking in pregnancy
Study conducted in a large group model managed care organisation in Los Angeles,
California (USA) with recruitment from November 1996 to June 1997
Participants Inclusion criteria: Smokers were identified at first visit as women who self-report “smok-
ing now”, “smoke but have cut down since pregnancy”, or “smoke from time to time”
Exclusion criteria: < 18 years of age, > 26 weeks’ gestation, do not speak English, or
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smoked less than 7 cigarettes pre-pregnancy
Recruitment: Researchers attempted to phone 931 women. 150 could not be contacted,
90 refused to be interviewed, 158 were not eligible and 34 were excluded as they expe-
rienced miscarriage (n = 34). 390/458 women (82%) agreed to participate (C = 131,I1
= 133, I2 = 126).
Baseline characteristics: Pre-pregnancy mean cigarettes per day: C = 17.1 (9.7), I1 =
17.6 (9.8), I2 = 16.3 (7.6). Mean cigarettes per day at intake: C = 6.6(7.3), I1 = 6.7(6.
5), I2 = 6.3(6.5).
60% white, approximately 50% college educated, with a mean age of 29.4. Mean
cigarette/day at first visit = 6.6
Progress + coding: None.
Interventions 3 interventions, based on stages of change model.
A: Control: Received a 32-page self-help booklet “living smoke-free”.
B: Intervention 1 (interactive computer program-IVR): received the same self-help
booklet and had access to a computerised interactive telephone support system, which
provided customised messages from a voice model. Participants responded to questions
using a touch-tone keypad.
C: Intervention 2 (MI): received the same self-help booklet and 4-6 x 10-15 min
telephone counselling sessions by nurse educators trained inMI. A personalised postcard
sent to reinforce verbal communication
Main intervention strategy: Counselling (single intervention) compared to a less in-
tensive intervention (self-help booklet). This study IDI compares arms A and C, please
see Ershoff 1999 (AvB) for A and B
Intensity: Frequency (C = 2, I = 5), Duration (C = 1, I = 3).
Intervention provided by study staff: efficacy study.
Outcomes Biochemically validated smoking cessation at 34weeks’ gestation (late pregnancy*).Mean
cigarettes per day*
Baseline mental health index and Cohen’s perceived stress scale.
Number of quit attempts and movement in stages of change.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “random assignment”
Allocation concealment (selection bias) Unclear risk No information.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition 58/390 (14.87) due to abortion
(n = 31), disenrolment from health plan (n
= 22) and preterm birth less than 32 weeks
(n = 5). Lost to follow-up not included as
continuing smokers in analysis as attrition
due to medical reasons and moving not re-
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included in this review, and attrition from
each study group not reported separately.
332 included in analysis (C = 111, I1 = 120,
I2 = 101)
Selective reporting (reporting bias) Unclear risk Results were difficult to interpret.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation by urinary cotinine
levels (< 80 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Authors state that care providers were blind
to group allocation. Educational interven-
tion so blinding women not feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete implementation Low risk Good process evaluation of each of the
methods. 79.2% received at least 1 call.
Mean 4 calls lasting 12 mins each
Equal baseline characteristics in study arms Low risk No significant differences reported.
Contamination of control group High risk 11% control group received individual
smoking cessation counselling as they were
classified as high-risk patients
Gielen 1997
Methods Randomised controlled trial of counselling and a self-help guide to support women to
stop smoking during pregnancy
Study conducted in Baltimore (USA). Study dates not reported
Participants Inclusion criteria: Pregnant women currently smoking (even 1 puff in the past 7 days)
, either African-American or white
Exclusion criteria: > 28 weeks’ gestation; changing to another prenatal clinic or could
not complete baseline interview
Recruitment: 2319 women assessed, 32% currently smoking by above definition. 72
were excluded for gestation, ethnicity or changing providers, leaving 662 eligible of
whom 510 agreed to participate (77%). 25 quit prior to first visit, 18 did not wish to
quit, leaving 467 (C = 235, I = 232) randomised
Baseline characteristics: Mean cigarettes/day at intake I = 9.7, C = 7.5 (P = 0.01).
85% were on medical assistance. African American: I = 81% C = 89%
Progress + coding: Low SES and ethnic minority population.
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Interventions Control: Usual clinic and inpatient smoking cessation: A brief discussion with a nurse/
health counsellor about the risks of smoking; a recommendation to quit and pamphlets
from the area’s voluntary agencies.
Intervention: Peer health counsellors recruited from local communities, received 2 ses-
sions training from PIs who explained content, rationale and how it was to be provided,
then observed in practice by PIs with feedback to her.
(i) A Pregnant Woman’s Guide to Quit Smoking (RA Windsor), 6th Grade level.
(ii) 15 mins 1:1 counselling session with peer health counsellor on how to use the Guide,
showing how it is organised to be used daily, and discussing women’s thoughts and
concerns about quitting, targeting cessation or relapse prevention, as appropriate.
(iii) Educational materials for cessation support persons included with the Guide.
(iv) Reinforcement at each clinic visit from doctors and nurses, written prescription to
stop smoking provided directly from doctor to woman; 2 letters of encouragement (from
the doctor and the counsellor) mailed to the woman 1-2 weeks after her first visit
Main intervention strategy: Counselling (multiple intervention) compared to UC.
Intensity: Frequency (C = 0, I = 6), Duration (C = 0, I = 2). UC intensity F = 1, I = 1
Intervention provided by study staff: Efficacy study.
Outcomes Biochemically validated 7-day point prevalence abstinence in hospital after delivery (late
pregnancy*), 6 (6-11*)months postpartumabstinence, and> 50% reduction in cotinine*
from baseline to late pregnancy interview.
Smoking cessation data collected at 3 months but not reported
Notes Guide developed through needs assessment with pregnant women, constructs from the
PRECEDE/PROCEED diagnosis and social learning theory, tested with focus groups,
additional section on relapse prevention, and on passive smoking postpartum.
Results show high rate of misclassification by self-report (I = 37%, C = 48%)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided.
Allocation concealment (selection bias) Unclear risk Described as “randomly assigned”.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 16.3% attrition due to miscarriage, termi-
nation and change of care provider (C = 37,
I = 34). 145/391 (37%) remaining women
did not provide saliva samples and were
treated as smokers in the analysis but those
lost to follow-up for other reasons were ex-
cluded from the analysis in reports and in
this review
6* months postpartum abstinence was col-
lected and only small sample of 6-month
data reported (C = 48, I = 46), however all
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missing data included as continuing smok-
ers in this review
Selective reporting (reporting bias) High risk Threemonth postpartum outcomes not re-
ported andminimal follow-up for 6-month
postpartum data
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-report of ’not even a puff in past 7 days’
biochemically validated by salivary cotinine
< 30 ng/mL
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Process evaluation showing good imple-
mentation.
Equal baseline characteristics in study arms Unclear risk Women in control group reported signif-
icantly fewer cigarettes per day and more
likely to be African-American
Contamination of control group High risk Same care providers delivering intervention
who were providing care to control group
Glover 2014 (AvB)
Methods This 3-armed randomised controlled trial, of voucher distribution aimed to investigate if
pregnant indigenous NZ women who smoke, were more likely to abstain from smoking
if given products or vouchers. This study was conducted amongst self-identified Maori
women in Auckland, NewZealand with recruitment occurring betweenDecember 2012
and June 2013
Participants Inclusion criteria: > 16 years, self-identified as Maori, residing in the Auckland region,
are 2-30 weeks pregnant and are daily smokers
Exclusion criteria: If they were no longer smoking daily or if they were participating in
any other smoking trials
Recruitment: Only 32% (24/74) participation rate, (A = 8 B = 8 C = 8) Women were
identified through independentmidwives,GP clinics, the district health board,maternity
services, a Facebook page, pamphlets and flyers, radio and newspaper articles
Baseline characteristics: Mean cigarettes per day- 9, First cigarette within 5 mins of
waking up - 46%, Mean Age- 25 years, Single (A = 38%, B = 38%, C = 25%)
Progress + coding: Low SES
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Interventions A: Control: A less intensive intervention, where participants were provided with cessa-
tion support, including information about different cessation products and services. In
addition, the research assistant was a trained Quit Card (for accessing heavily subsidised
NRT) provider
B: Intervention 1: For the voucher condition participants were provided with a $25
voucher from Farmers Trading Company, a general department store with branches
throughout NZ that does not stock artificial infant food, alcohol or cigarettes
C: Intervention 2: Product participants were able to choose from 24 different products
packs. If they were abstinent for all 8 weeks they were eligible to receive products to the
value of NZ$200
Main Intervention Strategy: Smoking Cessation Intervention: Incentives (single) v Less
intensive intervention. Arms A and B are compared in this study ID
Intensity: Frequency (C = 6 I = 6) Duration (C = 1 I = 4)
Outcomes Continuous (weekly) biochemically validated abstinence for 8 weeks in late pregnancy*
(exhaled CO < 7 ppm), mean weekly self-reported smoking status
Notes Thiswas a feasibility study andmany of the variableswere regarding thewomen’s financial
situation and use of cessation products and services during the intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Immediately after baseline data had been
recorded, participants were randomised in
a 1:1 ratio to 1 of 3 arms using envelope
randomisation prepared by a statistician
Allocation concealment (selection bias) Unclear risk Not clear whether the envelope used for
randomisation was opaque
Incomplete outcome data (attrition bias)
All outcomes
Low risk Dropouts were assumed to have relapsed
back to smoking.
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking was biochemically validated, par-
ticipants were considered to be smokers if
they reported smoking during the previous
week or if they had a COmeasure < 7 ppm
for 1 month
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear, as the research assistant collecting
outcome data and research administrator
were not blinded to treatment allocation
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Participants and the research assistant
(RA) collecting the outcome data and re-
search administrator were not blinded to
treatment allocation, but the researchers
analysing the data were
Incomplete implementation High risk Only 37.5% retention rate.
Equal baseline characteristics in study arms Low risk Baseline characteristics seemed equal in all
3 study arms.
Contamination of control group Low risk Main intervention strategies were provision
of vouchers.
Glover 2014 (AvC)
Methods This 3-armed randomised controlled trial, of voucher distribution aimed to investigate if
pregnant indigenous NZ women who smoke, were more likely to abstain from smoking
if given products or vouchers. This study was conducted amongst self-identified Maori
women in Auckland, NewZealand with recruitment occurring betweenDecember 2012
and June 2013
Participants Inclusion criteria: > 16 years, self-identified as Maori, residing in the Auckland region,
are 2-30 weeks pregnant and were daily smokers
Exclusion criteria: If they were no longer smoking daily or if they were participating in
any other smoking trials
Recruitment: Only 32% (24/74) participation rate, (A = 8 B = 8 C = 8) Women were
identified through independentmidwives,GP clinics, the district health board,maternity
services, a Facebook page, pamphlets and flyers, radio and newspaper articles
Baseline characteristics: Mean cigarettes per day- 9, First cigarette within 5 mins of
waking up- 46%, Mean Age - 25 years, Single (A = 38%, B = 38%, C = 25%)
Progress + coding: Low SES.
Interventions A: Control:A less intensive intervention, where participants were provided with cessa-
tion support, including information about different cessation products and services. In
addition, the research assistant was a trained Quit Card (for accessing heavily subsidised
NRT) provider
B: Intervention 1: For the voucher condition participants were provided with a $25
voucher from Farmers Trading Company, a general department store with branches
throughout NZ that does not stock artificial infant food, alcohol or cigarettes
C: Intervention 2: Product participants were able to choose from 24 different products
packs. If they were abstinent for all 8 weeks they were eligible to receive products to the
value of NZ$200
Main Intervention Strategy: Smoking Cessation Intervention: Incentives (single) v Less
intensive intervention. Arms A and C are compared in this study ID
Intensity: Frequency (C = 6 I = 6) Duration (C = 1 I = 4).
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Outcomes Mean weekly self-reported smoking status, Continuous biochemically validated absti-
nence for 8 weeks*
Notes Thiswas a feasibility study andmany of the variableswere regarding thewomen’s financial
situation and use of cessation products and services during the intervention
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Immediately after baseline data had been
recorded, participants were randomised in
a 1:1 ratio to 1 of 3 arms using envelope
randomisation prepared by a statistician
Allocation concealment (selection bias) Unclear risk Not clear whether the envelope used for
randomisation was opaque
Incomplete outcome data (attrition bias)
All outcomes
Low risk Dropouts were assumed to have relapsed
back to smoking.
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking was biochemically validated, par-
ticipants were considered to be smokers if
they reported smoking during the previous
week or if they had a COmeasure < 7 ppm
for 1 month
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear, as the research assistant collecting
outcome data and research administrator
were not blinded to treatment allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Participants and the research assistant
(RA) collecting the outcome data and re-
search administrator were not blinded to
treatment allocation, but the researchers
analysing the data were
Incomplete implementation High risk Only 37.5% retention rate.
Equal baseline characteristics in study arms Low risk Baseline characteristics seemed equal in all
3 study arms.
Contamination of control group Low risk Main intervention strategies were provision
of vouchers.
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Methods This randomised controlled trial aimed to measure the effectiveness of home-based
visiting from trained lay-persons to reduce LBW.
The study was conducted in the prenatal clinic of a university hospital in Cleveland,
USA, from March 1987 to September 1989
Participants Inclusion criteria: Living within 5-mile radius of clinic, 17-28 weeks’ gestation, ‘low’
family function rating, at least 1 stressful life event during pregnancy, and additional risk
factors such as smoking, low maternal weight-height ratio, aged over 27 years, or history
of a previous premature baby
Exclusion criteria: White patients, difficulty reading English.
Recruitment: Every person registering at clinic was eligible to be screened. The first 105
screened participants were dropped from the study when it was found that they had
difficulty reading the questions. 1326 women screened. 1022 ‘low risk, 190 ‘high risk’
women - of which 145 were randomised (I = 87, C = 58). 8.5% of low risk and 15%
high risk women were smokers
Baseline characteristics: Smoking characteristics not reported.
Predominantly black, poor, inner city population.
No progress plus coding as outcomes not able to be included in this review
Interventions Control: Routine care from obstetrical staff in the clinic.
Intervention: 2 non-professional black women who demonstrated rapport with women
served as home-visitors and were trained in childbirth education, community resources,
and nutrition during pregnancy. 4 x 1 hour home visits occurred at 4-6 week intervals.
The home visitors followed a protocol which included psychosocial support, efforts at
stress reduction, information on health risks (especially smoking and drinking), nutrition
education, and a small gift
Main intervention strategy: Not coded as outcomes not included in this review.
Provided by study staff: efficacy study.
Outcomes Smoking outcomes were not able to be included in this review as it is unclear how many
smokers were included in each study arm. LBW was the primary outcome for this study,
but was not included in this review, as aspects other than the smoking component of
the intervention may have had an effect on birthweight. See Table 1 for summary of
outcomes not able to be included in this meta-analysis
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Table of random numbers.
Allocation concealment (selection bias) Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
High risk 24/87 dropped out and unclear if included
in analysis. 7 refused intervention, 11 could
not be contacted, 5 transferred care, 1 mis-
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carried prior to visit
Numbers reported as randomised different
in abstract (154) and flow chart (145)
Selective reporting (reporting bias) Unclear risk Unclear if selective reporting as smoking
cessation was not the primary aim of the
intervention
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Not applicable. Smoking outcomes not re-
ported.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women and home visitors not blinded, as
would be expected in an educational inter-
vention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed only 63/87
women received home visits
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Home visiting intervention so risk contam-
ination of control group is low
Haddow 1991
Methods Randomised controlled trial of providing feedback on cotinine to support women to
stop smoking in pregnancy and reduce LBW
Study conducted in physicians offices and clinic sites within Maine (USA) from 1984
to 1987
Participants Inclusion criteria: Pregnant women with a singleton live pregnancy; having maternal
serum AFP screening at 15-20 weeks’ gestation; who smoked >= 10 cigarettes a day
Exclusion criteria: Not further specified.
Recruitment: Physicians approached (no consent from women). 25,628 women com-
pleted maternal serum screening form, 97% answered question on smoking and 17%
smoked >= 10 cigarettes/day. 2848 women were randomised (C = 1425, I = 1423)
Baseline characteristics:Mean cigarettes/day at baseline: C = 16.3, I = 16.1
Maternal education (mean years): C = 11.8, I = 11.9.
Progress + coding: None.
Interventions Control: Standard medical care not otherwise specified.
Intervention: Report on cotinine generated for her physicianwith interpretation relating
smoking level to birthweight. Physician explained this to the woman and also gave her a
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copy of the report and a pregnancy-specific booklet about how to quit, using the cotinine
information also + repeat measure 1 month later, 2 copies to physician, comparison of
1st and 2nd cotinine, report commenting on the change and its interpretation
Main intervention strategy: Feedback (multiple intervention) compared to UC.
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 2). UC intensity: F = 0, I = 0
Intervention provided by existing staff: Effectiveness study
Outcomes No smoking cessation data. Smoking data limited to comparability at first assessment
and mean serum cotinine levels, which could not be included as they are disaggregated
by low and high study site participation
Mean birthweight*; low* and very low* birthweight; preterm birth* (< 37 weeks); still-
births (> 20 weeks)*; neonatal deaths*; postneonatal deaths
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers.
Allocation concealment (selection bias) Unclear risk Information not provided.
Incomplete outcome data (attrition bias)
All outcomes
High risk 2700/2848 (94.8%) included in analysis.
3% lost to follow-up and 2% multiple
gestations or fetal deaths. Only 695/1343
(48%) women in the intervention groups
provided repeat serum cotinine for com-
parison.No ITT analysis. No smoking out-
comes reported and unable to re-include
data for mean cotinine and birth outcomes
Selective reporting (reporting bias) High risk Results difficult to interpret. Smoking ces-
sation not recorded
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Serum cotinine measurement at baseline
for both the experimental and comparison
groups but it was not clear that any follow-
up measurements were made for the com-
parison group
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Caregivers aware of group allocation. Ex-
perimental group given feedback on serum
cotinine levels
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed less than good
implementation with differential impact
on perinatal outcome by completeness with
second blood samples taken for cotinine
measurement
Equal baseline characteristics in study arms Low risk Intervention groups similar at trial entry.
Contamination of control group Low risk Intervention not provided by care provider.
Hajek 2001
Methods Cluster-randomised controlled trial of a brief midwife-delivered intervention to support
women to stop smoking in pregnancy
Study conducted in 9 hospital and community trusts in the UK. Years of data collection
not reported
Participants 290 midwives randomised to provide intervention or control care
Inclusion criteria:Pregnant women currently smoking or stopped within the last 3
months
Exclusion criteria: Not further specified.
Recruitment: Women were recruited at first visit (approximately 12 weeks’ gestation)
. Estimated 8700 eligible women. Only 178/290 (61%) midwives (C = 86, I = 92)
recruited any women. Financial incentives were paid to boost recruitment. 1287 women
provided informed consent
Baseline characteristics: Current smokers (C = 440, I = 441); Spontaneous quitters (C
= 135, I = 114). 189 current smokers were assessed as ’not motivated to stop’ therefore
received no intervention. Mean cigarettes/day: Smokers (C = 9.7, I = 10.1), Ex-smokers
(C = 10.9, I = 12.6)
> 70%married, 26%-27% smokers and 10%-15% ex-smokers had no educational qual-
ifications
Progress + coding: None.
Interventions Control: Midwives received 1 hour of training to discuss the study and were asked to
provide UC and any usual pamphlets
Intervention:Midwives received 2 hours training which included using the COmonitor
and providing ’stage of change’ based advice, CO assessments. Intervention group also
received written advice and motivational materials for current and recent smokers, in-
cluding designating a ’quit date’, a ’quiz’ and the offer of ’buddying’ to another pregnant
smoker for support
Main intervention strategy: Counselling (tailored) compared to UC.
Intensity: Frequency (C = 0, I = 5), Duration (C = 0, I = 2).
Intervention provided by routine midwives: Effectiveness study
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Outcomes Biochemically validated point prevalence abstinence at birth (late pregnancy*), relapse
prevention*, and self-reported continuous abstinence at 6 (6-11) months postpartum
among baseline smokers* and spontaneous quitters.
Birthweight for smokers and ex-smokers reported, but not by intervention group so not
included in this review
Participants and midwives views of interventions reviewed.
Notes Clustering effect not reported, so sensitivity analysis conducted using 4 ICCs and out-
come figures adjusted using conservative intracluster correlation of 0.1
Discussion of barriers includes 65% of midwives reporting the intervention could not
be undertaken in the time they had available. Sample size justification
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Cluster-randomisation of midwives ade-
quate. Consecutive names on a list of mid-
wives
Allocation concealment (selection bias) Unclear risk Midwives randomised.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 167/1287 (12.9%) (C = 83, I = 84) ex-
cluded from analysis due to moving away,
being untraceable or deemed unsuitable
for follow-up (e.g. miscarriage). 1120 in
sample. 51/1287 non-responders were in-
cluded as continuing smokers
Selective reporting (reporting bias) Unclear risk Unclear if all outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation by expiredCO<10
ppm.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Midwives aware of allocation group. Edu-
cational intervention. Blinding women not
feasible
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessment not re-
ported. Not blinded if performed by mid-
wives
Incomplete implementation High risk Process evaluation showed poor implemen-
tation in some areas.
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Equal baseline characteristics in study arms High risk Control group slightly more interested in
quitting smoking and less nicotine depen-
dent
Contamination of control group Low risk Cluster trial design tominimise risk of con-
tamination.
Harris 2015
Methods A 2-armed single randomised controlled trial of a web-based contingency management
program; Motiv8. This study was conducted in Rural Appalachia, Ohio and Kentucky
on a community sample of pregnant smokers, recruited from prenatal clinics
Participants Inclusion criteria: Adults aged 18 years and older, daily smokers (reporting smoking at
least 2 cigarettes per day verified by breath CO readings and urinary cotinine levels), and
were <= 12 weeks pregnant
Exclusion criteria: Not stated.
Recruitment: 47% participation rate (C = 10 I = 7).
Baseline characteristics: Nicotine dependence (modified Fagerstroms test) (C = 4.90 I
= 5.71), Cigarettes per day (C = 13.69 I = 9.45) Mean Age (C = 24.20 I = 24.00)
Progress + coding: Low SES.
Interventions Control: Intensive phone delivered cessation counselling program based on Smoking
Cessation for Healthy Births (SCHB)
Intervention: TheMotiv8 program lasted 6 weeks and consisted of 5 phases: Baseline (7
days), Shaping (4 days), Abstinence (21 days), Thinning (5 days), and Return to Baseline
(5 days). During each phase, participants submitted video recordings of themselves twice
per day (at least 8 hours apart) giving breath samples using the Smokerlyzer. They could
earn vouchers exchangeable for online purchases with major retailers (e.g. Best Buy, Wal-
Mart) for criterion breath samples based on program phase. For the Abstinence phase,
participants were required to have breath CO levels <= 4 ppm
Main Intervention strategy: Incentives (single) v alternative Intervention
Intensity: Frequency (C = 4, I = 6) Duration (C = 4, I = 4).
Intervention provided by study staff: efficacy study
Outcomes Biochemically validated smoking abstinence in late pregnancy*, Smoking reduction by
50% urine cotinine levels*
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Reporting smoking at least 2 cigarettes per
day verified by breath CO readings and uri-
nary cotinine levels
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Allocation concealment (selection bias) Low risk As randomisation was done by computer,
allocation of participant to control or in-
tervention would have been concealed
Incomplete outcome data (attrition bias)
All outcomes
Low risk Any missing data were coded as non absti-
nent/reduction.
Selective reporting (reporting bias) Low risk All outcomes are reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking was biochemically validated by
breath CO levels <= 4 ppm and urinary co-
tinine levels
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Blinding did not seem to occur as physician
and participant would know which arm of
the trial they were in
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk This was not described.
Incomplete implementation High risk Only 68%of interventionparticipants pro-
vided the required breath samples at fol-
low-up and in control, phone counsellors
provided on average 3.9 of the required 5
phone calls
Equal baseline characteristics in study arms Low risk Baseline characteristics in both arms appear
equal.
Contamination of control group Low risk Intervention and control were either deliv-
ered via the web or mobile phone so con-
tamination very unlikely
Hartmann 1996
Methods Randomised controlled trial of self-help materials and health education to support
women to stop smoking in pregnancy
Study conducted in a teaching hospital (academic) clinic in North Carolina, USA from
August 1991 to January 1993
Participants Inclusion criteria: Pregnant women who smoke.
Exclusion criteria: > 36 weeks’ gestation, psychiatric diagnosis.
Recruitment: 842/846 (99%) women attending the clinic completed survey and 793/
846 provided a CO breath sample.; 2 were excluded as > 36 weeks’ gestation; 1 for
psychiatric diagnosis; leaving 266 (32%) eligible smokers (smoked at least once in the
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prior week). 12 refused, 4 were missed, 2 were not pregnant and 1 was a private patient.
247 women randomised
Baseline characteristics: Mean cigarettes/day (C = 14.4, I = 13.5), Want to quit (C =
81%, I = 84%). Smokers in household (C = 75%, I = 78%)
White (C = 74%, I = 78%), Single (C = 44%, I = 47%), < 12 yrs education (C = 43%,
I = 48%)
Progress + coding: Low SES.
Interventions All 1- to 4-year residents given didactic and role play training for smoking cessation
counselling, including self-assessment of current techniques and skills, which they were
asked to continue with for the control group.
Control: Standard care; residents reminded not to alter amount or time of this; help
was provided if woman sought it and prenatal classes included discussion of substance
abuse, including cigarettes.
Intervention: (i) residents provided counselling at each visit, and a brief script aimed
at setting a quit date or negotiated an alternative assignment such as a smoking diary at
every contact;
(ii) given Windsor’s self-directed 7-day smoking cessation guide;
(iii) quit date patients given written prescription to quit, letter of support from doctor,
contacted by volunteer smoking cessation counsellor to review the quit plan and encour-
age follow-through charts flagged, prompts with flow sheet, most recent CO and self-
report included for care provider;
(iv) successful quitters sent an encouraging postcard each week
Main intervention strategy: Counselling (multiple intervention) compared to UC.
Intensity: Frequency (C = 0, I = 6), Duration (C = 0, I = 2). UC intensity: F = 1, D = 1
Intervention provided by existing staff: Effectiveness study
Outcomes Biochemically validated abstinence at last prenatal visit (late pregnancy*). > 50% reduc-
tion in self-reported smoking*, mean cigarettes per day*
Cost-effectiveness data reported.
Notes SDs for mean cigarettes per day were not reported, therefore we calculated a mean SD
from 14 studies with available mean cigarette SDs (6.5) to include in this review, as
recommended by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers.
Allocation concealment (selection bias) High risk State that neither the enrolling nurse nor
the patient were aware of allocation, but
experimental group notes were flagged
Incomplete outcome data (attrition bias)
All outcomes
High risk Attrition 40/247 (16%) (4 miscarriages
first trimester, 3 miscarriages second
trimester, 3 terminations, 15 moved to al-
164Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Hartmann 1996 (Continued)
ternative care, and12 lost to follow-up) 207
included in analysis (C = 100, I = 107).
Those lost to follow-up not able to be re-
included in analysis in this review as num-
bers not reported by study arm
Selective reporting (reporting bias) Unclear risk Not apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Exhaled CO measured at each visit for the
experimental group and at 3 visits for the
comparison group. < 5 ppm counted as
non-smokers
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Case notes flagged. States patient not aware
of randomisation status
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk No process evaluation reported.
Equal baseline characteristics in study arms Low risk No significant differences noted.
Contamination of control group High risk Concerns about residents having to treat
similar/consecutive patients differently,
and self-help manuals accidentally given to
some controls. Discussion section reports
evidence of contamination with self-help
materials being given to controls
Haug 1994
Methods Cluster-randomised controlled trial of brief GP counselling to support women to stop
smoking in pregnancy and prevent relapse postpartum
Study conducted in Western Norway from November 1986 to November 1987
Participants Inclusion criteria: No indications of serious social or medical problems, living with a
partner, and smoking at least 5 cigarettes per day before pregnancy and still smoking at
least 1 cigarette per day at the first checkup
Exclusion criteria: Not further specified.
Recruitment: All 398 GPs in western Norway were invited by mail to participate in
the study. 187 participating GPs were asked to recruit 4 pregnant and 4 non-pregnant
women for the study, at the first checkup in the first trimester. 1/3 pregnant and non-
pregnant women ended up in control groups. The GPs who recruited pregnant women
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for the intervention groups recruited non-pregnant women for the control groups. 2379
pregnant women screened, 674 fulfilled inclusion criteria, 144 refused to participate
(21%). 530 pregnant women were randomised (unclear how many each group)
Baseline characteristics:Mean age starting smoking 27.6, mean cigarettes per day = 9.5
Mean age 25.9. 18-34 years of age, all living with a partner
Progress + coding: None.
Interventions Control: Ordinary control programme during pregnancy and for first year after delivery
(UC)
Intervention: (i) < 15 mins GP consultation at initial visit about hazards of smoking,
how to stop and how to avoid relapse; (ii) information about problems related to ’the
smoking fetus’; (iii) delivered with aid of a 5-page ’flip-over’; (iv) 8-page booklet. Women
invited to consult their GPs after 1, 6, 12 and 18 months to discuss their smoking habits
Main intervention strategy: Counselling (multiple intervention) compared with UC.
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 1). UC intensity: F = 0, D = 0
Intervention provided by existing staff (GPs): Effectiveness study
Outcomes Self-reported abstinence 6 months after study entry (late pregnancy*), biochemically
validated at 12 months after study entry (0-5 months postpartum*), self-reported absti-
nence 15 (6-11 months postpartum*) and 18 months after study entry (12-17 months
postpartum*)
Self-reported reduction and increase in smoking. Mean cigarettes/day and mean thio-
cyanate (not included as only reported by smoking status at 18 months postpartum)
An associated reference (Haug 1992) reports results of a survey of GPs delivering the
intervention
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk GPs described as randomly allocated.
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk 180/530 dropped out due to spontaneous
abortions (24), serious complications (8),
moved to another district (31) or for other
unknown reasons (117). Only 350/530 (C
= 98, I = 252) included in analysis and we
were unable to re-include those lost to fol-
low-up for other reasons in this review as
theywere not reported by group allocation.
Further dropouts not explained (C = 97
and I = 244 in outcome tables-re-included
in this review as continuing smokers)
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Selective reporting (reporting bias) Unclear risk Not clear if biochemically validated out-
comes reported.
Other bias High risk Unequal recruitment to study arms (higher
recruitment in intervention arms)
Biochemical validation of smoking absti-
nence (detection bias)
High risk Biochemical validation of smoking only at
study entry and after 12 months (urinary
thiocaynate).Unclear if thosewhohadhigh
thiocaynate levels were considered smok-
ers. No cut-off levels reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk 59% residents did not document consulta-
tion. 1 component dropped
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group High risk Same providers asked to provide control
and intervention arms for pregnant and
non-pregnant women
Haug 2004
Methods Randomised controlled trial of motivational enhancement therapy to support women
to stop smoking in pregnancy
Dates of research and location not stated. Assume USA from author affiliations
Participants Inclusion criteria: Opioid-dependent women, <= 26 weeks’ gestation, receiving meth-
adone, currently smoking at least 5 cigarettes per day, enrolled in hospital prenatal pro-
gram.
Exclusion criteria: Not further specified.
Recruitment: During first 48 hours of 7-day residential program. 77 women ran-
domised. 14 women excluded from analysis due to miscarriage, abortion, premature
delivery and miscalculated gestational age. 63 included in analysis (I = 30, C = 33)
Baseline characteristics: Mean cigarettes per day 19.9 (SD 11.5).
Approximately 50% had lifetime major depressive disorder, 32% were depressed in
last month, and 39% had anxiety disorder. 84% African American, 79% single, 97%
unemployed. 94% had less than high school education. Not coded for equity analysis as
outcomes not able to be included in this review
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Interventions Control: Health practitioner advice by trained research staff and printed materials from
American Lung Association and American Cancer Society
Intervention: As control + Motivational Enhancement therapy using ‘ProjectMATCH’
manual with modifications for nicotine dependence, provided over 4 sessions by masters
level research associates
Main strategy and intensity not coded as outcomes unable to be included inmeta-analysis
Outcomes Mean cigarettes per day,mean exhaledCO,mean cotinine,movement in stages of change
were collected and authors report that there was no significant difference. However, not
actual figures were provided to be able to include these outcomes in meta-analysis in this
review
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Just states participants were ’randomly as-
signed’ to 1 of 2 conditions
Allocation concealment (selection bias) Unclear risk Not stated
Incomplete outcome data (attrition bias)
All outcomes
High risk Participant attrition was 14% (n = 9). Final
figures not reported so unclear how many
included in analysis
Selective reporting (reporting bias) Unclear risk Actual smoking rates not reported, despite
this being a primary outcome for the study.
However, authors did not claim resultswere
significant
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Cotinine and CO validationmeasured, but
not reported.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Intervention providers and women not
blinded as counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete implementation Unclear risk Process evaluation not reported.
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Equal baseline characteristics in study arms Unclear risk Intervention group had lower mean edu-
cation levels, were more likely to be Cau-
casian, and had higher rates of pre-preg-
nancy cigarettes per day. Other factors
equal
Contamination of control group Low risk Masters level research associates provided
the intervention.
Hegaard 2003
Methods Quasi-randomised trial of counselling and optional NRT, to support women to stop
smoking in pregnancy
Study conducted in a large midwifery centre in the Netherlands, with data collection
from 1996 to 1998
Participants Inclusion criteria: All pregnant women attending first prenatal visit.
Exclusion criteria: Inability to speak Danish, age below 18 years, gestation of more than
22 weeks, verified psychiatric diseases, and alcohol or drug abuse
Recruitment: 696/905 (77%) eligible women attending first AN clinic who smoked
agreed to participate in study (informed consent) and were randomised (C = 347, I =
348). 647 included in final analysis (C = 320, I = 327)
Baseline characteristics: Mean cigarettes/day = 11, Significant difference in partner
smoking (I = 67%, C = 77%, P = 0.03), mean salivary cotinine (C = 141, I = 139)
Mean age 29 yrs, > 12 yrs in school (C = 45%, I = 43%), mostly married
Progress + coding: None.
Interventions Control: UC, which included routine information about the risk of smoking in preg-
nancy and general advice on smoking cessation or reduction in a standard 30-min con-
sultation
Intervention: (i) Extended initial consultation (from 30 to 40 mins) which included a
dialogue about smoking and motivation for cessation
(ii) written information about risks of smoking and passive smoking
(iii) invitation to join smoking cessation program, based on CBT. The program involved
9 appointments (individually or in a group) over a period of 14 weeks. 3 attendances
prepared participants for quitting and 6 were used to maintain cessation and to hand
out NRT. CO readings at each visit
(iv) NRT offered to all women (2 mg gum or 15 mg patch x 16 h) for 11 weeks
(v) encouragement at subsequent 5-6 AN visits.
Main intervention strategy: Counselling (tailored) compared with UC.
Intensity: Frequency (C = 0, I = 6), Duration (C = 0, I = 6). UC intensity: F = 1, D = 1
Intervention provided by specially trained midwife (study staff ): Efficacy study
Outcomes Biochemically validated smoking cessation at 37 weeks’ gestation (late pregnancy*),
mean birthweight*, LBW*. Preterm births* reported in attrition and re-included in both
numerator and denominator for this outcome
Regression analysis for passive smoke exposure, years of education reported
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Notes SDs for mean birthweight were not reported, therefore we calculated a mean SD from 13
studies with available birthweight SDs (578) to include in this review, as recommended
by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quasi-randomised by odd or even birth
date. Included in review despite inadequate
sequence generation as there is a low like-
lihood of interference with birth date allo-
cation
Allocation concealment (selection bias) High risk Quasi-randomised by odd or even birth
date.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: 10 had miscarriage or stillbirth
(C = 5, I = 5); 21 moved out of area (C
= 12, I = 9); 17 had a premature delivery
(C = 10, I = 7). These were excluded from
analysis
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking cessation validated by salivary co-
tinine <= 30 ng/mL
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Providers and participants not able to be
blinded to educational intervention and
NRT provision not blinded (no placebo)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete implementation High risk Only 87 women (27%) accepted participa-
tion: 81 in a group and 6 women accepted
an individual smoking cessation program.
71 of 87 participants (82%) participated
in 3 or more of a total of 9 meetings in
the smoking cessation program. 75 (86%)
of 87 women participating in the smoking
cessation program were using nicotine sub-
stitution in the form of a 15 mg nicotine
patch (16 h/day) or 2 mg nicotine chewing
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gum or a 15 mg nicotine patch (16 h/day)
plus 2 mg nicotine chewing gum
Equal baseline characteristics in study arms Unclear risk Mostly equal except more women were ex-
posed to passive smoking in the home in
the intervention group (77%) than in the
control group (67%) (P = 0.03)
Contamination of control group Unclear risk The strengths of the study include ab-
sence of treatment diffusion as all partici-
pants in the intervention group were seen
by specially trained midwives as opposed
to participants in the control group who
were all consulting midwives without such
training. The study enjoys a second advan-
tage which is that intervention and con-
trol group participants were seen at differ-
ent week days and hence could not easily
share information.
The secretaries summoning the pregnant
women were continuously reminded about
this allocation criterion to avoid treatment
diffusion between the intervention and the
control group. p814
Heil 2008
Methods Randomised controlled trial of financial incentives to support women to stop smoking
in pregnancy and prevent relapse postpartum
Study conducted in Greater Burlington, Vermont (USA) with data collection from 2001
to 2003
Participants Inclusion criteria: Self-reported smoking (even a puff in the last 7 days), gestational age
less than 20 weeks, living within study clinic county and not planning to move until at
least 6 months postpartum, and speaks English
Exclusion criteria: Incarceration or previous participation in the study or living with
anyone who has previously participated in the study
Recruitment: Participants were recruited from 1 of 4 large obstetric practices in the
Women, Infants and Children (WIC) program. 182 women were eligible for the study,
and 82 (45%) agreed to participate. Mean gestation at recruitment (I = 8.9, C = 9.5).
77 included in analysis (C = 40, I = 37)
Baseline characteristics: Pre-pregnancy cigarettes per day (I = 18.7, C = 18.4),
Health insurance (I = 19%, C = 13%).
Progress + coding: Low SES as WIC program recipients.
Interventions Control (non-contingent voucher): Participants received voucher independent of smok-
ing status. US$ 15.00 per AN visit and US$ 20.00 per postpartum visit, to result in
comparable average earnings to the contingent group. Both groups received routine ad-
vice from the clinic
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Intervention (contingent voucher): participants chose a quit date, and reported daily to
the clinic for COmonitoring for 5 days, then urine cotinine monitoring twice weekly for
7 weeks, weekly for 4 weeks, and then every 2 weeks for the remainder of the pregnancy.
Vouchers were given dependent on biochemical validation, beginning at US$ 6.25 and
escalated by US$ 1.25 to a maximum of US$ 45.00. Positive test results reset voucher
back to original value, but 2 consecutive negative tests restored value to pre-reset value.
It is unclear who delivered the intervention
Main intervention strategy: Incentives (single intervention) compared to alternative
intervention
Intensity: Frequency (C = 6, I = 6), Duration (C = 6, I = 6).
Intervention provided by study staff: efficacy study.
Outcomes Biochemically validated smoking cessation (7-day point prevalence) at >= 28 weeks’
gestation (late pregnancy*), 12 weeks (0-5 months*) and 24 weeks’ (6-11 months*)
postpartum. Reduction in mean cotinine
Meanbirthweight*, gestational age, fetal growthmeasures (US), andproportionofNICU
admissions, LBW* infants, and preterm births*
Nicotine withdrawal symptoms reported in associated reference (Heil 2004).
Notes Sample size justification. Some discussion of cost implications
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “randomisation stratified to
clinics”. Details of randomisation not de-
scribed
Allocation concealment (selection bias) Unclear risk No information.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 5 women withdrew from the study due to
fetal demise or termination of pregnancy
and were not included in the final analysis
(I = 3, C = 2)
Selective reporting (reporting bias) Low risk Detailed birth outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation using exhaled CO
for 5 days (< 6 ppm) and then urine coti-
nine (< 80 ng/mL) after 2 weeks
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and providers not blinded as
receiving incentives for participation
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Compliance with periodic assessments was
relatively high (83%-95%)
Equal baseline characteristics in study arms Low risk No significant differences in socio-demo-
graphics or smoking characteristics were
noted
Contamination of control group Low risk Very unlikely - as clear voucher schemes for
abstinence and non-abstinence
Hennrikus 2010
Methods Randomised controlled trial of mobilising peer social networks to support pregnant
women to stop smoking
The study was conducted in urban Women, Infants and Children (WIC) clinics in
Minnesota and an urban university outpatient obstetric clinic in Ohio, USA from 2005
to 2007
Participants Inclusion criteria: Pregnant women in the first or second trimester, a current smoker,
and at least 18 years old
Exclusion criteria: Not further specified.
Recruitment: Each eligible and consenting participant identified a woman in her social
network to act as a supporter. 872 women screened in waiting areas. 82/156 (53%)
eligible women and their supporters agreed to participate (C = 28, I = 54)
Baseline characteristics:Median number of cigarettes smoked per day = 5 (range = 1-25)
and 52% smoked their first cigarette within 30 min of waking. 52% of supporters were
current smokers and 22% were former smokers. There were no significant differences
between study arms
67% from racial minority groups, 65% had high school education or less. Median age =
24
Progress + coding: Low SES as all WIC program recipients; ethnic minority.
Interventions Control: 1 in-person counselling session for control and intervention participants de-
signed to increase motivation to quit and provide information about community smok-
ing cessation resources
Intervention: Peer-supporters in the intervention group had 1 in-person visit and
monthly telephone sessions. The primary goal was to develop strategies to help the par-
ticipant quit smoking by identifying specific activities to support efforts to quit. Women
and their supporters were given a pregnancy scrapbook that included pages related to
smoking cessation tasks
Main intervention strategy: Social support (single intervention) compared to a less
intensive intervention
Intensity: Frequency (C = 2, I = 4), Duration (C = 2, I = 5- estimated)
Intervention provided by specific staff: Efficacy study.
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Outcomes Biochemically validated smoking status just prior to expected delivery date (late preg-
nancy*) and 3 (0-5*) months postpartum
Women’s perceptions of peer support behaviours reported (both positive and negative)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Blocked random allocation sequence
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition: C = 25%, I = 11% by end of
pregnancy. C = 19%, I = 32% by 3months
postpartum. Report ITT analysis for end of
pregnancy validated quits. 7 women who
had miscarriages were excluded from the
analysis. All randomised participants in-
cluded in the analysis in this review (drop-
outs included as continuing smokers)
Selective reporting (reporting bias) Low risk All primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported smoking status biochemically
validated using urinary cotinine (< 100 ng/
mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and
providers to this social support interven-
tion
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded as ’evaluation
staff were blinded to group assignment’
Incomplete implementation High risk Process evaluation showed over 90% sup-
porters received at least 1 counselling ses-
sion, but contacts with supporters occurred
less frequently than the planned monthly
intervals because of difficulty reaching sup-
porters
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Hennrikus 2010 (Continued)
Equal baseline characteristics in study arms Unclear risk Significantly more intervention partici-
pants had other children (78% vs 57%, P
= 0.052) and significantly fewer were white
(22% vs 54%, P = 0.016), but other char-
acteristics equal
Contamination of control group Low risk Contaminationunlikelywith this interven-
tion which required researchers to contact
intervention group at home
Herbec 2014
Methods This 2-armed randomised controlled trial aimed to assess the effectiveness of ’Mum-
sQuit’ an Internet-based smoking cessation website. The study was conducted in the
UK between March 2012 and October 2013
Participants Inclusion criteria:Pregnant women with access to the Internet, aged 18 or more, UK
based, smoking daily, willing to make a serious quit attempt, and use a stop smoking
website which sends email reminders, as well as agree to be followed up over the telephone
at 2 months, and provide informed consent
Exclusion criteria: Being male or not being pregnant.
Recruitment:200/336 = 59.5% eligible women participated (C = 101 I = 99)
Baseline characteristics: Mean cigarettes per day 14.7, Mean age of smoking initiation,
15.9 years, Mean Age 27.87 years. Appalachian women have a lower than average SES
and lower levels of education
Progress + coding: Low SES
Interventions Control: The control condition involved a 1 page static, non personalised website that
provided brief standard advice for users. The content of the control website was based
on a widely used manual for smoking cessation support for practitioners
Intervention: MumsQuit offers an interactive, personalised, and structured quit plan
that emulates the support from an expert smoking cessation advisor from NHS Stop
Smoking Services. The intervention delivers 33 evidence- or theory-based behavior
change techniques and provides up to 4 weeks of pre quit date support and up to 4
weeks of post quit date support, with email reminders sent to notify users when new
intervention sessions are being released
Main Intervention strategy: Health Education (single) v Less intensive intervention.
Intensity: Frequency (C = 2 I = 4) Duration (C = 1 I = 2).
Outcomes Self-reported continuous 4-week abstinence assessed at 8 weeks post-baseline*
Notes Also a process evaluation, lots of outcomes regarding amount of logins and time spent
on each page of the website
Risk of bias
Bias Authors’ judgement Support for judgement
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Herbec 2014 (Continued)
Random sequence generation (selection
bias)
Low risk After consenting, participants were ran-
domised by the computer to receive access
to either MumsQuit or the control condi-
tion,with allocation concealment and lock-
ing of emails to minimize duplicate sign
ups
Allocation concealment (selection bias) Low risk Participants were randomised by the com-
puter to receive access to either MumsQuit
or the control condition, with allocation
concealment and locking of emails to min-
imize duplicate sign ups
Incomplete outcome data (attrition bias)
All outcomes
Low risk Control and intervention were compared
using logistic regression according to the
ITT principle with participants lost to fol-
low-up treated as smokers. 33% were lost
to follow-up with no significant differences
between control and intervention
Selective reporting (reporting bias) Low risk Both primary and secondary outcomes are
reported.
Other bias Unclear risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Smoking was not biochemically validated
and was self-report.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear as to whether women were blinded
regarding their allocation, providers not ap-
plicable as this was a computer-generated
intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Main outcome was self-report of smoking
status.
Incomplete implementation Unclear risk 33.5% lost to follow-up.
Equal baseline characteristics in study arms Low risk No differences between study arms in base-
line characteristics
Contamination of control group Low risk Intervention and control were automated
websites.
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Hiett 2000
Methods Randomised controlled study of health education and feedback to support women to
stop smoking
Location and study dates unclear. Assume USA due to author affiliations
Participants Inclusion criteria: Women enrolling for prenatal care.
Exclusion criteria: Not further specified.
Recruitment: 49 women randomised (I = 26, C = 23).
Baseline characteristics: Not reported (abstract only).
Interventions Control: Usual prenatal care.
Intervention: Education and at least 8 encounters with a program counsellor. Peak flow
values and CO levels were obtained at each prenatal visit and shared with intervention
group participants only
Main intervention strategy and intensity not coded as outcomes not reported
Outcomes Smoking cessation (biochemically validated) was collected but actual figures not reported
so unable to include results in this meta-analysis. Peak flow values reported
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk States ‘women were randomised into two
groups’.
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Data not reported.
Selective reporting (reporting bias) High risk Actual figures not reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of smoking status
using urine cotinine and CO (cut-off levels
not reported)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel unlikely to be
blinded to educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Not reported.
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Hiett 2000 (Continued)
Equal baseline characteristics in study arms Low risk Groups similar with maternal age, Fager-
strom scores, initial peak flow values and
initial urine cotinine levels
Contamination of control group Unclear risk Not stated who delivered intervention.
Higgins 2014 (AvB)
Methods This 3-armed randomised controlled trial aimed to investigate different schedules of
financial incentives for smoking cessation inpregnantwomen and its impact on cessation.
This study was conducted in Burlington VT in the USA between 2006-2011 and women
were recruited from obstetric practices and the Women, Infants, and Children (WIC)
office
Participants Inclusion criteria: Smoking in the past 7 days, gestational age ≤ 25 weeks, residing
within the county in which clinic is located, plan to remain in the geographical area for
≥ 6 months following delivery, and English speaking
Exclusion criteria:incarceration, previous participation in a voucher-based incentive
trial for smoking cessation, currently residing with a trial participant, regular use of
opioid, psychomotor stimulant, or antipsychotic medications
Recruitment:43.8% participation rate (C = 42 I = 44).
Baseline characteristics:Partner smokes % (A = 77 B = 85 C = 82) Mean age first started
smoking (A = 15.2 B = 16.3 C = 14.9) Married% (A = 21 B = 18 C = 10)
Progress + coding: Low SES, women were recruited from WIC.
Interventions A: Control: In this condition, vouchers were delivered independent of smoking status.
Voucher values were $15.00 per visit antepartum and $20.00 per visit postpartum, values
that resulted in payment amounts comparable to average earnings in the CV condition
in prior trials (Heil et al., 2008). All else was the same as in the CV and RCV conditions
B: Intervention 1: Usual contingent voucher condition (CV)-Vouchers redeemable for
retail items were earned contingent on submitting breath CO specimens≤ 6 ppmduring
the initial 5 days of the cessation effort. Beginning in Week 2, vouchers were delivered
contingent on urine-cotinine levels ≤ 80 ng/mL, a criterion that required a longer du-
ration of smoking abstinence than breath CO (Higgins et al., 2007a). Voucher delivery
was independent of self-reported smoking status and based exclusively on meeting the
biochemical-verification criterion. Unauthorised failure to complete a scheduled assess-
ment was treated as a positive test result consistent with an ITT approach (Friedman
et al., 1998). Vouchers began at $6.25, and escalated by $1.25 per consecutive negative
specimen to a maximum of $45.00, where they remained barring positive test results or
missed abstinence monitoring visits. Positive test results or missed visits reset the voucher
value back to the original low value, but 2 consecutive negative tests restored the value
to the pre-reset level
C: Intervention 2: Revised contingent voucher condition (RCV)-The same voucher
schedule as outlined above was followed in this RCV condition except that potential
earnings were rescheduled, moving $296.25 forward as bonuses available during Weeks
1-6 by meeting a≤ 4 ppm breath CO criterion during Week 1, testing cotinine negative
at the first urine test on the 2ndMonday of the quit attempt, and thereafter by submitting
2 cotinine-negative specimens per week through Week 6. More specifically, bonuses
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Higgins 2014 (AvB) (Continued)
earned by reaching a cut-off of ≤ 4 ppm CO during Week 1 started at $18.75 and
increased by $3.75 for each successive negative sample reaching a maximum potential
bonus of $33.75 for the 5th consecutive negative specimen meeting the ≤ 4-ppm CO
cut-off during Week 1. Women in this condition earned the same incentive as in the CV
condition if theymet the≤ 6 ppmCO but not the≤ 4 ppm cut-off inWeek 1. The goal
was to provide bonuses for those who could achieve this more stringent criterion and thus
decrease the likelihood of low-level smoking that can undermine longer-term abstinence
(Higgins et al., 2006), but assure that a woman still received an incentive if she met the
slightly more liberal criterion ≤ 6 ppm criterion effective in prior trials (Higgins et al.,
2012). Testing cotinine-negative on the 2nd Monday resulted in an additional bonus of
$87.50 above usual CV incentive earnings on that date. 5 more bonuses of $15.50 each
were available on Thursdays (2nd test day of each week) during Weeks 2-6 if a woman
also had tested negative for smoking at the earlier test conducted that same week
Main Intervention Strategy: Incentives (multiple) v alternative intervention. Arms A
and B are compared in this study ID, please see Higgins 2014 (AvC) for arms A and C.
Intensity: Frequency (C = 6 I = 6) Duration (C = 6 I = 6).
Outcomes Biochemically verified 7-day smoking abstinence at 24 weeks’ gestation*, Continued
smoking at 12 weeks postpartum (0-5 months)* Continued smoking at 24 weeks post-
partum (6-12 months)*, Birthweight*, LBW*, preterm births*, NICU admissions*, ges-
tational age, estimated fetal growth (fetal weight gain, abdominal circumference, femur
length, head circumference, biparietal diameter, lean thigh area
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Women were randomised to the 3 different
conditions, however does not explain how
this was done
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk All randomised women were included in
the primary analysis with the exception of
fetal demise (A = 3, B = 5, C = 4)
Selective reporting (reporting bias) Low risk Both primary and secondary outcomes re-
ported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking abstinence was biochemically val-
idated, breath specimens were analysed us-
ing CO monitors and urine cotinine lev-
els determined using onsite enzyme im-
munoassay testing
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Higgins 2014 (AvB) (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Unclear
Equal baseline characteristics in study arms Unclear risk Only 2 characteristics differed significantly
between treatment conditions: more of
those assigned to the RCV condition
worked outside the home compared to the
CVbut not theNCV conditions, and those
assigned to the RCV condition reported
higher mean ratings of stress across past
week than those assigned to the CV but
not the NCV conditions (Table 1). These
2 characteristics were not significantly cor-
related with smoking abstinence or birth
outcomes
Contamination of control group Low risk As main intervention component was in-
centives, no risk of contamination of con-
trol group
Higgins 2014 (AvC)
Methods This 3-armed randomised controlled trial aimed to investigate different schedules of
financial incentives for smoking cessation inpregnantwomen and its impact on cessation.
This study was conducted in Burlington VT in the USA between 2006-2011 and women
were recruited from obstetric practices and the Women, Infants, and Children (WIC)
office
Participants Inclusion criteria: Smoking in the past 7 days, gestational age ≤ 25 weeks, residing
within the county in which clinic is located, plan to remain in the geographical area for
≥ 6 months following delivery, and English speaking
Exclusion criteria:incarceration, previous participation in a voucher-based incentive
trial for smoking cessation, currently residing with a trial participant, regular use of
opioid, psychomotor stimulant, or antipsychotic medications
Recruitment:43.8% participation rate (C = 42 I = 44).
Baseline characteristics:Partner smokes % (A = 77 B = 85 C = 82) Mean age first started
smoking (A = 15.2 B = 16.3 C = 14.9) Married% (A = 21 B = 18 C = 10)
Progress + coding: Low SES, women were recruited from WIC.
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Higgins 2014 (AvC) (Continued)
Interventions A: Control: In this condition, vouchers were delivered independent of smoking status.
Voucher values were $15.00 per visit antepartum and $20.00 per visit postpartum, values
that resulted in payment amounts comparable to average earnings in the CV condition
in prior trials (Heil et al., 2008). All else was the same as in the CV and RCV conditions
B: Intervention 1: Usual contingent voucher condition (CV)-Vouchers redeemable for
retail items were earned contingent on submitting breath CO specimens≤ 6 ppmduring
the initial 5 days of the cessation effort. Beginning in Week 2, vouchers were delivered
contingent on urine-cotinine levels ≤ 80 ng/mL, a criterion that required a longer du-
ration of smoking abstinence than breath CO (Higgins et al., 2007a). Voucher delivery
was independent of self-reported smoking status and based exclusively on meeting the
biochemical-verification criterion. Unauthorised failure to complete a scheduled assess-
ment was treated as a positive test result consistent with an ITT approach (Friedman
et al., 1998). Vouchers began at $6.25, and escalated by $1.25 per consecutive negative
specimen to a maximum of $45.00, where they remained barring positive test results or
missed abstinence monitoring visits. Positive test results or missed visits reset the voucher
value back to the original low value, but 2 consecutive negative tests restored the value
to the pre-reset level
C: Intervention 2: Revised contingent voucher condition (RCV)-The same voucher
schedule as outlined above was followed in this RCV condition except that potential
earnings were rescheduled, moving $296.25 forward as bonuses available during Weeks
1-6 by meeting a≤ 4 ppm breath CO criterion during Week 1, testing cotinine negative
at the first urine test on the 2ndMonday of the quit attempt, and thereafter by submitting
2 cotinine-negative specimens per week through Week 6. More specifically, bonuses
earned by reaching a cut-off of ≤ 4 ppm CO during Week 1 started at $18.75 and
increased by $3.75 for each successive negative sample reaching a maximum potential
bonus of $33.75 for the 5th consecutive negative specimen meeting the ≤ 4-ppm CO
cut-off during Week 1. Women in this condition earned the same incentive as in the CV
condition if theymet the≤ 6 ppmCO but not the≤ 4 ppm cut-off inWeek 1. The goal
was to provide bonuses for those who could achieve this more stringent criterion and thus
decrease the likelihood of low-level smoking that can undermine longer-term abstinence
(Higgins et al., 2006), but assure that a woman still received an incentive if she met the
slightly more liberal criterion ≤ 6 ppm criterion effective in prior trials (Higgins et al.,
2012). Testing cotinine-negative on the 2nd Monday resulted in an additional bonus of
$87.50 above usual CV incentive earnings on that date. 5 more bonuses of $15.50 each
were available on Thursdays (2nd test day of each week) during Weeks 2-6 if a woman
also had tested negative for smoking at the earlier test conducted that same week
Main Intervention Strategy: Incentives (multiple) v alternative intervention. Here arms
A and C are compared, please see Higgins 2014 (AvB) for arms A and B.
Intensity: Frequency (A = 6, I = 6) Duration (A = 6, I = 6).
Outcomes Biochemically verified 7-day smoking abstinence at 24 weeks’ gestation* Continued
smoking at 24 weeks postpartum*, Continued smoking at 12 weeks postpartum* Birth-
weight*, LBW*, gestational age, preterm births*, NICU admissions*, estimated fetal
growth (fetal weight gain, abdominal circumference, femur length, head circumference,
biparietal diameter, lean thigh area
Notes
Risk of bias
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Higgins 2014 (AvC) (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Women were randomised to the 3 different
conditions, however does not explain how
this was done
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk All randomised women were included in
the primary analysis with the exception of
fetal demise (A = 3, B = 5, C = 4)
Selective reporting (reporting bias) Low risk Both primary and secondary outcomes re-
ported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking abstinence was biochemically val-
idated, breath specimens were analysed us-
ing CO monitors and urine cotinine lev-
els determined using onsite enzyme im-
munoassay testing
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Unclear.
Equal baseline characteristics in study arms High risk Only 2 characteristics differed significantly
between treatment conditions: more of
those assigned to the RCV condition
worked outside the home compared to the
CVbut not theNCV conditions, and those
assigned to the RCV condition reported
higher mean ratings of stress across past
week than those assigned to the CV but
not the NCV conditions (Table 1). These
2 characteristics were not significantly cor-
related with smoking abstinence or birth
outcomes
Contamination of control group Low risk As main intervention component was in-
centives, no risk of contamination of con-
trol group
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Hjalmarson 1991
Methods Quasi-randomised trial of a self-help manual to support women to stop smoking in
pregnancy
Study conducted in public health maternity clinics in Gothenburg, Sweden, with data
collection from 1987 to 1988
Participants Inclusion criteria: Pregnant women registered as daily smokers (at least 1 cigarette per
day), gestational age less than 12 weeks, and speak Swedish
Exclusion criteria: Not further specified.
Recruitment: 13/14 public health clinics participated. Women born days 1-10 of each
monthwere allocated to the control group andwomen born on days 11-31were allocated
to the intervention group. Unequal group sizes were allocated as it was expected more
intervention women would refuse to participate. 723 eligible continuing smokers were
randomised (C = 231, I = 492). 417/492 (85%) of the intervention group agreed to
participate, and the control group were not asked for consent
Baseline characteristics: Mean cigarettes/day 16.8. Mean age 28.4 years.
Progress + coding: None.
Interventions Control: Given an information sheet by their doctor with basic facts about smoking and
pregnancy, as included in the last pages of the self-help manual
Intervention: Given a self-help manual on stopping smoking, based on Windsor 1985
(AvC). The manual was revised and pilot tested. The manual contained 2 phases, a
preparatory (one week) and cessation phase. The smoker was given new assignments
every day to the quit day and the tasks were based on the principle of behaviour therapy.
The cessation period was followed for the first 5 days with new information daily
Main intervention strategy: Health education (single intervention) compared to less
intensive intervention
Intensity: Frequency (C = 1, I = 1), Duration (C = 1, I = 1).
Intervention provided by existing staff (obstetrician provided self-help manual): Effec-
tiveness study
Outcomes Biochemically validated smoking cessation at 30-34 weeks’ gestation (late pregnancy*),
8 weeks postpartum (0-5 months), mean birthweight*, preterm births* (< 36 wks), LBW
babies*, mean cigarettes per day at 30-34 weeks’ gestation among baseline smokers*.
Mean cigarettes per day at baseline, week 12-14, week 30-34 among all randomised
women, 8 weeks after delivery among baseline smokers and all randomised women
Notes SDs for mean birthweight were not reported, therefore we calculated a mean SD from 13
studies with available birthweight SDs (578) to include in this review, as recommended
by the cochrane handbook.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Allocation by birth date is not random se-
quence. However, this study was included
as interference is unlikely with birth dates
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Hjalmarson 1991 (Continued)
Allocation concealment (selection bias) High risk Allocation would not be concealed as allo-
cated by birth dates (days 1-10 = control,
days 11-31 = intervention)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Loss to follow-up from miscarriage and
moving out of district (C = 10% or 23, I =
11% or 46), not included in analysis. How-
ever, all other dropouts included as contin-
uing smokers
Selective reporting (reporting bias) Low risk All primary outcomes appear to be re-
ported.
Other bias High risk Unclear why there are 444 in intervention
group and 209 in control group, when re-
port states 10% of 231 were excluded and
11% of 492 were excluded
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of smoking status
using serum thiocyanate (100 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel unlikely to be
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Manual given to all women who agreed to
participate (85% of total assigned to inter-
vention - i.e. 15% refused to participate)
Equal baseline characteristics in study arms Unclear risk Only age and mean no of cigarettes re-
ported.
Contamination of control group Low risk Unlikely control group would accidentally
be given the self-help manual
Hughes 2000
Methods Randomised controlled trial of stage of change orientated MI to support women to stop
smoking in pregnancy
The study was conducted in infertility and prenatal clinics in 3 hospitals in Ontario
(Canada), with data collection from January 1996 to July 1999
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Hughes 2000 (Continued)
Participants Inclusion criteria: Newly referred infertile and pregnant patients who reported smoking
more than 3 cigarettes in past 6 months
Exclusion criteria: Women attending genetic counselling or with habitual abortion or
who had previously been evaluated in consultation
Recruitment: All women attending infertility and prenatal clinics who reported smoking
were invited. Unclear how many were eligible. 110 pregnant women randomised (I =
56, C = 54)
Baseline characteristics: Mean cigarettes/day = 12.19 (SD 6.81); (I = 13.43 +-7.07, C
= 12 +- 6.69
Interventions Control: Standard information that was already provided in the clinics about the impact
of smoking on pregnancy
Intervention: Scripted stage-based information and encouragement to quit at each pre-
natal visit by physicians, Stage-specific information booklet, optional referral for more
in-depth counselling in a smoking cessation clinic
Main intervention strategy: Counselling (tailored intervention) compared with UC.
Intensity not coded as outcomes unable to be included in meta-analysis
Outcomes Stage of change, biochemically validated cessation at 12 months post follow-up but
data for intervention and control groups were combined so outcomes were unable to be
included in this review. See Table 1 for description of outcomes.
Relative value of intervention components reported.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomised using computer-generated,
blocked schedule, administered through
numbered, opaque, sealed envelopes
Allocation concealment (selection bias) Low risk Opaque sealed envelopes.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No attrition reported and not stated how,
if any, dropouts were assessed
Selective reporting (reporting bias) High risk Smoking cessation outcomes not reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Biochemical validation with exhaled CO,
but levels used to determine smoking status
were not reported
Blinding of participants and personnel
(performance bias)
High risk Providers and women not able to be
blinded.
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Hughes 2000 (Continued)
All outcomes
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated whether outcome assessors
blinded.
Incomplete implementation Unclear risk Process evaluation not reported.
Equal baseline characteristics in study arms Low risk No significant differences noted.
Contamination of control group High risk Same care providers offering intervention
and control interventions, therefore high
risk of contamination
Kemp 2011
Methods This 2-armed randomised controlled trial of a broader nurse home-visiting intervention
to improve maternal and child health with a tobacco cessation component. This study
was conducted in the home setting in a socio-economically disadvantaged area of Sydney,
New South Wales (Australia) from February 2003 to March 2005
Participants Inclusion criteria: Mothers living in the 2168 postcode, who were able to communicate
in English, were booked into their local public hospital for confinement and reported 1
or more risk factors for poor maternal or child outcomes, unclear how baseline smoking
status was assessed
Exclusion criteria: Mothers who needed an interpreter and those who did not have risk
factors for poor maternal and child outcomes
Recruitment: Participants were recruited from public hospitals. 338 women were eligi-
ble, with 208 randomised (smokers and non-smokers), with 73 smokers included in the
analysis (C = 31 I = 42). Participation rate unclear
Baseline characteristics: No baseline characteristics of the subgroup of smokers reported
Progress + coding: None, as unable to determine characteristics of subgroup of smokers
Interventions Control:Usual universal care, in accordance with standard practice in New SouthWales
Intervention: A sustained and structured nurse home visiting AN and postnatal parent-
ing education and support programme based on an ecological framework
Main Intervention strategy:Maternal health intervention with smoking cessation com-
ponent: social support (multiple) vs UC
Intensity: Frequency (C = 0 I = 6) Duration (C = 0 I = 4).
Intervention conducted by researchers: efficacy study.
Outcomes Self-reported continuous abstinence 0-24 months (18 + months postpartum)* House-
hold always smoke free (0-24 months) other outcomes not reported by smoking status.
See Table 1 for summary of results.
Notes
Risk of bias
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Kemp 2011 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A permuted block design was used to ran-
domly allocate mothers to the intervention
or comparison group
Allocation concealment (selection bias) Low risk Allocation was concealed from all nurses
and other research staff until after mothers
consented to participate in the study and
baseline data had been collected by the re-
search assistant blinded to the allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk States that ITT analysis was used, however
also states that those who had not com-
pleted any data points for the outcomes
were deleted form analysis
Selective reporting (reporting bias) Unclear risk No smoking outcomes are reported, only 2
years postpartum.
Other bias Unclear risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Smoking is not biochemically validated.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not explicitly reported, however not feasi-
ble to blind participants to a social support
intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Standardised testing was undertaken by
child psychologists who were blinded to
group allocation
Incomplete implementation Unclear risk Not reported
Equal baseline characteristics in study arms Low risk No significant differences noted among
smokers and non-smokers
Contamination of control group Low risk Main component home visit.
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Kendrick 1995
Methods Cluster-randomised controlled trial to support women to stop smoking and prevent
relapse during pregnancy and postpartum
Study conducted inpublic prenatal andWICclinics inMaryland,Colorado andMissouri
(USA), with data collection from 1987 to 1991
Participants Inclusion criteria: Smoking defined as “even a puff within the last 7 days before the
women knew she was pregnant”, whowere aggregated into ’enrolment smokers’ (smoked
within 7 days before study enrolment) and ’recent quitters (smoked before they thought
they were pregnant)
Exclusion criteria: Not further specified.
Recruitment: 1741/5262, 1936/6087 and 1895/4943 pregnant women screened in
Colorado, Missouri and Maryland respectively, with nearly 50% of women in each state
smoking. Participation rates ranged from 66% in Maryland to 79% in Missouri
Baseline characteristics: Mean cigarettes/day at enrolment combined for smokers = 12
cigarettes/day
High proportions were young, < 12 years education, white, unmarried and poor. Mean
gestation at enrolment = 15.2 - 16.6 weeks
Progress + coding: Low SES.
Interventions Control: UC not otherwise specified by usual clinic staff.
Intervention: Based on stages of change, but differed by State, locally adapted with some
detailed development.
Colorado: 1-5 mins counselling; assessing smoking status; quitting tips; supportive state-
ments by nurse-clinicians; healthcare providers’ Guide; 8 brochures for pregnant smok-
ers; additional 1 for women postpartum.
Maryland: brief clinic-based counselling program + self-help material focusing on the
stages of quitting.
Missouri: “becoming a life-long smoker” 6mins with clinic patient brochures, flip charts;
1-2 mins at WIC clinics training staff, chart documentation and forms.
All included effects of smoking on the fetus; benefits of quitting; quitting techniques;
developing social support; preventing relapse and limiting exposure to environmental
tobacco smoke. All materials were at 6th Grade reading level
Main intervention strategy: Counselling (multiple intervention) compared to UC.
Intensity: Frequency (C = 0, I = 2), Duration (C = 0, I = 1). UC intensity: F = 0, D = 0
Intervention provided by existing staff: Effectiveness study
Outcomes Biochemically validated point prevalence abstinence at 8 months gestation (late preg-
nancy*). Smoking outcomes for ’recent quitters’ (relapse prevention) were not reported.
Birthweight and proportion of LBW babies are not reported by intervention group so
were unable to be included in meta-analysis
Notes Intracluster correlation of 0.003 reported and used for adjusting outcome figures in
analysis. Substantial misclassification of self-report as non-smoking: 28% at enrolment;
35% at 8th month; 49% of self-reported quitters at intervention clinics; 32% of self-
reported quitters at control clinics. Process evaluation suggested less difference between
I and C clinics than might have been expected.
Project staff felt that the use of existing staff to deliver the new interventions and to
collect data affected the study negatively especially given the time needed to process
questionnaires and urine samples. This led to less than full implementation and variable
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motivation to promote smoking cessation counselling among staff
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Clinics stratified by size of clinic and also
by prior LBWprogramme (Colorado) or%
minority clients (Maryland), and randomly
assigned to deliver either intervention or
continue with standard care. No details of
randomisation provided
Allocation concealment (selection bias) Unclear risk Cluster-randomised trial.
Incomplete outcome data (attrition bias)
All outcomes
High risk In the 3 states combined, the reasons for
loss to follow-up at the 8th month were
early termination of pregnancy (7.6%);
enrolment after 32 weeks (6.1%); lost,
moved, or unable to locate (27.7%); re-
ferred to another care provider (2.8%); and
refused data collection (1.0%). The total
numbers of enrolment smokers were not
reported by intervention groups, and attri-
tion rates were not reported by interven-
tion groups, sowewere unable to re-include
data for respondents lost to follow-up. Re-
port states loss to follow-up was balanced
in experimental and control groups. Vary-
ing enrolment and attrition rates in differ-
ent centres. No ITT analysis
Selective reporting (reporting bias) Unclear risk High rates of non-disclosure for smoking
outcomes.
Other bias Unclear risk Uneven recruitment to study arms inMary-
land, which affected the overall allocation
(C = 1767, I = 1467)
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation by urinary cotinine
(> 85 ng/mL indicates active smoker)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear whether participants and providers
were aware of clinic allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
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Incomplete implementation High risk Process evaluation reported that imple-
mentation was less than ideal
Equal baseline characteristics in study arms Low risk Intervention and control sites were similar
at enrolment, indicating that stratification
and randomisation had been effective (data
not shown)
Contamination of control group Unclear risk Many patients at control clinics also re-
ported having received (non-SCIP) mate-
rials and counselling which indicated that
UC included exposure to smoking cessa-
tion messages
Lawrence 2003 (AvB)
Methods 3-armed cluster-randomised trial of self-help manuals and computer-generated advice
to support women to stop smoking in pregnancy
Study conducted in community midwife clinics in theWest Midlands region of the UK,
with data collection from July 1998 to March 2001
Participants Inclusion criteria: Head midwife in every trust in region invited to participate and 16/
19 agreed to participate. 204 potential midwifery practices identified, and 103 excluded
by head midwife as those trusts were already involved in other regions or the practice
crossed trust boundaries. Women were eligible if aged 16 years or over and a ’current
smoker’ at booking
Exclusion criteria: Women not fluent in English.
Recruitment: 72/101 practices were randomly sampled (C = 24, I1 = 24, I2 = 23).
Further practices were later added to each arm due to slow recruitment, particularly in
the control arm (C = 17, I1 = 12, I2 = 0), leaving active practices (C = 32, I1 = 30, I2
= 22). Participating midwives were asked to recruit all eligible women seen in routine
AN appointments. Initial target of 1440 participants was reduced to 900 due to slow
recruitment. Eligible smokers approached: C = 328/965 (34%),I1 (manuals) = 327/694
(47%), I2 (computer) = 397/529 (75%). Participation rate: C = 289/328 (88%), I1 =
305/327 (93%),I2 = 324/397 (82%).
Baseline characteristics:Mean cigarettes per day at baseline were similar between groups
(reported in 6 smoking categories). Majority (over 60%) smoked 5-20 cigarettes per day
and over 50% had a partner who smoked. Median Fagerstrom score 3 in all arms
63.6% of participants on < $300/week.
Progress + coding: Low SES.
Interventions A: Control: Standard care. Midwives received a half-day training on research protocol,
and asked all midwives to give women the Health Education Authority booklet “Think-
ing about stopping”
B: Intervention 1 (self-help booklets): Midwives received 2 and a half days training
on theory of transtheoretical model. Participants received a set of 6 stage-based self-help
manuals “Pro-Change programme for a healthy pregnancy”. The midwife assessed each
participant’s stage of change and pointed the woman to the appropriate manual. No
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more than 15 mins was spent on the intervention
C: Intervention 2 (self-help booklets + computerised advice): Midwives received
the same training as for I1, and participants received the same self-help manual and
intervention as I1. Additionally, the participants used a computer programme, which
consisted of questions and auto feedback of what stage they were in and what this meant,
and a range of other concepts. It took about 20 mins for the woman to complete. Printed
information of the feedback was sent to the participant within a week of the intervention
Main intervention strategy: Counselling (single intervention) compared with UC. In-
tervention 1(arm B) was compared with the control arm in this study ID
Intensity: Frequency (C = 0, I = 2); Duration (C = 0, I = 1).
Intervention provided by existing staff (Midwives providing self-help manuals): effec-
tiveness study
Outcomes Biochemically validated point prevalence abstinence at 28-30 weeks’ gestation (late preg-
nancy)* (T3) and 10 days post-birth* (T4) (0-5 months postpartum).
Effect of midwife training (attitudes, expectations, confidence, concerns and routine
practice) was assessed by pre-post training questionnaires
Subsequent papers (Lawrence 2005b) measure and describe self-reported smoking ces-
sation at 18 months postpartum, movement in stage of change, partner quitting, social
support mobilisation, and the stress of receiving the intervention (Lawrence 2002)
Notes Intracluster correlation of 0.003 reported in sample size calculation (see Kendrick 1995)
and used for adjusting outcome data included in this meta-analysis. Sample size calcu-
lation given, but unable to recruit sufficient numbers
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A computerised minimisation programme
was used to stratify 72 eligible practices into
3 equal groups from 101 available practices
Allocation concealment (selection bias) High risk Further practices were added to the sample
because of slow recruitment - these were
not randomly allocated
Incomplete outcome data (attrition bias)
All outcomes
Low risk Different rates of recruitment and follow-
up in different arms of the trial. 272 (C
= 1 04, I1 = 86, I2 = 82) women (22.
5%) withdrew from the study or were lost
to follow-up. Data on smoking status were
only available for 67% of women. Where
there was no urine sample available women
were treated as continuing smokers. All
randomised participants were included in
the denominator in this analysis, with only
those reported as confirmed non-smokers
at T4 included as quitters
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Selective reporting (reporting bias) Unclear risk Not apparent.
Other bias High risk Slow recruitment to standard care arm, so
additional practices needed to be added
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine analysis (< 1.5 ug/L).
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Neither providers nor women blinded to
this educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete implementation Low risk 77% T4 questionnaires complete in I2.
Equal baseline characteristics in study arms Low risk There was little difference at recruitment
between the midwives or recruited women
in the 3 trial arms
Contamination of control group Low risk Cluster design to reduce risk of contami-
nation.
Lawrence 2003 (AvC)
Methods 3-armed cluster-randomised trial of self-help manuals and computer-generated advice
to support women to stop smoking in pregnancy
Study conducted in community midwife clinics in theWest Midlands region of the UK,
with data collection from July 1998 to March 2001
Participants Inclusion criteria: Head midwife in every trust in region invited to participate and 16/
19 agreed to participate. 204 potential midwifery practices identified, and 103 excluded
by head midwife as those trusts were already involved in other regions or the practice
crossed trust boundaries. Women were eligible if aged 16 years or over and a ’current
smoker’ at booking
Exclusion criteria: Women not fluent in English.
Recruitment: 72/101 practices were randomly sampled (C = 24, I1 = 24, I2 = 23).
Further practices were later added to each arm due to slow recruitment, particularly in
the control arm (C = 17, I1 = 12, I2 = 0), leaving active practices (C = 32, I1 = 30, I2
= 22). Participating midwives were asked to recruit all eligible women seen in routine
AN appointments. Initial target of 1440 participants was reduced to 900 due to slow
recruitment. Eligible smokers approached: C = 328/965 (34%),I1 (manuals) = 327/694
(47%), I2 (computer) = 397/529 (75%). Participation rate: C = 289/328 (88%), I1 =
305/327 (93%),I2 = 324/397 (82%).
Baseline characteristics:Mean cigarettes per day at baseline were similar between groups
(reported in 6 smoking categories). Majority (over 60%) smoked 5-20 cigarettes per day
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and over 50% had a partner who smoked. Median Fagerstrom score 3 in all arms
63.6% of participants on < $300/week.
Progress + coding: Low SES.
Interventions A: Control: Standard care. Midwives received a half-day training on research protocol,
and asked all midwives to give women the Health Education Authority booklet “Think-
ing about stopping”
B: Intervention 1 (self-help booklets): Midwives received 2 and a half days training
on theory of transtheoretical model. Participants received a set of 6 stage-based self-help
manuals “Pro-Change programme for a healthy pregnancy”. The midwife assessed each
participant’s stage of change and pointed the woman to the appropriate manual. No
more than 15 mins was spent on the intervention
C: Intervention 2 (self-help booklets + computerised advice): Midwives received
the same training as for I1, and participants received the same self-help manual and
intervention as I1. Additionally, the participants used a computer programme, which
consisted of questions and auto feedback of what stage they were in and what this meant,
and a range of other concepts. It took about 20 mins for the woman to complete. Printed
information of the feedback was sent to the participant within a week of the intervention
Main intervention strategy: Counselling (multiple intervention) compared with UC.
Intervention 2 (arm c) was compared with the control arm in this study ID
Intensity: Frequency (C = 0, I = 3); Duration (C = 0, I = 3).
Intervention provided by existing staff (Midwives providing self-help manuals): effec-
tiveness study
Outcomes Biochemically validated point prevalence abstinence at 28-30 weeks’ gestation (late preg-
nancy)* (T3) and 10 days post-birth* (T4) (0-5 months postpartum).
Effect of midwife training (attitudes, expectations, confidence, concerns and routine
practice) was assessed by pre-post training questionnaires
Subsequent papers (Lawrence 2005b) measure and describe self-reported smoking ces-
sation at 18 months postpartum, movement in stage of change, partner quitting, social
support mobilisation, and the stress of receiving the intervention
Notes Intracluster correlation of 0.003 reported in sample size calculation (see Kendrick 1995)
and used for adjusting outcome data included in this meta-analysis. Sample size calcu-
lation given, but unable to recruit sufficient numbers
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A computerised minimisation programme
was used to stratify 72 eligible practices into
3 equal groups from 101 available practices
Allocation concealment (selection bias) High risk Further practices were added to the sample
because of slow recruitment - these were
not randomly allocated
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Different rates of recruitment and follow-
up in different arms of the trial. 272 (C
= 1 04, I1 = 86, I2 = 82) women (22.
5%) withdrew from the study or were lost
to follow-up. Data on smoking status were
only available for 67% of women. Where
there was no urine sample available women
were treated as continuing smokers. All
randomised participants were included in
the denominator in this analysis, with only
those reported as confirmed non-smokers
at T4 included as quitters
Selective reporting (reporting bias) Unclear risk Not apparent.
Other bias High risk Slow recruitment to standard care arm, so
additional practices needed to be added
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine analysis (< 1.5 ug/L).
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Neither providers nor women blinded to
this educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported
Incomplete implementation Low risk 77% T4 questionnaires complete in I2.
Equal baseline characteristics in study arms Low risk There was little difference at recruitment
between the midwives or recruited women
in the 3 trial arms
Contamination of control group Low risk Cluster design to reduce risk of contami-
nation.
Lee 2015
Methods This 2-armed randomised controlled trial of a theory-guided cognitive-behavioural coun-
selling (CBC) intervention for smoking cessation during pregnancy. Participants were
recruited at the Women, Infants and Children Clinics (WIC) in Center in Philadelphia
USA with recruitment occurring between January 2003 to May 2007
Participants Inclusion criteria: Women were eligible for study participation if they: 1) were pregnant
(between 1-25 weeks post-gestation); 2) had smoked at least 1 puff of a cigarette in the
30 days prior to the recruitment; 3) were 18 years or older; and 4) were reachable by a
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telephone at the point of initial contact
Exclusion criteria: Participants who had miscarriages, stillbirth, and neonatal death
during the study period were dropped from the study
Recruitment: Participants were recruited fromWIC clinics at their prenatal clinic visit,
where written consent was obtained. 513 women were eligible, with 277 randomised
54% participation (C = 137 I = 140)
Baseline characteristics: Mean cigarettes/day C = 7.90 (7.62) I = 7.37 (7.17) Fagerstrom
score: C = 2.01 (1.11), I = 2.04 (1.14). Participants were predominantly non-White
(African American = 56% and Hispanic = 12%; non-Hispanic White = 33.83%), single
(89%), low-income (50% < $15,000), with a mean age of 27 years, education level
of high school or less (> 50%), and with an average of 2 children in the household.
Approximately 40% 12 years education or above. > 85% single. 63% Black, 12%-13%
Hispanic, 23%-24% white. ’Low-income, uninsured women’.
Progress + coding: Low SES, ethnic minority, single population.
Interventions Control: 5A’s model of smoking cessation counselling was provided, though it is unclear
if this was provided by routine providers or study staff
Intervention: Building on established cognitive-affective processing protocols and
guided by the C-SHIP model, the intervention sessions were designed to identify and
address participants’ cognitive-affective barriers to smoking cessation in the context of
pregnancy and postpartum adaptation and provided by masters level health educators.
Participants in the CBC intervention met with a health educator: for 45 mins (session
1) during their second trimester visit (13-25 weeks’ gestation); for 15 mins (session 2)
during their third trimester visit (26-38 weeks’ gestation); and for 45 mins (session 3)
during the first postpartum visit (2-6 weeks postpartum). Session 4 was a booster session
delivered by telephone at 8-10 weeks postpartum for 15 min
Main Intervention strategy: Counselling (single) vs less intensive intervention.
Intensity: Frequency (C = 4, I = 4) Duration (C = 2, I = 3).
Outcomes Biochemically validated smoking abstinence at late pregnancy* and 1 and 5* months
post partum
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Following the baseline assessment, partic-
ipants were allocated to either: (1) the C-
SHIP based CBC intervention; or (2) the
BP control condition, using computer-gen-
erated random number sequences
Allocation concealment (selection bias) Low risk Allocation was concealed from all nurses
and other research staff until after mothers
consented to participate in the study and
baseline data had been collected by the RA
blinded to the allocation
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Incomplete outcome data (attrition bias)
All outcomes
Low risk Both ITT and responder-only approaches
were conducted for each follow-up time
point. For the ITT approach, participants
who did not complete follow-up assess-
ments were coded as smokers
Selective reporting (reporting bias) Low risk All primary outcomes seem to be reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Cessation rates were assessed through self-
reported 7-day point prevalence abstinence
which was biochemically verified through
saliva cotinine level < 10 mg
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not clear.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Details regarding who undertook the out-
come assessment, not given
Incomplete implementation Unclear risk Of the total 4 counselling sessions, 128 (46
%) completed all 4 sessions, 58 (21 %)
completed 3 sessions only, and 28 (10 %)
completed 2 sessions only. 63 (23%) par-
ticipants never returned for the following
sessions after the first session
Equal baseline characteristics in study arms Low risk Baseline characteristics appear equal.
Contamination of control group Low risk Care providers did not provide the inter-
vention.
LeFevre 1995
Methods A randomised controlled trial (RADIUS) of routine US screening to improve perinatal
outcomes, including smoking in pregnancy
The study was conducted in Missouri, USA, with data collection from November 1987
to May 1991
Participants Inclusion criteria: Last menstrual period known within 1 week, gestational age < 18
weeks, no plans to change providers. All women enrolled in the RADIUS study who
reported any smoking in the year before enrolment in the study were evaluated in the
subgroup analysis
Exclusion criteria:Medical or obstetric complications, planning anUS for other reasons,
twin pregnancy, not intending to continue pregnancy
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Recruitment: 53,367 pregnant women were screened for entry into RADIUS study; 32,
317 ineligible or excluded; leaving 21,050. 3163 refused (85% participation), 2357 had
miscarriage or change of provider; leaving 15,530 randomised (C = 7718, I = 7812), 23.
8% (3,571) of whom were smokers in year before enrolment, and 1901 who were still
smoking at enrolment. 3,571 smokers included in this analysis (C = 1803, I = 1768)
Baseline characteristics:
95% aged 20-35, 95% white, Education: high school or less (C = 30%, I = 29%), some
college (C = 29%, I = 30%), college graduation (C = 42%, I = 41%)
Progress + coding: None.
Interventions Control: US only if ordered by their physician for medical reasons.
Intervention: US at 18-20 and 31-33 weeks, no details about feedback to the mother
or others. No specific smoking intervention provided
Main intervention strategy: Feedback (single intervention) as part of a broader inter-
vention to improve maternal health compared to UC
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 2). UC intensity: F = 0, D = 0
Intervention provided by study staff: efficacy study.
Outcomes Mean number of cigarettes per day*.
Self-reported smoking cessation recorded on birth certificate, but unable to determine
how many smokers in each group so smoking outcomes not included in this review
Mean birthweight, preterm births (< 36 weeks), very preterm birth (< 33 weeks), and
adverse perinatal outcomes, but were not included in this review as other aspects of the
intervention may have impacted on perinatal outcomes
Notes SDs for mean cigarettes per day were not reported, therefore we calculated a mean SD
from 14 studies with available mean cigarette SDs (6.5) to include in this review, as
recommended by the cochrane handbook.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified computer randomisation.
Allocation concealment (selection bias) Unclear risk Information not provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Small loss to follow-up (approximately 2%)
. Miscarriage: C = 63, I = 64, records lost
or moved: C = 121, I = 131, leaving C =
7534, I = 7617; Available case analysis but
smoking cessation was not a primary out-
come
Selective reporting (reporting bias) Low risk None apparent.
Other bias Low risk No other bias detected.
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Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation.
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Smoking status not revealed to sonog-
rapher. Intervention not explicitly about
smoking cessation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk The mean number of sonograms obtained
was 2.2 per woman in the US-screening
group
Equal baseline characteristics in study arms Low risk Baseline characteristics appear equal.
Contamination of control group Low risk The mean number of sonograms obtained
was 0.6 per woman in the control group
and 55 percent had no sonograms. Only
2% of control group had 2 USs
Lilley 1986
Methods A randomised controlled trial of counselling intervention to support women to stop
smoking in pregnancy
The study was conducted in an AN clinic in Newcastle Hospital (UK), from March to
May 1982
Participants Inclusion criteria: All pregnant women currently smoking >= 1 cigarette a day at the
time of the first AN clinic under care of 4 consultant obstetricians
Exclusion criteria: Women 28 weeks’ gestation or more.
Recruitment: 156 smokers identified in clinics and 5 were excluded as over 28 weeks’
gestation. 151 randomised (C = 74, I = 77)
Baseline characteristics: Mean cigarettes per day before pregnancy: C = 18.3, I = 18.1.
Mean cigarettes per day at booking: C = 14.4, I = 15.1. Mean age: C = 25 years, I = 22.
7 years. Partner unemployment: C = 53%, I = 57%
Progress + coding: Low SES as study in ’deprived area’ and high partner unemployment
Interventions Control: Usual AN care with possible exposure to a concurrent television series (6 x 10-
min programme on stopping smoking in pregnancy).
Intervention: (i) 10 mins anti-smoking advice from SHO (Resident) based on Health
Education Council Booklet “So you want to stop smoking for you and your baby”,
an additional leaflet from the same source, and copies of the booklet for other family
members;
(ii) woman’s GP sent a letter describing the purpose of the study and a booklet, asked to
reinforce the information at usual contacts;
(iii) 2 weeks later a letter of reinforcement was sent to the woman;
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(iv) 4 weeks later there was a pre-planned home visit to provide anti-smoking advice
with a letter of the same advice sent if the woman was not at home;
(v) possible exposure to the concurrent TV series.
Main intervention strategy: Health education (multiple intervention) compared toUC.
Intensity: Frequency: (C = 0, I = 4), Duration (C = 0, I = 2) Estimate
Intervention provided by existing staff (resident): Effectiveness study
Outcomes Self-reported smoking cessation 9-16 weeks after booking visit (late pregnancy*). Mean
cigarettes per day* (the SD used in the analysis in this review was calculated from a P
value of 0.05 given in the paper)
Notes Short interval between intervention and assessment.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as balanced “simple random al-
location” in blocks.
Allocation concealment (selection bias) Unclear risk Information not provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Small loss to follow-up, some missing data
but balanced across groups. Attrition6/151
(4%, C = 3, I = 3): not pregnant (C = 1),
1 guilt over previous stillbirth (I = 1), and
miscarriages or medical complications (C =
2, I = 2). 145 included in analysis (C = 73,
I = 72)
Selective reporting (reporting bias) Low risk None apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation of self-reported
smoking cessation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Neither women nor providers blinded to
this educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk A home visit at 4 weeks was made to the
remaining 76 test patients. 31 (41%) were
found at home; 29 were given further anti-
smoking advice; 45 (59%) were out and a
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letter of encouragement was left
Equal baseline characteristics in study arms Unclear risk Mean age of test mothers 22.7, controls 25.
Report notes other variableswere equal, but
figures are not reported
Contamination of control group Low risk Main component home visit.
Lillington 1995
Methods Cluster-randomised controlled trial of ’Time for a Change’ behavioural intervention
to support low-income African American and Hispanic women to stop smoking and
prevent relapse in pregnancy and prevent relapse postpartum
Study conducted in 4 Women, Infant, and Children (WIC) clinics in south and central
Los Angeles (USA) from October 1990 to December 1992
Participants Inclusion criteria: 4 clinic sites identified from similar neighbourhoods and pair-
matched based on ethnic mix. Pregnant women at least 18 years of age who had smoked
in the previous year
Exclusion criteria: Not further specified.
Recruitment: Clinics randomly assigned. All pregnantwomenwere asked about smoking
and participants in intervention sites were asked for informed consent. 8019 women
screened (419 current smokers and 692 ex-smokers). 768/1102 (69%) current (410) or
ex-smokers (692) entered the study. 18% refused (198), 12% (132) ineligible due to
young age, early delivery or referral to a different clinic
Baseline characteristics: Smoking: Current 40.5% (I = 51%, C = 36.5%); ex-smoker
59.5% (I = 49%, C = 63.5%)
Mean age 26.8 (I = 27.3, C = 26.6). African American 53%, Hispanic 42.6%
Progress + coding: Low SES in this review asWIC clinic recipients, and ethnic minority
population
Interventions Control: UC, including printed information about the risks of smoking during preg-
nancy and a group quit-smoking message as part of the initial WIC visit
Intervention: (i) Assessment of smoking motivation and intention to quit. (ii) Bilingual
health educators (Spanish and English) with bachelors degrees provided 15 mins indi-
vidual counselling that included risk information and quit messages or reinforcement.
Participants were asked to select a quit date and nominate a significant other as a ’quit
buddy’. (iii) Self-help guide ’Time for a change’ with an explanation of how to use it and
behavioural counselling. (iv) Explanation of how to win prizes ($100) by completing
activity sheets (v) booster postcard 1 month after study entry
Main intervention strategy: Counselling (multiple intervention) compared with UC.
Intensity: Frequency: (C = 0, I = 4), Duration (C = 0, I = 2). UC intensity: F = 1, D = 1
Intervention provided by dedicated study staff: efficacy study
Outcomes Self-reported smoking cessation and relapse prevention at 9 months gestation (late preg-
nancy*), and 6 weeks postpartum (0-5 months postpartum*)
Differential quit rates reported by African-American and Hispanic ethnic status
Participants views of intervention.
200Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Lillington 1995 (Continued)
Notes Adjustment for clustering not reported. Standard adjustments as described in methods
in this review
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk 4 participating clinics were identified from
similar neighbourhoods and pair-matched
based on ethnic mix. 2 clinics were ’ran-
domly assigned’ as control sites, and 2 clin-
ics were assigned as intervention sites
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk 28% attrition (213/768), C = 28%, I =
25% (not stated how many from each arm,
so not able to be re-included in this review)
. Dropouts due to inability to contact, mis-
carriage or discontinuance with the WIC
program. 555 included in analysis (C =
400, I = 155)
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported.
Other bias High risk Unequal recruitment to each study arm.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported abstinence only. Only able to
obtain biochemical validation with salivary
cotinine (cut-off 20 ng/mL) on 111/254
women who reported they were not smok-
ing. High misclassification. Self-reported
rates used in this review
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Providers and women not able to be
blinded due to educational nature of inter-
vention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Only 12/155 women returned and com-
pleted 12 worksheets.
Equal baseline characteristics in study arms High risk Intervention group had a significantly
higher proportion of smokers at baseline
(51% vs 36%) and a significantly lower
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proportion of participants in the third
trimester for the initial WIC visit (27% vs
36%)
Contamination of control group Low risk Cluster trial at service level with minimal
contact with control organisations
Loeb 1983
Methods Randomised controlled trial of interventions (individual and group), based on the ’MR-
FIT’ trial, to support women to stop smoking during pregnancy
Study conducted in 1 of 2 hospitals in the Kaiser Permanente HMO of Oregon (USA),
with women recruited between July 1979 and September 1980
Participants Inclusion criteria: Pregnantwomenwho answered ’yes’ to a questionnaire aboutwhether
they now smoked
Exclusion criteria: Not further specified.
Recruitment: 3856 pregnant women screened in first AN visit: 963 self-reported current
smokers (25%) were randomised (C = 486, I = 477). All women in intervention group
were invited to participate in study but high refusal rates (37%). After some changes to
recruitment strategy refusal rate dropped to 30.6%
Baseline characteristics: Partner smoking: 74.1%.
Mean age 23.3 years. 66.2% married. 21% smokers in receipt of public assistance but
only 7% of non-smokers
Progress + coding: None.
Interventions Control: UC: normal medical care for the duration of their pregnancy
Intervention: (i) letter of invitation, reminder letter;
(ii) group information meeting on programme for respondents with short information
session by physician;
(iii) individual session with trained smoking counsellor;
(iv) 6 x 1.5 hour group sessions, once a week;
(v) subsequent optional support groups, individual sessions and phone calls
Main intervention strategy: Counselling (tailored intervention) compared with UC.
Intensity: Frequency (C = 0, I = 6), Duration (C = 0, I = 6).
Intervention provided by dedicated project staff: efficacy study
Outcomes Self-reported smoking cessation in late pregnancy*. Biochemically validated with cord
blood thiocyanate in a random subsample (C = 24, I = 29)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No details of randomisation.
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Allocation concealment (selection bias) Unclear risk Described as “randomly assigned”.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition rates high at all stages of this study.
Approximately 45% lost to follow-up. I
= 271/477 (56.8%) completed last ques-
tionnaire, with ’similar numbers in control
group’ (C = 276/486). However. all drop-
outs included as continuing smokers in this
review
Selective reporting (reporting bias) Unclear risk Birth outcomes reported by smoking sta-
tus, not intervention group
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Biochemical validation with urine thio-
cyanate at delivery on a small subsample (C
= 24, I = 29)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and providers not blinded to
allocation.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Very poor response to group sessions so in-
tervention changed over the course of the
trial to individual counselling, which also
had very low participation overall: 18% ac-
tive; 25.2% dropped out; 38% did not par-
ticipate; 18% could not be contacted
Equal baseline characteristics in study arms Unclear risk Differences between intervention and con-
trol group not reported
Contamination of control group Low risk UC providers not delivering intervention.
Loukopoulou 2012
Methods This 2-armed randomised controlled trial, tested 30 mins of individualised cognitive-
behavioural counselling delivered by a trained healthcare professional, with participants
recruited from 2 Hospitals in Athens Greece, between November 2009 and June 2012
Participants Inclusion criteria: > 18 years old, currently pregnant and currently cigarette smokers of
> 5 cigarettes over the past 7 days
Exclusion criteria: > 24 weeks’ gestation at the time of entry, limited or no telephone
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access, not planning to live at the same address for 1 year, unable to read and/or speak
Greek fluently, current alcohol or substance abusers (defined as strong cravings for alco-
hol, inability to limit drinking, continued use of alcohol despite the repeated problems)
and current depression (according to the Greek validated version of the Goldberg’s Gen-
eral Health Questionnaire (GHQ)
Recruitment: No information was given regarding how women were approached, how-
ever (n = 84) were randomised. Unclear how many in each study arm
Baseline characteristics: No baseline characteristics reported.
Progress + coding: None.
Interventions Control: The control group consisted of a face-to-face low intensity intervention which
lasts 5 mins and included brief advice and the provision of a leaflet on smoking and
pregnancy
Intervention: The intervention consisted of 30 mins of individualized cognitive-be-
havioural counselling delivered by a trained healthcare professional and a self-help man-
ual especially tailored for smoking cessation during pregnancy
Main Intervention strategy: Counselling (single) vs less intensive intervention
Intensity: Frequency (C = 1 I = 2) Duration (C = 1 I = 2).
Outcomes Mean urinary cotinine and urinary nicotine reported in abstract, but unable to be in-
cluded as numbers in study arms unknown. Biochemically validated smoking status at
32nd week of gestation. Infant’s birthweight, prematurity of birth, complications during
pregnancy, smoking relapse among quitters at 6 months post partum were collected but
results not yet reported so not included in this review
Notes No results paper published yet, just protocol and abstract. No response from 2 emails
sent to authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The participants’ assignment to each group
was computer-generated
Allocation concealment (selection bias) Low risk After the informed consent form has been
signed a study entry number was assigned
to each participant. This number will be on
the outside of an envelope, which will al-
locate accordingly the participant to either
the experimental or the control group
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No information given.
Selective reporting (reporting bias) Unclear risk Outcomes not yet reported.
Other bias Low risk No other bias detected.
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Loukopoulou 2012 (Continued)
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Smoking status was biochemically vali-
dated with urine cotinine
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Stated that this is a single-blind trial and
that participants will not be aware of their
allocation to intervention or control butt
that researchers will be aware
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk No data reported.
Equal baseline characteristics in study arms Unclear risk No information on baseline characteristics
given.
Contamination of control group Low risk Care providers did not provide the inter-
vention.
Lowe 1997
Methods A randomised controlled trial of brief counselling to support women who had recently
quit smoking to prevent relapse during pregnancy and postpartum
The studywas conducted alongside a concurrent trial (Windsor 1993) to support women
to stop smoking during pregnancy, relapse prevention among women who had stopped
smoking since the beginning of pregnancy, in 4 public maternity clinics in Birmingham,
Alabama (USA) from 1987 to1989
Participants Inclusion criteria: Pregnant women reporting as having quit within 3 months of first
prenatal visit
Exclusion criteria: Not further specified.
Recruitment: 106/115 women who were invited agreed to participate (92%) and were
randomised (C = 54, I = 52)
Baseline characteristics: All recent quitters within 3 months of first visit. No other
baseline characteristics reported, though report states there was no significant differences
in age, race, gestation, or smoking history between intervention and control, or those
lost to follow-up
Progress + coding: None.
Interventions Control: Usual prenatal care, including nurses’ advice to all women not to smoke.
Intervention: i) 10-min counselling by health educator using smoking relapse prevention
materials on effects of smoking; benefits of maintaining cessation; possible problems;
smoking triggers; solutions to smoking cues; strategies for staying quit, contract, and flip
chart (5th grade reading material)
ii) “stay quit buddy” encouragement, non-smoking gifts and pamphlets,
iii) clinic reinforcement by prenatal staff through reminder form in the notes and to
confirm abstinence, praise, encourage continuing cessation
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Main intervention strategy: Counselling (multiple intervention) compared to UC.
Intensity: Frequency (C = 0, I = 5), Duration (C = 0, I = 2).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Biochemically validated relapse in late pregnancy*.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “randomly assigned”.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 3 had a miscarriage, 4 moved and 2 had
babies for adoption, leaving C = 2/54, I =
7/52 included in analysis. Smoking status
reported on 80% (C = 38, I = 40), but ITT
analysis for main outcome, so those subse-
quently lost to follow-up treated as contin-
uing smokers
Selective reporting (reporting bias) Unclear risk Unclear what data were collected. Only
smoking outcomes reported
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of non-smoking or
reporting smoking less than or equal to 7
cigarettes since quitting with salivary thio-
cyanate analysis (cut-off levels not stated)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Notes flagged. Providers and women not
blinded to allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Process evaluation showed good imple-
mentation.
Equal baseline characteristics in study arms Low risk Figures not reported but author states there
was no difference
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Contamination of control group High risk Issues of possible ’contamination’ in clinics
with individual randomisation discussed
Lowe 2002
Methods Cluster-randomised trial to evaluate dissemination of a behaviourally-based program to
support women to stop smoking in pregnancy
Study conducted in Queensland (Australia). Data collection dates not stated
Participants Inclusion criteria: Public hospitals which provided AN and delivery care for 10 or more
patients a year, had less than 50% Aboriginal and Torres Strait Islander population, and
did not currently provide any AN smoking cessation care
Exclusion criteria: Not further specified.
Recruitment: Hospitals were matched on number of births, location of population
centre (rural/metropolitan), and whether they had a specific AN clinic
80 (92% public hospitals) hospitals eligible. 10 omitted as they stopped providing AN
care. 70 hospitals (35 pairs) included
Baseline characteristics: Characteristics of individuals not reported.
No outcomes included in study so not coded.
Interventions Control: Received ‘awareness’ phase of intervention based in Rogers’ Diffusion of Inno-
vation theory. Flyers were distributed to all hospitals
Intervention: Control +‘Persuasion’ phase, which included an educational workshop and
presentation. ‘Implementation phase’ where each hospital conducted the recommended
program
Main intervention strategy: Intensive dissemination vs less intensive intervention. No
outcomes to include in analysis
Intensity: NA
Outcomes Self-reported implementation of program at each hospital. Success was defined as the
routine offer of an evidence-based smoking cessation program to at least 80% of the
pregnant clients who smoke
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Report states hospitals were randomised
into intervention and control groups,
within matched pairs
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk Complete follow-up could not be obtained
primarily due to the inability to contact ei-
ther the medical superintendent or the di-
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rector of nursing after a minimum of 3 at-
tempts
High attrition (37% hospitals), though
those not respondingwere included in anal-
ysis as ‘not implemented’
Selective reporting (reporting bias) Unclear risk Smoking cessation rates not reported, but
not included as an aimof this dissemination
study
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Smoking status not assessed in this dissem-
ination study.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Unclear whether control hospitals were
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete implementation High risk 37% reported as ’not implemented’.
Equal baseline characteristics in study arms Low risk Matching of the hospitals was successful
as there were no differences in number of
births, rurality, and whether they had a spe-
cialised AN service at baseline
Contamination of control group Low risk Cluster design likely to minimise risk of
contamination.
Malchodi 2003
Methods Randomised controlled trial of peer counselling to support women to stop smoking in
pregnancy
Study conducted in a large urban clinic in Hartford Hospital (USA), with recruitment
from January 1998 to February 2000
Participants Inclusion criteria: Pregnant women who smoke at least 1 cigarette per day in week
before learning of pregnancy, less than 20 weeks’ gestation, literate in English or Spanish,
18 years of age or older, and intending to carry to term
Exclusion criteria: Women using smokeless tobacco or nicotine replacement products,
or who reported current substance abuse or dependence
Recruitment: All pregnant women screened at first prenatal visit and invited if met
criteria. Informed consent obtained. Participation rate not reported, but states high
smoking prevalence in pregnancy (29%) and hospital had over 4000 deliveries per year,
and only 142 women recruited to study (C = 75, I = 67)
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Baseline characteristics: Mean cigarettes/day at baseline significantly higher in inter-
vention group: C = 11.2 (SD 8.4); I = 13.3 (SD 13.3). Baseline CO C = 7.25 (SD 8.4),
I = 5.12 (SD 5.01). Short term Fagerstrom score: C = 3.8 (2.87), I = 4.2 (2.44)
Mean age C = 26, I = 26. Approximately 40% 12 years education or above. > 85% single.
63% Black, 12%-13% Hispanic, 23%-24% white. ’Low-income, uninsured women’.
Progress + coding: Low SES, ethnic minority, single population.
Interventions Control: UC, which included the programof “Ask, Advise, Arrange andAssist”, based on
cognitive behaviour, described by Windsor 2000a, and provision of self-help materials,
and smoking cessation counselling as per protocol as each visit
Intervention: As for the control group + peer counselling from lay community health
outreach workers (telephone or home visits). Peer counsellors received 2 x 3 hours of
training
Main intervention strategy: Social support (single intervention) compared to less in-
tensive intervention
Intensity: Frequency (C = 5, I = 6), Duration (C = 2, I = 5).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Biochemically validated smoking abstinence*, and reduction (cigarettes/day) at 36weeks’
gestation (late pregnancy). Mean exhaled CO
Mean birthweight* and proportion of babies* born LBW were provided by the study
authors (unpublished data)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated list.
Allocation concealment (selection bias) Unclear risk Information not provided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk High attrition rates (C = 27/75 or 36%, I
= 29/67 or 43%). ITT analyses for whole
sample and for those remaining at follow-
up
Selective reporting (reporting bias) Unclear risk Birth outcomes only reported by smoking
status not intervention group
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine levels at baseline and at
36 weeks’ gestation (200 ng/mL cut-off )
. Exhaled CO at each prenatal visit (< 8
ppm)
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Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk States that caregivers were masked but
women may have discussed but edu-
cational/counselling support intervention
that women may have discussed with care-
givers
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Process evaluation suggests reasonable im-
plementation (median 6 contacts for those
who remained in study), but high attrition
limits exposure to intervention
Equal baseline characteristics in study arms High risk The peer counselling group had a greater
proportion of heavier smokers at baseline
Contamination of control group High risk Discussion notes that quit rate in control
group higher than expected and that ’UC’
in this trial may be more comprehensive.
Which is likely as prompts etc were pro-
vided as part of trial participation to remind
providers to offer support as per guidelines.
Providers were also given training about the
guidelines from trial staff
Manfredi 1999
Methods Cluster-randomised controlled dissemination trial of “It’s Time” program, in 33 prenatal,
family planning and paediatric clinics
Study was conducted in Chicago (USA) between November 1994 and July 1996
Participants Inclusion criteria: 33 prenatal, family-planning and well-child clusters at 12 public
health clinics were included. Services were matched into pairs on type of public health
clinic (health department, neighbourhood health centre, university clinic), location (ur-
ban/rural), and racial mix. 10 months baseline measures were taken. The intervention
was randomly assigned to 6 intervention and 6 control public health clinics
Exclusion criteria: Not further specified.
Recruitment: 1495 smokers identified (21% of women screened). 77% (1112) women
in intervention group and 85% (1045) women in the control group agreed to participate.
63% (516) women in intervention group and 61% (548) women in control group
completed the follow-up assessments (T2)
Baseline characteristics: Mean cigarettes per day: C = 10.96, I = 12.01,
Black C = 68.3%, I = 81.2%, > high school ed C = 39.2%, I = 38.9%
Not coded as no outcomes included in review.
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Interventions Control: Not stated.
Intervention: (i) Provider focused: Charts flagged with ‘smoker’ sticker, charts prepared
with booklets and agreement form, documentation;
(ii) Patient focused: motivational video played in waiting room, posters, brief provider
advice, booklet, agreement form, letters reminding women of advice, 15-min motiva-
tional interview
Main intervention strategy: Counselling (multiple intervention) vs UC. Intensity not
coded as no outcomes able to be included in this review
Outcomes Dissemination and smoking cessation outcomes reported, but not able to include in this
review as we were unable to separate pregnant women from women attending family
planning and paediatric clinics
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Just states ‘randomly allocated’.
Allocation concealment (selection bias) Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
High risk 37%-39% attrition (due mostly to lack of
working telephones) and not clear how ac-
counted for in analysis. Conducted analy-
sis which suggests those lost to attrition did
not differ significantly in race, cigarettes,
stage of readiness, motivation, or confi-
dence
Selective reporting (reporting bias) Unclear risk Actual outcomes for each service not re-
ported so difficult to assess
Other bias Low risk No other bias detected
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking status, not biochem-
ically validated.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women and provider not able to be
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
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Incomplete implementation Unclear risk Not reported, despite being a dissemina-
tion trial.
Equal baseline characteristics in study arms Unclear risk Smokers in intervention clinics slightly
older and more likely to be African-Amer-
ican
Contamination of control group Low risk Low risk of contamination as cluster trial.
Mauriello 2013
Methods This single-blind 2-armed randomised controlled trial of the (Healthy Pregnancy: Step
by Step) is a broad maternal and child health program which aims to address smoking
cessation, stress management, and fruit and vegetable consumption in pregnant women.
The study was conducted in Connecticut, Rhode Island and New York in the USA from
December 2011 to September 2012
Participants Inclusion criteria: > 18 years, English or Spanish speaking, and less than 19 weeks’
gestation
Exclusion criteria: Not stated.
Recruitment: Prenatal health staff at each participating location invited all pregnant
womenwhomet the eligibility requirements to participate. 392womenwere approached,
with 117 smokers randomised (C = 60 I = 57)
Baseline characteristics: Characteristics of smokers at baseline not reported.
Progress + coding: None.
Interventions Control: The UC arm received a ’March of Dimes’ brochure on the target behaviours
at the conclusion of their first assessment
Intervention: To test an iPad-delivered multiple behaviour tailored intervention for
pregnant women that addresses smoking cessation, stress management and fruit and
vegetable consumption
Main Intervention strategy:MaternalHealth interventionwith smoking cessation com-
ponent: Health education (single) vs UC
Intensity: Frequency (C = 0 I = 3) Duration (C = 0 I = 3).
Outcomes Smoking outcomes not reported as authors state numbers were too small. Fruit and
vegetable consumption and stress management reported. See Table 1 for summary of
reported results.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A randomised 2 x 2 factorial repeated mea-
sures design was employed with randomi-
sation on the individual level stratified on
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behaviour risk
Allocation concealment (selection bias) Unclear risk States that computer allocation was used so
assume concealed from researchers
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Smoking outcomes not reported as num-
bers were too small.
Selective reporting (reporting bias) Unclear risk Smoking outcomes not reported as num-
bers were too small.
Other bias Unclear risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No evidence of validation is reported and
no smoking outcomes reported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not reported.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear as smoking was not assessed.
Incomplete implementation Low risk Process evaluation not undertaken.
Equal baseline characteristics in study arms Unclear risk Baseline characteristics appear to be equal.
Contamination of control group Low risk Intervention was self-administered via an
iPad application, so no likelihood of con-
tamination
Mayer 1990 (AvB)
Methods 3-armed randomised controlled trial comparing 2 smoking cessation interventions to
support women to stop smoking in pregnancy
Study conducted inWIC clinics in Grand Rapids, Michigan (USA), from 1985 to 1986
Participants Inclusion criteria: Pregnant women currently smoking (>= 1 cigarette/day).
Exclusion criteria: Not further specified.
Recruitment: 271/641 attending the clinics (42%) identified as smokers. 219/271 (81%)
agreed to participate and were randomised (C = 77, I1 = 70,I2 = 72).
Baseline characteristics: Mean cigarettes/day prior to pregnancy I = 19.9, C = 20.3.
75% white. 76.5% on medicaid.
Progress + coding: Low SES as WIC recipients.
Interventions A: Control: UC which included printed information about the risks of smoking in
pregnancy.
B: Intervention 1 (risk information): 10-min discussion with a health educator using a
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flip chart and a brochure but with no behaviour change counselling or self-help manual.
C: Intervention 2 (multi-component): 20-min 1:1 counselling including risk infor-
mation (“Because I Love My Baby” ALA, flip chart and brochure to take away), and
behavioural change manual adapted fromWindsor 1985 (AvC) and the ALA “Freedom
from Smoking” focusing on contracting and self-monitoring (CBT). An individual be-
havioural contract was developed during the session which specified a quit date and
selection of some significant other as a co-signer
Main intervention strategy: Health education (single intervention) compared to UC.
Intervention 1 (arm B) compared with control in this study I.D
Intensity: Frequency (C = 0, I = 2), Duration (C = 0, I = 1).
Unclear whether intervention provided by existing staff or dedicated project workers
Outcomes Self-reported smoking cessation at 9 months gestation (late pregnancy*) and approxi-
mately 4.7 weeks after birth (0-5 months postpartum*)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “randomly assigned”.
Allocation concealment (selection bias) Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 15% attrition (33/219) at follow-up. All
those lost to follow-up were treated as con-
tinuing smokers
Selective reporting (reporting bias) Low risk Not apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Biochemically validated with salivary thio-
cyanate in approximately a third of partici-
pants (n = 66), but no adjustment for mis-
classification
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Caregivers not blinded to this educational
intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete implementation Unclear risk No process evaluation.
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Equal baseline characteristics in study arms Unclear risk Differences between study participants and
refusals on variables available from the
WIC record were relatively minor for im-
portant variables as were study group dif-
ferences
Contamination of control group Low risk Health educator, not UC provider, offering
intervention.
Mayer 1990 (AvC)
Methods 3-armed randomised controlled trial comparing 2 smoking cessation interventions to
support women to stop smoking in pregnancy
Study conducted inWIC clinics in Grand Rapids, Michigan (USA), from 1985 to 1986
Participants Inclusion criteria: Pregnant women currently smoking (>= 1 cigarette/day).
Exclusion criteria: Not further specified.
Recruitment: 271/641 attending the clinics (42%) identified as smokers. 219/271 (81%)
agreed to participate and were randomised (C = 77, I1 = 70,I2 = 72).
Baseline characteristics: Mean cigarettes/day prior to pregnancy I = 19.9, C = 20.3.
75% white. 76.5% on medicaid.
Progress + coding: Low SES as WIC recipients.
Interventions A: Control: UC which included printed information about the risks of smoking in
pregnancy.
B: Intervention 1 (risk information): 10-min discussion with a health educator using a
flip chart and a brochure but with no behaviour change counselling or self-help manual.
C: Intervention 2 (multi-component): 20-min 1:1 counselling including risk infor-
mation (“Because I Love My Baby” ALA, flip chart and brochure to take away), and
behavioural change manual adapted fromWindsor 1985 (AvC) and the ALA “Freedom
from Smoking” focusing on contracting and self-monitoring (CBT)
Main intervention strategy: Counselling (multiple intervention) compared to UC.
Intervention 2 compared (arm C) with control in this review
Intensity: Frequency (C = 0, I = 2), Duration (C = 0, I = 2).
Unclear whether intervention provided by existing staff or dedicated project workers
Outcomes Self-reported smoking cessation at 9 months gestation (late pregnancy*) and approxi-
mately 4.7 weeks after birth (0-5 months postpartum*)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “randomly assigned”.
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Allocation concealment (selection bias) Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 15% attrition (33/219) at follow-up. All
those lost to follow-up were treated as con-
tinuing smokers
Selective reporting (reporting bias) Low risk Not apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Biochemically validated with salivary thio-
cyanate in approximately a third of partici-
pants (n = 66), but no adjustment for mis-
classification
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Caregivers not blinded to this educational
intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete implementation Unclear risk No process evaluation.
Equal baseline characteristics in study arms Unclear risk Differences between study participants and
refusals on variables available from the
WIC record were relatively minor for im-
portant variables as were study group dif-
ferences
Contamination of control group Low risk Health educator, not UC provider, offering
intervention.
McBride 1999
Methods 3-armed randomised controlled trial of an intervention to support women to stop smok-
ing and prevent relapse in pregnancy and postpartum
The study was conducted at the Group Health Cooperative of Puget Sound (Seattle,
USA) (HMO), and Park-Nicollet of Minnesota (USA), a multispecialty group practice.
Years of data collection not stated
Participants Inclusion criteria: Women who had completed the baseline survey, were < 20 weeks of
pregnancy, were currently smoking or had smoked in the 30 days before pregnancy but
had quit at the time of the baseline survey
Exclusion criteria: Unable to speak English.
Recruitment: Women booked for a first prenatal visit were offered, by letter, study
participation and unless they opted out were given a baseline telephone interview to
assess smoking status. 9152 approached, 714 ineligible because of miscarriage, pregnancy
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termination, inability to speak English; 697 (8%) refused; 262 could not be reached
by telephone after repeated attempts. 7479 (82%) completed survey. 1007/7479 (13%)
were current smokers or recent quitters and were randomised: 897 participated (457
from Seattle, 440 from Minnesota), C = 297, I1 = 294, I2 = 306. Current smoker at
baseline = 56% (C = 165, I1 = 176, I2 = 160).
Baseline characteristics: Mean cigarettes/day before pregnancy = 14.9; Current mean
cigarettes/day = 4.8. Mean age 27.7 years; Household income >= 30000 $US 67%;
College graduates 17%; 88% white
Progress + coding: None.
Interventions There were 3 stages of change-based interventions, all delivered by mail or telephone
without involving prenatal care providers.
A: Control: Self-help booklet “Stop now for your baby”; 5th grade reading level; health
effects of smoking during pregnancy; specific suggestions for quitting (setting date, en-
listing support). For recent quitters: stress reduction techniques; suggestions for handling
high-risk situations; pregnancy-appropriate behavioural alternatives to smoking.
B: Intervention 1: High-intensity interventions in pre- and postpartum groups also
received: (i) a personalised letter acknowledging baseline readiness for change, personal
health concerns, motivation to quit, comparison with other pregnant women who had
successfully quit. (ii) relapse prevention kit within 2 weeks of completing the 28-week
follow-up survey. (iii) a booklet which discussed transition from pregnancy and factors
that influence cessation and relapse; practical tips for high-risk situations, strategies for
avoiding self-defeating reactions to slips, personal anecdotes from women who quit. (iv)
3 AN counselling phone calls: 2 weeks after the booklet and 1 and 2 months later. Calls
were open-ended but with standardised protocol based on MI and with stage-based
objectives average 8.5 min.
C: Intervention 2: The pre-post group received as for group 2 + an additional 3 coun-
selling calls in the first 4 months after birth reinforcing themes from the Relapse Pre-
vention booklet; 3 newsletters at 2, 6 and 12 months postpartum about health effects of
environmental tobacco smoke and the importance of being a non-smoking parent
Main intervention strategy: Counselling (multiple intervention) compared to less in-
tensive intervention. Intervention 1 and 2 were only reported as combined outcomes
in late pregnancy, and included in this review. Postpartum outcomes are reported by
intervention group and combines smokers at baseline and spontaneous quitters
Intensity: Frequency (C = 2, I = 6); Duration (C = 1, I = 3).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Self-reported 7-day point prevalence abstinence at 28 weeks’ gestation (late pregnancy*)
, with sample biochemically validated. (combined I1 and I2), relapse prevention in late
pregnancy (spontaneous quitters*), abstinence at 8 weeks (0-5 months*), 6 months* (6-
11 months), and 12 months (12-17 months) postpartum (combined baseline smokers
and spontaneous quitters). Response rates were 92% at 28 weeks; 91% at 8 weeks’
postpartum; 89% at 6 months postpartum; 87% at 12 months postpartum
A subsequent paper reports partner abstinence.
Notes Process evaluation describes participation in specific intervention components, including
relapse prevention
Risk of bias
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McBride 1999 (Continued)
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not described.Theywere stratified by base-
line smoking status
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 110/1007 (11%) attrition. 88 miscarried
and 22 were sent wrong intervention ma-
terial and were excluded from analysis. 897
women included in final analysis. For self-
reported smoking status non-respondents
were treated as continuing smokers
Selective reporting (reporting bias) Unclear risk Smoking outcomes only reported and only
combined outcomes for abstinence at 28
weeks’ gestation
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Salivary cotinine analysis. Salivary cotinine
requested from all who reported abstaining
for 7 days (< 20 ng/mL as cut-off ). 64%-
78% returned saliva samples and as there
were no differences, outcomes reported are
based on self-reported status
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind providers and women
to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All samples were analysed for cotinine at
the American Health Foundation labora-
tory. The computer-assisted telephone sur-
veys were implemented by trained inter-
viewers who had no role in intervention ac-
tivities
Incomplete implementation Low risk Over 90% in the intervention group re-
called receiving the self-help booklet, re-
lapse prevention kit, counselling calls and
newsletters
Equal baseline characteristics in study arms Unclear risk There were some baseline differences re-
ported in text.
Contamination of control group Low risk The intervention was delivered via mail
and telephone without involving prenatal
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healthcare providers
McBride 2004 (AvB)
Methods 3-armed randomised controlled trial of counselling and social support interventions to
support women to stop smoking during pregnancy and prevent relapse postpartum
The study was conducted inWomack ArmyMedical Centre at Fort Bragg in Feyettville,
North Carolina (USA) from 1996 to 2001
Participants Inclusion criteria: <= 20 weeks pregnant, >= 18 years of age, current smokers or recent
quitters (i.e. were smokers in the 30 days prior to pregnancy but not smoking at intake),
livingwith an intimate partner, andwilling tohave the partner contacted for participation
in the study
Exclusion criteria: Not further specified.
Recruitment: 6156 woman screened at first prenatal clinic appointments were sent
introductory letters with a toll-free number to call to decline contact. 997 pregnant
smokers or recent quitters underwent further screening and 625 eligible women were
randomised
Baseline characteristics: Active smokers (C = 91, I1 = 87, I2 = 89). Recent quitters
(C = 107, I1 = 105, I2 = 104). Current mean cigarettes per day 6 (SD 5). 52% had a
partner who smoked
Mean age 24 years; Household income >= 20000 $US 44%; > high school 52%; 96%
married; 77% white
Progress + coding: none.
Interventions A: Control: ’UC’ where women received provider advice to quit smoking at the first
prenatal visit and were mailed the American Cancer Society’s self-help guide, “Make
Yours a Fresh Start Family,” written at the fifth-grade reading level and designed for
pregnant women
B: Intervention 1 (woman only): Control plus late pregnancy relapse-prevention kit
(a booklet and gift items) and 6 counselling calls (3 in pregnancy and 3 in postpartum)
initiated by a health advisor, who used a standardised protocol based on MI techniques.
All intervention contacts were completed by 4 months postpartum. Prenatal calls were
timed to occur in each trimester and emphasised using self-help materials to take stage-
appropriate steps towards cessation or to develop skills for remaining abstinent. Postpar-
tum calls were timed to occur at monthly intervals and emphasised skills for remaining
abstinent in the transition from pregnancy to parenting
C: Intervention 2 (partner-assisted group): Woman only intervention plus a PA ad-
junct, in which the smoker described how her partner could be a coach to build and
maintain the confidence she needed to quit smoking. An “It Takes Two” booklet and
companion video were developed to guide couples in discussing support behaviours re-
lated to the woman’s smoking. Partners received 6 separate calls (3 in pregnancy and 3
postpartum) from the woman’s health advisor. These calls were made separately to the
2 individuals (pregnant woman and partner) and guided by a MI protocol similar to
that used for counselling the women. The second and 4th calls to the couple focused on
developing a written agreement regarding helpful partner support behaviours. Partners
who smoked were given self-help cessation guides, free nicotine patches if needed, and
stage-appropriate counselling
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McBride 2004 (AvB) (Continued)
Main intervention strategy: Counselling (single intervention) compared to a less in-
tensive intervention. Intervention 1 (arm b) compared to control in this study ID
Intensity: Frequency (C = 2, I = 4); Duration (C = 1, I = 4). Estimate as duration of
calls not reported
Intervention provided by dedicated project staff: efficacy study
Outcomes Self-reported point prevalence abstinence at 28 weeks pregnancy among continuing
smokers in pregnancy (late pregnancy*), relapse prevention at 28weeks pregnancy among
spontaneous quitters (late pregnancy*), continued abstinence of combined spontaneous
quitters and smokers at 2 (0-5*), 6 (6-11*) and 12 (12-17) months postpartum
Partner cessation and perceived support were reported.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Reported as ’stratified by smoking status,
partners smoking status and partners will-
ingness to be involved and randomised to
one of 3 conditions’
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 42 (7%) women who miscarried were ex-
cluded resulting in a sample of 583 (C =
198, I1 = 192, I2 = 193). An ITT approach
was used, in which all randomised women
(other than those who hadmiscarried) were
included in the final analysis as continuing
smokers. Dropout rates did not differ sig-
nificantly across groups
Selective reporting (reporting bias) Low risk All primary outcomes appear to be re-
ported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking status only.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants to so-
cial support intervention, requiring partner
consent
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
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McBride 2004 (AvB) (Continued)
Incomplete implementation High risk Partner participation decreased steadily
throughout the trial
Equal baseline characteristics in study arms Low risk Baseline characteristics appear equal.
Contamination of control group Low risk Care providers not providing intervention.
McBride 2004 (AvC)
Methods 3-armed randomised controlled trial of counselling and social support interventions to
support women to stop smoking during pregnancy and prevent relapse postpartum
The study was conducted inWomack ArmyMedical Centre at Fort Bragg in Feyettville,
North Carolina (USA) from 1996 to 2001
Participants Inclusion criteria: <= 20 weeks pregnant, >= 18 years of age, current smokers or recent
quitters (i.e. were smokers in the 30 days prior to pregnancy but not smoking at intake),
livingwith an intimate partner, andwilling tohave the partner contacted for participation
in the study
Exclusion criteria: Not further specified.
Recruitment: 6156 woman screened at first prenatal clinic appointments were sent
introductory letters with a toll-free number to call to decline contact. 997 pregnant
smokers or recent quitters underwent further screening and 625 eligible women were
randomised
Baseline characteristics: Active smokers (C = 91, I1 = 87, I2 = 89). Recent quitters
(C = 107, I1 = 105, I2 = 104). Current mean cigarettes per day 6 (SD 5). 52% had a
partner who smoked
Mean age 24 years; Household income >= 20000 $US 44%; > high school 52%; 96%
married; 77% white
Progress + coding: none.
Interventions A: Control: ’UC’ where women received provider advice to quit smoking at the first
prenatal visit and were mailed the American Cancer Society’s self-help guide, “Make
Yours a Fresh Start Family,” written at the fifth-grade reading level and designed for
pregnant women
B: Intervention 1 (woman only): Control plus late pregnancy relapse-prevention kit
(a booklet and gift items) and 6 counselling calls (3 in pregnancy and 3 in postpartum)
initiated by a health advisor, who used a standardised protocol based on MI techniques.
All intervention contacts were completed by 4 months postpartum. Prenatal calls were
timed to occur in each trimester and emphasised using self-help materials to take stage-
appropriate steps towards cessation or to develop skills for remaining abstinent. Postpar-
tum calls were timed to occur at monthly intervals and emphasised skills for remaining
abstinent in the transition from pregnancy to parenting
C: Intervention 2 (partner-assisted group): Woman only intervention plus a PA ad-
junct, in which the smoker described how her partner could be a coach to build and
maintain the confidence she needed to quit smoking. An “It Takes Two” booklet and
companion video were developed to guide couples in discussing support behaviours re-
lated to the woman’s smoking. Partners received 6 separate calls (3 in pregnancy and 3
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McBride 2004 (AvC) (Continued)
postpartum) from the woman’s health advisor. These calls were made separately to the
2 individuals (pregnant woman and partner) and guided by a MI protocol similar to
that used for counselling the women. The second and 4th calls to the couple focused on
developing a written agreement regarding helpful partner support behaviours. Partners
who smoked were given self-help cessation guides, free nicotine patches if needed, and
stage-appropriate counselling
Main intervention strategy: Social support (multiple intervention) compared to a less
intensive intervention. Intervention 2 (arm c) compared to control in this study ID
Intensity: Frequency (C = 2, I = 6); Duration (C = 1, I = 5). Estimate as duration of
calls not reported
Intervention provided by dedicated project staff: efficacy study
Outcomes Self-reported point prevalence abstinence at 28 weeks pregnancy among continuing
smokers in pregnancy (late pregnancy*), relapse prevention at 28weeks pregnancy among
spontaneous quitters (late pregnancy*), continued abstinence of combined spontaneous
quitters and smokers at 2 (0-5*), 6 (6-11*) and 12*(12-17) months postpartum
Partner cessation and perceived support were reported.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Reported as ’stratified by smoking status,
partners smoking status and partners will-
ingness to be involved and randomised to
one of 3 conditions’
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 42 (7%) women who miscarried were ex-
cluded resulting in a sample of 583 (C =
198, I1 = 192, I2 = 193). An ITT approach
was used, in which all randomised women
(other than those who hadmiscarried) were
included in the final analysis as continuing
smokers. Dropout rates did not differ sig-
nificantly across groups
Selective reporting (reporting bias) Low risk All primary outcomes appear to be re-
ported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking status only.
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McBride 2004 (AvC) (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants to so-
cial support intervention, requiring partner
consent
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Partner participation decreased steadily
throughout the trial
Equal baseline characteristics in study arms Low risk Baseline characteristics appear equal.
Contamination of control group Low risk Care providers not providing intervention.
McLeod 2004
Methods 4-armed cluster-randomised trial (2 x 2) to support women to stop smoking in pregnancy
and breastfeed postpartum
Study conducted in the lower North Island, New Zealand, with recruitment from June
1999 to September 2000
Participants Inclusion criteria: The midwifery team was the unit of randomisation, which were
stratified by locality and randomised into 1 of 4 groups. All midwives in selected localities
in the lower north island were invited to take part. Midwives asked all pregnant women
who had smoked at the time they conceived to take part in the study
Exclusion criteria: Not further specified.
Recruitment: 93/121 (77%) midwives invited (from 62 midwifery teams), agreed to
participate, and were randomised into 1 of 4 study arms (C = 23,I1 = 22,I2 = 22, I3 = 26)
. 61 midwives recruited women to the study (76%). 46/349 (13%) women approached
declined to take part in the study, 6 were ineligible, and 297 were recruited (C = 60, I1
= 60, I2 = 69, I3 = 108)
Baseline characteristics: Partner smoking (C = 50%, I1 = 47%, I2 = 62%, I3 = 49%).
Mean age: C = 24.9, I1 = 26.1, I2 = 27.3, I3 = 25.1. Maori: C = 42%. I1 = 36%. I2 =
20%, I3 = 27%. Over 50% in receipt of community services card.
Progress + coding: Low SES.
Interventions Intervention developed with provider input and detailed discussion of provider views
included
A: Control: ’Usual’ maternity care from a midwife, which ranged from asking about
smoking, giving advice to quit and to providing more detailed smoking-cessation advice
B: Intervention 1 (smoking education): Midwife training to implement education and
support for smoking cessation and reduction
C: Intervention 2 (breastfeeding): Midwife training and support to implement educa-
tion and support for breastfeeding for women who smoked
D: Intervention 3 (combined): Midwife training to implement smoking education and
breastfeeding programmes
Smoking education included MI provided by a midwife (who was allocated an extra
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McLeod 2004 (Continued)
funded visit and given 4 hours training with a counsellor), flip-chart, video-tape
Main intervention strategy: Counselling (single intervention) compared toUC.Groups
A and C compared to groups B and D in this review
Intensity: Frequency (C = 0, I = 2), Duration (C = 0, I = 2). UC intensity: F = 1, D = 1
Intervention provided by existing staff (midwives): Effectiveness study
Outcomes Biochemically validated smoking cessation at 28 and 36 weeks’ gestation* (late preg-
nancy), and 6 weeks and 4 months postpartum* (0-5 months postpartum). Smoking
reduction outcomes of self-reported ’cut down a little’ or ’cut down significantly’ are not
included in this review as outcomes unclear
Breastfeeding outcomes also reported.
Notes Design effect for clustering reported, so outcome figures used for adjusting figures in
this review
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random sequence generation using excel
for each stratum.
Allocation concealment (selection bias) Low risk Group allocation by external statistician.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Missing data for most outcomes, 28% at-
trition for 4-month postnatal follow-up.
However, all randomised women included
in analysis in this review
Selective reporting (reporting bias) Unclear risk Smoking status only reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Serum cotinine samples provided by 108
women. 17/19 self-reported non-smokers
had cotinine levels consistent with non-
smoking, but outcomes not adjusted for
misclassification. 15 ng/mL cut-off level
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not possible to blind midwives to alloca-
tion group.Women were not aware of mid-
wife group allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
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McLeod 2004 (Continued)
Incomplete implementation Unclear risk There were problems with some midwives
not recruiting any women to the study, but
the degree of implementation among those
women recruited is not reported
Equal baseline characteristics in study arms High risk When compared with control group,
women in the smoking group were older
and less likely to beMaori. Also the number
of women recruited to the combined group
was much larger than the other groups,
which suggests potential issueswith recruit-
ment
Contamination of control group Unclear risk Cluster-study design to avoid contamina-
tion.
Mejdoubi 2014
Methods A single-blind, parallel-group, randomised controlled trial to assess the VoorZorg nurse
visitationprogramme, and its effects on smoking, pregnancy outcomes andbreastfeeding,
carried out in 20 different municipalities, the Netherlands between 2007 and 2009
Participants Inclusion criteria: Age < 26 years, <= 28 weeks pregnancy with the first child, low
educational level and some knowledge of theDutch language.Womenhad to have at least
1 risk factor: no social support, previously or currently experiencing domestic violence,
psychosocial symptoms, unwanted and/or unplanned pregnancy, financial problems,
housing difficulties, no education and/or employment and alcohol and/or drug use
Exclusion criteria: Not stated.
Recruitment: Women were actively recruited by GPs and midwives, with 460 pregnant
women randomised (C = 223 I = 237)
Baseline characteristics: Attempted to quit smoking (C = 80% I = 82%). Stopped
smoking after aware of the pregnancy (C = 20% I = 13%). Mean age (C = 19.2 I = 19.5)
Employed C = 28% I = 29%, Prevocational Education (C = 96% I = 94%) (rest primary
school only)
Progress + coding: Low SES due to inclusion criteria being presence of at least 1 risk
factor
Interventions Control: UC, which for pregnant women in the Netherlands includes maternal health
care delivered by a midwife
Intervention: Women in the intervention group were offered,in addition to UC, ap-
proximately 10 home visits during pregnancy, 20 during the first year and 20 during the
second life year of the child by trained, specialised VoorZorg nurses. According to the
protocol, 6 domains were discussed during the home visits: (1) the health status of the
mother, (2) the child’s health and safety,(3) the personal development of the mother, (4)
the role of the mother, (5) the mother’s relation with her partner, family and friends and
(6) the use of (health) care organisations
Main Intervention strategy:MaternalHealth interventionwith smoking cessation com-
ponent: social support (single) vs UC
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Mejdoubi 2014 (Continued)
Intensity: Frequency (C = 0, I = 6) Duration (C = 0, I = 4).
Intervention provided by study staff: efficacy study
Outcomes Self-reported abstinence in late pregnancy* (32 weeks of pregnancy), abstinence at 2
months post birth (0-5 months pp)*, mean number of cigarettes smoked per day*, birth-
weight, prematurity, LBW (< 2500 g), weeks of gestation, adverse pregnancy outcomes,
small for gestational age and breastfeeding. Birth outcomes not included in this review
as other aspects of intervention other than smoking cessation may have contributed to
these outcomes
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Participants were randomly assigned into
the control or intervention group after be-
ing stratified by region and ethnicity by use
of the computer-generated list of random
numbers
Allocation concealment (selection bias) Low risk Randomisationwas performedwith a com-
puter-generated list, so assume researcher
was blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Last observation carried forward approach
was conducted to replace missing data
Selective reporting (reporting bias) Low risk All outcomes are reported.
Other bias Unclear risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Cigarette smoking was assessed by self-re-
port measure.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Interviewers were blinded from allocation,
however as the intervention was health ed-
ucation is was not feasible to blind women
or providers
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Interviewers were blinded at follow-up.
Incomplete implementation Low risk Good implementation.
Equal baseline characteristics in study arms Low risk Baseline characteristics appeared to be
equal.
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Contamination of control group Low risk Main component of the intervention is
home visitation.
Messimer 1989
Methods Cluster-randomised controlled trial to test the effectiveness of the ALA smoking in
pregnancy intervention to support women to stop smoking in pregnancy
Study conducted in 11 private obstetric practices in Michigan and Upper Wisconsin
(USA), with recruitment from August 1985 to June 1986
Participants Inclusion criteria: 24 physicians in 11 private practices participated in the study (12
family physicians and 12 obstetricians). Study practices randomised into ’roughly equal
groups’. Women smoking at first AN appointment, less than 28 weeks’ gestation were
recruited to study
Exclusion criteria: Not further specified.
Recruitment: All women attending those clinics invited to participate. After giving
informed consent, each woman was assigned a code number and had a questionnaire
pack placed in her chart. 639 women screened (5 refusals), 206 smokers (32%), 69/209
had quit since becoming pregnant and 137 continuing smokers were included in the
study (C = 70, I = 67)
Baseline characteristics: Pre-pregnancy mean cigarettes per day = 20; current mean
cigarettes per day = 11
98% white, 70% married, majority (80%) completed high school
Progress + coding: None.
Interventions Control: 3 counselling sessions with physician on risks, ashtrays removed from waiting
rooms and staff asked not to smoke in front of patients
Intervention: Control plus (i) use of ALA materials (because you love your baby flip
chart; because you love your baby packets, because you love your baby poster) (ii) en-
couragement to send off for materials (freedom from smoking manual), (iii) slide tape
presentation at each women’s first obstetrics visit
Main intervention strategy: Counselling (multiple intervention) compared to less in-
tensive intervention
Intensity: Frequency (C = 3, I = 5), Duration (C = 1, I = 2).
Intervention provided by existing staff (physicians): Effectiveness study
Outcomes Self-reported smoking abstinence at 32-36 weeks’ gestation (late pregnancy*) and first
postpartum visit (timing not specified but assumed is standard 6 weeks pp visit), 0-5
months pp*
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified by size - and then assigned by coin
toss.
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Allocation concealment (selection bias) High risk Allocation not concealed with coin toss
randomisation.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: 7 miscarriages (C = 4, I = 3), 2
therapeutic abortions (C = 0, I = 2), 11
moved (C = 6, I = 5) and 8 had an incom-
plete dataset (C = 4, I = 4). Those with in-
complete dataset were re-included as con-
tinuing smokers in this review (C = 60, I =
57)
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation of smoking sta-
tus (self-report only)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind providers and women
to educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Exact rates not reported - but ’only minor
deviations’ suggests very high implementa-
tion
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Cluster-randomised by clinic - so unlikely
to have ALA materials
Moore 1998
Methods Randomised controlled trial of nurse telephone support, which aimed to reduce infants
born LBW and preterm, and included advice on smoking
Study conducted in a community public clinic in the USA. Location and dates of data
collection unclear
Participants Inclusion criteria: Women with a preterm labour risk score of at least 7 on the Wake
Forest University School of Medicine risk assessment tool; English-speaking; access to
telephone; 22-32 weeks’ gestation
Exclusion criteria: Not further specified.
Recruitment: 1850/3127 (59.2%) eligible women contacted. 1554 (84%) agreed to
participate and were randomised (C = 779, I = 775)
Baseline characteristics: 21.2% (n = 253) identified themselves as smokers.
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Black = 1113, White or other = 320.
Progress + coding: Not coded for this review as outcomes unable to be included
Interventions Control: Booklet about preventing preterm labour, available in regular clinic. $10 gift
certificate for completing questionnaire at 34 weeks’ gestation
Intervention: As control + instruction about signs of preterm labour, nurse telephone
call schedule. 3 telephone calls per week which addressed: assessment of health status
(including cigarette use); recommendations; and discussion of additional issues impor-
tant to mother. $25 gift certificate at 37 weeks or after the birth of their baby if they
returned their assessment and remained in contact with the nurse by telephone
Main intervention strategy: Maternal health intervention with smoking component:
Counselling (single intervention) compared to UC
Intensity: Not coded as outcomes not able to be included.
Outcomes LBW and preterm births. Outcomes not included in study as unclear what proportion of
outcomes were related to smokers. Furthermore, other aspects of the intervention (other
than smoking cessation) may have impacted on perinatal outcomes so not included in
this review
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random assignment by biostatistician us-
ing computer randomisation table
Allocation concealment (selection bias) Low risk Opaque sealed envelopes.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 7.8% attrition due to moving or multiple
pregnancies, leaving 1433 included in birth
outcome analysis. I = 718, C = 715
Selective reporting (reporting bias) Unclear risk Smoking rates not reported, though not the
primary aim of study
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking, but not reported as
an outcome in this study
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women and providers not able to be
blinded to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessor blinded.
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Incomplete implementation Low risk Process evaluation not reported.
Equal baseline characteristics in study arms Low risk No significant differences between groups.
Contamination of control group Unclear risk Telephone intervention so unlikely calls
were made to wrong women
Moore 2002
Methods Cluster-randomised trial of self-help booklets to support women to stop smoking and
prevent relapse in pregnancy
Study conducted in 3 NHS hospital trusts in England (UK), with recruitment fromMay
1998 to July 2000
Participants Inclusion criteria: Midwives were the unit of randomisation. Women attending first
visit; >= 16 years; < 17 weeks’ gestation; literate in English were eligible. Smokers counted
as those who reported “I smoke now”, “I smoke now but have cut down since I thought
I might be pregnant”, or “I have stopped smoking since I thought I might be pregnant”
Exclusion criteria: Not further specified.
Recruitment: All 128 community midwives in 3 trusts agreed to participate and were
randomly allocated to 6 strata (C = 64, I = 64). 3 midwives went on maternity leave
and did not recruit any women (C = 64, I = 61). 8586 women screened and 1527/1803
(85%) eligible women consented to participate (C = 803, I = 724)
Baseline characteristics: Current smokers: C = 97, I = 97; Current but reduced since
pregnancy: C = 464, I = 445 (All current smokers C = 561, I = 542); Recent quitters:
C = 242, I = 182. Mean cigarettes per day before pregnancy: C = 15.1, I = 16. Mean
cigarettes per day at baseline C = 5.5, I = 6.4
Maternal age: C = 26.7, I = 27.2. Left full time education by 16 years: C = 63.6%, I =
61%.
Progress + coding: Low SES.
Interventions Control:Midwives continued to give routine advice according to usual practice.
Intervention:Midwives spent at least 5 mins introducing a series of 5 self-help booklets
“Stop for Good”, based on stages of change theory, and gave them a copy of the first
booklet. Subsequent booklets were mailed directly to the woman
Main intervention strategy: Counselling (single intervention) compared to UC.
Intensity: Frequency: (C = 0, I = 4), Duration (C = 0, I = 1). UC intensity: F = 1, D = 1
Intervention provided by existing staff: Effectiveness study
Outcomes 7-day point prevalence abstinence at 26 weeks’ gestation (late pregnancy*), with 94%
validated by urine cotinine (80 ng/mL). Self-reported mean cigarettes per day in late
pregnancy*. Relapse prevention for recent quitters not reported separately so outcomes
for smokers and recent quitters are combined in this analysis.
Stillbirths or neonatal deaths (not included as unable to separate), and preterm births (<
27 weeks) not included as rates < 36-37 weeks not reported. Reported as ’attrition’
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Notes Reported intracluster correlation of 0.031 used to adjust outcome data for inclusion in
outcome tables. Sample size justification
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified random allocation by computer-
generated random numbers. 118 midwives
stratified according to workload and ran-
domly allocated to provide intervention or
control care
Allocation concealment (selection bias) Unclear risk No information.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 92/1527 (6%) excluded from analysis due
to miscarriage or termination (C = 36, I
= 40), stillbirth or neonatal death (C = 9,
I = 6)-not included as unable to separate,
preterm birth (C = 1). Those lost to further
follow-up (C = 50, I = 68) were included as
continuing smokers in this review, leaving
1435 (C = 757, I = 678)
Selective reporting (reporting bias) High risk Outcomes not reported separately for base-
line smokers and spontaneous quitters
Other bias Unclear risk Some unequal recruitment in each arm
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine levels analysed (cut-off 60
ng/mL and 100 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Midwives randomised. Educational inter-
vention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcome assessment blinding not re-
ported.However, follow-up rates were high
in both groups, and all data coding and
cleaningwas undertakenblind to treatment
allocation
Incomplete implementation High risk Detailed qualitative and quantitative pro-
cess analysis of participants’ and midwives’
views of the intervention, which suggested
poor implementation in some areas
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Equal baseline characteristics in study arms High risk There were some differences between the 2
treatment groups at baseline, most notably
in the numbers of women who had stopped
smoking before the booking appointment
and in the quantity of cigarettes consumed
before the pregnancy and at the time of
booking
Contamination of control group High risk Some concerns about contamination of
control group reported.
Naughton 2012
Methods Pilot randomised controlled trial to evaluate the feasibility, acceptability and potential
effectiveness of tailored leaflets and SMS text messaging self-help intervention (MiQuit)
to support women to stop smoking in pregnancy
Study conducted in 7 National Health Service Trusts in the south east, east and north
east of England (UK), with recruitment between December 2008 and October 2009
Participants Inclusion criteria: Pregnant women less than 21 weeks’ gestation, 16 years of age and
over, smoked >= 7 cigarettes per week, owned or had regular use of a mobile phone, and
could understand written English
Exclusion criteria: Not further specified.
Recruitment: 625 women were referred by midwives to the study and 207/512 (40%)
eligible women agreed to participate and were randomised to the study (C = 105, I =
102)
Baseline characteristics: Cigarettes per day before pregnancy and at enrolment reported
by 6 categories and equal in both arms. Majority (over 60%) 11-20 cigarettes/day before
pregnancy and approximately 50% 4-10 cigarettes/day at enrolment
Median age 26-27 years; 16% did not complete high school; 100% white
Progress + coding: None.
Interventions Control: Participants received a non-tailored self-help leaflet, whichmatched the tailored
leaflet in format and style, and the same assessment texts as MiQuit participants but no
intervention texts
Intervention:Participants receive MiQuit tailored self-help leaflet by post. Thereafter,
automated tailored text message component of intervention is initiated. 80 texts sent
out over 11 weeks. MiQuit participants could also request instant response supportive
texts at any time of the day
Main intervention strategy: Health education (multiple intervention) compared to less
intensive intervention
Intensity: Frequency: (C = 2, I = 6), Duration: (C = 1, I = 1).
Technological intervention: Unclear whether efficacy or effectiveness study
Outcomes Biochemically validated 7-day point prevalence at 3-month follow-up (late pregnancy)
*, self-reported 4-week point prevalence, initiation and frequency of quit attempts and
7-day point prevalence at 3 and 7 weeks after enrolment; Self-efficacy (5-point scale),
acceptability measures
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Notes Process evaluation showed 98% intervention and 89% control participants received the
leaflet and 87% intervention participants reported reading text messages at least once
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Generation of the randomisation tables
and allocation of participants were imple-
mented in a computer programme and
managed by SS who had no contact with
participants or involvement in data collec-
tion or entry
Allocation concealment (selection bias) Low risk ’The allocation sequence was concealed
from other members of the research team,
midwives, and participants’ (p570)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Drop-outs due to miscarriage or stillbirth
were excluded from the analysis (I = 6, C =
3). Reported as combined figure. 11% fur-
ther attrition for other reasons (I = 10, C =
13), were included in analysis as continu-
ing smokers (C = 96, I = 102)
Selective reporting (reporting bias) Low risk All primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of self-reported
smoking cessation with salivary cotinine (<
13 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Women unlikely to be blinded to educa-
tional intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk ’FN undertook data collection and was
blinded to group allocation until all data
had been collected.’ (p570)
Incomplete implementation Low risk 90%MiQuit participants reported reading
all the leaflet at least once
Equal baseline characteristics in study arms Low risk There were no differences between trial
arms on baseline variables except that more
participants in the control arm had smoked
233Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Naughton 2012 (Continued)
in a previous pregnancy (difference ad-
justed for in analyses)
Contamination of control group Low risk Technological intervention so low risk of
contamination between study arms
Olds 1986
Methods 4-armed randomised controlled trial which aimed to improve the uptake of prenatal care
and pregnancy outcomes (especially LBW), and included advice about smoking
Study conducted in a semi-rural county of New York State (USA), with recruitment
between April 1978 and September 1980
Participants Inclusion criteria: Pregnant women with no prior live births + any of the following:
< 19 years; single; low socio-economic status, and any other women with no prior live
births who wished to participate in the program
Exclusion criteria: > 25 weeks’ gestation (though some were enrolled at 25-29 weeks)
Recruitment: Through private obstetricians’ offices, planned parenthood, public schools
health department AN clinics and other health and human service agencies. 10% of
target population entered prenatal care too late, 10% were not referred from private
care. 500 women were interviewed and 400 enrolled (80%). Families were stratified by
marital status, race, and 7 geographic regions (C = 90, I1 = 94, I2 = 100, I3 = 116). 141
smokers (C = 64, I = 77).
Baseline characteristics: Mean cigarettes per day at intake: C = 6.94, I = 7.65.
47% < 19 years old, 62% single, 61% low SES (15% had none of these factors). Non-
Whites (46) excluded because too few; serious maternal or fetal conditions (20) excluded
Progress + coding: Low SES.
Interventions Control: Health and developmental screening of the baby at 12 and 24 months;
A: Intervention 1: Control + free transport to pregnancy and well-child visits (control);
B: Intervention 2: 1 + nurse home visits during pregnancy (intervention);
C: Intervention 3: 2 + nurse home visits in child’s first 2 years.
The focus of the home visiting was individualised from a detailed curriculum dealing
with information on fetal and infant development; improvement of maternal diet; mon-
itoring weight gain; elimination of cigarettes, alcohol and drugs; identifying pregnancy
complications; encouraging rest, exercise and hygiene; preparing for labour birth and
early newborn care. The intervention was also described as enhancement of informal
support systems (partners, family and friends) and linkage of parents to community
services, including nutritional care, prenatal providers and other services
Main intervention strategy: Maternal health intervention with smoking cessation com-
ponent: Social support (tailored intervention) compared to UC. Intervention 2 and 3
(nurse-visiting arms) compared to control and intervention 1 arms (no nurse visiting)
in this review.
Intensity: Freqency (C = 0, I = 6), Duration (C = 0, I = 4). UC intensity: F = 0, D = 0
Intervention provided by dedicated study team: Efficacy study
Outcomes Cotinine levels taken in a subsample (n =116), but nowomen reported smoking cessation
at 32 weeks’ gestation (late pregnancy)*. Mean cigarettes per day at 32 weeks (late
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pregnancy*). No mean cotinine levels reported for inclusion. Self-reported reduction
in cigarettes, but not reported as a mean for inclusion in this review. Birth outcomes
were not included as aspects of the intervention, other than smoking cessation, may
potentially improve birth outcomes
Notes SDs for mean cigarettes per day were not reported, therefore we calculated a mean SD
from 14 studies with available mean cigarette SDs (6.5) to include in this review, as
recommended by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided.
Allocation concealment (selection bias) Unclear risk Not specified.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 6.5% attrition (C = 12, I = 14) due tomov-
ing or miscarriage. However outcomes for
307/400 women only reported. Outcomes
for all smokers at intake reported
Selective reporting (reporting bias) Low risk Detailed range of outcomes reported.
Other bias Unclear risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Serum cotinine analysis on subsample of
116. No self-reported cessation to validate
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Home visitation programme. Blinding of
participants and personnel not viable
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk The interviewers and medical record re-
viewers hired by the research project did
not know to which treatment the women
had been assigned
Incomplete implementation Unclear risk Not reported.
Equal baseline characteristics in study arms High risk Women assigned anurse had less social sup-
port.
Contamination of control group Low risk Home visits.
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Methods 3-armed randomised controlled trial of home visiting during pregnancy by paraprofes-
sionals and nurses to improve maternal and child health, and included advice about
smoking
The study was conducted in 21 prenatal clinics in Denver (USA) from March 1994 to
June 1995
Participants Inclusion criteria: Pregnant women with no previous live births and either qualified for
Medicaid or had no private medical insurance
Exclusion criteria: Not further specified.
Recruitment: By written invite, and were not required to respond. 735/1135 eligible
women participated in the study, 70 of whom were smokers (C = 25, I1 = 21,I2 = 24).
Baseline characteristics: Not reported among smoking subgroup.
Interventions A: Control: Developmental screening and referral services for children at 6, 12, 15, 21
and 24 months old
B: Intervention 1 (Paraprofessional): Screening and referral plus paraprofessional home
visiting for first 2 years of infants life. Aimed to improve maternal and fetal health,
improve health and development of child, and enhance parents personal development
C: Intervention 2 (Nurse): Screening and referral plus nurse home visiting for first 2
years of infants life. Aimed to improve maternal and fetal health, improve health and
development of child, and enhance parents personal development
Main intervention strategy: Maternal health intervention with smoking component:
Social support (single) vs less intensive intervention. Not coded or compared in this
review as outcomes unable to be included
Outcomes Outcomes not able to be included in meta-analysis, as only mean reduction in cotinine
reported. See Table 1 for outcome summary.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random sequence.
Allocation concealment (selection bias) Unclear risk Allocation conducted in separate data cen-
tre.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Unclear whether all randomised smokers
were included in cotinine analysis
Selective reporting (reporting bias) High risk Smoking cessation rates not reported, but
are not a primary outcome of this study
Other bias Low risk No other bias detected.
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Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Unclear whether all randomisedwomen in-
cluded in cotinine analysis
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Providers and women not able to be
blinded as social support intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded to allocation.
Study team unaware of allocation, unless
the participant told them
Incomplete implementation Low risk Paraprofessionals completed an average of
6.3 visits and nurses an average of 6.5 visits
Equal baseline characteristics in study arms Unclear risk Baseline characteristics of smokers not re-
ported. But treatment groups similar with
’few exceptions’
Contamination of control group Low risk Home visits.
Ondersma 2012 (A+C v B+D)
Methods 4-armed (2 x 2 factorial design) randomised controlled trial of a computer-delivered brief
intervention (CD-5As) and incentives to support women to stop smoking in pregnancy
The studywas conducted in 4 prenatal care clinics inDetroit,MI (USA)with recruitment
from July 2008 to November 2009, and final evaluation completed by January 2010
Participants Inclusion criteria: Pregnant women aged 18 years or older, being no further than 27
weeks’ gestation, and reporting smoking in the past week
Exclusion criteria: Unable to understand spoken English.
Recruitment: 1317 women were screened while in the clinic waiting area. 110/114
(96%) eligible women provided consent and were randomised (C = 26, I1: CD-5As only
= 26, I2: CM-Lite only = 28, I3 = CM-Lite + CD 5As = 30).
Baseline characteristics: Average cigarettes per day in week prior to recruitment: mean
= 8 (SD 8.2). 70% lived with a smoker. 52.8% had a Fagerstrom score >= 4 (nicotine
dependence)
Mean age 27.9 (6.4); 90% Black. K6 emotional distress 14.9.
Progress + coding: Low SES and ethnic minority.
Interventions A: Control: UC from prenatal care from care-providers without influence from the
research team
B: Intervention 1 CD-5As only: Computer-delivered brief intervention designed to be
consistent with ’5As national guidelines (USA)’ (Ask, Advise, Assess, Assist, Arrange)
and-for those who are unwilling to set a quit goal-the 5Rs (with steps involving the
highlighting of Relevance, Risks, Rewards, Roadblocks, and Repetition). The ’Advice’
included a 5-min video featuring a male black obstetrician and 3 testimonials from
women of varying race, which was direct but designed to be positive and frame the
benefits of quitting rather than the risks of smoking
237Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ondersma 2012 (A+C v B+D) (Continued)
C: Intervention 2 CM-Lite (incentives) only: This modified version of ’contingency
management’ was designed for use with non-treatment-seeking persons in a healthcare
setting with the presumption of (a) at least occasional repeat office visits and (b) limited
ability of medical staff to monitor participants or participate in training. Thus, no
proactive tracking was provided in CM-Lite: It was designed to be patient-initiated, with
staff checking eligibility if and when a patient asks to have their smoking status verified
rather than relying on staff to check the eligibility of every incoming patient. CM-
Lite calls for testing at prenatal care visits only and unlimited incentivisation attempts,
but only up to a maximum of 5 episodes of reinforcement (in the form of retail gift
cards worth $50), only at prenatal clinic visits, each at least a week apart. CM-Lite was
delivered with the help of a website which facilitated the process of verifying eligibility
of participants, provided step-by-step guidance in how to conduct a valid test for urinary
cotinine, recorded the results of testing, and provided a record of all incentive attempts
and their outcome
D: Intervention 3 CD-5As + CM-Lite combined.
Main intervention strategy: Health education (single intervention) compared to UC.
Intervention 1 + 3 (arms B + D) compared with control + intervention 2 (arms A + C)
in this study ID to capitalise on factorial design to assess effect of health education
Intensity: Frequency (C = 0, I = 1), Duration (C = 0, I = 1).
Technological intervention: unclear whether delivered by existing staff (Effectiveness
study) or dedicated project staff (efficacy study)
Outcomes Biochemically validated abstinence (cotinine; 7-day point prevalence + CO; and 30-day
abstinence) at 10-week follow-up (late pregnancy*). We have used cotinine validated
outcomes in this review as it is more comparable with other studies in this review where
only 1 validation method is reported. Secondary help-seeking (Quitline), self-reported
sustained abstinence in the past 30 days, Fagerstrom Test for nicotine dependence; Base-
line K6 measure of overall emotional distress; Acceptability (satisfaction-related mea-
sures)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer randomisation of all partici-
pants into either CD-5As or time con-
trol conditions and after participants com-
pleted all computer-delivered content-re-
search assistants used a predetermined list
of computer-generated random numbers
to further randomise half of all participants
into the CM condition
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition 16/110 (14.5%) lost to follow-
up. All analyses were on an ITT basis that
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analysed participants as allocated to condi-
tion without respect to completion of treat-
ment elements. Only 2 women who with-
drew due to miscarriage (1 in combined
arm and 1 in UC arm) were excluded from
the analysis in this review. A = 25, B = 26,
C = 28, D = 29 (n = 108 included)
Selective reporting (reporting bias) Low risk All primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported 7-day abstinence biochemi-
cally validated with expired CO (< 4 ppm)
and urinary cotinine (< 100 ng/mL)*
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Each intervention involved the same level
of interaction with the computer and
took the same approximate amount of
time, thus keeping research assistants blind
to computer-delivered intervention condi-
tion. Not feasible to blind participants
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk It is not stated whether outcome assessors
were blinded.
Incomplete implementation Unclear risk Process evaluation showed all participants
assigned to CD-5As condition completed
the items and evaluations and gave high
satisfaction ratings. Of the participants as-
signed to CM-Lite only 37.9% initiated
testing of at least 1 urine sample (mean 3.
7, SD 1.9)
Equal baseline characteristics in study arms Low risk There were no significant differences be-
tween conditions on any of the baseline
characteristics examined, although 1 vari-
able (minority vs non-minority race) was
below P = .10 and so was controlled for in
subsequent analyses
Contamination of control group Low risk The risk of contamination between study
arms is low as interventions are all provided
via technology
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Methods 4-armed (2 x 2 factorial design) randomised controlled trial of a computer-delivered brief
intervention (CD-5As) and incentives to support women to stop smoking in pregnancy
The studywas conducted in 4 prenatal care clinics inDetroit,MI (USA)with recruitment
from July 2008 to November 2009, and final evaluation completed by January 2010
Participants Inclusion criteria: Pregnant women aged 18 years or older, being no further than 27
weeks’ gestation, and reporting smoking in the past week
Exclusion criteria: Unable to understand spoken English.
Recruitment: 1317 women were screened while in the clinic waiting area. 110/114
(96%) eligible women provided consent and were randomised (C = 26, I1: CD-5As only
= 26, I2: CM-Lite only = 28, I3 = CM-Lite + CD 5As = 30).
Baseline characteristics: Average cigarettes per day in week prior to recruitment: mean
= 8 (SD 8.2). 70% lived with a smoker. 52.8% had a Fagerstrom score >= 4 (nicotine
dependence)
Mean age 27.9 (6.4); 90% Black. K6 emotional distress 14.9.
Progress + coding: Low SES and ethnic minority.
Interventions A: Control: UC from prenatal care from care-providers without influence from the
research team
B: Intervention 1 CD-5As only: Computer-delivered brief intervention designed to be
consistent with ’5As national guidelines (USA)’ (Ask, Advise, Assess, Assist, Arrange)
and-for those who are unwilling to set a quit goal-the 5Rs (with steps involving the
highlighting of Relevance, Risks, Rewards, Roadblocks, and Repetition). The ’Advice’
included a 5-min video featuring a male black obstetrician and 3 testimonials from
women of varying race, which was direct but designed to be positive and frame the
benefits of quitting rather than the risks of smoking
C: Intervention 2 CM-Lite (incentives) only: This modified version of ’contingency
management’ was designed for use with non-treatment-seeking persons in a healthcare
setting with the presumption of (a) at least occasional repeat office visits and (b) limited
ability of medical staff to monitor participants or participate in training. Thus, no
proactive tracking was provided in CM-Lite: It was designed to be patient-initiated, with
staff checking eligibility if and when a patient asks to have their smoking status verified
rather than relying on staff to check the eligibility of every incoming patient. CM-
Lite calls for testing at prenatal care visits only and unlimited incentivisation attempts,
but only up to a maximum of 5 episodes of reinforcement (in the form of retail gift
cards worth $50), only at prenatal clinic visits, each at least a week apart. CM-Lite was
delivered with the help of a website which facilitated the process of verifying eligibility
of participants, provided step-by-step guidance in how to conduct a valid test for urinary
cotinine, recorded the results of testing, and provided a record of all incentive attempts
and their outcome
Intervention 3 CD-5As + CM-Lite combined.
Main intervention strategy: Incentives (tailored intervention) compared to UC. Inter-
vention 2 compared with control in this study ID
Intensity: Frequency (C = 0, I = 5), Duration (C = 0, I = 1).
Technological intervention: unclear whether delivered by existing staff (Effectiveness
study) or dedicated project staff (efficacy study)
Outcomes Biochemically validated abstinence (cotinine; 7-day point prevalence + CO; and 30-day
abstinence) at 10-week follow-up (late pregnancy*). We have used cotinine validated
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outcomes in this review as it is more comparable with other studies in this review where
only 1 validation method is reported. Secondary help-seeking (Quitline), self-reported
sustained abstinence in the past 30 days, Fagerstrom Test for nicotine dependence; Base-
line K6 measure of overall emotional distress; Acceptability (satisfaction-related mea-
sures)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer randomisation of all partici-
pants into either CD-5As or time con-
trol conditions and after participants com-
pleted all computer-delivered content-re-
search assistants used a predetermined list
of computer-generated random numbers
to further randomise half of all participants
into the CM condition
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition 16/110 (14.5%) lost to follow-
up. All analyses were on an ITT basis that
analysed participants as allocated to condi-
tion without respect to completion of treat-
ment elements. Only 2 women who with-
drew due to miscarriage (one in combined
arm and 1 in UC arm) were excluded from
the analysis in this review. A = 25, B = 26,
C = 28, D = 29 (n = 108 included)
Selective reporting (reporting bias) Low risk All primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported 7-day abstinence biochemi-
cally validated with expired CO (< 4 ppm)
and urinary cotinine (< 100 ng/mL)*
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Each intervention involved the same level
of interaction with the computer and
took the same approximate amount of
time, thus keeping research assistants blind
to computer-delivered intervention condi-
tion. Not feasible to blind participants
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Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk It is not stated whether outcome assessors
were blinded.
Incomplete implementation Unclear risk Process evaluation showed all participants
assigned to CD-5As condition completed
the items and evaluations and gave high
satisfaction ratings. Of the participants as-
signed to CM-Lite only 37.9% initiated
testing of at least 1 urine sample (mean 3.
7, SD 1.9)
Equal baseline characteristics in study arms Low risk There were no significant differences be-
tween conditions on any of the baseline
characteristics examined, although 1 vari-
able (minority vs non-minority race) was
below P = .10 and so was controlled for in
subsequent analyses
Contamination of control group Low risk The risk of contamination between study
arms is low as interventions are all provided
via technology
Ondersma 2012 (AvD)
Methods 4-armed (2 x 2 factorial design) randomised controlled trial of a computer-delivered brief
intervention (CD-5As) and incentives to support women to stop smoking in pregnancy
The studywas conducted in 4 prenatal care clinics inDetroit,MI (USA)with recruitment
from July 2008 to November 2009, and final evaluation completed by January 2010
Participants Inclusion criteria: Pregnant women aged 18 years or older, being no further than 27
weeks’ gestation, and reporting smoking in the past week
Exclusion criteria: Unable to understand spoken English.
Recruitment: 1317 women were screened while in the clinic waiting area. 110/114
(96%) eligible women provided consent and were randomised (C = 26, I1: CD-5As only
= 26, I2: CM-Lite only = 28, I3 = CM-Lite + CD 5As = 30).
Baseline characteristics: Average cigarettes per day in week prior to recruitment: mean
= 8 (SD 8.2). 70% lived with a smoker. 52.8% had a Fagerstrom score >= 4 (nicotine
dependence)
Mean age 27.9 (6.4); 90% Black. K6 emotional distress 14.9.
Progress + coding: Low SES and ethnic minority.
Interventions A: Control: UC from prenatal care from care-providers without influence from the
research team
B: Intervention 1 CD-5As only: Computer-delivered brief intervention designed to be
consistent with ’5As national guidelines (USA)’ (Ask, Advise, Assess, Assist, Arrange)
and-for those who are unwilling to set a quit goal-the 5Rs (with steps involving the
highlighting of Relevance, Risks, Rewards, Roadblocks, and Repetition). The ’Advice’
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included a 5-min video featuring a male black obstetrician and 3 testimonials from
women of varying race, which was direct but designed to be positive and frame the
benefits of quitting rather than the risks of smoking
C: Intervention 2 CM-Lite (incentives) only: This modified version of ’contingency
management’ was designed for use with non-treatment-seeking persons in a healthcare
setting with the presumption of (a) at least occasional repeat office visits and (b) limited
ability of medical staff to monitor participants or participate in training. Thus, no
proactive tracking was provided in CM-Lite: It was designed to be patient-initiated, with
staff checking eligibility if and when a patient asks to have their smoking status verified
rather than relying on staff to check the eligibility of every incoming patient. CM-
Lite calls for testing at prenatal care visits only and unlimited incentivisation attempts,
but only up to a maximum of 5 episodes of reinforcement (in the form of retail gift
cards worth $50), only at prenatal clinic visits, each at least a week apart. CM-Lite was
delivered with the help of a website which facilitated the process of verifying eligibility
of participants, provided step-by-step guidance in how to conduct a valid test for urinary
cotinine, recorded the results of testing, and provided a record of all incentive attempts
and their outcome
D: Intervention 3 CD-5As + CM-Lite combined.
Main intervention strategy: Incentives (multiple intervention) compared to UC. In-
tervention 3 compared with control in this study ID
Intensity: Frequency (C = 0, I = 5), Duration (C = 0, I = 1). UC intensity unclear: F =
0, D = 0
Technological intervention: unclear whether delivered by existing staff (Effectiveness
study) or dedicated project staff (efficacy study)
Outcomes Biochemically validated abstinence (cotinine; 7-day point prevalence + CO; and 30-day
abstinence) at 10-week follow-up (late pregnancy*). We have used cotinine validated
outcomes in this review as it is more comparable with other studies in this review where
only 1 validation method is reported. Secondary help-seeking (Quitline), self-reported
sustained abstinence in the past 30 days, Fagerstrom Test for nicotine dependence; K6
measure of overall emotional distress; Acceptability (satisfaction-related measures)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer randomisation of all partici-
pants into either CD-5As or time con-
trol conditions and after participants com-
pleted all computer-delivered content-re-
search assistants used a predetermined list
of computer-generated random numbers
to further randomise half of all participants
into the CM condition
Allocation concealment (selection bias) Unclear risk Not reported.
243Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ondersma 2012 (AvD) (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition 16/110 (14.5%) lost to follow-
up. All analyses were on an intent-to-treat
basis that analysed participants as allocated
to condition without respect to completion
of treatment elements. Only 2 women who
withdrew due to miscarriage (one in com-
bined arm and 1 in UC arm) were excluded
from the analysis in this review. A = 25, B
= 26, C = 28, D = 29 (n = 108 included)
Selective reporting (reporting bias) Low risk All primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported 7-day abstinence biochemi-
cally validated with expired CO (< 4 ppm)
and urinary cotinine (< 100 ng/mL)*
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Each intervention involved the same level
of interaction with the computer and
took the same approximate amount of
time, thus keeping research assistants blind
to computer-delivered intervention condi-
tion. Not feasible to blind participants
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk It is not stated whether outcome assessors
were blinded.
Incomplete implementation Unclear risk Process evaluation showed all participants
assigned to CD-5As condition completed
the items and evaluations and gave high
satisfaction ratings. Of the participants as-
signed to CM-Lite only 37.9% initiated
testing of at least 1 urine sample (mean 3.
7, SD 1.9)
Equal baseline characteristics in study arms Low risk There were no significant differences be-
tween conditions on any of the baseline
characteristics examined, although 1 vari-
able (minority vs non-minority race) was
below P = .10 and so was controlled for in
subsequent analyses
Contamination of control group Low risk The risk of contamination between study
arms is low as interventions are all provided
via technology
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Oude Wesselink 2014
Methods This cluster-randomised controlled trial (Programme C) was part of a larger programme
carried out by the Dutch Healthcare Inspectorate which aimed to improve the provision
of smoking-cessation counselling to pregnant women by primary care midwives
Participants Inclusion criteria: Not stated.
Exclusion criteria: Any practices that had a large part of the staff and owner changed
Recruitment: 14 intervention and 38 control practices.
Baseline characteristics: Not stated.
Progress + coding: None.
Interventions Control:Nothing implemented.
Intervention: Intervention involved a site visit to improve provider provision of smoking
cessation services (outcome). The supervision programme consisted of 3 elements: an-
nouncement of a deadline by which changes must be made (Programme A), assessments
with questionnaires and personal report (Programme B) and assessments with site visits
and personal report, which was the Randomised Controlled Trial (Programme C)
Main Intervention strategy: Other (dissemination) v UC
Progress plus coding: None and not included.
Outcomes No smoking outcomes reported. Only provision of smoking cessation services by
providers. See Table 1 for summary of results.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Intervention (project C) aimed at changing
provider practice (outcomes) so no infor-
mation on pregnant smokers provided
Allocation concealment (selection bias) Unclear risk Intervention (project C) aimed at changing
provider practice (outcomes) so no infor-
mation on pregnant smokers provided
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Intervention (project C) aimed at changing
provider practice (outcomes) so no infor-
mation on pregnant smokers provided
Selective reporting (reporting bias) Unclear risk Intervention (project C) aimed at changing
provider practice (outcomes) so no infor-
mation on pregnant smokers provided
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk No smoking outcomes reported, so not ap-
plicable.
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Oude Wesselink 2014 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Intervention (project C) aimed at changing
provider practice (outcomes) so no infor-
mation on pregnant smokers provided
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Intervention (project C) aimed at changing
provider practice (outcomes) so no infor-
mation on pregnant smokers provided
Incomplete implementation Unclear risk Intervention (project C) aimed at changing
provider practice (outcomes) so no infor-
mation on pregnant smokers provided
Equal baseline characteristics in study arms Unclear risk Intervention (project C) aimed at changing
provider practice (outcomes) so no infor-
mation on pregnant smokers provided
Contamination of control group Unclear risk Intervention (project C) aimed at changing
provider practice (outcomes) so no infor-
mation on pregnant smokers provided
Panjari 1999
Methods Randomised controlled trial of counselling interventions to support women to stop
smoking in pregnancy
Study conducted in a public AN clinic in Melbourne, Victoria, Australia. Data collected
from April 1994 to June 1996
Participants Inclusion criteria: Women who identified as “current smokers” at their first AN visit at
approximately 12 weeks’ gestation (“even a puff in the last 7 days”)
Exclusion criteria: > 20 weeks’ gestation; twin pregnancy; not literate in English; drug
dependency
Recruitment: 9193 women screened, 1942 (21%) current smokers and 625 (7%) spon-
taneous quitters (not included in study but described in Panjari 1997). 1013/1942 smok-
ers (52%) agreed to participate (929 refused or not eligible) and were randomised (C =
537, I = 476).
Baseline characteristics: Mean cigarettes per day = 21 before pregnancy and 11 at time
of first AN visit. 74% had a smoking partner
Mean age 26 years.
Progress + coding: Low SES as authors note mostly low income women.
Interventions Control: UC, which included advice at the discretion of the caregiver, and 0 pamphlet
“Smoking & Pregnancy” distributed during a group pregnancy information session
Intervention: As for the control group plus 4 counselling sessions by a midwife specif-
ically trained and employed to provide smoking cessation counselling, using CBT. Ses-
sions included video presentation, interactive discussion and strong verbal messages.
These were followed up with a 5- to 10-min personalised counselling session
Main intervention strategy: Counselling (single intervention) compared to UC.
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Panjari 1999 (Continued)
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 3). UC intensity: F = 1, D = 1
Intervention provided by dedicated project staff: efficacy study
Outcomes Self-reported smoking cessation biochemically validated with urine cotinine at 36 weeks’
gestation (late pregnancy*), 6 weeks postpartum (0-5 months)*, and 6 months (6-11
months*) postpartum*. Preterm births*, mean birthweight*, proportion LBW* (< 2500
g)
Reduction in mean cigarettes/day* and mean urinary cotinine levels*
Breastfeeding at 6 weeks and 6 months postpartum. General health assessment at first
visit and 36 weeks
General health questionnaire (including stress and depression measurement) at baseline
and end of pregnancy but data not reported
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information.
Allocation concealment (selection bias) Unclear risk Described as “randomly allocated”.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 28% attrition (381/1013). 72/1013 (C =
35, I = 37) were excluded as they were over
20 weeks’ gestation, had a twin pregnancy
or were transferred to the chemical depen-
dency clinic. 209/1013 (C = 109, I = 100)
excluded due to transfer to another hospi-
tal, miscarriage, termination of pregnancy
and withdrawal from the study. The num-
bers of those who withdrew from the study
were not reported separately in this group,
therefore all were re-included as continu-
ing smokers in this review (but were not
included in mean outcome data)
Selective reporting (reporting bias) Low risk A detailed list of birth outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine levels measured at base-
line and in late pregnancy (< 115/ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention delivered by
clinic midwife.
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Panjari 1999 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed 71% women in
the intervention group received the full in-
tervention
Equal baseline characteristics in study arms Low risk There were no statistically significant dif-
ferences between women allocated to the
intervention and the control groups in
terms of socio-demographic variables and
smoking patterns
Contamination of control group Low risk Intervention provided by a research mid-
wife, not UC provider
Parker 2007 (AvB)
Methods 3-armed randomised controlled trial aimed to evaluate the feasibility, cost and effec-
tiveness of a telephone counselling intervention to support women to stop smoking in
pregnancy
Study conducted at 22 urban prenatal care clinics in Rhode Island (Connecticut) and
Massachusetts (USA). Study period not reported
Participants Inclusion criteria: Pregnant women who had smoked at least 1 puff of a cigarette within
the past 30 days, no more than 26 weeks pregnant, had access to a telephone where she
could be reached, and speak English or Spanish
Exclusion criteria: Not further specified.
Recruitment: 8526 pregnant women were assessed at their first or second visit. 1065/
1582 eligible women (67%) agreed to participate and were randomly assigned to 3
conditions (C (self-help materials) = 378; I1 (Self-helpmaterials + quit and win contest)
= 329; I2 (self-help materials + quit and win contest + MI counselling calls = 358)
Baseline characteristics: Stratified by participation in calls: Mean cigarettes per day at
baseline: 7.9 (6.3) to 8.7 (5.8). Baseline cotinine: 869 to 1239 ng/mL
Majority white, 40% <= 11 years education.
Progress + coding: Low SES as 80% Medicaid recipients.
Interventions A: Control: Participants received self-help materials, which included a quit kit (A
Smoker’s Guide toQuit Smoking) and a video (Commit toQuit), which had been shown
to be effective in significantly reducing exposure or assisting pregnant women to quit
smoking (SCRIPT trials)
B: Intervention 1: Received the quit kit and were enrolled in a “Quit and Win” (Q&
W)monetary incentive lottery program. Eligibility for the prize (US$100) was restricted
to smokers who reported abstinence for at least 30 days and had their report confirmed
by urinary cotinine.
C: Intervention 2: Received the quit kit, the Q&Wprogram, and up to 3MI telephone
calls
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Parker 2007 (AvB) (Continued)
This study ID compares the control group and Intervention 1 (arm b)
Main intervention strategy: Incentives (single intervention) compared to a less intensive
intervention
Intensity: Frequency (C = 1, I = 1), Duration (C = 1, I = 1).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Self-reported smoking cessation biochemically validated with urinary cotinine (< 80
ng/mL) at 32 weeks’ gestation (late pregnancy)*, 6 weeks and 6 months postpartum
(outcomes not reported). Cost-effectiveness analysis. Outcome data from conference
abstract with all 3 arms and 89% valid cotinine assessments used in this analysis, as
outcome data for arms A and B in main report are unclear
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported.
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition: C = 101/378 (27%), I = 118/358
(33%) by 6 months postpartum (reasons
not reported). All randomised women in-
cluded in analysis
Selective reporting (reporting bias) Unclear risk Smoking cessation at 6weeks and 6months
postpartum not reported
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Biochemical validation of self-reported
smoking status using urinary cotinine (<
80 ng/mL). Conference report states only
219/245 women had a valid cotinine as-
sessment, and 17.2% self-reported smok-
ers required reclassification. Pg 1045 states
“Samples were obtained from 114 women
during the first prenatal visit, from113dur-
ing the third trimester, and 23 during the 6
month postpartum visit.Wewere unable to
contact the remainder of the women, and
therefore did not have samples to confirm
their self-reported smoking status”
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Parker 2007 (AvB) (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not feasible for participants and personnel
to be blinded to educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed researchers were
unable to reach 14%, 86% received 1 call,
60% 2 calls and 46% 3 calls
Equal baseline characteristics in study arms Low risk The absence of significant differences
for multiple salient predictors and other
weaker predictors of smoking behaviour
change strongly suggested that the call
groups were comparable at baseline
Contamination of control group Low risk Specific counsellors providing intervention
so low risk of contamination
Parker 2007 (AvC)
Methods 3-armed randomised controlled trial aimed to evaluate the feasibility, cost and effec-
tiveness of a telephone counselling intervention to support women to stop smoking in
pregnancy
Study conducted at 22 urban prenatal care clinics in Rhode Island (Connecticut) and
Massachusetts (USA). Study period not reported
Participants Inclusion criteria: Pregnant women who had smoked at least 1 puff of a cigarette within
the past 30 days, no more than 26 weeks pregnant, had access to a telephone where she
could be reached, and speak English or Spanish
Exclusion criteria: Not further specified.
Recruitment: 8526 pregnant women were assessed at their first or second visit. 1065/
1582 eligible women (67%) agreed to participate and were randomly assigned to 3
conditions (C (self-help materials) =378; I1 (Self-help materials + quit and win contest)
= 329; I2 (self-help materials + quit and win contest + MI counselling calls = 358)
Baseline characteristics: Stratified by participation in calls: Mean cigarettes per day at
baseline: 7.9 (6.3) to 8.7 (5.8). Baseline cotinine: 869 to 1239 n g/mL
Majority white, 40% <= 11 years education.
Progress + coding: Low SES as 80% Medicaid recipients.
Interventions A: Control: Participants received self-help materials, which included a quit kit (A
Smoker’s Guide toQuit Smoking) and a video (Commit toQuit), which had been shown
to be effective in significantly reducing exposure or assisting pregnant women to quit
smoking (SCRIPT trials)
B: Intervention 1: Received the quit kit and were enrolled in a “Quit and Win” (Q&
W)monetary incentive lottery program. Eligibility for the prize (US$100) was restricted
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Parker 2007 (AvC) (Continued)
to smokers who reported abstinence for at least 30 days and had their report confirmed
by urinary cotinine.
C: Intervention 2: Received the quit kit, the Q&Wprogram, and up to 3MI telephone
calls
This study ID compares the control group (arm A) and Intervention 2 (arm C)
Main intervention strategy: Counselling (multiple intervention) compared to a less
intensive intervention
Intensity: Frequency (C = 1, I = 4), Duration (C = 1, I = 3).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Self-reported smoking cessation biochemically validated with urinary cotinine (< 80
ng/mL) at 32 weeks’ gestation (late pregnancy)*, 6 weeks and 6 months postpartum
(outcomes not reported). Cost-effectiveness analysis. Outcome data from conference
abstract with all 3 arms and 89% valid cotinine assessments used in this analysis, as
outcome data for arms A and B in main report are unclear
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported.
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition: C = 101/378 (27%), I = 118/358
(33%) by 6 months postpartum (reasons
not reported). All randomised women in-
cluded in analysis
Selective reporting (reporting bias) High risk Smoking cessation at 6weeks and 6months
postpartum not reported
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Biochemical validation of self-reported
smoking status using urinary cotinine (< 80
ng/mL).Conference report states only 219/
245 self-reported quitters had biochemi-
cally confirmed smoking status, and 17.
2% required reclassification. Pg 1045 states
“Samples were obtained from 114 women
during the first prenatal visit, from113dur-
ing the third trimester, and 23 during the 6
month postpartum visit.Wewere unable to
contact the remainder of the women, and
therefore did not have samples to confirm
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Parker 2007 (AvC) (Continued)
their self-reported smoking status”
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not feasible for participants and personnel
to be blinded to educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed researchers were
unable to reach 14%, 86% received 1 call,
60% 2 calls and 46% 3 calls
Equal baseline characteristics in study arms Low risk The absence of significant differences
for multiple salient predictors and other
weaker predictors of smoking behaviour
change strongly suggested that the call
groups were comparable at baseline
Contamination of control group Low risk Specific counsellors providing intervention
so low risk of contamination
Patten 2009
Methods Randomised controlled pilot study of a targeted intervention to support pregnantAlaskan
Native women to stop smoking in pregnancy
Study conducted in the Y-K Delta region in Western Alaska (USA), with recruitment
from 2007 to 2008
Participants Inclusion criteria: Pregnant Alaskan women ≥ 18 years, ≤ 24 weeks’ gestation, self-
reported smoking or Iqmik/ST use in the last 7 days, planning to quit in the next 30
days, access to a telephone and VCR/DVD player, and willing to participate in all study
procedures
Exclusion criteria: Planning an abortion, current (past 3 months) participation in phar-
macological or behavioural tobacco treatment, and another woman from her household
had enrolled
Recruitment: 293 women expressed an interest in the study and were referred to study
co-ordinator. 81 did not attend screening appointment, 114 reported not smoking and
4 were ineligible. 35/94 (37%) of the remaining eligible women agreed to participate
and were randomised (C = 18, I = 17)
Baseline smoking characteristics: Current tobacco use (in past 7 days): Iqmik C = 44%
(8), I = 47% (8); Commercial chew C = 22% (4), I = 18% (3); Cigarette smoking C =
33% (6), I = 35% (6). Spouse/partner uses tobacco: C = 78% (14), I = 54% (7). Smoking
ban in the home C =89% (16), I = 88% (14). Chewing ban in the home C = 12% (2),
I = 19% (3)
Baseline characteristics not reported.
Progress + coding: Low SES, ethnic minority population.
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Patten 2009 (Continued)
Interventions Control: Participants in the control arm received an intervention consistent with the 5-
component treatment (5A’s) recommended for pregnant smokers by the Clinical Practice
Guideline: Ask, Advise, Assess, Assist, and Arrange. At the first visit, participants in this
condition received a brief (5-min) face-to-face intervention based on the 5A’s and 4
pregnancy and culturally specific brochures. The counsellor encouraged and assisted the
participant to set a quit date. Participants requesting NRT or another medication from
the counsellor were referred to the YKDRH clinical cessation program and enrolment
in this program was tracked as part of this study
Intervention: At the first visit women in the intervention group received:
(i) a self-help guide adapted from the SCRIPT trials (Windsor 1999) and from culturally
appropriate brochures developed and used by the YKDRH clinical cessation program
(ii) 15-25 mins of face-to-face counselling based on the 5A’s
(iii) a video which was produced that included stories of Alaska Native women who
stopped using tobacco during pregnancy. Focus groups suggested that story-telling was a
potentially acceptable intervention component. The counsellor then discussed the video
with the woman
(iv) A further 4 x 10- to 15-min proactive interactive sessionswere provided by telephone,
based on a counsellor manual which was developed based on completed evaluation
research, atWeeks 1, 2, 4, and 6. These sessions provided opportunities for the counsellor
to teach additional cessation skills and reinforce self-efficacy. Thewomanwas encouraged
to set a quit date at each contact, if she had not quit
Main intervention strategies: Counselling (multiple intervention) compared to a less
intensive intervention
Intensity: Frequency (C = 2, I = 6), Duration (C = 2, I = 3).
Intervention provided by dedicated study staff: Efficacy study
Outcomes Biochemically validated tobacco use in (salivary cotinine < 20 ng/mL) 60 days post
randomisation (late pregnancy*). Acceptability to women
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk 35 participants were stratified by primary
type of tobacco used (Iqmik, commercial
ST, or cigarettes) and randomly assigned
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: C = 1/18 (6%), I = 5/17 (29%)
. 1 miscarriage in each study arm ex-
cluded from this analysis. All other drop-
outs counted as continuing smokers
Selective reporting (reporting bias) Low risk All primary outcomes reported.
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Patten 2009 (Continued)
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported tobacco use status biochemi-
cally validated using salivary cotinine (< 20
ng/mL). Some women were using NRT
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Not reported.
Incomplete implementation Low risk Process evaluation showed good treatment
compliance and acceptability of interven-
tion
Equal baseline characteristics in study arms High risk Level of education and spouse/partner
smoking unequal.
Contamination of control group High risk Assessments and interventions provided by
the same individual in each community
Pbert 2004
Methods Cluster-randomised controlled trial of implementation of the “Quit Together” program
which aims to support women to stop smoking and prevent relapse in pregnancy
Study conducted WIC clinics in Massachusetts (USA) of implementation, with data
collection from May 1997 to November 2000
Participants Unit of randomisation was 6 community health centres with on-site WIC programs,
prenatal services and paediatric services, and patients of diverse race and ethnicity. 1
control site was dropped due to low recruitment
Inclusion criteria: Pregnant women, English or Spanish speaking, less than 32 weeks’
gestation, current smoker or spontaneous quitter, planning to remain in area for 6months
after delivery
Exclusion criteria: Not further specified.
Recruitment: 7853 women screened. 609/693 (88%) eligible smokers and ex-smokers
consented, completed baseline interviews and were randomised (C = 300, I = 309)
Baseline characteristics: Current smokers (C =72.3%, I = 70.2%), spontaneous quitters
(C = 27.7%, I = 29.8%). Mean cigarettes per day before pregnancy: C = 18.43, I = 14.
89
Mean age 26 years.White (C = 78.6%, I = 22.8%), Black (C = 1.8%, I = 39%), Hispanic
(C = 4.7%, I = 27.6%). Unmarried: C = 60.8%, I = 68.8%. Medicaid C = 63.1%, I =
65.5%. < High school C = 62.2%, I = 46.7%
Progress + coding: Low SES as high proportion of WIC recipients.
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Interventions Control: UC condition, in which no training or intervention occurred
Intervention: The dissemination intervention consisted of:
(i) provider training based on national clinical practice guidelines, (ii) an office practice
management system for routine screening and follow-up reminders, and (iii) establish-
ment of program boards. The intervention to women was based on MI and the “4A’s”
from the ’SCRIPT trial’ conducted by Windsor 2000b.
Main intervention strategy: Counselling (single intervention) and intensive dissemi-
nation compared to UC
Intensity: Frequency (C = 0, I = 2), Duration (C = 0, I = 1). UC intensity: F = 0, D = 0
Intervention provided by existing staff: Effectiveness study
Outcomes Biochemically validated smoking cessation and relapse prevention at 1 month postpar-
tum combined (late pregnancy*), and 3 (0-5*) and 6 (6-11*) months postpartum. 6-
month figures not reported in text but estimated from Figure 3 to be I = 11%, C = 4%
Mean cigarettes/day* estimated from figure 4.
Associated references describe detailed organisational change and implementation pro-
cesses for the clinic setting (Zapka 2004), subanalysis of a range of outcomes by socio-
economic status; and clinical knowledge of nicotine dependence (Bonollo 2002).
Notes No estimates of clustering effect reported, so sensitivity analysis conducted and intra-
cluster correlation of 0.10 used to adjust data for inclusion in outcome tables
SDs for mean cigarettes per day were not reported, therefore we calculated a mean SD
from 14 studies with available mean cigarette SDs (6.5) to include in this review, as
recommended by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
High risk 34/609 (6%) had amiscarriage and 12/609
(2%) transferred to another health service.
13 women excluded for other reasons (un-
explained), but they are not reported by in-
tervention group to be re-included and the
figures reported in the flow chart are com-
bined with dropouts for other reasons. Also
high loss to follow-up. 550/609 women in-
cluded in this analysis
Selective reporting (reporting bias) Unclear risk Trial part of a nutritional program, but only
smoking outcomes in this report
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Pbert 2004 (Continued)
Other bias Unclear risk One control site dropped due to low re-
cruitment. Otherwise recruitment to study
arms appears balanced
Biochemical validation of smoking absti-
nence (detection bias)
Low risk A woman was considered to be a smoker
if she reported smoking in 30 days prior
to 1 month postpartum interview. Salivary
cotinine was analysed for women reporting
abstinence in 7 days prior to the interview
(<= 20 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Sites aware of allocation status.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Process evaluation not reported.
Equal baseline characteristics in study arms Unclear risk While no differences between SI and UC
were statistically significant, some were
large (e.g. race/ethnicity, education). This
reflects the variability in size and race/eth-
nicity distributions among CHCs, the unit
of randomisation
Contamination of control group Low risk Cluster design to avoid contamination.
Peterson 1992
Methods 3-armed randomised controlled trial of self-help materials and counselling to support
women to stop smoking and prevent relapse during pregnancy and postpartum
Study conducted at a large Boston HMO (USA), with recruitment from March 1986
to September 1988
Participants Inclusion criteria: English-speaking literate women enrolling in prenatal care; who
reported themselves as currently occasional or regular smokers or who had quit smoking
in the previous 3 months
Exclusion criteria: < 18 years of age; > 24 weeks’ gestation.
Recruitment: 1442 women screened during early pregnancy class. 317 current smokers
and recent quitters were identified. Participants from 3 centres were randomised to
control andfirst intervention (I1) arms, andparticipants from the third arm (Intervention
2) were not randomly allocated and are not included in analysis in this review. 93/317
attrition, leaving 224 included (C = 78, I1 = 71, I2 (not randomised) = 75).
Baseline characteristics: Baseline smokers: 142 (C = 47, I1 = 43, I2 = 52) and baseline
spontaneous quitters: 104 (C = 36, I1 = 34, I2 = 34) analysed at 6 months gestation.
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Peterson 1992 (Continued)
Majority 17-28 years, No participants less than high school, less than $US 20000/yr (C
= 18.7%, I1 = 20%, I2 = 32.3%). Over 80% married and majority white.
Progress + coding: None.
Interventions A: Control: Routine obstetric care, including a mailed list of community-based smoking
cessation resources other pregnancy-related health education materials. Brief repeated
counselling by obstetricians and midwives for both groups as part of routine care.
B: Intervention 1: Pregnancy-specific self-help manual (ALA and Harvard Community
Health Plan (HMO)) and audiotape on safe aerobic exercise and pregnancy-related
relaxation, mailed with other health-related education. Smoking component emphasised
behavioural strategies for quitting, issues and concerns specific to pregnant women, non-
smoking as part of a continuum of care in pregnancy; included a maintenance section
for the postpartum period
C: Intervention 2: As for I1 plus training for obstetrician and nurse practitioner to
provide training, and support letters from physician
Main intervention strategy: Health education (single intervention) compared to UC.
Intervention 1 and control only compared in this review as arm C was not randomised
Intensity: Frequency (C = 0, I = 2), Duration (C = 0, I = 1).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Smoking cessation for smokers and spontaneous quitters at 6 months gestation (late
pregnancy* and 8 weeks postpartum (0-5 months*)
Description of costs.
Notes Substantial misclassification of non-smoking self-report at 6 months gestation 24%
controls 21% intervention (and 30% in clinic where the interventionwasmore intensive)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Table of random numbers. Allocation to
intervention arm2was not randomised but
offered to all eligible enrollees at 1 clinic:
therefore data from this intervention arm
are not included in the review
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
High risk 93/317 (29%) were excluded from analyses
due to miscarriage, therapeutic abortion,
moving, or left the Harvard Health Plan,
leaving 217 included. However, 246 (C =
83, I1 = 77, I2 = 86) ’baseline smokers and
spontaneous quitters’ included in analysis
at 6 months gestation and 219 included in
8 weeks postpartum. It is not clear which
randomisedwomen are included in analysis
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Peterson 1992 (Continued)
Selective reporting (reporting bias) Unclear risk None apparent but results were not simple
to interpret.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation in 50% women.
Those refusing urine test were coded as
smoking
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk State that caregivers were blinded as mate-
rials to the intervention group weremailed.
Not feasible to blind women
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk All women received materials for interven-
tion 1 used in this review. Some implemen-
tation problems noted with the counselling
arm (I2), but that was not included in this
review.
Equal baseline characteristics in study arms High risk Differences in educational attainment.
Contamination of control group Low risk Unlikely with mail out of materials.
Polanska 2004
Methods Cluster-randomised trial of intervention to support women to stop smoking and prevent
relapse in pregnancy and postpartum
Study conducted in the Lodz district, Poland, with data collection fromDecember 2000
to December 2001
Participants Unit of randomisation was maternity units, selected from 33 in district and stratified by
size. Control = 1 small, 2 medium, 2 big; Intervention = 2 small, 4 medium, 4 big (as
higher refusal expected in intervention arms
Inclusion criteria: Current smokers or women who quit 1 month before the visit
Exclusion criteria: Not further specified.
Recruitment: 15/33 maternity units were allocated to intervention (10) or control (5)
groups
All pregnant women screened. 194/194 (100%) eligible women in control group and
216/275 (78.5%) eligible women in the intervention group agreed to participate
Baseline characteristics: Current smokers: C = 156, I = 158. Spontaneous quitters: C
= 38, I = 58. Cigarettes per day: < 5 (C = 8.8%, I = 10.3%), 5-50 (C = 54.7%, I = 46%)
, > 10 (C = 36.5%, I = 43.7%). Fagerstrom score 0-6 (C = 98.9%, I = 92.3%)
Mean age: C = 25.9, I = 25.5; < 12 years education: C = 76.2%, I = 74.3%; Unmarried:
C = 39.2%, I = 52.5%
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Progress + coding: Low SES population as described by author.
Interventions Control: Received standard written information about health risks of smoking
Intervention: Received 4-9 midwife home visits, based on a booklet translated from
English (Ottawa) toPolish and adapted toPolish conditions: “How to talk about smoking
with high risk pregnant smokers”
Main intervention strategy: Counselling (single intervention) compared to UC.
Intensity: Frequency (C = 0, I = 6), Duration (C = 0, I = 4). UC intensity: F = 1, D = 1
Intervention provided by midwives, which appear to be existing staff, though this is not
explicitly reported: coded as effectiveness study
Outcomes Self-reported smoking cessation ’shortly after delivery at home’ (0-5 months postpar-
tum*)
Relapse prevention rates* in text (p274). Mean birthweight* calculated by combined
smokers and quitters in Table 6
An associated reference (Polanska 2005) reports relapse after 12 months* (12-17 months
postpartum). All randomised from women from original study included as denominator
and those not included in the follow-up analysis assumed to have relapsed in this review.
Spontaneous quitters and smokers combined from Table 2 to calculate self-reported
abstinence at 12 months
Notes No estimates of clustering effect reported, so sensitivity analysis conducted and intra-
cluster correlation of 0.10 used to adjust data for inclusion in outcome tables
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Notes random allocation, but no descrip-
tion of how this occurred. Only 15/33 eli-
gible clinics allocated
Allocation concealment (selection bias) Unclear risk Not specified.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: Miscarriages:
Smokers: I = 9/158 and C = 12/156.
Spontaneous quitters: I = 2/58 and C = 1/
38. Not included in analysis
Those lost to follow-up: Smokers: (C = 6,
I = 6) and Spontaneous quitters (C = 0,
I = 2) are included in analysis of smoking
outcomes
Selective reporting (reporting bias) Unclear risk Birthweight and relapse prevention out-
comes difficult to interpret and unable to
be included
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Polanska 2004 (Continued)
Other bias Unclear risk Twice as many sites were allocated to the
intervention arms as the control arms as it
was assumed more women would refuse to
participate in intervention activities. How-
ever recruitment to study arms was equal
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking status only.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel not blinded to
this educational intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Number of visits received not reported.
Equal baseline characteristics in study arms High risk Intervention group more likely to be mar-
ried, have fewer children, and have a higher
smoking addiction
Contamination of control group Low risk Cluster-design tominimise risk of contam-
ination.
Pollak 2013
Methods This 2-armed randomised controlled trial aimed to determine the acceptability of a SMS
text based Scheduled gradual reduction (SGR) intervention plus support messages to
promote cessation during pregnancy
This study was conducted in the USA with women recruited from 4 clinics, including
a county health department that provides care for uninsured and underinsured patients
as well as a U.S. Army medical center
Participants Inclusion criteria: > 18 years of age, English-speaking, have smoked at least 100 cigarettes
in their lifetime, smoked 5 or more cigarettes per day in the prior 7 days, are willing to
try quit smoking, are between 10 and 30 weeks pregnant, and have a cell phone with
unlimited texting
Exclusion criteria: Women were excluded if they could not properly provide consent
Recruitment: 31/64 = 48% participation rate (C = 15 I = 16) Study staff obtained
written consent from women
Baseline characteristics: Mean Age (C = 27 I = 29) Mean number of cigarettes per day
(C = 10 I = 10) Partner smokes (C = 87% I = 56%) Further than high school (C = 53%
I = 38%)
Progress + coding: None.
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Interventions Control: SMS support messages, women were asked to choose a quit date within the
next 2-3 weeks and then texted them that quit date. Staff explained that women would
receive up to 5 messages per day for 5 weeks. Each week there was a new theme for
a subset of messages, such as reasons for quitting, getting ready for quit date, partner
smoking and handling slips.
Intervention: Support messages plus a scheduled gradual reduction (SGR) Staff told
women randomised to support messages plus SGR that they would receive support
messages for 5 weeks as described in Support Messages Alone section. Instead of setting a
quit date within 2-3 weeks, they received “alertmessages”that were designed to help them
gradually cut down to zero cigarettes by the end of the 4th week. Study staff explained
that the purpose of the SGR program was to break the connection between cues and
smoking. Staff explained that it works when women follow the schedule closely, smoking
only when they receive alerts
Main Intervention strategy: Health Education (single) v alternative Intervention
Intensity: Frequency (C = 6, I = 6) Duration (C = 4, I = 4).
Technological intervention: unclear if efficacy or effectiveness
Outcomes Biochemically validated 7-day point prevalence of smoking cessation at end of preg-
nancy*. Many outcomes were based around the feasibility, acceptability and efficacy of
the intervention and study itself
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Study staff randomised women, stratified
by number of cigarettes smoked and part-
ner smoking status
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Those who were lost to follow-up were
counted as smokers.
Selective reporting (reporting bias) Low risk As this is a pilot study, efficacy, validity and
feasibility were all reported
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking was biochemically validated,
saliva samples were analysed for the pres-
ence of cotinine using radioimmunoassay.
A cut point of 10 ng/mL for saliva cotinine
with pregnant women was used to discrim-
inate abstainers and smokers
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Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Participants and personnel likely to have
been aware of group allocation, although
not explicitly stated
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Unclear as to whether the research staff
were blinded to the outcome assessment
Incomplete implementation Low risk Of the 31 women enrolled, 86% of women
in both arms reported reading “all or most”
of the support messages. Women in the
SGR arm responded to 68% of alert texts
within 60 min
Equal baseline characteristics in study arms Unclear risk Women in the control armweremore likely
to be partnered with a smoker. Women in
the intervention arm were heavier smok-
ers, were less likely to have reduced their
smoking during the pregnancy, and were
less likely to have attempted to quit
Contamination of control group Low risk Intervention was provided directly to par-
ticipants via theirmobile phone, so low risk
of contamination
Prapavessis 2014
Methods This 2-armed randomised controlled trial aimed to assess the impact of 20mins of exercise
on cravings amongst pregnant smokers who were recruited from London, Ontario,
Canada and St. George’s Hospital, South West London, England
Participants Inclusion criteria: Pregnant women between 20 and 40 years of age, in their second
trimester of pregnancy (13-24 weeks), smoking more than 5 cigarettes per day and at
least 10 cigarettes per day prior to gravidity, were not receiving psychiatric treatment,
did not present contraindications to exercise, and did not meet the physical activity
guidelines for pregnancy (i.e. exercising less than 3 times per week for 30 mins at a
moderate intensity; Participants were also screened with the Physical Activity Readiness
Medical Examination for pregnancy for contraindications to exercise
Exclusion criteria: Not stated.
Recruitment: 30 eligible women (C = 16 I = 14) There were no significant differences
between the 2 samples in the 2 locations
Baseline characteristics:MeanAge- 25.7 years, FagerstromTest for cigarette dependence
- 3.3,
Progress + coding: None.
Interventions Control: Passive control condition required participants to watch a 27-min gardening
show to reduce cravings
Intervention: The exercise condition entailed a single bout of treadmill walking at
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Prapavessis 2014 (Continued)
a mild-to-moderate intensity (25% to 55% of heart-rate reserve) for 20 mins, which
commenced upon reaching the lower limit of the heart-rate prescription. Approximately
2 mins and 5 mins were allocated for warm-up and cool-down, respectively
Main Intervention strategy: Single smoking cessation intervention: exercise vs alterna-
tive Intervention
Intensity: Frequency (C = 1 I = 1) Duration (C = 2 I = 2).
Intervention provided by study staff: efficacy study
Outcomes No smoking cessation outcomes reported. Primary outcomes were cigarette cravings and
tobacco withdrawal symptoms. Cigarette cravings were assessed using a 7 point scale
(1=not at all, 4=somewhat, 7=extremely) Tobacco withdrawal symptoms (irritability,
tension, restlessness, difficulty concentrating and stress) were tested using the Mood and
Physical Symptoms Scale. See Table 1 for summary of results.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation was reported to have been
carried out with a computer-generated
scheme
Allocation concealment (selection bias) Unclear risk Group allocation was concealed from par-
ticipants but not researchers, as participants
were informed of the aims of the study
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No reports of missing data or participants
lost to follow-up, so no detail regarding in-
complete data or attrition rates in study
arms
Selective reporting (reporting bias) Unclear risk No smoking outcomes were reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking was biochemically validated and
abstinence was confirmed by a reduction in
expired CO levels (< 10 ppm), but is not
reported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Group allocation was concealed from par-
ticipants, but not researchers
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk No detail regarding who undertook the
outcome assessment andwhether theywere
blind to allocation of participant
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Prapavessis 2014 (Continued)
Incomplete implementation Unclear risk No details of implementation.
Equal baseline characteristics in study arms High risk Marital status, number of previous quit at-
tempts and hours abstained from smoking
was different fromcontrol and intervention
groups (37.5%married in intervention and
0% in control)
Contamination of control group Low risk Intervention was exercise so unlikely con-
tamination of control group
Price 1991 (AvB)
Methods 3-armed randomised controlled trial of 2 brief interventions to support women to stop
smoking in pregnancy
Study conducted in an inner urban setting, Toledo, Ohio (USA), with recruitment from
December 1987 to March 1989
Participants Inclusion criteria: Not specified.
Exclusion criteria: > 28 weeks’ gestation.
Recruitment: All 1,164 patients screened, 486 current smokers (42%). 293 refused or
were ineligible (40% participation). 193 smokers randomised to study (C = 71, I1 = 52,
I2 = 70).
Baseline characteristics: Baseline smoking not reported.
Mean age = 22.6 (5.6), ranging from 15-43 years. 58% single, 70% white, 87% had
not graduated from high school. Author describes population as “Typically low income,
single and poor”
Progress + coding: Low SES.
Interventions A: Control: UC not specified or assessed but “usual for physicians to address this issue
with participants at least 1 prenatal visit”.
B: Intervention 1: ALA self-help booklet (with brief overview and explanation) empha-
sising behaviour modification skills, relation techniques and the support of significant
others, and were given an opportunity to ask questions of the health educator. Progress
reviewed with health educator at the second visit
C: Intervention 2: Tailored educational videotape 6.5mins, potential fetal risks, benefits
if mother quit + pamphlet on how to quit and opportunity to ask questions of the health
educator. 1 month later they viewed a second 4-min video and the health educator was
available to answer questions
Main intervention strategy: Counselling (single intervention) compared to UC. The
control and intervention 1 (arm b) are compared in this study ID
Intensity: Frequency (C = 0, I = 2), Duration (C = 0, I = 1).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Biochemically validated smoking cessation ’two or three weeks prior to delivery’ (late
pregnancy*). Smoking reduction* and mean cigarettes/day*
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Notes Program was developed with input from a questionnaire (based on Health Belief Model)
and open-ended questions about the advantages and disadvantages of smoking when
pregnant from local population.
Commentary on the contextual factors in the lives of indigent women which lead them
to have different perceptions about the relative importance of smoking
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported.
Allocation concealment (selection bias) High risk Tossed die (allocation could therefore be
changed). Method resulted in 3 unequal
groups, so randomisation to only 2 groups
for some of the study period, which was
the control and intervention 2 (videotape)
group, compared in this review
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition 44% (C = 46, I1 = 13,I2 =
25). Reasons for attrition not reported.
However all dropouts treated as continuing
smokers in this review
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking cessation was biochemically val-
idated using exhaled CO (<= 7 ppm cut-
off )
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk 44% did not receive intervention.
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Specific educators providing intervention
(pregnancy care providers not involved)
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Price 1991 (AvC)
Methods 3-armed randomised controlled trial of 2 brief interventions to support women to stop
smoking in pregnancy
Study conducted in an inner urban setting, Toledo, Ohio (USA), with recruitment from
December 1987 to March 1989
Participants Inclusion criteria: Not specified.
Exclusion criteria: > 28 weeks’ gestation.
Recruitment: All 1,164 patients screened, 486 current smokers (42%). 293 refused or
were ineligible (40% participation). 193 smokers randomised to study (C = 71, I1 = 52,
I2 = 70).
Baseline characteristics: Baseline smoking not reported.
Mean age=22.6 (5.6), ranging from 15-43 years. 58% single, 70% white, 87% had not
graduated from high school. Author describes population as “Typically low income,
single and poor”
Progress + coding: Low SES.
Interventions A: Control: UC not specified or assessed but “usual for physicians to address this issue
with participants at least 1 prenatal visit”.
B: Intervention 1: ALA self-help booklet (with brief overview and explanation) empha-
sising behaviour modification skills, relation techniques and the support of significant
others, and were given an opportunity to ask questions of the health educator. Progress
reviewed with health educator at the second visit
C: Intervention 2: Tailored educational videotape 6.5mins, potential fetal risks, benefits
if mother quit + pamphlet on how to quit and opportunity to ask questions of the health
educator. 1 month later they viewed a second 4-min video and the health educator was
available to answer questions
Main intervention strategy: Counselling (single intervention) compared to UC. The
control and intervention 2 (video-tape, arm c) are compared in this study ID
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 2).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Biochemically validated smoking cessation ’two or three weeks prior to delivery’ (late
pregnancy*). Smoking reduction* and mean cigarettes/day*
Notes Program was developed with input from a questionnaire (based on Health Belief Model)
and open-ended questions about the advantages and disadvantages of smoking when
pregnant from local population.
Commentary on the contextual factors in the lives of indigent women which lead them
to have different perceptions about the relative importance of smoking
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not reported.
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Allocation concealment (selection bias) High risk Tossed die (allocation could therefore be
changed). Method resulted in 3 unequal
groups, so randomisation to only 2 groups
for some of the study period, which was
the control and intervention 2 (videotape)
group, compared in this review
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition 44% (C = 46, I1 = 13,I2 =
25). Reasons for attrition not reported.
However all dropouts treated as continuing
smokers in this review
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking cessation was biochemically val-
idated using exhaled CO (<= 7 ppm cut-
off )
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk 44% did not receive intervention.
Equal baseline characteristics in study arms Unclear risk Not reported.
Contamination of control group Low risk Specific educators providing intervention
(pregnancy care providers not involved)
Reading 1982
Methods Randomised controlled trial of US feedback on health beliefs and behaviours to improve
maternal health, including smoking
Study conducted in London, England (UK). Recruitment dates not specified
Participants Inclusion criteria: Caucasian origin, aged between 18 and 32 years, married or within
a stable relationship, attending King’s College Hospital AN booking clinics
Exclusion criteria: Women with a previous history of miscarriage, extended infertility
investigations, or meet criteria for risk of congenital malformations
Recruitment: Women ’briefly informed that the study involved a continuing evaluation
of aspects of obstetric care and that they would be seen on occasions throughout the
pregnancy’. 6 women refused. 194 women recruited (see associated reference (Reading
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1982), and were randomised to 3 arms: control (delayed US) = 55;I1 (low feedback)
= 62; and I2 (high feedback = 67). The control arm was added during the course of
recruitment and is not included in this review. 129 women included, 65 (50%) smokers
at baseline (I1 = 26/62, I 2= 39/67).
Baseline characteristics: Smoking characteristics not reported. Selective inclusion cri-
teria: Pregnant women at 10-14 weeks’ gestation; 18 to 32 years; 85% had planned
pregnancy, at low risk of complications; 86% nulliparous
Progress + coding: None.
Interventions A: Control:Women were assessed in the clinic following a delay interval
B: Intervention 1 (low feedback): Routine US at 16 weeks’ gestation in which women
were unable to view the monitor screen, did not receive specific visual or verbal feedback,
and they received a global evaluation of the form “all is well”.
C: Intervention 2 (high feedback): Women were shown the monitor screen and pro-
vided with standardised visual and verbal feedback as to fetal size, shape, and movement.
No clear smoking cessation component
Main intervention strategy: Maternal health intervention with smoking component:
Feedback (single intervention) compared to UC. Intervention 1 (B:low feedback) com-
pared to Intervention 2 (C:high feedback) in this review as no control group outcomes
reported. Control group details only reported in associated reference, but no smoking
outcomes available
Intensity: Frequency (C = 1, I = 1), Duration (C = 1, I = 1).
Unclear whether dedicated project staff delivered the intervention or not
Outcomes Self-reported smoking cessation at 16 weeks’ gestation (late pregnancy*), without bio-
chemical validation. Self-reported reduction in smoking*
Notes Cites evidence for the reliability of self-report.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “assigned at random”.
Allocation concealment (selection bias) Unclear risk No information.
Incomplete outcome data (attrition bias)
All outcomes
High risk Attrition: 3/129 (2%) from low feedback
group in smoking outcomes. But consider-
able amounts of missing data for some vari-
ables. Those lost to follow-up not included
in ITT analysis, and unclear whether they
were smokers at baseline so not re-included
Selective reporting (reporting bias) Unclear risk Data collected not specified.
Other bias Low risk No other bias detected.
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Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation of quitting.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Intervention with verbal feedback, so not
feasible to blind women. State that those
providing care were not involved in the
study
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk 3/62 low feedback group did not attend
next visit at 16 weeks
Equal baseline characteristics in study arms Low risk Data in Tables 1 and 2 seem similar.
Contamination of control group High risk Assuming same ultrasonographer provid-
ing intervention for control and interven-
tion groups
Rigotti 2006
Methods Randomised controlled trial of a telephone counselling intervention to support women
to stop smoking and prevent relapse during pregnancy and postpartum
Study conducted in a network-managed care organisation and a group of 65 community-
based prenatal care practicesMassachusetts, NewEngland (USA), with recruitment from
September 2001 to July 2004
Participants Inclusion criteria: Pregnant smokers (at least 1 cigarette in the past 7 days), at least
18 years of age, 26 weeks or less gestation, willing to consider altering smoking during
pregnancy, reachable by telephone, English speaking and expected to live inNewEngland
for the next year
Exclusion criteria: Not further specified.
Recruitment: Smokers initially identified on ’Obstetric Risk Assessment’ form, yielded
low recruitment so 65/140 obstetric or family practices agreed to refer patients and 35
sent in 1 or more referral forms. 1444 pregnant smokers were referred to the study and
665 assessed as eligible. 442/446 (66%) agreed to participate and were randomised (C
= 222, I = 220)
Baseline characteristics: Mean cigarettes per day before pregnancy: C = 20.8, I = 20.9;
Current mean cigarettes per day: C = 10, I = 10.4; Partner smoking: C = 62%, I = 71%
Mean age: C = 28.1, I = 28.9; Mean years education: C = 13, I = 13.1; White: C = 87%,
I = 88%; Private health insurance: C = 70%, I = 75%. Depression in last month: C = 1.
3%, I = 1.3%
Progress + coding: None.
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Interventions Control: In addition to UC, the control group were mailed a validated pregnancy-tai-
lored smoking cessation booklet, and their prenatal care providers were sent the ACOG
smoking cessation practice guideline, with a reminder to address smoking at the par-
ticipant’s visits. The enrolment call concluded with a trained counsellor providing brief
smoking counselling (less than 5 mins). Smokers who requested further assistance were
referred to the Massachusetts telephone quit-line
Intervention: The intervention group received as for the control group, plus a series of
telephone calls accompanied by additional mailed written materials. Each participant
had a dedicated counsellor who offered up to 90 mins of counselling during pregnancy
and up to 15 mins over the 2 months postpartum. The trained counsellor tailored the
call to the participant’s needs, consistent with the 5-step smoking cessation guideline,
and drew on social learning theory and the transtheoretical model of change, the health
belief model, and the principles of MI
Main intervention strategy: Counselling (multiple intervention) compared to a less
intensive intervention
Intensity: Frequency (C = 2, I = 4), Duration (C = 1, I = 3).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Biochemically validated 7-day point prevalence abstinence at 28 weeks to term (late
pregnancy*), and 3 (0-5) months postpartum*. Also measured reduction in smoking
(proportion > 50% reduction in cigarettes per day*), sustained abstinence at both time
points, and number of quit attempts
Self-efficacy and social support at baseline and follow-up. Concerns about weight gain
reported in an associated reference (Berg 2008). Women’s satisfaction with the interven-
tion.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated.
Allocation concealment (selection bias) Low risk Stated that recruiters were not aware of
group allocation.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: 21/442 (5%)were excluded from
the analysis due to miscarriage (C = 10/
220, I = 11/222). 113 women did not have
final assessment due to refusal (22%), baby
born before assessment or lost to follow-
up, but were included in the final analysis
(ITT analysis) and in this review (C = 209,
I = 212). Missing data (up to 30%) for out-
comes measured in the postnatal period
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Selective reporting (reporting bias) High risk Not clear if all outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Salivary cotinine (<= 20 ng/mL cut-off )
confirmation in 66%, and those refusing to
provide a sample were included as contin-
uing smokers
Blinding of participants and personnel
(performance bias)
All outcomes
High risk All providers and women sent smoking ces-
sation practice guideline
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Mean number of calls received was 5.
Equal baseline characteristics in study arms High risk Both groups were similar, though the in-
tervention group had a significantly higher
proportion of women who hadmade a quit
attempt this pregnancy and had social sup-
port to quit from partner and significant
differences in parity, gestation, and partner
smoking
Contamination of control group Low risk Trained counsellors delivering intervention
not UC givers.
Robling 2016
Methods This non-blinded, randomised controlled, parallel-group trial. The Family Nurse Part-
nership (FNP) aimed to improve maternal and child outcomes for teenage first-time
mothers and included a smoking cessation component, The study was conducted in
community settings at 18 partnerships between local authorities and primary and sec-
ondary care organisation within England, UK and recruitment ran from June 16, 2009,
and July 28, 2010
Participants Inclusion criteria: To be eligible, womenhad to be nulliparous, aged 19 years or younger,
living within the catchment area of a local FNP team, at less than 25 weeks’ gestation,
and able to provide consent and speak English. Women expecting multiple births and
those with a previous pregnancy ending in miscarriage, stillbirth, or termination were
eligible
Exclusion criteria: Women planning to have their child adopted or to move outside of
the FNP catchment area for longer than 3 months were not eligible
Recruitment: Women were identified and approached via local maternity services and
recruited usually at their home by locally-based researchers. 3251 women were screened,
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with 1645 women randomised to intervention or control. However it is unclear what
proportion of these were smokers
Baseline characteristics: Characteristics of smokers participating is unclear as partici-
pants are smokers and non-smokers
Progress + coding: Low SES as low rates of employment (20%) among both smokers
and non-smokers
Interventions Control: UC, all participants (universally offered) received publicly funded health and
social care, which included screening, education and immunisation and support from
birth to child’s second birthday
Intervention: The FNP is a home visiting intervention that involves up to 64 structured
home visits with a protocol to guide smoking cessation advice. Core specialist
training was provided for nurses including MI.
Main Intervention strategy: Maternal health intervention with smoking cessation com-
ponent; social support (single) vs UC
Intensity: Frequency: (C = 0, I =6), Duration: (C = 0, I =4). However it is unclear what
proportion of these visits included discussions on smoking cessation
Outcomes Biochemically validated abstinence in late pregnancy (34-36 weeks’ gestation)*. Other
outcomes not reported by smoking status, and other aspects of the intervention may
have contributed to these outcomes and so they are not reported in this review. (Birth-
weight (child measure), emergency attendances and hospital admissions of child within
2 years of birth, and proportion of women with a second pregnancy within 2 years of
first birth. Secondary outcomes include: Intention to breastfeed, Prenatal attachment,
Injuries and ingestions, Breast feeding (initiation and duration), Language development,
Education, Employment, Income/benefits, Home (tenure), Health status, Self-efficacy,
Social support and Paternal involvement)
Notes Difference in study arm denominator data between table 1 (I = 428 and C = 442) and
S6.1 appendix (I = 439 and C = 431) but totals the same (870) baseline smokers, but we
used data from S6.1 in this review. No response from authors to request for clarification
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Researchers will use a remote randomisa-
tion service (automated telephone or web)
provided byBristol RandomisedTrialsCol-
laboration (BRTC) to allocate the woman
to the intervention or UC
Allocation concealment (selection bias) Low risk Automated allocation.
Incomplete outcome data (attrition bias)
All outcomes
Low risk All analyses were done by ITT without im-
putation, with outcome values compared
between groups using mixed-effects 3-level
regressionmodels to adjust for site as a strat-
ification variable and to allow for clustering
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by a family nurse in the intervention group
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Unclear risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Biomarker calibrated self-reported tobacco
use by the mother at late pregnancy. When
only baseline cotinine concentrations were
available, women reporting not smoking
at late pregnancy and who were classified
as either accurate or over-reporters of to-
bacco use (from comparing baseline self-
report and cotinine concentrations; ap-
pendix) were also categorised as non-smok-
ers. Urinary cotinine < 100 ng/mL consid-
ered non-smokers
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Mothers and field-based researchers (even
if also assessors) were not masked to group
allocation, but assessors collecting data
by computer-assisted telephone interview
were masked to allocation
Incomplete implementation Low risk Process evaluation showed that > 99% re-
ceived at least 1 visit, The average nurse-re-
ported duration of valid visits was 79 mins.
Clients receive 80%/65%/60% or more of
expected visits during pregnancy, infancy,
toddlerhood phase respectively
Equal baseline characteristics in study arms Low risk No significant differences noted.
Contamination of control group Low risk Main intervention component is home vis-
its therefore low risk of contamination of
the control group
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Secker-Walker 1994
Methods Randomised controlled trial of counselling to support women to stop smoking in preg-
nancy and postpartum
Study conducted at the University of Vermont, Burlington (USA), with recruitment
from May 1984 to June 1987
Participants Inclusion criteria: Pregnant women less than 25 weeks’ gestation, smoking at least 1
cigarette a day
Exclusion criteria: Not further specified.
Recruitment: Women receiving prenatal care from obstetricians and nurse-midwives,
or residents through Maternal, Infant & Child clinic for under-insured or non-insured
women, were randomly assigned (23% Medicaid in study). 775/808 (96%) smokers
invited agreed to participate. 175/775 women spontaneously quit before their first visit
and were randomised into a separate study of relapse prevention (C = 86, I = 89) (Secker-
Walker 1995). 600 smokers randomised (C = 300, I = 300).
Baseline characteristics: Mean cigarettes per day pre-pregnancy C = 25.1, I = 24.4.
Mean cigarettes per day at first prenatal visit: C = 12.4, I = 14.1
Mean age: 24 years; Less than high school: C = 30.7%, I = 28.2%; Medicaid recipient
C = 23.2%, I = 25.3% (50% private insurance)
Progress + coding: Low SES due to high rates of women who had not completed high
school
Interventions Control: ’Usual advice about smoking provided by obstetrician or midwife’.
Intervention: Counselling from a trained health educator who: addressed concerns re
smoking and pregnancy, health benefits of stopping, perception of the advantages and
disadvantages of stopping, problem solving around those issues and coming to a decision.
If agreeing to quit and formulating a plan, women were provided with skills rehearsal
and a pregnancy-specific booklet. Follow-up at second AN clinic, 36 weeks and 6-week
check (where infant health and parental rolemodelling was discussed) and re-encouraged
to quit.
Health educators given selected readings, discussion, rehearsal with psychologist + health
educator (both former smokers) about smoking and smoking cessation counselling tech-
niques + ALA training group for class leaders + 4-week pilot
The relapse prevention component was individualised but carried out within a defined
protocol. Counselling about preventing relapse and a booklet. Follow-up at second AN
clinic, 36 weeks and 6-week check (where infant health and parental role modelling was
discussed)
Main intervention strategy: Counselling (multiple intervention) compared to UC.
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 3). UC intensity: F = 1, D = 1
Intervention provided by dedicated project staff: Efficacy study
Outcomes Smoking cessation at 36 weeks’ gestation (75% biochemically validated with cotinine)
(late pregnancy*), Long-term quitting measured at 8-15 months’ pp (6-11 months pp*)
, 16-24 pp (18 months postpartum), and 25-54 pp (self-reported)
Relapse prevention* reported in associated reference (Secker-Walker 1995).
Mean birthweight*, LBW*, other smoking-related complications (PPROM, placental
abruption and placenta praevia)
Reduction in mean cotinine/creatinine ratio at 36 weeks’ gestation
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Notes Sample size calculated for 10% increase (from 10% to 20%) in quitting.
No adjustment for misclassification.
Recall of advice about smoking.
Separate paper (Secker-Walker 1992) evaluates training program for residents.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “randomly assigned”.
Allocation concealment (selection bias) Unclear risk Not stated. Unclear when randomisation
took place.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Smokers: Attrition 39/600 (6.5%) due to
miscarriage (27), fetal deaths (7), infant
deaths (5), 48 transferred care (C = 24, I =
24), and were excluded from analysis, leav-
ing C = 258, I = 255
Further losses were: 41 dropped out of
study (C = 4, I = 37), and 59 were lost
to follow-up (C = 28, I = 31), but were
re-included in this review as continuing
smokers, but are not included in mean
birthweight and other birth outcomes anal-
yses. Significant difference in pregnancy
dropout rates for I (13% dropout rate) and
C (1.4% dropout rate). Those lost to fol-
low-up smoked more
Voluntary dropouts treated as continuing
smokers for some analyses
Spontaneous quitters: attrition 8/175 (5%)
due to miscarriage (5), abortion (1), fetal
demise (1), and infant death (1) and lost
records (2) were excluded from analysis,
leaving C = 80, I = 85. Further attrition:
transferred care (15)-not reported by study
arm, dropped out of study (9), lost to fol-
low-up (8), re-included in baseline as con-
tinuing smokers in this review
Differential withdrawal in I and C groups
a concern; good information collected on
dropouts being different
Selective reporting (reporting bias) Unclear risk Data collected not specified. Only smoking
outcomes reported
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Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine/creatinine ratio levels
measured at 36 weeks (< 80 ng/mg)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention in AN clinics.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk All but 9 intervention women not lost to
follow-up received all 3 counselling ses-
sions before 36 weeks, and 89% received
the postpartum 1
Equal baseline characteristics in study arms High risk Mostly similar but women in intervention
group tended to smoke more cigarettes at
time of their first visit
Contamination of control group Low risk A separate health educator provided inter-
vention.
Secker-Walker 1997
Methods Randomised controlled trial of a videotape to support women to stop smoking in preg-
nancy
Study conducted in the offices of ’University Associates in Obstyetrics and Gynecology’,
in Burlington, Vermont (USA), with recruitment from November 1992 to April 1993
Participants Inclusion criteria: Pregnant women smoking ’an average of one or more cigarettes per
day’
Exclusion criteria: Not further specified.
Recruitment: Women recruited through University prenatal clinics where obstetricians
and nurse-midwives provide private prenatal care, and residents provide prenatal care
for under-insured women. 60/67 (89%) smokers who were invited agreed to participate
and were randomly assigned (C = 30, I = 30)
Baseline characteristics: Mean cigarettes per day before pregnancy = 22.6.
Mean age: 23 years; 30% married; 33% had less than high school education; 98% white
Progress + coding: Low SES in this review as participants recruited from a state-sup-
ported clinic for underinsured women
Interventions Control: Advice from an obstetrician or nurse-midwife (as per prompt sheet) and a
booklet on quitting. The protocol for this advice has been described in Secker-Walker
1992.
Intervention: As for control plus a 29-min videotape of 4 women going through the
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process of quitting during pregnancy; talking about feelings; coping with weight gain;
getting support, which could be borrowed and taken home. Based on social learning
theory
Main intervention strategy: Counselling (single intervention) compared to a less in-
tensive intervention
Intensity: Frequency (C = 1, I = 2), Duration (C = 1, I = 2).
Unclear if technological intervention provided by existing staff or dedicated project staff
Outcomes Smoking cessation in late pregnancy* (36/40), biochemically validated with exhaled CO
measurements
Process evaluation included perceptions of the videotape contents
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “randomly assigned”.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 4/60 (7%) women, all in the intervention
had a miscarriage and 7 (C = 2, I = 5)
moved to another care-provider, and were
excluded from the analysis
3 (C = 1, I = 2) lost to follow-up butwere re-
included in this review, leaving C = 28, I =
21. Loss to follow-up not balanced, greater
loss from the intervention group
Selective reporting (reporting bias) Low risk Not apparent.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk ExhaledCO (< 8 ppm) used to validate self-
reported smoking cessation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk 53% viewed the videotape. 17% had no
VCR, and 10% reported having no time
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Equal baseline characteristics in study arms High risk Mean exhaled CO level was significantly
lower in intervention group
Contamination of control group Low risk Video tape unlikely to be provided to
women in control group
Secker-Walker 1998
Methods Randomised controlled trial of a counselling intervention to support women to stop
smoking in pregnancy and prevent relapse postpartum
The study was conducted in offices of the ’University Associates in Obstetrics and Gy-
necology’ in Vermont (USA), with recruitment from October 1988 to October 1992
Participants Inclusion criteria: Woman who reported smoking 1 or more cigarettes per day at onset
of pregnancy
Exclusion criteria: Not further specified.
Recruitment: Women recruited through the state-supported (Maternal and Infant Care)
prenatal clinic for underserved women or attending the Adolescent clinic for women 12
to 18 years. 524/544 (96%) women who were invited agreed to participate and were
randomised. 399 current smokers (C = 202, I = 197); 125 spontaneous quitters (C = 63,
I = 62) (separate paper).
Baseline characteristics: Smokers:Mean cigarettes per day before pregnancy C = 25.1, I
= 26.1; mean cigarettes per day at first prenatal visit: C = 11.8, I = 13.4. Another smoker
in the household (C = 82.6%, I = 78.5%)
Mean age: 23 years, < high school (C = 41%, I = 48%), 27%married;Medicaid recipients
(C = 73.1%, I = 71.9%); Adolescent clinic (C = 13.5%, I = 11.9%)
Spontaneous quitters: Mean cigarettes per day before pregnancy (C = 14.1, I = 13.5).
Other smokers in household (C = 64%, I = 70%)
Mean age: C = 21.9, I = 20.9; < high school (C = 27%, I = 36%); 29%married; Medicaid
recipients (C = 68.1%, I = 65.1%); adolescent clinic (C = 14.9%, I = 11.4%)
Progress + coding: Low SES.
Interventions Control: Physician acknowledged women’s smoking, gave a rationale for quitting, strong
recommendation to quit and provided smoking cessation booklet designed for pregnant
women. All participants received: baseline questionnaire, measurement of exhaled CO,
and brief standardised health risk message from a research nurse about the effects of
smoking on the fetus and pregnancy.
Intervention: A structured smoking cessation protocol provided by physicians trained
in its use (Secker-Walker 1992) at 1st, 2nd, 3rd and 5th visits: acknowledging the
woman’s smoking, her exhaled CO level, any progress towards quitting, rationale for
and unambiguous recommendation to quit, asking how she felt about quitting and
acknowledging her response, asking how she could be helped and telling her about the
counsellor, eliciting a commitment to change smoking behaviour before the next prenatal
visit and referring her to the counsellor. The aim was to gain her agreement to set a
quit date, a date when she would quit for 24 hours or a date when she would cut her
consumption by half. Counsellor advised women on ways to accomplish the behaviour
change.
2nd, 3rd, 5th and 7th visit included praise for those who had quit with referral to
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counsellor for help in staying quit. 36 week visits included a briefer protocol followed
with referral for those who wanted to change, praise for success and referral to a nurse
counsellor if smoking
Main intervention strategy: Counselling (multiple intervention) compared to less in-
tensive intervention
Intensity: Frequency (C = 1, I = 5), Duration (C = 1, I = 3).
Intervention provided by existing staff, with referral to a counsellor: Effectiveness study
Outcomes Biochemically validated 7-day point prevalence abstinence at 36 weeks’ gestation (late
pregnancy *) and 1 year postpartum*. Mean cigarettes per day at 36 weeks’ gestation*
and 12 months postpartum. Mean exhaled CO*. Mean birthweight*. LBW*
Relapse prevention at 36 weeks’ gestation (late pregnancy*) and 12 months postpartum
reported in associated reference (Secker-Walker 1998b)
Preterm births* are reported in attrition and are re-included in both numerator and
denominator for this outcome
Notes Methods included a detailed process evaluation of participants’ views and recall of
provider advice. Sample size justification
Separate paper reports relationship between exhaledCO and birthweight (Secker-Walker
1997b)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “randomly assigned”.
Allocation concealment (selection bias) Unclear risk No details provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk High attrition. More than 25% lost to fol-
low-up in pregnancy and more than 30%
lost to longer-term follow-up
Smokers: 109/399 (27% attrition) 24 (6%)
women with miscarriage (14), fetal demise
(5) and infant deaths (5) were excluded
from analysis and are not reported by group
allocation. Report states 376 women re-
main included (instead of 375) (C = 191,
I = 185)
68 women transferred care (C = 34, I = 34)
, 17 delivered before 36 weeks (C = 8, I = 9)
and were not included in 36-week analysis
12 women withdrew from study (C = 5, I
= 7) and 3 lost to follow-up (C = 3), and
were re-included as continuing smokers in
this review, but are not included in mean
cigarettes per day or perinatal outcomes.
114 (I) and 110 (UC) were contacted 1
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year after birth, including 16 (I) and 18
(UC) lost to follow-up during pregnancy.
Women with adverse outcomes were not
included in the analysis
Spontaneous quitters: 33/125 (26%) attri-
tion. Women with miscarriage (5), abor-
tion (1), infant death (1), pregnancy loss (1)
, moving to another clinic or moving (22;
C = 13, I = 9), delivering before 36 weeks
(I = 2). All excluded from analysis leaving
C = 48, I = 44
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported cessation with biochemical
validation by exhaled CO (< 6 ppm) or uri-
nary cotinine (< 500 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Intervention by clinic staff. Notes flagged.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Methods included a detailed process eval-
uation of participants’ views and recall of
provider advice and suggests ‘to a large ex-
tent the intervention was implemented as
planned’
Equal baseline characteristics in study arms Unclear risk No significant differences except for larger
proportion of women in intervention
group had not made a quit attempt in the
past
Contamination of control group Unclear risk No women in cessation group received ces-
sation counselling beyond the physician ad-
vice. Though the same physician provided
advice so unclear if this was influenced by
the intervention
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Methods Randomised controlled trial of a multifaceted intervention to support women to stop
smoking in pregnancy
Study conducted in a large university hospital obstetric clinic in Baltimore (USA) with
enrolment over a 2.5-year period (dates not specified)
Participants Inclusion criteria: Pregnant women who were smoking >= 10 cigarettes/day immedi-
ately prior to pregnancy, < 18 weeks’ gestation
Exclusion criteria: Not further specified.
Recruitment: Eligiblewomen sought by a variety ofmethods butmajoritywere attending
1 of 52 private obstetricians or a hospital AN clinic. Obstetric staff sought permission
for study staff to contact women. 935 women recruited (participation rate unclear) (C =
472, I = 463). 157/935 had spontaneously quit (C = 17% or 80, I = 16% or 74, which
only add up to 154). Smoking rates among spontaneous quitters not reported separately
so all randomised women included in analyses
Baseline characteristics: Mean cigarettes per day pre-pregnancy: C = 20.7, I = 20.9;
mean cigarettes per day at randomisation: C = 11.7, I = 10.7
Mean age 24.9 years, Mean education 12.3 years, Black C = 41.3%, I = 40.3%
Progress + coding: None.
Interventions Control: UC, not further specified.
Intervention: At least 1 personal visit, supplemented by frequent mail and telephone
contacts (at least 1 visit and 1 call/month) from 1 of 2 health educators (MEd level,
trained in pregnancy counselling and smoking intervention), providing information,
support, practical guidance and behavioural strategies for quitting.
Information on quitting and health risks of smoking was mailed every 2 weeks with
“homework” linked to telephone calls; group sessions were also available. There was a
monthly lottery and in the last year of the study a monthly newsletter. Hypnosis was
offered by discontinued as poorly accepted
Main intervention strategy: Counselling (tailored) compared to UC.
Intensity: Frequency (C = 0, I = 6), Duration (C = 0, I = 6). UC intensity: F = 0, I = 0
Intervention provided by dedicated study staff: Efficacy study
Outcomes Self-reported smoking at 8 months gestation (late pregnancy*)
Mean cigarettes per day* at 8 months gestation and mean thiocyanate*
Mean birthweight*, LBW*, very LBW*, perinatal deaths*, neonatal deaths*, stillbirths*
% Apgar scores < 7 at 1 min and 5 mins; length and head circumference
Notes Change of criteria for enrolment after the first 185 as 35% of these had smoked < 10/
day and 71% of that group had quit spontaneously with little relapse.
Detailed account of the intervention is in Nowicki 1984.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not stated.
Allocation concealment (selection bias) Unclear risk No information.
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Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: 56/935 (6%), 35 miscarriages (C
= 17/572, I = 18/463), 1 fetal death (C =
1), 20 stillbirths (C = 11, I = 9) excluded
from analysis, leaving C = 443, I = 436.
Women lost to follow-up included as con-
tinuing smokers in this review.Missingdata
for mean outcomes not included
Selective reporting (reporting bias) High risk Extensive range of outcomes reported.
Outcomes not reported separately for
spontaneous quitters
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking outcomes were not
validated by salivary thiocyanate, despite it
being collected. Mean thiocyanate for each
group reported only
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Group sessions in the interventionwere not
readily accepted
Equal baseline characteristics in study arms Low risk Groups ’similar’ at time of randomisation.
Contamination of control group Low risk Specific personnel employed to deliver in-
tervention - not usual carers
Solomon 2000
Methods Randomised controlled trial of telephone peer support to help women stop smoking in
pregnancy
Study conducted in a large obstetric practice in Burlington, Vermont (USA), with re-
cruitment from 1996 to 1997
Participants Inclusion criteria: Women reporting smoking at least 1 cigarette in the past week at
their first AN visit
Exclusion criteria: Not further specified.
Recruitment: 151/186 (81%) women approached agreed to participate and were ran-
domised (C = 74, I = 77)
Baseline characteristics: Mean cigarettes/day before pregnancy: C = 20.2, I = 22.6;
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Mean cigarettes per day at first visit: C = 9.8, I = 10.5. Mean exhaled CO: C = 11.3, I =
11.3. Mean other smokers in household: C = 1.5, I = 1.3
Mean age C = 23.7, I = 23.1; Mean years education: C = 11.5, I = 11.7; White: C =
96%, I = 94.8%. Medicaid recipient: C = 74.6%, C = 77.5%
Progress + coding: Low SES.
Interventions Control: Received brief smoking cessation advice (including encouraging a quit date)
from a midwife or obstetrician at each of the 3 prenatal visits and stage-appropriate
printed materials. Midwives and obstetricians were provided with a 45-min training
session and protocol prompt sheets were placed in charts at first prenatal visits
Intervention: Received the same as the control group, plus any women in the experi-
mental visit who reported they possibly, probably or definitely intended to quit smoking
were offered telephone peer support by the obstetrician/midwife. The telephone peer
support was provided by a female ex-smoker, who received 8 hours of training. The
support person called the participant within several days of referral to provide support,
encouragement and reinforcement of positive changes in smoking behaviour. Ongoing
calls typically occurred on a weekly basis, but more frequently around a quit date. On
average calls lasted 10 mins
Main intervention strategy: Social support (tailored intervention) compared to a less
intensive intervention
Intensity: Frequency: (C = 3, I = 6), Duration (C = 1, I = 4).
Unclear whether intervention provided by dedicated or existing staff
Outcomes Biochemically validated 7-day point prevalence abstinence at 28-34/40 gestation (late
pregnancy*)
Proportion of self-reported smoking reduction by more than 50%* was reported for a
proportion (135 women) but unclear how many had dropped out of intervention and
control groups. As report states ’no significant difference’ in dropouts by intervention
group (total n = 16) we have imputed 8 for each arm and calculated the number of
reductions from a proportion of the remaining sample
Movement in stages of change also reported for this group.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk States participantswere randomised into ei-
ther experimental or control condition
Allocation concealment (selection bias) Unclear risk No information.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 16/151 (11%) attrition at follow-up. Un-
clear how many from each arm, so out-
comes (> 50% reduction and SOC move-
ment) reported as a proportion of those
remaining were not able to be included.
All randomised women were included in
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the primary outcome of smoking cessation,
with those lost to follow-up treated as con-
tinuing smokers
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine assessment at 28-34weeks
used to confirm smoking status (cut-off <
80 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to allocation.Medical charts flagged
and referral for social support required by
care providers
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Process evaluation showed 53% received
the peer intervention. 9 (12%) had low in-
tentions of quitting smoking during preg-
nancy and were never offered the peer sup-
port, 9 (12%) had no home telephone and
were not referred, and 15 (19%) refused
the offering, leaving 44 (57%) who were
referred for peer support. Data from log
sheets completed by the telephone support
person revealed that 3 women referredwere
never reached; therefore, only 53% of the
women in the experimental condition re-
ceived the peer support intervention
Equal baseline characteristics in study arms Low risk Baseline comparisons of women in the ex-
perimental and control conditions revealed
no significant differences in demographics,
pregnancy history, or smoking information
Contamination of control group Low risk Unlikely telephone counselling would have
been provided to control group in error
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Methods Randomised controlled trial of intensive late pregnancy intervention to support ’resistant’
smokers to stop smoking in pregnancy
Study conducted in 3 large multispecialty clinics in Houstan and Dallas metropolitan
areas, Texas (USA). Enrolment over a 17-month period, dates not specified
Participants Inclusion criteria: Women were screened for eligibility into 2 concurrent studies: Preg-
nant women who smoked more than 5 cigarettes per week prior to pregnancy, fluent
in English, over 18 years, less than 20 weeks’ gestation at first prenatal visit. Women
who continue to smoke at 28 weeks’ gestation, after having counselling and 8 self-help
booklets earlier in pregnancy care, and had telephone access, were eligible for this study
Exclusion criteria: Women who had quit smoking at 28 weeks (continuous abstinence
for 28 days), were enrolled in a large trial to prevent postpartum relapse (Project PANDA)
Recruitment: 6956 (99%) women completed intake screening. 1255 current and recent
smokers received brief intervention in early pregnancy as described by Ershoff 1989.
522/1255 (42%) had transferred care, had fetal demise or abortion, were over 34 weeks’
gestation, or could not be reached. All 269/733 (37%)who reported continuing to smoke
at 28 weeks and were randomised to this study, as data collection and implementation
were adopted as routine procedures, and required no formal written consent (C = 135,
I = 134)
Baseline characteristics: > 61 cigarettes/week before pregnancy: I = 57.9%, C = 43%;
Partner smoking: C = 62.5%, I = 69.6%
Mean age: C = 28.1, I = 28.6; Married: C = 71.1%, I = 65.7%, White: C = 76.3%, I =
81.3%. < high school: C = 11%, I = 9%
Progress + coding: None.
Interventions Control: All women smoking at intake (< 20 weeks), were provided with MI counselling
(3-5 mins) and a series of 8 motivational self-help books (first given in person and 7
mailed weekly thereafter), based on “stage of change” program as described by Ershoff
1989.
Intervention: The high-intensity intervention group (and their partners) then received:
(i) a 20- to 30-min MI telephone counselling call (conducted by trained counsellors and
nurse health educators),
(ii) a personalised, stages of change based feedback letter,
(iii) a final MI-based telephone call conducted 4-5 days after the feedback letter was sent
The MI counselling calls were adapted from the Motivational Enhancement Therapy
developed for Project MATCH (Miller 1992).
Main intervention strategy: Counselling (multiple intervention) compared to less in-
tensive intervention
Intensity: Frequency: (C = 6, I = 6), Duration: (C = 1, I = 3).
Intervention provided by dedicated project staff: efficacy study
Outcomes Biochemically validated smoking cessation at 34 weeks’ gestation (late pregnancy*)
Self-reported smoking cessation at 6 weeks, 3 months* and 6 months* postpartum
Movement in “stages of change”. Breastfeeding rates and general health behaviours ob-
tained but not reported
Discussion of provider views.
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random number list.
Allocation concealment (selection bias) Unclear risk No details provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 35% attrition for cotinine testing: 175/269
provided cotinine subsample (C = 82, I =
84). 39% attrition for 6 weeks postpartum
follow-up
All women lost to follow-up for coti-
nine validated smoking status at 36/40
were included in this review as continuing
smokers. Analysis includes all randomised
women
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine analysis (cut-off 80 ng/
mL) for a subset of the sample at 34 weeks’
gestation, but womenwithout cotinine val-
idation were included as continuing smok-
ers. Postpartum outcomes self-reported
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel likely to have
been aware of group allocation, though no
formal consent requested
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Described as “single blind” (cotinine anal-
ysis performed blind)
Incomplete implementation High risk Only 55% of the experimental group re-
ceived the full intervention (32% were
never able to be reached). Implementation
analysis suggested an effect in women who
received full implementation: 43% vs 34%
control group
Equal baseline characteristics in study arms High risk Group differences were found on number
of cigarettes smoked per week at baseline,
but nodifferences in demographic variables
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Contamination of control group Low risk Specific counsellors delivered the interven-
tion.
Stotts 2004
Methods Randomised controlled trial (pilot study) of MI intervention to support women to stop
smoking in pregnancy
Study conducted in a university-based, public obstetric/gynaecology clinic (USA). Exact
location and recruitment dates not reported
Participants Inclusion criteria: Pregnant women who reported smoking in the past 7 days who were
at least 16 years of age, fluent in English, less than 28 weeks’ gestation
Exclusion criteria: Not further specified.
Recruitment: Women attending a university-based, public obstetric/gynaecology clinic.
Unclear how many women were approached or eligible, though author communication
reports challenges with recruitment. 54 women randomised (C = 28, I = 21, from author
communication)
Baseline characteristics: Not reported but discussion describes women as ’socio-eco-
nomically disadvantaged pregnant smokers’
Progress + coding: Low SES.
Interventions Control: UC, which in this university-based prenatal clinic included physicians or nurses
acknowledging a pregnant woman’s reported smoking and recommending that she quit
Intervention: MI intervention over the course of 8 weeks: (i) 1 face-to-face MI ses-
sion; (ii) 3 MI-based telephone counselling calls; and (iii) 1 personalised feedback letter
providing assessment results. MI incorporated specific counselling strategies, including
personalised and objective feedback, to create a supportive, non-confrontational envi-
ronment through which clients can resolve ambivalence and initiate change
Main intervention strategy: Counselling (multiple intervention) compared to UC.
Intensity: Frequency: (C = 0, I = 4), Duration (C = 0, I = 2). UC intensity F = 1, I = 1
2 masters-level counsellors delivered the intervention: Efficacy study
Outcomes Biochemically validated smoking cessation at post-treatment assessment (late preg-
nancy*)
Stages of change, processes of change, self-efficacy, decisional balance, and depression
scores also reported
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk States women ’were randomized’ into an
intervention or UC condition
Allocation concealment (selection bias) Unclear risk Not reported.
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Stotts 2004 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Outcomes reported as percentages. 5
women excluded from the analysis (as per
author communication) for which there
was no data (C = 2, I = 3), so abstinent per-
centages are based on C = 5/28 and I = 3/
21. These women were included as contin-
uing smokers in this review
Selective reporting (reporting bias) Unclear risk Primary outcomes reported, author com-
munication states low recruitment so fo-
cused on other outcomes in this pilot study
Other bias Unclear risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemically validated smoking cessation
with salivary cotinine (cut-off > 20 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Not reported.
Equal baseline characteristics in study arms Low risk Not reported but author states “ Ini-
tial comparisons of socio-demographic and
smoking history variables revealed no dif-
ferences between the MI and UC groups”
Contamination of control group Low risk Unlikely as intervention delivered by spe-
cific counsellors.
Stotts 2009 (AvB)
Methods 3-armed randomised controlled trial of personalised feedback during US and counselling
to support women to stop smoking in pregnancy
The study was conducted in Women, Infant and Child (WIC) clinics in Houston and
Harris County Area, University of Texas Houston Medical School obstetric clinics and
the local community (USA). Recruitment years not reported
Participants Inclusion criteria: Pregnant women reporting having smoked a cigarette in the past 7
days; age 16 years and older; English speaking, and gestational age between 16 and 26
weeks (to recruit later-pregnancy continuing smokers who have had the most difficulty
stopping smoking for the pregnancy)
Exclusion criteria: Not further specified.
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Stotts 2009 (AvB) (Continued)
Recruitment: Via routine prenatal screening and widely distributed advertisements.
4258 women were screened. 360/725 (49.6%) of eligible women agreed to participate
and were randomly assigned to 3 conditions: C (BP) = 120, I1 (BP + US) = 120, I2 (MI
+ US) = 120.
Baseline characteristics: Mean number of cigarettes per day: C = 11.72 (8.73), I1 =
11.78 (9.47), I2 = 11.03 (8.14). Partner smoking: C = 68 (68), I1 = 82 (79.6), I2 = 76
(72.4). Baseline cotinine: C = 117, I1 = 116, I2 = 131.
Mean gestational age: C = 23.63, I2 = 22.48, I2 = 21.12; Mean age: 24.65,I1 = 25.45,
I2 = 25.21; Mean years education: C = 11.40, I1 = 11.37, I 2= 11.63; White: C = 65.
22%, I1= 57.02%, I2 = 49.57% (remainder African-American and Hispanic); Income
< $US15,000/yr: C = 49.58%, I1 = 55.85%, I2 = 56.67%.
Progress + coding: Low SES.
Interventions A: Control (BP): Best Practice or “BP” counselling based on the Agency for Healthcare
Research Quality practice guidelines for identifying patients who smoke and intervening
for smoking cessation (5A’s and 5R’s). Nurses trained and instructed to keep counselling
to 10-15 mins. Participants were also given American Cancer Society literature on pre-
natal smoking cessation and the toll-free number for the quit smoking hotline
B: Intervention1:BP+US feedback sessions lasting approximately 30mins. In addition
to providing routine US results, the US session was designed to provide information
regarding the effect of cigarette smoke on the fetus using a motivational style. The
sonographers received 2 hours of training and a laminated prompt card. Smoking risk
messages were incorporated into discussion
C: Intervention 2: BP +US +MI consisting of 1 45- to 50-min, face-to-face, individual
counselling session conducted immediately after the US; 1 personalised feedback letter
mailed 1 week later; and 1 follow-up counselling session conducted via telephone 2
weeks subsequent to the initial session, provided by master’s level counsellors. Elements
of the transtheoretical model were included and smoking in the household and social
networks were also addressed
Main intervention strategy: Feedback (single intervention) compared to a less intensive
intervention. Control compared with Intervention 1 (arm B) in this study ID
Intensity: Frequency (C = 2, I = 2), Duration (C = 1, I = 2).
Intervention provided by dedicated study staff: Efficacy study
Outcomes Biochemically validated smoking cessation at 8 months gestation (late pregnancy*)
’Predictors of abstinence’ including: Stages of change, depression (Beck’s Depression
Inventory), baseline smoking, ethnicity, and social networks reported
Notes Concerns about potential distress with the USs intervention were considered in a pilot
study of 30 women (Groff 2005) indicated no significant increase in anxiety post-US.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A block randomisation method, using
blocks of 6 (2 per condition), was used to
generate 360 slots, 120 per intervention
group
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Stotts 2009 (AvB) (Continued)
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition:16/360 (4.4%), C = 6, I1 = 5, I2
= 5 (reasons not reported). Analyses were
conducted using an ITT approach with
all randomised participants included in the
baseline and those lost to follow-up treated
as continued smoking
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported smoking status biochemically
validated using salivary cotinine (< 20 ng/
mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcome assessor blinding not reported.
Incomplete implementation Unclear risk Procecss evaluation not reported.
Equal baseline characteristics in study arms Low risk Treatment group differences only for ges-
tational age at baseline
Contamination of control group Low risk Low risk of contamination as counselling
provided by specialist counsellors, not ac-
cessible to the control group
Stotts 2009 (AvC)
Methods 3-armed randomised controlled trial of personalised feedback during US and counselling
to support women to stop smoking in pregnancy
The study was conducted in Women, Infant and Child (WIC) clinics in Houston and
Harris County Area, University of Texas Houston Medical School obstetric clinics and
the local community (USA). Recruitment years not reported
Participants Inclusion criteria: Pregnant women reporting having smoked a cigarette in the past 7
days; age 16 years and older; English speaking, and gestational age between 16 and 26
weeks (to recruit later-pregnancy continuing smokers who have had the most difficulty
stopping smoking for the pregnancy)
Exclusion criteria: Not further specified.
Recruitment: Via routine prenatal screening and widely distributed advertisements.
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Stotts 2009 (AvC) (Continued)
4258 women were screened. 360/725 (49.6%) of eligible women agreed to participate
and were randomly assigned to 3 conditions: C (BP) = 120, I1 (BP + US) = 120, I2 (MI
+ US) = 120.
Baseline characteristics: Mean number of cigarettes per day: C = 11.72 (8.73), I1 =
11.78 (9.47), I2 = 11.03 (8.14). Partner smoking: C = 68 (68), I1 = 82 (79.6), I2 = 76
(72.4). Baseline cotinine: C = 117, I1 = 116, I2 = 131.
Mean gestational age: C = 23.63, I2 = 22.48, I2 = 21.12; Mean age: 24.65,I1 = 25.45,
I2 = 25.21; Mean years education: C = 11.40, I1 = 11.37, I 2= 11.63; White: C = 65.
22%, I1= 57.02%, I2 = 49.57% (remainder African-American and Hispanic); Income
< $US15,000/yr: C = 49.58%, I1 = 55.85%, I2 = 56.67%.
Progress + coding: Low SES.
Interventions A: Control (BP): Best Practice or “BP” counselling based on the Agency for Healthcare
Research Quality practice guidelines for identifying patients who smoke and intervening
for smoking cessation (5A’s and 5R’s). Nurses trained and instructed to keep counselling
to 10-15 mins. Participants were also given American Cancer Society literature on pre-
natal smoking cessation and the toll-free number for the quit smoking hotline
B: Intervention 1: BP + US feedback sessions lasting approximately 30 mins. In addi-
tion to providing routine US results, the US session was designed to provide informa-
tion regarding the effect of cigarette smoke on the fetus using a motivational style. The
sonographers received 2 hours of training and a laminated prompt card. Smoking risk
messages were incorporated into discussion
C: Intervention 2: BP +US +MI consisting of 1 45- to 50-min, face-to-face, individual
counselling session conducted immediately after the US; 1 personalised feedback letter
mailed 1 week later; and 1 follow-up counselling session conducted via telephone 2
weeks subsequent to the initial session, provided by master’s level counsellors. Elements
of the transtheoretical model were included and smoking in the household and social
networks were also addressed
Main intervention strategy: Feedback (multiple intervention) compared to a less in-
tensive intervention. Control compared with intervention 2 (arm c) in this study ID
Intensity: Frequency (C = 2, I = 4), Duration (C = 1, I = 3).
Intervention provided by dedicated study staff: Efficacy study
Outcomes Biochemically validated smoking cessation at 8 months gestation (late pregnancy*)
’Predictors of abstinence’ including: Stages of change, depression (Beck’s Depression
Inventory), baseline smoking, ethnicity, and social networks reported
Notes Concerns about potential distress with the USs intervention were considered in a pilot
study of 30 women (Groff 2005) indicated no significant increase in anxiety post-US.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk A block randomisation method, using
blocks of 6 (2 per condition), was used to
generate 360 slots, 120 per intervention
group
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Stotts 2009 (AvC) (Continued)
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition:16/360 (4.4%), C = 6, I1 = 5, I2
= 5 (reasons not reported). Analyses were
conducted using an ITT approach with
all randomised participants included in the
baseline and those lost to follow-up treated
as continued smoking
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported smoking status biochemically
validated using salivary cotinine (< 20 ng/
mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcome assessor blinding not reported.
Incomplete implementation Unclear risk Procecss evaluation not reported.
Equal baseline characteristics in study arms Low risk Treatment group differences only for ges-
tational age at baseline
Contamination of control group Low risk Low risk of contamination as counselling
provided by specialist counsellors, not ac-
cessible to the control group
Strecher 2000
Methods Randomised controlled trial of computer-generated messages to support women to stop
smoking in pregnancy
Study conducted in 2 university hospitals in North Carolina and Michigan (USA), with
recruitment from December 1996 to December 1997
Participants Inclusion criteria: Women who have “smoked 100 cigarettes in their lifetime and still
smoking” or “had quit since becoming pregnant”
Exclusion criteria: Not further specified.
Recruitment: Unclear how many women screened during first prenatal visit. using a
self-administered computer screening program. 173 women randomised (C = 85, I =
88)
Baseline characteristics: Mean cigarettes per day before pregnancy: C = 18.7, I = 20.3;
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Strecher 2000 (Continued)
current mean cigarettes per day: C = 11.8, I = 12.9; Mean cotinine: C = 2597, I = 2701;
Mean smokers in household: C = 1.1, I = 1.0
Mean age: C = 26.6, I = 25.5; Mean education: C = 12.5, I = 12.5; White: C = 81.2%,
I = 87.4%
Progress + coding: None.
Interventions Control: Received “a pregnant woman’s guide to quit smoking” at the first visit
Intervention: Entered personal data into a hand-held computer at AN visits, which
subsequently generated personalised tailored messages, which were posted to the woman
Main intervention strategy: Health education (single intervention) compared to less
intensive intervention
Intensity: Frequency (C = I, I = 6), Duration (C = 1, I = 2).
Unclear if intervention provided by dedicated project or existing staff as technological
intervention
Outcomes Biochemically validated smoking cessation at 6 weeks postpartum* (0-5 months pp)
Biochemically validated cessation at 24/40 gestation (’mid-term’) and self-reported ces-
sation 3 months postpartum but outcomes not reported
Mean cigarettes per day and cotinine concentrations collected and reported as ’not
significant’ but actual figures not reported
Participant evaluation of using hand-held computers and reactions to computerised
materials
Notes Numbers in paper inconsistent: I = 88, C = 85 in methods section, I = 104, C = 87 in
results section. No justification for change of denominators
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk By computer algorithm.
Allocation concealment (selection bias) Unclear risk Not described.
Incomplete outcome data (attrition bias)
All outcomes
High risk Outcome data (C = 87, I = 104) are incon-
sistent with figures reported as randomised
inmethods and baseline data table (C = 85,
I = 88). If comparing outcome data using
ITT and excluding those ’lost to follow-up’
it appears that more than 30% of the con-
trol group (30/87) were lost to follow-up.
In this review we have used the ITT data
(C = 87, I = 104) as the denominator
Selective reporting (reporting bias) High risk Results are conflicting and actual figures for
pregnancy (24/40) are not reported, nor are
figures for mean cigarettes per day or coti-
nine concentrations
293Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
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Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine analysis at 24 weeks’ ges-
tation and at 6 weeks postpartum (cut-off
< 80 ng/mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel not blinded to
intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Process evaluation not reported.
Equal baseline characteristics in study arms Low risk Baseline comparisons revealed no signif-
icant differences in age, race, education,
number of cigarettes smoked before preg-
nancy, and baseline stage of change
Contamination of control group Low risk Technological intervention so contamina-
tion unlikely.
Tappin 2000
Methods Randomised controlled trial (pilot study) of home-based MI to support women to stop
smoking in pregnancy
Study conducted in a Glasgow Hospital, Scotland (UK), with recruitment from March
to May 1997
Participants Inclusion criteria: Women who identified as smokers on a questionnaire at AN clinic
booking
Exclusion criteria: Not further specified.
133/393 (34%) women screened identified as smokers and 100/133 (75%) agreed to
participate and were randomised (C =5 0, I = 50)
Baseline characteristics: Mean cigarettes per day pre-pregnancy C = 18.1, I = 19.6;
current mean cigarettes per day C = 13.2, I = 14.8; partner smoking: C = 82%, I = 90%;
Mean cotinine C = 126 ng/mL, I = 136 ng/mL
Mean age: C = 25.9, I = 26.6; 76% ’severely deprived’ participants
Progress + coding: Low SES.
Interventions Control: Received usual advice from their prenatal providers, which should include
information about smoking
Intervention: Received 2 to 5 MI sessions (mean 2.6 hours), based on stages of change,
in the clients’ home conducted by a midwife with 3 weeks training in smoking cessation
counselling
Main intervention strategy: Counselling (single intervention) compared to UC.
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Intensity: Frequency: (C = 0, I = 4), Duration (C = 0, I = 4). UC intensity: F = 1, D = 1
Intervention provided by dedicated study staff: Efficacy study
Outcomes Biochemically validated smoking cessation at >= 27/40 (late pregnancy*). >= 50% re-
duction in cotinine*
Mean birthweight*, preterm births*, stillbirths*.
Ranking interviews measured movement around the ’cycle of change’
Detailed evaluation of participant and midwifery views of interventions
Notes SDs for mean birthweight were not reported, therefore we calculated a mean SD from 13
studies with available birthweight SDs (578) to include in this review, as recommended
by the cochrane handbook
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomnumbers stratified by deprivation.
Allocation concealment (selection bias) Low risk Group allocation by telephone.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Low attrition (2%). Some missing data for
cotinine validation. Smoking outcome re-
sults reported for all of those randomised,
and those with missing data counted as
continuing smokers in this review
Selective reporting (reporting bias) Low risk Detailed outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Serum cotinine levels measured.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk Good process evaluation of implemen-
tation quality according to rating tool,
showed 79% of women in the intervention
group received at least 2 counselling ses-
sions
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Equal baseline characteristics in study arms Low risk No apparent difference.
Contamination of control group Low risk Specific counsellors provided intervention
at home so contamination unlikely. Less
than 20% of the control group recalled be-
ing given smoking information at the time
of booking
Tappin 2005
Methods Randomised controlled trial of home-based counselling to support women to stop smok-
ing in pregnancy
Study conducted in 2 hospitals inGlasgow, Scotland (UK), with recruitment fromMarch
2001 to May 2003
Participants Inclusion criteria: Women reporting smoking at prenatal booking visit and less than or
equal to 24 weeks’ gestation
Exclusion criteria: Not further specified.
Recruitment: 762/1684 (45%) eligible women agreed to participate (C = 411, I = 351)
Baseline characteristics: Current mean cigarettes per day: C = 11.3, I = 11.7; At least
1 other smoker in house: C = 66%, I = 65%
Mean age: C = 26.9, I = 26.5; Most deprived social category (6-7): C = 73%, I = 69%
Progress + coding: Low SES.
Interventions Control:Midwives provided standardhealth promotion including informationon smok-
ing in pregnancy from a book given to all women in pregnancy in Scotland
Intervention: Women also were offered 2 to 5 additional home visits of about 30 mins
duration from the same study midwife
Main intervention strategy: Counselling (single intervention) compared to UC.
Intensity: Frequency: (C = 0, I = 4), Duration (C = 0, I = 4). UC intensity: F = 1, D = 1
Intervention provided by dedicated study staff: Efficacy study
Outcomes Biochemically validated and self-reported quitting soon after the routine 36 week AN
visit (late pregnancy*), reduction (mean cotinine*, and biochemically validated, which
was at least half baseline measurement*), and increased smoking, mean birthweight*,
preterm delivery*, very LBW*, LBW*, neonatal death*, stillbirths*, and admission to
NICU*
Data collected on other adverse events including AN admissions, miscarriage, termina-
tion of pregnancy, and assisted delivery
Discussion of participant and provider views of intervention and thorough process eval-
uation showed good implementation
Notes Sample size calculated by recruitment to achieve sufficient power not able to be achieved
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Low risk Stratified central randomisation.
Allocation concealment (selection bias) Low risk Group allocation provided by central ad-
ministrator.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 29/762 (4%)women lost to follow-up: fetal
loss = 6 (C = 2, I = 4) were excluded from
this analysis; no late interview or cotinine
= 10 (C = 5, I = 5), Not traceable 12 (C
= 7, I = 5). Some missing data for cotinine
validation
All randomised participants (except fetal
losses) included in smoking outcomes, and
those with missing data counted as contin-
uing smokers
Selective reporting (reporting bias) Low risk Detailed outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Serum cotinine (cut-off < 13.7 ng/mL) or
salivary cotinine (cut-off < 14.2 ng/mL)
used to validate self-reported abstinence
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Midwife intervention, with caregivers not
blinded.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk ’A second administrator, blind to the ran-
dom allocation, established a primary out-
come’
Incomplete implementation High risk 26% of women did not have any home vis-
its.
Equal baseline characteristics in study arms Low risk No apparent major difference noted.
Contamination of control group Low risk Research midwives provided the interven-
tion.
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Methods This 2-armed randomised controlled trial, aimed to assess the efficacy of financial in-
centives added to routine pregnancy stop smoking services. This study was conducted in
Greater Glasgow, Scotland, UK between December 2011 to February 2013 with follow-
up occurring in September 2013
Participants Inclusion criteria: Women were eligible if they were smokers with an exhaled CO level
of at least 7 ppm, aged 16 years or more, less than 24 weeks pregnant, resident in NHS
Greater Glasgow and Clyde, and able to understand and speak English for telephone
consent
Exclusion criteria: Not stated.
Recruitment: 612/1722=35.5%women agreed to participate (C = 306 I = 306).Women
were recruited through NHS stop smoking services
Baseline characteristics: Mean Fagerstrom score (C = 5.32 I = 4.85), partner smokes
(C = 66.3 I = 59) Mean age at delivery (C = 27.66 I = 28.27)
Progress + coding: None.
Interventions Control: The control group was offered routine specialist pregnancy support by the
stop smoking services, which included the offer of a face-to-face appointment to discuss
smoking and cessation and, for those who attended and set a quit date, the offer of free
NRT for 10 weeks provided by pharmacy services, and 4 weekly support phone calls
Intervention: The incentives group was offered the same routine support plus up to
£400 of shopping vouchers (Love2shop) for engaging with stop smoking services or for
quitting during pregnancy, or both. Intervention participants received £50 of vouchers if
they attended their face-to-face appointment and set a quit date. Confirmed quitters were
sent a further £50 voucher. 12 weeks after stopping smoking, women in the incentives
group who were quitters at 4 weeks were contacted by stop smoking services (routine
practice) and, if confirmed to be abstinent CO breath test result < 10 ppm), were sent
a £100 voucher. A research nurse visited self-reported quitters to collect a CO level,
and saliva and urine for cotinine estimation. Women in the incentives group who were
confirmed as abstinent by the CO breath test (< 10 ppm) were sent a final £200 voucher
Main Intervention strategy: Incentives (single) v UC
Intensity: Frequency (C = 0 I = 4) Duration (C = 0 I = 4).
Outcomes Cotinine verified cessation at 34-38 weeks’ gestation*, self-reported quit at 6 months
postpartum*, preterm birth*, mean birthweight*. Stillbirths and miscarriages combined
so not included in this review. Engagement. Cost-effectiveness
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The Glasgow Clinical Trials Unit embed-
ded the randomisation in the trial database
using randomised permuted blocks, with
a block length of 4, thus facilitating equal
distribution of clients between the inter-
ventions
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Tappin 2015 (Continued)
Allocation concealment (selection bias) Low risk Allocation was concealed from staff and
clients until after consent and recruitment
Incomplete outcome data (attrition bias)
All outcomes
Low risk No evidence of unequal attrition in study
arms and ITT analysis was used for missing
data. 15% were lost to follow-up and were
counted as smokers
Selective reporting (reporting bias) Low risk Both primary and secondary outcomes are
reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Smoking is biochemically validated, with
cotinine verified cessation through saliva (<
14.2 ng/mL) or urine < 44.7 ng/mL
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and
providers to this intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Helpline staff, who ascertained the primary
outcome, self report of smoking status in
late pregnancy, were blind to allocation sta-
tus
Incomplete implementation Unclear risk 15% were lost to follow-up and were
counted as smokers.
Equal baseline characteristics in study arms Low risk Baseline characteristics appear even in both
groups.
Contamination of control group Low risk Incentives were the main intervention
component, therefore contamination more
likely
Thornton 1997
Methods Randomised controlled trial of counselling intervention to support women to stop smok-
ing and prevent relapse in pregnancy
Study conducted in a large public AN clinic, in Rotunda Ireland, with recruitment
during 3 months in 1995
Participants Inclusion criteria: Women who ’currently smoke’ or had spontaneously quit since be-
coming pregnant
Exclusion criteria: Non-viable pregnancy identified at first visit or intending to deliver
at another hospital
Recruitment: 967/524 (54%) women attending the public clinic were smokers. 418/
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518 (81%) eligible women agreed to participate and were randomised (C = 209, I = 209)
Baseline characteristics: Current smoker: C = 192, I = 203; Spontaneous quitter: C =
17, I = 6; 34% smoked more than 20 cigarettes per day currently; Partner smoking: C
= 74%, I = 69.9%
< 21 years age C = 17%, I = 24%; Mean gestation at first visit I = 15.5, C = 15.3; Not
living with partner C = 39.2%, I = 42.6%; age finished education C = 16.1, I = 16.0;
Lower social class C = 71.5%, I = 70.9%
Progress + coding: Low SES.
Interventions Control: Routine prenatal advice on a range of health issues, from midwives and obste-
tricians
Intervention: As for the control group + (i) structured 1 to 1 counselling by a trained
facilitator (based on stages of change theory); (ii) partners invited to be involved in the
program; (iii) an information pack (developed in collaboration with a focus group of
women), which included a self-help booklet; (iv) and invited to join a stop smoking
support group. A CO monitor was available for the intervention group, to quantify
smoking habit and act as a motivational tool
Main intervention strategy: Counselling (tailored) compared to UC.
Intensity: Frequency: (C = 0, I = 5); Duration (C = 0, I = 2). UC intensity: F = 1, D = 1
Intervention provided by dedicated study staff: Efficacy study
Outcomes Biochemically validated smoking cessation* and relapse prevention* at delivery (late
pregnancy) and 3months postpartum among baseline smokers* and spontaneous quitter.
Mean cigarettes per day at delivery*, reduction in daily cigarettes since first visit, quit
attempts, comparisons of quitters and non quitters at various stages.
Infant outcomes at birth (singleton births): mean birthweight*, proportion LBW (2500
g)*, preterm births*, stillbirths*, neonatal deaths*, NICU admissions*, delivery type,
mean gestation
Infant outcomes at 3months postpartum: neonatal deaths, attendance at GP; attendance
or admission to hospital
Notes Detailed process analysis and participant feedback of program implementation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random number tables with restricted ran-
domisation in groups of 10
Allocation concealment (selection bias) Low risk Sealed opaque envelopes.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 31/418 (7%) attrition at delivery (I = 13/
209 or 6.2%, C 18/209 or = 8.6%). Mis-
carriage (7), delivered elsewhere (3), moved
overseas (2), changed care provider (7) or
never returned to Rotunda hospital after
first visit (12), and were excluded from this
analysis
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All other women lost to follow-up counted
as continuing smokers in this review
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Exhaled CO measurement on 145/209
womenonpostnatal ward (cut-off < 4ppm)
. Presume smoking outcomes reported are
those biochemically validated although this
is not explicitly stated
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and study
personnel to counselling intervention. In-
tervention provided by trained facilitator,
with staff unaware of allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Detailed process evaluation describes how
women rarely initiated contact at subse-
quent visits and the groups sessions were
poorly attended
Equal baseline characteristics in study arms High risk Intervention group were less likely to have
spontaneously quit, or be employed
Contamination of control group Low risk Research facilitator provided intervention.
Tsoh 2010
Methods Randomised controlled trial of a computer-delivered brief intervention ’Video Doctor’
to support women to stop smoking in pregnancy
Study conducted as part of ’Health in Pregnancy’ study in 5 community prenatal clinics
in San Francisco Bay Area (USA), with recruitment from 2006 to December 2007
Participants Inclusion criteria: Pregnant women ’smoking in the past 30 days’ who were English-
speaking, 18 years or older, and less than 26 weeks pregnant
Exclusion criteria: Not further specified.
Recruitment: 1208 women were screened for eligibility in the prenatal clinic waiting
rooms and 114 refused (91% participation in screening). 42/410 (10%) eligible women
identified as smokers on a risk assessment using a laptop computer via a low-literacy
computerised interview with audio voiceover, and were randomised (C = 19, I = 23)
Baseline characteristics: Current mean cigarettes per day I = 6.8, C = 6.7.
Mean age C = 26.8, I = 27.5; White C = 31.6%, I = 17.4% (remaining Hispanic, Back
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or ’other’); Less than high school C = 21.1%, I = 26.1%; Married C = 26.3%, I = 47.
8%
Progress + coding: None.
Interventions Control: Received the clinic’s UC and did not interact with the ’VideoDoctor’ program.
All participants received a gift card ($30-$50) for completing assessments
Intervention: Participants received tailored advice from ’Video Doctor’, a multimedia
interactive intervention delivered on a laptop computer via a secure Internet connection.
An actor-portrayed Video Doctor delivered interactive risk-reduction messages designed
to simulate an ideal discussion with a prenatal health care provider who provided non-
judgmental counselling following several key principles of MI. At the conclusion of
each intervention session, the program automatically printed 2 documents: (a) a cueing
sheet for providers, which offered a summary of the patient’s risk profile and suggested
risk-reduction counselling statements; and (b) an educational worksheet for participants
with questions for self-reflection, harm reduction tips, and local resources. The cueing
sheet was placed in the patient’s medical record for the provider’s use during the prenatal
appointment
Main intervention strategy: Counselling (multiple intervention) compared to UC.
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 2).
Technological intervention which prompted UC providers: Effectiveness study
Outcomes Self-reported 30-day abstinence after 1 month and 2 months (late pregnancy*). Mean
reduction in cigarettes smoked per day and days smoked
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Women reporting risks were stratified by
risk combination and randomly assigned
by the computer to intervention or UC
groups
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition: I = 5/23 (22%), C = 5/19 (26%)
at 1-month follow-up and I = 9/23 (39%)
, C = 13/19 (32%) at 2-month follow-up
(reasons not reported)
All randomised participants included in
analysis and women lost to follow-up
treated as continuing smokers in this review
Selective reporting (reporting bias) Low risk Primary outcomes reported.
Other bias Low risk No other bias detected.
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Biochemical validation of smoking absti-
nence (detection bias)
High risk Self-reported smoking cessation outcomes
only - no biochemical validation of smok-
ing status
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel as intervention includes counselling
component
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Blinding of outcome assessor not reported.
Incomplete implementation Low risk Only 3 women in the UC group did not
recall receiving provider advice
Equal baseline characteristics in study arms Low risk Similar baseline characteristics.
Contamination of control group Unclear risk Some risk of contamination between study
arms as same provider delivering coun-
selling to intervention and control groups.
Process evaluation showed77.8% interven-
tion group received 2 provider advice ses-
sions, compared to 21.4% control group
Tuten 2012 (AvB)
Methods 3-armed randomised controlled trial of contingent incentives to support women to stop
smoking in pregnancy
Study conducted in the Center for Addiction and Pregnancy Treatment, at the Johns
Hopkins Bayview Medical Center, Baltimore (USA), with recruitment from May 2005
to January 2009
Participants Inclusion criteria: Requiring methadone during pregnancy, nicotine dependent or
smoking 10 or more cigarettes daily, aged 18 years or older, <= 30 weeks’ gestation, and
capable of providing informed consent
Exclusion criteria: NRT.
Recruitment: 1072/1181 women screened smoked (90.7%). 125/1072 were eligible,
and 102/125 (82%) agreed to participate, and were randomised to 3 conditions (C =
32, I1 (non-contingent incentives) = 28, I2 (contingent incentives) = 42).
Baseline characteristics: Current mean cigarettes per day = 18.0.
Mean age 30.8 years; 65% Caucasian; 11.1 mean years education; 85.3% currently
single. 94.7% unemployed
Progress + coding: Low SES.
Interventions A: Control: As part of UC, inpatients at the centre were provided with specific infor-
mation about the adverse effects associated with cigarette smoking for the mother and
the infant. In addition, patients were provided with educational materials about risks
of smoking during pregnancy. During follow-up obstetric appointments, patients were
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asked routinely about their cigarette smoking and commended on efforts to abstain.
TAU participants were informed that they would be compensated for providing urine
and breath samples, but that they would not earn incentives as part of their study par-
ticipation
B: Intervention 1 (non-contingent incentives): Participants were informed that they
had the chance to earn vouchers, but whether they earned a voucher and the amount
they earned was determined by an already generated schedule and thus was not linked
to their own cigarette smoking. NCBI participants were required to leave CO and urine
samples to receive any voucher earnings generated by the ’yoked’ schedule, for 12 weeks
or until delivery
C: Intervention 2 (contingent incentives): Incentives contingent upon cigarette smok-
ing reduction or abstinence for a period of 12 weeks or until delivery. Smoking targets
were minimal during the initial weeks of intervention, and increased gradually to ensure
adequate learning and reinforcement. Incentives could be earned for each sample left
on Monday, Wednesday and Friday (3 samples per week) if the following reduction and
abstinence targets were met: week 1: any reduction; weeks 2-4: 10% reduction; weeks
5-7: 25% reduction; weeks 8-9: 50% reduction; week 10-11: 75% reduction; and week
12 until delivery: abstinence (CO < 4 ppm.). Participants had the opportunity to earn
a $7.50 voucher for the first smoking reduction target, and the value of the voucher
increased by $1/day for each consecutive target met throughout the 12-week incentive
period to a maximum of $41.50. If a contingent participant failed to meet the tobacco
use reduction target during the 12-week incentive period, she earned $0 for that sample
and the incentive schedule was reset to the original voucher value of $7.50. If the par-
ticipant again met the target reduction on 5 consecutive occasions, she earned vouchers
at the previously attained level
Main intervention strategy: Incentives (single intervention) compared to UC. Non-
Contingent incentives (arm b) compared to UC in this study ID
Intensity: Frequency: (C = 0, I = 6), Duration (C = 0, I = 5).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Biochemically validated point prevalence abstinence after 12 weeks of intervention
(late pregnancy*); 75% cotinine reduction (> 50% reduction*); mean cotinine*. Mean
cigarettes per day 1 and 3 months post intervention and 6 weeks postpartum, however
only 6 weeks postpartum mean cigarettes per day reported for arm B so this outcome is
not included for this arm in this review
Mean birthweight*, preterm births*, LBW*, NICU admissions*.
Spontaneous abortion, length of hospital stay, mean gestational age at delivery, mean 1-
and 5-min Apgars, urine toxicology and treatment for NAS
Comparisons with non-contingent incentives (arm 2) are also reported
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk States patients were ’randomly assigned’ to
1 of 3 conditions
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Allocation concealment (selection bias) Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
High risk 33% attrition (34/102) for pregnancy and
birth outcomes and no explanation as to
reasons for missing data. Unclear whether
all women randomisedwere included in the
outcome assessment, as percentage results
only are reported. Assume all persons not
meeting ’nonsmoking targets’ (p1872) are
counted as continuing smokers
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported,
except smoking outcomes postpartum
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Exhaled CO (< 4 ppm) validation to eval-
uate changes during in-patient treatment
phase used in this study as not smoking.
Urine cotinine (cut-off 200 ng/mL) also
collected but unclear if used for validation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to incentives intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if outcome assessment was
blinded.
Incomplete implementation Low risk This was a well-accepted intervention with
high rates of participation among all 3 con-
ditions
Equal baseline characteristics in study arms Low risk The conditions did not differ significantly
on demographic, pre-treatment or baseline
cigarette smoking measures
Contamination of control group Low risk Unlikely given the design of the study.
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Methods 3-armed randomised controlled trial of contingent incentives to support women to stop
smoking in pregnancy
Study conducted in the Center for Addiction and Pregnancy Treatment, at the Johns
Hopkins Bayview Medical Center, Baltimore (USA), with recruitment from May 2005
to January 2009
Participants Inclusion criteria: Requiring methadone during pregnancy, nicotine dependent or
smoking 10 or more cigarettes daily, aged 18 years or older, <= 30 weeks’ gestation, and
capable of providing informed consent
Exclusion criteria: NRT.
Recruitment: 1072/1181 women screened smoked (90.7%). 125/1072 were eligible,
and 102/125 (82%) agreed to participate, and were randomised to 3 conditions (C =
32, I1 (non-contingent incentives) = 28, I2 (contingent incentives) = 42).
Baseline characteristics: Current mean cigarettes per day = 18.0.
Mean age 30.8 years; 65% Caucasian; 11.1 mean years education; 85.3% currently
single. 94.7% unemployed
Progress + coding: Low SES.
Interventions A:Control: As part ofUC, inpatients at the centre are providedwith specific information
about the adverse effects associated with cigarette smoking for themother and the infant.
In addition, patients are provided with educational materials about risks of smoking
during pregnancy. During follow-up obstetric appointments, patients are asked routinely
about their cigarette smoking and commended on efforts to abstain. TAU participants
were informed that they would be compensated for providing urine and breath samples,
but that they would not earn incentives as part of their study participation
B: Intervention 1 (non-contingent incentives): Participants were informed that they
had the chance to earn vouchers, but whether they earned a voucher and the amount
they earned was determined by an already generated schedule and thus was not linked
to their own cigarette smoking. NCBI participants were required to leave CO and urine
samples to receive any voucher earnings generated by the ’yoked’ schedule, for 12 weeks
or until delivery
C: Intervention 2 (contingent incentives): Incentives contingent upon cigarette smok-
ing reduction or abstinence for a period of 12 weeks or until delivery. Smoking targets
were minimal during the initial weeks of intervention, and increased gradually to ensure
adequate learning and reinforcement. Incentives could be earned for each sample left
on Monday, Wednesday and Friday (3 samples per week) if the following reduction and
abstinence targets were met: week 1: any reduction; weeks 2-4: 10% reduction; weeks
5-7: 25% reduction; weeks 8-9: 50% reduction; week 10-11: 75% reduction; and week
12 until delivery: abstinence (CO < 4 ppm.). Participants had the opportunity to earn
a $7.50 voucher for the first smoking reduction target, and the value of the voucher
increased by $1/day for each consecutive target met throughout the 12-week incentive
period to a maximum of $41.50. If a contingent participant failed to meet the tobacco
use reduction target during the 12-week incentive period, she earned $0 for that sample
and the incentive schedule was reset to the original voucher value of $7.50. If the par-
ticipant again met the target reduction on 5 consecutive occasions, she earned vouchers
at the previously attained level
Main intervention strategy: Incentives (single intervention) compared to UC. Contin-
gent incentives (arm c) compared to UC in this study ID
Intensity: Frequency: (C = 0, I = 6), Duration (C = 0, I = 5).
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Intervention provided by dedicated project staff: Efficacy study
Outcomes Biochemically validated point prevalence abstinence after 12 weeks of intervention
(late pregnancy*); 75% cotinine reduction (> 50% reduction*); mean cotinine*; mean
cigarettes per day 1 and 3 months post intervention* and 6 weeks postpartum
Mean birthweight*, preterm births*, LBW*, NICU admissions*.
Spontaneous abortion, length of hospital stay, mean gestational age at delivery, mean 1-
and 5-min Apgars, urine toxicology and treatment for NAS
Comparisons with non-contingent incentives (arm 2) are also reported
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk States patients were ’randomly assigned’ to
1 of 3 conditions
Allocation concealment (selection bias) Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
High risk 33% attrition (34/102) for pregnancy and
birth outcomes and no explanation as to
reasons for missing data. Unclear whether
all women randomisedwere included in the
outcome assessment, as percentage results
only are reported. Assume all persons not
meeting ’nonsmoking targets’ (p1872) are
counted as continuing smokers
Selective reporting (reporting bias) Low risk Primary outcomes appear to be reported,
except smoking outcomes postpartum
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Exhaled CO (< 4 ppm) validation to eval-
uate changes during in-patient treatment
phase used in this study as not smoking.
Urine cotinine (cut-off 200 ng/mL) also
collected but unclear if used for validation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and per-
sonnel to incentives intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if outcome assessment was
blinded.
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Incomplete implementation Low risk This was a well-accepted intervention with
high rates of participation among all 3 con-
ditions
Equal baseline characteristics in study arms Low risk The conditions did not differ significantly
on demographic, pre-treatment or baseline
cigarette smoking measures
Contamination of control group Low risk Unlikely given the design of the study.
Ussher 2015
Methods This 2-armed randomised controlled trial aimed to determine the effectiveness of a
physical activity intervention for smoking cessation during pregnancy. The study was
conducted in 13 AN clinics in hospitals in London, Surrey, Kent, and Cheshire, England,
UK between April 2009 and November 2012
Participants Inclusion criteria: Women wanting to stop smoking, wanting help with stopping smok-
ing, agreeing to set a date for quitting smoking within 1 week of the baseline visit, age
16-50 years, being at 10-24 weeks of gestation, cigarette consumption of 5 or more daily
before pregnancy, currently smoking 1 or more cigarettes daily, and being able to walk
continuously for 15 mins
Exclusion criteria: Exclusion criteria were medical conditions potentially exacerbated by
exercise or advised against exercise by a doctor, inability to provide informed consent or
complete questionnaires in English, drug or alcohol dependence, and currently using or
wanting to use NRT.Women were recruited irrespective of their current level of physical
activity or motivation towards increasing their activity
Recruitment: 789/5513 (14.3%) eligible women agreed to participate (C = 395 I = 393)
. Women were recruited by phone after their initial visit at their AN clinic
Baseline characteristics: Median No. of cigarettes smoked daily at baseline (C = 10 I =
10) Median Fagerström test of cigarette dependence score (C = 4 I = 4) Partner smokes
(C = 261 I = 250) Mean age at leaving full time education (years)* (C = 17.8 I = 18.0)
Progress + coding: None.
Interventions Control: All participants offered 6 weekly sessions of 20 mins of individual behavioural
cessation support, starting 1 week before the quit date and ending 4 weeks afterwards.
This intervention aimed to support smoking cessation by reinforcing commitment to
abstinence and solving women’s problems about maintaining abstinence. It incorporated
all 43 behaviour-change techniques defined in a published taxonomy 16 and as described
in the protocol,15 except for the provision of rewards contingent on successfully stopping
smoking. The emphasis was on the importance of avoiding lapses, managing withdrawal
symptoms and urges to smoke, enhancing self-confidence, and prevention of relapse
Intervention: Behavioural cessation support plus a physical activity intervention, com-
bining supervised exercise with physical activity consultations. 14 sessions of supervised
exercise were offered over 8 weeks; twice a week for 6 weeks then weekly for 2 weeks.
At each session, the participants walked at a moderate intensity on a treadmill for up
to 30 mins. Immediately before each treadmill session, the women received behavioural
support
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Main Intervention strategy: Smoking Cessation Intervention: Execercise (single) v UC.
Intensity: Frequency (C = 6 I = 6) Duration (C = 4 I = 6).
Outcomes Biochemically validated abstinence validated by exhaled CO at end of pregnancy* and at
four weeks after quit date, self-reported abstinence by telephone 6 months after birth*,
miscarriage, stillbirth*, neonatal death*, mean birthweight (g)*, mean gestational age at
delivery, preterm births*, LBW (< 2500 g)*, admission toNICU*, Apgar score at 5mins,
cord blood arterial pH < 7, congenital abnormalities, assisted vaginal delivery, caesarean
delivery
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk An independent statistician generated a
randomisation list using Stata, with ran-
dom permuted blocks of random size strat-
ified by recruitment centre, in a 1:1 ratio.
At enrolment the sequence was concealed
from researchers who confirmed consent
and eligibility on an online database before
allocation was revealed
Allocation concealment (selection bias) Low risk At enrolment the sequence was concealed
from researchers who confirmed consent
and eligibility on an online database before
allocation was revealed
Incomplete outcome data (attrition bias)
All outcomes
Low risk Analysis was performed on an ITT ba-
sis; participants with missing outcome data
were assumed to be smoking
Selective reporting (reporting bias) Low risk Primary and secondary outcomes are re-
ported.
Other bias Low risk No other bias was detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Self-reported outcomes of smoking are val-
idated by exhaled CO (< 8 ppm) and sali-
vary cotinine (<10 ng/mL) levels
Blinding of participants and personnel
(performance bias)
All outcomes
High risk It was not feasible to mask participants or
researchers to group allocation
309Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Ussher 2015 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Out of the 14 sessions offered in the inter-
vention arm, a median of 4 were completed
Equal baseline characteristics in study arms Low risk Baseline characteristics were equal in both
study arms.
Contamination of control group Low risk Intervention was the undertaking of exer-
cise and therefore contamination was un-
likely
Valbo 1994
Methods Randomised controlled trial of US feedback and cognitive-behavioural modification, to
support women to stop smoking in pregnancy
Study conducted in the National University Hospital, Oslo, Norway (Europe), with
recruitment from June 1990 to October 1991
Participants Inclusion criteria: Pregnant women attending AN clinic for 18 weeks for US, and still
smoking 10 cigarettes per day or more (heavy smokers)
Exclusion criteria: Not further specified.
Recruitment: Not stated how many women approached or eligible (1800 births/year,
study over 15 months). 112 women randomised (C = 56, I = 56)
Baseline characteristics: Mean cigarettes per day at 18 weeks’ gestation: C = 14.8, I =
12.5. Smoking partner: C = 80%, I = 74%
Mean age: C = 28.4, I = 20.2.
Progress + coding: None.
Interventions Control: Routine 18-week US and information on the negative effects of smoking
and encouragement to quit, reinforced by a pamphlet, provided at the time of the US
examination.
Intervention: At the time of the 18-week US scan, offered theWindsor self-helpmanual
(translated into Norwegian) describing a 10-day program which includes relapse preven-
tion. During US (by midwife and obstetrician), women were given information about
the negative effects of smoking. 2 weeks later women were sent an encouraging reminder
and an appointment for an additional 32-week scan by an obstetrician, in which women
were further encouraged to quit. A second reminder was sent 2 weeks later
Main intervention strategy: Feedback (multiple intervention) compared to UC.
Intensity: Frequency (C = 0, I = 3), Duration (C = 0, I = 2). UC intensity: F = 1, D = 1
Intervention provided by existing staff: Effectiveness study
Outcomes Self-reported abstinence at delivery (late pregnancy*); self-reported reduction in smoking
at birth* mean cigarettes per day at birth*. Stillbirths* reported in attrition and re-
included in both numerator and denominator for this outcome
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Notes Process evaluation suggested that the acceptance of the manual was low (mean score 2.
6 on a 7-point scale) and that it was staff involvement which had the most impact
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as “consecutively randomised”.
Allocation concealment (selection bias) High risk Women consecutively randomised into 2
groups.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition: 1 stillbirth in intervention arm
excluded from analysis. 7 women who did
not returnquestionnaires (C=6, I = 1)were
not included in the study report but have
been re-included as continuing smokers in
this review (C = 56, I = 55)
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Unclear risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not feasible to blind participants and
providers to educational intervention and
US. Although it is unclear if consent was
sought so participants may have been blind
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk No process evaluation reported but assume
most women received manual and USs
Equal baseline characteristics in study arms Unclear risk Intervention group had significantly higher
daily smoking on entry
Contamination of control group High risk UC providers offering intervention and
control components.
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Methods Randomised controlled trial of hypnosis to support women to stop smoking during
pregnancy
Study conducted in Buskerud Central Hospital in Oslo, Norway (Europe), with recruit-
ment from January 1992 to June 1993
Participants Inclusion criteria: Women still smoking at 18-week US visit.
Exclusion criteria: Not further specified.
Recruitment: Expected numbers of pregnant smokers were 630. 158 (25%) agreed to
participate and were randomised (78, I = 80)
Baseline characteristics: Mean cigarettes/day prior to pregnancy I = 15.6, C = 15.0;
Mean cigarettes per day at 18 weeks’ gestation C = 9.7, I = 11.3; Partner smoking C =
73%, I = 71%
Mean age C = 26.5, I = 27.9.
Progress + coding: None.
Interventions Control: “Routine pregnancy health care”.
Intervention: Anaesthesiologist provided 2 x 45 min sessions at 2-week interval of a
protocol-based script (Handbook of the American Society of Clinical Hypnosis); the
tape played after hypnosis was established emphasised the unpleasant effects of smoking,
affirmed her wish to quit, encouraged her will and capacity to quit, and instructed her
in meeting cravings with relaxation techniques and self-hypnosis, explained during the
session. Second visit tape was different with more weight on her capacity and taking
control. Both tapes avoided “moralizing about her responsibility for pregnancy outcome”
Main intervention strategy: Counselling (single intervention) compared to UC.
Intensity: Frequency (C = 0, I = 4); Duration (C = 0, I = 3).
Intervention provided by dedicated study staff: Efficacy study
Outcomes Self-reported abstinence at birth (late pregnancy*), mean cigarettes per day at birth*,
Self-reported reduction in smoking*
(The SD used in the analysis in this review was calculated from a P value = 0.2 given in
the paper) and increase at end of pregnancy,
Perinatal deaths*.
Notes Process evaluation did not rate the intervention highly: mean score of 2.05/7
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The numbers from 1 to 100 were set up
in random order, and by drawing lot, the
women willing to participate were ran-
domised into the intervention or control
group
Allocation concealment (selection bias) Unclear risk Women allocated to groups by drawing lots
(it was not clear when this took place)
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Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Of 80 allocated to intervention, 13 did not
receive an appointment in time, and 15
did not attend, and were excluded from the
analysis
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Unclear risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk No biochemical validation.
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Psychological intervention, authors state
that usual caregivers were not aware of
group allocation
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk 28/80 women randomised did not receive
the intervention
Equal baseline characteristics in study arms High risk Significantly more smokers in intervention
group at entry.
Contamination of control group Low risk Dedicated hypnotist provided interven-
tion.
Vilches 2009 (AvB)
Methods 4-armed cluster-randomised controlled trial of counselling interventions to support
women to stop smoking in pregnancy
Study conducted in primary healthcare clinics in Malaga, southern Spain, with data
collection from 2001-2003
Participants Inclusion criteria: 12/23 community clinics selected to balance neighbourhood SES
(low, medium, and high). Women included if less than 15 weeks’ gestation and smoked
at least 1 cigarette since knowing they were pregnant
Exclusion criteria: not further specified.
Recruitment: 12 clinics ’randomly selected’, stratified by SES status of neighbourhood.
3 randomly allocated to each study arm, based on SES status (3 levels, low, medium,
high: so 1 level each study arm). Clinics balanced across study arms
Women identified in 1999 in a preconceptual program (2932 women screened in 23
clinics - 38% were smokers). 719 eligible smokers from the 12 clinics were invited, of
whom 455 agreed to participate (63% participation). 132 women spontaneously quit
smoking after baseline and 27 had a spontaneous abortion; both were excluded from the
study. 296 women were randomised (C = 54, I1 = 71, I2 = 47, I3 = 124).
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Baseline characteristics: Mean cigarettes per day before becoming pregnant 20.6 (9.
58); Fagerstrom score: 4.78 (SD 5.38)
97.7% married. Education: 4% did not complete junior high school, 45% completed
junior level only (9 years), 33% 12 years school, 17% university level. SES: 4.8% high,
24.6% medium/high, 53.4% medium/low, 17.1% low SES
Progress + coding: None.
Interventions A: Control: UC.
All 3 interventions were based on CBT, adapted to pregnant women taking into account
factors important to women for smoking and quitting, but differ in intensity (frequency
and duration).
B: Intervention 1 (low intensity): 1 session of 30 mins by midwives who were trained
in smoking cessation psychosocial education, provided with audiovisual materials and
gave women a pamphlet. Delivered in 2nd trimester, usually before week 24. Included
smokers and those who had spontaneously quit. Able to invite companions or people
involved in pregnancy to session. Session covered basic smoking risks and benefits of
quitting, motivational therapy and CBT for self-control to quit smoking, self-monitor-
ing, developing alternative behaviours, stimulus control, setting a quit date and how to
obtain social support.
C: Intervention 2 (medium intensity): I1 + additional 3 group sessions x 90 mins over
4 weeks in 3rd trimester (weekly and then after 15 days) in clinic. Provided by midwife
with additional training. Reviewed homework, introduced topic of day, set objectives
and activity to complete before the following week. Recommended that by second week
they abstain from tobacco. Only pregnant women invited to groups (6-10 women in
each group), no partners. Audiovisual materials and self-help guide to support sessions.
D: Intervention 3 (high intensity): I1 + 5 x 90 mins weekly group sessions in 3rd
trimester provided by clinical psychologist. Midwife present in sessions. Reviewed home-
work, set objectives and goals etc (similar to I2), counselled to quit smoking on 4th week
of program. Used audiovisual equipment. CO monitoring and feedback provided in
2nd session with MI. Included relapse prevention. Companions not included in group
sessions
Main intervention strategy: Counselling (single intervention) compared to UC. Inter-
vention 1 (low intensity) and control (UC) compared in this study ID
Intensity: Frequency (C = 0, I = 2); Duration (C = 0, I = 2).
Intervention provided by dedicated study staff: Efficacy study
Outcomes Self-reported mean cigarettes per day in late pregnancy*, Mean exhaled CO, Mean
birthweight*
Biochemically validated point prevalence abstinence rates not reported. Breastfeeding
rates at 8 weeks postpartum reported
Notes Report in Spanish.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Clinics described as ’randomly assigned’.
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Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk 455 consented and 132 excluded as they
spontaneously quit smoking, and further
27 excluded due to spontaneous abortion.
Substantial attrition in this study (92% in
I3): 296 randomised, 204 started interven-
tion and 142 completed intervention and
used in the analysis. Not able to be re-in-
cluded as mean outcomes only reported (e.
g. mean cigarettes/day, mean CO).
Randomised: C = 54, I1 = 71,I2 = 47, I3
= 124.
Started intervention: C = 54,I1 = 71, I2 =
12, I3 = 67
Completed intervention and analysed: C =
54, I1 = 71, I2 = 8, I3 = 9.
Selective reporting (reporting bias) High risk Biochemically validated smoking cessation
rates, proportion of preterm births, and
stages of change outcomes stated as primary
and secondary outcomes and not reported
Other bias High risk Tried to balance women across study arms
and clinics (40 per arm per clinic) but were
unable to achieve this
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Exhaled CO validation measured but bio-
chemically confirmed smoking cessation
rates not reported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk States clinics were not aware of allocation.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded.
Incomplete implementation High risk Only 8% completed the high- and
medium-intensity interventions (group
sessions)
Equal baseline characteristics in study arms Unclear risk Baseline characteristics not reported by in-
dividual study arm
Contamination of control group Low risk Cluster-randomised trial design minimises
risk of contamination
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Methods 4-armed cluster-randomised controlled trial of counselling interventions to support
women to stop smoking in pregnancy
Study conducted in primary health care clinics in Malaga, southern Spain, with data
collection from 2001-2003
Participants Inclusion criteria: 12/23 community clinics selected to balance neighbourhood SES
(low, medium, and high). Women included if less than 15 weeks’ gestation and smoked
at least 1 cigarette since knowing they were pregnant
Exclusion criteria: not further specified.
Recruitment: 12 clinics ’randomly selected’, stratified by SES status of neighbourhood.
3 randomly allocated to each study arm, based on SES status (3 levels, low, medium,
high: so 1 level each study arm). Clinics balanced across study arms
Women identified in 1999 in a preconceptual program (2932 women screened in 23
clinics - 38% were smokers). 719 eligible smokers from the 12 clinics were invited, of
whom 455 agreed to participate (63% participation). 132 women spontaneously quit
smoking after baseline and 27 had a spontaneous abortion; both were excluded from the
study. 296 women were randomised (C = 54, I1 = 71, I2 = 47, I3 = 124).
Baseline characteristics: Mean cigarettes per day before becoming pregnant 20.6 (9.
58); Fagerstrom score: 4.78 (SD 5.38)
97.7% married. Education: 4% did not complete junior high school, 45% completed
junior level only (9 years), 33% 12 years school, 17% university level. SES: 4.8% high,
24.6% medium/high, 53.4% medium/low, 17.1% low SES
Progress + coding: None.
Interventions A: Control: UC.
All 3 interventions were based on CBT, adapted to pregnant women taking into account
factors important to women for smoking and quitting, but differ in intensity (frequency
and duration).
B: Intervention 1 (low intensity): 1 session of 30 mins by midwives who were trained
in smoking cessation psychosocial education, provided with audiovisual materials and
gave women a pamphlet. Delivered in 2nd trimester, usually before week 24. Included
smokers and those who had spontaneously quit. Able to invite companions or people
involved in pregnancy to session. Session covered basic smoking risks and benefits of
quitting, motivational therapy and CBT for self-control to quit smoking, self-monitor-
ing, developing alternative behaviours, stimulus control, setting a quit date and how to
obtain social support.
C: Intervention 2 (medium intensity): I1 + additional 3 group sessions x 90 mins over
4 weeks in 3rd trimester (weekly and then after 15 days) in clinic. Provided by midwife
with additional training. Reviewed homework, introduced topic of day, set objectives
and activity to complete before the following week. Recommended that by second week
they abstain from tobacco. Only pregnant women invited to groups (6-10 women in
each group), no partners. Audiovisual materials and self-help guide to support sessions.
D: Intervention 3 (high intensity): I1 + 5 x 90 mins weekly group sessions in 3rd
trimester provided by clinical psychologist. Midwife present in sessions. Reviewed home-
work, set objectives and goals etc (similar to I2), counselled to quit smoking on 4th week
of program. Used audiovisual equipment. CO monitoring and feedback provided in
2nd session with MI. Included relapse prevention. Companions not included in group
sessions
Main intervention strategy: Counselling (single intervention) compared to UC. Inter-
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vention 2 (medium intensity) and control (UC) compared in this study ID
Intensity: Frequency (C = 0, I = 4); Duration (C = 0, I = 5).
Intervention provided by dedicated study staff: Efficacy study
Outcomes Self-reported mean cigarettes per day in late pregnancy*, Mean exhaled CO, Mean
birthweight*
Biochemically validated point prevalence abstinence rates not reported. Breastfeeding
rates at 8 weeks postpartum reported
Notes Report in Spanish.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Clinics described as ’randomly assigned’.
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk 455 consented and 132 excluded as they
spontaneously quit smoking, and further
27 excluded due to spontaneous abortion.
Substantial attrition in this study (92% in
I3): 296 randomised, 204 started interven-
tion and 142 completed intervention and
used in the analysis. Not able to be re-in-
cluded as mean outcomes only reported (e.
g. mean cigarettes/day, mean CO).
Randomised: C = 54, I1 = 71,I2 = 47, I3
= 124.
Started intervention: C = 54,I1 = 71, I2 =
12, I3 = 67
Completed intervention and analysed: C =
54, I1 = 71, I2 = 8, I3 = 9.
Selective reporting (reporting bias) High risk Biochemically validated smoking cessation
rates, proportion of preterm births, and
stages of change outcomes stated as primary
and secondary outcomes and not reported
Other bias High risk Tried to balance women across study arms
and clinics (40 per arm per clinic) but were
unable to achieve this
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Exhaled CO validation measured but bio-
chemically confirmed smoking cessation
rates not reported
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Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk States clinics were not aware of allocation.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded.
Incomplete implementation High risk Only 8% completed the high- and
medium-intensity interventions (group
sessions)
Equal baseline characteristics in study arms Unclear risk Baseline characteristics not reported by in-
dividual study arm
Contamination of control group Low risk Cluster-randomised trial design minimises
risk of contamination
Vilches 2009 (AvD)
Methods 4-armed cluster-randomised controlled trial of counselling interventions to support
women to stop smoking in pregnancy
Study conducted in primary health care clinics in Malaga, southern Spain, with data
collection from 2001-2003
Participants Inclusion criteria: 12/23 community clinics selected to balance neighbourhood SES
(low, medium, and high). Women included if less than 15 weeks’ gestation and smoked
at least 1 cigarette since knowing they were pregnant
Exclusion criteria: not further specified.
Recruitment: 12 clinics ’randomly selected’, stratified by SES status of neighbourhood.
3 randomly allocated to each study arm, based on SES status (3 levels, low, medium,
high: so 1 level each study arm). Clinics balanced across study arms
Women identified in 1999 in a preconceptual program (2932 women screened in 23
clinics - 38% were smokers). 719 eligible smokers from the 12 clinics were invited, of
whom 455 agreed to participate (63% participation). 132 women spontaneously quit
smoking after baseline and 27 had a spontaneous abortion; both were excluded from the
study. 296 women were randomised (C = 54, I1 = 71, I2 = 47, I3 = 124).
Baseline characteristics: Mean cigarettes per day before becoming pregnant 20.6 (9.
58); Fagerstrom score: 4.78 (SD 5.38)
97.7% married. Education: 4% did not complete junior high school, 45% completed
junior level only (9 years), 33% 12 years school, 17% university level. SES: 4.8% high,
24.6% medium/high, 53.4% medium/low, 17.1% low SES
Progress + coding: None.
Interventions A: Control: UC.
All 3 interventions were based on CBT, adapted to pregnant women taking into account
factors important to women for smoking and quitting, but differ in intensity (frequency
and duration).
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B: Intervention 1 (low intensity): 1 session of 30 mins by midwives who were trained
in smoking cessation psychosocial education, provided with audiovisual materials and
gave women a pamphlet. Delivered in 2nd trimester, usually before week 24. Included
smokers and those who had spontaneously quit. Able to invite companions or people
involved in pregnancy to session. Session covered basic smoking risks and benefits of
quitting, motivational therapy and CBT for self-control to quit smoking, self-monitor-
ing, developing alternative behaviours, stimulus control, setting a quit date and how to
obtain social support.
C: Intervention 2 (medium intensity): I1 + additional 3 group sessions x 90 mins over
4 weeks in 3rd trimester (weekly and then after 15 days) in clinic. Provided by midwife
with additional training. Reviewed homework, introduced topic of day, set objectives
and activity to complete before the following week. Recommended that by second week
they abstain from tobacco. Only pregnant women invited to groups (6-10 women in
each group), no partners. Audiovisual materials and self-help guide to support sessions.
D: Intervention 3 (high intensity): I1 + 5 x 90 mins weekly group sessions in 3rd
trimester provided by clinical psychologist. Midwife present in sessions. Reviewed home-
work, set objectives and goals etc (similar to I2), counselled to quit smoking on 4th week
of program. Used audiovisual equipment. CO monitoring and feedback provided in
2nd session with MI. Included relapse prevention. Companions not included in group
sessions
Main intervention strategy: Counselling (multiple intervention) compared to UC.
Intervention 3 (high intensity) and control (UC) compared in this study ID
Intensity: Frequency (C = 0, I = 6); Duration (C = 0, I = 5).
Intervention provided by dedicated study staff: Efficacy study
Outcomes Self-reported mean cigarettes per day in late pregnancy*, Mean exhaled CO, Mean
birthweight*
Biochemically validated point prevalence abstinence rates not reported. Breastfeeding
rates at 8 weeks postpartum reported
Notes Report in Spanish.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Clinics described as ’randomly assigned’.
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
High risk 455 consented and 132 excluded as they
spontaneously quit smoking, and further
27 excluded due to spontaneous abortion.
Substantial attrition in this study (92% in
I3): 296 randomised, 204 started interven-
tion and 142 completed intervention and
used in the analysis. Not able to be re-in-
cluded as mean outcomes only reported (e.
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g. mean cigarettes/day, mean CO).
Randomised: C = 54, I1 = 71,I2 = 47, I3
= 124.
Started intervention: C = 54,I1 = 71, I2 =
12, I3 = 67
Completed intervention and analysed: C =
54, I1 = 71, I2 = 8, I3 = 9.
Selective reporting (reporting bias) High risk Biochemically validated smoking cessation
rates, proportion of preterm births, and
stages of change outcomes stated as primary
and secondary outcomes and not reported
Other bias High risk Tried to balance women across study arms
and clinics (40 per arm per clinic) but were
unable to achieve this
Biochemical validation of smoking absti-
nence (detection bias)
Unclear risk Exhaled CO validation measured but bio-
chemically confirmed smoking cessation
rates not reported
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk States clinics were not aware of allocation.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Outcome assessors blinded.
Incomplete implementation High risk Only 8% completed the high and medium
intensity interventions (group sessions)
Equal baseline characteristics in study arms Unclear risk Baseline characteristics not reported by in-
dividual study arm
Contamination of control group Low risk Cluster-randomised trial design minimises
risk of contamination
Walsh 1997
Methods Randomised controlled trial of a counselling intervention to support women to stop
smoking in pregnancy
Study conducted in a public hospital AN clinic in Newcastle, Australia, with screening
from January 1990 to May 1991
Participants Inclusion criteria: Pregnant women attending their first AN clinic appointment who
answered yes to ’Are you a smoker?”, were less than 26 weeks’ gestation, ill or psycho-
logically unwell
Exclusion criteria: Not further specified.
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Recruitment: 1,909 pregnant women were screened by midwives, 725 smokers (38%).
293/538 (54%) eligible women agreed to participate and were randomised (C = 145, I
= 148)
Baseline characteristics: Not reported.
Progress + coding: None
Interventions Control: Doctor and midwife both informed women that smoking was an important
cause of pregnancy problems and they should stop; Midwife provided a package (sticker,
pamphlet on risks of smoking and2-page cessation guide), none ofwhichwere specifically
tailored to pregnant women.
Intervention (CBT): (i) 2-3 min standardised risk information from Doctor.
(ii) 14-min video on risk information rebuttal of barriers to quitting, cessation tips and
10-min standardised information
(iii) Counselling from midwife after the video, using a flip chart, with negotiation of a
quit date whenever possible
(iv) Self-helpmanual on risks, barriers and cessation plus 4 packets of confectionary gum
(v) Lottery chance (4 prizes) for biochemically validated abstainers at the next visit
(vi) Social support from accompanying adult (partner/friend/other) via support tip sheet,
contract and form letter, chart, reminder sticker in the medical record, form-letter and
sticker from 1st visit Midwife mailed within 10 days + 2nd visit and 34 to 36 week visit
5-min counselling from Midwife and 1-2 min risk advice from Doctor. Women still
smoking at 34-36 weeks were advised to attend an external cessation course
Main intervention strategy: Counselling (tailored) compared to a less intensive inter-
vention
Intensity: Frequency (C = 2, I = 3); Duration (C = 1, I = 2).
Intervention provided by existing staff: Effectiveness study
Outcomes Biochemically validated point prevalence abstinence at 34 weeks’ gestation (late preg-
nancy*) and 6-12 weeks’ postpartum*. Preterm births* are reported in attrition and re-
included in both numerator and denominator for this outcome
Program costs and time commitments.
Discussion of provider views and implementation issues in associated reference (Walsh
2000).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated.
Allocation concealment (selection bias) Low risk Described as “precoded questionnaires in
manila envelopes”.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition 14% due to: Leaving clinic (C =
7, I = 7), miscarriage or termination (C =
10, I = 10), and preterm birth (C = 3, I = 4)
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, leaving 252 included in analysis (C = 125,
I = 127)
25% lost to follow-up and further missing
data for some variables including cotinine
validation, however thosewithmissingdata
were treated as continuing smokers in the
analysis
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Urinary cotinine (<= 500 mmol/L) was
measured and revealed discrepancy with
self-reported smoking status. Biochemi-
cally validated with urinary cotinine (I =
86%, C = 78%)
Cotinine data inconsistent with self-report
were 52% in controls and 12% in the in-
tervention group
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Educational intervention by UC providers
and notes flagged.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation High risk Midwives involved in recruitment to the
trial had variable ’success’ in consent rates
(9%-76%). Overall participation was quite
low (54%)
Equal baseline characteristics in study arms Low risk Report states baseline characteristics were
equal on 12 variables tested
Contamination of control group Unclear risk Same care providers for both groups.
Wilkinson 2012
Methods Randomised controlled trial of the dietitian-led behaviour change ’Healthy start to preg-
nancy’ (HSP) workshop. The study was conducted in a tertiary Maternal Health service
in South East Queensland, Australia between 31 August 2010 and 7 March 2011
Participants Inclusion criteria: Women > 18 (or < 18 with parental consent) attending their booked
visit at the Maternal Health research site
Exclusion criteria: Women were excluded if they were unable to read and speak English
at a level that allowed completion of pen-and-paper survey
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Recruitment: 882 approached, 360 randomised (60 smokers), 178 to intervention (29
smokers) and 182 to control (31 smokers)
Baseline characteristics: Unable to determine baseline characteristics of smokers as just
a small subset of a larger nutritional intervention
Interventions Control: Usual nutrition care through the Maternal Health provider.
Intervention: A 60-min ’healthy start to pregnancy’, which included a smoking com-
ponent based on the 5 A’s and aimed to influence behaviours with demonstrated health
outcomes
Main Intervention strategy:Maternal health intervention with smoking cessation com-
ponent: Counselling (single) vs UC
Intensity: Frequency: (C = 0, I = 2); Duration: (C = 0, I = 3).
Progress + coding: None as unable to determine characteristics of subgroup of smokers
Outcomes Self-reported not smoking at 12 weeks*, Intention to breastfeed, diet quality index,
weekly mins of physical activity
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk The computerised randomisation process
was managed by the research hospitals clin-
ical research support unit
Allocation concealment (selection bias) Low risk Group allocation was concealed using
sealed opaque envelopes
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis was used.
Selective reporting (reporting bias) Low risk All primary outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
High risk Smoking was not biochemically validated,
just self-report.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not specified but not practical to blind
women and providers to educational inter-
vention
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All outcomes were self-report.
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Incomplete implementation Unclear risk Unclear as only a subset of participantswere
smokers.
Equal baseline characteristics in study arms Unclear risk Characteristics of smokers can not be deter-
mined as part of a broader maternal health
intervention
Contamination of control group Low risk Intervention was a health promotion work-
shop which control individuals did not at-
tend
Windsor 1985 (AvB)
Methods 3-armed randomised trial controlled trial (SCRIPT trial I) of interventions to support
women to stop smoking in pregnancy
Study conducted in public health clinics in Birmingham, Alabama (USA), fromOctober
1983 to September 1984
Participants Inclusion criteria: Pregnant women presenting for their first prenatal visit who reported
smoking at least 1 cigarette in the last 7 days
Exclusion criteria: >= 32 weeks’ gestation.
Recruitment: 460/1838 (25%) pregnant women screened were current smokers. 368/
460 (80%) agreed to participate. Unclear exactly how many randomised to each group
as attrition not reported by study arm
Baseline characteristics: No baseline data on cigarettes/day.
Mean age: 23.6; Black: 57%; Mean years education 11.5.
Progress + coding: Low SES as attending public clinics.
Interventions A: Control: Smoking cessation advice routinely given at prenatal visits: 2-3 mins within
a group prenatal education session at the 1st visit, whenmaternity clinic staff recommend
quitting.
B: Intervention 1:10 min standardised counselling session from a health educator (B
Comm H Ed) + ALA “Freedom from smoking” (ALA) manual (17 day self-directed
plan for quitting) + “Because you love your baby” pamphlet on the dangers and risk of
smoking and the benefits of quitting.
C: Intervention 2: as for I1 except that the manual was “A pregnant woman’s self-help
guide to quit smoking” (instead of the ALA manual)
Main intervention strategy: Counselling (multiple intervention) compared to UC.
Control and Intervention 1 (arm A and B) compared in this study ID, please seeWindsor
1985 (AvC) for intervention 2
Intensity: Frequency: (C = 0, I = 1); Duration: (C = 0, I = 1).
Intervention provided by dedicated study staff (health educators): Efficacy study
Outcomes Biochemically validated point prevalence abstinence at mid-pregnancy, and during last
month of pregnancy or within 48 hours of birth (late pregnancy*), and number of women
who self-reported reduction in smoking in late pregnancy*
Notes
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Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition 29/338 (9%) due to: leaving sys-
tem or moved (9), miscarriage or termina-
tion (10), and 10 who went to poorly at-
tended group discussions (this intervention
abandoned), leaving 309 included in anal-
ysis (C = 104, I1 = 103, I2 = 102). All
other women lost to follow-up were treated
as continuing smokers
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of self-reported
smoking cessation using salivary thio-
cyanate < 100 ug/mL
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Educational intervention by health educa-
tors in AN clinics. Participants unlikely to
be blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk “Multiple attempts were made to bring
pregnant smokers together for a peer-led,
focused group discussion: not feasible in
this setting”.
Pre-trial assessment showed no nurses (n =
80) had smoking cessation training and less
than 20% felt confident to advise women
on how to stop
Equal baseline characteristics in study arms Low risk Characteristics in study arms appear equal.
Contamination of control group Low risk Administered by trained health educators,
not involved in pregnancy care
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Methods 3-armed randomised trial controlled trial (SCRIPT trial I) of interventions to support
women to stop smoking in pregnancy
Study conducted in public health clinics in Birmingham, Alabama (USA), fromOctober
1983 to September 1984
Participants Inclusion criteria: Pregnant women presenting for their first prenatal visit who reported
smoking at least 1 cigarette in the last 7 days
Exclusion criteria: >= 32 weeks’ gestation.
Recruitment: 460/1838 (25%) pregnant women screened were current smokers. 368/
460 (80%) agreed to participate. Unclear exactly how many randomised to each group
as attrition not reported by study arm
Baseline characteristics: No baseline data on cigarettes/day.
Mean age: 23.6; Black: 57%; Mean years education 11.5.
Progress + coding: Low SES as attending public clinics.
Interventions A: Control: Smoking cessation advice routinely given at prenatal visits: 2-3 mins within
a group prenatal education session at the 1st visit, whenmaternity clinic staff recommend
quitting.
B: Intervention 1:10 min standardised counselling session from a health educator (B
Comm H Ed) + ALA “Freedom from smoking” (ALA) manual (17 day self-directed
plan for quitting) + “Because you love your baby” pamphlet on the dangers and risk of
smoking and the benefits of quitting.
C: Intervention 2: as for I1 except that the manual was “A pregnant woman’s self-help
guide to quit smoking” (instead of the ALA manual)
Main intervention strategy: Counselling (multiple intervention) compared to UC.
Control and Intervention 2 (armA andC) compared in this study ID, please seeWindsor
1985 (AvB) for intervention 1
Intensity: Frequency: (C = 0, I = 1); Duration: (C = 0, I = 1).
Intervention provided by dedicated study staff (health educators): Efficacy study
Outcomes Biochemically validated point prevalence abstinence at mid-pregnancy, and during last
month of pregnancy or within 48 hours of birth (late pregnancy*); and number of women
who self-reported reduction in smoking in late pregnancy*
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated.
Allocation concealment (selection bias) Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition 29/338 (9%) due to: leaving sys-
tem or moved (9), miscarriage or termina-
tion (10), and 10 who went to poorly at-
tended group discussions (this intervention
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abandoned), leaving 309 included in anal-
ysis (C = 104, I1 = 103, I2 = 102). All
other women lost to follow-up were treated
as continuing smokers
Selective reporting (reporting bias) Unclear risk Only smoking outcomes reported.
Other bias Low risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of self-reported
smoking cessation using salivary thio-
cyanate < 100 ug/mL
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Educational intervention by health educa-
tors in AN clinics. Participants unlikely to
be blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Unclear risk “Multiple attempts were made to bring
pregnant smokers together for a peer-led,
focused group discussion: not feasible in
this setting”.
Pre-trial assessment showed no nurses (n =
80) had smoking cessation training and less
than 20% felt confident to advise women
on how to stop
Equal baseline characteristics in study arms Low risk Characteristics in study arms appear equal.
Contamination of control group Low risk Administered by trained health educators,
not involved in pregnancy care
Windsor 1993
Methods Randomised controlled trial (SCRIPT trial II) of a cognitive behaviour therapy inter-
vention to support women to stop smoking in pregnancy
Study conducted in 4 public maternity clinics of the Jefferson County Health De-
partment in Birmingham, Alabama (USA), with recruitment from September 1987 to
November 1989
Participants Inclusion criteria: Pregnant women who self-reported smoking during the first prenatal
visit ’at least one puff of one cigarette in the last 7 days’
Exclusion criteria: >= 32 weeks’ gestation, did not stay for visit or did not return,
prisoners, or had difficulty reading the baseline questionnaire
Recruitment: 1171/4352 (27%) of women screened at first prenatal visit were current
smokers and 210 (3%) spontaneous quitters (who were included in a separate trial: Lowe
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1997). 994/1061 (94%) eligible women agreed to participate and were randomised (C
= 501, I = 493)
Baseline characteristics: Mean cotinine 114 ng/mL. 45% had low cotinine levels (< 99
ng/mL)
Mean age = 24.6 years; Mean education = 12.4 years; Black = 52%
Progress + coding: Low SES in this review as attending public maternity clinic
Interventions Control: 2-min talk on smoking in 30 min group session at first AN visit in which
women were urged to quit and given 2 pamphlets: “Smoking and the two of you”’+
“Where to find help if you want to stop” including the name, contact phone number
and cost of their local program.
Intervention: Based on cognitive behaviour therapy:
(i) 15-min standardised cessation skills and risk counselling session from trained female
health education counsellor + 7-day self-directed cessation guide on how to quit written
at 6th Grade level
(ii) Clinic reinforcement (chart sticker) + letter from Doctor within 7 days
(iii) Social support in form of a ’buddy’ letter, contract and buddy tip sheet + monthly
newsletter with testimonials, cessation tips and additional information on risks
Main intervention strategy: Counselling (multiple intervention) compared to a less
intensive intervention
Intensity: Frequency (C = 1, I = 4), Duration: (C = 1, I = 3).
Intervention provided by dedicated project staff: Efficacy study
Outcomes Biochemically validated point prevalence abstinence at 4-8 weeks after first visit (mid-
point), 32 weeks’ gestation (late pregnancy*). “Significant” reduction* if cotinine at least
50% value of baseline cotinine*
Cost estimates.
Separate trial reports data on spontaneous quitters (Lowe 1997).
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated.
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Attrition 180/994 (18%) due withdrawal
from the service,miscarriage or abortion (C
= 87, I = 93) were not included in analysis,
leaving C = 414, I = 400
Further 15% lost to follow-up survey or
cotinine analysis included as continuing
smokers in this review
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Selective reporting (reporting bias) Unclear risk Data on gestation and birthweight were
collected but the published analysis is by
stopping smoking and the timing of cessa-
tion rather than by allocation, so not in-
cluded in outcome tables
Other bias Unclear risk No other bias detected.
Biochemical validation of smoking absti-
nence (detection bias)
Low risk Biochemical validation of smoking status
using salivary cotinine (cut-off >= 30 ng/
mL)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Notes flagged. Educational intervention.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Process evaluation showed 100% imple-
mentation of counselling and social sup-
port, and 88% for re-inforcement at sub-
sequent visits
Equal baseline characteristics in study arms Low risk NS difference in baseline cotinine.
Contamination of control group Low risk Trained counsellor, not pregnancy care
provider, delivered the intervention
Windsor 2011
Methods Randomised controlled trial (SCRIPT Trial III) of counselling intervention provided by
routine care staff (effectiveness study) to support women to stop smoking in pregnancy
Study conducted in 16/67 counties providing Medicaid care in Birmingham, Alabama
(USA). Counties matched by number of smokers and percentage Black and White
women, and 1 county per dyad (n = 8) randomly selected to participate in study. There
were 10 prenatal care clinics and 28 regular staff members in the 8 counties selected.
Recruitment dates not reported, but study conducted over 5 years
Participants Inclusion criteria: Pregnant women who reported≥1 cigarette (’even one puff ’) in the
last 7 days, or had a cotinine level ≥20 ng/mL
Exclusion criteria: Not further specified.
Recruitment: 6,514womenwere screened at first ANvisit and 1340/1736 (77%) eligible
smokers agreed to participate. 1 trial site dropped out leaving 1093 whowere randomised
(C = 546, I = 547)
Baseline characteristics: Cigarettes per day: C = 9.8 (and 10.3 among dropouts), I
= 10.4 (and 12.0 among dropouts); Lives with smoker: C = 69.8 (and 75.3% among
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dropouts), I = 73.7 (and 66% among dropouts). Mean cotinine: C = 163, I = 181
Mean age: 22 years; Black C = 15.7%, I = 15.4%.
Progress + coding: Low SES as Medicaid clinics.
Interventions Staff orientation and assessment, and 3 hours SCRIPT training for staff in intervention
sites
Control: All participants received 4 elements of the “5A’s” best practice guidelines (Ask-
Advise-Remind)
Intervention: Participants received (Assist) Procedures 4 through 8:
(i) A 14 min ’Commit to Quit Smoking During and After Pregnancy’ video
(ii) A ’Pregnant Woman’s Guide to Quit Smoking’ written at 6th grade reading level and
includes a 10 day self-help guide for cessation (Windsor 1985 (AvC)), and
(iii) A ≤10-min counselling session (MI)
Main intervention strategy: Counselling (multiple intervention) compared to a less
intensive intervention
Intensity: Frequency (C = 2, I =2), Duration (C = 1, I = 2).
Intervention provided by existing staff: Effectiveness study
Outcomes Biochemically validated point prevalence abstinence in late pregnancy* (> 60 days after
first visit, and < 90 days postpartum)
Number with a “significant reduction” in cotinine* (> 50ng/mL at baseline and < 50%
at follow-up, quitters not included as significant reducers)
An additional ’historical’ control group also provides comparison pre and post interven-
tion
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Described as ’randomly selected’ counties.
Then “Smokers were randomly assigned at
each clinic to an experimental group or
control group after screening, consent, and
baseline assessment”
Allocation concealment (selection bias) Unclear risk Not reported.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Attrition: C = 97/546 (17%) and I = 95/
547(17%). Reasons for dropout not re-
ported. An intent-to-treat policy was used
in the computation of impact rates and all
dropouts included as continuing smokers
in this review
Selective reporting (reporting bias) Unclear risk Unclear if there was 1 or 2 assessments (i.
e. 1 assessment between > 60 days after first
visit and < 90 days post partum; or 2 ’as-
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Windsor 2011 (Continued)
sessments performed > 60 days after first
visit, and < 90 days postpartum’). Only 1
assessment reported.
Other bias High risk Figures in Table 1 (baseline, C = 546, I =
547) conflict with the outcome denomina-
tor in Table 2, which is reported to include
those lost to follow-up (C = 549, I = 544)
. Figures reported in Table 1 used for de-
nominator and Table 2 for numerator in
this report
Biochemical validation of smoking absti-
nence (detection bias)
High risk 72% self-reported quitters validated with
biochemical verification (salivary cotinine
< 20 ng/mL). 10%non-disclosure of smok-
ing detected
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Participants and personnel not blinded to
counselling intervention
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not reported.
Incomplete implementation Low risk Process evaluation showed reasonable im-
plementation (over 80%)
Equal baseline characteristics in study arms Unclear risk Equal on all variables apart from mean co-
tinine (ng/mL)
Contamination of control group High risk Process evaluation suggests there was sig-
nificant contamination of the randomised
control group with regular clinic staff pro-
viding the intervention to both study arms
AFP: alpha fetoprotein
ALA: American Lung Association
AN: antenatal
BP: blood pressure
C: control group
CBASP: Cognitive Behavioral Analysis System of Psychotherapy
CBT: cognitive behavioural therapy
CI: confidence interval
CO: carbon monoxide
ETSE: environmental tobacco smoke exposure
GP: general practitioner
HMO: Health Maintenance Organisation
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HW: health and wellness
I: intervention group
ICC: intracluster correlation co-efficient
IPV: intimate partner violence
ITT: intention-to-treat
LBW: low birthweight
MI: motivational interviewing
min(s): minute(s)
MRFIT: randomised trial of health promotion carried out in the US
NCBI: non-contingent behavioral incentives
NICU: neonatal intensive care unit
NNTB: number needed to treat for an additional beneficial outcome
NRT: nicotine replacement therapy
NS: non-significant
OPD: out-patient department
Pls: principal investigators
ppm: parts per million
PPROM: preterm, prelabour rupture of the membranes
RH: Rhesus
SD: standard deviation
SES: socioeconomic status
SHO: senior house officer
TAU: treatment as usual
TFS: teen fresh start
TFSB: teen fresh start + peer support
UC: usual care
UK: United Kingdom
US: ultrasound
USA: United States of America
vs: versus
WIC: Food program for Women, Infants and Children in the USA
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Albrecht 2011 Program description only, not a randomised controlled study.
Andrews 2007 Women included were not-pregnant, plus quasi-randomised study design
Boshier 2003 Cohort study, not a randomised study design.
Bowden 2010 Cohort study only, no control or comparison group.
Brandon 2012 Part of the intervention is provided during pregnancy but primary aim of the study is to prevent relapse after
pregnancy and postpartum outcomes only reported
Britton 2006 Quasi-experimental design. Control and experimental convenience samples collected consecutively
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Britton 2013 Retrospective audit only.
Chan 2005 Controlled observational study of bupropion for smoking cessation in pregnancy
Chi 2015 Directed at partners of smoking women not pregnant women who smoke
Coleman 2007 Randomised controlled trial of pharmacological intervention with equal psychosocial support in both arms
Culp 2007 Controlled trial/evaluation of “The Community-Based Family Resource and Support” (CBFRS) Program.
Control group not randomised
DeVries 2006 Quasi-cluster-randomised study with inadequate sequence generation (40 practices selected with matched
controls)
Disantis 2010 Non-randomised postpartum intervention to promote smoking cessation and breastfeeding
Dixon 2009 Longitudinal cohort study only.
Edwards 2009 Evaluation of ’SMART moms’ project, which has no control group
El-Mohandes 2013 Randomised-controlled trial of pharmacological interventions (nicotine replacement therapy) with equal
psychosocial support in both study arms
Emmons 2000 Controlled trial/evaluation of the “Healthy Baby Second Hand Smoke Study” uses historical controls. Good
documentation of implementation problems
Ershoff 1983 The intervention took place in 1 HMO clinic with historical controls from the same clinic and concurrent
controls from a second clinic. There was no randomisation of clinics and no adjustment of the data for
clustering
Everett-Murphy 2010 Evaluation of smoking cessation counselling using a historical control group only (pre-post study design,
not randomised and no contemporary control group)
Ferguson 2012 Pregnant women excluded from this study (non-pregnant study population)
Ferreira-Borges 2005 Pre-test post-test control group design (not randomised).
Fish 2011 Intervention aimed at partners of pregnant women only. Pregnant women not included in the intervention
French 2007 Controlled clinical trial of postpartum relapse prevention. Excluded as not a trial during pregnancy, and not
randomised
Gadomski 2011 Evaluation of ’The BABY and ME-Tobacco Free’ program for relapse prevention postpartum. Quasi-exper-
imental design with non-randomised control group (matched randomly selected controls)
Gebauer 1998 Study of effect of one 15-minute counselling session and a follow-up telephone call, performed 1994-95,
using historical controls from 1993-1994
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Gillies 1987 In this controlled clinical trial the intervention was carried out in 1 hospital with another hospital in the
same city acting as a control, after a prior descriptive study which showed the similarity between the 2 in
terms of social and demographic factors including smoking. There was no randomisation and recruitment
differed substantially across the 2 sites. Data for smoking reduction and smoking cessation are combined in
the paper with no separate data on cessation and no adjustment for clustering
Grange 2005 Cohort study design.
Hahn 2005 Controlled trial with a volunteer sample of non-pregnant contest registrants, compared with a randomly
selected group of smokers not exposed to the campaign/contest. Context registrants not randomised and
there is evidence of differences between groups
Hannover 2008 Counselling intervention aimed at relapse prevention postpartum only. Screened for participation during
birth admission
Hayes 2013 Consecutive recruitment.
Herbert 2011 Intervention to reduce ’Environmental Tobacco Smoke’ exposure aimed at postpartum relapse prevention
only
Higgins 2004 Pilot study with 37/53 participants consecutively assigned (not randomised)
Hotham 2006 Randomised controlled trial of pharmacotherapy (nicotine replacement therapy) with equal psychosocial
support in both study arms
Huang 2013 Assignment by alternate odd/even dates.
Hymowitz 2006 Postpartum trial only which measures paediatrician implementation of smoking cessation and relapse pre-
vention interventions
Jaakola 2001 Controlled study, not randomised, of effects of a population-based smoking cessation program and its impact
on smoking in pregnancy. Controls were matched on inclusion criteria from another district
Jimenez-Muro 2013 Postpartum intervention.
Johnston 2011 Cohort smoking data from a randomised controlled trial of maternal vaccines
Kaper 2006 Non-pregnant population.
Kapur 2001 Randomised controlled trial of pharmacotherapy with equal psychosocial support in both study arms
Karatay 2010 Evaluation of a motivational interviewing intervention with no control group
Kazemi 2012 Intervention aimed at partners of pregnant women only to reduce passive tobacco smoke exposure for
pregnant women in Iran
Kientz 2005 Unable to determine number allocated to each trial arm and unclear what happened if unequal flip of coin
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Langford 1983 Prenatal classes, rather than individual women, were randomly allocated to provide the intervention or not.
The intervention was provided in late pregnancy with no outcome data collected during pregnancy but only
data 4 months after birth. There was no adjustment for cluster-randomisation in the analysis of the study
findings
Lee 2008 Intervention aimed at partners of pregnant women only to reduce passive tobacco smoke exposure for
pregnant women in China
Levine 2013 Intervention is for postpartum women.
Loke 2005 Intervention aimed at smoking cessation in men (partners of pregnant women)
Lowe 1998a Quasi-randomised study with inadequate sequence generation (allocation by alternate clinic weeks)
Lowe 1998b Quasi-randomised study with inadequate sequence generation (allocation by alternate clinic weeks)
MacArthur 1987 Quasi-randomised study with inadequate sequence generation (allocation by date of clinic visit)
Miller 2003 A pilot study of a pharmacological intervention (bupropion).
Mullen 1997 Study designed to promote postpartum smoking cessation (not antepartum or part of a trial conducted in
pregnancy)
Murray 2008 Intervention to promote smoking cessation among a general (not specifically pregnant) primary care popu-
lation
NCT00507975 Double-blind study of nicotine replacement therapy.
NCT00744913 Randomised controlled trial of pharmacotherapy with equal psychosocial support in both study arms
O’Connor 1992 Quasi-randomised study with inadequate sequence generation (alternate allocation according to day of week)
Oncken 2008 Randomised controlled trial of pharmacotherapy (nicotine replacement therapy) with equal psychosocial
support in both arms
Peden 2008 Quasi-randomised study with sequential allocation to study arms
Phillips 2012 Intervention aimed at postpartum relapse prevention only. Mother’s were recruited during infant’s admission
to NICU
Polanska 2011 Observational cohort study only with no comparison group.
Pollak 2007 Randomised controlled trial of pharmacotherapy (nicotine replacement therapy) and equal psychosocial
support in both arms
Pollak 2014 Intervention aimed at partners of women who smoke.
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Power 1989 The intervention in this trial was unusual in that the focus was on anticipated benefits of smoking cessation
to women themselves (not on harm to the fetus and infant), and on alternative coping strategies, with
a designated midwife-facilitator to answer queries and provide friendly advice and encouragement. The
intervention was carried out in 1 hospital with another being a comparison setting, after a prior study which
showed the similarity between the 2 in social and demographic factors including smoking rates. There was
no randomisation. Recruitment differed significantly across the 2 hospitals. Data for smoking cessation and
smoking reduction are combined with no separate data on cessation and no adjustment for clustering
Ratner 1999 Postpartum intervention only. No interventions in pregnancy.
Reitzel 2010 Intervention aimed at postpartum relapse prevention only.
Rush 1992 Quasi-experimental study with inadequate sequence generation (group allocation by alternate weeks)
Scott 2000 This controlled clinical trial of the impact of using interactive software to promote smoking cessation, was
excluded as it used historical controls
Shakespeare 1990 Not a smoking in pregnancy intervention.
Simmons 2014 Not a randomised controlled trial.
Stanton 2004 Intervention aimed at partner’s of pregnant women only. Aim was to maximise potential of life-changing
period for men too. Did not include pregnant women
Suplee 2004 Randomised trial of relapse prevention counselling in the postpartum period only (not pregnancy)
Sutton 2007 Intervention of tailored smoking cessation letters, self-help materials and counselling for the general popu-
lation (not specifically pregnant women)
Valanis 2001 This prospective controlled clinical trial design to test the effect of a low intensity intervention, used historical
controls
Valbo 1991 Quasi-experimental study with inadequate sequence generation (3 months consecutive recruitment for each
arm)
Velasquez 2014 Preconceptual intervention and unable to determine how many participants were pregnant
Wadland 2007 General study population (not pregnant). Implementation trial to change provider behaviour and increase
referrals to quitline. Estimated smoking cessation outcome data only
Wen 2016 Not pregnant women.
Wiggins 2004 Cluster-randomised controlled trial comparing 2 postnatal interventions to improve maternal health
Wilkinson 2010 Quasi-experimental design with a non-randomised controlled pre-post test study design
Windsor 2000a Quasi-experimental study with inadequate sequence generation (80% control group not randomly assigned)
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Winickoff 2010 Intervention aimed at postpartum relapse prevention only with women recruited during birth admission
Wisborg 1998 This randomised study of the effect of midwifery training on smoking cessation intervention implementation
and pregnancy outcomes, was excluded due to concerns about allocation concealment (clinic day allocation)
Wisborg 2000 Randomised controlled trial of a pharmacological intervention (nicotine replacement therapy) and equal
psychosocial support in both study arms
Yilmaz 2006 Postnatal intervention in pediatric setting.
HMO: Health Maintenance Organisation
NICU: neonatal intensive care unit
Characteristics of ongoing studies [ordered by study ID]
Accornero 2014
Trial name or title Quit Smoking Now (with contingency management).
Methods Randomised controlled trial (2 arms).
Participants Pregnant women attending prenatal care at Jackson Health System, Miami-Dade, Florida
Interventions Women will receive standard of care Quit Smoking Now tobacco education and support plus prize-based
contingency management
Outcomes Their smoking status will be monitored from quit date through 3 months postpartum via carbon monoxide
and salivary cotinine levels
Starting date October 2015-August 2017.
Contact information Veronica H Accornero, vaccornero@med.miami.edu
Notes
Althabe 2012
Trial name or title Not stated.
Methods Cluster-randomised controlled trial.
Participants Pregnant women attending antenatal care in Argentina and Uruguay
Interventions A multifaceted intervention to implement the “5A’s” strategy
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Althabe 2012 (Continued)
Outcomes Provision of smoking advice and smoking abstinence.
Starting date Not stated.
Contact information F Althabe: Department of Mother and Child Health Research, Institute for Clinical Effectiveness and Health
Policy (IECS), Buenos Aires, Argentina
Notes Email sent to author 11/11/15, study started in 2011 and notes completion as August 2014. Published by
time of this review submission (10/12/2016) but not included in this update
Blasco Oliete 2004
Trial name or title Not stated.
Methods Randomised clinical trial.
Participants Pregnant women smoking at least 1 cigarette each day attending 4 clinics in Madrid, Spain
Interventions Brief counselling (3 to 5 minutes) on smoking cessation compared with a group intervention over 3 half-hour
sessions
Outcomes Not clear.
Starting date Not clear.
Contact information meliton65@eresmas.com No response from authors to written request for further trial information on 18/7/
2012
Notes Original article in Spanish. Email sent to author 11/11/15, no response
Study report (2004) describes the study design. No papers including results have yet been identified
Bronshtein 2015
Trial name or title The Mommy check-up study.
Methods Randomised controlled trial.
Participants Pregnant women aged 18-45 in Michigan, USA who attended.
Interventions SmokeFreeMom is a mobile text messaging service designed for pregnant women across the USA to help
them quit smoking
Outcomes Abstinence from smoking, 7-day point-prevalence.
Starting date January 2015-April 2015.
Contact information Elena Bronshtein, ebronsht@med.wayne.edu
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Bronshtein 2015 (Continued)
Notes Emailed 11/11/2015, replied 11/11/15 and advised that the study is completed and will provide outcomes
when available
Cooper 2015
Trial name or title Mi-Quit.
Methods Randomised controlled trial.
Participants Pregnant women recruited from hospital antenatal clinics in England
Interventions MiQuit is an automated responsive text message support programme lasting 12 weeks, which provides tailored
smoking cessation support and advice to the participant’s mobile phone
Outcomes No primary outcome as this is a feasibility study.
Starting date February 2014.
Contact information Sue Cooper, sue.cooper@nottingham.ac.uk
Notes Started recruitment Feb 2014, emailed 11/11/15, replied; all data collected, trying to get published by May
Everett 2008
Trial name or title Not stated.
Methods Ongoing study of intervention to promote smoking cessation among men and women during pregnancy
Participants Pregnant women and their partners.
Interventions Not clear.
Outcomes Not clear.
Starting date Not clear.
Contact information everettk@health.missouri.edu Minimal study information provided in response to email request sent 18/7/
2012
Notes Email sent to author 11/11/15, no response.
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Gleeson 1997
Trial name or title Not clear.
Methods Randomised controlled trial.
Participants Pregnant smokers recruited from their antenatal clinics.
Interventions Each mother allocated to the intervention group receives between 4 and 6 visits by the smoking cessation
advisor
Outcomes No outcomes as a protocol paper.
Starting date Not clear.
Contact information No author contact details, BMJ contacted.
Notes
Higgins 2014
Trial name or title Financial incentives for smoking cessation among disadvantaged pregnant women
Methods Randomised controlled clinical trial.
Participants Pregnant women.
Interventions Financial incentives provided contingent on biochemically confirmed smoking abstinence
Outcomes 7-day point prevalence abstinence levels at final antepartum assessment; collected at approximately 28 weeks’
gestation
Starting date January 2014-May 2018.
Contact information Mary Ellen Lynch, mlynch1@uvm.edu
Notes
Lasater 2005
Trial name or title Reducing ETS exposure of pregnant women and newborns.
Methods Randomised 2-arm study in 6 prenatal clinics designed to develop and evaluate the efficacy of 5 tailored
DVDs in reducing exposure to ETS among low-income pregnant/postpartum women
Participants Pregnant women who attend first prenatal visit by 16 weeks’ gestation who are exposed to tobacco smoke
daily. Exclusion criteria: women expecting complications or multiple births
Interventions Provision of tailored DVDs to take home.
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Lasater 2005 (Continued)
Outcomes Salivary cotinine concentration of mother and baby.
Starting date Feb 2006.
Contact information Thomas M Lasater, Brown University, Rhode Island.
email: thomas lasater@brown.edu
Notes Started in Feb 2006 and estimated completion date Feb 2009. Email sent to author 11/11/2015
Lynagh 2012
Trial name or title RCT protocol of varying financial incentive amounts for smoking cessation among pregnant women
Methods RCT (pilot).
Participants 90 consenting pregnant women.
Interventions 2 intervention arms will be assessed: (1) a $AUD20 incremental personal financial incentive; and (2) a
$AUD40 incremental personal financial incentive.
Women from both intervention groups will have an opportunity to receive a PFI at 8 study intervention
sessions contingent upon smoking abstinence
Outcomes (i) consent rates; (ii) loss to follow-up rates of study participants and (iii) participant compliance with saliva and
hair cotinine analyses for biochemical validation of smoking status. Womens perceptions of the intervention
will also be ascertained by 6 interview questions
Starting date Not clear.
Contact information marita.lynagh@newcastle.edu.au
Notes Email sent to author 11/11/2015 Received magazine article with some results 17/11/2015. Australian New
Zealand Clinical Trials Registry (ANZCTR) number: ACTRN12612000399897
Patten 2014
Trial name or title Community intervention to reduce tobacco use among Alaskan pregnant women
Methods Randomised controlled cluster clinical trial.
Participants Pregnant Alaska native women over the age of 18 years who are < 26 weeks’ gestation and have access to a
working telephone
Interventions A novel, multi-component, theory-based intervention for reducing tobacco use during pregnancy, incorpo-
rating both individually targeted and community level components delivered by female elders ”Native Sisters
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Patten 2014 (Continued)
Outcomes Tobacco use status, biochemically verified tobacco use, changes from baseline in self-efficacy for non-tobacco
use scores
Starting date May 2014-April 2018.
Contact information Christi A Patten, patten.christi@mayo.edu
Notes
Ruger 2008
Trial name or title Not stated.
Methods Randomised controlled trial.
Participants 302 low-income pregnant women less than 28 weeks pregnant, English or Spanish-speaking, and who were
not receiving inpatient drug treatment were recruited frommultiple obstetric sites in the Boston metropolitan
area (USA). Current smokers or women smoking in the past 3 months (recent quitters) were included
Interventions Motivational interviewing interventions to promote smoking cessation and reduce ETS exposure provided
during 3 home visits, with feedback provided about the household nicotine levels
Outcomes Smoking cessation at end of pregnancy and relapse prevention; infant health outcomes; life-years and quality
of life; primary cost data and economic analysis
Starting date 1997-2000.
Contact information jennifer.ruger@yale.edu
Notes Email sent to author 11/11/15, no response.
Zhu 2004
Trial name or title Telephone intervention (California Smokers’ Helpline) or pregnant smokers
Methods Randomised trial.
Participants Pregnant smokers who called the helpline for services.
Interventions Control group received a self-help quit kit of writtenmaterials, including the AmericanCancer Society booklet
for pregnant smokers. Intervention group received the quit kit plus up to 7 counselling calls
Outcomes Self-reported smoking cessation in third trimester.
Starting date
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Zhu 2004 (Continued)
Contact information Shu-Hong Zhu 2004, University of California. szhu@ucsd.edu
Notes Email sent to author 11/11/2015 and received reply ’The paper is under review and we should hear from the
editor in a few weeks’
ETS: environmental tobacco smoke
PFI: Personal Financial Incentive
RCT: randomised controlled trial
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D A T A A N D A N A L Y S E S
Comparison 1. Smoking cessation interventions: counselling vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 30 12432 Risk Ratio (M-H, Random, 95% CI) 1.44 [1.19, 1.73]
1.1 Single interventions 13 4565 Risk Ratio (M-H, Random, 95% CI) 1.33 [1.01, 1.74]
1.2 Multiple interventions 11 4048 Risk Ratio (M-H, Random, 95% CI) 1.42 [1.04, 1.93]
1.3 Tailored interventions 6 3819 Risk Ratio (M-H, Random, 95% CI) 1.49 [1.01, 2.20]
2 Abstinence in late pregnancy:
biochemically validated only
21 9703 Risk Ratio (M-H, Random, 95% CI) 1.23 [1.04, 1.45]
2.1 Single interventions 9 3903 Risk Ratio (M-H, Random, 95% CI) 1.12 [0.90, 1.41]
2.2 Multiple interventions 8 3823 Risk Ratio (M-H, Random, 95% CI) 1.26 [0.92, 1.73]
2.3 Tailored interventions 4 1977 Risk Ratio (M-H, Random, 95% CI) 1.42 [0.84, 2.41]
3 Continued abstinence (relapse
prevention) in late pregnancy
for spontaneous quitters
8 688 Risk Ratio (M-H, Random, 95% CI) 1.06 [0.93, 1.21]
3.1 Single interventions 2 100 Risk Ratio (M-H, Random, 95% CI) 1.00 [0.93, 1.07]
3.2 Multiple interventions 3 297 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.93, 1.26]
3.3 Tailored interventions 3 291 Risk Ratio (M-H, Random, 95% CI) 1.19 [0.97, 1.46]
4 Abstinence at 0 to 5 months
postpartum
11 2926 Risk Ratio (M-H, Random, 95% CI) 1.59 [1.26, 2.01]
4.1 Single interventions 7 1924 Risk Ratio (M-H, Random, 95% CI) 1.58 [1.21, 2.06]
4.2 Multiple interventions 3 635 Risk Ratio (M-H, Random, 95% CI) 2.55 [1.17, 5.53]
4.3 Tailored interventions 1 367 Risk Ratio (M-H, Random, 95% CI) 1.18 [0.62, 2.25]
5 Abstinence at 6 to 11 months
postpartum
6 2458 Risk Ratio (M-H, Random, 95% CI) 1.33 [1.00, 1.77]
5.1 Single interventions 3 1098 Risk Ratio (M-H, Random, 95% CI) 1.36 [0.99, 1.86]
5.2 Multiple interventions 2 733 Risk Ratio (M-H, Random, 95% CI) 1.69 [0.48, 5.96]
5.3 Tailored interventions 1 627 Risk Ratio (M-H, Random, 95% CI) 0.99 [0.40, 2.46]
6 Abstinence at 12 to 17 months
postpartum
2 431 Risk Ratio (M-H, Random, 95% CI) 2.20 [1.23, 3.96]
6.1 Single interventions 2 431 Risk Ratio (M-H, Random, 95% CI) 2.20 [1.23, 3.96]
7 Abstinence at 18+ months
postpartum
3 798 Risk Ratio (M-H, Random, 95% CI) 0.98 [0.50, 1.92]
7.1 Single interventions 1 239 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.31, 4.42]
7.2 Multiple interventions 2 559 Risk Ratio (M-H, Random, 95% CI) 0.92 [0.43, 2.00]
8 Reduction in late pregnancy:
biochemically validated
2 1002 Risk Ratio (M-H, Random, 95% CI) 0.79 [0.49, 1.28]
8.1 Single interventions 1 756 Risk Ratio (M-H, Random, 95% CI) 0.63 [0.34, 1.20]
8.2 Multiple interventions 1 246 Risk Ratio (M-H, Random, 95% CI) 1.04 [0.51, 2.13]
9 Reduction in late pregnancy: self
reported (various definitions)
5 839 Risk Ratio (M-H, Random, 95% CI) 1.66 [1.27, 2.17]
9.1 Single interventions 2 323 Risk Ratio (M-H, Random, 95% CI) 1.61 [1.06, 2.43]
9.2 Multiple interventions 3 516 Risk Ratio (M-H, Random, 95% CI) 1.74 [1.17, 2.57]
10 Biochemical measures in late
pregnancy: mean cotinine
6 1884 Std. Mean Difference (IV, Random, 95% CI) -0.44 [-0.76, -0.12]
10.1 Single interventions 4 1443 Std. Mean Difference (IV, Random, 95% CI) -0.35 [-0.69, -0.02]
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10.2 Multiple interventions 2 441 Std. Mean Difference (IV, Random, 95% CI) -1.20 [-3.64, 1.24]
11 Mean cigarettes per day in late
pregnancy
11 Std. Mean Difference (IV, Random, 95% CI) Totals not selected
11.1 Single interventions 7 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
11.2 Multiple interventions 2 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
11.3 Tailored interventions 2 Std. Mean Difference (IV, Random, 95% CI) 0.0 [0.0, 0.0]
12 NICU admissions 2 1140 Risk Ratio (M-H, Random, 95% CI) 0.82 [0.52, 1.29]
12.1 Single interventions 1 762 Risk Ratio (M-H, Random, 95% CI) 0.71 [0.47, 1.07]
12.2 Tailored interventions 1 378 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.55, 2.46]
13 Very low birthweight infants (<
1500 g)
2 1666 Risk Ratio (M-H, Random, 95% CI) 1.27 [0.60, 2.71]
13.1 Single interventions 1 731 Risk Ratio (M-H, Random, 95% CI) 0.91 [0.32, 2.59]
13.2 Tailored interventions 1 935 Risk Ratio (M-H, Random, 95% CI) 1.83 [0.62, 5.43]
14 Preterm births 5 2653 Risk Ratio (M-H, Random, 95% CI) 0.90 [0.64, 1.27]
14.1 Single interventions 3 1571 Risk Ratio (M-H, Random, 95% CI) 0.83 [0.60, 1.17]
14.2 Tailored interventions 2 1082 Risk Ratio (M-H, Random, 95% CI) 1.13 [0.46, 2.80]
15 Mean birthweight 11 4925 Mean Difference (IV, Random, 95% CI) 40.27 [7.87, 72.66]
15.1 Single interventions 6 1995 Mean Difference (IV, Random, 95% CI) 52.87 [-0.41, 106.
15]
15.2 Multiple interventions 2 588 Mean Difference (IV, Random, 95% CI) 72.91 [-89.12, 234.
95]
15.3 Tailored interventions 3 2342 Mean Difference (IV, Random, 95% CI) 23.25 [-52.12, 98.
62]
16 Perinatal deaths 2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
16.1 Single interventions 1 130 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
16.2 Tailored interventions 1 935 Risk Ratio (M-H, Random, 95% CI) 1.10 [0.52, 2.31]
17 Stillbirths 4 2212 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.51, 2.30]
17.1 Single interventions 2 859 Risk Ratio (M-H, Random, 95% CI) 2.58 [0.38, 17.48]
17.2 Tailored interventions 2 1353 Risk Ratio (M-H, Random, 95% CI) 0.92 [0.41, 2.10]
18 Neonatal deaths 3 2095 Risk Ratio (M-H, Random, 95% CI) 2.06 [0.61, 6.92]
18.1 Single interventions 1 762 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.07, 18.65]
18.2 Tailored interventions 2 1333 Risk Ratio (M-H, Random, 95% CI) 2.35 [0.61, 9.07]
19 Low birthweight infants (<
2500 g)
6 3836 Risk Ratio (M-H, Random, 95% CI) 0.87 [0.70, 1.08]
19.1 Single interventions 2 1460 Risk Ratio (M-H, Random, 95% CI) 0.79 [0.56, 1.11]
19.2 Multiple interventions 1 414 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.45, 2.61]
19.3 Tailored interventions 3 1962 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.66, 1.32]
Comparison 2. Smoking cessation interventions: counselling vs less intensive intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 18 5657 Risk Ratio (M-H, Random, 95% CI) 1.25 [1.07, 1.47]
1.1 Single interventions 7 1145 Risk Ratio (M-H, Random, 95% CI) 1.21 [0.82, 1.80]
1.2 Multiple interventions 10 4260 Risk Ratio (M-H, Random, 95% CI) 1.24 [1.07, 1.44]
1.3 Tailored interventions 1 252 Risk Ratio (M-H, Random, 95% CI) 2.39 [1.03, 5.56]
2 Abstinence in late pregnancy:
biochemically validated only
15 4919 Risk Ratio (M-H, Random, 95% CI) 1.31 [1.10, 1.56]
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2.1 Single interventions 6 967 Risk Ratio (M-H, Random, 95% CI) 1.37 [0.89, 2.12]
2.2 Multiple interventions 8 3700 Risk Ratio (M-H, Random, 95% CI) 1.25 [1.06, 1.47]
2.3 Tailored interventions 1 252 Risk Ratio (M-H, Random, 95% CI) 2.39 [1.03, 5.56]
3 Continued abstinence (relapse
prevention) in late pregnancy
(spontaneous quitters)
5 904 Risk Ratio (M-H, Random, 95% CI) 1.06 [0.99, 1.13]
3.1 Single interventions 3 416 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.96, 1.15]
3.2 Multiple interventions 2 488 Risk Ratio (M-H, Random, 95% CI) 1.06 [0.96, 1.17]
4 Abstinence at 0 to 5 months
postpartum
8 2647 Risk Ratio (M-H, Random, 95% CI) 1.15 [0.93, 1.43]
4.1 Single interventions 3 749 Risk Ratio (M-H, Random, 95% CI) 1.07 [0.81, 1.42]
4.2 Multiple interventions 4 1646 Risk Ratio (M-H, Random, 95% CI) 1.19 [0.99, 1.43]
4.3 Tailored interventions 1 252 Risk Ratio (M-H, Random, 95% CI) 12.80 [1.70, 96.35]
5 Abstinence at 6 to 11 months
postpartum
4 1661 Risk Ratio (M-H, Random, 95% CI) 1.09 [0.91, 1.31]
5.1 Single interventions 2 495 Risk Ratio (M-H, Random, 95% CI) 1.14 [0.84, 1.54]
5.2 Multiple interventions 2 1166 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.80, 1.38]
6 Abstinence at 12 to 17 months
postpartum
3 1578 Risk Ratio (M-H, Random, 95% CI) 1.11 [0.87, 1.41]
6.1 Single interventions 1 390 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.76, 1.52]
6.2 Multiple interventions 2 1188 Risk Ratio (M-H, Random, 95% CI) 1.25 [0.71, 2.20]
7 Reduction in late pregnancy:
biochemically validated
2 857 Risk Ratio (M-H, Random, 95% CI) 1.35 [0.98, 1.87]
7.1 Multiple interventions 2 857 Risk Ratio (M-H, Random, 95% CI) 1.35 [0.98, 1.87]
8 Reduction in late pregnancy:
self-reported > 50%
2 1235 Risk Ratio (M-H, Random, 95% CI) 1.35 [1.07, 1.71]
8.1 Multiple interventions 2 1235 Risk Ratio (M-H, Random, 95% CI) 1.35 [1.07, 1.71]
9 Mean cigarettes per day in late
pregnancy
2 397 Std. Mean Difference (IV, Random, 95% CI) -0.11 [-0.30, 0.09]
9.1 Single interventions 1 121 Std. Mean Difference (IV, Random, 95% CI) 0.01 [-0.34, 0.37]
9.2 Multiple interventions 1 276 Std. Mean Difference (IV, Random, 95% CI) -0.16 [-0.40, 0.08]
10 Low birthweight infants (<
2500 g)
2 503 Risk Ratio (M-H, Random, 95% CI) 0.58 [0.32, 1.04]
10.1 Single interventions 1 227 Risk Ratio (M-H, Random, 95% CI) 0.55 [0.25, 1.21]
10.2 Multiple interventions 1 276 Risk Ratio (M-H, Random, 95% CI) 0.61 [0.25, 1.50]
11 Preterm births 3 794 Risk Ratio (M-H, Random, 95% CI) 0.82 [0.47, 1.42]
11.1 Single interventions 1 227 Risk Ratio (M-H, Random, 95% CI) 0.55 [0.25, 1.21]
11.2 Multiple interventions 1 308 Risk Ratio (M-H, Random, 95% CI) 1.17 [0.46, 2.95]
11.3 Tailored interventions 1 259 Risk Ratio (M-H, Random, 95% CI) 1.30 [0.30, 5.71]
12 Mean birthweight 3 546 Mean Difference (IV, Random, 95% CI) 56.02 [-31.46, 143.
50]
12.1 Single interventions 1 227 Mean Difference (IV, Random, 95% CI) 57.00 [-93.50, 207.
50]
12.2 Multiple interventions 2 319 Mean Difference (IV, Random, 95% CI) 76.01 [-88.59, 240.
61]
13 Stillbirths 1 242 Risk Ratio (M-H, Random, 95% CI) 1.84 [0.17, 20.04]
13.1 Single interventions 1 242 Risk Ratio (M-H, Random, 95% CI) 1.84 [0.17, 20.04]
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Comparison 3. Smoking cessation interventions: counselling vs alternative intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 1 257 Risk Ratio (M-H, Random, 95% CI) 1.15 [0.86, 1.53]
1.1 Single interventions 1 257 Risk Ratio (M-H, Random, 95% CI) 1.15 [0.86, 1.53]
2 Abstinence in late pregnancy:
biochemically validated only
1 257 Risk Ratio (M-H, Random, 95% CI) 1.15 [0.86, 1.53]
2.1 Single interventions 1 257 Risk Ratio (M-H, Random, 95% CI) 1.15 [0.86, 1.53]
3 Abstinence at 0 to 5 months
postpartum
1 257 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.63, 1.76]
3.1 Single interventions 1 257 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.63, 1.76]
4 Abstinence at 6 to 11 months
postpartum
1 257 Risk Ratio (M-H, Random, 95% CI) 0.76 [0.33, 1.73]
4.1 Single interventions 1 257 Risk Ratio (M-H, Random, 95% CI) 0.76 [0.33, 1.73]
Comparison 4. Smoking cessation interventions: health education vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 5 629 Risk Ratio (M-H, Random, 95% CI) 1.59 [0.99, 2.55]
1.1 Single interventions 4 484 Risk Ratio (M-H, Random, 95% CI) 1.53 [0.93, 2.49]
1.2 Multiple interventions 1 145 Risk Ratio (M-H, Random, 95% CI) 4.06 [0.46, 35.41]
2 Abstinence in late pregnancy:
biochemically validated only
3 337 Risk Ratio (M-H, Random, 95% CI) 1.45 [0.82, 2.58]
2.1 Single interventions 3 337 Risk Ratio (M-H, Random, 95% CI) 1.45 [0.82, 2.58]
3 Continued abstinence (Relapse
prevention) in late pregnancy
for spontaneous quitters
1 70 Risk Ratio (M-H, Random, 95% CI) 1.02 [0.86, 1.23]
3.1 Single interventions 1 70 Risk Ratio (M-H, Random, 95% CI) 1.02 [0.86, 1.23]
4 Abstinence at 0 to 5 months
postpartum
2 237 Risk Ratio (M-H, Random, 95% CI) 3.56 [1.31, 9.67]
4.1 Single interventions 2 237 Risk Ratio (M-H, Random, 95% CI) 3.56 [1.31, 9.67]
5 Mean cigarettes per day in late
pregnancy
2 687 Std. Mean Difference (IV, Random, 95% CI) -0.55 [-0.94, -0.15]
5.1 Single interventions 1 552 Std. Mean Difference (IV, Random, 95% CI) -0.72 [-0.89, -0.55]
5.2 Multiple interventions 1 135 Std. Mean Difference (IV, Random, 95% CI) -0.32 [-0.66, 0.02]
6 Low birth weight 1 552 Risk Ratio (M-H, Random, 95% CI) 1.10 [0.66, 1.84]
6.1 Single interventions 1 552 Risk Ratio (M-H, Random, 95% CI) 1.10 [0.66, 1.84]
7 Preterm births (< 37 weeks) 1 552 Risk Ratio (M-H, Random, 95% CI) 1.03 [0.53, 2.00]
7.1 Single interventions 1 552 Risk Ratio (M-H, Random, 95% CI) 1.03 [0.53, 2.00]
8 Mean birthweight 1 552 Mean Difference (IV, Fixed, 95% CI) -12.0 [-102.29, 78.
29]
8.1 Single interventions 1 552 Mean Difference (IV, Fixed, 95% CI) -12.0 [-102.29, 78.
29]
9 Perinatal deaths 1 552 Risk Ratio (M-H, Random, 95% CI) 4.40 [0.49, 39.08]
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9.1 Single interventions 1 552 Risk Ratio (M-H, Random, 95% CI) 4.40 [0.49, 39.08]
Comparison 5. Smoking cessation interventions: health education vs less intensive intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 4 1282 Risk Ratio (M-H, Random, 95% CI) 1.20 [0.85, 1.70]
1.1 Single interventions 2 853 Risk Ratio (M-H, Random, 95% CI) 1.41 [0.99, 2.01]
1.2 Multiple interventions 1 198 Risk Ratio (M-H, Random, 95% CI) 1.59 [0.68, 3.73]
1.3 Tailored interventions 1 231 Risk Ratio (M-H, Random, 95% CI) 0.74 [0.44, 1.26]
2 Abstinence in late pregnancy:
biochemically validated only
3 1082 Risk Ratio (M-H, Random, 95% CI) 1.15 [0.70, 1.91]
2.1 Single interventions 1 653 Risk Ratio (M-H, Random, 95% CI) 1.46 [0.88, 2.43]
2.2 Multiple interventions 1 198 Risk Ratio (M-H, Random, 95% CI) 1.59 [0.68, 3.73]
2.3 Tailored interventions 1 231 Risk Ratio (M-H, Random, 95% CI) 0.74 [0.44, 1.26]
3 Abstinence at 0 to 5 months
postpartum
2 Risk Ratio (M-H, Random, 95% CI) Subtotals only
3.1 Single interventions 2 844 Risk Ratio (M-H, Random, 95% CI) 1.55 [1.01, 2.36]
4 Mean cigarettes per day in late
pregnancy
1 127 Mean Difference (IV, Random, 95% CI) -0.70 [-3.37, 1.97]
4.1 Tailored interventions 1 127 Mean Difference (IV, Random, 95% CI) -0.70 [-3.37, 1.97]
5 Low birthweight (< 2500 g) 1 620 Risk Ratio (M-H, Random, 95% CI) 0.60 [0.28, 1.29]
5.1 Single interventions 1 620 Risk Ratio (M-H, Random, 95% CI) 0.60 [0.28, 1.29]
6 Preterm births 1 618 Risk Ratio (M-H, Random, 95% CI) 0.76 [0.32, 1.80]
6.1 Single interventions 1 618 Risk Ratio (M-H, Random, 95% CI) 0.76 [0.32, 1.80]
7 Mean birthweight 1 620 Mean Difference (IV, Fixed, 95% CI) 71.0 [-26.58, 168.
58]
7.1 Single interventions 1 620 Mean Difference (IV, Fixed, 95% CI) 71.0 [-26.58, 168.
58]
Comparison 6. Smoking cessation interventions: health education vs alternative intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 1 31 Risk Ratio (M-H, Random, 95% CI) 1.88 [0.19, 18.60]
1.1 Single interventions 1 31 Risk Ratio (M-H, Random, 95% CI) 1.88 [0.19, 18.60]
2 Abstinence in late pregnancy:
biochemically validated
1 31 Risk Ratio (M-H, Random, 95% CI) 1.88 [0.19, 18.60]
2.1 Single interventions 1 31 Risk Ratio (M-H, Random, 95% CI) 1.88 [0.19, 18.60]
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Comparison 7. Smoking cessation interventions: feedback vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 2 355 Risk Ratio (M-H, Random, 95% CI) 4.39 [1.89, 10.21]
1.1 Multiple interventions 2 355 Risk Ratio (M-H, Random, 95% CI) 4.39 [1.89, 10.21]
2 Abstinence in late pregnancy:
biochemically validated only
1 244 Risk Ratio (M-H, Random, 95% CI) 3.88 [1.38, 10.93]
2.1 Multiple interventions 1 244 Risk Ratio (M-H, Random, 95% CI) 3.88 [1.38, 10.93]
3 Reduction in late pregnancy:
biochemically validated
1 244 Risk Ratio (M-H, Random, 95% CI) 1.48 [0.93, 2.37]
3.1 Multiple interventions 1 244 Risk Ratio (M-H, Random, 95% CI) 1.48 [0.93, 2.37]
4 Reduction in late pregnancy:
self-reported (various
definitions)
1 111 Risk Ratio (M-H, Random, 95% CI) 1.88 [1.24, 2.84]
4.1 Multiple interventions 1 111 Risk Ratio (M-H, Random, 95% CI) 1.88 [1.24, 2.84]
5 Mean cigarettes per day in late
pregnancy
1 104 Mean Difference (IV, Random, 95% CI) -3.0 [-4.68, -1.32]
5.1 Multiple interventions 1 104 Mean Difference (IV, Random, 95% CI) -3.0 [-4.68, -1.32]
6 Low birthweight (< 2500 g) 1 2848 Risk Ratio (M-H, Random, 95% CI) 0.82 [0.63, 1.06]
6.1 Multiple interventions 1 2848 Risk Ratio (M-H, Random, 95% CI) 0.82 [0.63, 1.06]
7 Preterm births 2 3111 Risk Ratio (M-H, Random, 95% CI) 0.60 [0.28, 1.29]
7.1 Multiple interventions 2 3111 Risk Ratio (M-H, Random, 95% CI) 0.60 [0.28, 1.29]
8 Mean birthweight 2 3006 Mean Difference (IV, Random, 95% CI) 79.43 [-53.05, 211.
91]
8.1 Multiple interventions 2 3006 Mean Difference (IV, Random, 95% CI) 79.43 [-53.05, 211.
91]
9 Stillbirths 2 2960 Risk Ratio (M-H, Random, 95% CI) 1.28 [0.69, 2.39]
9.1 Multiple interventions 2 2960 Risk Ratio (M-H, Random, 95% CI) 1.28 [0.69, 2.39]
Comparison 8. Smoking cessation interventions: feedback vs less intensive intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 3 439 Risk Ratio (M-H, Random, 95% CI) 1.29 [0.75, 2.20]
1.1 Single interventions 2 259 Risk Ratio (M-H, Random, 95% CI) 1.06 [0.48, 2.36]
1.2 Multiple interventions 1 180 Risk Ratio (M-H, Random, 95% CI) 1.57 [0.71, 3.47]
2 Abstinence in late pregnancy:
biochemically validated only
3 439 Risk Ratio (M-H, Random, 95% CI) 1.29 [0.75, 2.20]
2.1 Single interventions 2 259 Risk Ratio (M-H, Random, 95% CI) 1.06 [0.48, 2.36]
2.2 Multiple interventions 1 180 Risk Ratio (M-H, Random, 95% CI) 1.57 [0.71, 3.47]
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Comparison 9. Smoking cessation interventions: incentives vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 5 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Single interventions 3 731 Risk Ratio (M-H, Random, 95% CI) 2.73 [1.72, 4.35]
1.2 Multiple interventions 1 41 Risk Ratio (M-H, Random, 95% CI) 0.83 [0.17, 3.93]
1.3 Tailored interventions 1 41 Risk Ratio (M-H, Random, 95% CI) 0.70 [0.13, 3.68]
2 Abstinence in late
pregnancy:biochemically
validated only
5 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Single interventions 3 731 Risk Ratio (M-H, Random, 95% CI) 2.73 [1.72, 4.35]
2.2 Multiple interventions 1 41 Risk Ratio (M-H, Random, 95% CI) 0.83 [0.17, 3.93]
2.3 Tailored interventions 1 41 Risk Ratio (M-H, Random, 95% CI) 0.70 [0.13, 3.68]
3 Abstinence at 0 to 5 months
postpartum
2 150 Risk Ratio (M-H, Random, 95% CI) 1.09 [0.56, 2.13]
3.1 Multiple interventions 2 150 Risk Ratio (M-H, Random, 95% CI) 1.09 [0.56, 2.13]
4 Abstinence at 6 to 11 months
postpartum
1 609 Risk Ratio (M-H, Random, 95% CI) 3.88 [2.10, 7.16]
4.1 Single interventions 1 609 Risk Ratio (M-H, Random, 95% CI) 3.88 [2.10, 7.16]
5 Reduction in late pregnancy:
biochemically validated
2 Risk Ratio (M-H, Random, 95% CI) Totals not selected
5.1 Single interventions 2 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
6 Biochemical measures in late
pregnancy: mean cotinine
2 102 Mean Difference (IV, Random, 95% CI) -2.00 [-6.61, 2.60]
6.1 Single interventions 2 102 Mean Difference (IV, Random, 95% CI) -2.00 [-6.61, 2.60]
7 Mean cigarettes per day in late
pregnancy
1 74 Mean Difference (IV, Random, 95% CI) -8.2 [-10.83, -5.57]
7.1 Single interventions 1 74 Mean Difference (IV, Random, 95% CI) -8.2 [-10.83, -5.57]
8 Low birthweight 4 215 Risk Ratio (M-H, Random, 95% CI) 0.70 [0.40, 1.23]
8.1 Single interventions 2 68 Risk Ratio (M-H, Random, 95% CI) 0.64 [0.32, 1.28]
8.2 Multiple interventions 2 147 Risk Ratio (M-H, Random, 95% CI) 0.84 [0.32, 2.21]
9 Preterm births 5 753 Risk Ratio (M-H, Random, 95% CI) 1.15 [0.73, 1.82]
9.1 Single interventions 3 606 Risk Ratio (M-H, Random, 95% CI) 1.30 [0.77, 2.18]
9.2 Multiple interventions 2 147 Risk Ratio (M-H, Random, 95% CI) 0.61 [0.21, 1.77]
10 Mean birthweight 5 797 Mean Difference (IV, Random, 95% CI) 109.38 [60.51, 158.
26]
10.1 Single interventions 3 650 Mean Difference (IV, Random, 95% CI) 41.69 [-50.96, 134.
33]
10.2 Multiple interventions 2 147 Mean Difference (IV, Random, 95% CI) 126.49 [67.80, 185.
19]
11 NICU admissions 2 68 Risk Ratio (M-H, Random, 95% CI) 0.80 [0.51, 1.26]
11.1 Single interventions 2 68 Risk Ratio (M-H, Random, 95% CI) 0.80 [0.51, 1.26]
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Comparison 10. Smoking cessation interventions: incentives vs less intensive intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 4 Risk Ratio (M-H, Random, 95% CI) Subtotals only
1.1 Single interventions 3 731 Risk Ratio (M-H, Random, 95% CI) 0.81 [0.59, 1.12]
1.2 Multiple interventions 1 220 Risk Ratio (M-H, Random, 95% CI) 3.64 [1.84, 7.23]
2 Abstinence in late pregnancy:
biochemically validated only
4 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Single interventions 3 731 Risk Ratio (M-H, Random, 95% CI) 0.81 [0.59, 1.12]
2.2 Multiple interventions 1 220 Risk Ratio (M-H, Random, 95% CI) 3.64 [1.84, 7.23]
3 Abstinence at 0 to 5 months
postpartum
1 205 Risk Ratio (M-H, Random, 95% CI) 3.63 [1.54, 8.58]
3.1 Multiple interventions 1 205 Risk Ratio (M-H, Random, 95% CI) 3.63 [1.54, 8.58]
Comparison 11. Smoking cessation interventions: incentives vs alternative intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 4 212 Risk Ratio (M-H, Random, 95% CI) 2.36 [1.36, 4.09]
1.1 Single interventions 2 94 Risk Ratio (M-H, Random, 95% CI) 2.19 [0.53, 9.04]
1.2 Multiple interventions 2 118 Risk Ratio (M-H, Random, 95% CI) 2.20 [1.06, 4.55]
2 Abstinence in late pregnancy:
biochemicaly validated only
4 212 Risk Ratio (M-H, Random, 95% CI) 2.36 [1.36, 4.09]
2.1 Single interventions 2 94 Risk Ratio (M-H, Random, 95% CI) 2.19 [0.53, 9.04]
2.2 Multiple interventions 2 118 Risk Ratio (M-H, Random, 95% CI) 2.20 [1.06, 4.55]
3 Abstinence at 0 to 5 months
postpartum
3 195 Risk Ratio (M-H, Random, 95% CI) 1.79 [0.57, 5.61]
3.1 Single interventions 1 77 Risk Ratio (M-H, Random, 95% CI) 9.73 [1.29, 73.13]
3.2 Multiple interventions 2 118 Risk Ratio (M-H, Random, 95% CI) 1.13 [0.51, 2.52]
4 Abstinence at 6 to 11 months
postpartum
3 195 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.85, 1.01]
4.1 Single interventions 1 77 Risk Ratio (M-H, Random, 95% CI) 0.94 [0.85, 1.05]
4.2 Multiple interventions 2 118 Risk Ratio (M-H, Random, 95% CI) 0.90 [0.79, 1.03]
5 Smoking reduction: numbers of
women reducing smoking in
late pregnancy (biochemically
validated)
1 17 Risk Ratio (M-H, Random, 95% CI) 0.71 [0.18, 2.88]
5.1 Single interventions 1 17 Risk Ratio (M-H, Random, 95% CI) 0.71 [0.18, 2.88]
6 Low birthweight (under 2500 g) 3 184 Risk Ratio (M-H, Fixed, 95% CI) 0.60 [0.26, 1.40]
6.1 Single interventions 1 73 Risk Ratio (M-H, Fixed, 95% CI) 0.43 [0.12, 1.49]
6.2 Multiple interventions 2 111 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.26, 2.69]
7 Preterm birth (under 37 weeks) 3 184 Risk Ratio (M-H, Random, 95% CI) 0.48 [0.20, 1.14]
7.1 Single interventions 1 73 Risk Ratio (M-H, Random, 95% CI) 0.38 [0.11, 1.30]
7.2 Multiple interventions 2 111 Risk Ratio (M-H, Random, 95% CI) 0.60 [0.17, 2.12]
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8 Mean birthweight 3 184 Mean Difference (IV, Random, 95% CI) 134.58 [76.32, 192.
83]
8.1 Single interventions 1 73 Mean Difference (IV, Random, 95% CI) 253.0 [-3.67, 509.
67]
8.2 Multiple interventions 2 111 Mean Difference (IV, Random, 95% CI) 128.48 [65.86, 191.
10]
9 NICU admissions 3 184 Risk Ratio (M-H, Random, 95% CI) 0.64 [0.26, 1.55]
9.1 Single interventions 1 73 Risk Ratio (M-H, Random, 95% CI) 0.76 [0.24, 2.49]
9.2 Multiple interventions 2 111 Risk Ratio (M-H, Random, 95% CI) 0.49 [0.13, 1.95]
Comparison 12. Smoking cessation interventions: social support vs less intensive intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 7 781 Risk Ratio (M-H, Random, 95% CI) 1.21 [0.93, 1.58]
1.1 Single interventions 2 224 Risk Ratio (M-H, Random, 95% CI) 1.35 [0.57, 3.18]
1.2 Multiple interventions 4 406 Risk Ratio (M-H, Random, 95% CI) 1.35 [0.83, 2.18]
1.3 Tailored interventions 1 151 Risk Ratio (M-H, Random, 95% CI) 1.22 [0.59, 2.52]
2 Abstinence in late pregnancy:
biochemically validated only
6 601 Risk Ratio (M-H, Random, 95% CI) 1.42 [0.98, 2.07]
2.1 Single interventions 2 224 Risk Ratio (M-H, Random, 95% CI) 1.35 [0.57, 3.18]
2.2 Multiple interventions 3 226 Risk Ratio (M-H, Random, 95% CI) 1.93 [1.00, 3.74]
2.3 Tailored interventions 1 151 Risk Ratio (M-H, Random, 95% CI) 1.22 [0.59, 2.52]
3 Continued abstinence (relapse
prevention) in late pregnancy
1 211 Risk Ratio (M-H, Random, 95% CI) 1.02 [0.89, 1.16]
3.1 Multiple interventions 1 211 Risk Ratio (M-H, Random, 95% CI) 1.02 [0.89, 1.16]
4 Abstinence at 0 to 5 months
postpartum
2 472 Risk Ratio (M-H, Random, 95% CI) 1.34 [0.35, 5.14]
4.1 Single interventions 1 82 Risk Ratio (M-H, Random, 95% CI) 5.8 [0.33, 101.27]
4.2 Multiple interventions 1 390 Risk Ratio (M-H, Random, 95% CI) 0.98 [0.74, 1.31]
5 Abstinence at 6 to 11 months
postpartum
3 533 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.81, 1.44]
5.1 Multiple interventions 3 533 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.81, 1.44]
6 Abstinence at 12 to 17 months
postpartum
1 391 Risk Ratio (M-H, Random, 95% CI) 1.07 [0.76, 1.51]
6.1 Multiple interventions 1 391 Risk Ratio (M-H, Random, 95% CI) 1.07 [0.76, 1.51]
7 Smoking reduction: self reported
> 50% reduction
1 151 Risk Ratio (M-H, Random, 95% CI) 0.96 [0.64, 1.44]
7.1 Tailored interventions 1 151 Risk Ratio (M-H, Random, 95% CI) 0.96 [0.64, 1.44]
8 Low birthweight (< 2500 g) 1 79 Risk Ratio (M-H, Random, 95% CI) 1.00 [0.33, 2.99]
8.1 Single interventions 1 79 Risk Ratio (M-H, Random, 95% CI) 1.00 [0.33, 2.99]
9 Mean birthweight 1 142 Mean Difference (IV, Fixed, 95% CI) 28.0 [-152.48, 208.
48]
9.1 Single interventions 1 142 Mean Difference (IV, Fixed, 95% CI) 28.0 [-152.48, 208.
48]
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Comparison 13. Smoking cessation interventions: exercise vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 1 785 Risk Ratio (M-H, Random, 95% CI) 1.20 [0.72, 2.01]
1.1 Single interventions 1 785 Risk Ratio (M-H, Random, 95% CI) 1.20 [0.72, 2.01]
2 Abstinence in late pregnancy:
biochemically validated only
1 785 Risk Ratio (M-H, Random, 95% CI) 1.20 [0.72, 2.01]
2.1 Single interventions 1 785 Risk Ratio (M-H, Random, 95% CI) 1.20 [0.72, 2.01]
3 Abstinence at 6 to 11 months
postpartum
1 785 Risk Ratio (M-H, Random, 95% CI) 1.50 [0.81, 2.79]
3.1 Single interventions 1 785 Risk Ratio (M-H, Random, 95% CI) 1.50 [0.81, 2.79]
4 Low birthweight 1 712 Risk Ratio (M-H, Random, 95% CI) 0.88 [0.58, 1.32]
4.1 Single interventions 1 712 Risk Ratio (M-H, Random, 95% CI) 0.88 [0.58, 1.32]
5 Preterm births 1 704 Risk Ratio (M-H, Random, 95% CI) 1.32 [0.81, 2.14]
5.1 Single interventions 1 704 Risk Ratio (M-H, Random, 95% CI) 1.32 [0.81, 2.14]
6 Mean birthweight 1 713 Mean Difference (IV, Random, 95% CI) -14.40 [-104.15, 75.
35]
6.1 Single interventions 1 713 Mean Difference (IV, Random, 95% CI) -14.40 [-104.15, 75.
35]
7 Stillbirths 1 756 Risk Ratio (M-H, Random, 95% CI) 1.01 [0.14, 7.10]
7.1 Single interventions 1 756 Risk Ratio (M-H, Random, 95% CI) 1.01 [0.14, 7.10]
8 Neonatal deaths 1 775 Risk Ratio (M-H, Random, 95% CI) 0.34 [0.01, 8.31]
8.1 Single interventions 1 775 Risk Ratio (M-H, Random, 95% CI) 0.34 [0.01, 8.31]
Comparison 14. Smoking cessation interventions: other vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 1 194 Risk Ratio (M-H, Random, 95% CI) 1.63 [0.62, 4.32]
1.1 Single interventions 1 194 Risk Ratio (M-H, Random, 95% CI) 1.63 [0.62, 4.32]
2 Abstinence in late pregnancy:
biochemically validated only
1 194 Risk Ratio (M-H, Random, 95% CI) 1.63 [0.62, 4.32]
2.1 Single interventions 1 194 Risk Ratio (M-H, Random, 95% CI) 1.63 [0.62, 4.32]
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Comparison 15. Maternal health intervention with smoking cessation component: counselling vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 2 258 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.69, 1.25]
1.1 Single 2 258 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.69, 1.25]
2 Abstinence in late pregnancy:
biochemically validated only
1 198 Risk Ratio (M-H, Random, 95% CI) 1.00 [0.72, 1.40]
2.1 Single 1 198 Risk Ratio (M-H, Random, 95% CI) 1.00 [0.72, 1.40]
3 Abstinence at 0 to 5 months
postpartum
1 198 Risk Ratio (M-H, Random, 95% CI) 1.46 [0.97, 2.19]
3.1 Single interventions 1 198 Risk Ratio (M-H, Random, 95% CI) 1.46 [0.97, 2.19]
4 Smoking reduction: biochemical
measures in late pregnancy
1 198 Std. Mean Difference (IV, Random, 95% CI) 0.11 [-0.17, 0.39]
4.1 Mean cotinine 1 198 Std. Mean Difference (IV, Random, 95% CI) 0.11 [-0.17, 0.39]
Comparison 16. Maternal health intervention with smoking cessation component: health education vs less
intensive intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy:
biochemically validated only
1 530 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.65, 1.32]
1.1 Single interventions 1 530 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.65, 1.32]
2 Abstinence at 0 to 5 months
postpartum
1 530 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.67, 1.65]
2.1 Single interventions 1 530 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.67, 1.65]
Comparison 17. Maternal health intervention with smoking cessation component: feedback vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Smoking abstinence in late
pregnancy
1 65 Risk Ratio (M-H, Random, 95% CI) 2.11 [0.98, 4.57]
1.1 Single interventions 1 65 Risk Ratio (M-H, Random, 95% CI) 2.11 [0.98, 4.57]
2 Smoking reduction in late
pregnancy: self-reported
(various definitions)
1 65 Risk Ratio (M-H, Random, 95% CI) 0.95 [0.42, 2.18]
2.1 Single interventions 1 65 Risk Ratio (M-H, Random, 95% CI) 0.95 [0.42, 2.18]
3 Smoking reduction: self-reported
mean cigarettes per day
measured in late pregnancy or
at delivery
1 3571 Mean Difference (IV, Random, 95% CI) 1.5 [1.07, 1.93]
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3.1 Single interventions 1 3571 Mean Difference (IV, Random, 95% CI) 1.5 [1.07, 1.93]
Comparison 18. Maternal health intervention with smoking cessation component: social support vs usual care
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 4 Risk Ratio (M-H, Random, 95% CI) Totals not selected
1.1 Single interventions 2 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
1.2 Tailored interventions 2 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2 Abstinence in late
pregnancy:biochemically
validated only
3 Risk Ratio (M-H, Random, 95% CI) Totals not selected
2.1 Single interventions 1 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.2 Multiple interventions 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.3 Tailored interventions 2 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
3 Abstinence at 0 to 5 months
postpartum
1 130 Risk Ratio (M-H, Random, 95% CI) 1.23 [0.87, 1.74]
3.1 Single interventions 1 130 Risk Ratio (M-H, Random, 95% CI) 1.23 [0.87, 1.74]
4 Abstinence at 18 + months
postpartum
1 73 Risk Ratio (M-H, Random, 95% CI) 1.07 [0.58, 1.98]
4.1 Multiple interventions 1 73 Risk Ratio (M-H, Random, 95% CI) 1.07 [0.58, 1.98]
5 Smoking reduction: mean
cigarettes per day
2 271 Std. Mean Difference (IV, Random, 95% CI) -0.31 [-0.55, -0.07]
5.1 Single interventions 1 130 Std. Mean Difference (IV, Random, 95% CI) -0.22 [-0.57, 0.12]
5.2 Tailored interventions 1 141 Std. Mean Difference (IV, Random, 95% CI) -0.40 [-0.73, -0.06]
Comparison 19. Maternal health intervention with smoking cessation component: social support vs less intensive
intervention
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy 3 455 Risk Ratio (M-H, Random, 95% CI) 1.06 [0.68, 1.63]
1.1 Single interventions 2 262 Risk Ratio (M-H, Random, 95% CI) 0.98 [0.40, 2.39]
1.2 Multiple interventions 1 193 Risk Ratio (M-H, Random, 95% CI) 0.99 [0.51, 1.92]
2 Abstinence in late pregnancy:
biochemically validated only
2 389 Risk Ratio (M-H, Random, 95% CI) 1.13 [0.72, 1.78]
2.1 Single interventions 1 196 Risk Ratio (M-H, Random, 95% CI) 1.28 [0.68, 2.39]
2.2 Multiple interventions 1 193 Risk Ratio (M-H, Random, 95% CI) 0.99 [0.51, 1.92]
3 Abstinence at 0 to 5 months
postpartum
2 389 Risk Ratio (M-H, Random, 95% CI) 0.89 [0.51, 1.55]
3.1 Single interventions 1 196 Risk Ratio (M-H, Random, 95% CI) 0.91 [0.41, 2.03]
3.2 Multiple interventions 1 193 Risk Ratio (M-H, Random, 95% CI) 0.88 [0.41, 1.89]
4 Smoking reduction: self reported
mean cigarettes per day
1 64 Std. Mean Difference (IV, Fixed, 95% CI) 0.15 [-0.34, 0.64]
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4.1 Single interventions 1 64 Std. Mean Difference (IV, Fixed, 95% CI) 0.15 [-0.34, 0.64]
Comparison 20. Interventions for smoking cessation in pregnancy versus control: subgrouped by main interven-
tion strategy
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Abstinence in late pregnancy:
self-reported and biochemically
validated
97 26637 Risk Ratio (M-H, Random, 95% CI) 1.35 [1.23, 1.48]
1.1 Counselling 51 18276 Risk Ratio (M-H, Random, 95% CI) 1.31 [1.16, 1.47]
1.2 Health education 11 2142 Risk Ratio (M-H, Random, 95% CI) 1.22 [0.97, 1.55]
1.3 Feedback 6 859 Risk Ratio (M-H, Random, 95% CI) 1.92 [1.16, 3.17]
1.4 Incentives 13 1752 Risk Ratio (M-H, Random, 95% CI) 1.88 [1.12, 3.14]
1.5 Social support 14 2629 Risk Ratio (M-H, Random, 95% CI) 1.16 [0.96, 1.40]
1.6 Exercise 1 785 Risk Ratio (M-H, Random, 95% CI) 1.20 [0.72, 2.01]
1.7 Other 1 194 Risk Ratio (M-H, Random, 95% CI) 1.63 [0.62, 4.32]
2 Abstinence in late pregnancy:
biochemically validated only
73 Risk Ratio (M-H, Random, 95% CI) Subtotals only
2.1 Counselling 37 14521 Risk Ratio (M-H, Random, 95% CI) 1.23 [1.10, 1.38]
2.2 Health education 8 1744 Risk Ratio (M-H, Random, 95% CI) 1.16 [0.87, 1.55]
2.3 Feedback 4 683 Risk Ratio (M-H, Random, 95% CI) 1.60 [0.85, 3.03]
2.4 Incentives 13 1788 Risk Ratio (M-H, Random, 95% CI) 1.82 [1.10, 3.03]
2.5 Social support 9 1723 Risk Ratio (M-H, Random, 95% CI) 1.08 [0.94, 1.24]
2.6 Exercise 1 785 Risk Ratio (M-H, Random, 95% CI) 1.20 [0.72, 2.01]
2.7 Other 1 194 Risk Ratio (M-H, Random, 95% CI) 1.63 [0.62, 4.32]
3 Continued abstinence (Relapse
prevention) in late pregnancy
for spontaneous quitters
15 Risk Ratio (M-H, Random, 95% CI) Subtotals only
3.1 Counselling 13 1538 Risk Ratio (M-H, Random, 95% CI) 1.01 [0.92, 1.09]
3.2 Health education 1 70 Risk Ratio (M-H, Random, 95% CI) 1.02 [0.86, 1.23]
3.3 Social support 1 158 Risk Ratio (M-H, Random, 95% CI) 1.01 [0.86, 1.20]
4 Abstinence at 0 to 5 months
postpartum
35 Risk Ratio (M-H, Random, 95% CI) Subtotals only
4.1 Counselling 21 5891 Risk Ratio (M-H, Random, 95% CI) 1.29 [1.13, 1.46]
4.2 Health education 5 1378 Risk Ratio (M-H, Random, 95% CI) 1.50 [1.02, 2.20]
4.3 Incentives 4 400 Risk Ratio (M-H, Random, 95% CI) 2.23 [0.94, 5.30]
4.4 Social support 5 697 Risk Ratio (M-H, Random, 95% CI) 1.09 [0.86, 1.37]
5 Abstinence at 6 to 11 months
postpartum
19 Risk Ratio (M-H, Random, 95% CI) Subtotals only
5.1 Counselling 11 4277 Risk Ratio (M-H, Random, 95% CI) 1.15 [0.98, 1.34]
5.2 Incentives 4 804 Risk Ratio (M-H, Random, 95% CI) 3.39 [1.99, 5.76]
5.3 Social support 3 434 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.75, 1.49]
5.4 Exercise 1 785 Risk Ratio (M-H, Random, 95% CI) 1.50 [0.81, 2.79]
6 Abstinence at 12 to 17 months
postpartum
6 Risk Ratio (M-H, Random, 95% CI) Subtotals only
6.1 Counselling 5 1910 Risk Ratio (M-H, Random, 95% CI) 1.37 [0.98, 1.91]
6.2 Social support 1 292 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.69, 1.60]
356Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
7 Abstinence at 18+ months
postpartum
4 Risk Ratio (M-H, Random, 95% CI) Subtotals only
7.1 Counselling 3 798 Risk Ratio (M-H, Random, 95% CI) 0.98 [0.50, 1.92]
7.2 Social support 1 73 Risk Ratio (M-H, Random, 95% CI) 1.07 [0.58, 1.98]
8 Smoking reduction: numbers of
women reducing smoking in
late pregnancy
18 Risk Ratio (M-H, Random, 95% CI) Subtotals only
8.1 Biochemically validated
reduction
10 2531 Risk Ratio (M-H, Random, 95% CI) 1.26 [0.93, 1.71]
8.2 Self-reported some
reduction in smoking (various
definitions)
4 499 Risk Ratio (M-H, Random, 95% CI) 1.61 [1.22, 2.12]
8.3 Self-reported > 50%
reduction in smoking
4 1872 Risk Ratio (M-H, Random, 95% CI) 1.29 [1.08, 1.54]
9 Smoking reduction: biochemical
measures in late pregnancy
10 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
9.1 Mean cotinine levels 9 2258 Std. Mean Difference (IV, Random, 95% CI) -0.41 [-0.66, -0.15]
9.2 Mean thiocyanate level 1 769 Std. Mean Difference (IV, Random, 95% CI) -0.29 [-0.44, -0.15]
10 Smoking reduction:
self-reported mean cigarettes
per day measured in late
pregnancy or at delivery
24 Std. Mean Difference (IV, Random, 95% CI) Subtotals only
10.1 Counselling 13 3814 Std. Mean Difference (IV, Random, 95% CI) -0.19 [-0.36, -0.01]
10.2 Health education 4 1436 Std. Mean Difference (IV, Random, 95% CI) -0.29 [-0.71, 0.14]
10.3 Feedback 2 3675 Std. Mean Difference (IV, Random, 95% CI) -0.18 [-1.02, 0.67]
10.4 Incentives 1 74 Std. Mean Difference (IV, Random, 95% CI) -1.43 [-1.94, -0.91]
10.5 Social support 4 736 Std. Mean Difference (IV, Random, 95% CI) -0.23 [-0.39, -0.07]
11 Low birthweight (under 2500
g)
18 9402 Risk Ratio (M-H, Random, 95% CI) 0.83 [0.72, 0.94]
11.1 Counselling 8 4339 Risk Ratio (M-H, Random, 95% CI) 0.83 [0.68, 1.01]
11.2 Health education 2 1172 Risk Ratio (M-H, Random, 95% CI) 0.87 [0.49, 1.55]
11.3 Feedback 1 2848 Risk Ratio (M-H, Random, 95% CI) 0.82 [0.63, 1.06]
11.4 Incentives 5 252 Risk Ratio (M-H, Random, 95% CI) 0.63 [0.37, 1.08]
11.5 Social support 1 79 Risk Ratio (M-H, Random, 95% CI) 1.00 [0.33, 2.99]
11.6 Exercise 1 712 Risk Ratio (M-H, Random, 95% CI) 0.88 [0.58, 1.32]
12 Very low birthweight (under
1500 g)
3 4366 Risk Ratio (M-H, Random, 95% CI) 1.11 [0.62, 2.01]
12.1 Counselling 2 1666 Risk Ratio (M-H, Random, 95% CI) 1.27 [0.60, 2.71]
12.2 Feedback 1 2700 Risk Ratio (M-H, Random, 95% CI) 0.90 [0.35, 2.32]
13 Preterm birth (under 37 weeks) 19 9222 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.77, 1.11]
13.1 Counselling 8 3447 Risk Ratio (M-H, Random, 95% CI) 0.93 [0.71, 1.20]
13.2 Health education 2 1170 Risk Ratio (M-H, Random, 95% CI) 0.92 [0.55, 1.56]
13.3 Feedback 2 3111 Risk Ratio (M-H, Random, 95% CI) 0.60 [0.28, 1.29]
13.4 Incentives 6 790 Risk Ratio (M-H, Random, 95% CI) 0.91 [0.52, 1.59]
13.5 Exercise 1 704 Risk Ratio (M-H, Random, 95% CI) 1.32 [0.81, 2.14]
14 Mean birthweight (g) 26 11338 Mean Difference (IV, Random, 95% CI) 55.60 [29.82, 81.38]
14.1 Counselling 14 5471 Mean Difference (IV, Random, 95% CI) 42.17 [11.79, 72.55]
14.2 Health education 2 1172 Mean Difference (IV, Random, 95% CI) 27.35 [-53.88, 108.
58]
14.3 Feedback 2 3006 Mean Difference (IV, Random, 95% CI) 79.43 [-53.05, 211.
91]
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14.4 Incentives 6 834 Mean Difference (IV, Random, 95% CI) 114.01 [63.91, 164.
11]
14.5 Social support 1 142 Mean Difference (IV, Random, 95% CI) 28.0 [-152.48, 208.
48]
14.6 Exercise 1 713 Mean Difference (IV, Random, 95% CI) -14.40 [-104.15, 75.
35]
15 Stillbirths 8 6170 Risk Ratio (M-H, Random, 95% CI) 1.20 [0.76, 1.90]
15.1 Counselling 5 2454 Risk Ratio (M-H, Random, 95% CI) 1.14 [0.55, 2.33]
15.2 Feedback 2 2960 Risk Ratio (M-H, Random, 95% CI) 1.28 [0.69, 2.39]
15.3 Exercise 1 756 Risk Ratio (M-H, Random, 95% CI) 1.01 [0.14, 7.10]
16 Perinatal deaths 4 4465 Risk Ratio (M-H, Random, 95% CI) 1.13 [0.72, 1.77]
16.1 Counselling 2 1065 Risk Ratio (M-H, Random, 95% CI) 1.10 [0.52, 2.31]
16.2 Health education 1 552 Risk Ratio (M-H, Random, 95% CI) 4.40 [0.49, 39.08]
16.3 Feedback 1 2848 Risk Ratio (M-H, Random, 95% CI) 1.05 [0.59, 1.87]
17 Neonatal deaths 5 5680 Risk Ratio (M-H, Random, 95% CI) 1.04 [0.41, 2.64]
17.1 Counselling 3 2095 Risk Ratio (M-H, Random, 95% CI) 2.06 [0.61, 6.92]
17.2 Feedback 1 2810 Risk Ratio (M-H, Random, 95% CI) 0.40 [0.08, 2.07]
17.3 Exercise 1 775 Risk Ratio (M-H, Random, 95% CI) 0.34 [0.01, 8.31]
18 NICU admissions 8 2100 Risk Ratio (M-H, Random, 95% CI) 0.78 [0.61, 0.98]
18.1 Counselling 2 1140 Risk Ratio (M-H, Random, 95% CI) 0.82 [0.52, 1.29]
18.2 Incentives 5 252 Risk Ratio (M-H, Random, 95% CI) 0.77 [0.51, 1.15]
18.3 Exercise 1 708 Risk Ratio (M-H, Random, 95% CI) 0.76 [0.47, 1.22]
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Analysis 1.1. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 1
Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Baric 1976 9/63 2/47 1.3 % 3.36 [ 0.76, 14.82 ]
Dunkley 1997 4/50 0/50 0.4 % 9.00 [ 0.50, 162.89 ]
Haug 1994 42/229 8/93 4.0 % 2.13 [ 1.04, 4.37 ]
Lawrence 2003 (AvB) 13/297 2/141 1.4 % 3.09 [ 0.71, 13.49 ]
McLeod 2004 37/163 14/109 5.2 % 1.77 [ 1.00, 3.11 ]
Moore 2002 88/523 108/567 8.4 % 0.88 [ 0.68, 1.14 ]
Panjari 1999 33/476 31/537 6.0 % 1.20 [ 0.75, 1.93 ]
Pbert 2004 5/26 2/18 1.3 % 1.73 [ 0.38, 7.96 ]
Price 1991 (AvB) 2/52 0/35 0.4 % 3.40 [ 0.17, 68.67 ]
Price 1991 (AvC) 4/71 1/35 0.7 % 1.97 [ 0.23, 16.99 ]
Tappin 2000 2/48 2/49 0.9 % 1.02 [ 0.15, 6.96 ]
Tappin 2005 17/347 19/409 4.6 % 1.05 [ 0.56, 2.00 ]
Valbo 1996 5/52 8/78 2.3 % 0.94 [ 0.32, 2.71 ]
Subtotal (95% CI) 2397 2168 36.8 % 1.33 [ 1.01, 1.74 ]
Total events: 261 (Experimental), 197 (Control)
Heterogeneity: Tau2 = 0.05; Chi2 = 16.38, df = 12 (P = 0.17); I2 =27%
Test for overall effect: Z = 2.06 (P = 0.040)
2 Multiple interventions
Gielen 1997 12/193 11/198 3.5 % 1.12 [ 0.51, 2.48 ]
Hartmann 1996 27/113 16/106 5.2 % 1.58 [ 0.91, 2.77 ]
Kendrick 1995 48/822 65/1063 7.2 % 0.95 [ 0.67, 1.37 ]
Lawrence 2003 (AvC) 17/311 2/141 1.4 % 3.85 [ 0.90, 16.45 ]
Lillington 1995 7/16 4/18 2.5 % 1.97 [ 0.70, 5.50 ]
Mayer 1990 (AvC) 8/72 2/77 1.3 % 4.28 [ 0.94, 19.48 ]
Secker-Walker 1994 29/255 26/258 5.8 % 1.13 [ 0.68, 1.86 ]
0.01 0.1 1 10 100
Favours [control] Favours [experimental]
(Continued . . . )
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(. . . Continued)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Stotts 2004 3/24 5/30 1.6 % 0.75 [ 0.20, 2.83 ]
Tsoh 2010 6/23 2/19 1.4 % 2.48 [ 0.56, 10.89 ]
Windsor 1985 (AvB) 6/103 1/52 0.7 % 3.03 [ 0.37, 24.50 ]
Windsor 1985 (AvC) 14/102 1/52 0.8 % 7.14 [ 0.96, 52.79 ]
Subtotal (95% CI) 2034 2014 31.4 % 1.42 [ 1.04, 1.93 ]
Total events: 177 (Experimental), 135 (Control)
Heterogeneity: Tau2 = 0.06; Chi2 = 13.81, df = 10 (P = 0.18); I2 =28%
Test for overall effect: Z = 2.21 (P = 0.027)
3 Tailored interventions
Eades 2012 1/124 2/107 0.6 % 0.43 [ 0.04, 4.69 ]
Hajek 2001 80/365 73/367 8.1 % 1.10 [ 0.83, 1.46 ]
Hegaard 2003 23/327 7/320 3.3 % 3.22 [ 1.40, 7.39 ]
Loeb 1983 42/477 39/486 6.6 % 1.10 [ 0.72, 1.67 ]
Sexton 1984 167/436 79/443 8.6 % 2.15 [ 1.70, 2.71 ]
Thornton 1997 20/190 14/177 4.5 % 1.33 [ 0.69, 2.55 ]
Subtotal (95% CI) 1919 1900 31.7 % 1.49 [ 1.01, 2.20 ]
Total events: 333 (Experimental), 214 (Control)
Heterogeneity: Tau2 = 0.14; Chi2 = 20.07, df = 5 (P = 0.001); I2 =75%
Test for overall effect: Z = 2.02 (P = 0.043)
Total (95% CI) 6350 6082 100.0 % 1.44 [ 1.19, 1.73 ]
Total events: 771 (Experimental), 546 (Control)
Heterogeneity: Tau2 = 0.09; Chi2 = 56.68, df = 29 (P = 0.002); I2 =49%
Test for overall effect: Z = 3.83 (P = 0.00013)
Test for subgroup differences: Chi2 = 0.25, df = 2 (P = 0.88), I2 =0.0%
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Analysis 1.2. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 2
Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Lawrence 2003 (AvB) 13/297 2/141 1.2 % 3.09 [ 0.71, 13.49 ]
McLeod 2004 37/163 14/109 6.6 % 1.77 [ 1.00, 3.11 ]
Moore 2002 88/523 108/567 16.4 % 0.88 [ 0.68, 1.14 ]
Panjari 1999 33/476 31/537 8.5 % 1.20 [ 0.75, 1.93 ]
Pbert 2004 5/26 2/18 1.2 % 1.73 [ 0.38, 7.96 ]
Price 1991 (AvB) 2/52 0/35 0.3 % 3.40 [ 0.17, 68.67 ]
Price 1991 (AvC) 4/71 1/35 0.6 % 1.97 [ 0.23, 16.99 ]
Tappin 2000 2/48 2/49 0.7 % 1.02 [ 0.15, 6.96 ]
Tappin 2005 17/347 19/409 5.5 % 1.05 [ 0.56, 2.00 ]
Subtotal (95% CI) 2003 1900 41.1 % 1.12 [ 0.90, 1.41 ]
Total events: 201 (Experimental), 179 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 8.74, df = 8 (P = 0.36); I2 =8%
Test for overall effect: Z = 1.01 (P = 0.31)
2 Multiple interventions
Gielen 1997 12/193 11/198 3.8 % 1.12 [ 0.51, 2.48 ]
Hartmann 1996 27/113 16/106 6.7 % 1.58 [ 0.91, 2.77 ]
Kendrick 1995 48/822 65/1063 11.9 % 0.95 [ 0.67, 1.37 ]
Lawrence 2003 (AvC) 17/311 2/141 1.3 % 3.85 [ 0.90, 16.45 ]
Secker-Walker 1994 29/255 26/258 7.9 % 1.13 [ 0.68, 1.86 ]
Stotts 2004 3/24 5/30 1.5 % 0.75 [ 0.20, 2.83 ]
Windsor 1985 (AvB) 6/103 1/52 0.6 % 3.03 [ 0.37, 24.50 ]
Windsor 1985 (AvC) 14/102 1/52 0.7 % 7.14 [ 0.96, 52.79 ]
Subtotal (95% CI) 1923 1900 34.5 % 1.26 [ 0.92, 1.73 ]
Total events: 156 (Experimental), 127 (Control)
Heterogeneity: Tau2 = 0.05; Chi2 = 9.50, df = 7 (P = 0.22); I2 =26%
Test for overall effect: Z = 1.45 (P = 0.15)
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(. . . Continued)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
3 Tailored interventions
Eades 2012 1/124 2/107 0.5 % 0.43 [ 0.04, 4.69 ]
Hajek 2001 80/365 73/367 15.1 % 1.10 [ 0.83, 1.46 ]
Hegaard 2003 23/327 7/320 3.5 % 3.22 [ 1.40, 7.39 ]
Thornton 1997 20/190 14/177 5.3 % 1.33 [ 0.69, 2.55 ]
Subtotal (95% CI) 1006 971 24.5 % 1.42 [ 0.84, 2.41 ]
Total events: 124 (Experimental), 96 (Control)
Heterogeneity: Tau2 = 0.14; Chi2 = 6.59, df = 3 (P = 0.09); I2 =54%
Test for overall effect: Z = 1.30 (P = 0.19)
Total (95% CI) 4932 4771 100.0 % 1.23 [ 1.04, 1.45 ]
Total events: 481 (Experimental), 402 (Control)
Heterogeneity: Tau2 = 0.03; Chi2 = 25.66, df = 20 (P = 0.18); I2 =22%
Test for overall effect: Z = 2.38 (P = 0.017)
Test for subgroup differences: Chi2 = 0.80, df = 2 (P = 0.67), I2 =0.0%
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Analysis 1.3. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 3
Continued abstinence (relapse prevention) in late pregnancy for spontaneous quitters.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 3 Continued abstinence (relapse prevention) in late pregnancy for spontaneous quitters
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Pbert 2004 16/23 12/16 8.3 % 0.93 [ 0.63, 1.37 ]
Polanska 2004 38/38 23/23 32.1 % 1.00 [ 0.93, 1.07 ]
Subtotal (95% CI) 61 39 40.3 % 1.00 [ 0.93, 1.07 ]
Total events: 54 (Experimental), 35 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.54, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.06 (P = 0.95)
2 Multiple interventions
Lillington 1995 15/16 17/19 19.1 % 1.05 [ 0.86, 1.28 ]
Lowe 1997 37/52 25/45 11.4 % 1.28 [ 0.94, 1.75 ]
Secker-Walker 1994 31/85 31/80 8.2 % 0.94 [ 0.64, 1.39 ]
Subtotal (95% CI) 153 144 38.7 % 1.08 [ 0.93, 1.26 ]
Total events: 83 (Experimental), 73 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.70, df = 2 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 1.00 (P = 0.32)
3 Tailored interventions
Eades 2012 10/24 2/8 1.0 % 1.67 [ 0.46, 6.06 ]
Hajek 2001 72/111 68/128 17.9 % 1.22 [ 0.99, 1.51 ]
Thornton 1997 3/6 10/14 2.1 % 0.70 [ 0.29, 1.66 ]
Subtotal (95% CI) 141 150 21.0 % 1.19 [ 0.97, 1.46 ]
Total events: 85 (Experimental), 80 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.76, df = 2 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 1.70 (P = 0.090)
Total (95% CI) 355 333 100.0 % 1.06 [ 0.93, 1.21 ]
Total events: 222 (Experimental), 188 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 12.70, df = 7 (P = 0.08); I2 =45%
Test for overall effect: Z = 0.90 (P = 0.37)
Test for subgroup differences: Chi2 = 3.22, df = 2 (P = 0.20), I2 =38%
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Analysis 1.4. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 4
Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 4 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Dunkley 1997 2/50 0/50 0.6 % 5.00 [ 0.25, 101.58 ]
Haug 1994 42/229 8/93 10.7 % 2.13 [ 1.04, 4.37 ]
Lawrence 2003 (AvB) 15/297 5/141 5.6 % 1.42 [ 0.53, 3.84 ]
McLeod 2004 17/106 9/82 9.6 % 1.46 [ 0.69, 3.11 ]
Panjari 1999 54/339 47/393 41.6 % 1.33 [ 0.93, 1.91 ]
Pbert 2004 1/26 1/18 0.7 % 0.69 [ 0.05, 10.36 ]
Polanska 2004 28/62 6/38 8.9 % 2.86 [ 1.31, 6.26 ]
Subtotal (95% CI) 1109 815 77.7 % 1.58 [ 1.21, 2.06 ]
Total events: 159 (Experimental), 76 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 4.76, df = 6 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 3.39 (P = 0.00070)
2 Multiple interventions
Lawrence 2003 (AvC) 25/311 5/141 6.2 % 2.27 [ 0.89, 5.80 ]
Lillington 1995 4/16 2/18 2.3 % 2.25 [ 0.47, 10.69 ]
Mayer 1990 (AvC) 5/72 0/77 0.7 % 11.75 [ 0.66, 208.84 ]
Subtotal (95% CI) 399 236 9.1 % 2.55 [ 1.17, 5.53 ]
Total events: 34 (Experimental), 7 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.21, df = 2 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 2.37 (P = 0.018)
3 Tailored interventions
Thornton 1997 19/190 15/177 13.2 % 1.18 [ 0.62, 2.25 ]
Subtotal (95% CI) 190 177 13.2 % 1.18 [ 0.62, 2.25 ]
Total events: 19 (Experimental), 15 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.62)
Total (95% CI) 1698 1228 100.0 % 1.59 [ 1.26, 2.01 ]
Total events: 212 (Experimental), 98 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 8.26, df = 10 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 3.89 (P = 0.00010)
Test for subgroup differences: Chi2 = 2.25, df = 2 (P = 0.32), I2 =11%
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Analysis 1.5. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 5
Abstinence at 6 to 11 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 5 Abstinence at 6 to 11 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Haug 1994 35/229 10/93 18.6 % 1.42 [ 0.73, 2.75 ]
Panjari 1999 54/339 47/393 61.5 % 1.33 [ 0.93, 1.91 ]
Pbert 2004 1/26 0/18 0.8 % 2.11 [ 0.09, 49.08 ]
Subtotal (95% CI) 594 504 80.9 % 1.36 [ 0.99, 1.86 ]
Total events: 90 (Experimental), 57 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.11, df = 2 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 1.90 (P = 0.058)
2 Multiple interventions
Gielen 1997 7/193 2/198 3.3 % 3.59 [ 0.76, 17.07 ]
Secker-Walker 1994 5/157 6/185 5.9 % 0.98 [ 0.31, 3.16 ]
Subtotal (95% CI) 350 383 9.3 % 1.69 [ 0.48, 5.96 ]
Total events: 12 (Experimental), 8 (Control)
Heterogeneity: Tau2 = 0.36; Chi2 = 1.72, df = 1 (P = 0.19); I2 =42%
Test for overall effect: Z = 0.82 (P = 0.42)
3 Tailored interventions
Hajek 2001 9/315 9/312 9.8 % 0.99 [ 0.40, 2.46 ]
Subtotal (95% CI) 315 312 9.8 % 0.99 [ 0.40, 2.46 ]
Total events: 9 (Experimental), 9 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.02 (P = 0.98)
Total (95% CI) 1259 1199 100.0 % 1.33 [ 1.00, 1.77 ]
Total events: 111 (Experimental), 74 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.35, df = 5 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 1.99 (P = 0.047)
Test for subgroup differences: Chi2 = 0.56, df = 2 (P = 0.76), I2 =0.0%
0.01 0.1 1 10 100
Favours [control] Favours [experimental]
365Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.6. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 6
Abstinence at 12 to 17 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 6 Abstinence at 12 to 17 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Haug 1994 34/229 7/93 56.7 % 1.97 [ 0.91, 4.29 ]
Polanska 2004 22/69 5/40 43.3 % 2.55 [ 1.05, 6.21 ]
Total (95% CI) 298 133 100.0 % 2.20 [ 1.23, 3.96 ]
Total events: 56 (Experimental), 12 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.18, df = 1 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 2.65 (P = 0.0081)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 7
Abstinence at 18+ months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 7 Abstinence at 18+ months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Lawrence 2003 (AvB) 7/159 3/80 25.4 % 1.17 [ 0.31, 4.42 ]
Subtotal (95% CI) 159 80 25.4 % 1.17 [ 0.31, 4.42 ]
Total events: 7 (Experimental), 3 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.24 (P = 0.81)
2 Multiple interventions
Lawrence 2003 (AvC) 6/137 3/80 24.2 % 1.17 [ 0.30, 4.54 ]
Secker-Walker 1994 7/157 10/185 50.3 % 0.82 [ 0.32, 2.12 ]
Subtotal (95% CI) 294 265 74.6 % 0.92 [ 0.43, 2.00 ]
Total events: 13 (Experimental), 13 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.17, df = 1 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 0.20 (P = 0.84)
Total (95% CI) 453 345 100.0 % 0.98 [ 0.50, 1.92 ]
Total events: 20 (Experimental), 16 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.26, df = 2 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 0.05 (P = 0.96)
Test for subgroup differences: Chi2 = 0.09, df = 1 (P = 0.76), I2 =0.0%
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Analysis 1.8. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 8
Reduction in late pregnancy: biochemically validated.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 8 Reduction in late pregnancy: biochemically validated
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tappin 2005 14/347 26/409 55.6 % 0.63 [ 0.34, 1.20 ]
Subtotal (95% CI) 347 409 55.6 % 0.63 [ 0.34, 1.20 ]
Total events: 14 (Experimental), 26 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.41 (P = 0.16)
2 Multiple interventions
Gielen 1997 14/125 13/121 44.4 % 1.04 [ 0.51, 2.13 ]
Subtotal (95% CI) 125 121 44.4 % 1.04 [ 0.51, 2.13 ]
Total events: 14 (Experimental), 13 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.91)
Total (95% CI) 472 530 100.0 % 0.79 [ 0.49, 1.28 ]
Total events: 28 (Experimental), 39 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 1.04, df = 1 (P = 0.31); I2 =4%
Test for overall effect: Z = 0.95 (P = 0.34)
Test for subgroup differences: Chi2 = 1.04, df = 1 (P = 0.31), I2 =4%
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Analysis 1.9. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 9
Reduction in late pregnancy: self reported (various definitions).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 9 Reduction in late pregnancy: self reported (various definitions)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Price 1991 (AvC) 37/123 10/70 18.2 % 2.11 [ 1.12, 3.97 ]
Valbo 1996 22/52 24/78 34.6 % 1.38 [ 0.87, 2.18 ]
Subtotal (95% CI) 175 148 52.8 % 1.61 [ 1.06, 2.43 ]
Total events: 59 (Experimental), 34 (Control)
Heterogeneity: Tau2 = 0.02; Chi2 = 1.19, df = 1 (P = 0.27); I2 =16%
Test for overall effect: Z = 2.26 (P = 0.024)
2 Multiple interventions
Hartmann 1996 34/107 20/100 31.7 % 1.59 [ 0.98, 2.57 ]
Windsor 1985 (AvB) 20/103 5/52 8.6 % 2.02 [ 0.80, 5.08 ]
Windsor 1985 (AvC) 17/102 4/52 6.8 % 2.17 [ 0.77, 6.11 ]
Subtotal (95% CI) 312 204 47.2 % 1.74 [ 1.17, 2.57 ]
Total events: 71 (Experimental), 29 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.42, df = 2 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 2.74 (P = 0.0061)
Total (95% CI) 487 352 100.0 % 1.66 [ 1.27, 2.17 ]
Total events: 130 (Experimental), 63 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.71, df = 4 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 3.67 (P = 0.00025)
Test for subgroup differences: Chi2 = 0.07, df = 1 (P = 0.80), I2 =0.0%
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Analysis 1.10. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 10
Biochemical measures in late pregnancy: mean cotinine.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 10 Biochemical measures in late pregnancy: mean cotinine
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Panjari 1999 318 720 (688) 356 769 (735) 23.7 % -0.07 [ -0.22, 0.08 ]
Tappin 2005 290 113 (70) 364 117 (83) 23.6 % -0.05 [ -0.21, 0.10 ]
Vilches 2009 (AvB) 71 5.76 (4.9) 18 11.55 (4.8) 14.4 % -1.18 [ -1.72, -0.63 ]
Vilches 2009 (AvC) 8 7 (6.63) 18 11.55 (4.8) 8.8 % -0.82 [ -1.68, 0.05 ]
Subtotal (95% CI) 687 756 70.6 % -0.35 [ -0.69, -0.02 ]
Heterogeneity: Tau2 = 0.08; Chi2 = 18.00, df = 3 (P = 0.00044); I2 =83%
Test for overall effect: Z = 2.05 (P = 0.040)
2 Multiple interventions
Secker-Walker 1994 188 1208 (1384) 226 1228 (1612) 22.9 % -0.01 [ -0.21, 0.18 ]
Vilches 2009 (AvD) 9 1.17 (1.17) 18 11.55 (4.8) 6.5 % -2.51 [ -3.59, -1.43 ]
Subtotal (95% CI) 197 244 29.4 % -1.20 [ -3.64, 1.24 ]
Heterogeneity: Tau2 = 2.96; Chi2 = 19.90, df = 1 (P<0.00001); I2 =95%
Test for overall effect: Z = 0.96 (P = 0.33)
Total (95% CI) 884 1000 100.0 % -0.44 [ -0.76, -0.12 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 37.94, df = 5 (P<0.00001); I2 =87%
Test for overall effect: Z = 2.67 (P = 0.0075)
Test for subgroup differences: Chi2 = 0.45, df = 1 (P = 0.50), I2 =0.0%
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Analysis 1.11. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 11 Mean
cigarettes per day in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 11 Mean cigarettes per day in late pregnancy
Study or subgroup Experimental Control
Std.
Mean
Difference
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Moore 2002 353 10.3 (5.6) 403 10.1 (5.4) 0.04 [ -0.11, 0.18 ]
Panjari 1999 284 8.7 (7.6) 326 11.5 (9.7) -0.32 [ -0.48, -0.16 ]
Pbert 2004 119 8 (6.5) 172 10.5 (6.5) -0.38 [ -0.62, -0.15 ]
Price 1991 (AvC) 71 4.3 (8.1) 70 2.3 (5.6) 0.29 [ -0.05, 0.62 ]
Valbo 1996 52 9.9 (5.4) 78 9 (4.4) 0.19 [ -0.17, 0.54 ]
Vilches 2009 (AvB) 71 5 (6.5) 18 5.36 (5.76) -0.06 [ -0.57, 0.46 ]
Vilches 2009 (AvC) 8 8.5 (9.68) 18 5.36 (5.76) 0.43 [ -0.42, 1.27 ]
2 Multiple interventions
Hartmann 1996 107 9.1 (6.5) 100 12.2 (6.5) -0.48 [ -0.75, -0.20 ]
Vilches 2009 (AvD) 9 0.11 (0.33) 18 5.36 (5.76) -1.07 [ -1.93, -0.21 ]
3 Tailored interventions
Sexton 1984 388 6.4 (8.7) 395 12.8 (11.5) -0.63 [ -0.77, -0.48 ]
Thornton 1997 196 10.4 (8.3) 191 12.5 (10.7) -0.22 [ -0.42, -0.02 ]
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Analysis 1.12. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 12 NICU
admissions.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 12 NICU admissions
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tappin 2005 32/351 53/411 69.8 % 0.71 [ 0.47, 1.07 ]
Subtotal (95% CI) 351 411 69.8 % 0.71 [ 0.47, 1.07 ]
Total events: 32 (Experimental), 53 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.64 (P = 0.10)
2 Tailored interventions
Thornton 1997 14/189 12/189 30.2 % 1.17 [ 0.55, 2.46 ]
Subtotal (95% CI) 189 189 30.2 % 1.17 [ 0.55, 2.46 ]
Total events: 14 (Experimental), 12 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.41 (P = 0.68)
Total (95% CI) 540 600 100.0 % 0.82 [ 0.52, 1.29 ]
Total events: 46 (Experimental), 65 (Control)
Heterogeneity: Tau2 = 0.03; Chi2 = 1.33, df = 1 (P = 0.25); I2 =25%
Test for overall effect: Z = 0.85 (P = 0.40)
Test for subgroup differences: Chi2 = 1.33, df = 1 (P = 0.25), I2 =25%
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Analysis 1.13. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 13 Very
low birthweight infants (< 1500 g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 13 Very low birthweight infants (< 1500 g)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tappin 2005 6/331 8/400 51.7 % 0.91 [ 0.32, 2.59 ]
Subtotal (95% CI) 331 400 51.7 % 0.91 [ 0.32, 2.59 ]
Total events: 6 (Experimental), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.18 (P = 0.85)
2 Tailored interventions
Sexton 1984 9/463 5/472 48.3 % 1.83 [ 0.62, 5.43 ]
Subtotal (95% CI) 463 472 48.3 % 1.83 [ 0.62, 5.43 ]
Total events: 9 (Experimental), 5 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.10 (P = 0.27)
Total (95% CI) 794 872 100.0 % 1.27 [ 0.60, 2.71 ]
Total events: 15 (Experimental), 13 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.84, df = 1 (P = 0.36); I2 =0.0%
Test for overall effect: Z = 0.63 (P = 0.53)
Test for subgroup differences: Chi2 = 0.84, df = 1 (P = 0.36), I2 =0.0%
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Analysis 1.14. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 14
Preterm births.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 14 Preterm births
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Panjari 1999 18/339 34/391 27.8 % 0.61 [ 0.35, 1.06 ]
Tappin 2000 5/48 4/49 6.9 % 1.28 [ 0.36, 4.47 ]
Tappin 2005 35/342 43/402 39.9 % 0.96 [ 0.63, 1.46 ]
Subtotal (95% CI) 729 842 74.6 % 0.83 [ 0.60, 1.17 ]
Total events: 58 (Experimental), 81 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 2.07, df = 2 (P = 0.35); I2 =4%
Test for overall effect: Z = 1.06 (P = 0.29)
2 Tailored interventions
Hegaard 2003 7/334 10/330 11.4 % 0.69 [ 0.27, 1.80 ]
Thornton 1997 14/209 8/209 14.0 % 1.75 [ 0.75, 4.08 ]
Subtotal (95% CI) 543 539 25.4 % 1.13 [ 0.46, 2.80 ]
Total events: 21 (Experimental), 18 (Control)
Heterogeneity: Tau2 = 0.22; Chi2 = 2.03, df = 1 (P = 0.15); I2 =51%
Test for overall effect: Z = 0.26 (P = 0.79)
Total (95% CI) 1272 1381 100.0 % 0.90 [ 0.64, 1.27 ]
Total events: 79 (Experimental), 99 (Control)
Heterogeneity: Tau2 = 0.03; Chi2 = 4.93, df = 4 (P = 0.29); I2 =19%
Test for overall effect: Z = 0.58 (P = 0.56)
Test for subgroup differences: Chi2 = 0.38, df = 1 (P = 0.54), I2 =0.0%
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Analysis 1.15. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 15 Mean
birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 15 Mean birthweight
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Panjari 1999 337 3250 (526) 391 3166 (589) 16.0 % 84.00 [ 2.99, 165.01 ]
Polanska 2004 149 3104 (745) 144 3138 (1090) 2.3 % -34.00 [ -248.49, 180.49 ]
Tappin 2000 48 3205 (578) 49 3271 (578) 2.0 % -66.00 [ -296.06, 164.06 ]
Tappin 2005 351 3078 (602) 411 3048 (642) 13.4 % 30.00 [ -58.42, 118.42 ]
Vilches 2009 (AvB) 71 3268.7 (423.97) 18 3140.83 (375.12) 2.6 % 127.87 [ -71.52, 327.26 ]
Vilches 2009 (AvC) 8 3262.5 (521.55) 18 3140.83 (375.12) 0.7 % 121.67 [ -279.14, 522.48 ]
Subtotal (95% CI) 964 1031 37.0 % 52.87 [ -0.41, 106.15 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 3.14, df = 5 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 1.94 (P = 0.052)
2 Multiple interventions
Secker-Walker 1994 279 3291 (468) 282 3255 (466) 17.6 % 36.00 [ -41.29, 113.29 ]
Vilches 2009 (AvD) 9 3398.89 (489.78) 18 3140.83 (375.12) 0.8 % 258.06 [ -105.84, 621.96 ]
Subtotal (95% CI) 288 300 18.4 % 72.91 [ -89.12, 234.95 ]
Heterogeneity: Tau2 = 6642.11; Chi2 = 1.37, df = 1 (P = 0.24); I2 =27%
Test for overall effect: Z = 0.88 (P = 0.38)
3 Tailored interventions
Hegaard 2003 327 3401 (578) 320 3433 (578) 13.2 % -32.00 [ -121.08, 57.08 ]
Sexton 1984 463 3278 (627) 472 3186 (566) 17.9 % 92.00 [ 15.39, 168.61 ]
Thornton 1997 380 3267 (624) 380 3266 (613) 13.6 % 1.00 [ -86.95, 88.95 ]
Subtotal (95% CI) 1170 1172 44.7 % 23.25 [ -52.12, 98.62 ]
Heterogeneity: Tau2 = 2581.28; Chi2 = 4.79, df = 2 (P = 0.09); I2 =58%
Test for overall effect: Z = 0.60 (P = 0.55)
Total (95% CI) 2422 2503 100.0 % 40.27 [ 7.87, 72.66 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 9.79, df = 10 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 2.44 (P = 0.015)
Test for subgroup differences: Chi2 = 0.52, df = 2 (P = 0.77), I2 =0.0%
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Analysis 1.16. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 16
Perinatal deaths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 16 Perinatal deaths
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Valbo 1996 0/52 0/78 Not estimable
Subtotal (95% CI) 52 78 Not estimable
Total events: 0 (Experimental), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Tailored interventions
Sexton 1984 14/463 13/472 100.0 % 1.10 [ 0.52, 2.31 ]
Subtotal (95% CI) 463 472 100.0 % 1.10 [ 0.52, 2.31 ]
Total events: 14 (Experimental), 13 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.25 (P = 0.81)
Test for subgroup differences: Not applicable
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Analysis 1.17. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 17
Stillbirths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 17 Stillbirths
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tappin 2000 1/48 0/49 5.6 % 3.06 [ 0.13, 73.34 ]
Tappin 2005 2/351 1/411 9.9 % 2.34 [ 0.21, 25.72 ]
Subtotal (95% CI) 399 460 15.5 % 2.58 [ 0.38, 17.48 ]
Total events: 3 (Experimental), 1 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 0.97 (P = 0.33)
2 Tailored interventions
Sexton 1984 9/463 11/472 74.6 % 0.83 [ 0.35, 1.99 ]
Thornton 1997 2/209 1/209 9.9 % 2.00 [ 0.18, 21.89 ]
Subtotal (95% CI) 672 681 84.5 % 0.92 [ 0.41, 2.10 ]
Total events: 11 (Experimental), 12 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.45, df = 1 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 0.19 (P = 0.85)
Total (95% CI) 1071 1141 100.0 % 1.08 [ 0.51, 2.30 ]
Total events: 14 (Experimental), 13 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.41, df = 3 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Chi2 = 0.94, df = 1 (P = 0.33), I2 =0.0%
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Analysis 1.18. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 18
Neonatal deaths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 18 Neonatal deaths
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tappin 2005 1/351 1/411 19.2 % 1.17 [ 0.07, 18.65 ]
Subtotal (95% CI) 351 411 19.2 % 1.17 [ 0.07, 18.65 ]
Total events: 1 (Experimental), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.91)
2 Tailored interventions
Sexton 1984 5/454 2/461 55.1 % 2.54 [ 0.50, 13.02 ]
Thornton 1997 2/209 1/209 25.7 % 2.00 [ 0.18, 21.89 ]
Subtotal (95% CI) 663 670 80.8 % 2.35 [ 0.61, 9.07 ]
Total events: 7 (Experimental), 3 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.03, df = 1 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 1.24 (P = 0.21)
Total (95% CI) 1014 1081 100.0 % 2.06 [ 0.61, 6.92 ]
Total events: 8 (Experimental), 4 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.22, df = 2 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 1.17 (P = 0.24)
Test for subgroup differences: Chi2 = 0.20, df = 1 (P = 0.66), I2 =0.0%
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Analysis 1.19. Comparison 1 Smoking cessation interventions: counselling vs usual care, Outcome 19 Low
birthweight infants (< 2500 g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 1 Smoking cessation interventions: counselling vs usual care
Outcome: 19 Low birthweight infants (< 2500 g)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Panjari 1999 20/337 37/391 17.0 % 0.63 [ 0.37, 1.06 ]
Tappin 2005 44/332 59/400 35.5 % 0.90 [ 0.63, 1.29 ]
Subtotal (95% CI) 669 791 52.5 % 0.79 [ 0.56, 1.11 ]
Total events: 64 (Experimental), 96 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 1.23, df = 1 (P = 0.27); I2 =19%
Test for overall effect: Z = 1.36 (P = 0.17)
2 Multiple interventions
Secker-Walker 1994 9/188 10/226 6.0 % 1.08 [ 0.45, 2.61 ]
Subtotal (95% CI) 188 226 6.0 % 1.08 [ 0.45, 2.61 ]
Total events: 9 (Experimental), 10 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.18 (P = 0.86)
3 Tailored interventions
Hegaard 2003 12/327 10/320 6.9 % 1.17 [ 0.51, 2.68 ]
Sexton 1984 31/463 42/472 23.4 % 0.75 [ 0.48, 1.18 ]
Thornton 1997 19/190 15/190 11.2 % 1.27 [ 0.66, 2.42 ]
Subtotal (95% CI) 980 982 41.5 % 0.93 [ 0.66, 1.32 ]
Total events: 62 (Experimental), 67 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 2.05, df = 2 (P = 0.36); I2 =2%
Test for overall effect: Z = 0.39 (P = 0.70)
Total (95% CI) 1837 1999 100.0 % 0.87 [ 0.70, 1.08 ]
Total events: 135 (Experimental), 173 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 3.98, df = 5 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 1.29 (P = 0.20)
Test for subgroup differences: Chi2 = 0.71, df = 2 (P = 0.70), I2 =0.0%
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Analysis 2.1. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 1 Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Cinciripini 2000 3/42 5/40 1.3 % 0.57 [ 0.15, 2.24 ]
Dornelas 2006 15/53 5/52 2.6 % 2.94 [ 1.15, 7.51 ]
Ershoff 1989 33/126 20/116 7.2 % 1.52 [ 0.93, 2.49 ]
Ershoff 1999 (AvC) 21/101 25/111 6.8 % 0.92 [ 0.55, 1.54 ]
Lee 2015 21/140 16/137 5.3 % 1.28 [ 0.70, 2.35 ]
McBride 2004 (AvB) 25/87 33/91 8.6 % 0.79 [ 0.52, 1.22 ]
Secker-Walker 1997 5/21 0/28 0.3 % 14.50 [ 0.85, 248.56 ]
Subtotal (95% CI) 570 575 32.2 % 1.21 [ 0.82, 1.80 ]
Total events: 123 (Experimental), 104 (Control)
Heterogeneity: Tau2 = 0.13; Chi2 = 13.11, df = 6 (P = 0.04); I2 =54%
Test for overall effect: Z = 0.97 (P = 0.33)
2 Multiple interventions
Cook 1995 8/23 2/20 1.2 % 3.48 [ 0.83, 14.52 ]
McBride 1999 72/341 30/160 9.9 % 1.13 [ 0.77, 1.65 ]
Messimer 1989 8/30 4/29 2.0 % 1.93 [ 0.65, 5.73 ]
Parker 2007 (AvC) 77/358 72/378 13.1 % 1.13 [ 0.85, 1.50 ]
Patten 2009 0/16 1/17 0.3 % 0.35 [ 0.02, 8.08 ]
Rigotti 2006 21/209 16/212 5.1 % 1.33 [ 0.71, 2.48 ]
Secker-Walker 1998 19/142 14/149 4.8 % 1.42 [ 0.74, 2.73 ]
Stotts 2002 27/134 28/135 7.6 % 0.97 [ 0.61, 1.56 ]
Windsor 1993 57/400 35/414 9.5 % 1.69 [ 1.13, 2.51 ]
Windsor 2011 65/547 55/546 11.3 % 1.18 [ 0.84, 1.66 ]
Subtotal (95% CI) 2200 2060 64.7 % 1.24 [ 1.07, 1.44 ]
Total events: 354 (Experimental), 257 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 7.55, df = 9 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 2.79 (P = 0.0053)
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(. . . Continued)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
3 Tailored interventions
Walsh 1997 17/127 7/125 3.1 % 2.39 [ 1.03, 5.56 ]
Subtotal (95% CI) 127 125 3.1 % 2.39 [ 1.03, 5.56 ]
Total events: 17 (Experimental), 7 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.02 (P = 0.043)
Total (95% CI) 2897 2760 100.0 % 1.25 [ 1.07, 1.47 ]
Total events: 494 (Experimental), 368 (Control)
Heterogeneity: Tau2 = 0.03; Chi2 = 23.49, df = 17 (P = 0.13); I2 =28%
Test for overall effect: Z = 2.74 (P = 0.0061)
Test for subgroup differences: Chi2 = 2.30, df = 2 (P = 0.32), I2 =13%
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Analysis 2.2. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 2 Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Cinciripini 2000 3/42 5/40 1.5 % 0.57 [ 0.15, 2.24 ]
Dornelas 2006 15/53 5/52 3.1 % 2.94 [ 1.15, 7.51 ]
Ershoff 1989 33/126 20/116 8.9 % 1.52 [ 0.93, 2.49 ]
Ershoff 1999 (AvC) 21/101 25/111 8.5 % 0.92 [ 0.55, 1.54 ]
Lee 2015 21/140 16/137 6.6 % 1.28 [ 0.70, 2.35 ]
Secker-Walker 1997 5/21 0/28 0.4 % 14.50 [ 0.85, 248.56 ]
Subtotal (95% CI) 483 484 29.0 % 1.37 [ 0.89, 2.12 ]
Total events: 98 (Experimental), 71 (Control)
Heterogeneity: Tau2 = 0.12; Chi2 = 9.29, df = 5 (P = 0.10); I2 =46%
Test for overall effect: Z = 1.41 (P = 0.16)
2 Multiple interventions
Cook 1995 8/23 2/20 1.4 % 3.48 [ 0.83, 14.52 ]
Parker 2007 (AvC) 77/358 72/378 17.2 % 1.13 [ 0.85, 1.50 ]
Patten 2009 0/16 1/17 0.3 % 0.35 [ 0.02, 8.08 ]
Rigotti 2006 21/209 16/212 6.3 % 1.33 [ 0.71, 2.48 ]
Secker-Walker 1998 19/142 14/149 5.9 % 1.42 [ 0.74, 2.73 ]
Stotts 2002 27/134 28/135 9.6 % 0.97 [ 0.61, 1.56 ]
Windsor 1993 57/400 35/414 12.0 % 1.69 [ 1.13, 2.51 ]
Windsor 2011 65/547 55/546 14.5 % 1.18 [ 0.84, 1.66 ]
Subtotal (95% CI) 1829 1871 67.2 % 1.25 [ 1.06, 1.47 ]
Total events: 274 (Experimental), 223 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 6.67, df = 7 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 2.62 (P = 0.0087)
3 Tailored interventions
Walsh 1997 17/127 7/125 3.8 % 2.39 [ 1.03, 5.56 ]
Subtotal (95% CI) 127 125 3.8 % 2.39 [ 1.03, 5.56 ]
Total events: 17 (Experimental), 7 (Control)
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(. . . Continued)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Heterogeneity: not applicable
Test for overall effect: Z = 2.02 (P = 0.043)
Total (95% CI) 2439 2480 100.0 % 1.31 [ 1.10, 1.56 ]
Total events: 389 (Experimental), 301 (Control)
Heterogeneity: Tau2 = 0.02; Chi2 = 18.16, df = 14 (P = 0.20); I2 =23%
Test for overall effect: Z = 3.07 (P = 0.0021)
Test for subgroup differences: Chi2 = 2.30, df = 2 (P = 0.32), I2 =13%
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Analysis 2.3. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 3 Continued abstinence (relapse prevention) in late pregnancy (spontaneous quitters).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 3 Continued abstinence (relapse prevention) in late pregnancy (spontaneous quitters)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Dornelas 2006 10/14 16/19 2.8 % 0.85 [ 0.58, 1.25 ]
Ershoff 1989 73/87 67/84 20.7 % 1.05 [ 0.91, 1.21 ]
McBride 2004 (AvB) 89/105 85/107 26.2 % 1.07 [ 0.94, 1.21 ]
Subtotal (95% CI) 206 210 49.7 % 1.05 [ 0.96, 1.15 ]
Total events: 172 (Experimental), 168 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.25, df = 2 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 0.99 (P = 0.32)
2 Multiple interventions
McBride 1999 225/259 110/137 45.5 % 1.08 [ 0.98, 1.19 ]
Secker-Walker 1998 28/44 33/48 4.8 % 0.93 [ 0.69, 1.24 ]
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(. . . Continued)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Subtotal (95% CI) 303 185 50.3 % 1.06 [ 0.96, 1.17 ]
Total events: 253 (Experimental), 143 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 1.04, df = 1 (P = 0.31); I2 =4%
Test for overall effect: Z = 1.21 (P = 0.23)
Total (95% CI) 509 395 100.0 % 1.06 [ 0.99, 1.13 ]
Total events: 425 (Experimental), 311 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.35, df = 4 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 1.67 (P = 0.095)
Test for subgroup differences: Chi2 = 0.05, df = 1 (P = 0.82), I2 =0.0%
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Analysis 2.4. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 4 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 4 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Cinciripini 2000 2/42 3/40 1.5 % 0.63 [ 0.11, 3.60 ]
Lee 2015 25/140 16/137 11.1 % 1.53 [ 0.85, 2.74 ]
McBride 2004 (AvB) 62/192 65/198 29.1 % 0.98 [ 0.74, 1.31 ]
Subtotal (95% CI) 374 375 41.7 % 1.07 [ 0.81, 1.42 ]
Total events: 89 (Experimental), 84 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 2.14, df = 2 (P = 0.34); I2 =6%
Test for overall effect: Z = 0.48 (P = 0.63)
2 Multiple interventions
McBride 1999 222/600 89/297 39.2 % 1.23 [ 1.01, 1.51 ]
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(. . . Continued)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Messimer 1989 3/30 3/29 1.9 % 0.97 [ 0.21, 4.41 ]
Rigotti 2006 14/209 15/212 8.0 % 0.95 [ 0.47, 1.91 ]
Stotts 2002 14/134 14/135 8.1 % 1.01 [ 0.50, 2.03 ]
Subtotal (95% CI) 973 673 57.2 % 1.19 [ 0.99, 1.43 ]
Total events: 253 (Experimental), 121 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.83, df = 3 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 1.83 (P = 0.067)
3 Tailored interventions
Walsh 1997 13/127 1/125 1.1 % 12.80 [ 1.70, 96.35 ]
Subtotal (95% CI) 127 125 1.1 % 12.80 [ 1.70, 96.35 ]
Total events: 13 (Experimental), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.47 (P = 0.013)
Total (95% CI) 1474 1173 100.0 % 1.15 [ 0.93, 1.43 ]
Total events: 355 (Experimental), 206 (Control)
Heterogeneity: Tau2 = 0.02; Chi2 = 9.09, df = 7 (P = 0.25); I2 =23%
Test for overall effect: Z = 1.30 (P = 0.19)
Test for subgroup differences: Chi2 = 5.79, df = 2 (P = 0.06), I2 =65%
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Analysis 2.5. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 5 Abstinence at 6 to 11 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 5 Abstinence at 6 to 11 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Dornelas 2006 5/53 2/52 1.3 % 2.45 [ 0.50, 12.08 ]
McBride 2004 (AvB) 59/192 55/198 33.3 % 1.11 [ 0.81, 1.51 ]
Subtotal (95% CI) 245 250 34.6 % 1.14 [ 0.84, 1.54 ]
Total events: 64 (Experimental), 57 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.93, df = 1 (P = 0.33); I2 =0.0%
Test for overall effect: Z = 0.84 (P = 0.40)
2 Multiple interventions
McBride 1999 172/600 77/297 60.2 % 1.11 [ 0.88, 1.39 ]
Stotts 2002 10/134 14/135 5.3 % 0.72 [ 0.33, 1.56 ]
Subtotal (95% CI) 734 432 65.4 % 1.05 [ 0.80, 1.38 ]
Total events: 182 (Experimental), 91 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 1.09, df = 1 (P = 0.30); I2 =8%
Test for overall effect: Z = 0.37 (P = 0.71)
Total (95% CI) 979 682 100.0 % 1.09 [ 0.91, 1.31 ]
Total events: 246 (Experimental), 148 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.12, df = 3 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 0.97 (P = 0.33)
Test for subgroup differences: Chi2 = 0.14, df = 1 (P = 0.70), I2 =0.0%
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Analysis 2.6. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 6 Abstinence at 12 to 17 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 6 Abstinence at 12 to 17 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
McBride 2004 (AvB) 49/192 47/198 34.7 % 1.08 [ 0.76, 1.52 ]
Subtotal (95% CI) 192 198 34.7 % 1.08 [ 0.76, 1.52 ]
Total events: 49 (Experimental), 47 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.41 (P = 0.68)
2 Multiple interventions
McBride 1999 145/600 71/297 53.5 % 1.01 [ 0.79, 1.29 ]
Secker-Walker 1998 21/142 12/149 11.8 % 1.84 [ 0.94, 3.59 ]
Subtotal (95% CI) 742 446 65.3 % 1.25 [ 0.71, 2.20 ]
Total events: 166 (Experimental), 83 (Control)
Heterogeneity: Tau2 = 0.11; Chi2 = 2.69, df = 1 (P = 0.10); I2 =63%
Test for overall effect: Z = 0.78 (P = 0.43)
Total (95% CI) 934 644 100.0 % 1.11 [ 0.87, 1.41 ]
Total events: 215 (Experimental), 130 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 2.69, df = 2 (P = 0.26); I2 =26%
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Chi2 = 0.20, df = 1 (P = 0.65), I2 =0.0%
0.01 0.1 1 10 100
Favours [control] Favours [experimental]
387Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.7. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 7 Reduction in late pregnancy: biochemically validated.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 7 Reduction in late pregnancy: biochemically validated
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Cook 1995 6/23 4/20 8.4 % 1.30 [ 0.43, 3.97 ]
Windsor 1993 67/400 51/414 91.6 % 1.36 [ 0.97, 1.91 ]
Total (95% CI) 423 434 100.0 % 1.35 [ 0.98, 1.87 ]
Total events: 73 (Experimental), 55 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 1.84 (P = 0.065)
Test for subgroup differences: Not applicable
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Analysis 2.8. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 8 Reduction in late pregnancy: self-reported > 50%.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 8 Reduction in late pregnancy: self-reported > 50%
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Rigotti 2006 61/209 46/212 50.8 % 1.35 [ 0.97, 1.87 ]
Windsor 1993 67/400 51/414 49.2 % 1.36 [ 0.97, 1.91 ]
Total (95% CI) 609 626 100.0 % 1.35 [ 1.07, 1.71 ]
Total events: 128 (Experimental), 97 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 2.50 (P = 0.012)
Test for subgroup differences: Not applicable
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Analysis 2.9. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 9 Mean cigarettes per day in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 9 Mean cigarettes per day in late pregnancy
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Ershoff 1999 (AvC) 60 8.1 (8) 61 8 (8) 30.6 % 0.01 [ -0.34, 0.37 ]
Subtotal (95% CI) 60 61 30.6 % 0.01 [ -0.34, 0.37 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.07 (P = 0.95)
2 Multiple interventions
Secker-Walker 1998 135 10.2 (8.4) 141 11.5 (7.8) 69.4 % -0.16 [ -0.40, 0.08 ]
Subtotal (95% CI) 135 141 69.4 % -0.16 [ -0.40, 0.08 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.33 (P = 0.18)
Total (95% CI) 195 202 100.0 % -0.11 [ -0.30, 0.09 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.62, df = 1 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 1.07 (P = 0.29)
Test for subgroup differences: Chi2 = 0.62, df = 1 (P = 0.43), I2 =0.0%
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Analysis 2.10. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 10 Low birthweight infants (< 2500 g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 10 Low birthweight infants (< 2500 g)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Ershoff 1989 9/118 15/109 56.9 % 0.55 [ 0.25, 1.21 ]
Subtotal (95% CI) 118 109 56.9 % 0.55 [ 0.25, 1.21 ]
Total events: 9 (Experimental), 15 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.47 (P = 0.14)
2 Multiple interventions
Secker-Walker 1998 7/135 12/141 43.1 % 0.61 [ 0.25, 1.50 ]
Subtotal (95% CI) 135 141 43.1 % 0.61 [ 0.25, 1.50 ]
Total events: 7 (Experimental), 12 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.08 (P = 0.28)
Total (95% CI) 253 250 100.0 % 0.58 [ 0.32, 1.04 ]
Total events: 16 (Experimental), 27 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 1.82 (P = 0.069)
Test for subgroup differences: Chi2 = 0.02, df = 1 (P = 0.88), I2 =0.0%
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Analysis 2.11. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 11 Preterm births.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 11 Preterm births
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Ershoff 1989 9/118 15/109 50.0 % 0.55 [ 0.25, 1.21 ]
Subtotal (95% CI) 118 109 50.0 % 0.55 [ 0.25, 1.21 ]
Total events: 9 (Experimental), 15 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.47 (P = 0.14)
2 Multiple interventions
Secker-Walker 1998 9/151 8/157 35.9 % 1.17 [ 0.46, 2.95 ]
Subtotal (95% CI) 151 157 35.9 % 1.17 [ 0.46, 2.95 ]
Total events: 9 (Experimental), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.33 (P = 0.74)
3 Tailored interventions
Walsh 1997 4/131 3/128 14.1 % 1.30 [ 0.30, 5.71 ]
Subtotal (95% CI) 131 128 14.1 % 1.30 [ 0.30, 5.71 ]
Total events: 4 (Experimental), 3 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.35 (P = 0.73)
Total (95% CI) 400 394 100.0 % 0.82 [ 0.47, 1.42 ]
Total events: 22 (Experimental), 26 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.90, df = 2 (P = 0.39); I2 =0.0%
Test for overall effect: Z = 0.71 (P = 0.48)
Test for subgroup differences: Chi2 = 1.90, df = 2 (P = 0.39), I2 =0.0%
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Analysis 2.12. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 12 Mean birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 12 Mean birthweight
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Ershoff 1989 118 3366 (578) 109 3309 (578) 33.8 % 57.00 [ -93.50, 207.50 ]
Subtotal (95% CI) 118 109 33.8 % 57.00 [ -93.50, 207.50 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.74 (P = 0.46)
2 Multiple interventions
Cook 1995 23 2961 (578) 20 2713 (578) 6.4 % 248.00 [ -98.36, 594.36 ]
Secker-Walker 1998 135 3256 (452) 141 3221 (506) 59.8 % 35.00 [ -78.09, 148.09 ]
Subtotal (95% CI) 158 161 66.2 % 76.01 [ -88.59, 240.61 ]
Heterogeneity: Tau2 = 5405.09; Chi2 = 1.31, df = 1 (P = 0.25); I2 =24%
Test for overall effect: Z = 0.91 (P = 0.37)
Total (95% CI) 276 270 100.0 % 56.02 [ -31.46, 143.50 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.31, df = 2 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 1.26 (P = 0.21)
Test for subgroup differences: Chi2 = 0.03, df = 1 (P = 0.87), I2 =0.0%
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Analysis 2.13. Comparison 2 Smoking cessation interventions: counselling vs less intensive intervention,
Outcome 13 Stillbirths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 2 Smoking cessation interventions: counselling vs less intensive intervention
Outcome: 13 Stillbirths
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Ershoff 1989 2/126 1/116 100.0 % 1.84 [ 0.17, 20.04 ]
Total (95% CI) 126 116 100.0 % 1.84 [ 0.17, 20.04 ]
Total events: 2 (Experimental), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.62)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Smoking cessation interventions: counselling vs alternative intervention,
Outcome 1 Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 3 Smoking cessation interventions: counselling vs alternative intervention
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Cinciripini 2010 58/128 51/129 100.0 % 1.15 [ 0.86, 1.53 ]
Total (95% CI) 128 129 100.0 % 1.15 [ 0.86, 1.53 ]
Total events: 58 (Experimental), 51 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.93 (P = 0.35)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 Smoking cessation interventions: counselling vs alternative intervention,
Outcome 2 Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 3 Smoking cessation interventions: counselling vs alternative intervention
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Cinciripini 2010 58/128 51/129 100.0 % 1.15 [ 0.86, 1.53 ]
Total (95% CI) 128 129 100.0 % 1.15 [ 0.86, 1.53 ]
Total events: 58 (Experimental), 51 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.93 (P = 0.35)
Test for subgroup differences: Not applicable
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Analysis 3.3. Comparison 3 Smoking cessation interventions: counselling vs alternative intervention,
Outcome 3 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 3 Smoking cessation interventions: counselling vs alternative intervention
Outcome: 3 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Cinciripini 2010 24/128 23/129 100.0 % 1.05 [ 0.63, 1.76 ]
Total (95% CI) 128 129 100.0 % 1.05 [ 0.63, 1.76 ]
Total events: 24 (Experimental), 23 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.19 (P = 0.85)
Test for subgroup differences: Not applicable
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Analysis 3.4. Comparison 3 Smoking cessation interventions: counselling vs alternative intervention,
Outcome 4 Abstinence at 6 to 11 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 3 Smoking cessation interventions: counselling vs alternative intervention
Outcome: 4 Abstinence at 6 to 11 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Cinciripini 2010 9/128 12/129 100.0 % 0.76 [ 0.33, 1.73 ]
Total (95% CI) 128 129 100.0 % 0.76 [ 0.33, 1.73 ]
Total events: 9 (Experimental), 12 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
Test for subgroup differences: Not applicable
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Analysis 4.1. Comparison 4 Smoking cessation interventions: health education vs usual care, Outcome 1
Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 4 Smoking cessation interventions: health education vs usual care
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Burling 1991 9/70 4/69 17.4 % 2.22 [ 0.72, 6.86 ]
Mayer 1990 (AvB) 5/70 2/77 8.6 % 2.75 [ 0.55, 13.72 ]
Ondersma 2012 (A+C v B+D) 14/55 7/53 32.6 % 1.93 [ 0.84, 4.40 ]
Peterson 1992 9/43 11/47 36.7 % 0.89 [ 0.41, 1.95 ]
Subtotal (95% CI) 238 246 95.3 % 1.53 [ 0.93, 2.49 ]
Total events: 37 (Experimental), 24 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 3.08, df = 3 (P = 0.38); I2 =3%
Test for overall effect: Z = 1.68 (P = 0.092)
2 Multiple interventions
Lilley 1986 4/72 1/73 4.7 % 4.06 [ 0.46, 35.41 ]
Subtotal (95% CI) 72 73 4.7 % 4.06 [ 0.46, 35.41 ]
Total events: 4 (Experimental), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.27 (P = 0.21)
Total (95% CI) 310 319 100.0 % 1.59 [ 0.99, 2.55 ]
Total events: 41 (Experimental), 25 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 3.86, df = 4 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 1.93 (P = 0.053)
Test for subgroup differences: Chi2 = 0.74, df = 1 (P = 0.39), I2 =0.0%
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Analysis 4.2. Comparison 4 Smoking cessation interventions: health education vs usual care, Outcome 2
Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 4 Smoking cessation interventions: health education vs usual care
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Burling 1991 9/70 4/69 22.2 % 2.22 [ 0.72, 6.86 ]
Ondersma 2012 (A+C v B+D) 14/55 7/53 37.2 % 1.93 [ 0.84, 4.40 ]
Peterson 1992 9/43 11/47 40.7 % 0.89 [ 0.41, 1.95 ]
Total (95% CI) 168 169 100.0 % 1.45 [ 0.82, 2.58 ]
Total events: 32 (Experimental), 22 (Control)
Heterogeneity: Tau2 = 0.05; Chi2 = 2.50, df = 2 (P = 0.29); I2 =20%
Test for overall effect: Z = 1.28 (P = 0.20)
Test for subgroup differences: Not applicable
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Analysis 4.3. Comparison 4 Smoking cessation interventions: health education vs usual care, Outcome 3
Continued abstinence (Relapse prevention) in late pregnancy for spontaneous quitters.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 4 Smoking cessation interventions: health education vs usual care
Outcome: 3 Continued abstinence (Relapse prevention) in late pregnancy for spontaneous quitters
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Peterson 1992 30/34 31/36 100.0 % 1.02 [ 0.86, 1.23 ]
Total (95% CI) 34 36 100.0 % 1.02 [ 0.86, 1.23 ]
Total events: 30 (Experimental), 31 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.27 (P = 0.79)
Test for subgroup differences: Not applicable
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Analysis 4.4. Comparison 4 Smoking cessation interventions: health education vs usual care, Outcome 4
Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 4 Smoking cessation interventions: health education vs usual care
Outcome: 4 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Mayer 1990 (AvB) 5/70 0/77 12.1 % 12.08 [ 0.68, 214.66 ]
Peterson 1992 11/43 4/47 87.9 % 3.01 [ 1.03, 8.74 ]
Total (95% CI) 113 124 100.0 % 3.56 [ 1.31, 9.67 ]
Total events: 16 (Experimental), 4 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.85, df = 1 (P = 0.36); I2 =0.0%
Test for overall effect: Z = 2.49 (P = 0.013)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours [control] Favours [experimental]
401Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 4.5. Comparison 4 Smoking cessation interventions: health education vs usual care, Outcome 5
Mean cigarettes per day in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 4 Smoking cessation interventions: health education vs usual care
Outcome: 5 Mean cigarettes per day in late pregnancy
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Donovan 1977 263 9.2 (9.7304) 289 16.4 (10.2) 56.8 % -0.72 [ -0.89, -0.55 ]
Subtotal (95% CI) 263 289 56.8 % -0.72 [ -0.89, -0.55 ]
Heterogeneity: not applicable
Test for overall effect: Z = 8.19 (P < 0.00001)
2 Multiple interventions
Lilley 1986 66 13.1 (9.1) 69 16 (9.1) 43.2 % -0.32 [ -0.66, 0.02 ]
Subtotal (95% CI) 66 69 43.2 % -0.32 [ -0.66, 0.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.83 (P = 0.067)
Total (95% CI) 329 358 100.0 % -0.55 [ -0.94, -0.15 ]
Heterogeneity: Tau2 = 0.06; Chi2 = 4.31, df = 1 (P = 0.04); I2 =77%
Test for overall effect: Z = 2.73 (P = 0.0063)
Test for subgroup differences: Chi2 = 4.31, df = 1 (P = 0.04), I2 =77%
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Analysis 4.6. Comparison 4 Smoking cessation interventions: health education vs usual care, Outcome 6
Low birth weight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 4 Smoking cessation interventions: health education vs usual care
Outcome: 6 Low birth weight
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Donovan 1977 26/263 26/289 100.0 % 1.10 [ 0.66, 1.84 ]
Total (95% CI) 263 289 100.0 % 1.10 [ 0.66, 1.84 ]
Total events: 26 (Experimental), 26 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.36 (P = 0.72)
Test for subgroup differences: Not applicable
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Analysis 4.7. Comparison 4 Smoking cessation interventions: health education vs usual care, Outcome 7
Preterm births (< 37 weeks).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 4 Smoking cessation interventions: health education vs usual care
Outcome: 7 Preterm births (< 37 weeks)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Donovan 1977 16/263 17/289 100.0 % 1.03 [ 0.53, 2.00 ]
Total (95% CI) 263 289 100.0 % 1.03 [ 0.53, 2.00 ]
Total events: 16 (Experimental), 17 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.10 (P = 0.92)
Test for subgroup differences: Not applicable
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Analysis 4.8. Comparison 4 Smoking cessation interventions: health education vs usual care, Outcome 8
Mean birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 4 Smoking cessation interventions: health education vs usual care
Outcome: 8 Mean birthweight
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Single interventions
Donovan 1977 263 3172 (567) 289 3184 (510) 100.0 % -12.00 [ -102.29, 78.29 ]
Total (95% CI) 263 289 100.0 % -12.00 [ -102.29, 78.29 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.26 (P = 0.79)
Test for subgroup differences: Not applicable
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Analysis 4.9. Comparison 4 Smoking cessation interventions: health education vs usual care, Outcome 9
Perinatal deaths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 4 Smoking cessation interventions: health education vs usual care
Outcome: 9 Perinatal deaths
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Donovan 1977 4/263 1/289 100.0 % 4.40 [ 0.49, 39.08 ]
Total (95% CI) 263 289 100.0 % 4.40 [ 0.49, 39.08 ]
Total events: 4 (Experimental), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.33 (P = 0.18)
Test for subgroup differences: Not applicable
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Analysis 5.1. Comparison 5 Smoking cessation interventions: health education vs less intensive
intervention, Outcome 1 Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 5 Smoking cessation interventions: health education vs less intensive intervention
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Herbec 2014 28/99 21/101 29.9 % 1.36 [ 0.83, 2.23 ]
Hjalmarson 1991 56/444 18/209 29.0 % 1.46 [ 0.88, 2.43 ]
Subtotal (95% CI) 543 310 58.9 % 1.41 [ 0.99, 2.01 ]
Total events: 84 (Experimental), 39 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.04, df = 1 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 1.91 (P = 0.056)
2 Multiple interventions
Naughton 2012 12/96 8/102 13.6 % 1.59 [ 0.68, 3.73 ]
Subtotal (95% CI) 96 102 13.6 % 1.59 [ 0.68, 3.73 ]
Total events: 12 (Experimental), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.07 (P = 0.28)
3 Tailored interventions
Ershoff 1999 (AvB) 20/120 25/111 27.4 % 0.74 [ 0.44, 1.26 ]
Subtotal (95% CI) 120 111 27.4 % 0.74 [ 0.44, 1.26 ]
Total events: 20 (Experimental), 25 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
Total (95% CI) 759 523 100.0 % 1.20 [ 0.85, 1.70 ]
Total events: 116 (Experimental), 72 (Control)
Heterogeneity: Tau2 = 0.04; Chi2 = 4.50, df = 3 (P = 0.21); I2 =33%
Test for overall effect: Z = 1.04 (P = 0.30)
Test for subgroup differences: Chi2 = 4.45, df = 2 (P = 0.11), I2 =55%
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Analysis 5.2. Comparison 5 Smoking cessation interventions: health education vs less intensive
intervention, Outcome 2 Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 5 Smoking cessation interventions: health education vs less intensive intervention
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Hjalmarson 1991 56/444 18/209 39.3 % 1.46 [ 0.88, 2.43 ]
Subtotal (95% CI) 444 209 39.3 % 1.46 [ 0.88, 2.43 ]
Total events: 56 (Experimental), 18 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.48 (P = 0.14)
2 Multiple interventions
Naughton 2012 12/96 8/102 22.8 % 1.59 [ 0.68, 3.73 ]
Subtotal (95% CI) 96 102 22.8 % 1.59 [ 0.68, 3.73 ]
Total events: 12 (Experimental), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.07 (P = 0.28)
3 Tailored interventions
Ershoff 1999 (AvB) 20/120 25/111 37.9 % 0.74 [ 0.44, 1.26 ]
Subtotal (95% CI) 120 111 37.9 % 0.74 [ 0.44, 1.26 ]
Total events: 20 (Experimental), 25 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
Total (95% CI) 660 422 100.0 % 1.15 [ 0.70, 1.91 ]
Total events: 88 (Experimental), 51 (Control)
Heterogeneity: Tau2 = 0.10; Chi2 = 4.13, df = 2 (P = 0.13); I2 =52%
Test for overall effect: Z = 0.55 (P = 0.58)
Test for subgroup differences: Chi2 = 4.11, df = 2 (P = 0.13), I2 =51%
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Analysis 5.3. Comparison 5 Smoking cessation interventions: health education vs less intensive
intervention, Outcome 3 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 5 Smoking cessation interventions: health education vs less intensive intervention
Outcome: 3 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Hjalmarson 1991 70/444 19/209 77.3 % 1.73 [ 1.07, 2.80 ]
Strecher 2000 10/104 8/87 22.7 % 1.05 [ 0.43, 2.53 ]
Subtotal (95% CI) 548 296 100.0 % 1.55 [ 1.01, 2.36 ]
Total events: 80 (Experimental), 27 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.97, df = 1 (P = 0.32); I2 =0.0%
Test for overall effect: Z = 2.03 (P = 0.043)
Test for subgroup differences: Not applicable
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Analysis 5.4. Comparison 5 Smoking cessation interventions: health education vs less intensive
intervention, Outcome 4 Mean cigarettes per day in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 5 Smoking cessation interventions: health education vs less intensive intervention
Outcome: 4 Mean cigarettes per day in late pregnancy
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Tailored interventions
Ershoff 1999 (AvB) 66 7.3 (7.3) 61 8 (8) 100.0 % -0.70 [ -3.37, 1.97 ]
Total (95% CI) 66 61 100.0 % -0.70 [ -3.37, 1.97 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.51 (P = 0.61)
Test for subgroup differences: Not applicable
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Analysis 5.5. Comparison 5 Smoking cessation interventions: health education vs less intensive
intervention, Outcome 5 Low birthweight (< 2500 g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 5 Smoking cessation interventions: health education vs less intensive intervention
Outcome: 5 Low birthweight (< 2500 g)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Hjalmarson 1991 14/422 11/198 100.0 % 0.60 [ 0.28, 1.29 ]
Total (95% CI) 422 198 100.0 % 0.60 [ 0.28, 1.29 ]
Total events: 14 (Experimental), 11 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.31 (P = 0.19)
Test for subgroup differences: Not applicable
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Analysis 5.6. Comparison 5 Smoking cessation interventions: health education vs less intensive
intervention, Outcome 6 Preterm births.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 5 Smoking cessation interventions: health education vs less intensive intervention
Outcome: 6 Preterm births
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Hjalmarson 1991 13/421 8/197 100.0 % 0.76 [ 0.32, 1.80 ]
Total (95% CI) 421 197 100.0 % 0.76 [ 0.32, 1.80 ]
Total events: 13 (Experimental), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.62 (P = 0.53)
Test for subgroup differences: Not applicable
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Analysis 5.7. Comparison 5 Smoking cessation interventions: health education vs less intensive
intervention, Outcome 7 Mean birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 5 Smoking cessation interventions: health education vs less intensive intervention
Outcome: 7 Mean birthweight
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Single interventions
Hjalmarson 1991 422 3430 (578) 198 3359 (578) 100.0 % 71.00 [ -26.58, 168.58 ]
Total (95% CI) 422 198 100.0 % 71.00 [ -26.58, 168.58 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.43 (P = 0.15)
Test for subgroup differences: Not applicable
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Analysis 6.1. Comparison 6 Smoking cessation interventions: health education vs alternative intervention,
Outcome 1 Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 6 Smoking cessation interventions: health education vs alternative intervention
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Pollak 2013 2/16 1/15 100.0 % 1.88 [ 0.19, 18.60 ]
Total (95% CI) 16 15 100.0 % 1.88 [ 0.19, 18.60 ]
Total events: 2 (Experimental), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.54 (P = 0.59)
Test for subgroup differences: Not applicable
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Analysis 6.2. Comparison 6 Smoking cessation interventions: health education vs alternative intervention,
Outcome 2 Abstinence in late pregnancy: biochemically validated.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 6 Smoking cessation interventions: health education vs alternative intervention
Outcome: 2 Abstinence in late pregnancy: biochemically validated
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Pollak 2013 2/16 1/15 100.0 % 1.88 [ 0.19, 18.60 ]
Total (95% CI) 16 15 100.0 % 1.88 [ 0.19, 18.60 ]
Total events: 2 (Experimental), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.54 (P = 0.59)
Test for subgroup differences: Not applicable
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Analysis 7.1. Comparison 7 Smoking cessation interventions: feedback vs usual care, Outcome 1
Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 7 Smoking cessation interventions: feedback vs usual care
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Cope 2003 22/143 4/101 66.6 % 3.88 [ 1.38, 10.93 ]
Valbo 1994 11/55 2/56 33.4 % 5.60 [ 1.30, 24.11 ]
Total (95% CI) 198 157 100.0 % 4.39 [ 1.89, 10.21 ]
Total events: 33 (Experimental), 6 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.16, df = 1 (P = 0.69); I2 =0.0%
Test for overall effect: Z = 3.43 (P = 0.00059)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours [control] Favours [experimental]
413Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 7.2. Comparison 7 Smoking cessation interventions: feedback vs usual care, Outcome 2
Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 7 Smoking cessation interventions: feedback vs usual care
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Cope 2003 22/143 4/101 100.0 % 3.88 [ 1.38, 10.93 ]
Total (95% CI) 143 101 100.0 % 3.88 [ 1.38, 10.93 ]
Total events: 22 (Experimental), 4 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.57 (P = 0.010)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours [control] Favours [experimental]
414Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 7.3. Comparison 7 Smoking cessation interventions: feedback vs usual care, Outcome 3 Reduction
in late pregnancy: biochemically validated.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 7 Smoking cessation interventions: feedback vs usual care
Outcome: 3 Reduction in late pregnancy: biochemically validated
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Cope 2003 42/143 20/101 100.0 % 1.48 [ 0.93, 2.37 ]
Total (95% CI) 143 101 100.0 % 1.48 [ 0.93, 2.37 ]
Total events: 42 (Experimental), 20 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.65 (P = 0.098)
Test for subgroup differences: Not applicable
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Analysis 7.4. Comparison 7 Smoking cessation interventions: feedback vs usual care, Outcome 4 Reduction
in late pregnancy: self-reported (various definitions).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 7 Smoking cessation interventions: feedback vs usual care
Outcome: 4 Reduction in late pregnancy: self-reported (various definitions)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Valbo 1994 35/55 19/56 100.0 % 1.88 [ 1.24, 2.84 ]
Total (95% CI) 55 56 100.0 % 1.88 [ 1.24, 2.84 ]
Total events: 35 (Experimental), 19 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.96 (P = 0.0031)
Test for subgroup differences: Not applicable
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Analysis 7.5. Comparison 7 Smoking cessation interventions: feedback vs usual care, Outcome 5 Mean
cigarettes per day in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 7 Smoking cessation interventions: feedback vs usual care
Outcome: 5 Mean cigarettes per day in late pregnancy
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Multiple interventions
Valbo 1994 54 8 (4.1) 50 11 (4.6) 100.0 % -3.00 [ -4.68, -1.32 ]
Total (95% CI) 54 50 100.0 % -3.00 [ -4.68, -1.32 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.50 (P = 0.00046)
Test for subgroup differences: Not applicable
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Analysis 7.6. Comparison 7 Smoking cessation interventions: feedback vs usual care, Outcome 6 Low
birthweight (< 2500 g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 7 Smoking cessation interventions: feedback vs usual care
Outcome: 6 Low birthweight (< 2500 g)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Haddow 1991 99/1423 121/1425 100.0 % 0.82 [ 0.63, 1.06 ]
Total (95% CI) 1423 1425 100.0 % 0.82 [ 0.63, 1.06 ]
Total events: 99 (Experimental), 121 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.53 (P = 0.13)
Test for subgroup differences: Not applicable
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Analysis 7.7. Comparison 7 Smoking cessation interventions: feedback vs usual care, Outcome 7 Preterm
births.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 7 Smoking cessation interventions: feedback vs usual care
Outcome: 7 Preterm births
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Cope 2003 6/149 13/114 33.9 % 0.35 [ 0.14, 0.90 ]
Haddow 1991 109/1423 137/1425 66.1 % 0.80 [ 0.63, 1.01 ]
Total (95% CI) 1572 1539 100.0 % 0.60 [ 0.28, 1.29 ]
Total events: 115 (Experimental), 150 (Control)
Heterogeneity: Tau2 = 0.21; Chi2 = 2.72, df = 1 (P = 0.10); I2 =63%
Test for overall effect: Z = 1.31 (P = 0.19)
Test for subgroup differences: Not applicable
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Analysis 7.8. Comparison 7 Smoking cessation interventions: feedback vs usual care, Outcome 8 Mean
birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 7 Smoking cessation interventions: feedback vs usual care
Outcome: 8 Mean birthweight
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Multiple interventions
Cope 2003 78 3260 (578) 80 3080 (578) 31.1 % 180.00 [ -0.27, 360.27 ]
Haddow 1991 1423 3263 (542) 1425 3229 (537) 68.9 % 34.00 [ -5.63, 73.63 ]
Total (95% CI) 1501 1505 100.0 % 79.43 [ -53.05, 211.91 ]
Heterogeneity: Tau2 = 6224.01; Chi2 = 2.40, df = 1 (P = 0.12); I2 =58%
Test for overall effect: Z = 1.18 (P = 0.24)
Test for subgroup differences: Not applicable
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Analysis 7.9. Comparison 7 Smoking cessation interventions: feedback vs usual care, Outcome 9 Stillbirths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 7 Smoking cessation interventions: feedback vs usual care
Outcome: 9 Stillbirths
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Haddow 1991 21/1423 17/1425 96.2 % 1.24 [ 0.66, 2.33 ]
Valbo 1994 1/56 0/56 3.8 % 3.00 [ 0.12, 72.10 ]
Total (95% CI) 1479 1481 100.0 % 1.28 [ 0.69, 2.39 ]
Total events: 22 (Treatment), 17 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.29, df = 1 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.78 (P = 0.44)
Test for subgroup differences: Not applicable
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Analysis 8.1. Comparison 8 Smoking cessation interventions: feedback vs less intensive intervention,
Outcome 1 Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 8 Smoking cessation interventions: feedback vs less intensive intervention
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Bauman 1983 3/36 6/43 16.7 % 0.60 [ 0.16, 2.22 ]
Stotts 2009 (AvB) 17/120 6/60 37.4 % 1.42 [ 0.59, 3.41 ]
Subtotal (95% CI) 156 103 54.1 % 1.06 [ 0.48, 2.36 ]
Total events: 20 (Experimental), 12 (Control)
Heterogeneity: Tau2 = 0.05; Chi2 = 1.15, df = 1 (P = 0.28); I2 =13%
Test for overall effect: Z = 0.15 (P = 0.88)
2 Multiple interventions
Stotts 2009 (AvC) 22/120 7/60 45.9 % 1.57 [ 0.71, 3.47 ]
Subtotal (95% CI) 120 60 45.9 % 1.57 [ 0.71, 3.47 ]
Total events: 22 (Experimental), 7 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
Total (95% CI) 276 163 100.0 % 1.29 [ 0.75, 2.20 ]
Total events: 42 (Experimental), 19 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.60, df = 2 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Chi2 = 0.47, df = 1 (P = 0.49), I2 =0.0%
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Analysis 8.2. Comparison 8 Smoking cessation interventions: feedback vs less intensive intervention,
Outcome 2 Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 8 Smoking cessation interventions: feedback vs less intensive intervention
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Bauman 1983 3/36 6/43 16.7 % 0.60 [ 0.16, 2.22 ]
Stotts 2009 (AvB) 17/120 6/60 37.4 % 1.42 [ 0.59, 3.41 ]
Subtotal (95% CI) 156 103 54.1 % 1.06 [ 0.48, 2.36 ]
Total events: 20 (Experimental), 12 (Control)
Heterogeneity: Tau2 = 0.05; Chi2 = 1.15, df = 1 (P = 0.28); I2 =13%
Test for overall effect: Z = 0.15 (P = 0.88)
2 Multiple interventions
Stotts 2009 (AvC) 22/120 7/60 45.9 % 1.57 [ 0.71, 3.47 ]
Subtotal (95% CI) 120 60 45.9 % 1.57 [ 0.71, 3.47 ]
Total events: 22 (Experimental), 7 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
Total (95% CI) 276 163 100.0 % 1.29 [ 0.75, 2.20 ]
Total events: 42 (Experimental), 19 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.60, df = 2 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Chi2 = 0.47, df = 1 (P = 0.49), I2 =0.0%
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Analysis 9.1. Comparison 9 Smoking cessation interventions: incentives vs usual care, Outcome 1
Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 9 Smoking cessation interventions: incentives vs usual care
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tappin 2015 69/316 26/313 97.2 % 2.63 [ 1.72, 4.01 ]
Tuten 2012 (AvB) 0/28 0/16 Not estimable
Tuten 2012 (AvC) 13/42 0/16 2.8 % 10.67 [ 0.67, 169.71 ]
Subtotal (95% CI) 386 345 100.0 % 2.73 [ 1.72, 4.35 ]
Total events: 82 (Experimental), 26 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 1.01, df = 1 (P = 0.31); I2 =1%
Test for overall effect: Z = 4.25 (P = 0.000022)
2 Multiple interventions
Ondersma 2012 (AvD) 4/29 2/12 100.0 % 0.83 [ 0.17, 3.93 ]
Subtotal (95% CI) 29 12 100.0 % 0.83 [ 0.17, 3.93 ]
Total events: 4 (Experimental), 2 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.24 (P = 0.81)
3 Tailored interventions
Ondersma 2012 (AvC) 3/28 2/13 100.0 % 0.70 [ 0.13, 3.68 ]
Subtotal (95% CI) 28 13 100.0 % 0.70 [ 0.13, 3.68 ]
Total events: 3 (Experimental), 2 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.43 (P = 0.67)
Test for subgroup differences: Chi2 = 4.16, df = 2 (P = 0.12), I2 =52%
0.01 0.1 1 10 100
Favours [control] Favours [experimental]
423Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 9.2. Comparison 9 Smoking cessation interventions: incentives vs usual care, Outcome 2
Abstinence in late pregnancy:biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 9 Smoking cessation interventions: incentives vs usual care
Outcome: 2 Abstinence in late pregnancy:biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tappin 2015 69/316 26/313 97.2 % 2.63 [ 1.72, 4.01 ]
Tuten 2012 (AvB) 0/28 0/16 Not estimable
Tuten 2012 (AvC) 13/42 0/16 2.8 % 10.67 [ 0.67, 169.71 ]
Subtotal (95% CI) 386 345 100.0 % 2.73 [ 1.72, 4.35 ]
Total events: 82 (Experimental), 26 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 1.01, df = 1 (P = 0.31); I2 =1%
Test for overall effect: Z = 4.25 (P = 0.000022)
2 Multiple interventions
Ondersma 2012 (AvD) 4/29 2/12 100.0 % 0.83 [ 0.17, 3.93 ]
Subtotal (95% CI) 29 12 100.0 % 0.83 [ 0.17, 3.93 ]
Total events: 4 (Experimental), 2 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.24 (P = 0.81)
3 Tailored interventions
Ondersma 2012 (AvC) 3/28 2/13 100.0 % 0.70 [ 0.13, 3.68 ]
Subtotal (95% CI) 28 13 100.0 % 0.70 [ 0.13, 3.68 ]
Total events: 3 (Experimental), 2 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.43 (P = 0.67)
Test for subgroup differences: Chi2 = 4.16, df = 2 (P = 0.12), I2 =52%
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Analysis 9.3. Comparison 9 Smoking cessation interventions: incentives vs usual care, Outcome 3
Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 9 Smoking cessation interventions: incentives vs usual care
Outcome: 3 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Higgins 2014 (AvB) 7/32 7/39 50.7 % 1.22 [ 0.48, 3.11 ]
Higgins 2014 (AvC) 7/40 7/39 49.3 % 0.98 [ 0.38, 2.52 ]
Total (95% CI) 72 78 100.0 % 1.09 [ 0.56, 2.13 ]
Total events: 14 (Experimental), 14 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.11, df = 1 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 0.26 (P = 0.80)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours [control] Favours [experimental]
425Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 9.4. Comparison 9 Smoking cessation interventions: incentives vs usual care, Outcome 4
Abstinence at 6 to 11 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 9 Smoking cessation interventions: incentives vs usual care
Outcome: 4 Abstinence at 6 to 11 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tappin 2015 47/306 12/303 100.0 % 3.88 [ 2.10, 7.16 ]
Total (95% CI) 306 303 100.0 % 3.88 [ 2.10, 7.16 ]
Total events: 47 (Experimental), 12 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 4.33 (P = 0.000015)
Test for subgroup differences: Not applicable
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Analysis 9.5. Comparison 9 Smoking cessation interventions: incentives vs usual care, Outcome 5
Reduction in late pregnancy: biochemically validated.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 9 Smoking cessation interventions: incentives vs usual care
Outcome: 5 Reduction in late pregnancy: biochemically validated
Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tuten 2012 (AvB) 0/28 1/16 0.20 [ 0.01, 4.53 ]
Tuten 2012 (AvC) 20/42 0/16 16.21 [ 1.04, 253.21 ]
0.01 0.1 1 10 100
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Analysis 9.6. Comparison 9 Smoking cessation interventions: incentives vs usual care, Outcome 6
Biochemical measures in late pregnancy: mean cotinine.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 9 Smoking cessation interventions: incentives vs usual care
Outcome: 6 Biochemical measures in late pregnancy: mean cotinine
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Tuten 2012 (AvB) 28 8.7 (2.8) 16 8.4 (4.2) 51.0 % 0.30 [ -2.00, 2.60 ]
Tuten 2012 (AvC) 42 4 (5.5) 16 8.4 (4.2) 49.0 % -4.40 [ -7.05, -1.75 ]
Total (95% CI) 70 32 100.0 % -2.00 [ -6.61, 2.60 ]
Heterogeneity: Tau2 = 9.44; Chi2 = 6.89, df = 1 (P = 0.01); I2 =85%
Test for overall effect: Z = 0.85 (P = 0.39)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours experimental Favours control
Analysis 9.7. Comparison 9 Smoking cessation interventions: incentives vs usual care, Outcome 7 Mean
cigarettes per day in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 9 Smoking cessation interventions: incentives vs usual care
Outcome: 7 Mean cigarettes per day in late pregnancy
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Tuten 2012 (AvC) 42 8.7 (5.6) 32 16.9 (5.8) 100.0 % -8.20 [ -10.83, -5.57 ]
Total (95% CI) 42 32 100.0 % -8.20 [ -10.83, -5.57 ]
Heterogeneity: not applicable
Test for overall effect: Z = 6.12 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 9.8. Comparison 9 Smoking cessation interventions: incentives vs usual care, Outcome 8 Low
birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 9 Smoking cessation interventions: incentives vs usual care
Outcome: 8 Low birthweight
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tuten 2012 (AvB) 6/17 5/11 37.6 % 0.78 [ 0.31, 1.93 ]
Tuten 2012 (AvC) 6/30 4/10 28.8 % 0.50 [ 0.18, 1.42 ]
Subtotal (95% CI) 47 21 66.3 % 0.64 [ 0.32, 1.28 ]
Total events: 12 (Experimental), 9 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.39, df = 1 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 1.27 (P = 0.21)
2 Multiple interventions
Higgins 2014 (AvB) 3/38 4/36 15.4 % 0.71 [ 0.17, 2.96 ]
Higgins 2014 (AvC) 4/37 4/36 18.3 % 0.97 [ 0.26, 3.60 ]
Subtotal (95% CI) 75 72 33.7 % 0.84 [ 0.32, 2.21 ]
Total events: 7 (Experimental), 8 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.10, df = 1 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 0.35 (P = 0.73)
Total (95% CI) 122 93 100.0 % 0.70 [ 0.40, 1.23 ]
Total events: 19 (Experimental), 17 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.70, df = 3 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 1.23 (P = 0.22)
Test for subgroup differences: Chi2 = 0.20, df = 1 (P = 0.65), I2 =0.0%
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Analysis 9.9. Comparison 9 Smoking cessation interventions: incentives vs usual care, Outcome 9 Preterm
births.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 9 Smoking cessation interventions: incentives vs usual care
Outcome: 9 Preterm births
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tappin 2015 40/265 26/273 56.6 % 1.58 [ 1.00, 2.52 ]
Tuten 2012 (AvB) 6/17 3/11 14.0 % 1.29 [ 0.41, 4.13 ]
Tuten 2012 (AvC) 5/30 3/10 12.4 % 0.56 [ 0.16, 1.92 ]
Subtotal (95% CI) 312 294 83.0 % 1.30 [ 0.77, 2.18 ]
Total events: 51 (Experimental), 32 (Control)
Heterogeneity: Tau2 = 0.05; Chi2 = 2.44, df = 2 (P = 0.30); I2 =18%
Test for overall effect: Z = 0.98 (P = 0.33)
2 Multiple interventions
Higgins 2014 (AvB) 2/38 4/36 7.4 % 0.47 [ 0.09, 2.43 ]
Higgins 2014 (AvC) 3/37 4/36 9.6 % 0.73 [ 0.18, 3.03 ]
Subtotal (95% CI) 75 72 17.0 % 0.61 [ 0.21, 1.77 ]
Total events: 5 (Experimental), 8 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.15, df = 1 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 0.92 (P = 0.36)
Total (95% CI) 387 366 100.0 % 1.15 [ 0.73, 1.82 ]
Total events: 56 (Experimental), 40 (Control)
Heterogeneity: Tau2 = 0.04; Chi2 = 4.56, df = 4 (P = 0.34); I2 =12%
Test for overall effect: Z = 0.59 (P = 0.55)
Test for subgroup differences: Chi2 = 1.57, df = 1 (P = 0.21), I2 =36%
0.01 0.1 1 10 100
Favours experimental Favours control
429Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 9.10. Comparison 9 Smoking cessation interventions: incentives vs usual care, Outcome 10 Mean
birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 9 Smoking cessation interventions: incentives vs usual care
Outcome: 10 Mean birthweight
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Tappin 2015 295 3140 (600) 287 3102 (590) 18.3 % 38.00 [ -58.68, 134.68 ]
Tuten 2012 (AvB) 17 2696 (657) 11 2701 (598) 1.1 % -5.00 [ -476.62, 466.62 ]
Tuten 2012 (AvC) 30 2863 (694) 10 2701 (598) 1.2 % 162.00 [ -284.14, 608.14 ]
Subtotal (95% CI) 342 308 20.5 % 41.69 [ -50.96, 134.33 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.32, df = 2 (P = 0.85); I2 =0.0%
Test for overall effect: Z = 0.88 (P = 0.38)
2 Multiple interventions
Higgins 2014 (AvB) 38 3344.8 (101.9) 36 3188.6 (105) 40.1 % 156.20 [ 109.02, 203.38 ]
Higgins 2014 (AvC) 37 3284.9 (105.8) 36 3188.6 (105) 39.4 % 96.30 [ 47.94, 144.66 ]
Subtotal (95% CI) 75 72 79.5 % 126.49 [ 67.80, 185.19 ]
Heterogeneity: Tau2 = 1199.86; Chi2 = 3.02, df = 1 (P = 0.08); I2 =67%
Test for overall effect: Z = 4.22 (P = 0.000024)
Total (95% CI) 417 380 100.0 % 109.38 [ 60.51, 158.26 ]
Heterogeneity: Tau2 = 970.53; Chi2 = 6.22, df = 4 (P = 0.18); I2 =36%
Test for overall effect: Z = 4.39 (P = 0.000012)
Test for subgroup differences: Chi2 = 2.30, df = 1 (P = 0.13), I2 =56%
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Analysis 9.11. Comparison 9 Smoking cessation interventions: incentives vs usual care, Outcome 11 NICU
admissions.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 9 Smoking cessation interventions: incentives vs usual care
Outcome: 11 NICU admissions
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Tuten 2012 (AvB) 9/17 7/11 50.1 % 0.83 [ 0.44, 1.57 ]
Tuten 2012 (AvC) 14/30 6/10 49.9 % 0.78 [ 0.41, 1.47 ]
Total (95% CI) 47 21 100.0 % 0.80 [ 0.51, 1.26 ]
Total events: 23 (Experimental), 13 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.02, df = 1 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 0.95 (P = 0.34)
Test for subgroup differences: Not applicable
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Analysis 10.1. Comparison 10 Smoking cessation interventions: incentives vs less intensive intervention,
Outcome 1 Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 10 Smoking cessation interventions: incentives vs less intensive intervention
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Glover 2014 (AvB) 0/8 1/4 1.2 % 0.19 [ 0.01, 3.75 ]
Glover 2014 (AvC) 2/8 0/4 1.3 % 2.78 [ 0.16, 47.20 ]
Parker 2007 (AvB) 51/329 72/378 97.5 % 0.81 [ 0.59, 1.13 ]
Subtotal (95% CI) 345 386 100.0 % 0.81 [ 0.59, 1.12 ]
Total events: 53 (Experimental), 73 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.65, df = 2 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 1.26 (P = 0.21)
2 Multiple interventions
Donatelle 2000 34/112 9/108 100.0 % 3.64 [ 1.84, 7.23 ]
Subtotal (95% CI) 112 108 100.0 % 3.64 [ 1.84, 7.23 ]
Total events: 34 (Experimental), 9 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 3.70 (P = 0.00022)
Test for subgroup differences: Chi2 = 15.05, df = 1 (P = 0.00), I2 =93%
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Analysis 10.2. Comparison 10 Smoking cessation interventions: incentives vs less intensive intervention,
Outcome 2 Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 10 Smoking cessation interventions: incentives vs less intensive intervention
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Glover 2014 (AvB) 0/8 1/4 1.2 % 0.19 [ 0.01, 3.75 ]
Glover 2014 (AvC) 2/8 0/4 1.3 % 2.78 [ 0.16, 47.20 ]
Parker 2007 (AvB) 51/329 72/378 97.5 % 0.81 [ 0.59, 1.13 ]
Subtotal (95% CI) 345 386 100.0 % 0.81 [ 0.59, 1.12 ]
Total events: 53 (Experimental), 73 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.65, df = 2 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 1.26 (P = 0.21)
2 Multiple interventions
Donatelle 2000 34/112 9/108 100.0 % 3.64 [ 1.84, 7.23 ]
Subtotal (95% CI) 112 108 100.0 % 3.64 [ 1.84, 7.23 ]
Total events: 34 (Experimental), 9 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 3.70 (P = 0.00022)
Test for subgroup differences: Chi2 = 15.05, df = 1 (P = 0.00), I2 =93%
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Analysis 10.3. Comparison 10 Smoking cessation interventions: incentives vs less intensive intervention,
Outcome 3 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 10 Smoking cessation interventions: incentives vs less intensive intervention
Outcome: 3 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Donatelle 2000 22/103 6/102 100.0 % 3.63 [ 1.54, 8.58 ]
Total (95% CI) 103 102 100.0 % 3.63 [ 1.54, 8.58 ]
Total events: 22 (Experimental), 6 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.94 (P = 0.0033)
Test for subgroup differences: Not applicable
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Analysis 11.1. Comparison 11 Smoking cessation interventions: incentives vs alternative intervention,
Outcome 1 Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Smoking cessation interventions: incentives vs alternative intervention
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Harris 2015 2/7 3/10 13.3 % 0.95 [ 0.21, 4.29 ]
Heil 2008 15/37 4/40 29.6 % 4.05 [ 1.48, 11.11 ]
Subtotal (95% CI) 44 50 42.9 % 2.19 [ 0.53, 9.04 ]
Total events: 17 (Experimental), 7 (Control)
Heterogeneity: Tau2 = 0.64; Chi2 = 2.50, df = 1 (P = 0.11); I2 =60%
Test for overall effect: Z = 1.09 (P = 0.28)
2 Multiple interventions
Higgins 2014 (AvB) 14/39 4/20 31.9 % 1.79 [ 0.68, 4.74 ]
Higgins 2014 (AvC) 18/40 3/19 25.2 % 2.85 [ 0.95, 8.51 ]
Subtotal (95% CI) 79 39 57.1 % 2.20 [ 1.06, 4.55 ]
Total events: 32 (Experimental), 7 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.39, df = 1 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 2.13 (P = 0.033)
Total (95% CI) 123 89 100.0 % 2.36 [ 1.36, 4.09 ]
Total events: 49 (Experimental), 14 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.96, df = 3 (P = 0.40); I2 =0.0%
Test for overall effect: Z = 3.07 (P = 0.0022)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 1.00), I2 =0.0%
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Analysis 11.2. Comparison 11 Smoking cessation interventions: incentives vs alternative intervention,
Outcome 2 Abstinence in late pregnancy: biochemicaly validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Smoking cessation interventions: incentives vs alternative intervention
Outcome: 2 Abstinence in late pregnancy: biochemicaly validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Harris 2015 2/7 3/10 13.3 % 0.95 [ 0.21, 4.29 ]
Heil 2008 15/37 4/40 29.6 % 4.05 [ 1.48, 11.11 ]
Subtotal (95% CI) 44 50 42.9 % 2.19 [ 0.53, 9.04 ]
Total events: 17 (Experimental), 7 (Control)
Heterogeneity: Tau2 = 0.64; Chi2 = 2.50, df = 1 (P = 0.11); I2 =60%
Test for overall effect: Z = 1.09 (P = 0.28)
2 Multiple interventions
Higgins 2014 (AvB) 14/39 4/20 31.9 % 1.79 [ 0.68, 4.74 ]
Higgins 2014 (AvC) 18/40 3/19 25.2 % 2.85 [ 0.95, 8.51 ]
Subtotal (95% CI) 79 39 57.1 % 2.20 [ 1.06, 4.55 ]
Total events: 32 (Experimental), 7 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.39, df = 1 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 2.13 (P = 0.033)
Total (95% CI) 123 89 100.0 % 2.36 [ 1.36, 4.09 ]
Total events: 49 (Experimental), 14 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.96, df = 3 (P = 0.40); I2 =0.0%
Test for overall effect: Z = 3.07 (P = 0.0022)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 1.00), I2 =0.0%
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Analysis 11.3. Comparison 11 Smoking cessation interventions: incentives vs alternative intervention,
Outcome 3 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Smoking cessation interventions: incentives vs alternative intervention
Outcome: 3 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Heil 2008 9/37 1/40 21.4 % 9.73 [ 1.29, 73.13 ]
Subtotal (95% CI) 37 40 21.4 % 9.73 [ 1.29, 73.13 ]
Total events: 9 (Experimental), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 2.21 (P = 0.027)
2 Multiple interventions
Higgins 2014 (AvB) 9/39 4/20 41.9 % 1.15 [ 0.40, 3.29 ]
Higgins 2014 (AvC) 7/40 3/19 36.7 % 1.11 [ 0.32, 3.82 ]
Subtotal (95% CI) 79 39 78.6 % 1.13 [ 0.51, 2.52 ]
Total events: 16 (Experimental), 7 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 0.31 (P = 0.76)
Total (95% CI) 116 79 100.0 % 1.79 [ 0.57, 5.61 ]
Total events: 25 (Experimental), 8 (Control)
Heterogeneity: Tau2 = 0.52; Chi2 = 4.18, df = 2 (P = 0.12); I2 =52%
Test for overall effect: Z = 1.00 (P = 0.32)
Test for subgroup differences: Chi2 = 3.77, df = 1 (P = 0.05), I2 =73%
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Analysis 11.4. Comparison 11 Smoking cessation interventions: incentives vs alternative intervention,
Outcome 4 Abstinence at 6 to 11 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Smoking cessation interventions: incentives vs alternative intervention
Outcome: 4 Abstinence at 6 to 11 months postpartum
Study or subgroup Experimental Control
Risk
Ratio(Non-
event) Weight
Risk
Ratio(Non-
event)
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Heil 2008 3/37 1/40 60.1 % 0.94 [ 0.85, 1.05 ]
Subtotal (95% CI) 37 40 60.1 % 0.94 [ 0.85, 1.05 ]
Total events: 3 (Experimental), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.08 (P = 0.28)
2 Multiple interventions
Higgins 2014 (AvB) 6/39 2/20 17.8 % 0.94 [ 0.77, 1.15 ]
Higgins 2014 (AvC) 7/40 1/19 22.1 % 0.87 [ 0.73, 1.04 ]
Subtotal (95% CI) 79 39 39.9 % 0.90 [ 0.79, 1.03 ]
Total events: 13 (Experimental), 3 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.32, df = 1 (P = 0.57); I2 =0.0%
Test for overall effect: Z = 1.54 (P = 0.12)
Total (95% CI) 116 79 100.0 % 0.93 [ 0.85, 1.01 ]
Total events: 16 (Experimental), 4 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.60, df = 2 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 1.81 (P = 0.070)
Test for subgroup differences: Chi2 = 0.27, df = 1 (P = 0.61), I2 =0.0%
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Analysis 11.5. Comparison 11 Smoking cessation interventions: incentives vs alternative intervention,
Outcome 5 Smoking reduction: numbers of women reducing smoking in late pregnancy (biochemically
validated).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Smoking cessation interventions: incentives vs alternative intervention
Outcome: 5 Smoking reduction: numbers of women reducing smoking in late pregnancy (biochemically validated)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Harris 2015 2/7 4/10 100.0 % 0.71 [ 0.18, 2.88 ]
Total (95% CI) 7 10 100.0 % 0.71 [ 0.18, 2.88 ]
Total events: 2 (Experimental), 4 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.47 (P = 0.64)
Test for subgroup differences: Not applicable
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Analysis 11.6. Comparison 11 Smoking cessation interventions: incentives vs alternative intervention,
Outcome 6 Low birthweight (under 2500 g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Smoking cessation interventions: incentives vs alternative intervention
Outcome: 6 Low birthweight (under 2500 g)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Single interventions
Heil 2008 3/34 8/39 58.0 % 0.43 [ 0.12, 1.49 ]
Subtotal (95% CI) 34 39 58.0 % 0.43 [ 0.12, 1.49 ]
Total events: 3 (Experimental), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.33 (P = 0.18)
2 Multiple interventions
Higgins 2014 (AvB) 3/38 2/18 21.1 % 0.71 [ 0.13, 3.89 ]
Higgins 2014 (AvC) 4/37 2/18 20.9 % 0.97 [ 0.20, 4.82 ]
Subtotal (95% CI) 75 36 42.0 % 0.84 [ 0.26, 2.69 ]
Total events: 7 (Experimental), 4 (Control)
Heterogeneity: Chi2 = 0.07, df = 1 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 0.29 (P = 0.77)
Total (95% CI) 109 75 100.0 % 0.60 [ 0.26, 1.40 ]
Total events: 10 (Experimental), 12 (Control)
Heterogeneity: Chi2 = 0.66, df = 2 (P = 0.72); I2 =0.0%
Test for overall effect: Z = 1.18 (P = 0.24)
Test for subgroup differences: Chi2 = 0.60, df = 1 (P = 0.44), I2 =0.0%
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Analysis 11.7. Comparison 11 Smoking cessation interventions: incentives vs alternative intervention,
Outcome 7 Preterm birth (under 37 weeks).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Smoking cessation interventions: incentives vs alternative intervention
Outcome: 7 Preterm birth (under 37 weeks)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Heil 2008 3/34 9/39 51.5 % 0.38 [ 0.11, 1.30 ]
Subtotal (95% CI) 34 39 51.5 % 0.38 [ 0.11, 1.30 ]
Total events: 3 (Experimental), 9 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.54 (P = 0.12)
2 Multiple interventions
Higgins 2014 (AvB) 2/38 2/18 21.8 % 0.47 [ 0.07, 3.10 ]
Higgins 2014 (AvC) 3/37 2/18 26.7 % 0.73 [ 0.13, 3.99 ]
Subtotal (95% CI) 75 36 48.5 % 0.60 [ 0.17, 2.12 ]
Total events: 5 (Experimental), 4 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.11, df = 1 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 0.79 (P = 0.43)
Total (95% CI) 109 75 100.0 % 0.48 [ 0.20, 1.14 ]
Total events: 8 (Experimental), 13 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.37, df = 2 (P = 0.83); I2 =0.0%
Test for overall effect: Z = 1.66 (P = 0.097)
Test for subgroup differences: Chi2 = 0.25, df = 1 (P = 0.61), I2 =0.0%
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Analysis 11.8. Comparison 11 Smoking cessation interventions: incentives vs alternative intervention,
Outcome 8 Mean birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Smoking cessation interventions: incentives vs alternative intervention
Outcome: 8 Mean birthweight
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Heil 2008 34 3355 (560) 39 3102 (556) 4.9 % 253.00 [ -3.67, 509.67 ]
Subtotal (95% CI) 34 39 4.9 % 253.00 [ -3.67, 509.67 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.93 (P = 0.053)
2 Multiple interventions
Higgins 2014 (AvB) 38 3348.8 (101.9) 18 3188.6 (105) 47.9 % 160.20 [ 101.87, 218.53 ]
Higgins 2014 (AvC) 37 3284.9 (105.8) 18 3188.6 (105) 47.2 % 96.30 [ 37.01, 155.59 ]
Subtotal (95% CI) 75 36 95.1 % 128.48 [ 65.86, 191.10 ]
Heterogeneity: Tau2 = 1141.21; Chi2 = 2.27, df = 1 (P = 0.13); I2 =56%
Test for overall effect: Z = 4.02 (P = 0.000058)
Total (95% CI) 109 75 100.0 % 134.58 [ 76.32, 192.83 ]
Heterogeneity: Tau2 = 956.92; Chi2 = 3.14, df = 2 (P = 0.21); I2 =36%
Test for overall effect: Z = 4.53 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.85, df = 1 (P = 0.36), I2 =0.0%
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Analysis 11.9. Comparison 11 Smoking cessation interventions: incentives vs alternative intervention,
Outcome 9 NICU admissions.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 11 Smoking cessation interventions: incentives vs alternative intervention
Outcome: 9 NICU admissions
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Heil 2008 4/34 6/39 57.6 % 0.76 [ 0.24, 2.49 ]
Subtotal (95% CI) 34 39 57.6 % 0.76 [ 0.24, 2.49 ]
Total events: 4 (Experimental), 6 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.45 (P = 0.66)
2 Multiple interventions
Higgins 2014 (AvB) 1/38 2/18 14.7 % 0.24 [ 0.02, 2.44 ]
Higgins 2014 (AvC) 3/37 2/18 27.7 % 0.73 [ 0.13, 3.99 ]
Subtotal (95% CI) 75 36 42.4 % 0.49 [ 0.13, 1.95 ]
Total events: 4 (Experimental), 4 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.59, df = 1 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 1.01 (P = 0.31)
Total (95% CI) 109 75 100.0 % 0.64 [ 0.26, 1.55 ]
Total events: 8 (Experimental), 10 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.81, df = 2 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 0.99 (P = 0.32)
Test for subgroup differences: Chi2 = 0.22, df = 1 (P = 0.64), I2 =0.0%
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Analysis 12.1. Comparison 12 Smoking cessation interventions: social support vs less intensive
intervention, Outcome 1 Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 12 Smoking cessation interventions: social support vs less intensive intervention
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Hennrikus 2010 7/54 1/28 1.7 % 3.63 [ 0.47, 28.05 ]
Malchodi 2003 16/67 16/75 19.3 % 1.12 [ 0.61, 2.06 ]
Subtotal (95% CI) 121 103 21.0 % 1.35 [ 0.57, 3.18 ]
Total events: 23 (Experimental), 17 (Control)
Heterogeneity: Tau2 = 0.13; Chi2 = 1.22, df = 1 (P = 0.27); I2 =18%
Test for overall effect: Z = 0.68 (P = 0.50)
2 Multiple interventions
Albrecht 1998 3/26 5/58 3.9 % 1.34 [ 0.35, 5.19 ]
Albrecht 2006 (AvB) 12/47 4/25 6.9 % 1.60 [ 0.57, 4.44 ]
Albrecht 2006 (AvC) 17/45 3/25 5.7 % 3.15 [ 1.02, 9.70 ]
McBride 2004 (AvC) 33/89 33/91 48.7 % 1.02 [ 0.70, 1.50 ]
Subtotal (95% CI) 207 199 65.2 % 1.35 [ 0.83, 2.18 ]
Total events: 65 (Experimental), 45 (Control)
Heterogeneity: Tau2 = 0.07; Chi2 = 4.01, df = 3 (P = 0.26); I2 =25%
Test for overall effect: Z = 1.22 (P = 0.22)
3 Tailored interventions
Solomon 2000 14/77 11/74 13.8 % 1.22 [ 0.59, 2.52 ]
Subtotal (95% CI) 77 74 13.8 % 1.22 [ 0.59, 2.52 ]
Total events: 14 (Experimental), 11 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.55 (P = 0.58)
Total (95% CI) 405 376 100.0 % 1.21 [ 0.93, 1.58 ]
Total events: 102 (Experimental), 73 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 5.20, df = 6 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 1.40 (P = 0.16)
Test for subgroup differences: Chi2 = 0.05, df = 2 (P = 0.97), I2 =0.0%
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Analysis 12.2. Comparison 12 Smoking cessation interventions: social support vs less intensive
intervention, Outcome 2 Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 12 Smoking cessation interventions: social support vs less intensive intervention
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Hennrikus 2010 7/54 1/28 3.4 % 3.63 [ 0.47, 28.05 ]
Malchodi 2003 16/67 16/75 37.7 % 1.12 [ 0.61, 2.06 ]
Subtotal (95% CI) 121 103 41.1 % 1.35 [ 0.57, 3.18 ]
Total events: 23 (Experimental), 17 (Control)
Heterogeneity: Tau2 = 0.13; Chi2 = 1.22, df = 1 (P = 0.27); I2 =18%
Test for overall effect: Z = 0.68 (P = 0.50)
2 Multiple interventions
Albrecht 1998 3/26 5/58 7.6 % 1.34 [ 0.35, 5.19 ]
Albrecht 2006 (AvB) 12/47 4/25 13.4 % 1.60 [ 0.57, 4.44 ]
Albrecht 2006 (AvC) 17/45 3/25 11.1 % 3.15 [ 1.02, 9.70 ]
Subtotal (95% CI) 118 108 32.1 % 1.93 [ 1.00, 3.74 ]
Total events: 32 (Experimental), 12 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.16, df = 2 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 1.96 (P = 0.050)
3 Tailored interventions
Solomon 2000 14/77 11/74 26.9 % 1.22 [ 0.59, 2.52 ]
Subtotal (95% CI) 77 74 26.9 % 1.22 [ 0.59, 2.52 ]
Total events: 14 (Experimental), 11 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.55 (P = 0.58)
Total (95% CI) 316 285 100.0 % 1.42 [ 0.98, 2.07 ]
Total events: 69 (Experimental), 40 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 3.63, df = 5 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 1.84 (P = 0.066)
Test for subgroup differences: Chi2 = 0.93, df = 2 (P = 0.63), I2 =0.0%
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Analysis 12.3. Comparison 12 Smoking cessation interventions: social support vs less intensive
intervention, Outcome 3 Continued abstinence (relapse prevention) in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 12 Smoking cessation interventions: social support vs less intensive intervention
Outcome: 3 Continued abstinence (relapse prevention) in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Albrecht 2006 (AvC) 84/104 85/107 100.0 % 1.02 [ 0.89, 1.16 ]
Total (95% CI) 104 107 100.0 % 1.02 [ 0.89, 1.16 ]
Total events: 84 (Experimental), 85 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
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Analysis 12.4. Comparison 12 Smoking cessation interventions: social support vs less intensive
intervention, Outcome 4 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 12 Smoking cessation interventions: social support vs less intensive intervention
Outcome: 4 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Hennrikus 2010 5/54 0/28 17.5 % 5.80 [ 0.33, 101.27 ]
Subtotal (95% CI) 54 28 17.5 % 5.80 [ 0.33, 101.27 ]
Total events: 5 (Experimental), 0 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.20 (P = 0.23)
2 Multiple interventions
McBride 2004 (AvC) 62/192 65/198 82.5 % 0.98 [ 0.74, 1.31 ]
Subtotal (95% CI) 192 198 82.5 % 0.98 [ 0.74, 1.31 ]
Total events: 62 (Experimental), 65 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.91)
Total (95% CI) 246 226 100.0 % 1.34 [ 0.35, 5.14 ]
Total events: 67 (Experimental), 65 (Control)
Heterogeneity: Tau2 = 0.55; Chi2 = 1.51, df = 1 (P = 0.22); I2 =34%
Test for overall effect: Z = 0.43 (P = 0.67)
Test for subgroup differences: Chi2 = 1.46, df = 1 (P = 0.23), I2 =32%
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Analysis 12.5. Comparison 12 Smoking cessation interventions: social support vs less intensive
intervention, Outcome 5 Abstinence at 6 to 11 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 12 Smoking cessation interventions: social support vs less intensive intervention
Outcome: 5 Abstinence at 6 to 11 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Albrecht 2006 (AvB) 8/47 4/25 7.0 % 1.06 [ 0.35, 3.19 ]
Albrecht 2006 (AvC) 4/45 3/25 4.2 % 0.74 [ 0.18, 3.05 ]
McBride 2004 (AvC) 59/193 55/198 88.7 % 1.10 [ 0.81, 1.50 ]
Total (95% CI) 285 248 100.0 % 1.08 [ 0.81, 1.44 ]
Total events: 71 (Experimental), 62 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.29, df = 2 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.52 (P = 0.61)
Test for subgroup differences: Not applicable
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Analysis 12.6. Comparison 12 Smoking cessation interventions: social support vs less intensive
intervention, Outcome 6 Abstinence at 12 to 17 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 12 Smoking cessation interventions: social support vs less intensive intervention
Outcome: 6 Abstinence at 12 to 17 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
McBride 2004 (AvC) 49/193 47/198 100.0 % 1.07 [ 0.76, 1.51 ]
Total (95% CI) 193 198 100.0 % 1.07 [ 0.76, 1.51 ]
Total events: 49 (Experimental), 47 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.38 (P = 0.70)
Test for subgroup differences: Not applicable
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Analysis 12.7. Comparison 12 Smoking cessation interventions: social support vs less intensive
intervention, Outcome 7 Smoking reduction: self reported > 50% reduction.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 12 Smoking cessation interventions: social support vs less intensive intervention
Outcome: 7 Smoking reduction: self reported > 50% reduction
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Tailored interventions
Solomon 2000 29/77 29/74 100.0 % 0.96 [ 0.64, 1.44 ]
Total (95% CI) 77 74 100.0 % 0.96 [ 0.64, 1.44 ]
Total events: 29 (Experimental), 29 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.19 (P = 0.85)
Test for subgroup differences: Not applicable
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Analysis 12.8. Comparison 12 Smoking cessation interventions: social support vs less intensive
intervention, Outcome 8 Low birthweight (< 2500 g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 12 Smoking cessation interventions: social support vs less intensive intervention
Outcome: 8 Low birthweight (< 2500 g)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Malchodi 2003 5/36 6/43 100.0 % 1.00 [ 0.33, 2.99 ]
Total (95% CI) 36 43 100.0 % 1.00 [ 0.33, 2.99 ]
Total events: 5 (Experimental), 6 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.01 (P = 0.99)
Test for subgroup differences: Not applicable
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Analysis 12.9. Comparison 12 Smoking cessation interventions: social support vs less intensive
intervention, Outcome 9 Mean birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 12 Smoking cessation interventions: social support vs less intensive intervention
Outcome: 9 Mean birthweight
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Single interventions
Malchodi 2003 67 3100 (481) 75 3072 (614) 100.0 % 28.00 [ -152.48, 208.48 ]
Total (95% CI) 67 75 100.0 % 28.00 [ -152.48, 208.48 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
Test for subgroup differences: Not applicable
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Analysis 13.1. Comparison 13 Smoking cessation interventions: exercise vs usual care, Outcome 1
Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 13 Smoking cessation interventions: exercise vs usual care
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Ussher 2015 30/392 25/393 100.0 % 1.20 [ 0.72, 2.01 ]
Total (95% CI) 392 393 100.0 % 1.20 [ 0.72, 2.01 ]
Total events: 30 (Experimental), 25 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.71 (P = 0.48)
Test for subgroup differences: Not applicable
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Analysis 13.2. Comparison 13 Smoking cessation interventions: exercise vs usual care, Outcome 2
Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 13 Smoking cessation interventions: exercise vs usual care
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Ussher 2015 30/392 25/393 100.0 % 1.20 [ 0.72, 2.01 ]
Total (95% CI) 392 393 100.0 % 1.20 [ 0.72, 2.01 ]
Total events: 30 (Experimental), 25 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.71 (P = 0.48)
Test for subgroup differences: Not applicable
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Analysis 13.3. Comparison 13 Smoking cessation interventions: exercise vs usual care, Outcome 3
Abstinence at 6 to 11 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 13 Smoking cessation interventions: exercise vs usual care
Outcome: 3 Abstinence at 6 to 11 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Ussher 2015 24/392 16/393 100.0 % 1.50 [ 0.81, 2.79 ]
Total (95% CI) 392 393 100.0 % 1.50 [ 0.81, 2.79 ]
Total events: 24 (Experimental), 16 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.30 (P = 0.19)
Test for subgroup differences: Not applicable
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Analysis 13.4. Comparison 13 Smoking cessation interventions: exercise vs usual care, Outcome 4 Low
birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 13 Smoking cessation interventions: exercise vs usual care
Outcome: 4 Low birthweight
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Ussher 2015 38/353 44/359 100.0 % 0.88 [ 0.58, 1.32 ]
Total (95% CI) 353 359 100.0 % 0.88 [ 0.58, 1.32 ]
Total events: 38 (Experimental), 44 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.62 (P = 0.53)
Test for subgroup differences: Not applicable
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Analysis 13.5. Comparison 13 Smoking cessation interventions: exercise vs usual care, Outcome 5 Preterm
births.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 13 Smoking cessation interventions: exercise vs usual care
Outcome: 5 Preterm births
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Ussher 2015 35/356 26/348 100.0 % 1.32 [ 0.81, 2.14 ]
Total (95% CI) 356 348 100.0 % 1.32 [ 0.81, 2.14 ]
Total events: 35 (Experimental), 26 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.11 (P = 0.27)
Test for subgroup differences: Not applicable
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Analysis 13.6. Comparison 13 Smoking cessation interventions: exercise vs usual care, Outcome 6 Mean
birthweight.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 13 Smoking cessation interventions: exercise vs usual care
Outcome: 6 Mean birthweight
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Ussher 2015 354 3132.4 (581.7) 359 3146.8 (640) 100.0 % -14.40 [ -104.15, 75.35 ]
Total (95% CI) 354 359 100.0 % -14.40 [ -104.15, 75.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.31 (P = 0.75)
Test for subgroup differences: Not applicable
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Analysis 13.7. Comparison 13 Smoking cessation interventions: exercise vs usual care, Outcome 7
Stillbirths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 13 Smoking cessation interventions: exercise vs usual care
Outcome: 7 Stillbirths
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Ussher 2015 2/377 2/379 100.0 % 1.01 [ 0.14, 7.10 ]
Total (95% CI) 377 379 100.0 % 1.01 [ 0.14, 7.10 ]
Total events: 2 (Experimental), 2 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.01 (P = 1.0)
Test for subgroup differences: Not applicable
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Analysis 13.8. Comparison 13 Smoking cessation interventions: exercise vs usual care, Outcome 8
Neonatal deaths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 13 Smoking cessation interventions: exercise vs usual care
Outcome: 8 Neonatal deaths
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Ussher 2015 0/384 1/391 100.0 % 0.34 [ 0.01, 8.31 ]
Total (95% CI) 384 391 100.0 % 0.34 [ 0.01, 8.31 ]
Total events: 0 (Experimental), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
Test for subgroup differences: Not applicable
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Analysis 14.1. Comparison 14 Smoking cessation interventions: other vs usual care, Outcome 1 Abstinence
in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 14 Smoking cessation interventions: other vs usual care
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Campbell 2006 10/98 6/96 100.0 % 1.63 [ 0.62, 4.32 ]
Total (95% CI) 98 96 100.0 % 1.63 [ 0.62, 4.32 ]
Total events: 10 (Experimental), 6 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.99 (P = 0.32)
Test for subgroup differences: Not applicable
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Analysis 14.2. Comparison 14 Smoking cessation interventions: other vs usual care, Outcome 2 Abstinence
in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 14 Smoking cessation interventions: other vs usual care
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Campbell 2006 10/98 6/96 100.0 % 1.63 [ 0.62, 4.32 ]
Total (95% CI) 98 96 100.0 % 1.63 [ 0.62, 4.32 ]
Total events: 10 (Experimental), 6 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.99 (P = 0.32)
Test for subgroup differences: Not applicable
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Analysis 15.1. Comparison 15 Maternal health intervention with smoking cessation component: counselling
vs usual care, Outcome 1 Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 15 Maternal health intervention with smoking cessation component: counselling vs usual care
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single
El-Mohandes 2011 44/106 38/92 80.1 % 1.00 [ 0.72, 1.40 ]
Wilkinson 2012 9/29 14/31 19.9 % 0.69 [ 0.35, 1.34 ]
Total (95% CI) 135 123 100.0 % 0.93 [ 0.69, 1.25 ]
Total events: 53 (Experimental), 52 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 1.00, df = 1 (P = 0.32); I2 =0%
Test for overall effect: Z = 0.47 (P = 0.64)
Test for subgroup differences: Not applicable
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Analysis 15.2. Comparison 15 Maternal health intervention with smoking cessation component: counselling
vs usual care, Outcome 2 Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 15 Maternal health intervention with smoking cessation component: counselling vs usual care
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single
El-Mohandes 2011 44/106 38/92 100.0 % 1.00 [ 0.72, 1.40 ]
Total (95% CI) 106 92 100.0 % 1.00 [ 0.72, 1.40 ]
Total events: 44 (Experimental), 38 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.03 (P = 0.98)
Test for subgroup differences: Not applicable
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Analysis 15.3. Comparison 15 Maternal health intervention with smoking cessation component: counselling
vs usual care, Outcome 3 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 15 Maternal health intervention with smoking cessation component: counselling vs usual care
Outcome: 3 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
El-Mohandes 2011 42/106 25/92 100.0 % 1.46 [ 0.97, 2.19 ]
Total (95% CI) 106 92 100.0 % 1.46 [ 0.97, 2.19 ]
Total events: 42 (Experimental), 25 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.81 (P = 0.071)
Test for subgroup differences: Not applicable
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Analysis 15.4. Comparison 15 Maternal health intervention with smoking cessation component: counselling
vs usual care, Outcome 4 Smoking reduction: biochemical measures in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 15 Maternal health intervention with smoking cessation component: counselling vs usual care
Outcome: 4 Smoking reduction: biochemical measures in late pregnancy
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Mean cotinine
El-Mohandes 2011 106 146 (139.4) 92 131.9 (117.6) 100.0 % 0.11 [ -0.17, 0.39 ]
Total (95% CI) 106 92 100.0 % 0.11 [ -0.17, 0.39 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.76 (P = 0.45)
Test for subgroup differences: Not applicable
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Analysis 16.1. Comparison 16 Maternal health intervention with smoking cessation component: health
education vs less intensive intervention, Outcome 1 Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 16 Maternal health intervention with smoking cessation component: health education vs less intensive intervention
Outcome: 1 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Bullock 2009 (A+C v B+D) 49/270 51/260 100.0 % 0.93 [ 0.65, 1.32 ]
Total (95% CI) 270 260 100.0 % 0.93 [ 0.65, 1.32 ]
Total events: 49 (Experimental), 51 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.43 (P = 0.67)
Test for subgroup differences: Not applicable
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Analysis 16.2. Comparison 16 Maternal health intervention with smoking cessation component: health
education vs less intensive intervention, Outcome 2 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 16 Maternal health intervention with smoking cessation component: health education vs less intensive intervention
Outcome: 2 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Bullock 2009 (A+C v B+D) 35/270 32/260 100.0 % 1.05 [ 0.67, 1.65 ]
Total (95% CI) 270 260 100.0 % 1.05 [ 0.67, 1.65 ]
Total events: 35 (Experimental), 32 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.23 (P = 0.82)
Test for subgroup differences: Not applicable
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Analysis 17.1. Comparison 17 Maternal health intervention with smoking cessation component: feedback
vs usual care, Outcome 1 Smoking abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 17 Maternal health intervention with smoking cessation component: feedback vs usual care
Outcome: 1 Smoking abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Reading 1982 19/39 6/26 100.0 % 2.11 [ 0.98, 4.57 ]
Total (95% CI) 39 26 100.0 % 2.11 [ 0.98, 4.57 ]
Total events: 19 (Experimental), 6 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.90 (P = 0.058)
Test for subgroup differences: Not applicable
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Analysis 17.2. Comparison 17 Maternal health intervention with smoking cessation component: feedback
vs usual care, Outcome 2 Smoking reduction in late pregnancy: self-reported (various definitions).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 17 Maternal health intervention with smoking cessation component: feedback vs usual care
Outcome: 2 Smoking reduction in late pregnancy: self-reported (various definitions)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Reading 1982 10/39 7/26 100.0 % 0.95 [ 0.42, 2.18 ]
Total (95% CI) 39 26 100.0 % 0.95 [ 0.42, 2.18 ]
Total events: 10 (Experimental), 7 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.12 (P = 0.91)
Test for subgroup differences: Not applicable
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Analysis 17.3. Comparison 17 Maternal health intervention with smoking cessation component: feedback
vs usual care, Outcome 3 Smoking reduction: self-reported mean cigarettes per day measured in late
pregnancy or at delivery.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 17 Maternal health intervention with smoking cessation component: feedback vs usual care
Outcome: 3 Smoking reduction: self-reported mean cigarettes per day measured in late pregnancy or at delivery
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
LeFevre 1995 1768 14.5 (6.5) 1803 13 (6.5) 100.0 % 1.50 [ 1.07, 1.93 ]
Total (95% CI) 1768 1803 100.0 % 1.50 [ 1.07, 1.93 ]
Heterogeneity: not applicable
Test for overall effect: Z = 6.89 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 18.1. Comparison 18 Maternal health intervention with smoking cessation component: social
support vs usual care, Outcome 1 Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 18 Maternal health intervention with smoking cessation component: social support vs usual care
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Mejdoubi 2014 26/71 25/59 0.86 [ 0.56, 1.32 ]
Robling 2016 191/439 182/431 1.03 [ 0.88, 1.20 ]
2 Tailored interventions
Belizan 1995 59/255 30/237 1.83 [ 1.22, 2.73 ]
Olds 1986 0/77 0/64 Not estimable
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Analysis 18.2. Comparison 18 Maternal health intervention with smoking cessation component: social
support vs usual care, Outcome 2 Abstinence in late pregnancy:biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 18 Maternal health intervention with smoking cessation component: social support vs usual care
Outcome: 2 Abstinence in late pregnancy:biochemically validated only
Study or subgroup Experimental Control Risk Ratio Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Robling 2016 191/439 182/431 1.03 [ 0.88, 1.20 ]
2 Multiple interventions
3 Tailored interventions
Belizan 1995 59/255 30/237 1.83 [ 1.22, 2.73 ]
Olds 1986 0/77 0/64 Not estimable
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Analysis 18.3. Comparison 18 Maternal health intervention with smoking cessation component: social
support vs usual care, Outcome 3 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 18 Maternal health intervention with smoking cessation component: social support vs usual care
Outcome: 3 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Mejdoubi 2014 40/71 27/59 100.0 % 1.23 [ 0.87, 1.74 ]
Total (95% CI) 71 59 100.0 % 1.23 [ 0.87, 1.74 ]
Total events: 40 (Experimental ), 27 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.18 (P = 0.24)
Test for subgroup differences: Not applicable
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Analysis 18.4. Comparison 18 Maternal health intervention with smoking cessation component: social
support vs usual care, Outcome 4 Abstinence at 18 + months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 18 Maternal health intervention with smoking cessation component: social support vs usual care
Outcome: 4 Abstinence at 18 + months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Multiple interventions
Kemp 2011 16/42 11/31 100.0 % 1.07 [ 0.58, 1.98 ]
Total (95% CI) 42 31 100.0 % 1.07 [ 0.58, 1.98 ]
Total events: 16 (Experimental), 11 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.23 (P = 0.82)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours [control] Favours [experimental]
471Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 18.5. Comparison 18 Maternal health intervention with smoking cessation component: social
support vs usual care, Outcome 5 Smoking reduction: mean cigarettes per day.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 18 Maternal health intervention with smoking cessation component: social support vs usual care
Outcome: 5 Smoking reduction: mean cigarettes per day
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Single interventions
Mejdoubi 2014 71 2 (4) 59 3 (5) 48.3 % -0.22 [ -0.57, 0.12 ]
Subtotal (95% CI) 71 59 48.3 % -0.22 [ -0.57, 0.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.26 (P = 0.21)
2 Tailored interventions
Olds 1986 77 13.39 (6.5) 64 16 (6.5) 51.7 % -0.40 [ -0.73, -0.06 ]
Subtotal (95% CI) 77 64 51.7 % -0.40 [ -0.73, -0.06 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.34 (P = 0.019)
Total (95% CI) 148 123 100.0 % -0.31 [ -0.55, -0.07 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.52, df = 1 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 2.55 (P = 0.011)
Test for subgroup differences: Chi2 = 0.52, df = 1 (P = 0.47), I2 =0.0%
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Analysis 19.1. Comparison 19 Maternal health intervention with smoking cessation component: social
support vs less intensive intervention, Outcome 1 Abstinence in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 19 Maternal health intervention with smoking cessation component: social support vs less intensive intervention
Outcome: 1 Abstinence in late pregnancy
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Bullock 1995 2/31 5/35 7.7 % 0.45 [ 0.09, 2.16 ]
Bullock 2009 (AvC) 29/132 11/64 48.4 % 1.28 [ 0.68, 2.39 ]
Subtotal (95% CI) 163 99 56.2 % 0.98 [ 0.40, 2.39 ]
Total events: 31 (Experimental), 16 (Control)
Heterogeneity: Tau2 = 0.17; Chi2 = 1.47, df = 1 (P = 0.23); I2 =32%
Test for overall effect: Z = 0.04 (P = 0.97)
2 Multiple interventions
Bullock 2009 (AvD) 22/129 11/64 43.8 % 0.99 [ 0.51, 1.92 ]
Subtotal (95% CI) 129 64 43.8 % 0.99 [ 0.51, 1.92 ]
Total events: 22 (Experimental), 11 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.02 (P = 0.98)
Total (95% CI) 292 163 100.0 % 1.06 [ 0.68, 1.63 ]
Total events: 53 (Experimental), 27 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.52, df = 2 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.99), I2 =0.0%
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Analysis 19.2. Comparison 19 Maternal health intervention with smoking cessation component: social
support vs less intensive intervention, Outcome 2 Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 19 Maternal health intervention with smoking cessation component: social support vs less intensive intervention
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Bullock 2009 (AvC) 29/132 11/64 52.5 % 1.28 [ 0.68, 2.39 ]
Subtotal (95% CI) 132 64 52.5 % 1.28 [ 0.68, 2.39 ]
Total events: 29 (Experimental), 11 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.77 (P = 0.44)
2 Multiple interventions
Bullock 2009 (AvD) 22/129 11/64 47.5 % 0.99 [ 0.51, 1.92 ]
Subtotal (95% CI) 129 64 47.5 % 0.99 [ 0.51, 1.92 ]
Total events: 22 (Experimental), 11 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.02 (P = 0.98)
Total (95% CI) 261 128 100.0 % 1.13 [ 0.72, 1.78 ]
Total events: 51 (Experimental), 22 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.30, df = 1 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.54 (P = 0.59)
Test for subgroup differences: Chi2 = 0.30, df = 1 (P = 0.59), I2 =0.0%
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Analysis 19.3. Comparison 19 Maternal health intervention with smoking cessation component: social
support vs less intensive intervention, Outcome 3 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 19 Maternal health intervention with smoking cessation component: social support vs less intensive intervention
Outcome: 3 Abstinence at 0 to 5 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Single interventions
Bullock 2009 (AvC) 15/132 8/64 47.1 % 0.91 [ 0.41, 2.03 ]
Subtotal (95% CI) 132 64 47.1 % 0.91 [ 0.41, 2.03 ]
Total events: 15 (Experimental), 8 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.23 (P = 0.82)
2 Multiple interventions
Bullock 2009 (AvD) 16/129 9/64 52.9 % 0.88 [ 0.41, 1.89 ]
Subtotal (95% CI) 129 64 52.9 % 0.88 [ 0.41, 1.89 ]
Total events: 16 (Experimental), 9 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.32 (P = 0.75)
Total (95% CI) 261 128 100.0 % 0.89 [ 0.51, 1.55 ]
Total events: 31 (Experimental), 17 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.00, df = 1 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 0.39 (P = 0.69)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.96), I2 =0.0%
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Analysis 19.4. Comparison 19 Maternal health intervention with smoking cessation component: social
support vs less intensive intervention, Outcome 4 Smoking reduction: self reported mean cigarettes per day.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 19 Maternal health intervention with smoking cessation component: social support vs less intensive intervention
Outcome: 4 Smoking reduction: self reported mean cigarettes per day
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Single interventions
Bullock 1995 29 6 (6.5) 35 5 (6.5) 100.0 % 0.15 [ -0.34, 0.64 ]
Total (95% CI) 29 35 100.0 % 0.15 [ -0.34, 0.64 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.60 (P = 0.55)
Test for subgroup differences: Not applicable
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Analysis 20.1. Comparison 20 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 1 Abstinence in late pregnancy: self-reported and biochemically
validated.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 1 Abstinence in late pregnancy: self-reported and biochemically validated
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Baric 1976 9/63 2/47 0.4 % 3.36 [ 0.76, 14.82 ]
Cinciripini 2000 3/42 5/40 0.4 % 0.57 [ 0.15, 2.24 ]
Cinciripini 2010 58/128 51/129 2.6 % 1.15 [ 0.86, 1.53 ]
Cook 1995 8/23 2/20 0.4 % 3.48 [ 0.83, 14.52 ]
Dornelas 2006 15/53 5/52 0.8 % 2.94 [ 1.15, 7.51 ]
Dunkley 1997 4/50 0/50 0.1 % 9.00 [ 0.50, 162.89 ]
Eades 2012 1/124 2/107 0.1 % 0.43 [ 0.04, 4.69 ]
El-Mohandes 2011 44/106 38/92 2.4 % 1.00 [ 0.72, 1.40 ]
Ershoff 1989 33/126 20/116 1.8 % 1.52 [ 0.93, 2.49 ]
Ershoff 1999 (AvC) 21/101 12/55 1.4 % 0.95 [ 0.51, 1.79 ]
Gielen 1997 12/193 11/198 1.0 % 1.12 [ 0.51, 2.48 ]
Hajek 2001 80/365 73/367 2.6 % 1.10 [ 0.83, 1.46 ]
Hartmann 1996 27/113 16/106 1.5 % 1.58 [ 0.91, 2.77 ]
Haug 1994 42/229 8/93 1.1 % 2.13 [ 1.04, 4.37 ]
Hegaard 2003 23/327 7/320 0.9 % 3.22 [ 1.40, 7.39 ]
Kendrick 1995 48/822 65/1063 2.3 % 0.95 [ 0.67, 1.37 ]
Lawrence 2003 (AvB) 13/297 2/141 0.4 % 3.09 [ 0.71, 13.49 ]
Lawrence 2003 (AvC) 17/311 2/141 0.4 % 3.85 [ 0.90, 16.45 ]
Lee 2015 21/140 16/137 1.4 % 1.28 [ 0.70, 2.35 ]
Lillington 1995 7/16 4/18 0.7 % 1.97 [ 0.70, 5.50 ]
Loeb 1983 42/477 39/486 2.0 % 1.10 [ 0.72, 1.67 ]
Mayer 1990 (AvC) 8/72 1/39 0.2 % 4.33 [ 0.56, 33.39 ]
McBride 1999 72/341 30/160 2.2 % 1.13 [ 0.77, 1.65 ]
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(. . . Continued)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
McBride 2004 (AvB) 25/87 16/46 1.7 % 0.83 [ 0.49, 1.38 ]
McLeod 2004 37/163 14/109 1.5 % 1.77 [ 1.00, 3.11 ]
Messimer 1989 8/30 4/29 0.6 % 1.93 [ 0.65, 5.73 ]
Moore 2002 88/523 108/567 2.7 % 0.88 [ 0.68, 1.14 ]
Panjari 1999 33/476 31/537 1.8 % 1.20 [ 0.75, 1.93 ]
Parker 2007 (AvC) 77/358 36/189 2.3 % 1.13 [ 0.79, 1.61 ]
Patten 2009 0/16 1/17 0.1 % 0.35 [ 0.02, 8.08 ]
Pbert 2004 5/26 2/18 0.3 % 1.73 [ 0.38, 7.96 ]
Price 1991 (AvB) 2/52 0/35 0.1 % 3.40 [ 0.17, 68.67 ]
Price 1991 (AvC) 4/71 1/35 0.2 % 1.97 [ 0.23, 16.99 ]
Rigotti 2006 21/209 16/212 1.4 % 1.33 [ 0.71, 2.48 ]
Secker-Walker 1994 29/255 26/258 1.7 % 1.13 [ 0.68, 1.86 ]
Secker-Walker 1997 5/21 0/28 0.1 % 14.50 [ 0.85, 248.56 ]
Secker-Walker 1998 19/142 14/149 1.3 % 1.42 [ 0.74, 2.73 ]
Sexton 1984 167/436 79/443 2.8 % 2.15 [ 1.70, 2.71 ]
Stotts 2002 27/134 28/135 1.8 % 0.97 [ 0.61, 1.56 ]
Stotts 2004 3/24 5/30 0.4 % 0.75 [ 0.20, 2.83 ]
Tappin 2000 2/48 2/49 0.2 % 1.02 [ 0.15, 6.96 ]
Tappin 2005 17/347 19/409 1.3 % 1.05 [ 0.56, 2.00 ]
Thornton 1997 20/190 14/177 1.3 % 1.33 [ 0.69, 2.55 ]
Tsoh 2010 6/23 2/19 0.4 % 2.48 [ 0.56, 10.89 ]
Valbo 1996 5/52 8/78 0.6 % 0.94 [ 0.32, 2.71 ]
Walsh 1997 17/127 7/125 0.9 % 2.39 [ 1.03, 5.56 ]
Wilkinson 2012 9/29 14/31 1.3 % 0.69 [ 0.35, 1.34 ]
Windsor 1985 (AvB) 6/103 1/52 0.2 % 3.03 [ 0.37, 24.50 ]
Windsor 1985 (AvC) 14/102 1/52 0.2 % 7.14 [ 0.96, 52.79 ]
Windsor 1993 57/400 35/414 2.1 % 1.69 [ 1.13, 2.51 ]
Windsor 2011 65/547 55/546 2.4 % 1.18 [ 0.84, 1.66 ]
Subtotal (95% CI) 9510 8766 58.9 % 1.31 [ 1.16, 1.47 ]
Total events: 1376 (Experimental), 950 (Control)
Heterogeneity: Tau2 = 0.05; Chi2 = 83.67, df = 50 (P = 0.002); I2 =40%
Test for overall effect: Z = 4.51 (P < 0.00001)
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n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
2 Health education
Bullock 2009 (A+C v B+D) 38/205 26/130 1.9 % 0.93 [ 0.59, 1.45 ]
Burling 1991 9/70 4/69 0.6 % 2.22 [ 0.72, 6.86 ]
Ershoff 1999 (AvB) 20/120 13/56 1.4 % 0.72 [ 0.39, 1.34 ]
Herbec 2014 28/99 21/101 1.8 % 1.36 [ 0.83, 2.23 ]
Hjalmarson 1991 56/444 18/209 1.7 % 1.46 [ 0.88, 2.43 ]
Lilley 1986 4/72 1/73 0.2 % 4.06 [ 0.46, 35.41 ]
Mayer 1990 (AvB) 5/70 1/38 0.2 % 2.71 [ 0.33, 22.40 ]
Naughton 2012 12/96 8/102 0.9 % 1.59 [ 0.68, 3.73 ]
Ondersma 2012 (A+C v B+D) 12/40 3/27 0.5 % 2.70 [ 0.84, 8.67 ]
Peterson 1992 9/43 11/47 1.0 % 0.89 [ 0.41, 1.95 ]
Pollak 2013 2/16 1/15 0.2 % 1.88 [ 0.19, 18.60 ]
Subtotal (95% CI) 1275 867 10.4 % 1.22 [ 0.97, 1.55 ]
Total events: 195 (Experimental), 107 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 10.76, df = 10 (P = 0.38); I2 =7%
Test for overall effect: Z = 1.68 (P = 0.093)
3 Feedback
Bauman 1983 3/36 6/43 0.4 % 0.60 [ 0.16, 2.22 ]
Cope 2003 22/143 4/101 0.7 % 3.88 [ 1.38, 10.93 ]
Reading 1982 19/39 6/26 1.0 % 2.11 [ 0.98, 4.57 ]
Stotts 2009 (AvB) 17/120 6/60 0.9 % 1.42 [ 0.59, 3.41 ]
Stotts 2009 (AvC) 22/120 7/60 1.0 % 1.57 [ 0.71, 3.47 ]
Valbo 1994 11/55 2/56 0.4 % 5.60 [ 1.30, 24.11 ]
Subtotal (95% CI) 513 346 4.4 % 1.92 [ 1.16, 3.17 ]
Total events: 94 (Experimental), 31 (Control)
Heterogeneity: Tau2 = 0.14; Chi2 = 7.73, df = 5 (P = 0.17); I2 =35%
Test for overall effect: Z = 2.56 (P = 0.011)
4 Incentives
Donatelle 2000 34/112 9/108 1.2 % 3.64 [ 1.84, 7.23 ]
Glover 2014 (AvB) 0/8 1/4 0.1 % 0.19 [ 0.01, 3.75 ]
Glover 2014 (AvC) 2/8 0/4 0.1 % 2.78 [ 0.16, 47.20 ]
Harris 2015 2/7 3/10 0.4 % 0.95 [ 0.21, 4.29 ]
Heil 2008 15/37 4/40 0.7 % 4.05 [ 1.48, 11.11 ]
Higgins 2014 (AvB) 14/39 4/20 0.7 % 1.79 [ 0.68, 4.74 ]
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Higgins 2014 (AvC) 18/40 3/19 0.6 % 2.85 [ 0.95, 8.51 ]
Ondersma 2012 (AvC) 2/14 2/12 0.3 % 0.86 [ 0.14, 5.20 ]
Ondersma 2012 (AvD) 2/15 1/6 0.2 % 0.80 [ 0.09, 7.26 ]
Parker 2007 (AvB) 51/329 36/189 2.2 % 0.81 [ 0.55, 1.20 ]
Tappin 2015 69/316 26/313 2.0 % 2.63 [ 1.72, 4.01 ]
Tuten 2012 (AvB) 0/28 0/16 Not estimable
Tuten 2012 (AvC) 13/42 0/16 0.1 % 10.67 [ 0.67, 169.71 ]
Subtotal (95% CI) 995 757 8.5 % 1.88 [ 1.12, 3.14 ]
Total events: 222 (Experimental), 89 (Control)
Heterogeneity: Tau2 = 0.40; Chi2 = 32.44, df = 11 (P = 0.00065); I2 =66%
Test for overall effect: Z = 2.41 (P = 0.016)
5 Social support
Albrecht 1998 3/26 5/58 0.4 % 1.34 [ 0.35, 5.19 ]
Albrecht 2006 (AvB) 12/47 4/25 0.7 % 1.60 [ 0.57, 4.44 ]
Albrecht 2006 (AvC) 17/45 3/25 0.6 % 3.15 [ 1.02, 9.70 ]
Belizan 1995 59/255 30/237 2.1 % 1.83 [ 1.22, 2.73 ]
Bullock 1995 2/31 5/35 0.3 % 0.45 [ 0.09, 2.16 ]
Bullock 2009 (AvC) 14/66 5/32 0.8 % 1.36 [ 0.54, 3.44 ]
Bullock 2009 (AvD) 11/65 6/32 0.8 % 0.90 [ 0.37, 2.22 ]
Hennrikus 2010 7/54 1/28 0.2 % 3.63 [ 0.47, 28.05 ]
Malchodi 2003 16/67 16/75 1.4 % 1.12 [ 0.61, 2.06 ]
McBride 2004 (AvC) 33/89 17/45 1.9 % 0.98 [ 0.62, 1.56 ]
Mejdoubi 2014 26/71 25/59 2.0 % 0.86 [ 0.56, 1.32 ]
Olds 1986 0/77 0/64 Not estimable
Robling 2016 191/439 182/431 3.1 % 1.03 [ 0.88, 1.20 ]
Solomon 2000 14/77 11/74 1.1 % 1.22 [ 0.59, 2.52 ]
Subtotal (95% CI) 1409 1220 15.4 % 1.16 [ 0.96, 1.40 ]
Total events: 405 (Experimental), 310 (Control)
Heterogeneity: Tau2 = 0.02; Chi2 = 15.64, df = 12 (P = 0.21); I2 =23%
Test for overall effect: Z = 1.56 (P = 0.12)
6 Exercise
Ussher 2015 30/392 25/393 1.7 % 1.20 [ 0.72, 2.01 ]
Subtotal (95% CI) 392 393 1.7 % 1.20 [ 0.72, 2.01 ]
Total events: 30 (Experimental), 25 (Control)
Heterogeneity: not applicable
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Test for overall effect: Z = 0.71 (P = 0.48)
7 Other
Campbell 2006 10/98 6/96 0.7 % 1.63 [ 0.62, 4.32 ]
Subtotal (95% CI) 98 96 0.7 % 1.63 [ 0.62, 4.32 ]
Total events: 10 (Experimental), 6 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.99 (P = 0.32)
Total (95% CI) 14192 12445 100.0 % 1.35 [ 1.23, 1.48 ]
Total events: 2332 (Experimental), 1518 (Control)
Heterogeneity: Tau2 = 0.07; Chi2 = 167.16, df = 94 (P<0.00001); I2 =44%
Test for overall effect: Z = 6.23 (P < 0.00001)
Test for subgroup differences: Chi2 = 6.27, df = 6 (P = 0.39), I2 =4%
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Analysis 20.2. Comparison 20 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 2 Abstinence in late pregnancy: biochemically validated only.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 2 Abstinence in late pregnancy: biochemically validated only
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Cinciripini 2000 3/42 5/40 0.6 % 0.57 [ 0.15, 2.24 ]
Cinciripini 2010 58/128 51/129 7.4 % 1.15 [ 0.86, 1.53 ]
Cook 1995 8/23 2/20 0.6 % 3.48 [ 0.83, 14.52 ]
Dornelas 2006 15/53 5/52 1.3 % 2.94 [ 1.15, 7.51 ]
Eades 2012 1/124 2/107 0.2 % 0.43 [ 0.04, 4.69 ]
El-Mohandes 2011 44/106 38/92 6.4 % 1.00 [ 0.72, 1.40 ]
Ershoff 1989 33/126 20/116 3.8 % 1.52 [ 0.93, 2.49 ]
Ershoff 1999 (AvC) 21/101 25/111 3.6 % 0.92 [ 0.55, 1.54 ]
Gielen 1997 12/193 11/198 1.7 % 1.12 [ 0.51, 2.48 ]
Hajek 2001 80/365 73/367 7.5 % 1.10 [ 0.83, 1.46 ]
Hartmann 1996 27/113 16/106 3.1 % 1.58 [ 0.91, 2.77 ]
Hegaard 2003 23/327 7/320 1.6 % 3.22 [ 1.40, 7.39 ]
Kendrick 1995 48/822 65/1063 5.8 % 0.95 [ 0.67, 1.37 ]
Lawrence 2003 (AvB) 13/297 2/141 0.6 % 3.09 [ 0.71, 13.49 ]
Lawrence 2003 (AvC) 17/311 2/141 0.6 % 3.85 [ 0.90, 16.45 ]
Lee 2015 21/140 16/137 2.8 % 1.28 [ 0.70, 2.35 ]
McLeod 2004 37/163 14/109 3.1 % 1.77 [ 1.00, 3.11 ]
Moore 2002 88/523 108/567 8.3 % 0.88 [ 0.68, 1.14 ]
Panjari 1999 33/476 31/537 4.0 % 1.20 [ 0.75, 1.93 ]
Parker 2007 (AvC) 77/358 36/189 5.9 % 1.13 [ 0.79, 1.61 ]
Patten 2009 0/16 1/17 0.1 % 0.35 [ 0.02, 8.08 ]
Pbert 2004 5/26 2/18 0.5 % 1.73 [ 0.38, 7.96 ]
Price 1991 (AvB) 2/52 0/35 0.1 % 3.40 [ 0.17, 68.67 ]
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n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Price 1991 (AvC) 4/71 1/35 0.3 % 1.97 [ 0.23, 16.99 ]
Rigotti 2006 21/209 16/212 2.6 % 1.33 [ 0.71, 2.48 ]
Secker-Walker 1994 29/255 26/258 3.7 % 1.13 [ 0.68, 1.86 ]
Secker-Walker 1997 5/21 0/28 0.2 % 14.50 [ 0.85, 248.56 ]
Secker-Walker 1998 19/142 14/149 2.5 % 1.42 [ 0.74, 2.73 ]
Stotts 2002 27/134 28/135 4.1 % 0.97 [ 0.61, 1.56 ]
Stotts 2004 3/24 5/30 0.7 % 0.75 [ 0.20, 2.83 ]
Tappin 2000 2/48 2/49 0.3 % 1.02 [ 0.15, 6.96 ]
Tappin 2005 17/347 19/409 2.5 % 1.05 [ 0.56, 2.00 ]
Walsh 1997 17/127 7/125 1.6 % 2.39 [ 1.03, 5.56 ]
Windsor 1985 (AvB) 6/103 1/52 0.3 % 3.03 [ 0.37, 24.50 ]
Windsor 1985 (AvC) 14/102 1/52 0.3 % 7.14 [ 0.96, 52.79 ]
Windsor 1993 57/400 35/414 5.1 % 1.69 [ 1.13, 2.51 ]
Windsor 2011 65/547 55/546 6.2 % 1.18 [ 0.84, 1.66 ]
Subtotal (95% CI) 7415 7106 100.0 % 1.23 [ 1.10, 1.38 ]
Total events: 952 (Experimental), 742 (Control)
Heterogeneity: Tau2 = 0.02; Chi2 = 46.29, df = 36 (P = 0.12); I2 =22%
Test for overall effect: Z = 3.68 (P = 0.00024)
2 Health education
Bullock 2009 (A+C v B+D) 38/205 26/130 24.6 % 0.93 [ 0.59, 1.45 ]
Burling 1991 9/70 4/69 6.0 % 2.22 [ 0.72, 6.86 ]
Ershoff 1999 (AvB) 20/120 25/111 20.0 % 0.74 [ 0.44, 1.26 ]
Hjalmarson 1991 56/444 18/209 21.2 % 1.46 [ 0.88, 2.43 ]
Naughton 2012 12/96 8/102 9.8 % 1.59 [ 0.68, 3.73 ]
Ondersma 2012 (A+C v B+D) 12/40 3/27 5.6 % 2.70 [ 0.84, 8.67 ]
Peterson 1992 9/43 11/47 11.3 % 0.89 [ 0.41, 1.95 ]
Pollak 2013 2/16 1/15 1.6 % 1.88 [ 0.19, 18.60 ]
Subtotal (95% CI) 1034 710 100.0 % 1.16 [ 0.87, 1.55 ]
Total events: 158 (Experimental), 96 (Control)
Heterogeneity: Tau2 = 0.04; Chi2 = 8.98, df = 7 (P = 0.25); I2 =22%
Test for overall effect: Z = 1.00 (P = 0.32)
3 Feedback
Bauman 1983 3/36 6/43 17.0 % 0.60 [ 0.16, 2.22 ]
Cope 2003 22/143 4/101 23.4 % 3.88 [ 1.38, 10.93 ]
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Stotts 2009 (AvB) 17/120 6/60 28.3 % 1.42 [ 0.59, 3.41 ]
Stotts 2009 (AvC) 22/120 7/60 31.4 % 1.57 [ 0.71, 3.47 ]
Subtotal (95% CI) 419 264 100.0 % 1.60 [ 0.85, 3.03 ]
Total events: 64 (Experimental), 23 (Control)
Heterogeneity: Tau2 = 0.17; Chi2 = 5.12, df = 3 (P = 0.16); I2 =41%
Test for overall effect: Z = 1.44 (P = 0.15)
4 Incentives
Donatelle 2000 34/112 9/108 12.8 % 3.64 [ 1.84, 7.23 ]
Glover 2014 (AvB) 0/8 1/4 2.4 % 0.19 [ 0.01, 3.75 ]
Glover 2014 (AvC) 2/8 0/4 2.7 % 2.78 [ 0.16, 47.20 ]
Harris 2015 2/7 3/10 6.8 % 0.95 [ 0.21, 4.29 ]
Heil 2008 15/37 4/40 10.1 % 4.05 [ 1.48, 11.11 ]
Higgins 2014 (AvB) 14/39 4/20 10.4 % 1.79 [ 0.68, 4.74 ]
Higgins 2014 (AvC) 18/40 3/19 9.4 % 2.85 [ 0.95, 8.51 ]
Ondersma 2012 (AvC) 3/28 2/13 6.0 % 0.70 [ 0.13, 3.68 ]
Ondersma 2012 (AvD) 4/29 2/13 6.4 % 0.90 [ 0.19, 4.29 ]
Parker 2007 (AvB) 51/329 36/189 15.2 % 0.81 [ 0.55, 1.20 ]
Tappin 2015 69/316 26/313 15.0 % 2.63 [ 1.72, 4.01 ]
Tuten 2012 (AvB) 0/28 0/16 Not estimable
Tuten 2012 (AvC) 13/42 0/16 2.8 % 10.67 [ 0.67, 169.71 ]
Subtotal (95% CI) 1023 765 100.0 % 1.82 [ 1.10, 3.03 ]
Total events: 225 (Experimental), 90 (Control)
Heterogeneity: Tau2 = 0.40; Chi2 = 33.18, df = 11 (P = 0.00049); I2 =67%
Test for overall effect: Z = 2.32 (P = 0.020)
5 Social support
Albrecht 2006 (AvB) 12/47 4/25 1.9 % 1.60 [ 0.57, 4.44 ]
Albrecht 2006 (AvC) 17/45 3/25 1.5 % 3.15 [ 1.02, 9.70 ]
Bullock 2009 (AvC) 14/66 5/32 2.2 % 1.36 [ 0.54, 3.44 ]
Bullock 2009 (AvD) 11/65 6/32 2.4 % 0.90 [ 0.37, 2.22 ]
Hennrikus 2010 7/54 1/28 0.5 % 3.63 [ 0.47, 28.05 ]
Malchodi 2003 16/67 16/75 5.2 % 1.12 [ 0.61, 2.06 ]
Olds 1986 0/77 0/64 Not estimable
Robling 2016 191/439 182/431 82.5 % 1.03 [ 0.88, 1.20 ]
Solomon 2000 14/77 11/74 3.7 % 1.22 [ 0.59, 2.52 ]
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Subtotal (95% CI) 937 786 100.0 % 1.08 [ 0.94, 1.24 ]
Total events: 282 (Experimental), 228 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 6.45, df = 7 (P = 0.49); I2 =0.0%
Test for overall effect: Z = 1.05 (P = 0.29)
6 Exercise
Ussher 2015 30/392 25/393 100.0 % 1.20 [ 0.72, 2.01 ]
Subtotal (95% CI) 392 393 100.0 % 1.20 [ 0.72, 2.01 ]
Total events: 30 (Experimental), 25 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.71 (P = 0.48)
7 Other
Campbell 2006 10/98 6/96 100.0 % 1.63 [ 0.62, 4.32 ]
Subtotal (95% CI) 98 96 100.0 % 1.63 [ 0.62, 4.32 ]
Total events: 10 (Experimental), 6 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.99 (P = 0.32)
Test for subgroup differences: Chi2 = 6.31, df = 6 (P = 0.39), I2 =5%
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Analysis 20.3. Comparison 20 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 3 Continued abstinence (Relapse prevention) in late pregnancy for
spontaneous quitters.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 3 Continued abstinence (Relapse prevention) in late pregnancy for spontaneous quitters
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Dornelas 2006 10/14 16/19 4.0 % 0.85 [ 0.58, 1.25 ]
Eades 2012 10/24 2/8 0.4 % 1.67 [ 0.46, 6.06 ]
Ershoff 1989 46/87 67/84 8.6 % 0.66 [ 0.53, 0.83 ]
Hajek 2001 72/111 68/128 9.2 % 1.22 [ 0.99, 1.51 ]
Lillington 1995 15/16 17/19 9.9 % 1.05 [ 0.86, 1.28 ]
Lowe 1997 37/52 25/45 5.5 % 1.28 [ 0.94, 1.75 ]
McBride 1999 225/259 110/137 16.8 % 1.08 [ 0.98, 1.19 ]
McBride 2004 (AvB) 89/105 42/53 12.2 % 1.07 [ 0.91, 1.26 ]
Pbert 2004 16/23 12/16 3.9 % 0.93 [ 0.63, 1.37 ]
Polanska 2004 38/38 23/23 18.6 % 1.00 [ 0.93, 1.07 ]
Secker-Walker 1994 31/85 31/80 3.9 % 0.94 [ 0.64, 1.39 ]
Secker-Walker 1998 28/44 33/48 6.1 % 0.93 [ 0.69, 1.24 ]
Thornton 1997 3/6 10/14 0.9 % 0.70 [ 0.29, 1.66 ]
Subtotal (95% CI) 864 674 100.0 % 1.01 [ 0.92, 1.09 ]
Total events: 620 (Treatment), 456 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 23.94, df = 12 (P = 0.02); I2 =50%
Test for overall effect: Z = 0.11 (P = 0.91)
2 Health education
Peterson 1992 30/34 31/36 100.0 % 1.02 [ 0.86, 1.23 ]
Subtotal (95% CI) 34 36 100.0 % 1.02 [ 0.86, 1.23 ]
Total events: 30 (Treatment), 31 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.27 (P = 0.79)
3 Social support
McBride 2004 (AvC) 84/104 43/54 100.0 % 1.01 [ 0.86, 1.20 ]
Subtotal (95% CI) 104 54 100.0 % 1.01 [ 0.86, 1.20 ]
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Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Total events: 84 (Treatment), 43 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.17 (P = 0.87)
Test for subgroup differences: Chi2 = 0.04, df = 2 (P = 0.98), I2 =0.0%
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Analysis 20.4. Comparison 20 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 4 Abstinence at 0 to 5 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 4 Abstinence at 0 to 5 months postpartum
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Cinciripini 2000 2/42 3/40 0.5 % 0.63 [ 0.11, 3.60 ]
Cinciripini 2010 24/128 23/129 5.9 % 1.05 [ 0.63, 1.76 ]
Dunkley 1997 2/50 0/50 0.2 % 5.00 [ 0.25, 101.58 ]
El-Mohandes 2011 42/106 25/92 9.2 % 1.46 [ 0.97, 2.19 ]
Haug 1994 42/229 8/93 3.1 % 2.13 [ 1.04, 4.37 ]
Lawrence 2003 (AvB) 15/297 5/141 1.6 % 1.42 [ 0.53, 3.84 ]
Lawrence 2003 (AvC) 25/311 5/141 1.8 % 2.27 [ 0.89, 5.80 ]
Lee 2015 21/140 16/137 4.3 % 1.28 [ 0.70, 2.35 ]
Lillington 1995 4/16 2/18 0.7 % 2.25 [ 0.47, 10.69 ]
Mayer 1990 (AvC) 5/72 0/39 0.2 % 6.03 [ 0.34, 106.23 ]
McBride 1999 222/600 89/297 31.7 % 1.23 [ 1.01, 1.51 ]
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Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
McBride 2004 (AvB) 62/192 32/99 12.2 % 1.00 [ 0.70, 1.42 ]
McLeod 2004 17/106 9/82 2.8 % 1.46 [ 0.69, 3.11 ]
Messimer 1989 3/30 3/29 0.7 % 0.97 [ 0.21, 4.41 ]
Panjari 1999 54/339 47/393 11.5 % 1.33 [ 0.93, 1.91 ]
Pbert 2004 1/26 1/18 0.2 % 0.69 [ 0.05, 10.36 ]
Polanska 2004 28/62 6/38 2.6 % 2.86 [ 1.31, 6.26 ]
Rigotti 2006 14/209 15/212 3.2 % 0.95 [ 0.47, 1.91 ]
Stotts 2002 14/134 14/135 3.2 % 1.01 [ 0.50, 2.03 ]
Thornton 1997 19/190 15/177 3.8 % 1.18 [ 0.62, 2.25 ]
Walsh 1997 13/127 1/125 0.4 % 12.80 [ 1.70, 96.35 ]
Subtotal (95% CI) 3406 2485 100.0 % 1.29 [ 1.13, 1.46 ]
Total events: 629 (Treatment), 319 (Control)
Heterogeneity: Tau2 = 0.00; Chi2 = 20.58, df = 20 (P = 0.42); I2 =3%
Test for overall effect: Z = 3.90 (P = 0.000098)
2 Health education
Bullock 2009 (A+C v B+D) 27/206 16/130 31.0 % 1.06 [ 0.60, 1.90 ]
Hjalmarson 1991 70/444 19/209 39.7 % 1.73 [ 1.07, 2.80 ]
Mayer 1990 (AvB) 5/70 0/38 1.8 % 6.04 [ 0.34, 106.42 ]
Peterson 1992 11/43 4/47 11.5 % 3.01 [ 1.03, 8.74 ]
Strecher 2000 10/104 8/87 16.0 % 1.05 [ 0.43, 2.53 ]
Subtotal (95% CI) 867 511 100.0 % 1.50 [ 1.02, 2.20 ]
Total events: 123 (Treatment), 47 (Control)
Heterogeneity: Tau2 = 0.04; Chi2 = 4.91, df = 4 (P = 0.30); I2 =19%
Test for overall effect: Z = 2.06 (P = 0.039)
3 Incentives
Donatelle 2000 22/103 6/102 33.2 % 3.63 [ 1.54, 8.58 ]
Heil 2008 9/37 1/40 13.4 % 9.73 [ 1.29, 73.13 ]
Higgins 2014 (AvB) 9/39 4/20 28.7 % 1.15 [ 0.40, 3.29 ]
Higgins 2014 (AvC) 7/40 3/19 24.6 % 1.11 [ 0.32, 3.82 ]
Subtotal (95% CI) 219 181 100.0 % 2.23 [ 0.94, 5.30 ]
Total events: 47 (Treatment), 14 (Control)
Heterogeneity: Tau2 = 0.40; Chi2 = 6.30, df = 3 (P = 0.10); I2 =52%
Test for overall effect: Z = 1.81 (P = 0.070)
4 Social support
Bullock 2009 (AvC) 7/66 4/32 4.1 % 0.85 [ 0.27, 2.69 ]
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Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Bullock 2009 (AvD) 8/64 4/32 4.3 % 1.00 [ 0.33, 3.07 ]
Hennrikus 2010 5/54 0/28 0.7 % 5.80 [ 0.33, 101.27 ]
McBride 2004 (AvC) 62/192 33/99 45.4 % 0.97 [ 0.69, 1.37 ]
Mejdoubi 2014 40/71 27/59 45.6 % 1.23 [ 0.87, 1.74 ]
Subtotal (95% CI) 447 250 100.0 % 1.09 [ 0.86, 1.37 ]
Total events: 122 (Treatment), 68 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.44, df = 4 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 0.72 (P = 0.47)
Test for subgroup differences: Chi2 = 4.05, df = 3 (P = 0.26), I2 =26%
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Analysis 20.5. Comparison 20 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 5 Abstinence at 6 to 11 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 5 Abstinence at 6 to 11 months postpartum
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Cinciripini 2010 9/128 12/129 3.5 % 0.76 [ 0.33, 1.73 ]
Dornelas 2006 5/53 2/52 0.9 % 2.45 [ 0.50, 12.08 ]
Gielen 1997 7/193 2/198 1.0 % 3.59 [ 0.76, 17.07 ]
Hajek 2001 9/315 9/312 2.9 % 0.99 [ 0.40, 2.46 ]
Haug 1994 35/229 10/93 5.5 % 1.42 [ 0.73, 2.75 ]
McBride 1999 172/600 77/297 45.6 % 1.11 [ 0.88, 1.39 ]
McBride 2004 (AvB) 59/192 27/99 16.2 % 1.13 [ 0.77, 1.66 ]
Panjari 1999 54/339 47/393 18.3 % 1.33 [ 0.93, 1.91 ]
Pbert 2004 1/26 0/18 0.2 % 2.11 [ 0.09, 49.08 ]
Secker-Walker 1994 5/157 6/185 1.8 % 0.98 [ 0.31, 3.16 ]
Stotts 2002 10/134 14/135 4.0 % 0.72 [ 0.33, 1.56 ]
Subtotal (95% CI) 2366 1911 100.0 % 1.15 [ 0.98, 1.34 ]
Total events: 366 (Treatment), 206 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 6.78, df = 10 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 1.72 (P = 0.085)
2 Incentives
Heil 2008 3/37 1/40 5.7 % 3.24 [ 0.35, 29.82 ]
Higgins 2014 (AvB) 6/39 2/20 12.4 % 1.54 [ 0.34, 6.94 ]
Higgins 2014 (AvC) 7/40 1/19 6.9 % 3.33 [ 0.44, 25.14 ]
Tappin 2015 47/306 12/303 74.9 % 3.88 [ 2.10, 7.16 ]
Subtotal (95% CI) 422 382 100.0 % 3.39 [ 1.99, 5.76 ]
Total events: 63 (Treatment), 16 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.25, df = 3 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 4.50 (P < 0.00001)
3 Social support
Albrecht 2006 (AvB) 8/47 4/25 10.0 % 1.06 [ 0.35, 3.19 ]
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Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Albrecht 2006 (AvC) 4/45 3/25 6.0 % 0.74 [ 0.18, 3.05 ]
McBride 2004 (AvC) 59/193 28/99 84.0 % 1.08 [ 0.74, 1.58 ]
Subtotal (95% CI) 285 149 100.0 % 1.05 [ 0.75, 1.49 ]
Total events: 71 (Treatment), 35 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.26, df = 2 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 0.30 (P = 0.76)
4 Exercise
Ussher 2015 24/392 16/393 100.0 % 1.50 [ 0.81, 2.79 ]
Subtotal (95% CI) 392 393 100.0 % 1.50 [ 0.81, 2.79 ]
Total events: 24 (Treatment), 16 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.30 (P = 0.19)
Test for subgroup differences: Chi2 = 15.91, df = 3 (P = 0.00), I2 =81%
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Analysis 20.6. Comparison 20 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 6 Abstinence at 12 to 17 months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 6 Abstinence at 12 to 17 months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Haug 1994 34/229 7/93 13.0 % 1.97 [ 0.91, 4.29 ]
McBride 1999 145/600 71/297 35.2 % 1.01 [ 0.79, 1.29 ]
McBride 2004 (AvB) 49/192 23/99 25.3 % 1.10 [ 0.71, 1.69 ]
Polanska 2004 22/69 5/40 10.7 % 2.55 [ 1.05, 6.21 ]
Secker-Walker 1998 21/142 12/149 15.8 % 1.84 [ 0.94, 3.59 ]
Subtotal (95% CI) 1232 678 100.0 % 1.37 [ 0.98, 1.91 ]
Total events: 271 (Experimental), 118 (Control)
Heterogeneity: Tau2 = 0.07; Chi2 = 7.96, df = 4 (P = 0.09); I2 =50%
Test for overall effect: Z = 1.83 (P = 0.067)
2 Social support
McBride 2004 (AvC) 49/193 24/99 100.0 % 1.05 [ 0.69, 1.60 ]
Subtotal (95% CI) 193 99 100.0 % 1.05 [ 0.69, 1.60 ]
Total events: 49 (Experimental), 24 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.21 (P = 0.83)
Test for subgroup differences: Chi2 = 0.93, df = 1 (P = 0.33), I2 =0.0%
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Analysis 20.7. Comparison 20 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 7 Abstinence at 18+ months postpartum.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 7 Abstinence at 18+ months postpartum
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Lawrence 2003 (AvB) 7/159 3/80 25.4 % 1.17 [ 0.31, 4.42 ]
Lawrence 2003 (AvC) 6/137 3/80 24.2 % 1.17 [ 0.30, 4.54 ]
Secker-Walker 1994 7/157 10/185 50.3 % 0.82 [ 0.32, 2.12 ]
Subtotal (95% CI) 453 345 100.0 % 0.98 [ 0.50, 1.92 ]
Total events: 20 (Experimental), 16 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.26, df = 2 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 0.05 (P = 0.96)
2 Social support
Kemp 2011 16/42 11/31 100.0 % 1.07 [ 0.58, 1.98 ]
Subtotal (95% CI) 42 31 100.0 % 1.07 [ 0.58, 1.98 ]
Total events: 16 (Experimental), 11 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.23 (P = 0.82)
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Analysis 20.8. Comparison 20 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 8 Smoking reduction: numbers of women reducing smoking in late
pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 8 Smoking reduction: numbers of women reducing smoking in late pregnancy
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Biochemically validated reduction
Cook 1995 6/23 4/20 6.2 % 1.30 [ 0.43, 3.97 ]
Cope 2003 42/143 20/101 19.9 % 1.48 [ 0.93, 2.37 ]
Gielen 1997 14/125 13/121 12.2 % 1.04 [ 0.51, 2.13 ]
Harris 2015 2/7 4/10 4.2 % 0.71 [ 0.18, 2.88 ]
Tappin 2005 14/347 26/409 14.2 % 0.63 [ 0.34, 1.20 ]
Tuten 2012 (AvB) 0/28 1/16 0.9 % 0.20 [ 0.01, 4.53 ]
Tuten 2012 (AvC) 20/42 0/16 1.2 % 16.21 [ 1.04, 253.21 ]
Windsor 1985 (AvB) 20/103 5/52 8.4 % 2.02 [ 0.80, 5.08 ]
Windsor 1985 (AvC) 17/102 4/52 7.0 % 2.17 [ 0.77, 6.11 ]
Windsor 1993 67/400 51/414 25.8 % 1.36 [ 0.97, 1.91 ]
Subtotal (95% CI) 1320 1211 100.0 % 1.26 [ 0.93, 1.71 ]
Total events: 202 (Treatment), 128 (Control)
Heterogeneity: Tau2 = 0.06; Chi2 = 12.92, df = 9 (P = 0.17); I2 =30%
Test for overall effect: Z = 1.50 (P = 0.13)
2 Self-reported some reduction in smoking (various definitions)
Price 1991 (AvC) 37/123 10/70 17.9 % 2.11 [ 1.12, 3.97 ]
Reading 1982 10/39 7/26 10.7 % 0.95 [ 0.42, 2.18 ]
Valbo 1994 35/55 19/56 38.9 % 1.88 [ 1.24, 2.84 ]
Valbo 1996 22/52 24/78 32.5 % 1.38 [ 0.87, 2.18 ]
Subtotal (95% CI) 269 230 100.0 % 1.61 [ 1.22, 2.12 ]
Total events: 104 (Treatment), 60 (Control)
Heterogeneity: Tau2 = 0.01; Chi2 = 3.21, df = 3 (P = 0.36); I2 =6%
Test for overall effect: Z = 3.40 (P = 0.00068)
3 Self-reported > 50% reduction in smoking
Hartmann 1996 34/107 20/100 14.1 % 1.59 [ 0.98, 2.57 ]
Rigotti 2006 61/209 46/212 29.6 % 1.35 [ 0.97, 1.87 ]
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Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Solomon 2000 29/77 29/74 19.9 % 0.96 [ 0.64, 1.44 ]
Windsor 2011 87/544 65/549 36.4 % 1.35 [ 1.00, 1.82 ]
Subtotal (95% CI) 937 935 100.0 % 1.29 [ 1.08, 1.54 ]
Total events: 211 (Treatment), 160 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.94, df = 3 (P = 0.40); I2 =0.0%
Test for overall effect: Z = 2.77 (P = 0.0057)
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Analysis 20.9. Comparison 20 Interventions for smoking cessation in pregnancy versus control: subgrouped
by main intervention strategy, Outcome 9 Smoking reduction: biochemical measures in late pregnancy.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 9 Smoking reduction: biochemical measures in late pregnancy
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Mean cotinine levels
El-Mohandes 2011 106 146 (139.4) 92 131.9 (117.6) 12.8 % 0.11 [ -0.17, 0.39 ]
Panjari 1999 318 720 (688) 356 769 (735) 14.3 % -0.07 [ -0.22, 0.08 ]
Secker-Walker 1994 188 1208 (1384) 226 1228 (1612) 13.9 % -0.01 [ -0.21, 0.18 ]
Tappin 2005 290 113 (70) 364 117 (83) 14.3 % -0.05 [ -0.21, 0.10 ]
Tuten 2012 (AvB) 28 8.7 (2.8) 16 8.4 (4.2) 8.1 % 0.09 [ -0.53, 0.70 ]
Tuten 2012 (AvC) 42 4 (5.5) 16 8.4 (4.2) 8.3 % -0.84 [ -1.43, -0.24 ]
Tuten 2012 (AvC) 42 4 (5.5) 32 8.4 (4.2) 9.8 % -0.87 [ -1.36, -0.39 ]
Vilches 2009 (AvB) 71 5.76 (4.9) 18 11.55 (4.8) 8.9 % -1.18 [ -1.72, -0.63 ]
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Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Vilches 2009 (AvC) 8 7 (6.63) 18 11.55 (4.8) 5.5 % -0.82 [ -1.68, 0.05 ]
Vilches 2009 (AvD) 9 1.17 (1.17) 18 11.55 (4.8) 4.1 % -2.51 [ -3.59, -1.43 ]
Subtotal (95% CI) 1102 1156 100.0 % -0.41 [ -0.66, -0.15 ]
Heterogeneity: Tau2 = 0.11; Chi2 = 55.94, df = 9 (P<0.00001); I2 =84%
Test for overall effect: Z = 3.11 (P = 0.0019)
2 Mean thiocyanate level
Sexton 1984 380 2094 (1209) 389 2452 (1228) 100.0 % -0.29 [ -0.44, -0.15 ]
Subtotal (95% CI) 380 389 100.0 % -0.29 [ -0.44, -0.15 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.05 (P = 0.000052)
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Analysis 20.10. Comparison 20 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 10 Smoking reduction: self-reported mean cigarettes per
day measured in late pregnancy or at delivery.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 10 Smoking reduction: self-reported mean cigarettes per day measured in late pregnancy or at delivery
Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Counselling
Ershoff 1999 (AvC) 60 8.1 (8) 31 8 (8) 6.5 % 0.01 [ -0.42, 0.45 ]
Hartmann 1996 107 9.1 (6.5) 100 12.2 (6.5) 8.5 % -0.48 [ -0.75, -0.20 ]
Moore 2002 353 10.3 (5.6) 403 10.1 (5.4) 10.1 % 0.04 [ -0.11, 0.18 ]
Panjari 1999 284 8.7 (7.6) 326 11.5 (9.7) 9.9 % -0.32 [ -0.48, -0.16 ]
Pbert 2004 119 8 (6.5) 172 10.5 (6.5) 9.1 % -0.38 [ -0.62, -0.15 ]
Price 1991 (AvC) 71 4.3 (8.1) 70 2.3 (5.6) 7.8 % 0.29 [ -0.05, 0.62 ]
Secker-Walker 1998 135 10.2 (8.4) 141 11.5 (7.8) 9.1 % -0.16 [ -0.40, 0.08 ]
Sexton 1984 388 6.4 (8.7) 395 12.8 (11.5) 10.1 % -0.63 [ -0.77, -0.48 ]
Thornton 1997 196 10.4 (8.3) 191 12.5 (10.7) 9.5 % -0.22 [ -0.42, -0.02 ]
Valbo 1996 52 9.9 (5.4) 78 9 (4.4) 7.6 % 0.19 [ -0.17, 0.54 ]
Vilches 2009 (AvB) 71 5 (6.5) 18 5.36 (5.76) 5.6 % -0.06 [ -0.57, 0.46 ]
Vilches 2009 (AvC) 8 8.5 (9.68) 18 5.36 (5.76) 3.1 % 0.43 [ -0.42, 1.27 ]
Vilches 2009 (AvD) 9 0.11 (0.33) 18 5.36 (5.76) 3.0 % -1.07 [ -1.93, -0.21 ]
Subtotal (95% CI) 1853 1961 100.0 % -0.19 [ -0.36, -0.01 ]
Heterogeneity: Tau2 = 0.07; Chi2 = 70.80, df = 12 (P<0.00001); I2 =83%
Test for overall effect: Z = 2.09 (P = 0.037)
2 Health education
Donovan 1977 263 9.2 (9.7304) 289 16.4 (10.2) 27.0 % -0.72 [ -0.89, -0.55 ]
Ershoff 1999 (AvB) 66 7.3 (7.3) 30 8 (8) 21.9 % -0.09 [ -0.52, 0.34 ]
Hjalmarson 1991 444 10.7 (6.4) 209 10.6 (2.1999) 27.1 % 0.02 [ -0.15, 0.18 ]
Lilley 1986 66 13.1 (9.1) 69 16 (9.1) 24.0 % -0.32 [ -0.66, 0.02 ]
Subtotal (95% CI) 839 597 100.0 % -0.29 [ -0.71, 0.14 ]
Heterogeneity: Tau2 = 0.17; Chi2 = 38.08, df = 3 (P<0.00001); I2 =92%
Test for overall effect: Z = 1.31 (P = 0.19)
3 Feedback
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Study or subgroup Treatment Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
LeFevre 1995 1768 14.5 (6.5) 1803 13 (6.5) 52.6 % 0.23 [ 0.16, 0.30 ]
Valbo 1994 54 8 (4.8) 50 11 (4.6) 47.4 % -0.63 [ -1.03, -0.24 ]
Subtotal (95% CI) 1822 1853 100.0 % -0.18 [ -1.02, 0.67 ]
Heterogeneity: Tau2 = 0.35; Chi2 = 17.91, df = 1 (P = 0.00002); I2 =94%
Test for overall effect: Z = 0.41 (P = 0.68)
4 Incentives
Tuten 2012 (AvC) 42 8.7 (5.6) 32 16.9 (5.8) 100.0 % -1.43 [ -1.94, -0.91 ]
Subtotal (95% CI) 42 32 100.0 % -1.43 [ -1.94, -0.91 ]
Heterogeneity: not applicable
Test for overall effect: Z = 5.41 (P < 0.00001)
5 Social support
Belizan 1995 195 8.4 (8.1) 206 10.9 (12.5) 50.9 % -0.24 [ -0.43, -0.04 ]
Bullock 1995 29 6 (6.5) 35 5 (6.5) 9.8 % 0.15 [ -0.34, 0.64 ]
Mejdoubi 2014 71 2 (4) 59 3 (5) 19.0 % -0.22 [ -0.57, 0.12 ]
Olds 1986 77 13.39 (6.5) 64 16 (6.5) 20.3 % -0.40 [ -0.73, -0.06 ]
Subtotal (95% CI) 372 364 100.0 % -0.23 [ -0.39, -0.07 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 3.29, df = 3 (P = 0.35); I2 =9%
Test for overall effect: Z = 2.84 (P = 0.0045)
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Analysis 20.11. Comparison 20 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 11 Low birthweight (under 2500 g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 11 Low birthweight (under 2500 g)
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Ershoff 1989 9/118 15/109 2.9 % 0.55 [ 0.25, 1.21 ]
Hegaard 2003 12/327 10/320 2.7 % 1.17 [ 0.51, 2.68 ]
Panjari 1999 20/337 37/391 6.6 % 0.63 [ 0.37, 1.06 ]
Secker-Walker 1994 9/188 10/226 2.3 % 1.08 [ 0.45, 2.61 ]
Secker-Walker 1998 7/135 12/141 2.2 % 0.61 [ 0.25, 1.50 ]
Sexton 1984 31/463 42/472 9.1 % 0.75 [ 0.48, 1.18 ]
Tappin 2005 44/332 59/400 13.8 % 0.90 [ 0.63, 1.29 ]
Thornton 1997 19/190 15/190 4.3 % 1.27 [ 0.66, 2.42 ]
Subtotal (95% CI) 2090 2249 43.9 % 0.83 [ 0.68, 1.01 ]
Total events: 151 (Treatment), 200 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 5.61, df = 7 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 1.83 (P = 0.067)
2 Health education
Donovan 1977 26/263 26/289 6.7 % 1.10 [ 0.66, 1.84 ]
Hjalmarson 1991 14/422 11/198 3.0 % 0.60 [ 0.28, 1.29 ]
Subtotal (95% CI) 685 487 9.8 % 0.87 [ 0.49, 1.55 ]
Total events: 40 (Treatment), 37 (Control)
Heterogeneity: Tau2 = 0.07; Chi2 = 1.66, df = 1 (P = 0.20); I2 =40%
Test for overall effect: Z = 0.47 (P = 0.64)
3 Feedback
Haddow 1991 99/1423 121/1425 27.7 % 0.82 [ 0.63, 1.06 ]
Subtotal (95% CI) 1423 1425 27.7 % 0.82 [ 0.63, 1.06 ]
Total events: 99 (Treatment), 121 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.53 (P = 0.13)
4 Incentives
Heil 2008 3/34 8/39 1.2 % 0.43 [ 0.12, 1.49 ]
Higgins 2014 (AvB) 3/38 2/18 0.6 % 0.71 [ 0.13, 3.89 ]
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Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Higgins 2014 (AvC) 4/37 2/18 0.7 % 0.97 [ 0.20, 4.82 ]
Tuten 2012 (AvB) 6/17 5/11 2.2 % 0.78 [ 0.31, 1.93 ]
Tuten 2012 (AvC) 6/30 4/10 1.7 % 0.50 [ 0.18, 1.42 ]
Subtotal (95% CI) 156 96 6.3 % 0.63 [ 0.37, 1.08 ]
Total events: 22 (Treatment), 21 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.06, df = 4 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 1.69 (P = 0.091)
5 Social support
Malchodi 2003 5/36 6/43 1.5 % 1.00 [ 0.33, 2.99 ]
Subtotal (95% CI) 36 43 1.5 % 1.00 [ 0.33, 2.99 ]
Total events: 5 (Treatment), 6 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.01 (P = 0.99)
6 Exercise
Ussher 2015 38/353 44/359 10.8 % 0.88 [ 0.58, 1.32 ]
Subtotal (95% CI) 353 359 10.8 % 0.88 [ 0.58, 1.32 ]
Total events: 38 (Treatment), 44 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.62 (P = 0.53)
Total (95% CI) 4743 4659 100.0 % 0.83 [ 0.72, 0.94 ]
Total events: 355 (Treatment), 429 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 9.69, df = 17 (P = 0.92); I2 =0.0%
Test for overall effect: Z = 2.79 (P = 0.0053)
Test for subgroup differences: Chi2 = 1.20, df = 5 (P = 0.94), I2 =0.0%
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Analysis 20.12. Comparison 20 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 12 Very low birthweight (under 1500 g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 12 Very low birthweight (under 1500 g)
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Sexton 1984 9/463 5/472 29.6 % 1.83 [ 0.62, 5.43 ]
Tappin 2005 6/331 8/400 31.7 % 0.91 [ 0.32, 2.59 ]
Subtotal (95% CI) 794 872 61.3 % 1.27 [ 0.60, 2.71 ]
Total events: 15 (Treatment), 13 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.84, df = 1 (P = 0.36); I2 =0.0%
Test for overall effect: Z = 0.63 (P = 0.53)
2 Feedback
Haddow 1991 8/1343 9/1357 38.7 % 0.90 [ 0.35, 2.32 ]
Subtotal (95% CI) 1343 1357 38.7 % 0.90 [ 0.35, 2.32 ]
Total events: 8 (Treatment), 9 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.22 (P = 0.82)
Total (95% CI) 2137 2229 100.0 % 1.11 [ 0.62, 2.01 ]
Total events: 23 (Treatment), 22 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.16, df = 2 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 0.35 (P = 0.72)
Test for subgroup differences: Chi2 = 0.32, df = 1 (P = 0.57), I2 =0.0%
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Analysis 20.13. Comparison 20 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 13 Preterm birth (under 37 weeks).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 13 Preterm birth (under 37 weeks)
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Ershoff 1989 7/118 7/109 2.9 % 0.92 [ 0.33, 2.55 ]
Hegaard 2003 7/334 10/330 3.3 % 0.69 [ 0.27, 1.80 ]
Panjari 1999 18/339 34/391 8.1 % 0.61 [ 0.35, 1.06 ]
Secker-Walker 1998 9/151 8/157 3.4 % 1.17 [ 0.46, 2.95 ]
Tappin 2000 5/48 4/49 2.0 % 1.28 [ 0.36, 4.47 ]
Tappin 2005 35/342 43/402 11.8 % 0.96 [ 0.63, 1.46 ]
Thornton 1997 14/209 8/209 4.0 % 1.75 [ 0.75, 4.08 ]
Walsh 1997 4/131 3/128 1.4 % 1.30 [ 0.30, 5.71 ]
Subtotal (95% CI) 1672 1775 37.1 % 0.93 [ 0.71, 1.20 ]
Total events: 99 (Treatment), 117 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 5.43, df = 7 (P = 0.61); I2 =0.0%
Test for overall effect: Z = 0.57 (P = 0.57)
2 Health education
Donovan 1977 16/263 17/289 6.1 % 1.03 [ 0.53, 2.00 ]
Hjalmarson 1991 13/421 8/197 3.9 % 0.76 [ 0.32, 1.80 ]
Subtotal (95% CI) 684 486 10.0 % 0.92 [ 0.55, 1.56 ]
Total events: 29 (Treatment), 25 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.31, df = 1 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 0.30 (P = 0.77)
3 Feedback
Cope 2003 6/149 13/114 3.4 % 0.35 [ 0.14, 0.90 ]
Haddow 1991 109/1423 137/1425 20.9 % 0.80 [ 0.63, 1.01 ]
Subtotal (95% CI) 1572 1539 24.3 % 0.60 [ 0.28, 1.29 ]
Total events: 115 (Treatment), 150 (Control)
Heterogeneity: Tau2 = 0.21; Chi2 = 2.72, df = 1 (P = 0.10); I2 =63%
Test for overall effect: Z = 1.31 (P = 0.19)
4 Incentives
Heil 2008 3/34 9/39 2.1 % 0.38 [ 0.11, 1.30 ]
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(. . . Continued)
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Higgins 2014 (AvB) 2/38 2/18 0.9 % 0.47 [ 0.07, 3.10 ]
Higgins 2014 (AvC) 3/37 2/18 1.1 % 0.73 [ 0.13, 3.99 ]
Tappin 2015 40/265 26/273 10.5 % 1.58 [ 1.00, 2.52 ]
Tuten 2012 (AvB) 6/17 3/11 2.3 % 1.29 [ 0.41, 4.13 ]
Tuten 2012 (AvC) 5/30 3/10 2.0 % 0.56 [ 0.16, 1.92 ]
Subtotal (95% CI) 421 369 18.8 % 0.91 [ 0.52, 1.59 ]
Total events: 59 (Treatment), 45 (Control)
Heterogeneity: Tau2 = 0.15; Chi2 = 7.45, df = 5 (P = 0.19); I2 =33%
Test for overall effect: Z = 0.33 (P = 0.74)
5 Exercise
Ussher 2015 35/356 26/348 9.8 % 1.32 [ 0.81, 2.14 ]
Subtotal (95% CI) 356 348 9.8 % 1.32 [ 0.81, 2.14 ]
Total events: 35 (Treatment), 26 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.11 (P = 0.27)
Total (95% CI) 4705 4517 100.0 % 0.93 [ 0.77, 1.11 ]
Total events: 337 (Treatment), 363 (Control)
Heterogeneity: Tau2 = 0.03; Chi2 = 22.00, df = 18 (P = 0.23); I2 =18%
Test for overall effect: Z = 0.81 (P = 0.42)
Test for subgroup differences: Chi2 = 3.17, df = 4 (P = 0.53), I2 =0.0%
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Analysis 20.14. Comparison 20 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 14 Mean birthweight (g).
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 14 Mean birthweight (g)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Counselling
Cook 1995 23 2961 (578) 20 2713 (578) 0.5 % 248.00 [ -98.36, 594.36 ]
Ershoff 1989 118 3366 (578) 109 3309 (578) 2.5 % 57.00 [ -93.50, 207.50 ]
Hegaard 2003 327 3401 (578) 320 3433 (578) 5.4 % -32.00 [ -121.08, 57.08 ]
Panjari 1999 337 3250 (526) 391 3166 (589) 6.0 % 84.00 [ 2.99, 165.01 ]
Polanska 2004 149 3104 (745) 144 3138 (1090) 1.3 % -34.00 [ -248.49, 180.49 ]
Secker-Walker 1994 279 3291 (468) 282 3255 (466) 6.4 % 36.00 [ -41.29, 113.29 ]
Secker-Walker 1998 135 3256 (452) 141 3221 (506) 3.9 % 35.00 [ -78.09, 148.09 ]
Sexton 1984 463 3278 (627) 472 3186 (566) 6.4 % 92.00 [ 15.39, 168.61 ]
Tappin 2000 48 3205 (578) 49 3271 (578) 1.2 % -66.00 [ -296.06, 164.06 ]
Tappin 2005 351 3078 (602) 411 3048 (642) 5.4 % 30.00 [ -58.42, 118.42 ]
Thornton 1997 380 3267 (624) 380 3266 (613) 5.5 % 1.00 [ -86.95, 88.95 ]
Vilches 2009 (AvB) 71 3268.7 (423.97) 18 3140.83 (375.12) 1.5 % 127.87 [ -71.52, 327.26 ]
Vilches 2009 (AvC) 8 3262.5 (521.55) 18 3140.83 (375.12) 0.4 % 121.67 [ -279.14, 522.48 ]
Vilches 2009 (AvD) 9 3398.89 (489.78) 18 3140.83 (375.12) 0.5 % 258.06 [ -105.84, 621.96 ]
Subtotal (95% CI) 2698 2773 46.8 % 42.17 [ 11.79, 72.55 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 11.21, df = 13 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 2.72 (P = 0.0065)
2 Health education
Donovan 1977 263 3172 (567) 289 3184 (510) 5.3 % -12.00 [ -102.29, 78.29 ]
Hjalmarson 1991 422 3430 (578) 198 3359 (578) 4.8 % 71.00 [ -26.58, 168.58 ]
Subtotal (95% CI) 685 487 10.0 % 27.35 [ -53.88, 108.58 ]
Heterogeneity: Tau2 = 1143.82; Chi2 = 1.50, df = 1 (P = 0.22); I2 =33%
Test for overall effect: Z = 0.66 (P = 0.51)
3 Feedback
Cope 2003 78 3260 (578) 80 3080 (578) 1.8 % 180.00 [ -0.27, 360.27 ]
Haddow 1991 1423 3263 (542) 1425 3229 (537) 11.0 % 34.00 [ -5.63, 73.63 ]
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(. . . Continued)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Subtotal (95% CI) 1501 1505 12.8 % 79.43 [ -53.05, 211.91 ]
Heterogeneity: Tau2 = 6224.01; Chi2 = 2.40, df = 1 (P = 0.12); I2 =58%
Test for overall effect: Z = 1.18 (P = 0.24)
4 Incentives
Heil 2008 34 3355 (560) 39 3102 (556) 0.9 % 253.00 [ -3.67, 509.67 ]
Higgins 2014 (AvB) 38 3348.8 (101.9) 18 3188.6 (105) 8.5 % 160.20 [ 101.87, 218.53 ]
Higgins 2014 (AvC) 37 3284.9 (105.8) 18 3188.6 (105) 8.3 % 96.30 [ 37.01, 155.59 ]
Tappin 2015 295 3140 (600) 287 3102 (590) 4.8 % 38.00 [ -58.68, 134.68 ]
Tuten 2012 (AvB) 17 2696 (657) 11 2701 (598) 0.3 % -5.00 [ -476.62, 466.62 ]
Tuten 2012 (AvC) 30 2863 (694) 10 2701 (598) 0.3 % 162.00 [ -284.14, 608.14 ]
Subtotal (95% CI) 451 383 23.2 % 114.01 [ 63.91, 164.11 ]
Heterogeneity: Tau2 = 861.05; Chi2 = 6.51, df = 5 (P = 0.26); I2 =23%
Test for overall effect: Z = 4.46 (P < 0.00001)
5 Social support
Malchodi 2003 67 3100 (481) 75 3072 (614) 1.8 % 28.00 [ -152.48, 208.48 ]
Subtotal (95% CI) 67 75 1.8 % 28.00 [ -152.48, 208.48 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
6 Exercise
Ussher 2015 354 3132.4 (581.7) 359 3146.8 (640) 5.3 % -14.40 [ -104.15, 75.35 ]
Subtotal (95% CI) 354 359 5.3 % -14.40 [ -104.15, 75.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.31 (P = 0.75)
Total (95% CI) 5756 5582 100.0 % 55.60 [ 29.82, 81.38 ]
Heterogeneity: Tau2 = 1156.60; Chi2 = 36.44, df = 25 (P = 0.07); I2 =31%
Test for overall effect: Z = 4.23 (P = 0.000024)
Test for subgroup differences: Chi2 = 8.96, df = 5 (P = 0.11), I2 =44%
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Analysis 20.15. Comparison 20 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 15 Stillbirths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 15 Stillbirths
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Ershoff 1989 2/126 1/116 3.7 % 1.84 [ 0.17, 20.04 ]
Sexton 1984 9/463 11/472 27.5 % 0.83 [ 0.35, 1.99 ]
Tappin 2000 1/48 0/49 2.1 % 3.06 [ 0.13, 73.34 ]
Tappin 2005 2/351 1/411 3.6 % 2.34 [ 0.21, 25.72 ]
Thornton 1997 2/209 1/209 3.7 % 2.00 [ 0.18, 21.89 ]
Subtotal (95% CI) 1197 1257 40.6 % 1.14 [ 0.55, 2.33 ]
Total events: 16 (Treatment), 14 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.58, df = 4 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 0.35 (P = 0.73)
2 Feedback
Haddow 1991 21/1423 17/1425 51.9 % 1.24 [ 0.66, 2.33 ]
Valbo 1994 1/56 0/56 2.1 % 3.00 [ 0.12, 72.10 ]
Subtotal (95% CI) 1479 1481 53.9 % 1.28 [ 0.69, 2.39 ]
Total events: 22 (Treatment), 17 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.29, df = 1 (P = 0.59); I2 =0.0%
Test for overall effect: Z = 0.78 (P = 0.44)
3 Exercise
Ussher 2015 2/377 2/379 5.5 % 1.01 [ 0.14, 7.10 ]
Subtotal (95% CI) 377 379 5.5 % 1.01 [ 0.14, 7.10 ]
Total events: 2 (Treatment), 2 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.01 (P = 1.0)
Total (95% CI) 3053 3117 100.0 % 1.20 [ 0.76, 1.90 ]
Total events: 40 (Treatment), 33 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.96, df = 7 (P = 0.96); I2 =0.0%
Test for overall effect: Z = 0.79 (P = 0.43)
Test for subgroup differences: Chi2 = 0.09, df = 2 (P = 0.95), I2 =0.0%
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Analysis 20.16. Comparison 20 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 16 Perinatal deaths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 16 Perinatal deaths
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Sexton 1984 14/463 13/472 36.2 % 1.10 [ 0.52, 2.31 ]
Valbo 1996 0/52 0/78 Not estimable
Subtotal (95% CI) 515 550 36.2 % 1.10 [ 0.52, 2.31 ]
Total events: 14 (Treatment), 13 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.25 (P = 0.81)
2 Health education
Donovan 1977 4/263 1/289 4.2 % 4.40 [ 0.49, 39.08 ]
Subtotal (95% CI) 263 289 4.2 % 4.40 [ 0.49, 39.08 ]
Total events: 4 (Treatment), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.33 (P = 0.18)
3 Feedback
Haddow 1991 23/1423 22/1425 59.6 % 1.05 [ 0.59, 1.87 ]
Subtotal (95% CI) 1423 1425 59.6 % 1.05 [ 0.59, 1.87 ]
Total events: 23 (Treatment), 22 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.15 (P = 0.88)
Total (95% CI) 2201 2264 100.0 % 1.13 [ 0.72, 1.77 ]
Total events: 41 (Treatment), 36 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.56, df = 2 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 0.54 (P = 0.59)
Test for subgroup differences: Chi2 = 1.56, df = 2 (P = 0.46), I2 =0.0%
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Analysis 20.17. Comparison 20 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 17 Neonatal deaths.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 17 Neonatal deaths
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Sexton 1984 5/454 2/461 32.5 % 2.54 [ 0.50, 13.02 ]
Tappin 2005 1/351 1/411 11.3 % 1.17 [ 0.07, 18.65 ]
Thornton 1997 2/209 1/209 15.2 % 2.00 [ 0.18, 21.89 ]
Subtotal (95% CI) 1014 1081 59.1 % 2.06 [ 0.61, 6.92 ]
Total events: 8 (Treatment), 4 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.22, df = 2 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 1.17 (P = 0.24)
2 Feedback
Haddow 1991 2/1402 5/1408 32.4 % 0.40 [ 0.08, 2.07 ]
Subtotal (95% CI) 1402 1408 32.4 % 0.40 [ 0.08, 2.07 ]
Total events: 2 (Treatment), 5 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.09 (P = 0.28)
3 Exercise
Ussher 2015 0/384 1/391 8.5 % 0.34 [ 0.01, 8.31 ]
Subtotal (95% CI) 384 391 8.5 % 0.34 [ 0.01, 8.31 ]
Total events: 0 (Treatment), 1 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 0.66 (P = 0.51)
Total (95% CI) 2800 2880 100.0 % 1.04 [ 0.41, 2.64 ]
Total events: 10 (Treatment), 10 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 3.21, df = 4 (P = 0.52); I2 =0.0%
Test for overall effect: Z = 0.08 (P = 0.93)
Test for subgroup differences: Chi2 = 2.98, df = 2 (P = 0.23), I2 =33%
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Analysis 20.18. Comparison 20 Interventions for smoking cessation in pregnancy versus control:
subgrouped by main intervention strategy, Outcome 18 NICU admissions.
Review: Psychosocial interventions for supporting women to stop smoking in pregnancy
Comparison: 20 Interventions for smoking cessation in pregnancy versus control: subgrouped by main intervention strategy
Outcome: 18 NICU admissions
Study or subgroup Treatment Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 Counselling
Tappin 2005 32/351 53/411 31.8 % 0.71 [ 0.47, 1.07 ]
Thornton 1997 14/189 12/189 9.9 % 1.17 [ 0.55, 2.46 ]
Subtotal (95% CI) 540 600 41.7 % 0.82 [ 0.52, 1.29 ]
Total events: 46 (Treatment), 65 (Control)
Heterogeneity: Tau2 = 0.03; Chi2 = 1.33, df = 1 (P = 0.25); I2 =25%
Test for overall effect: Z = 0.85 (P = 0.40)
2 Incentives
Heil 2008 4/34 6/39 3.9 % 0.76 [ 0.24, 2.49 ]
Higgins 2014 (AvB) 1/38 2/18 1.0 % 0.24 [ 0.02, 2.44 ]
Higgins 2014 (AvC) 3/37 2/18 1.9 % 0.73 [ 0.13, 3.99 ]
Tuten 2012 (AvB) 9/17 7/11 13.7 % 0.83 [ 0.44, 1.57 ]
Tuten 2012 (AvC) 14/30 6/10 13.6 % 0.78 [ 0.41, 1.47 ]
Subtotal (95% CI) 156 96 34.2 % 0.77 [ 0.51, 1.15 ]
Total events: 31 (Treatment), 23 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 1.09, df = 4 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 1.30 (P = 0.19)
3 Exercise
Ussher 2015 27/352 36/356 24.1 % 0.76 [ 0.47, 1.22 ]
Subtotal (95% CI) 352 356 24.1 % 0.76 [ 0.47, 1.22 ]
Total events: 27 (Treatment), 36 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.14 (P = 0.26)
Total (95% CI) 1048 1052 100.0 % 0.78 [ 0.61, 0.98 ]
Total events: 104 (Treatment), 124 (Control)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.40, df = 7 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 2.11 (P = 0.035)
Test for subgroup differences: Chi2 = 0.07, df = 2 (P = 0.96), I2 =0.0%
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A D D I T I O N A L T A B L E S
Table 1. Primary outcomes from studies which met inclusion criteria, however outcomes were not able to be included in meta-
analysis
Study ID Main findings Rationale for not including outcomes in meta-
analysis
Byrd 1993 There was no statistically significant difference in
smoking status among those who received either type
of media or nurse counselling
Results could not be included as smoking cessation
rates were not reported by intervention group
Graham 1992 There was no decrease in the rate of low birthweight
for women who received the intervention
Smoking outcomes were not reported. Birthweight
outcomes were not included in this review, as aspects
other than the smoking component of the interven-
tion may have had an effect on birthweight, and it
is unclear how many smokers were in each group, or
what proportion quit
Haug 2004 There was no significant difference in smoking
between the intervention (motivational enhance-
ment therapy) and control groups on self-reported
cigarettes per day, mean carbon monoxide or mean
cotinine
Study reports actual outcome data for movement in
stages of change only. Outcome data for smoking
cessation, cigarettes per day, carbon monoxide and
cotinine levels are not reported
Hiett 2000 Significantly more women were able to quit smoking
when enrolled in the intervention
Actual cessation rates not reported (poster abstract
only available)
Hughes 2000 There was no difference between intervention and
control groups in mean delta stage of change or
12-month rate of maintained cessation in pregnant
women (-0.62 vs -0.65)
Data from intervention and control.
Outcomes were combined for intervention and con-
trol groups in pregnant women. Unable to extract
numbers
Kemp 2011 There was no significant difference in the number of
mothers who smoked and quit smoking postpartum
(0-24 months): Intervention group 16/42 (38%) vs
control 11/31 (36%), OR 0.89 (95% CI 0.34 to 2.
34) P = 0.82
Self-reported continuous abstinence 0-24 months
(18 + months postpartum)* Household always
smoke-free (0-24 months) other outcomes not re-
ported by smoking status
Loukopoulou 2012 Urinary nicotine was found to decrease by 190 ng/
mL in the intervention group (from 443 ng/mL to
253 ng/mL, P = 0.05), while urinary cotinine by 140
ng/mL (from 452 ng/mL to 312 ng/mL, P = 0.016)
among intervention group participants. On the con-
trary, among control group participants urinary nico-
tine and cotinine concentrations were not found to
decrease (cotinine: from 561 ng/mL to 737 ng/mL, P
= 0.551 and nicotine: 891 ng/mL to 1040 ng/mL, P
= 0.423). Comparing the 2 metabolites (nicotine vs
cotinine), the latter was found to be associated statis-
tically stronger with smoking cessation. Resuts were
No results paper published yet, just protocol and ab-
stract. No response from 2 emails sent to authors
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Table 1. Primary outcomes from studies which met inclusion criteria, however outcomes were not able to be included in meta-
analysis (Continued)
unable to be included as numbers in each study arm
were not reported
Lowe 2002 At 1 month, 65% of behaviourally-based interven-
tion hospitals agreed to provide materials about
smoking cessation, compared to 3% control hospi-
tals. After 1 year, 43% intervention hospitals still pro-
videdmaterials, compared to 9%of control hospitals.
McNemar’s Chi2 indicates a statistically meaningful
difference between the proportion of intervention
hospitals implementing the program and the propor-
tion of control hospitals implementing the program
(2 1 = 12, P = 0.0005)
Implementationdata only included.No smoking ces-
sation data provided
Manfredi 1999 Compared to controls, smokers attending family
planning, prenatal and well-child clinics, exposed to
the intervention were more likely to have quit (14.
5% vs 7.7%)
It was not possible to separate out which data were
related to pregnant women, as opposed to women
recruited from family planning andwell-child clinics.
Further, it was not clear at what stage in pregnancy
women were recruited and what the postpartum time
points were
Mauriello 2013 Multimodal intervention to address smoking, stress
and diet. However authors state there was insuffi-
cient data to analyse smoking trends so overall assess-
ment of ’risks’ were reported as follows: “Women in
the treatment group reported significantly fewer risks
than those in usual care at 1 month (.85 vs 1.20, OR
.70) and 4 months postpartum (.72 vs .91, OR .81)
.”
Smoking outcomes not reported as authors state
numbers were too small
Olds 2002 Nurse-visited mothers had greater reductions in co-
tinine (259 vs 12.32 ng/mL)
Only mean reduction in cotinine reported.
Oude Wesselink 2014 In the components of this dissemination intervention
which were randomised: “B) In practices that were
assessed with a questionnaire, the provision of coun-
selling improved partially compared to controls; C)
The provision of counselling did not differ between
practices that were visited and their controls.”
No smoking outcomes reported. Only provision of
smoking cessation services by providers
Prapavessis 2014 Smoking cessation outcomes were not reported for
this exercise intervention. Abstract reports “Exercise
(EC) significantly (P < 0.05) reduced cravings ( 2 =
0.46) compared with the passive control (PC), across
time. Nonsignificant, but nevertheless, large effects
were evident favouring the EC over time for TWS
restlessness ( 2 = 0.34), stress ( 2 = 0.24), irritability
( 2 = 0.21), tension ( 2 = 0.15), and depression (
2 = 0.14).”
No smoking cessation outcomes reported. Primary
outcomes were cigarette cravings and tobacco with-
drawal symptoms
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Table 1. Primary outcomes from studies which met inclusion criteria, however outcomes were not able to be included in meta-
analysis (Continued)
Moore 1998 There was no significant difference in LBW were 10.
9% in the intervention group and 14.0% in controls
(RR 0.75, 95%CI 0.55 to 1.03). Preterm births rates
were 9.7 in the intervention group and 11.0 in the
controls (RR 0.87, 95% CI 0.62 to 1.22)
Smoking outcomes were not reported. Birthweight
and pretermbirth outcomeswere not included in this
review, as aspects other than the smoking component
of the intervention may have had an effect on birth-
weight and preterm births
CI: confidence interval
LBW: low birthweight
RR: risk ratio
TWS: tobacco withdrawal symptoms
vs: versus
Table 2. Results of meta-regressions examining factors associated with smoking abstinence in late pregnancy
Explana-
tory
variable
k (n)1 RR2 (95% CI) RoRR3 (95% CI) P value Adjusted R2
%4
I2 % (Res)5 Overall model P
value6
1.2.1aMain intervention strategy 10% 41% 0.113
Coun-
selling (ref-
erence)
51 (18,
267)
1.31 (1.16, 1.48) 1.00
Health ed-
ucation
11 (2142) 1.26 (0.94, 1.69) 0.96 (0.70, 1.32) 0.813
Feedback 6 (859) 1.91 (1.22, 3.00) 1.46 (0.91, 2.33) 0.111
Incentives 12 (1708) 1.84 (1.34, 2.53) 1.41 (1.00, 1.98) 0.051
Social Sup-
port
13 (2488) 1.19 (0.94, 1.50) 0.91 (0.69, 1.18) 0.459
1.
2.1b Focus
of the inter-
vention
5% 40% 0.041
Men-
tal Health
(reference)
10 (2411) 1.07 (0.85, 1.36) 1.00
Smoking
cessation
84 (23,
847)
1.40 (1.27, 1.55) 1.30 (1.01, 1.68) 0.041
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Table 2. Results of meta-regressions examining factors associated with smoking abstinence in late pregnancy (Continued)
1.2.2 Com-
parison type
-9% 44% 0.421
Usual care
(reference)
46 (15,
782)
1.41 (1.22, 1.62) 1.00
Alterna-
tive inter-
vention
6 (500) 1.62 (1.06, 2.48) 1.16 (0.74, 1.81) 0.522
Less inten-
sive
43 (10,
170)
1.27 (1.11, 1.46) 0.91 (0.74, 1.11) 0.329
1.2.3a Intensity: frequency of con-
tact
-1% 42% 0.184
Single con-
tact at time
of routine
pregnancy
care (refer-
ence)
8 (1422) 1.90 (1.24, 2.89) 1.00
Single con-
tact, out-
side of rou-
tine preg-
nancy care
15 (5010) 1.11 (0.86, 1.43) 0.59 (0.36, 0.96) 0.033
2-
5 contacts
at time of
care
8 (2811) 1.73 (1.21, 2.48) 0.91 (0.52, 1.59) 0.742
2-5 con-
tact out-
side rou-
tine care
18 (6338) 1.23 (1.01, 1.51) 0.65 (0.41, 1.04) 0.071
> 5 contact
at time of
care
10 (2081) 1.36 (1.00, 1.84) 0.72 (0.43, 1.20) 0.206
> 5 contact
outside of
care
35 (8596) 1.38 (1.19, 1.60) 0.73 (0.47, 1.14) 0.164
1.2.3b Intensity: duration of con-
tact
-3% 37% 0.155
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Table 2. Results of meta-regressions examining factors associated with smoking abstinence in late pregnancy (Continued)
< 15 mins
(reference)
8 (1422) 1.26 (1.00, 1.58) 1.00
15 - 44
mins
15 (5010) 1.53 (1.22, 1.93) 1.22 (0.88, 1.68) 0.229
45 mins - <
2 hrs
8 (2811) 1.27 (1.05, 1.53) 1.01 (0.75, 1.35) 0.962
2 hrs - < 5
hrs
18 (6338) 1.14 (0.90, 1.44) 0.91 (0.66, 1.26) 0.556
5 hrs - < 8
hrs
10 (2081) 1.27 (0.91, 1.77) 1.01 (0.67, 1.51) 0.967
≥ 8 hrs 35 (8596) 1.74 (1.36, 2.23) 1.38 (0.99, 1.93) 0.058
1.2.4a Use
of self-help
manuals
-1% 39% 0.341
No (refer-
ence)
54 (11,
447)
1.33 (1.16, 1.52) 1.00
Yes 30 (11,
202)
1.48 (1.25, 1.74) 1.11 (0.90, 1.37) 0.341
1.2.4b Use of telephone support -6% 40% 0.869
No (refer-
ence)
75 (21,
928)
1.36 (1.22, 1.51) 1.00
Yes 20 (4524) 1.33 (1.09, 1.62) 0.98 (0.78, 1.23) 0.869
1.2.5
Social eco-
nomic sta-
tus
Not low
(reference)
29 (8417) 1.39 (1.19, 1.63) 1.00 -1% 42% 0.706
Low 63 (16,
962)
1.34 (1.18, 1.52) 0.96 (0.78, 1.18) 0.706
1.2.
6Newly in-
cluded tri-
als
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Table 2. Results of meta-regressions examining factors associated with smoking abstinence in late pregnancy (Continued)
Trials
in previous
review (ref-
erence)
82 (23,
311)
1.36 (1.23, 1.51) 1.00 -4% 42% 0.563
Trials in
update
13 (3141) 1.26 (0.99, 1.61) 0.93 (0.71, 1.21) 0.563
1.2.7aType
of trial
Efficacy
(reference)
62 (16,
765)
1.26 (1.12, 1.41) 1.00 -11% 44% 0.135
Effective-
ness
23 (7956) 1.50 (1.22, 1.83) 1.19 (0.95, 1.50) 0.135
1.2.7b Explicit strategy
for dissemination
No (refer-
ence)
91 (23,
236)
1.36 (1.23, 1.50) 1.00 -2% 43% 0.429
Yes 4 (3216) 1.16 (0.78, 1.72) 0.85 (0.57, 1.28) 0.429
1.2.7cUnit
of ran-
domisation
Individual
(reference)
84 (20,
930)
1.35 (1.22, 1.50) 1.00 -7% 43% 0.741
Clus-
ter: practi-
tioner level
4 (2416) 1.23 (0.88, 1.73) 0.91 (0.64, 1.30) 0.597
Clus-
ter: service
level
7 (3106) 1.51 (1.00, 2.29) 1.12 (0.73, 1.71) 0.598
1.2.8a Risk of bias: se-
quence generation
2% 40% 0.108
Low (refer-
ence)
45 (11,
211)
1.27 (1.10, 1.45) 1.00
High 3 (1544) 2.21 (1.32, 3.71) 1.75 (1.02, 2.98) 0.041
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Table 2. Results of meta-regressions examining factors associated with smoking abstinence in late pregnancy (Continued)
Unclear 47 (13,
697)
1.38 (1.21, 1.57) 1.09 (0.90, 1.32) 0.379
1.2.8b Risk of bias: allo-
cation concealment
6% 40% 0.032
Low (refer-
ence)
20 (6551) 1.26 (1.06, 1.49) 1.00
High 12 (3489) 2.01 (1.46, 2.75) 1.60 (1.12, 2.29) 0.011
Unclear 63 (16,
412)
1.31 (1.17, 1.48) 1.04 (0.85, 1.29) 0.678
1.2.8c Risk of bias: attri-
tion
Low (refer-
ence)
42 (11,
479)
1.32 (1.14, 1.54) 1.00 -6% 43% 0.926
High 14 (4060) 1.39 (1.09, 1.78) 1.05 (0.79, 1.41) 0.714
Unclear 39 (10,
913)
1.36 (1.18, 1.57) 1.03 (0.84, 1.27) 0.787
1.2.8d Risk of bias: selec-
tive reporting
-4% 42% 0.369
Low (refer-
ence)
50 (10,
272)
1.43 (1.24, 1.64) 1.00
High 7 (3230) 1.47 (1.09, 1.99) 1.03 (0.74, 1.44) 0.863
Unclear 38 (12,
950)
1.25 (1.09, 1.44) 0.88 (0.72, 1.07) 0.200
1.2.8e Risk of detection bias: outcome type (biochemically validated versus self-report)
Low risk
[biochem-
ically vali-
dated] (ref-
erence)
67 (17,
890)
1.38 (1.23, 1.55) -1% 40% 0.406
High risk
[self-
report]
23 (5988) 1.37 (1.14, 1.64) 0.99 (0.80, 1.23) 0.928
516Psychosocial interventions for supporting women to stop smoking in pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 2. Results of meta-regressions examining factors associated with smoking abstinence in late pregnancy (Continued)
Unclear
risk
5 (2574) 1.12 (0.84, 1.50)
)
0.81 (0.59, 1.11) 0.185
1.2.8f Risk of bias: blinding participants/person-
nel
Low (refer-
ence)
3 (175) 1.94 (0.86, 4.39) 1.00 2% 43% 0.214
High 66 (20,
764)
1.40 (1.25, 1.56) 0.72 (0.32, 1.64) 0.431
Unclear 26 (5513) 1.18 (0.98, 1.43) 0.61 (0.26, 1.41) 0.244
1.2.8g Risk of bias: blind-
ing outcome assessors
-1% 41% 0.111
Low (refer-
ence)
15 (4915) 1.18 (0.98, 1.43) 1.00
High 0 (0) - - - - -
Unclear 80 (21,
537)
1.41 (1.26, 1.57) 1.19 (0.96, 1.49) 0.111
1.2.8h Risk of bias: base-
line imbalance
Low (refer-
ence)
52 (15,
295)
1.33 (1.18, 1.50) 1.00 3% 40% 0.043
High 13 (4101) 1.09 (0.86, 1.38) 0.82 (0.63, 1.07) 0.138
Unclear 30 (7056) 1.61 (1.32, 1.95) 1.21 (0.96, 1.52) 0.101
1.2.8i Risk of bias: con-
tamination
Low (refer-
ence)
75 (19,
003)
1.36 (1.22, 1.52) 1.00 -4% 43% 0.723
High 14 (4266) 1.24 (0.98, 1.58) 0.91 (0.70, 1.19) 0.490
Unclear 6 (3183) 1.46 (0.99, 2.14) 1.07 (0.71, 1.60) 0.737
1.2.9
Program fi-
delity
69% 23% < 0.001
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Table 2. Results of meta-regressions examining factors associated with smoking abstinence in late pregnancy (Continued)
High
(good) fi-
delity (ref-
erence)
27 (8154) 1.26 (1.10, 1.44) 1.00
Low
(poor)
fidelity
37 (12,
770)
1.12 (0.99, 1.26) 0.89 (0.74, 1.07) 0.206
Unclear fi-
delity
31 (5528) 1.79 (1.52, 2.10) 1.42 (1.15, 1.75) 0.001
Table 3. Cross-tabulation of main intervention strategy by comparison type, for studies reporting the primary outcome
Comparison type Total
Usual care Less intensive inter-
vention
Alternative interven-
tion
Main intervention
strategy
Counselling 32 18 1 51
Health education 5 5 1 11
Feedback 2 4 0 6
Incentives 5 4 4 13
Social support 4 10 0 14
Exercise 0 1 0 1
Other (Diss) 0 1 0 1
Total 48 43 6 97
This includes specific smoking cessation strategies and broader maternal health interventions with a smoking cessation component (C
= 2, F = 1, I = 1, SS = 7)
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Table 4. Intensity of intervention meta-regression analysis - frequency of contact in intervention
Group Mean ES -95% CI +95% CI P N
1 1.89 1.24 2.89 .03 8
2 1.11 0.86 1.43 .41 15
3 1.73 0.21 22.48 .003 8
4 1.23 1.01 1.51 .04 18
5 1.36 1.00 1.84 .05 10
6 1.38 1.19 1.60 .00 37
1 = Single contact during/at time of routine pregnancy care visits (but not ‘usual care’) without strategies to quit; 2 = Single contact,
outside of ‘routine’ pregnancy care with strategies to quit; 3 = 2-5 contacts to sustain motivation to stop smoking provided during/
at time of routine pregnancy care visits; 4 = 2-5 contacts to sustain motivation to stop smoking provided outside of routine care;
5 = > 5 contacts to sustain motivation to stop smoking provided during/at time of routine care visits; 6 = > 5 contacts to sustain
motivation to stop smoking provided outside of routine care. 1 study, Campbell 2006, was treated as missing from this analysis as
the intervention frequency was unclear.
Table 5. Intensity of intervention meta-regression analysis - duration of contact in intervention
Group Mean ES -95% CI +95% CI P N
1 1.25 1.00 1.58 .05 20
2 1.53 1.22 1.93 .00 20
3 1.27 1.05 1.54 .02 20
4 1.14 0.90 1.44 .27 17
5 1.27 0.91 1.77 .16 7
6 1.74 1.35 2.23 .00 12
1 = Less than 15 mins; 2 = 15-44 mins; 3 = 24 mins to less than 2 hours; 4 = 2 hours to less than 5 hours; 5 = 5 hours to less than
8 hours; 6 = 8 or more hours. 1 study, Campbell 2006, was treated as missing from this analysis as the intervention duration was
unclear.
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A P P E N D I C E S
Appendix 1. Other Cochrane Reviews of smoking cessation interventions (May 2016)
Population-wide measures
Healthcare financing systems for increasing the use of tobacco dependence treatment (Reda 2012)*
Impact of entertainment media on adolescent smoking behaviours (Bhaumik 2015)
Impact of tobacco advertising and promotion on increasing adolescent smoking behaviours (Lovato 2011)*
Interventions for preventing tobacco sales to minors (Stead 2005a)*
Interventions for preventing tobacco smoking in public places (Serra 2008)*
Legislative smoking bans for reducing secondhand smoke exposure, smoking prevalence and tobacco consumption (Frazer 2016)
Mass media interventions for preventing smoking in young people (Brinn 2010)*
Mass media interventions for smoking cessation in adults (Bala 2013)
Tobacco packaging design for preventing tobacco uptake (protocol) (McNeill 2016)
Tobacco packaging design for preventing tobacco use (McNeill 2014)
Community interventions
Community interventions for preventing smoking in young people (Carson 2011)*
Community interventions for reducing smoking among adults (Secker-Walker 2002b)*
Community pharmacy personnel interventions for smoking cessation (Sinclair 2004)*
Family and carer smoking control programmes for reducing children’s exposure to environmental tobacco smoke (Baxi 2014)
Family-based programmes for preventing smoking by children and adolescents (Thomas 2015)
Impact of institutional bans on reducing harms and secondhand smoke exposure (Frazer 2016b)
School-based programmes for preventing smoking (Thomas 2013)
School policies for preventing smoking among young people (Coppo 2014)
Workplace interventions for smoking cessation (Cahill 2014)
Individual strategies
Acupuncture and related interventions for smoking cessation (White 2014)
Aversive smoking for smoking cessation (Hajek 2001b)*
Biomedical risk assessment as an aid for smoking cessation (Bize 2012)*
Enhancing partner support to improve smoking cessation (Park 2012)*
Exercise interventions for smoking cessation (Ussher 2014)
Group behaviour therapy programmes for smoking cessation (Stead 2005b)*
Hypnotherapy for smoking cessation (Barnes 2010)*
Incentives for preventing smoking in children and adolescents (Johnston 2012)*
Incentives for smoking cessation (Cahill 2015)
Individual behavioural counselling for smoking cessation (Lancaster 2005b)*
Internet-based interventions for smoking cessation (Civljak 2013)
Interventions for preventing weight gain after smoking cessation (Farley 2012)*
Interventions for smokeless tobacco use cessation (Ebbert 2015)
Interventions for waterpipe smoking cessation (Maziak 2015)
Mobile phone-based interventions for smoking cessation (Whittaker 2016)
Motivational interviewing for smoking cessation (Lindson-Hawley 2015)
Nursing interventions for smoking cessation (Rice 2013)
Physician advice for smoking cessation (Stead 2013a)
Print-based self-help interventions for smoking cessation (Hartmann-Boyce 2014)
Quit and Win contests for smoking cessation (Cahill 2008)*
Reduction versus abrupt cessation in smokers who want to quit (Lindson-Hawley 2012)*
Relapse prevention interventions for smoking cessation (Hajek 2013)
Smoking cessation interventions for pulmonary tuberculosis treatment outcomes (Jeyashree 2016)
Stage-based interventions for smoking cessation (Cahill 2010)*
Telephone counselling for smoking cessation (Stead 2013b)
Training health professionals in smoking cessation (Carson 2012c)
Use of electronic health records to support smoking cessation (Boyle 2014)
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Pharmacotherapies
Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation (Stead 2015)
Antidepressants for smoking cessation (Hughes 2014)
Anxiolytics for smoking cessation (Hughes 2000b)*
Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation (Cahill 2011)*
Clonidine for smoking cessation (Gourlay 2004)*
Combined pharmacotherapy and behavioural interventions for smoking cessation (Stead 2016)
Electronic cigarettes for smoking cessation and reduction (McRobbie 2014)
Interventions to increase adherence to medications for tobacco dependence (Hollands 2015)
Lobeline for smoking cessation (Stead 2012b)*
Mecamylamine (a nicotine antagonist) for smoking cessation (Lancaster 1998)*
Nicobrevin for smoking cessation (Stead 2006a)*
Nicotine receptor partial agonists for smoking cessation (Cahill 2016)
Nicotine replacement therapy for smoking cessation (Stead 2012a)*
Nicotine vaccines for smoking cessation (Hartmann-Boyce 2012)*
Opioid antagonists for smoking cessation (David 2013)
Pharmacological interventions for promoting smoking cessation during pregnancy (Coleman 2015)
Pharmacological interventions for smoking cessation: an overview and network meta-analysis (Cahill 2013)
Silver acetate for smoking cessation (Lancaster 2012)*
Specific population group interventions
Interventions for preoperative smoking cessation (Thomsen 2014)
Interventions for smoking cessation and reduction in individuals with schizophrenia (Tsoi 2013)*
Interventions for smoking cessation in hospitalised patients (Rigotti 2012)*
Interventions for smoking cessation in Indigenous populations (Carson 2012b)*
Interventions for smoking cessation in psychiatric settings (protocol) (Civljak 2015)
Interventions for tobacco cessation in the dental setting (Carr 2012)*
Interventions for tobacco use cessation in people living with HIV and AIDS (protocol) (Pool 2014)
Interventions for tobacco use prevention in Indigenous youth (Carson 2012)*
Psychosocial interventions for smoking cessation in patients with coronary heart disease (Barth 2015)
Smoking cessation advice for people with serious mental illness (Khanna 2016)
Smoking cessation interventions for smokers with current or past depression (van der Meer 2013)
Smoking cessation for chronic obstructive pulmonary disease (van der Meer 2001)*
Smoking cessation for the secondary prevention of coronary heart disease (Critchley 2012)*
Strategies to improve the delivery of tobacco use treatment in primary care practice (protocol) (Papadakis 2015)
Tobacco cessation interventions for young people (Stanton 2013)
Interventions for tobacco use cessation in people in treatment for or recovery from substance abuse (Apollonio 2016)
Interventions for smoking cessation in people diagnosed with lung cancer (Zeng 2015)
Interventions for smoking cessation in psychiatric settings (Protocol) (Civljak 2015)
Other
Interventions for recruiting smokers into cessation programmes (Marcano 2012)*
Interventions to reduce harm from continued tobacco use (Lindson-Hawley 2016)
System change interventions for smoking cessation (Thomas 2013)
*unchanged from previous update
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Appendix 2. Supplementary search strategy
Authors conducted a supplementary search for non-randomised studies, for the background and discussion, in MEDLINE, Embase, PsycLIT,
and CINAHL (June 2008 to 1 March 2013). The strategy below is the one used for Embase.
Embase
1. exp “PARAMETERS CONCERNING THE FETUS, NEWBORN AND PREGNANCY”/ or exp PREGNANCY/ or exp
PREGNANCY OUTCOME/ or exp PREGNANCY COMPLICATION/
2. pregnan*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug man-
ufacturer]
3. exp prenatal diagnosis/ or exp prenatal care/
4. antenatal.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug man-
ufacturer]
5. prenatal.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manu-
facturer]
6. exp PRENATALGROWTH/ or exp PRENATAL STRESS/ or exp PRENATALDISORDER/ or exp PRENATAL PERIOD/ or exp
PRENATAL DIAGNOSIS/ or exp PRENATALMORTALITY/ or exp PRENATAL DEVELOPMENT/ or exp PRENATAL CARE/
or exp PRENATAL SCREENING/ or exp PRENATAL EXPOSURE/
7. 1 or 2 or 3 or 4 or 5 or 6
8. exp maternal care/
9. matern*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manu-
facturer]
10. exp family planning/
11. family planning.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug
manufacturer]
12. exp PRECONCEPTION INJURY/
13. preconcept*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug
manufacturer]
14. 7 or 8 or 9 or 10 or 11 or 12 or 13
15. exp SMOKING/ or exp MATERNAL SMOKING/ or exp CIGARETTE SMOKING/
16. smok*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manu-
facturer]
17. exp TOBACCO/
18. tobacco.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug man-
ufacturer]
19. 15 or 16 or 17 or 18
20. exp SMOKING CESSATION PROGRAM/ or exp SMOKING CESSATION/
21. cessation.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug
manufacturer]
22. exp nicotine gum/ or exp nicotine patch/
23. quit*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manufac-
turer]
24. stop*.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug manu-
facturer]
25. exp NICOTINE PATCH/ or exp NICOTINE VACCINE/ or exp NICOTINE GUM/ or exp NICOTINE REPLACEMENT
THERAPY/
26. 20 or 21 or 22 or 23 or 24 or 25
27. exp NICOTINE/
28. nicotine.mp. [mp=title, abstract, subject headings, heading word, drug trade name, original title, device manufacturer, drug
manufacturer]
29. 19 or 27 or 28
30. 14 and 26 and 29
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Appendix 3. Data extraction summary
Methods
• Type of randomisation and number of study arms.
• Study aims, including whether the smoking cessation component was part of a broader study to improve maternal health, or it
was a dissemination study.
• Country, setting, and year of data collection.
Participants
• Inclusion and exclusion criteria.
• Participation rate of eligible study population, as an indicator of selection bias.
• Description of participants/study population, including pre-pregnancy cigarettes per day, ETS exposure, and partner smoking.
• PROGRESS-PLUS health equity assessment of participant characteristics and subgroup outcomes (including, socio-economic
status, education, ethnicity, social support, place of residence, occupation, young women, or other groups vulnerable to health
inequalities or social exclusion, such as women with mental illness).
• Age range and dropout rate by age.
Interventions
• A description of the control and intervention(s).
• Intervention provider.
• Main intervention strategies (including counselling, health education, feedback, incentives, social support, (as described in ’types
of interventions’).
• Intervention coded as single, multiple, or tailored.
• Comparison group coded as receiving usual care, less intensive intervention, or alternative intervention.
• Description of any structural elements to support the intervention (material resources, provider education, administrative
support or systems, alignment with other campaigns, including national guidelines, and other structural elements).
• Whether the intervention was provided by a dedicated research team (efficacy study) or routine care providers (effectiveness
study).
• Intensity (frequency and duration) rating of intervention as controls (as detailed below).
Frequency of intervention contact (estimate):
0: ‘Usual Care’.
1: Single contact during/at time of routine pregnancy care visits (but not ‘usual care’) without strategies to quit such as information,
education or advice to stop smoking in pregnancy, without any additional support to do so.
2: Single contact, outside of ‘routine’ pregnancy care with strategies to quit such as self-help materials and/or single counselling session
with strategies to quit.
3: Two to five contacts to sustain motivation to stop smoking provided during/at time of routine pregnancy care visits (but not ‘usual
care’).
4: Two to five contacts to sustain motivation to stop smoking provided outside of routine care (such as phone calls, letters, reminders,
peer support, incentives, optional NRT, feedback).
5: Greater than five contacts to sustain motivation to stop smoking provided during/at time of routine pregnancy care visits (but not
‘usual care’).
6: Greater than five contacts to sustain motivation to stop smoking provided outside of routine care (such as phone calls, letters,
reminders, peer support, incentives, optional NRT, feedback).
Total duration of intervention (estimate):
0: ’Usual Care’
1: Less than 15 minutes.
2: Fifteen to 44 minutes.
3: Forty-five minutes to less than two hours.
4: Two hours to less than five hours.
5: Five hours to less than eight hours.
6: More than eight hours.
Outcomes
• Outcome measures including smoking cessation and reduction, birthweight, mode of birth, perinatal outcomes, breastfeeding,
gestation, psychological measures, family functioning.
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• Timing within pregnancy of recruitment and outcome measurement.
• Adverse outcomes reported.
• Any supplementary outcomes not included in tables (e.g. subgroup analysis).
Outcomes included in meta-analysis are marked ’*’ in the Characteristics of included studies.
Notes
• Sample size calculation details.
• Any analysis or cluster adjustment details.
• Other comments.
WH A T ’ S N E W
Last assessed as up-to-date: 13 November 2015.
Date Event Description
14 September 2016 New citation required and conclusions have changed Minor changes to the conclusions include:
1. Interventions which provide social (peer and
partner) support to quit smoking no longer
demonstrated a significant effect.
2. While interventions continued to show that
smoking cessation interventions can significantly
reduce the proportion of infants born low
birthweight (< 2500 g), there was no longer a
significant difference in the proportion of infants
born preterm (< 37 weeks’ gestation).
3. A new trial of ’exercise’ compared to usual care
has been included, but did not demonstrate an effect
that was statistically significant.
These changes are likely due to the inclusion of several
large new trials as well as additional ’less intensive’
study arms from previously included studies
13 November 2015 New search has been performed Search updated and 16 new studies (total n = 102
studies) included as well as 18 additional study arms
from multi-arm trials (n = 120 study arms). However,
by time of publication of this review, new trials were
identified which will be included in future updates
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H I S T O R Y
Protocol first published: Issue 2, 1998
Review first published: Issue 3, 1998
Date Event Description
1 March 2013 New search has been performed For this update the review has been split into two re-
views. Pharmacological interventions (with equal psy-
chosocial support in both arms) are now covered in a
separate review by Coleman 2015. For this update, the
current review now covers all other interventions. The
title has been changed from ’Interventions for pro-
moting smoking cessation during pregnancy’ to ’Psy-
chosocial interventions for supporting women to stop
smoking in pregnancy’
Search updated. We identified 16 new studies meeting
the inclusion criteria
As a result of a change in the inclusion criteria we
excluded 13 studies from the previous version of the
review. We also included four studies that had been
previously excluded (three cluster trials and one ab-
stract report of a trial), as well as nine studies that
did not report any outcomes which could be used in
meta-analyses, and which are reported in a separate
table. We combined two reports of relapse preven-
tion (Ershoff 1995; Secker-Walker 1995) as ‘Associ-
atedReferences’ to the primary papers reporting smok-
ing cessation (Ershoff 1989; Secker-Walker 1994), and
another paper which did not report any usable out-
comes (Solomon 1996) as an ’Associated reference’ to
the primary report (Secker-Walker 1998).
A total of 77 randomised controlled trials, involving
over 29,000 women with relevant outcome data, were
included in the meta-analysis for this review (primary
outcome data for 21,948 women participating in 70
trials and secondary outcome data only for a further
7404 women participating in seven trials). A further
nine trials without outcomes are included but results
summarised in Table 1, making a total of 86 studies
included in this updated review.
1 March 2013 New citation required but conclusions have not
changed
This review has been updated.
The overall conclusions about the effectiveness of
smoking cessation interventions have not changed
17 November 2008 New citation required but conclusions have not
changed
Two new authors have joined the review team for this
substantive update, which includes the addition of risk
of bias assessments for all trials; additional outcomes
tables for smoking reduction, continued cessation in
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(Continued)
the postnatal period, neonatal intensive care unit ad-
missions, psychological impacts of smoking, views of
participants and providers; inclusion of additional data
from previously included cluster-randomised trials;
and risk of bias sensitivity analysis
17 November 2008 New search has been performed Search updated: 7 new randomised controlled tri-
als (Cope 2003; Dornelas 2006; Heil 2008; Higgins
2004; Hotham 2005; Pollak 2007; Rigotti 2006) and
4 cluster randomised controlled trials (Campbell
2006; McLeod 2004; Pbert 2004; Polanska 2004) in-
cluded. Mullen 1991 and Hughes 2000 previously in-
cluded have now been excluded.
3 November 2008 Amended Converted to new review format.
31 July 2003 New search has been performed We have updated the Background and Results sections
(comment on the differences between the interven-
tions when trials are grouped by intervention).
Twenty new trials reporting smoking cessation were
includedwith five additional cluster-randomised trials.
Nine additional trialswere excluded. Six trials provided
new data on fetal and perinatal outcomes.
The overall conclusions about the effectiveness of
smoking cessation interventions did not change. New
analyses grouping interventions by strategies showed
that the pooled cognitive-behavioural interventions
were effective, nicotine replacement therapy was bor-
derline, and trials using ’stages of change’ approaches
or feedback were not effective. The two trials using a
combination of rewards and social support were sig-
nificantly more effective than other strategies. The in-
creased information on perinatal outcomes strength-
ened the findings of a reduction in preterm birth and
low birthweight. One trial reported method of deliv-
ery and one reported breastfeeding: neither showed an
effect of the intervention
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C O N T R I B U T I O N S O F A U T H O R S
For this update:
Catherine Chamberlain (CC) planned and co-ordinated the review update, conducted the supplementary search and retrieved articles,
co-reviewed articles for inclusion, co-extracted data, and drafted the report.
Alison O’Mara-Eves (AO) provided statistical advice, generated tables 4 and 5 and provided feedback on drafts.
Jessie Porter (JP) co-reviewed articles for inclusion, extracted data for new studies and provided feedback on drafts.
Tim Coleman (TC) provided advice on the planning of the review, reviewed the ’Summary of findings’ tables and implications for
practice and research and provided feedback on drafts.
Susan Perlen (SP) provided advice in screening discrepancies, checked reported data, drafted ’agreements and disagreements with other
reviews’ and provided input into drafts.
James Thomas (JT) addressed queries about included studies and data, assisted with data extraction, and provided input into drafts.
Joanne McKenzie (JM) provided statistical advice, developed STATA do-files, conducted analysis and provided input into drafts.
Update (2013)
Catherine Chamberlain (CC) planned and co-ordinated the review update, conducted the supplementary search and retrieved articles,
co-reviewed articles for inclusion, co-extracted data, and drafted the report.
Alison O’Mara-Eves (AO) provided statistical advice, co-extracted and calculated effect size data for studies and assisted drafting the
review.
Sandy Oliver (SO) conceived and planned the review, addressed queries about included studies and data, provided input into drafts.
Jenny Caird (JC) co-extracted data and provided feedback on drafts.
Susan Perlen (SP) co-reviewed articles for inclusion and provided input into drafts.
Sandra Eades (SE) provided input into drafts.
James Thomas (JT) planned and co-ordinated the review update, addressed queries about included studies and data, assisted with data
analysis, and provided input into drafts.
Update (2009)
Judith Lumley (JL) screened retrieved papers against eligibility criteria, provided general advice on the review and contributed to the
final text.
CC co-ordinated and secured funding for the review, undertook searches, retrieved papers, extracted data, wrote to authors for additional
information, entered and analysed data, and wrote the review.
Therese Dowswell (TD) completed ’Risk of bias’ assessments for trials included prior to the 2009 update and revised data abstraction
records into an electronic format. TD revised the ’Risk of bias’ assessments for RevMan 5 format, extracted, entered and analysed data
on reduction and postpartum outcomes, and provided general advice and a methodological perspective on the review.
SO and Laura Oakley (LO) extracted and analysed data on participant and provider views, provided general advice and contributed to
the text of the review.
Lyn Watson (LW) provided expert statistical advice on including cluster trials, extracted data for cluster trials and adjusted the data.
Update (2004)
JL co-ordinated the review update, extracted data, conducted the analyses and interpretation of data and wrote the review.
CC searched and screened search results, retrieved papers, extracted data, wrote to authors for additional information and entered data.
SO and LO provided general advice and contributed to the final text.
Original review (1999)
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JL and SO conceived and designed the original review, and together with Elizabeth Waters (EW) and LO completed data extraction
and wrote the original review. JL carried out the analyses. EW was unable to contribute after 2002. All contributed to the final text.
D E C L A R A T I O N S O F I N T E R E S T
Catherine Chamberlain is receiving an Australian National Health and Medical Research Council Early Career Fellowship (1088813).
She was also awarded an NIHR Cochrane Review Incentive Scheme award (15/81/18) to support the preparation of this updated
review. Catherine Chamberlain is also an author on the Cochrane Review entitled ’Pharmacological Interventions to promote smoking
cessation in pregnancy“ (Coleman 2015).
Alison O’Mara-Eves: none known.
Jessie Porter: none known.
Tim Coleman has, in received awards fromNIHR, HTA and NIHR paid to his institution. These awards have been used to run research
projects. He has also received a single payment from Pierre Fabre Laboratories, France, for speaking at an educational meeting arranged
by Pierre Fabre Laboratories (who are manufacturers of nicotine replacement therapy). PFL are a manufacturer of transdermal nicotine
patches - the content of the presentation was not vetted and no attempt was made to influence the content of the presentation. Tim
Colemans is also an author and contact person for the Cochrane Review entitled ’Pharmacological Interventions to promote smoking
cessation in pregnancy” (Coleman 2015).
Susan M Perlen: none known.
James Thomas: none known.
Joanne E McKenzie: none known.
S O U R C E S O F S U P P O R T
Internal sources
• EPPI-Centre, Social Science Research Unit, Institute of Education, University of London, London, UK.
External sources
• National Institute for Health Research, UK.
Cochrane Review Incentive Scheme Award 15/81/18
• National Health and Medical Research Council Early Career Fellowship (1088813), Australia.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
This review forms one part of the evidence for the published protocol ’Interventions to promote smoking cessation in pregnancy’ (Lumley
1998). The original review was split into two separate reviews: Pharmacological interventions (to address concerns over safety of
pharmacological interventions in greater detail - Coleman 2015) and this review, which includes the majority of studies using a wide
range of psychosocial interventions to support women to stop smoking during pregnancy.
The Lumley 1998 protocol was developed in consultation with pregnant women, with the aim of addressing issues that were identified
as relevant to women. We have endeavoured to continue this principle of addressing current issues that are relevant in each update
of the review. Prior to each update, we have considered the recommendations of peer reviewers from the previous updates, and other
relevant information, as outlined in Why it is important to do this review, to identify factors for analysis ’a priori’.
While the review has evolved in each update, the major differences between the original Lumley 1998 protocol and this 2016 update
are listed below.
Background
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• Development of a logic model, in line with recent ’PRISM-Equity’ reporting guidelines.
Objectives
• Including assessment of whether interventions are effective in preventing relapse among women who have spontaneously quit
smoking in early pregnancy.
• Including assessment of cost-effectiveness.
• Including assessment of any reporting of ’other adverse effects’ by trial authors.
• ’Equity’ analysis of the effect of interventions among populations categorised as ’low socio-economic status (SES)’, ethnic, or
other vulnerable category, in line with recent PRISM-Equity reporting guidelines (separate protocol is available on request).
• Including assessment of whether interventions shown to be effective under trial conditions (efficacy studies) are effective if
implemented in routine care by pregnancy care providers (effectiveness studies).
• Assessment for additional ’Risk of bias’ categories, including: whether baseline characteristics were equal (as sequence generation
’unclear’ in many studies); whether the intervention was implemented as planned; and ’contamination’ or exposure of the control
group to the intervention.
• Assessment of whether studies included in this recent update are as effective as studies included in previous versions of this review.
Types of studies
• Quasi-randomised studies have been excluded (e.g. allocation by clinic day or week), unless it was considered there was a
relatively low risk of interference with the sequence generation (i.e. odd or even maternal date of birth or medical record number).
Types of interventions
• Pharmacotherapy interventions separated into another review, though sensitivity analyses has been conducted for psychosocial
interventions where pharmacological agents are optional for participants.
• Provision of Information about harmful effects of smoking and advice to stop smoking were combined into one ’main
intervention strategy’ of ’health education’.
• Provision of feedback of smoking status (e.g. carbon monoxide), effects of smoking on fetus (e.g. fetal movements), and positive
information about the fetus (e.g. ultrasound’) were combined into one main intervention strategy of ’feedback’.
• Rather than as separate interventions, provision of self-help manuals or telephone support was included in the main intervention
strategy of ’health education’ (if no personal contact) or ’counselling’ (if provided in conjunction with personal contact), with
sensitivity analyses reporting the effects of these interventions as a separate comparison (in text under each of the main strategies), and
as subgroup analyses for the whole dataset.
• Categorisation of primary outcomes (quitting in late pregnancy) and secondary outcomes (all other outcomes).
• Interventions were categorised as: ’single, multiple or tailored’ for subgroup analyses within each comparison, as many
interventions included more than one component/strategy.
• The ’intensity’ (frequency and duration) of each intervention has been coded.
• ’Stages of change’-based interventions have not been assessed separately.
• Exercise was included as an intervention.
Types of comparisons
• Comparisons have been categorised as ’usual care, less intensive or alternative’
Types of outcomes
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• Smoking abstinence in late pregnancy has been reported separately for women who had quit spontaneously in early pregnancy
(relapse prevention).
• Preterm births < 32 and < 30 weeks were not reported as often excluded from trials.
• Caesarean section rates, cost-effectiveness, and adverse events have been included in narrative synthesis.
’Risk of bias’ assessments
• Whether the baseline characteristics were equal, whether implementation difficulties were reported, and whether the control
group was exposed to the intervention (contamination) have been added to the ’Risk of bias’ assessments.
• Meta-regression analyses incorporated.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Pregnancy; Counseling; Health Education; Infant, Low Birth Weight; Motivation; Obstetric Labor, Premature; Patient Education as
Topic; Pregnancy Outcome; Randomized Controlled Trials as Topic; Smoking Cessation [∗methods]; Social Support
MeSH check words
Female; Humans; Infant, Newborn
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